Citrus Sinensis ID: 001700
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1025 | 2.2.26 [Sep-21-2011] | |||||||
| Q0WR59 | 1048 | Probable inactive recepto | no | no | 0.965 | 0.944 | 0.432 | 0.0 | |
| C0LGQ9 | 1037 | Probable LRR receptor-lik | no | no | 0.933 | 0.922 | 0.397 | 0.0 | |
| Q9SCT4 | 836 | Probably inactive leucine | no | no | 0.304 | 0.373 | 0.404 | 9e-56 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.288 | 0.377 | 0.411 | 6e-54 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.537 | 0.851 | 0.281 | 5e-52 | |
| Q94C77 | 757 | Receptor protein kinase-l | no | no | 0.598 | 0.809 | 0.284 | 2e-51 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.477 | 0.443 | 0.319 | 4e-47 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.481 | 0.472 | 0.317 | 2e-46 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.262 | 0.408 | 0.365 | 2e-44 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.483 | 0.455 | 0.310 | 4e-44 |
| >sp|Q0WR59|Y5020_ARATH Probable inactive receptor kinase At5g10020 OS=Arabidopsis thaliana GN=At5g10020 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/1042 (43%), Positives = 632/1042 (60%), Gaps = 52/1042 (4%)
Query: 13 VNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSS-DGCPRNWFGITC--TNGYVTS 69
NA+ +++ +LL+ +KGI + S Q I DT SL+ CP +W GI+C G + +
Sbjct: 19 ANAVTETELRSLLEFRKGIRDETSHQRISWSDTSSLTDPSTCPNDWPGISCDPETGSIIA 78
Query: 70 IMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNIT-DIGSIQSLEFLDLSHNLFHGL 128
I L+ GL G F T+ GL L N+S+S N G + +G I SL+ LDLS N F+G
Sbjct: 79 INLDRRGLSGELKFSTLSGLTRLRNLSLSGNSFSGRVVPSLGGISSLQHLDLSDNGFYGP 138
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
IP I L +L LN+SSN FEG FPSGF L +L+ LDL N GD+ + ++L +V
Sbjct: 139 IPGRISELWSLNHLNLSSNKFEGGFPSGFRNLQQLRSLDLHKNEIWGDVGEIFTELKNVE 198
Query: 189 HVDLSNNQFSGSLDLGLGDSSFIS-SIQYLNISENSLVGELFPHDGMPYFDNLEVFDASN 247
VDLS N+F+G L L + + S IS ++++LN+S N+L G+ F + + F NLE+ D N
Sbjct: 199 FVDLSCNRFNGGLSLPMENISSISNTLRHLNLSHNALNGKFFSEESIGSFKNLEIVDLEN 258
Query: 248 NHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSIT 307
N + G +P F SLRIL+L N+L G +P LLQ SS+ L ELDLS N G + I
Sbjct: 259 NQINGELPHFGSQPSLRILKLARNELFGLVPQELLQ-SSIPLLELDLSRNGFTGSISEIN 317
Query: 308 SATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLT 367
S+TL +NLSSN LSG LP+ C+++DLS N SGD+S +Q W + + LSSN L+
Sbjct: 318 SSTLTMLNLSSNGLSGDLPSSFKSCSVIDLSGNTFSGDVSVVQKWEATPDVLDLSSNNLS 377
Query: 368 GMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTK 427
G +PN TS F RL+ + NNS+ G LP++ G + VIDLS N +GF+ SFFT
Sbjct: 378 GSLPNFTSAFSRLSVLSIRNNSVSGSLPSLWGD-SQFSVIDLSSNKFSGFIPVSFFTFAS 436
Query: 428 LTDLNLSGNNFSGPLPLQ-------------------EIQNNPSTGSTQN-----LSLTS 463
L LNLS NN GP+P + ++ N TG +
Sbjct: 437 LRSLNLSRNNLEGPIPFRGSRASELLVLNSYPQMELLDLSTNSLTGMLPGDIGTMEKIKV 496
Query: 464 LDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPE 523
L+LA N LSG L ++K L++L+LSNN F+G IP+ LP+ + FNVS+N+LSG++PE
Sbjct: 497 LNLANNKLSGELPSDLNKLSGLLFLDLSNNTFKGQIPNKLPSQMVGFNVSYNDLSGIIPE 556
Query: 524 NLRNFPDSAFHPGNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVA 583
+LR++P S+F+PGNS L+ P DL+L G +H K + +IA+IV V G ++
Sbjct: 557 DLRSYPPSSFYPGNSKLSLPGRIPADSSGDLSLPGKKHHSKLSIRIAIIVASV-GAAIMI 615
Query: 584 LLCMLIYFRA-LWQRHGRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDP 642
L + Y R L HGR+ F + G SS + + SS +F D
Sbjct: 616 LFVLFAYHRTQLKDFHGRNRFTDQATTRDTKFGRSSRPSLFNFSSNVEQQSSSLSFSNDH 675
Query: 643 LPSS--------PMESAYDAGETSSVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQS 694
L ++ P A + + + + P L D+ ++ SS S
Sbjct: 676 LLTANSRSLSGIPGCEAEISEQGAPATSAPTNLL-------DDYPAASGRKSSSGGSPLS 728
Query: 695 KNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLD 754
+ RF+ +L+ SP++LAG+L DVSL TAEELS APAEV+GRS HGTLYKATLD
Sbjct: 729 SSPRFSDQPVMLDVYSPDRLAGELFFLDVSLKLTAEELSRAPAEVLGRSSHGTLYKATLD 788
Query: 755 SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814
+G +L VK LR G+ + KK+FARE KK+G++KHPN+V L+ YYWGP+E E+L++S+Y+
Sbjct: 789 NGHMLTVKWLRVGLVRHKKDFAREAKKIGSLKHPNIVPLRAYYWGPREQERLLLSDYLRG 848
Query: 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874
+SLA++L ET PR+ P+S +RL+VAV+VA+CL YLH +RA+PHGNLK TNI+L +P
Sbjct: 849 ESLAMHLYETTPRRYSPMSFSQRLKVAVEVAQCLLYLH-DRAMPHGNLKPTNIILSSPDN 907
Query: 875 NAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELL 934
+TDY +HR++T +G A+Q+LN ALGY PE +S SKP P+LKSDVYAFG+IL+ELL
Sbjct: 908 TVRITDYCVHRLMTPSGVAEQILNMSALGYSAPELSSASKPIPTLKSDVYAFGVILMELL 967
Query: 935 TGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVAL 994
T +S+G+I+ G VDLTDWVRL E R +C DR I G E+ + + D L VA+
Sbjct: 968 TRRSAGDIISGQTGAVDLTDWVRLCDQEGRRMDCIDRDIAGG---EEFSKGMEDALAVAI 1024
Query: 995 RCILPASERPDMMSVFEELSTI 1016
RCIL +ERP++ V + L++I
Sbjct: 1025 RCILSVNERPNIRQVLDHLTSI 1046
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGQ9|Y4294_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20940 OS=Arabidopsis thaliana GN=At4g20940 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 686 bits (1769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/1078 (39%), Positives = 619/1078 (57%), Gaps = 121/1078 (11%)
Query: 16 LGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDM 75
L D ALL+ KKGI DP+G +++SW+ +S+ +GCP +W GI C G V ++L+++
Sbjct: 4 LPSQDIMALLEFKKGIKHDPTGFVLNSWNDESIDFNGCPSSWNGIVCNGGNVAGVVLDNL 63
Query: 76 GLVGNFSFPTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGI- 133
GL + F L L +S+SNN L G + D+GS +SL+FLDLS NLF +P I
Sbjct: 64 GLTADADFSLFSNLTKLVKLSMSNNSLSGVLPNDLGSFKSLQFLDLSDNLFSSSLPKEIG 123
Query: 134 --VSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVD 191
VSL+NL L S N+F G P GGL L+ LD+ +N G + L++L +++++
Sbjct: 124 RSVSLRNLSL---SGNNFSGEIPESMGGLISLQSLDMSSNSLSGPLPKSLTRLNDLLYLN 180
Query: 192 LSNNQFSGSLDLG---------------------------LGDSSFI------------- 211
LS+N F+G + G L ++S++
Sbjct: 181 LSSNGFTGKMPRGFELISSLEVLDLHGNSIDGNLDGEFFLLTNASYVDISGNRLVTTSGK 240
Query: 212 ------SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRI 265
SI++LN+S N L G L G F NL+V D S N L G +P FN+V+ L +
Sbjct: 241 LLPGVSESIKHLNLSHNQLEGSL--TSGFQLFQNLKVLDLSYNMLSGELPGFNYVYDLEV 298
Query: 266 LRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSL 325
L+L +N+ SGSLP LL+ S++L+ LDLS N L GPV SI S TL ++LSSN L+G L
Sbjct: 299 LKLSNNRFSGSLPNNLLKGDSLLLTTLDLSGNNLSGPVSSIMSTTLHTLDLSSNSLTGEL 358
Query: 326 PARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV 385
P G C ++DLSNN+ G+L+R W N +E + LS N TG P+ T Q LR +
Sbjct: 359 PLLTGGCVLLDLSNNQFEGNLTRWSKWEN-IEYLDLSQNHFTGSFPDATPQLLRANHLNL 417
Query: 386 SNNSLEGDLPAVLGT-YPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSG---P 441
S N L G LP + T YP+L+V+D+S N L G + + + L +++L N +G P
Sbjct: 418 SYNKLTGSLPERIPTHYPKLRVLDISSNSLEGPIPGALLSMPTLEEIHLQNNGMTGNIGP 477
Query: 442 LP-------LQEIQNN------PST-GSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVY 487
LP L ++ +N P GS NL + L+LA N+LSG L ++ +L
Sbjct: 478 LPSSGSRIRLLDLSHNRFDGDLPGVFGSLTNLQV--LNLAANNLSGSLPSSMNDIVSLSS 535
Query: 488 LNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSPS 547
L++S N F G +P L + + FNVS+N+LSG VPENL+NFP +F+PGNS L P
Sbjct: 536 LDVSQNHFTGPLPSNLSSNIMAFNVSYNDLSGTVPENLKNFPPPSFYPGNSKLVLPAGSP 595
Query: 548 QQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH------GRD 601
+ + N + K+ +IV + ++ L+ +L++ +R G++
Sbjct: 596 GSSASEASKNKSTNKL---VKVVIIVSCAVALIILILVAILLFCICKSRRREERSITGKE 652
Query: 602 SFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETSSVV 661
+ +R + S G +S V + S + P + + + +TS++
Sbjct: 653 TNRRAQTIPSGSGGGMVVSAEDLVASRKGSSSEILS----PDEKLAVATGFSPSKTSNLS 708
Query: 662 TKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLF 721
P DS D+ L+ L+ SP++L G+LH
Sbjct: 709 WSPGS---GDSFPADQQLAR------------------------LDVRSPDRLVGELHFL 741
Query: 722 DVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKK 781
D S+ T EELS APAEV+GRS HGT Y+ATLD+G L VK LREG+AK +KEFA+EVKK
Sbjct: 742 DDSIKLTPEELSRAPAEVLGRSSHGTSYRATLDNGVFLTVKWLREGVAKQRKEFAKEVKK 801
Query: 782 LGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVA 841
NI+HPN+V+L+GYYWGP +HEKL++S+YI+ SLA +L + RK PPL+ +RL++A
Sbjct: 802 FSNIRHPNVVTLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLAWTQRLKIA 861
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901
VDVAR LNYLH +RA+PHGNLK+TNILL+ +NA + DY LHR++T AGT +Q+L+AG
Sbjct: 862 VDVARGLNYLHFDRAVPHGNLKATNILLDGAELNARVADYCLHRLMTQAGTVEQILDAGI 921
Query: 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961
LGYR PE A++ KP PS KSDVYAFG+ILLE+LTG+ +G+++ + VDLTDWVRL
Sbjct: 922 LGYRAPELAASRKPLPSFKSDVYAFGVILLEILTGRCAGDVITGEQEGVDLTDWVRLRVA 981
Query: 962 ENRSGECFDRLIMDGHDMEQPP---RILSDMLQVALRCILPASERPDMMSVFEELSTI 1016
E R ECFD ++ +M P + + ++L +ALRCI SERP + +++E+LS+I
Sbjct: 982 EGRGAECFDSVLT--QEMGSDPVTEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 9e-56, Method: Compositional matrix adjust.
Identities = 132/326 (40%), Positives = 194/326 (59%), Gaps = 14/326 (4%)
Query: 693 QSKNSRFTKNSDVLNACSPE-KLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKA 751
+ K S T ++ V S ++ G L FD +FTA++L A AE++G+S +GT YKA
Sbjct: 495 KDKTSEKTVSAGVAGTASAGGEMGGKLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKA 554
Query: 752 TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811
TL+ G+ +AVKRLRE KG KEF EV LG I+H NL++L+ YY GPK EKL++ +Y
Sbjct: 555 TLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLALRAYYLGPKG-EKLLVFDY 613
Query: 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA 871
++ SL+ +L P L P + R+++A ++R L +LH+ + H NL ++NILL+
Sbjct: 614 MSKGSLSAFLHARGPETLIPW--ETRMKIAKGISRGLAHLHSNENMIHENLTASNILLDE 671
Query: 872 PTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILL 931
T NA + DY L R++T+A + + AG LGYR PEF+ S K+DVY+ GII+L
Sbjct: 672 QT-NAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKN--ASAKTDVYSLGIIIL 728
Query: 932 ELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQ 991
ELLTGKS GE +DL WV + E + E FD +M + + L + L+
Sbjct: 729 ELLTGKSPGEPT----NGMDLPQWVASIVKEEWTNEVFDLELM--RETQSVGDELLNTLK 782
Query: 992 VALRCILPA-SERPDMMSVFEELSTI 1016
+AL C+ P+ + RP+ V E+L I
Sbjct: 783 LALHCVDPSPAARPEANQVVEQLEEI 808
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 127/309 (41%), Positives = 185/309 (59%), Gaps = 13/309 (4%)
Query: 715 AGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKE 774
G L FD + FTA++L A AE++G+S +GT+YKATL+ GS +AVKRLRE I K +KE
Sbjct: 469 GGKLVHFDGPMAFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKSQKE 528
Query: 775 FAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSI 834
F E+ LG I+HPNL++L+ YY GPK EKLV+ +Y++ SLA +L P ++
Sbjct: 529 FENEINVLGRIRHPNLLALRAYYLGPK-GEKLVVFDYMSRGSLATFLHARGPDV--HINW 585
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894
R+ + +AR L YLH I HGNL S+N+LL+ + A ++DY L R++T+A +
Sbjct: 586 PTRMSLIKGMARGLFYLHTHANIIHGNLTSSNVLLDE-NITAKISDYGLSRLMTAAAGSS 644
Query: 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD 954
+ AGALGYR PE + K + K+DVY+ G+I+LELLTGKS E + VDL
Sbjct: 645 VIATAGALGYRAPELSKLKK--ANTKTDVYSLGVIILELLTGKSPSEAL----NGVDLPQ 698
Query: 955 WVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCI-LPASERPDMMSVFEEL 1013
WV E + E FD +++ D+ + + L++AL C+ S RP+ V +L
Sbjct: 699 WVATAVKEEWTNEVFDLELLN--DVNTMGDEILNTLKLALHCVDATPSTRPEAQQVMTQL 756
Query: 1014 STIVLEKDS 1022
I E+ +
Sbjct: 757 GEIRPEETT 765
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 188/667 (28%), Positives = 316/667 (47%), Gaps = 116/667 (17%)
Query: 379 RLTSFKVSNNSLEGDLP-AVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNN 437
R+T+ ++ +L G +P + G +L+ + L LN L G L + + L L L GN
Sbjct: 71 RVTALRLPGETLSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNR 130
Query: 438 FSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEG 497
FSG +P E+ + S +L L+LA N SG + G L L L NNK G
Sbjct: 131 FSGEIP--EVLFSLS-------NLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSG 181
Query: 498 SIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLL-----------TFPNSP 546
S+ D + L +FNVS N L+G +P++L+ F +F G SL T P+ P
Sbjct: 182 SLLDLDLS-LDQFNVSNNLLNGSIPKSLQKFDSDSF-VGTSLCGKPLVVCSNEGTVPSQP 239
Query: 547 -SQQDVPDLTLRGHGNHMKPATK-------IALIVGLVCGVTMVALLCMLIYFRALWQRH 598
S ++P G+ K K +++G V G++++ ++ M++
Sbjct: 240 ISVGNIPGTV---EGSEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVL--------- 287
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
F++ G ++ + L++ H+ +P ++A +A E
Sbjct: 288 ----FRKKGNERTRA-----------------IDLATIKHHEVEIPGE--KAAVEAPENR 324
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
S V + Y P +V+ E +N+ +KL +
Sbjct: 325 SYVNE----YSPSAVKAVE----------------------------VNSSGMKKL---V 349
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE 778
+ + +F E+L A AEV+G+ GT YKA LD+ +++AVKRL++ + +EF +
Sbjct: 350 FFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKD-VTMADREFKEK 408
Query: 779 VKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL 838
++ +G + H NLV L+ YY+ EKL++ +++ SL+ L PPL+ + R
Sbjct: 409 IEVVGAMDHENLVPLRAYYYSG--DEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRS 466
Query: 839 RVAVDVARCLNYLHNERAI-PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL 897
+A+ AR L+YLH++ + HGN+KS+NILL + +A ++D+ L ++++++ T
Sbjct: 467 GIALGAARGLDYLHSQDPLSSHGNVKSSNILL-TNSHDARVSDFGLAQLVSASSTTPN-- 523
Query: 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVR 957
A GYR PE + S K+DVY+FG++LLELLTGK+ V + G +DL WV
Sbjct: 524 --RATGYRAPEVTDPRR--VSQKADVYSFGVVLLELLTGKAPSNSVMNEEG-MDLARWVH 578
Query: 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
+A E E FD +M + +++MLQ+ + C + PD V E+ +
Sbjct: 579 SVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDC---TEQHPDKRPVMVEVVRRI 635
Query: 1018 LEKDSQG 1024
E G
Sbjct: 636 QELRQSG 642
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 221/778 (28%), Positives = 338/778 (43%), Gaps = 165/778 (21%)
Query: 342 LSGDLSRMQNWGNYVEDIHLSSNFLTGMV------PNQTSQFLRLTSFKVSNNSLEGDLP 395
L+ LS ++NW NY + + TG+ PN T R+TS + N L G +
Sbjct: 42 LTDPLSVLRNW-NYDD---ATPCLWTGVTCTELGKPN-TPDMFRVTSLVLPNKHLLGSIT 96
Query: 396 AVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGS 455
L + P L+++DLS N NG L S F +T+L ++L NN SG LP S S
Sbjct: 97 PDLFSIPYLRILDLSSNFFNGSLPDSVFNATELQSISLGSNNLSGDLP-------KSVNS 149
Query: 456 TQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGL------------ 503
NL L L+L+ N+ +G + IS NL ++LS N F G IP G
Sbjct: 150 VTNLQL--LNLSANAFTGEIPLNISLLKNLTVVSLSKNTFSGDIPSGFEAAQILDLSSNL 207
Query: 504 -----------------------------PNGLKEF------NVSFNNLSGVVPENLR-- 526
PN ++F ++SFNNL+G +P +L
Sbjct: 208 LNGSLPKDLGGKSLHYLNLSHNKVLGEISPNFAEKFPANATVDLSFNNLTGPIPSSLSLL 267
Query: 527 NFPDSAFHPGN---------------SLLTFPNSPSQQDVPDLTLRGHG----------- 560
N +F GN S L+ P + S+ P + ++
Sbjct: 268 NQKAESFS-GNQELCGKPLKILCSIPSTLSNPPNISETTSPAIAVKPRSTAPINPLTEKP 326
Query: 561 -----NHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRHGRDSFKRDGEQKAFSEG 615
+ +KP+T A+ V + G+ + LL + +Y Q R +R E FS
Sbjct: 327 NQTGKSKLKPSTIAAITVADIVGLAFIGLLVLYVY-----QVRKR---RRYPESSKFSFF 378
Query: 616 SSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETSSVVTKPKELYHPDSVRK 675
L + KK PS + T +P SP E+ G S ++ +
Sbjct: 379 KFCLEKNEA--KKSKPSTTEVT-----VPESP-EAKTTCG--SCIILTGGRYDETSTSES 428
Query: 676 DEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHA 735
D V + ++ Q K S T+ L D + L A
Sbjct: 429 DVENQQTVQAFTRTDGGQLKQSSQTQ----------------LVTVDGETRLDLDTLLKA 472
Query: 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLR-EGIAKGK-KEFAREVKKLGNIKHPNLVSL 793
A ++G + G +YKA L++G+ AV+R+ E A K KEF REV+ + ++HPNLV +
Sbjct: 473 SAYILGTTGTGIVYKAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRI 532
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP--------PLSIDERLRVAVDVA 845
+G+ WG + EKL+IS+Y+ SL + T PL+ + RL++A +A
Sbjct: 533 RGFCWG--DDEKLLISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMA 590
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR 905
R L+Y+ NE+ HGN+K NILL A ++TD L R++T A + + Y+
Sbjct: 591 RGLSYI-NEKKQVHGNIKPNNILLNAEN-EPIITDLGLDRLMTPARESHTTGPTSSSPYQ 648
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965
PPE++++ KP P K DVY+FG+ILLELLT K + VD + ++ A EN
Sbjct: 649 PPEWSTSLKPNP--KWDVYSFGVILLELLTSK----VFSVDHDIDQFSNLSDSAAEENGR 702
Query: 966 GECFDRLIMDG---HDMEQPPRILSDMLQVALRCI--LPASERPDMMSVFEELSTIVL 1018
F RLI DG D+ + ++ + C+ LP +RP M + + L I +
Sbjct: 703 ---FLRLI-DGAIRSDVARHEDAAMACFRLGIECVSSLP-QKRPSMKELVQVLEKICV 755
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 173/542 (31%), Positives = 286/542 (52%), Gaps = 53/542 (9%)
Query: 95 VSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
+++ NQL+G I ++G +QSLEFL L N +G IP I +L + ++ S N+ G
Sbjct: 270 LALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 154 PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISS 213
P G + L+ L L N+ G I LS L ++ +DLS N +G + LG ++
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF---QYLRG 386
Query: 214 IQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFS-LRILRLGSNQ 272
+ L + +NSL G + P G ++ +L V D S+NHL G IPS+ + S + IL LG+N
Sbjct: 387 LFMLQLFQNSLSGTIPPKLG--WYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 273 LSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSS-----NKLSGSLPA 327
LSG++P + + L +L L+ N L VG S K+VN+++ N+ GS+P
Sbjct: 445 LSGNIPTGI--TTCKTLVQLRLARNNL---VGRFPSNLCKQVNVTAIELGQNRFRGSIPR 499
Query: 328 RVGHCTIVD---LSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFK 384
VG+C+ + L++N +G+L R + + +++SSN LTG VP++ L
Sbjct: 500 EVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLD 559
Query: 385 VSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPL 444
+ N+ G LP+ +G+ +L+++ LS N+L+G + + ++LT+L + GN F+G +P
Sbjct: 560 MCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPR 619
Query: 445 QEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLP 504
+ GS L + +L+L+YN L+G + P +S L +L L+NN G IP
Sbjct: 620 E-------LGSLTGLQI-ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFA 671
Query: 505 N--GLKEFNVSFNNLSGVVPENLRNFPDSAF--------HPGNSLL-TFPNSPSQQDVPD 553
N L +N S+N+L+G +P LRN S+F P N + T P +PSQ
Sbjct: 672 NLSSLLGYNFSYNSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQST--- 727
Query: 554 LTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRHGRD--SFKRDGEQKA 611
G M+ + IA+ ++ GV+++ L+ +++Y L +R R S +DG+
Sbjct: 728 ----GKPGGMRSSKIIAITAAVIGGVSLM-LIALIVY---LMRRPVRTVASSAQDGQPSE 779
Query: 612 FS 613
S
Sbjct: 780 MS 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 175/551 (31%), Positives = 260/551 (47%), Gaps = 57/551 (10%)
Query: 23 ALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFS 82
ALL+ K S + SW + SS C +W+G+ C+ G + + L + G+ G F
Sbjct: 53 ALLKWKSTFTNQTSSSKLSSWVNPNTSS-FC-TSWYGVACSLGSIIRLNLTNTGIEGTFE 110
Query: 83 FPTIIGLKMLCNVSVSNNQLMGNITDI-GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
L L V +S N+ G I+ + G LE+ DLS N G IP + L NL
Sbjct: 111 DFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDT 170
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
L++ N G+ PS G L K+ + + N G I L +V++ L N SGS+
Sbjct: 171 LHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSI 230
Query: 202 DLGLGD-------------------SSF--ISSIQYLNISENSLVGELFPHDG-MPYFDN 239
+G+ SSF + ++ LN+ EN L GE+ P G M D
Sbjct: 231 PSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDT 290
Query: 240 LEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
L + N L G IPS + +L +L L NQL+GS+P L + SM+ +L++S N+
Sbjct: 291 LSLH---TNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMI--DLEISENK 345
Query: 299 LEGPV----GSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQN 351
L GPV G +T+ L+ + L N+LSG +P + + T ++ L N +G L
Sbjct: 346 LTGPVPDSFGKLTA--LEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTIC 403
Query: 352 WGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSL 411
G +E++ L N G VP L + NS GD+ G YP L IDLS
Sbjct: 404 RGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSN 463
Query: 412 NHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQ----------EIQNNPSTG----STQ 457
N+ +G L ++ S KL LS N+ +G +P + ++ +N TG S
Sbjct: 464 NNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESIS 523
Query: 458 NLS-LTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSF 514
N++ ++ L L N LSG++ GI NL YL+LS+N+F IP L N L N+S
Sbjct: 524 NINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSR 583
Query: 515 NNLSGVVPENL 525
N+L +PE L
Sbjct: 584 NDLDQTIPEGL 594
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/287 (36%), Positives = 170/287 (59%), Gaps = 18/287 (6%)
Query: 727 FTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK 786
F E+L A AEV+G+ GT YKA L+ G+ + VKRL++ +A KKEF +++ +G IK
Sbjct: 344 FDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMAS-KKEFETQMEVVGKIK 402
Query: 787 HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
HPN++ L+ YY+ + EKL++ +++ SL+ L + PL D R+R+A+ AR
Sbjct: 403 HPNVIPLRAYYY--SKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAAR 460
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP 906
L +LH + HGN+K++NILL P + ++DY L+++ +++ +++ GY
Sbjct: 461 GLAHLHVSAKLVHGNIKASNILLH-PNQDTCVSDYGLNQLFSNSSPPNRL-----AGYHA 514
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966
PE T K + KSDVY+FG++LLELLTGKS + + G +DL WV + E +
Sbjct: 515 PEVLETRK--VTFKSDVYSFGVLLLELLTGKSPNQASLGEEG-IDLPRWVLSVVREEWTA 571
Query: 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEEL 1013
E FD +M H++E+ + +LQ+A+ C+ S PD V +E+
Sbjct: 572 EVFDVELMRYHNIEEE---MVQLLQIAMACV---STVPDQRPVMQEV 612
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 175/564 (31%), Positives = 261/564 (46%), Gaps = 68/564 (12%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITC--TNGYVTSIMLNDMG 76
SD ALL L K K P ++ +W + + C NWFG+ C + V ++ L+ G
Sbjct: 29 SDGLALLSLLKHFDKVPL-EVASTWKENTSETTPCNNNWFGVICDLSGNVVETLNLSASG 87
Query: 77 LVGNFSFPTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVS 135
L G I LK L + +S N G + + +G+ SLE+LDLS+N F G +P S
Sbjct: 88 LSGQLG-SEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGS 146
Query: 136 LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195
L+NL L + N+ G P+ GGL +L L + N G I LL + ++ L+NN
Sbjct: 147 LQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNN 206
Query: 196 QFSGSL--------DLG--------LG-----DSSFISSIQYLNISENSLVGELFPHDG- 233
+ +GSL +LG LG SS + L++S N G + P G
Sbjct: 207 KLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGN 266
Query: 234 ---------------------MPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSN 271
M + V D S+N L G IP SL L+L N
Sbjct: 267 CSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDN 326
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSNKLSGSLPARV 329
QL G +P AL + L L+L N+L G P+G +L ++ + +N L+G LP V
Sbjct: 327 QLQGEIPPALSKLKK--LQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEV 384
Query: 330 ---GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVS 386
H + L NN GD+ +E++ L N TG +P +L F +
Sbjct: 385 TQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILG 444
Query: 387 NNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQE 446
+N L G +PA + L+ + L N L+G +LP F S L+ +NL N+F G +P
Sbjct: 445 SNQLHGKIPASIRQCKTLERVRLEDNKLSG-VLPEFPESLSLSYVNLGSNSFEGSIP--- 500
Query: 447 IQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNG 506
S GS +N L ++DL+ N L+G + P + +L LNLS+N EG +P L
Sbjct: 501 ----RSLGSCKN--LLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGC 554
Query: 507 --LKEFNVSFNNLSGVVPENLRNF 528
L F+V N+L+G +P + R++
Sbjct: 555 ARLLYFDVGSNSLNGSIPSSFRSW 578
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1025 | ||||||
| 359479317 | 1020 | PREDICTED: probable inactive receptor ki | 0.992 | 0.997 | 0.714 | 0.0 | |
| 147798821 | 1020 | hypothetical protein VITISV_007077 [Viti | 0.992 | 0.997 | 0.713 | 0.0 | |
| 224131750 | 966 | predicted protein [Populus trichocarpa] | 0.937 | 0.994 | 0.680 | 0.0 | |
| 449516095 | 1017 | PREDICTED: probable inactive receptor ki | 0.989 | 0.997 | 0.641 | 0.0 | |
| 449452666 | 1017 | PREDICTED: probable inactive receptor ki | 0.989 | 0.997 | 0.641 | 0.0 | |
| 356553668 | 1055 | PREDICTED: probable inactive receptor ki | 0.977 | 0.949 | 0.617 | 0.0 | |
| 357493593 | 1022 | Receptor-like protein kinase BRI1-like p | 0.966 | 0.969 | 0.609 | 0.0 | |
| 356499271 | 1003 | PREDICTED: probable inactive receptor ki | 0.975 | 0.997 | 0.619 | 0.0 | |
| 297822319 | 1022 | ATP binding protein [Arabidopsis lyrata | 0.983 | 0.986 | 0.593 | 0.0 | |
| 145360375 | 1020 | Leucine-rich repeat protein kinase-like | 0.974 | 0.979 | 0.583 | 0.0 |
| >gi|359479317|ref|XP_002270284.2| PREDICTED: probable inactive receptor kinase At5g10020-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1404 bits (3633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 729/1021 (71%), Positives = 843/1021 (82%), Gaps = 4/1021 (0%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
M + LI LLLV A+GQSDF AL++LKKGI KDPSG ++DSWD+KSL+SDGCP NWFGI
Sbjct: 1 MHSTCLIFLLLVELAVGQSDFGALIELKKGIQKDPSG-VLDSWDSKSLASDGCPENWFGI 59
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C+ G+V SI LND+G+VG+F F I GLKML N+SVSNN G I D+GSI+SL +LDL
Sbjct: 60 ICSEGHVISITLNDLGIVGDFHFTAITGLKMLQNLSVSNNLFTGTIEDVGSIESLAYLDL 119
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
SHN FHGLIPS + L+NL+LLN+SSN+FEG P+GFG L KLKY+D RAN F GDIM L
Sbjct: 120 SHNAFHGLIPSDLTHLENLVLLNLSSNNFEGKGPTGFGDLEKLKYIDFRANGFSGDIMRL 179
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
LS+LGSVVHVDLS+NQFSGSLDLGLG SSF+SSIQY NIS NSLVG+LF HDGMPYFD+L
Sbjct: 180 LSELGSVVHVDLSSNQFSGSLDLGLGKSSFVSSIQYFNISCNSLVGQLFAHDGMPYFDSL 239
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFDASNN LVGAIPSFNFV SL+ILRLG N L+GSLP AL QESSM+LSELDL LNQLE
Sbjct: 240 EVFDASNNQLVGAIPSFNFVVSLQILRLGRNHLTGSLPEALFQESSMILSELDLGLNQLE 299
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
GPVGSITSATLK +NLSSN+L+G LPARVGHC+I+DLSNN LSG+LSRMQ+WGNYVE I
Sbjct: 300 GPVGSITSATLKNLNLSSNRLTGLLPARVGHCSIIDLSNNMLSGNLSRMQSWGNYVEIID 359
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LSSN LTG +PNQTSQFLRL S K+SNNSL G LP VLGTY ELKVIDLSLN L GFLLP
Sbjct: 360 LSSNKLTGTLPNQTSQFLRLISLKLSNNSLGGSLPPVLGTYQELKVIDLSLNQLTGFLLP 419
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS 480
SFF ST+LTDLNLSGNN +G +PLQ I + PS GSTQNLSL SLDL+ NSLSG L IS
Sbjct: 420 SFFNSTRLTDLNLSGNNLTGSIPLQAIPDIPSIGSTQNLSLVSLDLSGNSLSGHLPQEIS 479
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLL 540
FH LVYLNLSNN FEGSIPD LP+GLK F+VS+NNLSG+VPENLR FPDSAFHPGNSLL
Sbjct: 480 GFHELVYLNLSNNLFEGSIPDDLPDGLKGFSVSYNNLSGIVPENLRRFPDSAFHPGNSLL 539
Query: 541 TFPNSPSQQD-VPDLTLRGHG-NHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
FP+SPS + PDL LRG G +HMKPA + ALI GLV GV+M+ALL ++I + A W
Sbjct: 540 AFPHSPSSSNAAPDLDLRGQGSSHMKPAVRAALIAGLVGGVSMIALLFVMICYGAHWVEC 599
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
RDS K +G +K + +SS S ++K DPS++S +F QD SS + ++ G S
Sbjct: 600 SRDSLKGNGMKKGTEKETSSDLHTSALHKILDPSITSSSFPQDNTSSSHLGYEHEHGIIS 659
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNS-RFTKNSDVLNACSPEKLAGD 717
V KP + P+ +R+DEG+SSP+SLLS SNPS SK+ R +N DVL CSP+KLAGD
Sbjct: 660 LVTKKPSDGSPPEPIREDEGISSPISLLSPSNPSPSKSPYRPDENPDVLKVCSPDKLAGD 719
Query: 718 LHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAR 777
LHLFD SL+ T+EELSHAPAEVIGRSCHGTLYKATLDSG +LAVK LREGIAKG+KEF+R
Sbjct: 720 LHLFDGSLVVTSEELSHAPAEVIGRSCHGTLYKATLDSGHVLAVKWLREGIAKGRKEFSR 779
Query: 778 EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER 837
E KKLGNIKHPNLVSLQGYYWG +EHEKL+ISN+INA LA+YL + +PRK PPLS+ ER
Sbjct: 780 EAKKLGNIKHPNLVSLQGYYWGLREHEKLIISNFINAPCLALYLHQMEPRKFPPLSLVER 839
Query: 838 LRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL 897
L++A DVA CLN+LHNERAIPHGNLKSTNILLE +NA+LTDYSLHRI+T AGTA+QVL
Sbjct: 840 LKIARDVACCLNFLHNERAIPHGNLKSTNILLETRKLNALLTDYSLHRIMTPAGTAEQVL 899
Query: 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVR 957
NAGALGYRPPEFAS+SKPCPSLKSDVYA+G+ILLELLTGKSSGEIV + GVVDLT+WVR
Sbjct: 900 NAGALGYRPPEFASSSKPCPSLKSDVYAYGVILLELLTGKSSGEIVSGNTGVVDLTEWVR 959
Query: 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
LA ENR GECFDRLI ++ PPR L +MLQVAL+CILPASERPDM +V+E++S++V
Sbjct: 960 WLAAENRWGECFDRLIPGMQSVDHPPRCLHEMLQVALKCILPASERPDMRTVYEDISSVV 1019
Query: 1018 L 1018
L
Sbjct: 1020 L 1020
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147798821|emb|CAN67610.1| hypothetical protein VITISV_007077 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1401 bits (3626), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/1021 (71%), Positives = 842/1021 (82%), Gaps = 4/1021 (0%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
M + LI LLLV A+GQSDF AL++LKKGI KDPSG ++DSWD+KSL+SDGCP NWFGI
Sbjct: 1 MHSTCLIFLLLVELAVGQSDFGALIELKKGIQKDPSG-VLDSWDSKSLASDGCPENWFGI 59
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C+ G+V SI LND+G+VG+F F I GLKML N+SVSNN G I D+GSI+SL +LDL
Sbjct: 60 ICSEGHVISITLNDLGIVGDFHFTAITGLKMLQNLSVSNNLFTGTIEDVGSIESLAYLDL 119
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
SHN FHGLIPS + L+NL+LLN+SSN+FEG P+GFG L KLKY+D RAN F GDIM L
Sbjct: 120 SHNAFHGLIPSDLTHLENLVLLNLSSNNFEGKGPTGFGDLEKLKYIDFRANGFSGDIMRL 179
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
LS+LGSVVHVDLS+NQFSGSLDLGLG SSF+SSIQY NIS NSLVG+LF HDGMPYFD+L
Sbjct: 180 LSELGSVVHVDLSSNQFSGSLDLGLGKSSFVSSIQYFNISCNSLVGQLFAHDGMPYFDSL 239
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFDASNN LVGAIPSFNFV SL+ILRLG N L+GSLP AL QESSM+LSELDL LNQLE
Sbjct: 240 EVFDASNNQLVGAIPSFNFVVSLQILRLGRNHLTGSLPEALFQESSMILSELDLGLNQLE 299
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
GPVGSITSATLK +NLSSN+L+G LPARVGHC+I+DLSNN LSG+LSRMQ+WGNYVE I
Sbjct: 300 GPVGSITSATLKNLNLSSNRLTGLLPARVGHCSIIDLSNNMLSGNLSRMQSWGNYVEIID 359
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LSSN LTG +PNQTSQFLRL S K+SNNSL G LP VLGTY ELKVIDLSLN L GFLLP
Sbjct: 360 LSSNKLTGTLPNQTSQFLRLISLKLSNNSLGGSLPPVLGTYQELKVIDLSLNQLTGFLLP 419
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS 480
SFF ST+LTDLNLSGNN +G +PLQ I + PS STQNLSL SLDL+ NSLSG L IS
Sbjct: 420 SFFNSTRLTDLNLSGNNLTGSIPLQAIPDIPSIXSTQNLSLVSLDLSGNSLSGHLPQEIS 479
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLL 540
FH LVYLNLSNN FEGSIPD LP+GLK F+VS+NNLSG+VPENLR FPDSAFHPGNSLL
Sbjct: 480 GFHELVYLNLSNNLFEGSIPDDLPDGLKGFSVSYNNLSGIVPENLRRFPDSAFHPGNSLL 539
Query: 541 TFPNSPSQQD-VPDLTLRGHG-NHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
FP+SPS + PDL LRG G +HMKPA + ALI GLV GV+M+ALL ++I + A W
Sbjct: 540 AFPHSPSSSNAAPDLDLRGQGSSHMKPAVRAALIAGLVGGVSMIALLFVMICYGAHWVEC 599
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
RDS K +G +K + +SS S ++K DPS++S +F QD SS + ++ G S
Sbjct: 600 SRDSLKGNGMKKGTEKETSSDLHTSALHKILDPSITSSSFPQDNTSSSHLGYEHEHGIIS 659
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNS-RFTKNSDVLNACSPEKLAGD 717
V KP + P+ +R+DEG+SSP+SLLS SNPS SK+ R +N DVL CSP+KLAGD
Sbjct: 660 LVTKKPSDGSPPEPIREDEGISSPISLLSPSNPSPSKSPYRPDENPDVLKVCSPDKLAGD 719
Query: 718 LHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAR 777
LHLFD SL+ T+EELSHAPAEVIGRSCHGTLYKATLDSG +LAVK LREGIAKG+KEF+R
Sbjct: 720 LHLFDGSLVVTSEELSHAPAEVIGRSCHGTLYKATLDSGHVLAVKWLREGIAKGRKEFSR 779
Query: 778 EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER 837
E KKLGNIKHPNLVSLQGYYWG +EHEKL+ISN+INA LA+YL + +PRK PPLS+ ER
Sbjct: 780 EAKKLGNIKHPNLVSLQGYYWGLREHEKLIISNFINAPCLALYLHQMEPRKFPPLSLVER 839
Query: 838 LRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL 897
L++A DVA CLN+LHNERAIPHGNLKSTNILLE +NA+LTDYSLHRI+T AGTA+QVL
Sbjct: 840 LKIARDVACCLNFLHNERAIPHGNLKSTNILLETRKLNALLTDYSLHRIMTPAGTAEQVL 899
Query: 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVR 957
NAGALGYRPPEFAS+SKPCPSLKSDVYA+G+ILLELLTGKSSGEIV + GVVDLT+WVR
Sbjct: 900 NAGALGYRPPEFASSSKPCPSLKSDVYAYGVILLELLTGKSSGEIVSGNTGVVDLTEWVR 959
Query: 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
LA ENR GECFDRLI ++ PPR L +MLQVAL+CILPASERPDM +V+E++S++V
Sbjct: 960 WLAAENRWGECFDRLIPGMQSVDHPPRCLHEMLQVALKCILPASERPDMRTVYEDISSVV 1019
Query: 1018 L 1018
L
Sbjct: 1020 L 1020
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131750|ref|XP_002328099.1| predicted protein [Populus trichocarpa] gi|222837614|gb|EEE75979.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1321 bits (3418), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 695/1021 (68%), Positives = 804/1021 (78%), Gaps = 60/1021 (5%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
MQT+ LI+LLLVV ALGQSDF+ALL+L+KG KDPSG++ DSWD+KSL+SDGCP+ W+G+
Sbjct: 1 MQTICLILLLLVVAALGQSDFKALLELRKGFEKDPSGKVFDSWDSKSLASDGCPQTWYGV 60
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C NG+V SI LND+GLVGNFSFP + G KML N+SVSNNQLMG I+++GSI+SLEFLDL
Sbjct: 61 ICVNGHVVSITLNDVGLVGNFSFPVLAGFKMLRNLSVSNNQLMGTISNVGSIESLEFLDL 120
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
S N FHG +PSG+ LKNL+LLN+SSN+FEG PSGFG L L+YLDLR N F GDIM L
Sbjct: 121 SSNFFHGFVPSGVSKLKNLVLLNLSSNNFEGLVPSGFGNLESLEYLDLRHNSFSGDIMGL 180
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
LSQL VVHVDLS+NQFSGSLDLGLG++SF+SSI+YLN+S N LVG+LF HDG+PYFD+L
Sbjct: 181 LSQLDIVVHVDLSSNQFSGSLDLGLGNASFVSSIKYLNVSHNYLVGQLFAHDGVPYFDSL 240
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFD SNN + GAIP F FV SLRILRLG NQLSGSLP ALLQ+SSM+L+ELDLSLNQLE
Sbjct: 241 EVFDVSNNQITGAIPPFKFVVSLRILRLGGNQLSGSLPEALLQDSSMVLTELDLSLNQLE 300
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
GPVGSITS TL+K+N+SSNKLSG LPA GHC +DLSNN L+G+LSR+QNWGNYVE I
Sbjct: 301 GPVGSITSTTLRKMNISSNKLSGPLPATAGHCATIDLSNNMLTGNLSRIQNWGNYVEVIQ 360
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LSSN LTG +PNQTSQFLRLT+ K+SNNSL GDLP VLGTY ELKVIDLSLN L GFLLP
Sbjct: 361 LSSNSLTGTLPNQTSQFLRLTTLKISNNSLNGDLPPVLGTYSELKVIDLSLNFLTGFLLP 420
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS 480
FFTST LTDLNLS NNF+G +PLQE+ + S +NLSL SLDL++NSL G L P IS
Sbjct: 421 DFFTSTTLTDLNLSANNFTGEIPLQEVHD-----SRENLSLVSLDLSHNSLEGSLPPEIS 475
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLL 540
KFHNLVYLNLSNNK +GSIP LP+GLK F+VS NN SGVVP+NLR FPDSAFHPGNSLL
Sbjct: 476 KFHNLVYLNLSNNKLKGSIPGDLPDGLKGFDVSSNNFSGVVPDNLRRFPDSAFHPGNSLL 535
Query: 541 TFPNSPSQQDVPD--LTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
FP PS P + L+G + MKPA KIALI +V T++ALL M+IY+R H
Sbjct: 536 IFPYFPSSSKGPPALVNLKGGRSRMKPAIKIALIASMVGAATIIALLSMVIYYRTHRPTH 595
Query: 599 GRDSFKRDGEQKAF--SEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGE 656
G S K D + EGSS S R VNK S +S +FHQ
Sbjct: 596 GTRSLKGDERSEGVPQEEGSSISSSR--VNKNPSQSSASLSFHQ---------------- 637
Query: 657 TSSVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAG 716
S+ +T+ + LSS P VL SP+KLAG
Sbjct: 638 -SNSLTQ-------------------MGPLSSDTPG------------VLRVRSPDKLAG 665
Query: 717 DLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFA 776
+LHLFD SL FTAEELS APAEV+GRSCHG LYKATLDSG ++A+K L+EGIAKGKK+FA
Sbjct: 666 NLHLFDGSLTFTAEELSCAPAEVVGRSCHGALYKATLDSGYVMAIKWLKEGIAKGKKDFA 725
Query: 777 REVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDE 836
REVKKLG+I+HPNLVSLQGYYWGPK+HEK++I+ YINAQ LA YLQE++PRKL LS+D+
Sbjct: 726 REVKKLGSIRHPNLVSLQGYYWGPKDHEKMIITKYINAQCLAFYLQESEPRKLQSLSLDD 785
Query: 837 RLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896
RLR+AV+VA CLNYLHNERAIPHGNLKSTNILLE P MN +LTDYSLHRILTSAGTA+QV
Sbjct: 786 RLRIAVNVAWCLNYLHNERAIPHGNLKSTNILLEPPNMNPLLTDYSLHRILTSAGTAEQV 845
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWV 956
LNAGALGYRPPEFAS+SKPCPSLKSDVYAFG+ILLELLTGK S EIV DPGVVDLTDWV
Sbjct: 846 LNAGALGYRPPEFASSSKPCPSLKSDVYAFGVILLELLTGKCSWEIVSADPGVVDLTDWV 905
Query: 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTI 1016
RLL+ ENR+ ECFD+L+MD + E PR+L +MLQVALRCILPASERPDM +VFE+LST+
Sbjct: 906 RLLSEENRTSECFDKLLMDTPNAEA-PRVLDEMLQVALRCILPASERPDMKTVFEDLSTV 964
Query: 1017 V 1017
Sbjct: 965 A 965
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516095|ref|XP_004165083.1| PREDICTED: probable inactive receptor kinase At5g10020-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1219 bits (3154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 654/1019 (64%), Positives = 782/1019 (76%), Gaps = 5/1019 (0%)
Query: 1 MQTVSLIVLL-LVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFG 59
MQ LI+LL L+VN LGQSDF ALL+LKKGI KD SG++ DSWD+ SL SDGCP NWFG
Sbjct: 1 MQVTCLIILLFLLVNVLGQSDFAALLELKKGIIKDSSGKL-DSWDSMSLDSDGCPSNWFG 59
Query: 60 ITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLD 119
I C NG VTS+ ++ GLVG+F F I GL +L N+S+SNNQ G I +G +SLEFLD
Sbjct: 60 IVCVNGRVTSLTFDNAGLVGDFDFSAITGLSLLRNLSLSNNQFTGTIAKVGLFKSLEFLD 119
Query: 120 LSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH 179
LS N F G +PS ++ L NL+ LN SSN FEG FP+GFG L LKY+D+ N F GDI
Sbjct: 120 LSRNRFRGTVPSLLIGLVNLVSLNFSSNQFEGAFPTGFGKLADLKYVDVHGNGFSGDITG 179
Query: 180 LLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN 239
LSQ+GSVV+VDLS+N+F+GS+D G+G+ SFISSI+YLNIS N L G LFPHDGMPYFD+
Sbjct: 180 FLSQMGSVVYVDLSSNRFTGSMDAGVGNPSFISSIRYLNISHNLLTGVLFPHDGMPYFDS 239
Query: 240 LEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
LEVFDASNN VG IP FNFV SL+ L LG N+LSGSLP ALL++ SM+L+ELDLSLN+L
Sbjct: 240 LEVFDASNNQFVGNIPDFNFVVSLQTLILGRNKLSGSLPEALLRDRSMLLTELDLSLNEL 299
Query: 300 EGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDI 359
+GPVGSITS TLKK+N+SSNKL+GSLP VG C ++DLSNN LSGDLSR+Q+WGN+VE I
Sbjct: 300 QGPVGSITSTTLKKLNISSNKLTGSLPTMVGRCAVIDLSNNMLSGDLSRIQSWGNHVEVI 359
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLL 419
LSSN LTG + N++SQFLRL +SNNSLEG LP VLGTYPEL+VIDLS N LNG +
Sbjct: 360 QLSSNSLTGTLSNKSSQFLRLALLNISNNSLEGVLPTVLGTYPELEVIDLSHNRLNGPVP 419
Query: 420 PSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
+ F S KLTDLNLSGNNF+GP+PL E ++ S+ S Q+ SL SLDL+ NSL+GRL +
Sbjct: 420 STLFHSLKLTDLNLSGNNFTGPIPLYESIDSTSSSSLQSSSLKSLDLSRNSLTGRLPVEL 479
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSL 539
SK ++LVYLNLS N F+G IPD LPN LK F+VSFNNLSG VP NL F DSAFHPGNSL
Sbjct: 480 SKLNSLVYLNLSKNYFDGIIPDNLPNSLKGFDVSFNNLSGEVPGNLMRFSDSAFHPGNSL 539
Query: 540 LTFPNSPSQQD-VPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
L FP+SPS P L H MKP KI LI GL+ V L C+++Y+RA QR
Sbjct: 540 LNFPSSPSTPGYFPGLPSTMHRARMKPVVKIVLIAGLIVVAAFVVLFCIILYYRA--QRL 597
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
R S + ++ E +SS++ +S +KK + S+ F QD LP S + G+
Sbjct: 598 DRRSTSTNNAKEGAVEEASSVTSQSETDKKKNASIPPSGFRQDFLPPSHRVESRVGGDIW 657
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
SV K ++ + +S+ K EG+SSP+S +SSSNPS SK + + L SP+KLAGDL
Sbjct: 658 SVSDKARDFGYHESLGKGEGISSPMSFMSSSNPSPSKMQQHLDHPRALKVRSPDKLAGDL 717
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE 778
HLFD SLMFTAEELS APAEV+G+SCHGTLYKATLDSG +LAVK LREG+AKGKKEFARE
Sbjct: 718 HLFDGSLMFTAEELSRAPAEVVGKSCHGTLYKATLDSGHVLAVKWLREGMAKGKKEFARE 777
Query: 779 VKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL 838
VKKLG+IKHPNLVS+ GYYWGP++HEKLVIS +INAQSLA YLQE + + PLS+ RL
Sbjct: 778 VKKLGSIKHPNLVSINGYYWGPRDHEKLVISTFINAQSLAFYLQEMERGGVLPLSLPARL 837
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
+VA D++ CLN+ HNE+AIPHGNLKS+N+LLE TMNA LTDYSLHRILT AGTA+QVLN
Sbjct: 838 KVASDISHCLNFFHNEKAIPHGNLKSSNVLLETSTMNARLTDYSLHRILTPAGTAEQVLN 897
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958
AGALGYRPPEFAS+SKPCPSLKSDVYAFG+ILLELLTG+SSGEIVC PGVVDLTDWVR
Sbjct: 898 AGALGYRPPEFASSSKPCPSLKSDVYAFGVILLELLTGRSSGEIVCGIPGVVDLTDWVRY 957
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
LA ENR EC D+ I+D D E+PP+ L DMLQ+ALRC L A+ERPDM +V+EEL IV
Sbjct: 958 LARENRFDECIDKTILDLDDDEKPPKQLEDMLQMALRCTLSAAERPDMKTVYEELLVIV 1016
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452666|ref|XP_004144080.1| PREDICTED: probable inactive receptor kinase At5g10020-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1219 bits (3154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 654/1019 (64%), Positives = 782/1019 (76%), Gaps = 5/1019 (0%)
Query: 1 MQTVSLIVLL-LVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFG 59
MQ LI+LL L+VN LGQSDF ALL+LKKGI KD SG++ DSWD+ SL SDGCP NWFG
Sbjct: 1 MQVTCLIILLFLLVNVLGQSDFAALLELKKGIIKDSSGKL-DSWDSMSLDSDGCPSNWFG 59
Query: 60 ITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLD 119
I C NG VTS+ ++ GLVG+F F I GL +L N+S+SNNQ G I +G +SLEFLD
Sbjct: 60 IVCVNGRVTSLTFDNAGLVGDFDFSAITGLSLLRNLSLSNNQFTGTIAKVGLFKSLEFLD 119
Query: 120 LSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH 179
LS N F G +PS ++ L NL+ LN SSN FEG FP+GFG L LKY+D+ N F GDI
Sbjct: 120 LSRNRFRGTVPSLLIGLVNLVSLNFSSNQFEGAFPTGFGKLADLKYVDVHGNGFSGDITG 179
Query: 180 LLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN 239
LSQ+GSVV+VDLS+N+F+GS+D G+G+ SFISSI+YLNIS N L G LFPHDGMPYFD+
Sbjct: 180 FLSQMGSVVYVDLSSNRFTGSMDAGVGNPSFISSIRYLNISHNLLTGVLFPHDGMPYFDS 239
Query: 240 LEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
LEVFDASNN VG IP FNFV SL+ L LG N+LSGSLP ALL++ SM+L+ELDLSLN+L
Sbjct: 240 LEVFDASNNQFVGNIPDFNFVVSLQTLILGRNKLSGSLPEALLRDRSMLLTELDLSLNEL 299
Query: 300 EGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDI 359
+GPVGSITS TLKK+N+SSNKL+GSLP VG C ++DLSNN LSGDLSR+Q+WGN+VE I
Sbjct: 300 QGPVGSITSTTLKKLNISSNKLTGSLPTMVGRCAVIDLSNNMLSGDLSRIQSWGNHVEVI 359
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLL 419
LSSN LTG + N++SQFLRL +SNNSLEG LP VLGTYPEL+VIDLS N LNG +
Sbjct: 360 QLSSNSLTGTLSNKSSQFLRLALLNISNNSLEGVLPTVLGTYPELEVIDLSHNRLNGPVP 419
Query: 420 PSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
+ F S KLTDLNLSGNNF+GP+PL E ++ S+ S Q+ SL SLDL+ NSL+GRL +
Sbjct: 420 STLFHSLKLTDLNLSGNNFTGPIPLYESIDSTSSSSLQSSSLKSLDLSRNSLTGRLPVEL 479
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSL 539
SK ++LVYLNLS N F+G IPD LPN LK F+VSFNNLSG VP NL F DSAFHPGNSL
Sbjct: 480 SKLNSLVYLNLSKNYFDGIIPDNLPNSLKGFDVSFNNLSGKVPGNLMRFSDSAFHPGNSL 539
Query: 540 LTFPNSPSQQD-VPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
L FP+SPS P L H MKP KI LI GL+ V L C+++Y+RA QR
Sbjct: 540 LNFPSSPSTPGYFPGLPSTMHRARMKPVVKIVLIAGLIVVAAFVVLFCIILYYRA--QRL 597
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
R S + ++ E +SS++ +S +KK + S+ F QD LP S + G+
Sbjct: 598 DRRSTSTNNAKEGAVEEASSVTSQSETDKKKNASIPPSGFRQDFLPPSHRVESRVGGDIW 657
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
SV K ++ + +S+ K EG+SSP+S +SSSNPS SK + + L SP+KLAGDL
Sbjct: 658 SVSDKARDFGYHESLGKGEGISSPMSFMSSSNPSPSKMQQHLDHPRALKVRSPDKLAGDL 717
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE 778
HLFD SLMFTAEELS APAEV+G+SCHGTLYKATLDSG +LAVK LREG+AKGKKEFARE
Sbjct: 718 HLFDGSLMFTAEELSRAPAEVVGKSCHGTLYKATLDSGHVLAVKWLREGMAKGKKEFARE 777
Query: 779 VKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL 838
VKKLG+IKHPNLVS+ GYYWGP++HEKLVIS +INAQSLA YLQE + + PLS+ RL
Sbjct: 778 VKKLGSIKHPNLVSINGYYWGPRDHEKLVISTFINAQSLAFYLQEMERGGVLPLSLPARL 837
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
+VA D++ CLN+ HNE+AIPHGNLKS+N+LLE TMNA LTDYSLHRILT AGTA+QVLN
Sbjct: 838 KVASDISHCLNFFHNEKAIPHGNLKSSNVLLETSTMNARLTDYSLHRILTPAGTAEQVLN 897
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958
AGALGYRPPEFAS+SKPCPSLKSDVYAFG+ILLELLTG+SSGEIVC PGVVDLTDWVR
Sbjct: 898 AGALGYRPPEFASSSKPCPSLKSDVYAFGVILLELLTGRSSGEIVCGIPGVVDLTDWVRY 957
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
LA ENR EC D+ I+D D E+PP+ L DMLQ+ALRC L A+ERPDM +V+EEL IV
Sbjct: 958 LARENRFDECIDKTILDLDDDEKPPKQLEDMLQMALRCTLSAAERPDMKTVYEELLVIV 1016
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553668|ref|XP_003545175.1| PREDICTED: probable inactive receptor kinase At5g10020-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 630/1020 (61%), Positives = 773/1020 (75%), Gaps = 18/1020 (1%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
MQ + ++LLLV ALG SD ++LL+ KK I DPSG +++SWD++SL SDGCP+NW GI
Sbjct: 1 MQAIWFMLLLLVAIALGNSDIDSLLEFKKSIQNDPSGLVVNSWDSRSLDSDGCPKNWHGI 60
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C+ G V SI L++ GLVG F+F I GL ML N+S NN G++ I +I+SLE+ DL
Sbjct: 61 VCSEGSVISITLDNAGLVGEFNFLAISGLTMLRNLSAVNNHFTGDLLYIATIESLEYADL 120
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
S N F+G + S L+ L+ LN+SSN GT P F L +LKYLDL N F GDIMH+
Sbjct: 121 SLNKFNGPLLSNFTQLRKLIYLNLSSNELGGTLPIEFHKLEQLKYLDLHMNNFSGDIMHI 180
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
Q+GSV+++DLS N+ SG+ DLGL D SF+SSIQYLNIS NSL GELF HDGMPY DNL
Sbjct: 181 FYQMGSVLYIDLSCNRISGTPDLGLADESFLSSIQYLNISHNSLSGELFAHDGMPYLDNL 240
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFDASNN L G +PSF FV SLRILRL NQL+G LP ALL+ESSMMLSELDLS N+LE
Sbjct: 241 EVFDASNNQLEGNLPSFTFVVSLRILRLACNQLTGLLPEALLKESSMMLSELDLSQNKLE 300
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
GP+G ITS TL+K+NLSSNKL G LP RVGHC+I+DLSNN LSG+ SR++ WGNYVE +
Sbjct: 301 GPIGIITSVTLQKLNLSSNKLYGPLPLRVGHCSIIDLSNNTLSGNFSRIRYWGNYVEVVQ 360
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LS+N L GM+PN+TSQFLRLT+ KVSNNSLEG LP +LGTYPEL+ IDLSLN L+GF+LP
Sbjct: 361 LSTNSLGGMLPNETSQFLRLTALKVSNNSLEGFLPPILGTYPELEEIDLSLNQLSGFVLP 420
Query: 421 SFFTSTKLTDLNLSGNNFSGPLP-LQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
SFFTSTKL +LNLS N FSG +P L + NNP S +N SL LDL++N+LSG L +
Sbjct: 421 SFFTSTKLINLNLSNNKFSGSIPILFQPPNNPLV-SAENFSLVFLDLSHNNLSGTLPSNM 479
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSL 539
S+ HNL YLNL NN+ EG+IPD LP+ L+ NVSFNNLSGVVPE+L+ FPDSAFHPGN++
Sbjct: 480 SRLHNLAYLNLCNNQLEGTIPDDLPDELRVLNVSFNNLSGVVPESLKQFPDSAFHPGNTM 539
Query: 540 LTFPNSPSQ-QDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
L FP+S S +D +L LR H H K AT+IALI LV G ++A + ++IY++ H
Sbjct: 540 LVFPHSQSSPKDTSNLGLREHRLHKKSATRIALIACLVAGGFVMAFVAIIIYYKV---HH 596
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
++ + E + ++ S+ S ++ + LP + S+ DA
Sbjct: 597 EKERTSKQNEAMSITQESTFTSNTEAPDR-----------NLGALPPAQRGSSDDARNIH 645
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
V KP + + + +EG S+P+S+LS SNPS SK+ +F +N L SP+KL GDL
Sbjct: 646 PVGKKPIDPGPFELGKNEEGTSTPMSILSPSNPSSSKSYQF-ENPGSLKVSSPDKLVGDL 704
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE 778
H+FD SL+ T EELS APAEVIGRSCHGTLYKATLDSG LA+K LREGI KGKKE ARE
Sbjct: 705 HIFDGSLVLTVEELSCAPAEVIGRSCHGTLYKATLDSGHELAIKWLREGITKGKKELARE 764
Query: 779 VKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL 838
+KKLG IKHPNLVS+QGYY GPKEHEKL+ISNY+NAQSL +YLQETD R L PLS+DERL
Sbjct: 765 IKKLGTIKHPNLVSVQGYYLGPKEHEKLIISNYMNAQSLDIYLQETDKRNLHPLSLDERL 824
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
RVAV+VARCL++LH+E+AIPHGNLKSTNILLE P N +LTDYSLHRILT+AGTA+Q+LN
Sbjct: 825 RVAVEVARCLHFLHDEKAIPHGNLKSTNILLETPNRNVLLTDYSLHRILTAAGTAEQLLN 884
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958
AGALGYRPPEF+ +SKPCPSL SDVYAFG++LLELLTG++SGEIV PGVVDLTDWVR
Sbjct: 885 AGALGYRPPEFSRSSKPCPSLTSDVYAFGVVLLELLTGRNSGEIVSGIPGVVDLTDWVRF 944
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTIVL 1018
LA ++RS +CFDR IMD H+ E+ +IL +ML+VALRCILPAS+RPDM +VF +LSTI L
Sbjct: 945 LAEQDRSNQCFDRSIMDRHNGERQSKILDEMLKVALRCILPASDRPDMKTVFGDLSTISL 1004
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493593|ref|XP_003617085.1| Receptor-like protein kinase BRI1-like protein [Medicago truncatula] gi|355518420|gb|AET00044.1| Receptor-like protein kinase BRI1-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/1017 (60%), Positives = 758/1017 (74%), Gaps = 26/1017 (2%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
MQ + L++LLLV A G D +ALL+LKKGI DP G +++SWD+KSL S+GCP+NW+GI
Sbjct: 28 MQAIWLMLLLLVNTAFGNRDIDALLELKKGIQNDPFGLVLNSWDSKSLESNGCPQNWYGI 87
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C+ G V SI L++ LVG F+F I L ML N+SV NN G++ I ++SL+FLDL
Sbjct: 88 LCSEGNVISITLDNASLVGEFNFLAISNLPMLHNLSVVNNHFTGSMLHISPMKSLKFLDL 147
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
S N F+G +P V L++L+ LN+S N F GT P+ F L +L+YLD +N F GDIM +
Sbjct: 148 SLNKFNGSLPPSFVELRSLVYLNLSLNEFSGTVPNVFHKLDQLEYLDFHSNSFSGDIMEI 207
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
Q+GSV+HVDLSNN+FSG+LDLGLGD SF+ SIQ+LN+S NSLVGELF HDGMPY DNL
Sbjct: 208 FYQMGSVLHVDLSNNKFSGALDLGLGDVSFLFSIQHLNVSHNSLVGELFAHDGMPYLDNL 267
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFDASNN LVG IPSF FV SLRILRL NQL+GSLP LL+ESSMMLSELDLS N+LE
Sbjct: 268 EVFDASNNQLVGNIPSFTFVVSLRILRLACNQLTGSLPETLLKESSMMLSELDLSQNKLE 327
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
G +GSITS TL+K+N+SSNKLSG LP +V HC I+DLSNN LSG+LSR++ WGNYVE I
Sbjct: 328 GFIGSITSMTLRKLNISSNKLSGPLPLKVSHCAIIDLSNNMLSGNLSRIKYWGNYVEVIQ 387
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LS N L+G +PN+TSQ LRLTS KVSNNSLEG LP VLGTYPELK IDLSLN L+GFLLP
Sbjct: 388 LSKNSLSGTLPNETSQLLRLTSLKVSNNSLEGFLPPVLGTYPELKEIDLSLNRLSGFLLP 447
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS 480
+ F STKLT+LNLS N FSGP+P + N S +N SL LDL+ N+LSG L I
Sbjct: 448 TLFASTKLTNLNLSNNMFSGPIPFELQLPNNLLVSAENFSLMYLDLSNNNLSGILSSKIK 507
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLL 540
+ HNLVYLNL NNK EG+IP+ LP+ L+E NVSFNN SGVVP+NL FP+SAFHPGN++L
Sbjct: 508 ELHNLVYLNLCNNKLEGTIPNDLPDELRELNVSFNNFSGVVPDNLSQFPESAFHPGNTML 567
Query: 541 TFPNSP-SQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRHG 599
FPNS S +D + L G +H K T+ LI +V GV ++A++ +IY+R + Q+ G
Sbjct: 568 IFPNSHLSPKDSSNSNL-GSRSHEKTFTRSVLITCIVTGVFVIAIMAAMIYYR-IHQKKG 625
Query: 600 RDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETSS 659
S K+D + S+S S+R L S P + D G +
Sbjct: 626 STS-KQDATTSDIIQESTSPSKRRN------------------LESLPPSQSEDTGNINP 666
Query: 660 VVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLH 719
V PK+ P+ ++ +EG SSP+S++S+SNPS S + +F +N L SP+KL GDLH
Sbjct: 667 TVQNPKD---PEFIKNEEGTSSPMSIISASNPSPSTSHQF-ENPGSLEVSSPDKLVGDLH 722
Query: 720 LFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREV 779
LFD SLM TAEELS APAEV+GRSCHGTLYKATL+SG +LAVK LREGI KGKKE ARE+
Sbjct: 723 LFDGSLMLTAEELSCAPAEVVGRSCHGTLYKATLESGHVLAVKWLREGITKGKKELAREI 782
Query: 780 KKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLR 839
KKLG IKHPNLVS G Y GPKEHE+L++SNY+NA SL +YL E D R L PLS+DERLR
Sbjct: 783 KKLGTIKHPNLVSFLGCYLGPKEHERLIVSNYMNAHSLDIYLHEADKRNLHPLSLDERLR 842
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
VAV+VARCL YLH E+AIPHGNLKSTNILLE P N +LTDYSLHRILT+AGT++QVLNA
Sbjct: 843 VAVEVARCLLYLHTEKAIPHGNLKSTNILLETPNRNVLLTDYSLHRILTAAGTSEQVLNA 902
Query: 900 GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLL 959
GALGYRPPEF ++KPCPSLKSDVYAFG++LLELLTG+ SGE+V PG+ +LTDWVR L
Sbjct: 903 GALGYRPPEFTRSTKPCPSLKSDVYAFGVVLLELLTGRKSGEVVSGIPGMAELTDWVRFL 962
Query: 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTI 1016
A RS +CF+ ++D + E RIL DML+VA+RC L ASERPDM +VF++LSTI
Sbjct: 963 AEHGRSNQCFENSLVDNDNGEDSYRILDDMLKVAIRCTLSASERPDMKTVFDDLSTI 1019
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499271|ref|XP_003518465.1| PREDICTED: probable inactive receptor kinase At5g10020-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/1018 (61%), Positives = 772/1018 (75%), Gaps = 18/1018 (1%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
MQ + ++ LLV ALG SD +ALL+ KK I DPSG +++SWD++SL SDGCP+NW+GI
Sbjct: 1 MQAIWFMLSLLVAIALGNSDIDALLEFKKSIQNDPSGLVVNSWDSRSLDSDGCPKNWYGI 60
Query: 61 TCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDL 120
C+ G V SI L++ GLVG +F I GL ML N+S NNQ G++ I +I+SLE+LDL
Sbjct: 61 VCSEGSVLSITLDNAGLVGELNFLAINGLTMLRNLSAVNNQFTGDLLHIATIESLEYLDL 120
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
S N F+G + S V L+ L+ LN+SSN GT P F L +LKYLDL N F GDIMH+
Sbjct: 121 SLNKFNGPLLSNFVQLRKLVYLNLSSNELGGTLPVDFHKLEQLKYLDLHMNNFFGDIMHI 180
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
+GSV++VDLS+N+FSG+ DLGL D SF+SSIQYLNIS NSL GELF HDGMPY DNL
Sbjct: 181 FYPMGSVLYVDLSSNRFSGTPDLGLADESFLSSIQYLNISHNSLSGELFVHDGMPYLDNL 240
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
EVFDASNN L G IPSF FV SLRILRL NQL+G LP ALL+ESSMMLSELDLS N+LE
Sbjct: 241 EVFDASNNQLEGNIPSFTFVVSLRILRLACNQLTGLLPEALLKESSMMLSELDLSQNKLE 300
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
GP+G ITS TL+K+NLSSNKL G LP RVGHC+I+DLSNN LSG+ SR++ WGNYVE +
Sbjct: 301 GPIGIITSVTLRKLNLSSNKLYGPLPLRVGHCSIIDLSNNTLSGNFSRIRYWGNYVEVVQ 360
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LSSN L GM+PN+TSQFLRLTS KVSNNSLEG LP +LGTYPEL+ IDLSLN L+GFLLP
Sbjct: 361 LSSNSLGGMLPNETSQFLRLTSLKVSNNSLEGFLPPILGTYPELEEIDLSLNQLSGFLLP 420
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQ-EIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
SFFTSTKL +L+LS N FSG + +Q + NNP S +N SL LDL++N+LSG L +
Sbjct: 421 SFFTSTKLINLDLSNNKFSGSILIQFQPPNNPIV-SAENCSLVFLDLSHNNLSGTLPSNM 479
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSL 539
S+ HNL YLNL NN+ G+IPD LP+ L+ NVSFNNLSGVVPE+L+ FPDSAFHPGN++
Sbjct: 480 SRLHNLAYLNLCNNQLVGTIPDDLPDELRVLNVSFNNLSGVVPESLKQFPDSAFHPGNTM 539
Query: 540 LTFPN-SPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQRH 598
L FP+ PS +D +L LR H K AT+IALI LV G ++A + ++IY++ H
Sbjct: 540 LVFPHLQPSPKDTSNLGLREHRLQKKSATRIALIACLVAGGFVMAFVGIIIYYKV---HH 596
Query: 599 GRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPMESAYDAGETS 658
++ + E + ++ S+ S ++ + + LP + S+ DA
Sbjct: 597 EKERTSKQNEARGITQESTFTS-----------NIEEPYRNLEVLPPAQSGSSDDARNIH 645
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
V KP + + + +EG S+P+S+LS SNPS SK+ +F +N L SP+KL GDL
Sbjct: 646 PVGKKPIDFGPSELGKNEEGTSTPMSILSPSNPSSSKSYQF-ENPGSLKVSSPDKLVGDL 704
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE 778
H+FD SL TAEELS APAEVIGRSCHGTLYKATLDSG LAVK LREGI KGKKE ARE
Sbjct: 705 HIFDGSLALTAEELSCAPAEVIGRSCHGTLYKATLDSGHELAVKWLREGITKGKKELARE 764
Query: 779 VKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL 838
+KKLG IKHPNLVS+QGYY GPKEHEKL+ISNY+NAQSL +YL ETD L PLS+DERL
Sbjct: 765 IKKLGTIKHPNLVSVQGYYLGPKEHEKLIISNYMNAQSLDIYLHETDKGNLHPLSLDERL 824
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
RVAV+VA+CL++LH+E+AIPHGNLKSTNILLE P N +LTDY+LHRILT+AGTA+QVLN
Sbjct: 825 RVAVEVAQCLHFLHDEKAIPHGNLKSTNILLETPNRNVLLTDYTLHRILTAAGTAEQVLN 884
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958
AGALGYRPPEFA +SKPCPSL SDVYAFG+ILLELLTG++SGEIV PGVVDL DWVR
Sbjct: 885 AGALGYRPPEFARSSKPCPSLTSDVYAFGVILLELLTGRNSGEIVSGIPGVVDLIDWVRF 944
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTI 1016
LA +NRS +CFDR ++D ++ E+P +IL DML+VALRCILPAS+RPD+ +VF +LSTI
Sbjct: 945 LAEQNRSSQCFDRSLVDKNNGERPSKILDDMLKVALRCILPASDRPDLKTVFGDLSTI 1002
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822319|ref|XP_002879042.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] gi|297324881|gb|EFH55301.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1167 bits (3018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 612/1032 (59%), Positives = 764/1032 (74%), Gaps = 24/1032 (2%)
Query: 1 MQTVSLIVLLLV---VNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNW 57
MQ + ++ LLV ++ G SDFEALL+LKKG DP G+++ SWD K+LS+D CP NW
Sbjct: 1 MQIICSMIFLLVMMMISVSGFSDFEALLELKKGFQSDPFGKVLASWDAKALSTDRCPLNW 60
Query: 58 FGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEF 117
+G+TC++G VTSI LN +GL+GNFSFP I+GL+ML N+S+SNNQ G +++IGS +SL++
Sbjct: 61 YGVTCSSGGVTSIELNGLGLLGNFSFPVIVGLRMLQNLSISNNQFAGTLSNIGSFKSLKY 120
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNIS-SNSFEGTFPSGFGGLGKLKYLDLRANRFGGD 176
LD+S NLF G +PSGI +L+NL +N+S +N+ G P+GFG L KL+YLDL+ N F G+
Sbjct: 121 LDVSGNLFRGSLPSGIENLRNLEFVNLSGNNNLGGVVPAGFGSLQKLQYLDLQGNSFSGE 180
Query: 177 IMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPY 236
+M L SQL SV +VD+S N FSGSLDLGL SSF+SSI+YLN+S NSLVGELF HDG+P+
Sbjct: 181 VMSLFSQLISVEYVDISRNNFSGSLDLGLAKSSFVSSIRYLNVSGNSLVGELFAHDGIPF 240
Query: 237 FDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
FD+LEV DAS+N L G++P F+FV SL+ILRL NQLS SLP LLQESS +L+ELDLSL
Sbjct: 241 FDSLEVLDASSNRLSGSVPVFSFVVSLKILRLQDNQLSASLPPGLLQESSTILTELDLSL 300
Query: 297 NQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYV 356
NQLEGPVGSITS+TL+K+NLSSN+LSGSLP +VGHC I+DLSNN++SGDLSR+QNWG+ +
Sbjct: 301 NQLEGPVGSITSSTLEKLNLSSNRLSGSLPLKVGHCAIIDLSNNKISGDLSRIQNWGDSI 360
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
E I LSSN LTG +P QTSQFLRLTS +V+NNSLEG LP +LGTYPELK IDLS N LNG
Sbjct: 361 EIIRLSSNSLTGTLPGQTSQFLRLTSLEVANNSLEGVLPFILGTYPELKGIDLSHNQLNG 420
Query: 417 FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLL 476
L + F S KLTDLNLS NNFSG LPLQ+ + NLSLT++ L++NSL G L
Sbjct: 421 VLPSNLFISAKLTDLNLSNNNFSGSLPLQD------ASTAGNLSLTNIGLSHNSLGGVLS 474
Query: 477 PGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPG 536
+++FHNL+ L+LS N FEG+IPDGLP+ LK F VS NNLSG VPENLR FPDSAFHPG
Sbjct: 475 EELTRFHNLISLDLSYNNFEGNIPDGLPDSLKVFTVSANNLSGNVPENLRRFPDSAFHPG 534
Query: 537 NSLLTFPNSP-SQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALW 595
N+LL P SP + D D+TLR H HMK + K ALI+GLV G ++AL+C + +F +
Sbjct: 535 NALLNVPVSPETPVDKTDMTLRKHRYHMKSSVKAALIIGLVVGAALLALVCAMFHFMSRK 594
Query: 596 QRHGRDSFKRDGE----QKAFSEGSSSLSQRSGVNKKGDPSLSSFTFH---QDPLPSSPM 648
Q H + GE QK S+ ++ ++ V + S ++ T + P+ SS
Sbjct: 595 Q-HDEEKSDVTGEKSIVQKTEPSSSNVIAAKNSVQENESSSSTTSTPSIKAKLPVSSSRF 653
Query: 649 ESAYDAGETSSVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNA 708
D+ +S + +P E H DS RKDE LSS V SS PS K N +
Sbjct: 654 SQYSDSENSSPFLKEPTEELHSDSTRKDETLSSQVP---SSTPSLPKIQNSPDNPR--SR 708
Query: 709 CSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGI 768
+ +L G+L++FD SL TAEELS APAE IGRSCHGTLY+A L+S S+LAVK LREG
Sbjct: 709 QTSMRLDGNLYIFDSSLKLTAEELSRAPAEAIGRSCHGTLYRAVLNSDSVLAVKWLREGT 768
Query: 769 AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRK 828
AKGKKEFARE+KK+GNI HPNLVSLQ YYWGPKEHEKL+IS Y++A LA YLQE
Sbjct: 769 AKGKKEFAREIKKIGNINHPNLVSLQAYYWGPKEHEKLIISRYMDAPCLAFYLQEAGQIN 828
Query: 829 LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888
LPPL ++ RL++ +D+A CL+YLHN AIPHGNLKSTN+LL+ P + A LTDYSLHR++T
Sbjct: 829 LPPLLLENRLKITLDIASCLSYLHNGEAIPHGNLKSTNVLLKPPELTAHLTDYSLHRLIT 888
Query: 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPG 948
T++QVLNA ALGY PPEFAS+SKP PSLKSDVYAFG+ILLELLTGK SG+IVC DPG
Sbjct: 889 PEATSEQVLNAAALGYCPPEFASSSKPYPSLKSDVYAFGVILLELLTGKVSGDIVCSDPG 948
Query: 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMS 1008
VV+LT+WV LL +NR+ ECFD I+ +L+D+LQVAL CI PA ERPDM
Sbjct: 949 VVELTEWVLLLVGQNRATECFDPSIIGSQGSRNASGVLTDVLQVALSCISPAPERPDMKL 1008
Query: 1009 VFEELSTIVLEK 1020
V +ELS IVL++
Sbjct: 1009 VSQELSRIVLKR 1020
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145360375|ref|NP_180274.2| Leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|330252837|gb|AEC07931.1| Leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1137 bits (2942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/1042 (58%), Positives = 768/1042 (73%), Gaps = 43/1042 (4%)
Query: 1 MQTVSLIVLLLVVNAL---GQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNW 57
MQ + ++ LLV+ + G SDFEALL+LKKG DPS +++ SWD K+LSSD CP NW
Sbjct: 1 MQIICSMIFLLVMMVMKVSGFSDFEALLELKKGFQGDPSRKVLTSWDAKALSSDRCPLNW 60
Query: 58 FGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEF 117
+G+TC++G VTSI LN GL+G+FSFP I+GL+ML N+S++NNQ G +++IGS+ SL++
Sbjct: 61 YGVTCSSGGVTSIDLNGFGLLGSFSFPVIVGLRMLQNLSIANNQFSGTLSNIGSLTSLKY 120
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNIS-SNSFEGTFPSGFGGLGKLKYLDLRANRFGGD 176
LD+S NLFHG +PSGI +L+NL +N+S +N+ G PSGFG L KLKYLDL+ N F G+
Sbjct: 121 LDVSGNLFHGALPSGIENLRNLEFVNLSGNNNLGGVIPSGFGSLAKLKYLDLQGNSFSGE 180
Query: 177 IMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPY 236
+M L SQL SV +VD+S N FSGSLDLGL SSF+SSI++LN+S NSLVGELF HDG+P+
Sbjct: 181 VMSLFSQLISVEYVDISRNNFSGSLDLGLAKSSFVSSIRHLNVSGNSLVGELFAHDGIPF 240
Query: 237 FDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
FD+LEVFDAS+N L G++P F+FV SL+ILRL NQLS SLP LLQESS +L++LDLSL
Sbjct: 241 FDSLEVFDASSNQLSGSVPVFSFVVSLKILRLQDNQLSASLPPGLLQESSTILTDLDLSL 300
Query: 297 NQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYV 356
NQLEGP+GSITS+TL+K+NLSSN+LSGSLP +VGHC I+DLSNN++SG+LSR+QNWG+ V
Sbjct: 301 NQLEGPIGSITSSTLEKLNLSSNRLSGSLPLKVGHCAIIDLSNNKISGELSRIQNWGDSV 360
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
E I LSSN LTG +P QTSQFLRLTS K +NNSL+G LP +LGTYPELK IDLS N L+G
Sbjct: 361 EIIRLSSNSLTGTLPGQTSQFLRLTSLKAANNSLQGVLPFILGTYPELKEIDLSHNQLSG 420
Query: 417 FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLL 476
+ + F S KLT+LNLS NNFSG LPLQ+ + NLSLT++ L++NSL G L
Sbjct: 421 VIPSNLFISAKLTELNLSNNNFSGSLPLQD------ASTVGNLSLTNIGLSHNSLGGVLS 474
Query: 477 PGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPG 536
+++FHNL+ L+LS N FEG+IPDGLP+ LK F VS NNLSG VPENLR FPDSAFHPG
Sbjct: 475 EELTRFHNLISLDLSYNNFEGNIPDGLPDSLKMFTVSANNLSGNVPENLRRFPDSAFHPG 534
Query: 537 NSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQ 596
N+LL P S +D D+TLR HG HMK + K ALI+GLV G ++AL+C++ +F L +
Sbjct: 535 NALLNVPIS-LPKDKTDITLRKHGYHMKTSVKAALIIGLVVGTALLALVCVMFHF-MLRK 592
Query: 597 RHGRDSFKRDGEQKAF--SEGSSS--LSQRSGVNKKGDPSLSSFTFH---QDPLPSSPME 649
+H + GE+ +E SSS ++ ++ V + S ++ T + P+ SS
Sbjct: 593 QHDEEKSDVTGEKSIVPKTEPSSSNVIAAKNSVQENESSSSTTSTPSIKAKLPVSSSRFS 652
Query: 650 SAYDAGETSSVVTKPKELYHPDSVRKDEGLSS---------PVSLLSSSNPSQSKNSRFT 700
D+ +S + +P E H +S RKDE LSS P S NP+ + S
Sbjct: 653 QYSDSENSSPFLKEPNEELHSES-RKDEILSSQVSSSTPSLPKIQNSPDNPTSRQTSM-- 709
Query: 701 KNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILA 760
+L G+L++FD SL TAEELS APAE IGRSCHGTLY+A L+S S+LA
Sbjct: 710 ------------RLDGNLYIFDSSLKLTAEELSRAPAEAIGRSCHGTLYRAVLNSDSVLA 757
Query: 761 VKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVY 820
VK LREG AKGKKEFARE+KKLGNI HPNLVSLQ YYWGPKEHEKL+IS Y++A LA Y
Sbjct: 758 VKWLREGTAKGKKEFAREIKKLGNINHPNLVSLQAYYWGPKEHEKLIISRYMDAPCLAFY 817
Query: 821 LQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880
LQE LPPL ++ RL++ +D+A CL+YLHN AIPHGNLKSTN+LL+ P + A LTD
Sbjct: 818 LQEAGQLNLPPLLLENRLKITLDIASCLSYLHNGEAIPHGNLKSTNVLLKPPELTAHLTD 877
Query: 881 YSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSG 940
YSLHR++T T++QVLNA ALGY PPEFAS+SKP PSLKSDVYAFG+ILLELLTGK SG
Sbjct: 878 YSLHRLITPEATSEQVLNAAALGYCPPEFASSSKPYPSLKSDVYAFGVILLELLTGKVSG 937
Query: 941 EIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA 1000
+IVC DPGVV+LT+WV LL +NR+ ECFD I+ P +L+D+LQVAL CI PA
Sbjct: 938 DIVCSDPGVVELTEWVLLLVGQNRATECFDPSIVGSQGSRNPFGVLTDVLQVALSCISPA 997
Query: 1001 SERPDMMSVFEELSTIVLEKDS 1022
ERPDM V +ELS IVL++ +
Sbjct: 998 PERPDMKLVSQELSRIVLKRTA 1019
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1025 | ||||||
| TAIR|locus:2059253 | 1020 | AT2G27060 [Arabidopsis thalian | 0.978 | 0.983 | 0.560 | 2e-292 | |
| TAIR|locus:2184058 | 1048 | AT5G10020 [Arabidopsis thalian | 0.932 | 0.912 | 0.358 | 1.3e-148 | |
| TAIR|locus:2098267 | 836 | IMK2 "inflorescence meristem r | 0.284 | 0.349 | 0.416 | 4.5e-86 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.467 | 0.434 | 0.305 | 9.2e-74 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.484 | 0.451 | 0.318 | 3.5e-73 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.474 | 0.438 | 0.298 | 4e-73 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.541 | 0.573 | 0.284 | 1.2e-72 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.540 | 0.573 | 0.301 | 3.5e-72 | |
| TAIR|locus:2091353 | 1016 | AT3G28040 [Arabidopsis thalian | 0.475 | 0.479 | 0.297 | 4.6e-71 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.490 | 0.442 | 0.299 | 6.7e-71 |
| TAIR|locus:2059253 AT2G27060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2808 (993.5 bits), Expect = 2.0e-292, P = 2.0e-292
Identities = 580/1034 (56%), Positives = 723/1034 (69%)
Query: 1 MQTV-SLIVLL--LVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNW 57
MQ + S+I LL +V+ G SDFEALL+LKKG DPS +++ SWD K+LSSD CP NW
Sbjct: 1 MQIICSMIFLLVMMVMKVSGFSDFEALLELKKGFQGDPSRKVLTSWDAKALSSDRCPLNW 60
Query: 58 FGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEF 117
+G+TC++G VTSI LN GL+G+FSFP I+GL+ML N+S++NNQ G +++IGS+ SL++
Sbjct: 61 YGVTCSSGGVTSIDLNGFGLLGSFSFPVIVGLRMLQNLSIANNQFSGTLSNIGSLTSLKY 120
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNIS-SNSFEGTFPSGFGGLGKLKYLDLRANRFGGD 176
LD+S NLFHG +PSGI +L+NL +N+S +N+ G PSGFG L KLKYLDL+ N F G+
Sbjct: 121 LDVSGNLFHGALPSGIENLRNLEFVNLSGNNNLGGVIPSGFGSLAKLKYLDLQGNSFSGE 180
Query: 177 IMHLLSQLGSVVHVDLSNNQXXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPY 236
+M L SQL SV +VD+S N ++LN+S NSLVGELF HDG+P+
Sbjct: 181 VMSLFSQLISVEYVDISRNNFSGSLDLGLAKSSFVSSIRHLNVSGNSLVGELFAHDGIPF 240
Query: 237 FDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVAXXXXXXXXXXXXXXXX 296
FD+LEVFDAS+N L G++P F+FV SL+ILRL NQLS SLP
Sbjct: 241 FDSLEVFDASSNQLSGSVPVFSFVVSLKILRLQDNQLSASLPPGLLQESSTILTDLDLSL 300
Query: 297 NQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYV 356
NQLEGP+GSITS+TL+K+NLSSN+LSGSLP +VGHC I+DLSNN++SG+LSR+QNWG+ V
Sbjct: 301 NQLEGPIGSITSSTLEKLNLSSNRLSGSLPLKVGHCAIIDLSNNKISGELSRIQNWGDSV 360
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
E I LSSN LTG +P QTSQFLRLTS K +NNSL+G LP +LGTYPELK IDLS N L+G
Sbjct: 361 EIIRLSSNSLTGTLPGQTSQFLRLTSLKAANNSLQGVLPFILGTYPELKEIDLSHNQLSG 420
Query: 417 FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLL 476
+ + F S KLT+LNLS NNFSG LPLQ+ + G NLSLT++ L++NSL G L
Sbjct: 421 VIPSNLFISAKLTELNLSNNNFSGSLPLQDAS---TVG---NLSLTNIGLSHNSLGGVLS 474
Query: 477 PGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPG 536
+++FHNL+ L+LS N FEG+IPDGLP+ LK F VS NNLSG VPENLR FPDSAFHPG
Sbjct: 475 EELTRFHNLISLDLSYNNFEGNIPDGLPDSLKMFTVSANNLSGNVPENLRRFPDSAFHPG 534
Query: 537 NSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALWQ 596
N+LL P S +D D+TLR HG HMK + K ALI+GLV G ++AL+C++ +F L +
Sbjct: 535 NALLNVPIS-LPKDKTDITLRKHGYHMKTSVKAALIIGLVVGTALLALVCVMFHFM-LRK 592
Query: 597 RHGRDSFKRDGEQKAFXXXXXXXXXXXGVNKKGDPSLSSFTFHQDP-----LP-SSPMES 650
+H + GE+ + SS + P LP SS S
Sbjct: 593 QHDEEKSDVTGEKSIVPKTEPSSSNVIAAKNSVQENESSSSTTSTPSIKAKLPVSSSRFS 652
Query: 651 AYDAGETSSVVTK-PKELYHPDSVRKDEGXXXXXXXXXXXXXXXXXXXRFTKNSDVLNAC 709
Y E SS K P E H +S RKDE + + D N
Sbjct: 653 QYSDSENSSPFLKEPNEELHSES-RKDE------ILSSQVSSSTPSLPKIQNSPD--NPT 703
Query: 710 SPE---KLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLRE 766
S + +L G+L++FD SL TAEELS APAE IGRSCHGTLY+A L+S S+LAVK LRE
Sbjct: 704 SRQTSMRLDGNLYIFDSSLKLTAEELSRAPAEAIGRSCHGTLYRAVLNSDSVLAVKWLRE 763
Query: 767 GIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDP 826
G AKGKKEFARE+KKLGNI HPNLVSLQ YYWGPKEHEKL+IS Y++A LA YLQE
Sbjct: 764 GTAKGKKEFAREIKKLGNINHPNLVSLQAYYWGPKEHEKLIISRYMDAPCLAFYLQEAGQ 823
Query: 827 RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886
LPPL ++ RL++ +D+A CL+YLHN AIPHGNLKSTN+LL+ P + A LTDYSLHR+
Sbjct: 824 LNLPPLLLENRLKITLDIASCLSYLHNGEAIPHGNLKSTNVLLKPPELTAHLTDYSLHRL 883
Query: 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVD 946
+T T++QVLNA ALGY PPEFAS+SKP PSLKSDVYAFG+ILLELLTGK SG+IVC D
Sbjct: 884 ITPEATSEQVLNAAALGYCPPEFASSSKPYPSLKSDVYAFGVILLELLTGKVSGDIVCSD 943
Query: 947 PGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDM 1006
PGVV+LT+WV LL +NR+ ECFD I+ P +L+D+LQVAL CI PA ERPDM
Sbjct: 944 PGVVELTEWVLLLVGQNRATECFDPSIVGSQGSRNPFGVLTDVLQVALSCISPAPERPDM 1003
Query: 1007 MSVFEELSTIVLEK 1020
V +ELS IVL++
Sbjct: 1004 KLVSQELSRIVLKR 1017
|
|
| TAIR|locus:2184058 AT5G10020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 363/1012 (35%), Positives = 550/1012 (54%)
Query: 30 GIAKDP-SGQIID-SWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGN-FS---F 83
GI+ DP +G II + D + LS + G+T L ++ L GN FS
Sbjct: 66 GISCDPETGSIIAINLDRRGLSGELKFSTLSGLT---------RLRNLSLSGNSFSGRVV 116
Query: 84 PTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
P++ G+ L ++ +S+N G I I + SL L+LS N F G PSG +L+ L L
Sbjct: 117 PSLGGISSLQHLDLSDNGFYGPIPGRISELWSLNHLNLSSNKFEGGFPSGFRNLQQLRSL 176
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI---MHLLSQLGSVV-HVDLSNNQXX 198
++ N G F L ++++DL NRF G + M +S + + + H++LS+N
Sbjct: 177 DLHKNEIWGDVGEIFTELKNVEFVDLSCNRFNGGLSLPMENISSISNTLRHLNLSHN-AL 235
Query: 199 XXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFN 258
+ +++ N + GEL PH G +L + + N L G +P
Sbjct: 236 NGKFFSEESIGSFKNLEIVDLENNQINGEL-PHFGSQ--PSLRILKLARNELFGLVPQEL 292
Query: 259 FVFSLRILRL--GSNQLSGSLPVAXXXXXXXXXXXXXXXXNQLEGPVGSITSATLKKVNL 316
S+ +L L N +GS+ N L G + S + + ++L
Sbjct: 293 LQSSIPLLELDLSRNGFTGSI----SEINSSTLTMLNLSSNGLSGDLPS-SFKSCSVIDL 347
Query: 317 SSNKLSGSLPA-RVGHCT--IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
S N SG + + T ++DLS+N LSG L + + + + + +N ++G +P+
Sbjct: 348 SGNTFSGDVSVVQKWEATPDVLDLSSNNLSGSLPNFTSAFSRLSVLSIRNNSVSGSLPSL 407
Query: 374 --TSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDL 431
SQF + +S+N G +P T+ L+ ++LS N+L G P F ++ ++L
Sbjct: 408 WGDSQF---SVIDLSSNKFSGFIPVSFFTFASLRSLNLSRNNLEG---PIPFRGSRASEL 461
Query: 432 NLSGNNFSGPLPLQEIQNNPSTGSTQN-----LSLTSLDLAYNSLSGRLLPGISKFHNLV 486
L N++ + L ++ N TG + L+LA N LSG L ++K L+
Sbjct: 462 -LVLNSYP-QMELLDLSTNSLTGMLPGDIGTMEKIKVLNLANNKLSGELPSDLNKLSGLL 519
Query: 487 YLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSP 546
+L+LSNN F+G IP+ LP+ + FNVS+N+LSG++PE+LR++P S+F+PGNS L+ P
Sbjct: 520 FLDLSNNTFKGQIPNKLPSQMVGFNVSYNDLSGIIPEDLRSYPPSSFYPGNSKLSLPGRI 579
Query: 547 SQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRA-LWQRHGRDSFKR 605
DL+L G +H K + +IA+IV V G ++ L + Y R L HGR+ F
Sbjct: 580 PADSSGDLSLPGKKHHSKLSIRIAIIVASV-GAAIMILFVLFAYHRTQLKDFHGRNRFTD 638
Query: 606 DGEQKAFXXXXXXXXXXXGVNKKGDPSLSSFTFHQDPLPSSPMESAYDA-GETSSVVTKP 664
+ + + SS +F D L ++ S G + + +
Sbjct: 639 QATTRDTKFGRSSRPSLFNFSSNVEQQSSSLSFSNDHLLTANSRSLSGIPGCEAEISEQG 698
Query: 665 KELYHPDSVRKDEGXXXXXXXXXXXXXXXXXXXRFTKNSDVLNACSPEKLAGDLHLFDVS 724
+ D+ RF+ +L+ SP++LAG+L DVS
Sbjct: 699 APATSAPTNLLDDYPAASGRKSSSGGSPLSSSPRFSDQPVMLDVYSPDRLAGELFFLDVS 758
Query: 725 LMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGN 784
L TAEELS APAEV+GRS HGTLYKATLD+G +L VK LR G+ + KK+FARE KK+G+
Sbjct: 759 LKLTAEELSRAPAEVLGRSSHGTLYKATLDNGHMLTVKWLRVGLVRHKKDFAREAKKIGS 818
Query: 785 IKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDV 844
+KHPN+V L+ YYWGP+E E+L++S+Y+ +SLA++L ET PR+ P+S +RL+VAV+V
Sbjct: 819 LKHPNIVPLRAYYWGPREQERLLLSDYLRGESLAMHLYETTPRRYSPMSFSQRLKVAVEV 878
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGY 904
A+CL YLH +RA+PHGNLK TNI+L +P +TDY +HR++T +G A+Q+LN ALGY
Sbjct: 879 AQCLLYLH-DRAMPHGNLKPTNIILSSPDNTVRITDYCVHRLMTPSGVAEQILNMSALGY 937
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964
PE +S SKP P+LKSDVYAFG+IL+ELLT +S+G+I+ G VDLTDWVRL E R
Sbjct: 938 SAPELSSASKPIPTLKSDVYAFGVILMELLTRRSAGDIISGQTGAVDLTDWVRLCDQEGR 997
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELSTI 1016
+C DR I G + + + D L VA+RCIL +ERP++ V + L++I
Sbjct: 998 RMDCIDRDIAGGEEFSKG---MEDALAVAIRCILSVNERPNIRQVLDHLTSI 1046
|
|
| TAIR|locus:2098267 IMK2 "inflorescence meristem receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 4.5e-86, Sum P(2) = 4.5e-86
Identities = 127/305 (41%), Positives = 186/305 (60%)
Query: 713 KLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGK 772
++ G L FD +FTA++L A AE++G+S +GT YKATL+ G+ +AVKRLRE KG
Sbjct: 516 EMGGKLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGV 575
Query: 773 KEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPL 832
KEF EV LG I+H NL++L+ YY GPK EKL++ +Y++ SL+ +L P L P
Sbjct: 576 KEFEGEVTALGKIRHQNLLALRAYYLGPKG-EKLLVFDYMSKGSLSAFLHARGPETLIPW 634
Query: 833 SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892
+ R+++A ++R L +LH+ + H NL ++NILL+ T NA + DY L R++T+A
Sbjct: 635 --ETRMKIAKGISRGLAHLHSNENMIHENLTASNILLDEQT-NAHIADYGLSRLMTAAAA 691
Query: 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDL 952
+ + AG LGYR PEF+ S K+DVY+ GII+LELLTGKS GE +DL
Sbjct: 692 TNVIATAGTLGYRAPEFSKIKNA--SAKTDVYSLGIIILELLTGKSPGE----PTNGMDL 745
Query: 953 TDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011
WV + E + E FD +M + + L + L++AL C+ P+ + RP+ V E
Sbjct: 746 PQWVASIVKEEWTNEVFDLELM--RETQSVGDELLNTLKLALHCVDPSPAARPEANQVVE 803
Query: 1012 ELSTI 1016
+L I
Sbjct: 804 QLEEI 808
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 9.2e-74, Sum P(2) = 9.2e-74
Identities = 155/507 (30%), Positives = 255/507 (50%)
Query: 95 VSVSNNQLMGNIT-DIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
+++ NQL+G I ++G +QSLEFL L N +G IP I +L + ++ S N+ G
Sbjct: 270 LALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 154 PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQXXXXXXXXXXXXXXXXX 213
P G + L+ L L N+ G I LS L ++ +DLS N
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFM 389
Query: 214 XQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFS-LRILRLGSNQ 272
Q + +NSL G + P G ++ +L V D S+NHL G IPS+ + S + IL LG+N
Sbjct: 390 LQ---LFQNSLSGTIPPKLG--WYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 273 LSGSLPVAXXXXXXXXXXXXXXXXNQLEG--PVGSITSATLKKVNLSSNKLSGSLPARVG 330
LSG++P N L G P + + L N+ GS+P VG
Sbjct: 445 LSGNIPTGITTCKTLVQLRLAR--NNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVG 502
Query: 331 HCTIVD---LSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSN 387
+C+ + L++N +G+L R + + +++SSN LTG VP++ L +
Sbjct: 503 NCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCC 562
Query: 388 NSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEI 447
N+ G LP+ +G+ +L+++ LS N+L+G + + ++LT+L + GN F+G +P +E+
Sbjct: 563 NNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIP-REL 621
Query: 448 QNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN-- 505
GS L + +L+L+YN L+G + P +S L +L L+NN G IP N
Sbjct: 622 ------GSLTGLQI-ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLS 674
Query: 506 GLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSPSQQDVPDLTLRGHGNH--M 563
L +N S+N+L+G +P LRN S+F L P + Q P + G M
Sbjct: 675 SLLGYNFSYNSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGM 733
Query: 564 KPATKIALIVGLVCGVTMVALLCMLIY 590
+ + IA+ ++ GV+++ L+ +++Y
Sbjct: 734 RSSKIIAITAAVIGGVSLM-LIALIVY 759
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 3.5e-73, Sum P(2) = 3.5e-73
Identities = 173/543 (31%), Positives = 251/543 (46%)
Query: 11 LVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN-GYVTS 69
++V +L + LL+ K D +G + SW+ L S+ C NW GI CT+ VTS
Sbjct: 19 ILVRSLNEEG-RVLLEFK-AFLNDSNGYLA-SWN--QLDSNPC--NWTGIACTHLRTVTS 71
Query: 70 IMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNIT-DIGSIQSLEFLDLSHNLFHGL 128
+ LN M L G S P I L L ++VS N + G I D+ +SLE LDL N FHG+
Sbjct: 72 VDLNGMNLSGTLS-PLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGV 130
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
IP + + L L + N G+ P G L L+ L + +N G I +++L +
Sbjct: 131 IPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLR 190
Query: 189 HVDLSNNQXXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+ N + L ++EN L G L P + NL N
Sbjct: 191 IIRAGRN---GFSGVIPSEISGCESLKVLGLAENLLEGSL-PKQ-LEKLQNLTDLILWQN 245
Query: 249 HLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVAXXXXXXXXXXXXXXXXNQLEG--P--V 303
L G IP S + L +L L N +GS+P NQL G P +
Sbjct: 246 RLSGEIPPSVGNISRLEVLALHENYFTGSIP--REIGKLTKMKRLYLYTNQLTGEIPREI 303
Query: 304 GSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIH 360
G++ A +++ S N+L+G +P GH ++ L N L G + R +E +
Sbjct: 304 GNLIDAA--EIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLD 361
Query: 361 LSSNFLTGMVPNQTSQFLR-LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLL 419
LS N L G +P Q QFL L ++ +N LEG +P ++G Y V+D+S N L+G +
Sbjct: 362 LSINRLNGTIP-QELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIP 420
Query: 420 PSFFTSTKLTDLNLSGNNFSGPLP--------LQEIQ--NNPSTGSTQ----NL-SLTSL 464
F L L+L N SG +P L ++ +N TGS NL +LT+L
Sbjct: 421 AHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTAL 480
Query: 465 DLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLK--EFNVSFNNLSGVVP 522
+L N LSG + + K NL L L+NN F G IP + N K FN+S N L+G +P
Sbjct: 481 ELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIP 540
Query: 523 ENL 525
+ L
Sbjct: 541 KEL 543
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 4.0e-73, Sum P(2) = 4.0e-73
Identities = 155/519 (29%), Positives = 238/519 (45%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNG-YVTSIMLNDMGL 77
SD ALL L + PS I SW+ +SD P +W G+ C +V ++ L+ G+
Sbjct: 26 SDGAALLSLTRHWTSIPS-DITQSWN----ASDSTPCSWLGVECDRRQFVDTLNLSSYGI 80
Query: 78 VGNFSFPTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSL 136
G F P I LK L V +S N G+I + +G+ LE +DLS N F G IP + +L
Sbjct: 81 SGEFG-PEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGAL 139
Query: 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQ 196
+NL L++ NS G FP + L+ + N G I + + + + L +NQ
Sbjct: 140 QNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQ 199
Query: 197 XXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
Q L +++N+LVG L P + +NL D NN LVGAIP
Sbjct: 200 FSGPVPSSLGNITTL---QELYLNDNNLVGTL-PVT-LNNLENLVYLDVRNNSLVGAIP- 253
Query: 257 FNFVFSLRI--LRLGSNQLSGSLPVAXXXXXXXXXXXXXXXXNQLEGPVGSITSATLK-- 312
+FV +I + L +NQ +G LP L GP+ S K
Sbjct: 254 LDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCA--LSGPIPSCFGQLTKLD 311
Query: 313 KVNLSSNKLSGSLPARVGHC-TIVDLS--NNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM 369
+ L+ N SG +P +G C +++DL N+L G++ + ++ +HL +N L+G
Sbjct: 312 TLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGE 371
Query: 370 VPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLT 429
VP + L S ++ N+L G+LP + +L + L NH G + ++ L
Sbjct: 372 VPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLE 431
Query: 430 DLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLN 489
L+L+ N F+G +P P+ S + L L L YN L G + + L L
Sbjct: 432 VLDLTRNMFTGHIP-------PNLCSQKKLK--RLLLGYNYLEGSVPSDLGGCSTLERLI 482
Query: 490 LSNNKFEGSIPDGLPN-GLKEFNVSFNNLSGVVPENLRN 527
L N G +PD + L F++S NN +G +P +L N
Sbjct: 483 LEENNLRGGLPDFVEKQNLLFFDLSGNNFTGPIPPSLGN 521
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.2e-72, Sum P(2) = 1.2e-72
Identities = 176/619 (28%), Positives = 287/619 (46%)
Query: 4 VSLIVLLLV--VNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGIT 61
+ ++V +L+ V+ + ++ +AL+ +K + + + ++D WD + D C +W G+
Sbjct: 14 LGMVVFMLLGSVSPMN-NEGKALMAIKASFS-NVANMLLD-WDDVH-NHDFC--SWRGVF 67
Query: 62 CTNGY--VTSIMLNDMGLVGNFSFPTIIG-LKMLCNVSVSNNQLMGNITD-IGSIQSLEF 117
C N V S+ L+++ L G S + +G L L ++ + N+L G I D IG+ SL +
Sbjct: 68 CDNVSLNVVSLNLSNLNLGGEIS--SALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAY 125
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI 177
+D S NL G IP I LK L LN+ +N G P+ + LK LDL N+ G+I
Sbjct: 126 VDFSTNLLFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEI 185
Query: 178 MHLLSQLGSVVHVDLSNNQXXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPYF 237
LL + ++ L N Y ++ N+L G + P + +
Sbjct: 186 PRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLW---YFDVRGNNLTGTI-P-ESIGNC 240
Query: 238 DNLEVFDASNNHLVGAIPSFNFVF-SLRILRLGSNQLSGSLPVAXXXXXXXXXXXXXXXX 296
+ E+ D S N + G IP +N F + L L N+L+G +P
Sbjct: 241 TSFEILDVSYNQITGVIP-YNIGFLQVATLSLQGNKLTGRIPEVIGLMQALAVLDLSD-- 297
Query: 297 NQLEGPVGSITS--ATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQN 351
N+L GP+ I + K+ L NKL+G +P +G+ + + L++N L G +
Sbjct: 298 NELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELG 357
Query: 352 WGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSL 411
+ +++L++N L G++P+ S L F V N L G +P L ++LS
Sbjct: 358 KLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSS 417
Query: 412 NHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQ----------EIQNNPSTGSTQ---- 457
N G + L L+LSGNNFSG +PL + N G+
Sbjct: 418 NSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFG 477
Query: 458 NL-SLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSF 514
NL S+ +D+++N L+G + + + N+ L L+NNK G IPD L N L N+SF
Sbjct: 478 NLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISF 537
Query: 515 NNLSGVVPENLRNFPDSAFHP----GNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIA 570
NNLSG++P ++NF + F P GN L N P L P +++
Sbjct: 538 NNLSGIIPP-MKNF--TRFSPASFFGNPFLC-GNWVGSICGPSL----------PKSQVF 583
Query: 571 LIVGLVCGVT-MVALLCML 588
V ++C V + L+CM+
Sbjct: 584 TRVAVICMVLGFITLICMI 602
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 3.5e-72, Sum P(2) = 3.5e-72
Identities = 187/621 (30%), Positives = 295/621 (47%)
Query: 12 VVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN-GY-VTS 69
V +A+ ++ +AL+ +K G + ++D WD +SD C +W G+ C N Y V S
Sbjct: 22 VASAMN-NEGKALMAIK-GSFSNLVNMLLD-WDDVH-NSDLC--SWRGVFCDNVSYSVVS 75
Query: 70 IMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGL 128
+ L+ + L G S P I L+ L ++ + N+L G I D IG+ SL +LDLS NL +G
Sbjct: 76 LNLSSLNLGGEIS-PAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGD 134
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLL--SQL-- 184
IP I LK L LN+ +N G P+ + LK LDL N G+I LL +++
Sbjct: 135 IPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQ 194
Query: 185 -----GSVVHVDLSNN------------QXXXXXXXXXXXXXXXXXXQYLNISENSLVGE 227
G+++ LS++ + Q L+IS N + GE
Sbjct: 195 YLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGE 254
Query: 228 LFPHD-GMPYFDNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVAXXXXX 285
+ P++ G F + N L G IP + +L +L L N+L G P+
Sbjct: 255 I-PYNIG---FLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVG--PIPPILGN 308
Query: 286 XXXXXXXXXXXNQLEGPVGSITS--ATLKKVNLSSNKLSGSLPARVGHCTIV---DLSNN 340
N L GP+ S + L + L+ NKL G++P +G + +L+NN
Sbjct: 309 LSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANN 368
Query: 341 RLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGT 400
RL G + + + ++ N L+G +P LT +S+N+ +G +P LG
Sbjct: 369 RLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGH 428
Query: 401 YPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
L +DLS N+ +G + + L LNLS N+ SG LP + G+ +++
Sbjct: 429 IINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAE-------FGNLRSIQ 481
Query: 461 LTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLS 518
+ +D+++N LSG + + + NL L L+NNK G IPD L N L NVSFNNLS
Sbjct: 482 M--IDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLS 539
Query: 519 GVVPENLRNFPDSAFHPGNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCG 578
G+VP ++NF S F P + F +P ++ G + ++ ALI +V G
Sbjct: 540 GIVPP-MKNF--SRFAPAS----FVGNPYLCGNWVGSICGPLPKSRVFSRGALIC-IVLG 591
Query: 579 VTMVALLCM--LIYFRALWQR 597
V + LLCM L ++++ Q+
Sbjct: 592 V--ITLLCMIFLAVYKSMQQK 610
|
|
| TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 4.6e-71, Sum P(2) = 4.6e-71
Identities = 156/525 (29%), Positives = 233/525 (44%)
Query: 20 DFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCT--NGYVTSIMLNDMGL 77
D L+ K + DP + +SW D P +W + C V + L+ + L
Sbjct: 36 DVLGLIVFKSDL-NDPFSHL-ESWT----EDDNTPCSWSYVKCNPKTSRVIELSLDGLAL 89
Query: 78 VGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLK 137
G + I L+ L +S+SNN GNI + + L+ LDLSHN G IPS + S+
Sbjct: 90 TGKIN-RGIQKLQRLKVLSLSNNNFTGNINALSNNNHLQKLDLSHNNLSGQIPSSLGSIT 148
Query: 138 NLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQ 196
+L L+++ NSF GT F L+YL L N G I L + + ++LS N+
Sbjct: 149 SLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLSRNR 208
Query: 197 XXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
+ L++S NSL G + P G+ NL+ N GA+PS
Sbjct: 209 FSGNPSFVSGIWRLERL-RALDLSSNSLSGSI-PL-GILSLHNLKELQLQRNQFSGALPS 265
Query: 257 -FNFVFSLRILRLGSNQLSGSLPVAXXXXXXXXXXXXXXXXNQLEG--P--VGSITSATL 311
L + L SN SG LP N L G P +G +T L
Sbjct: 266 DIGLCPHLNRVDLSSNHFSGELP--RTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTG--L 321
Query: 312 KKVNLSSNKLSGSLPARVGHC-TIVDL--SNNRLSGDLSRMQNWGNYVEDIHLSSNFLTG 368
++ SSN+L+G LP+ + + ++ DL S N+LSG++ + + L N +G
Sbjct: 322 VHLDFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSG 381
Query: 369 MVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGT-YPELKVIDLSLNHLNGFLLPSFFTSTK 427
+P+ L L S N L G +P + L +DLS N L G +
Sbjct: 382 NIPDGFFD-LGLQEMDFSGNGLTGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIH 440
Query: 428 LTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVY 487
+ LNLS N+F+ +P P QNL T LDL ++L G + I + +L
Sbjct: 441 MRYLNLSWNHFNTRVP-------PEIEFLQNL--TVLDLRNSALIGSVPADICESQSLQI 491
Query: 488 LNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRNFPD 530
L L N GSIP+G+ N LK ++S NNL+G +P++L N +
Sbjct: 492 LQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQE 536
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 6.7e-71, Sum P(2) = 6.7e-71
Identities = 163/545 (29%), Positives = 250/545 (45%)
Query: 4 VSLIVLLLVVNAL-------GQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRN 56
+SL + LV+ A Q++ +AL K + DP G + SWD S+ P +
Sbjct: 5 ISLFFIFLVIYAPLVSYADESQAEIDALTAFKLNL-HDPLGALT-SWDP---STPAAPCD 59
Query: 57 WFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSL 115
W G+ CTN VT I L + L G S I GL+ML +S+ +N G I T + L
Sbjct: 60 WRGVGCTNHRVTEIRLPRLQLSGRIS-DRISGLRMLRKLSLRSNSFNGTIPTSLAYCTRL 118
Query: 116 EFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG 175
+ L +N G +P + +L +L + N++ N G P G L++LD+ +N F G
Sbjct: 119 LSVFLQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLPS--SLQFLDISSNTFSG 176
Query: 176 DIMHLLSQLGSVVHVDLSNNQXXXXXXXXXXXXXXXXXXQYLNISENSLVGELFPHDGMP 235
I L+ L + ++LS NQ QYL + N L G L P +
Sbjct: 177 QIPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSL---QYLWLDFNLLQGTL-P-SAIS 231
Query: 236 YFDNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVAXX-XXXXXXXXXXX 293
+L AS N + G IP+ + + L +L L +N SG++P +
Sbjct: 232 NCSSLVHLSASENEIGGVIPAAYGALPKLEVLSLSNNNFSGTVPFSLFCNTSLTIVQLGF 291
Query: 294 XXXNQLEGPVGSITSAT-LKKVNLSSNKLSGSLP---ARVGHCTIVDLSNNRLSGDLSRM 349
+ + P + T L+ ++L N++SG P + +D+S N SG++
Sbjct: 292 NAFSDIVRPETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIP-- 349
Query: 350 QNWGNY--VEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVI 407
+ GN +E++ L++N LTG +P + Q L NSL+G +P LG LKV+
Sbjct: 350 PDIGNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVL 409
Query: 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLA 467
L N +G++ S +L LNL NN +G P++ + SL+ LDL+
Sbjct: 410 SLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALT---------SLSELDLS 460
Query: 468 YNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLK--EFNVSFNNLSGVVPENL 525
N SG + IS NL +LNLS N F G IP + N K ++S N+SG VP L
Sbjct: 461 GNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVEL 520
Query: 526 RNFPD 530
P+
Sbjct: 521 SGLPN 525
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00017368001 | SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (1020 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1025 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-52 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-06 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-05 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.003 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.004 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.004 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-52
Identities = 175/537 (32%), Positives = 259/537 (48%), Gaps = 40/537 (7%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGI 60
L L L + L + E LL K I DP + + +W++ S+D C W GI
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPL-KYLSNWNS---SADVC--LWQGI 63
Query: 61 TCTN-GYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD--IGSIQSLEF 117
TC N V SI L+ + G S I L + +++SNNQL G I D + SL +
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI 177
L+LS+N F G IP G S+ NL L++S+N G P+ G LK LDL N G I
Sbjct: 123 LNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 178 MHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYF 237
+ L+ L S+ + L++NQ G + LG + S++++ + N+L GE+ G
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQ---MKSLKWIYLGYNNLSGEIPYEIGG--L 235
Query: 238 DNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
+L D N+L G IP S + +L+ L L N+LSG +P ++ S L LDLS
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF--SLQKLISLDLSD 293
Query: 297 NQLEG--PVGSITSATLKKVNLSSNKLSGSLPARVG---HCTIVDLSNNRLSGDLSRMQN 351
N L G P I L+ ++L SN +G +P + ++ L +N+ SG++ +
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353
Query: 352 WGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSL 411
N + + LS+N LTG +P L + +NSLEG++P LG L+ + L
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 412 NHLNGFLLPSFFTSTKLTD-LNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNS 470
N +G LPS FT L L++S NN G ++ SL L LA N
Sbjct: 414 NSFSG-ELPSEFTKLPLVYFLDISNNNLQG---------RINSRKWDMPSLQMLSLARNK 463
Query: 471 LSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENL 525
G LP L L+LS N+F G++P L + L + +S N LSG +P+ L
Sbjct: 464 FFGG-LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 9e-36
Identities = 123/369 (33%), Positives = 189/369 (51%), Gaps = 18/369 (4%)
Query: 84 PTIIG-LKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
P IG L L ++ + N L G I + +G++++L++L L N G IP I SL+ L+
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
L++S NS G P L L+ L L +N F G I L+ L + + L +N+FSG +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFV 260
LG + ++ L++S N+L GE+ +G+ NL +N L G IP S
Sbjct: 349 PKNLGKHN---NLTVLDLSTNNLTGEI--PEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSIT--SATLKKVNLSS 318
SLR +RL N SG LP + ++ LD+S N L+G + S +L+ ++L+
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLP--LVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 319 NKLSGSLPARVGHCTI--VDLSNNRLSGDLSRMQNWGNYVE--DIHLSSNFLTGMVPNQT 374
NK G LP G + +DLS N+ SG + R G+ E + LS N L+G +P++
Sbjct: 462 NKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR--KLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434
S +L S +S+N L G +PA P L +DLS N L+G + + L +N+S
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 435 GNNFSGPLP 443
N+ G LP
Sbjct: 580 HNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+G GT+Y A +G +A+K ++ E + +E RE++ L + HPN+V L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
++ Y SL L+ LS DE LR+ + + L YLH+ I
Sbjct: 61 EDENHL--YLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSNG-I 113
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +LK NILL++ L D+ L ++LTS + + + G Y PE
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 918 SLKSDVYAFGIILLEL 933
KSD+++ G+IL EL
Sbjct: 173 E-KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E +G G +Y A +G ++A+K ++ + I K ++ RE+K L +KHPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 796 YYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
+ ++ +KL ++ Y L L +K LS DE + L YLH
Sbjct: 65 VF---EDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLH-S 115
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
+ I H +LK NILL+ + L D+ L R L G Y PE K
Sbjct: 116 KGIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTF--VGTPEYMAPEVLL-GK 171
Query: 915 PCPSLKSDVYAFGIILLELLTGKS 938
D+++ G+IL ELLTGK
Sbjct: 172 GY-GKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 43/279 (15%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-----AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+ +G G +YK L AVK L+E + +EF RE + + + HPN+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L +E ++ Y+ L YL++ P+ LS+ + L A+ +AR + YL
Sbjct: 65 KL--LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYL 118
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPE 908
++ I H +L + N L+ V ++D+ L R L + G L R PE
Sbjct: 119 ESKNFI-HRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRK--RGGKLPIRWMAPE 173
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
K + KSDV++FG++L E+ T GE + + V
Sbjct: 174 SLKEGK--FTSKSDVWSFGVLLWEIFTL---GE---QPYPGMSNEE-VL----------- 213
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDM 1006
+ +G+ + QPP ++ + L+C +RP
Sbjct: 214 --EYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTF 250
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 42/279 (15%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-----AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+ +G G +YK TL AVK L+E + +EF RE + + + HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L +E +++ Y+ L YL++ P++L + L A+ +AR + YL
Sbjct: 65 KL--LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSL---SDLLSFALQIARGMEYL 119
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPE 908
++ I H +L + N L+ V ++D+ L R L + G L R PE
Sbjct: 120 ESKNFI-HRDLAARNCLVGEN--LVVKISDFGLSRDLYD--DDYYKVKGGKLPIRWMAPE 174
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
K + KSDV++FG++L E+ T GE + + LE
Sbjct: 175 SLKEGK--FTSKSDVWSFGVLLWEIFTL---GE---EPYPGMSNAE-----VLE------ 215
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDM 1006
+ G+ + +PP ++ ++ L+C +RP
Sbjct: 216 ---YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGK-KEFAREVKKLGNIKHPNLVSLQ 794
+G GT+YKA +G I+AVK L+ K + RE++ L + HPN+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ ++ + L ++ Y L YL + PLS DE ++A+ + R L YLH+
Sbjct: 65 DAF---EDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
I H +LK NILL+ + D+ L + L + ++ G Y PE
Sbjct: 117 NGII-HRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTF-VGTPWYMAPEVLLGG 173
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
K DV++ G+IL ELLTGK
Sbjct: 174 NGYGP-KVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 4e-19
Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 50/288 (17%)
Query: 738 EVIGRSCHGTLYKATL----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+ +G G +YK TL + AVK L+EG + ++EF E + + HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G + +++ Y+ L +L+ + L++ + L++A+ +A+ + YL
Sbjct: 65 RLLGVCTQGEPL--YIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP----- 906
+ H +L + N L+ + ++D+ L R + D G P
Sbjct: 119 E-SKNFVHRDLAARNCLVTE-NLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWMA 172
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966
PE S + KSDV++FG++L E+ T GE ++ + +
Sbjct: 173 PE--SLKDGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLELLE--------- 218
Query: 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEEL 1013
DG+ + +P ++ ++ L+C +RP F EL
Sbjct: 219 --------DGYRLPRPENCPDELYELMLQCWAYDPEDRPT----FSEL 254
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 65/290 (22%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 738 EVIGRSCHGTLYKATLDSGS----ILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVS 792
+ +G G +YK L +AVK L+E ++ +K+F +E + + + HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR----KLPPLSIDERLRVAVDVARCL 848
L G +E ++ Y+ L YL+++ P + LS+ + L A+ +A+ +
Sbjct: 61 LLGVC--TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--P 906
YL +++ + H +L + N L+ + ++D+ L R + G L R
Sbjct: 119 EYLASKKFV-HRDLAARNCLV-GEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMA 175
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDP--GVVDLTDWVRLLALENR 964
PE + KSDV++FG++L E+ T P G+ +L
Sbjct: 176 PESLKDGI--FTSKSDVWSFGVLLWEIFTL-------GATPYPGL----SNEEVL----- 217
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCI-LPASERPDMMSVFEEL 1013
+ G+ + +P ++ ++ L C L +RP + E L
Sbjct: 218 ------EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-17
Identities = 57/161 (35%), Positives = 84/161 (52%), Gaps = 7/161 (4%)
Query: 97 VSNNQLMGNITDIG-SIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPS 155
+SNN L G I + SL+ L L+ N F G +P S K L L++S N F G P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493
Query: 156 GFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQ 215
G L +L L L N+ G+I LS +V +DLS+NQ SG + + +S
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ-- 551
Query: 216 YLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
L++S+N L GE+ + G ++L + S+NHL G++PS
Sbjct: 552 -LDLSQNQLSGEIPKNLGN--VESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E IG+ G +YKA +G +A+K ++ + K++ E++ L KHPN+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC----LNYLH 852
Y K+ E ++ + + SL L+ T ++ E +A V + L YLH
Sbjct: 66 YL--KKDELWIVMEFCSGGSLKDLLKST------NQTLTESQ-IAY-VCKELLKGLEYLH 115
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
+ I H ++K+ NILL T + L D+ L L+ + + G + PE
Sbjct: 116 SNGII-HRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVI 169
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
KP K+D+++ GI +EL GK
Sbjct: 170 -NGKPY-DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 43/295 (14%)
Query: 740 IGRSCHGTLYKATLD-----SGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSL 793
+G G + D +G +AVK L G + + +F RE++ L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+G P +I Y+ + SL YLQ + +++ L + + + ++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLGS 127
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFAS 911
+R I H +L + NIL+E+ ++D+ L ++L V G PE
Sbjct: 128 QRYI-HRDLAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 912 TSKPCPSLKSDVYAFGIILLELLT-GKSS-------GEIVCVDPGVVDLTDWVRLLALEN 963
TSK S SDV++FG+ L EL T G S ++ + G + +T + LL
Sbjct: 186 TSK--FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK--- 240
Query: 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIV 1017
+G + +PP ++ + C +RP F +L IV
Sbjct: 241 -----------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS----FADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 40/283 (14%)
Query: 740 IGRSCHGTLYKATLDS-GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYW 798
+G +G +Y+ +AVK L+E +EF +E + IKHPNLV L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 71
Query: 799 GPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIP 858
+E +I+ ++ +L YL+E + +++ + + L +A ++ + YL + I
Sbjct: 72 -TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEKKNFI- 126
Query: 859 HGNLKSTNILLEAPTMNAVLTDYSLHRILT-SAGTADQVLNAGA---LGYRPPEFASTSK 914
H +L + N L+ + V D+ L R++T TA +AGA + + PE + +K
Sbjct: 127 HRDLAARNCLVGENHLVKV-ADFGLSRLMTGDTYTA----HAGAKFPIKWTAPESLAYNK 181
Query: 915 PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974
S+KSDV+AFG++L E+ T S PG +DL+ L LE
Sbjct: 182 --FSIKSDVWAFGVLLWEIATYGMSPY-----PG-IDLSQVYEL--LEK----------- 220
Query: 975 DGHDMEQPPRILSDMLQVALRCI-LPASERPDMMSVFEELSTI 1016
G+ ME+P + ++ C S+RP + + T+
Sbjct: 221 -GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK--KEFAREVKKLGNIKHPNLVSLQ 794
E++GR G++Y A D+G ++AVK + + + RE++ L +++HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
G +++ + Y++ SL+ L +K L + + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAYLH-S 119
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ-VLNAGALGYRPPEFASTS 913
I H ++K NIL++ L D+ + L T + G + PE
Sbjct: 120 NGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
+ +D+++ G ++E+ TGK
Sbjct: 179 EYGR--AADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 76.3 bits (186), Expect = 2e-14
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 19/265 (7%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKE---FAREVKKLGNIKHP-NLVSL 793
+G G +Y A ++A+K L + + KE F RE++ L ++ HP N+V L
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
++ ++ Y++ SL L++ + PLS E L + + L YLH
Sbjct: 64 YDFFQDEGSL--YLVMEYVDGGSLEDLLKK--IGRKGPLSESEALFILAQILSALEYLH- 118
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-----GALGYRPPE 908
+ I H ++K NILL+ L D+ L ++L G+ + G GY PE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 909 -FASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
S S SD+++ GI L ELLTG E + L + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQV 992
+ +L +L
Sbjct: 239 LSPS--NPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVK--RLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
IG G +Y A LD+G ++AVK R+++ K KE A E+K L +KHPNLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63
Query: 797 YWGPKEH-EKLVI-SNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLH 852
Y+G + H EK+ I Y + +L L+ +DE + + + L YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGR-------ILDEHVIRVYTLQLLEGLAYLH 116
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA--DQVLN-AGALGYRPPEF 909
I H ++K NI L+ + L D+ L + T ++V + AG Y PE
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 910 ASTSKPCPSLKS-DVYAFGIILLELLTGK 937
+ K ++ D+++ G ++LE+ TGK
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-13
Identities = 47/137 (34%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 25 LQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFP 84
L L+ G DP W D WF + + L++ GL G F
Sbjct: 386 LPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWF--------IDGLGLDNQGLRG-FIPN 436
Query: 85 TIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLN 143
I L+ L ++++S N + GNI +GSI SLE LDLS+N F+G IP + L +L +LN
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 144 ISSNSFEGTFPSGFGGL 160
++ NS G P+ GG
Sbjct: 497 LNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 351 NWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLS 410
W +++ + L + L G +PN S+ L S +S NS+ G++P LG+ L+V+DLS
Sbjct: 417 KW--FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS 474
Query: 411 LNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP 443
N NG + S T L LNL+GN+ SG +P
Sbjct: 475 YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 739 VIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK-KEFAREVKKLGNIKHPNLVSLQGY 796
+G G + K +G I+AVK +R I + K+ RE+ L P +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLHNE 854
++ + + Y++ SL L+E R I ER+ ++AV V + L YLH +
Sbjct: 68 FY--NNGDISICMEYMDGGSLDKILKEVQGR------IPERILGKIAVAVLKGLTYLHEK 119
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS--AGTADQVLNAGALGYRPPEFAST 912
I H ++K +NIL+ + L D+ + L + A T G Y PE
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQG 173
Query: 913 SKPCPSLKSDVYAFGIILLELLTGK 937
+ S+KSD+++ G+ L+EL TG+
Sbjct: 174 ND--YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAKGK-KEFAREVKKLGNIKHPNLVSLQ 794
++IGR G +YK L++G +A+K++ E I + K +E+ L N+KHPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN---Y 850
G + + L +I Y SL +++ P P E L VAV V + L Y
Sbjct: 66 GSI---ETSDSLYIILEYAENGSLRQIIKKFGP--FP-----ESL-VAVYVYQVLQGLAY 114
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
LH + I H ++K+ NIL L D+ + L D + G + PE
Sbjct: 115 LHEQGVI-HRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVI 171
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
S SD+++ G ++ELLTG
Sbjct: 172 EMSGAS--TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAR---EVKKLGNIKHPNLVSLQG 795
+G+ G + D+G + A+K L++ +KE E L I HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 796 YYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
++ + EKL ++ Y L +L K S + A ++ L YLH+
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLS-----KEGRFSEERARFYAAEIVLALEYLHSL 112
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG-TADQVLNAGALGYRPPEFASTS 913
I + +LK NILL+A + LTD+ L + L+S G + G Y PE
Sbjct: 113 GII-YRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSRTNTF--CGTPEYLAPEVLLGK 168
Query: 914 KPCPSLKSDVYAFGIILLELLTGKS 938
+ D ++ G++L E+LTGK
Sbjct: 169 GYGKA--VDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 69/290 (23%), Positives = 129/290 (44%), Gaps = 55/290 (18%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSL------ 793
+G G +++ + +A+K L+ +++F +EV+ L ++H +L+SL
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 794 -QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ Y +I+ + SL +L+ + + LP + + +A VA + YL
Sbjct: 74 GEPVY---------IITELMEKGSLLAFLRSPEGQVLP---VASLIDMACQVAEGMAYLE 121
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA--LGYR--PPE 908
+ +I H +L + NIL+ + V D+ L R++ + V + + Y+ PE
Sbjct: 122 EQNSI-HRDLAARNILVGEDLVCKV-ADFGLARLIK-----EDVYLSSDKKIPYKWTAPE 174
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
AS S KSDV++FGI+L E+ T G+ PG+ + E
Sbjct: 175 AASHGT--FSTKSDVWSFGILLYEMFTYGQ------VPYPGMNN--------------HE 212
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
+D+ I G+ M P + ++ ++ L C +RP ++ EEL I
Sbjct: 213 VYDQ-ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 27/204 (13%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G G ++ T + + +AVK L+ G + F E + + ++H LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQL---YAV 69
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARC--LNYLHNER 855
E +++ Y++ SL +L++ + R KLP L +D +VA +A +NY+H +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIERMNYIHRD- 127
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT-SAGTADQVLNAGA---LGYRPPEFAS 911
L+S NIL+ + + D+ L R++ + TA Q GA + + PE A
Sbjct: 128 ------LRSANILV-GDGLVCKIADFGLARLIEDNEYTARQ----GAKFPIKWTAPEAAL 176
Query: 912 TSKPCPSLKSDVYAFGIILLELLT 935
+ ++KSDV++FGI+L EL+T
Sbjct: 177 YGRF--TIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 53/186 (28%), Positives = 98/186 (52%), Gaps = 14/186 (7%)
Query: 754 DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813
++G ++AVK+L+ A+ ++F RE++ L +++H N+V +G + ++ Y+
Sbjct: 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 814 AQSLAVYLQETDPRKLPPLSIDER--LRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA 871
SL YLQ+ R +D R L A + + + YL ++R + H +L + NIL+E+
Sbjct: 91 YGSLRDYLQKHRER------LDHRKLLLYASQICKGMEYLGSKRYV-HRDLATRNILVES 143
Query: 872 PTMNAVLTDYSLHRILTSAGTADQVLNAG--ALGYRPPEFASTSKPCPSLKSDVYAFGII 929
+ D+ L ++L +V G + + PE + SK S+ SDV++FG++
Sbjct: 144 -ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVV 200
Query: 930 LLELLT 935
L EL T
Sbjct: 201 LYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 760 AVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAV 819
AVK L+ G K+F E + + ++HP L+ L Y E +++ + SL
Sbjct: 34 AVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVCTLEEPIYIVTELMKYGSLLE 90
Query: 820 YLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLT 879
YLQ R L + + + +A VA + YL + I H +L + N+L+ + V
Sbjct: 91 YLQGGAGRAL---KLPQLIDMAAQVASGMAYLEAQNYI-HRDLAARNVLVGENNICKV-A 145
Query: 880 DYSLHRILTSAGTADQVLNA--GA---LGYRPPEFASTSKPCPSLKSDVYAFGIILLELL 934
D+ L R++ + + A GA + + PE A ++ S+KSDV++FGI+L E++
Sbjct: 146 DFGLARVI-----KEDIYEAREGAKFPIKWTAPEAALYNRF--SIKSDVWSFGILLTEIV 198
Query: 935 T 935
T
Sbjct: 199 T 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (158), Expect = 4e-11
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 38/215 (17%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNLV 791
E +G +G +YKA +G I+A+K++R EGI RE+ L +KHPN+V
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI---PSTALREISLLKELKHPNIV 61
Query: 792 SLQGYYWGPKEHEKLV-ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
L + KL + Y + L YL ++ PLS + + + R L Y
Sbjct: 62 KLLDVIHTER---KLYLVFEYCD-MDLKKYLD----KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA--DQVLNAGALGYRPPE 908
H+ R I H +LK NIL+ L D+ L R +V+ L YR PE
Sbjct: 114 CHSHR-ILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVT---LWYRAPE 168
Query: 909 ------FASTSKPCPSLKSDVYAFGIILLELLTGK 937
ST+ D+++ G I E++TGK
Sbjct: 169 ILLGSKHYSTA-------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 739 VIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAR-EVKKLGNIKHPNLVSLQG 795
V+GR G ++ ++ +K++ E + K ++ A+ E + L + HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 796 YYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
YY E + L+I Y +LA Y+Q+ L D L V + L+++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---DTILHFFVQILLALHHVHT- 119
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
+ I H +LK+ NILL+ M + D+ + +IL+S A V+ G Y PE K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCE-GK 176
Query: 915 PCPSLKSDVYAFGIILLELLTGKSSGE 941
P + KSD++A G +L EL + K + E
Sbjct: 177 PY-NQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 759 LAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
+A+K ++EG + + EF E K + + H LV L G K+ +++ Y++ L
Sbjct: 31 VAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTEYMSNGCLL 87
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878
YL+E R P + L + DV + YL +++ I H +L + N L++ V
Sbjct: 88 NYLREHGKRFQP----SQLLEMCKDVCEGMAYLESKQFI-HRDLAARNCLVDDQGCVKV- 141
Query: 879 TDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GK 937
+D+ L R + V + + + PPE SK S KSDV+AFG+++ E+ + GK
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF--SSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G G ++ T + + +AVK L+ G + F +E + + ++H LV L Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQL---YAV 69
Query: 800 PKEHEKL-VISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVARCLNYLHNERAI 857
E E + +++ Y++ SL +L+ + +KL P +D +A +A + YL + I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD----MAAQIAEGMAYLESRNYI 125
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--GA---LGYRPPEFAST 912
H +L + NIL+ + + D+ L R++ D A GA + + PE A+
Sbjct: 126 -HRDLAARNILV-GENLVCKIADFGLARLI-----EDDEYTAREGAKFPIKWTAPEAANY 178
Query: 913 SKPCPSLKSDVYAFGIILLELLT 935
+ ++KSDV++FGI+L E++T
Sbjct: 179 GRF--TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 738 EVIGRSCHGTLYKATL--DSGSIL--AVKRLR-EGIAKGK-KEFAREVKKLGNIKHPNLV 791
+++G G++ + L D GS L AVK ++ + + +EF E + + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 792 SLQGYYWGPKEHEK----LVISNYINAQSLAVYL----QETDPRKLPPLSIDERLRVAVD 843
L G + +K +VI ++ L +L P KLP + L+ VD
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP---LQTLLKFMVD 121
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG 903
+A + YL N I H +L + N +L M + D+ L + + S Q G +
Sbjct: 122 IALGMEYLSNRNFI-HRDLAARNCML-REDMTVCVADFGLSKKIYSGDYYRQ----GRIA 175
Query: 904 YRPPEF---ASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLL 959
P ++ S + + KSDV+AFG+ + E+ T G++ PGV
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------PGV---------- 219
Query: 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
EN E +D L G+ ++QP L ++ + C +RP + E L I
Sbjct: 220 --ENH--EIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 40/221 (18%)
Query: 730 EELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGIAKGKKEFAREV---K 780
EEL+ IG +GT+YKA L++G +A+K++R EGI RE+ K
Sbjct: 2 EELAE-----IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLK 53
Query: 781 KLGNIKHPNLVSLQGYYWGPKEHEKLVIS---NYINAQSLAVYLQETDPRKLPPLSIDER 837
+L + +HPN+V L GP+ +L ++ +++ Q LA YL + LPP +I +
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDL 112
Query: 838 LRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT--SAGTADQ 895
+R + R +++LH+ R + H +LK NIL+ + + D+ L RI + A T+
Sbjct: 113 MR---QLLRGVDFLHSHRIV-HRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVV 167
Query: 896 VLNAGALGYRPPEF---ASTSKPCPSLKSDVYAFGIILLEL 933
V L YR PE +S + P D+++ G I EL
Sbjct: 168 V----TLWYRAPEVLLQSSYATPV-----DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 2e-10
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
+ IG+ G +Y G + +K L K +++ EVK L + HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 795 GYYWGPKEHEKLVI-SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
YY +E KL I Y + L+ +++ P ++ L V + L YLH+
Sbjct: 64 -YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHS 121
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++K NI L + L D+ + ++L+S + + G Y PE +
Sbjct: 122 RK-ILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQ-N 177
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
KP + KSD+++ G +L EL T K
Sbjct: 178 KPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 739 VIGRSCHGTLYKATLD-SGSILAVKRLRE-GIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
V+G+ G +YK +G I A+K++ G + +K+ RE+K L + + P +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ KE E ++ Y++ SLA L++ P L+ +A + + L+YLH +R
Sbjct: 68 F--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKRH 120
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-GALGYRPPE-FASTSK 914
I H ++K +N+L+ + + D+ + ++L + T DQ G + Y PE S
Sbjct: 121 IIHRDIKPSNLLINS-KGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSPERIQGESY 177
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
S +D+++ G+ LLE GK
Sbjct: 178 ---SYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E IG+ G +YK L + +AVK R + K++F +E + L HPN+V L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
++ ++ + SL +L++ R L++ + L++++D A + YL ++
Sbjct: 61 CV--QKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 857 IPHGNLKSTNILLEAPTMNAVL--TDYSLHR-----ILTSAGTADQVLNAGALGYRPPEF 909
I H +L + N L+ N VL +D+ + R I T + Q+ + + PE
Sbjct: 115 I-HRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQI----PIKWTAPEA 166
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGKSS 939
+ + + +SDV+++GI+L E + +
Sbjct: 167 LNYGR--YTSESDVWSYGILLWETFSLGDT 194
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGK-----KEFAREVKKLGNIKHPNLV 791
E++G G++Y+ LD G AVK + K+ +E+ L ++HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 792 SLQGYYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
Y +E + L I + SLA L++ P + + R + L Y
Sbjct: 66 Q---YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEY 117
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPE 908
LH+ + H ++K NIL++ N V L D+ + + + A G+ + PE
Sbjct: 118 LHDRNTV-HRDIKGANILVDT---NGVVKLADFGMAKQVVEFSFAKSF--KGSPYWMAPE 171
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ L +D+++ G +LE+ TGK
Sbjct: 172 VIAQQGGY-GLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 27/204 (13%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G+ C G ++ T + + +A+K L+ G + F +E + + ++H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPL---YAV 69
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARC--LNYLHNER 855
E +++ ++ SL +L+E D + KLP L +D ++A +A +NY+H +
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIERMNYIHRD- 127
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT-SAGTADQVLNAGA---LGYRPPEFAS 911
L++ NIL+ + + D+ L R++ + TA Q GA + + PE A
Sbjct: 128 ------LRAANILV-GDNLVCKIADFGLARLIEDNEYTARQ----GAKFPIKWTAPEAAL 176
Query: 912 TSKPCPSLKSDVYAFGIILLELLT 935
+ ++KSDV++FGI+L EL+T
Sbjct: 177 YGRF--TIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 727 FTAEELSHAPAEVIGRSCHGTLYKATL-DSGSILAVKRLR-EGIAKGKKEFARE---VKK 781
FTAE+L IGR GT+ K SG+I+AVKR+R K +K + V +
Sbjct: 1 FTAEDLKDL--GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR 58
Query: 782 LGNIKHPNLVSLQGYYWGPKEHE-------KLVISNYINAQSLAVYLQETDPRKLPPLSI 834
+ P +V ++G E +L+ + VY I
Sbjct: 59 SSDC--PYIVK----FYGALFREGDCWICMELMDISLDKFYKY-VYEVLKS-------VI 104
Query: 835 DERL--RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY--SLHRILTSA 890
E + ++AV + LNYL E I H ++K +NILL+ N L D+ S + + A
Sbjct: 105 PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIA 163
Query: 891 GTADQVLNAGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLELLTGK 937
T D AG Y PE +++ ++SDV++ GI L E+ TGK
Sbjct: 164 KTRD----AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREG-----IAKGKKEFAREVKKLGNIKHPNLVSL 793
IG +G ++K ++G I+A+K+ E I KK RE++ L +KHPNLV+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALREIRMLKQLKHPNLVNL 65
Query: 794 QGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ + KL ++ Y + L E +PR +P I + + + +N+ H
Sbjct: 66 IEVF---RRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIW---QTLQAVNFCH 117
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTA--DQVLNAGALGYRPPE 908
I H ++K NIL+ T L D+ RILT G D V YR PE
Sbjct: 118 KHNCI-HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYV---ATRWYRAPE 170
Query: 909 F--ASTSKPCPSLKSDVYAFGIILLELLTG 936
T P DV+A G + ELLTG
Sbjct: 171 LLVGDTQYGPP---VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 740 IGRSCHGTLYKATL------DSGSI-LAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+G G +Y+ T SG I +AVK LR+G + KKEF +E + N HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 792 SLQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPP--LSIDERLRVAVDVARCL 848
L G +E +I + L YL++ + P L++ E L + +DVA+
Sbjct: 63 KLLGVCL---LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLT----DYSLHRILTSAGTADQVLNAGALGY 904
YL I H +L + N L+ +A D+ L R + + + G L
Sbjct: 120 VYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-RKEGEGLLPV 177
Query: 905 R--PPEFASTSKPCPSLKSDVYAFGIILLELLT 935
R PE S + +SDV++FG+++ E+LT
Sbjct: 178 RWMAPE--SLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-10
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 15/226 (6%)
Query: 332 CTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLE 391
+DL+ NRL ++S + + + L +N +T + P L +S+N +E
Sbjct: 95 LPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE 153
Query: 392 GDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNP 451
LP+ L P LK +DLS N L+ L + L +L+LSGN S L
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS---DLPPEIELL 208
Query: 452 STGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSI-PDGLPNGLKEF 510
S +L LDL+ NS+ LL +S NL L LSNNK E G + L+
Sbjct: 209 S-------ALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETL 260
Query: 511 NVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSPSQQDVPDLTL 556
++S N +S + GNSL + + L
Sbjct: 261 DLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306
|
Length = 394 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 738 EVIGRSCHGTLYKATLD----SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVS 792
+VIG G +++ L +A+K L+ G K +++F E +G H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L+G K ++I+ Y+ +L YL++ D + + LR +A + YL
Sbjct: 71 LEGVV--TKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLR---GIAAGMKYLS 124
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFA 910
+ + H +L + NIL+ + + ++D+ L R+L + G + R PE
Sbjct: 125 DMNYV-HRDLAARNILVNS-NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 911 STSKPCPSLKSDVYAFGIILLELLT 935
+ K + SDV++FGI++ E+++
Sbjct: 183 AYRKFTSA--SDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 48/274 (17%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G+ C G ++ T + + +A+K L+ G + F +E + + ++H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL---YAV 69
Query: 800 PKEHEKLVISNYINAQSLAVYL--QETDPRKLPPLSIDERLRVAVDVARC--LNYLHNER 855
E +++ Y++ SL +L + +LP L +D ++A +A +NY+H +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVERMNYVHRD- 127
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT-SAGTADQVLNAGA---LGYRPPEFAS 911
L++ NIL+ + + D+ L R++ + TA Q GA + + PE A
Sbjct: 128 ------LRAANILV-GENLVCKVADFGLARLIEDNEYTARQ----GAKFPIKWTAPEAAL 176
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971
+ ++KSDV++FGI+L EL T G + PG+V NR E D+
Sbjct: 177 YGRF--TIKSDVWSFGILLTELTT---KGRVPY--PGMV------------NR--EVLDQ 215
Query: 972 LIMDGHDMEQPPRILSDMLQVALRCILP-ASERP 1004
+ G+ M PP + + +C ERP
Sbjct: 216 -VERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 754 DSGSILAVKRLREGIAKGKKEFAR---EVKKLGNIKHPNLVSLQGYYWGPKEHEKL-VIS 809
+G +A+K LR + + + AR E + HPN+V+L G L +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDS--GEAPPGLLFAVF 58
Query: 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869
Y+ ++L L LP E R+ + V L HN + I H +LK NI++
Sbjct: 59 EYVPGRTLREVLAADGA--LPA---GETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 870 EAP--TMNAVLTDYSLHRILTSAGTAD-QVLNA-----GALGYRPPEFASTSKPCPSLKS 921
+A + D+ + +L AD L G Y PE P S
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP--NS 170
Query: 922 DVYAFGIILLELLTGK 937
D+YA+G+I LE LTG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 55/195 (28%), Positives = 78/195 (40%), Gaps = 46/195 (23%)
Query: 406 VID-LSLNH--LNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLT 462
ID L L++ L GF+ L +NLSGN+ G +P PS GS SL
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP-------PSLGSIT--SLE 469
Query: 463 SLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVP 522
LDL+YNS +G + + + +L LNL+ N G +P L G SFN
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL-GGRLLHRASFN------- 521
Query: 523 ENLRNFPDSAFHPGNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMV 582
F ++ +P LR G H+ KI + G+ V
Sbjct: 522 -------------------FTDNAGLCGIPG--LRACGPHLSVGAKIGIAFGV-----SV 555
Query: 583 ALLCMLIYFRALWQR 597
A L ++I W+R
Sbjct: 556 AFLFLVICAMCWWKR 570
|
Length = 623 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 62/295 (21%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKK-EFAREVKKLGNIKHPNLVSLQGY 796
E++G+ G ++K TL + +AVK +E + + K +F E + L HPN+V L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ ++ + +L+ +K L + ++ A+D A + YL ++
Sbjct: 61 C--TQRQPIYIVMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 857 IPHGNLKSTNILLEAPTMNAVL--TDYSLHR-----ILTSAG--------TADQVLNAGA 901
I H +L + N L+ N VL +D+ + R I +S+G TA + LN G
Sbjct: 115 I-HRDLAARNCLVGE---NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961
S +SDV+++GI+L E S G VC PG+ +
Sbjct: 171 Y---------------SSESDVWSYGILLWETF---SLG--VCPYPGMTN---------- 200
Query: 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASE-RPDMMSVFEELST 1015
++ E ++ G+ M P + D+ +V RC E RP + +EL+
Sbjct: 201 -QQAREQVEK----GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 57/241 (23%), Positives = 108/241 (44%), Gaps = 37/241 (15%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNL 790
+G G ++ + ++AVK L+E +K+F RE + L N +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDP---------RKLPPLSIDERLRVA 841
V G + +++ Y+ L +L+ P + L++ + L++A
Sbjct: 71 VKFYGVC--TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD--QVLNA 899
V +A + YL ++ + H +L + N L+ + + D+ + R + T D +V
Sbjct: 129 VQIASGMVYLASQHFV-HRDLATRNCLVGYDLV-VKIGDFGMSRDVY---TTDYYRVGGH 183
Query: 900 GALGYR--PPEFASTSKPCPSLKSDVYAFGIILLELLT-GK------SSGEIV-CVDPGV 949
L R PPE K + +SDV++FG++L E+ T GK S+ E++ C+ G
Sbjct: 184 TMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
Query: 950 V 950
+
Sbjct: 242 L 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 37/291 (12%)
Query: 739 VIGRSCHGTLYKATL----DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVS 792
++G+ G++ +A L S +AVK L+ I + +EF RE + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 793 LQGYYWGPKEHEKL----VISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVARC 847
L G + +L VI ++ L +L + + P L + +R +D+A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPP 907
+ YL ++ I H +L + N +L M + D+ L + + S Q A L +
Sbjct: 126 MEYLSSKNFI-HRDLAARNCML-NENMTVCVADFGLSKKIYSGDYYRQG-CASKLPVKWL 182
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966
S + + SDV+AFG+ + E++T G++ GV EN
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY------AGV------------EN--S 222
Query: 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASE-RPDMMSVFEELSTI 1016
E ++ LI G+ ++QPP L D+ ++ +C P + RP + ++L I
Sbjct: 223 EIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 33/89 (37%), Positives = 46/89 (51%)
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI 177
L L + G IP+ I L++L +N+S NS G P G + L+ LDL N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 178 MHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206
L QL S+ ++L+ N SG + LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 36/213 (16%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNLVSL 793
IG +G +Y+A SG I+A+K++R +GI RE+ L N++HPN+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIVEL 71
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL-----PPLSIDERLRVAVDVARCL 848
+ ++V+ ++++ L + E D L P S + + + + R L
Sbjct: 72 K----------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNAGALGYRP 906
YLH E I H +LK +N+LL T L D+ L R L YR
Sbjct: 122 QYLH-ENFIIHRDLKVSNLLL---TDKGCLKIADFGLAR-TYGLPAKPMTPKVVTLWYRA 176
Query: 907 PE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE T+ + D++A G IL ELL K
Sbjct: 177 PELLLGCTTY---TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 736 PAEVIGRSCHG--TLYKATLDSGSI----LAVKRLREGIAKGKKEFAREVKKLGNIKHPN 789
P V+G+ G TLY+ T D + + + RL E K +++ E+ L ++HPN
Sbjct: 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPN 60
Query: 790 LVSLQGYYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVAR 846
+++ YY + L+I Y N +L + + E + + +
Sbjct: 61 IIA---YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE-----EEMVLWYLFQIVS 112
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL-TSAGTADQVLNAGALGYR 905
++Y+H I H ++K+ NI L + L D+ + +IL + A+ V+ G Y
Sbjct: 113 AVSYIHKA-GILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMAETVV--GTPYYM 168
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE K + KSD++A G +L ELLT K
Sbjct: 169 SPELCQGVKY--NFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQ 794
E IG+ GT+ K S G IL K + G K K++ EV L +KHPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 795 GYYWGPKEHEK-----LVISNYINAQSLAVYLQETDPRKLPPLSIDER--LRVAVDVARC 847
YY + ++ ++ Y LA +Q+ + I+E R+ +
Sbjct: 63 RYY--DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER---KYIEEEFIWRILTQLLLA 117
Query: 848 LNYLHN----ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG 903
L HN + H +LK NI L+A N L D+ L +IL D +G
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKILGH----DSSFAKTYVG 172
Query: 904 ---YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
Y PE + KSD+++ G ++ EL
Sbjct: 173 TPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLRE-GIAKGKKEFAREVKKLGNIKHPNL 790
E +G G +YK L S + +A+K L+E K ++EF +E + + +++HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-----------PLSIDERLR 839
V L G KE ++ Y+ L +L P L + L
Sbjct: 71 VCLLGVC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+A+ +A + YL + H +L + N L+ + ++D+ L R + SA +V +
Sbjct: 129 IAIQIAAGMEYL-SSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY-RVQSK 185
Query: 900 GALGYR--PPEFASTSKPCPSLKSDVYAFGIILLEL 933
L R PPE K +SD+++FG++L E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTT--ESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 7e-09
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKE-----FAREVKKLGNIKHPNLVSL 793
IG +G +YKA +G ++A+K++R + +KE RE+K L ++HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYL----QETD-----PRKLPPLSIDERLRVAVDV 844
KE +V S + +Y+ + D + + +
Sbjct: 64 -------KE---IVTSKGKGS----IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMN---AVLTDYSLHRILTSAGTADQVLNAGA 901
L YLH+ I H ++K +NIL+ N L D+ L R T +AD
Sbjct: 110 LEGLQYLHS-NGILHRDIKGSNILI----NNDGVLKLADFGLARPYTKRNSADYTNRVIT 164
Query: 902 LGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YRPPE +T + D+++ G IL EL GK
Sbjct: 165 LWYRPPELLLGATRY---GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 47/289 (16%)
Query: 739 VIGRSCHGTLYKAT----LDSGSI-LAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVS 792
V+G GT+YK + I +A+K LRE + K KE E + ++ HP++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G + +I+ + L Y++ + + L V +A+ ++YL
Sbjct: 74 LLGICLSSQ---VQLITQLMPLGCLLDYVRNHKDN-IGSQYL---LNWCVQIAKGMSYL- 125
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGA---LGYRPPE 908
E+ + H +L + N+L++ P V +TD+ L ++L + G + + E
Sbjct: 126 EEKRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLDV--DEKEYHAEGGKVPIKWMALE 181
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
S + KSDV+++G+ + EL+T G E + P V++ D
Sbjct: 182 --SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI---PA-VEIPD------------- 222
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELST 1015
L+ G + QPP D+ V ++C ++ A RP + E S
Sbjct: 223 ----LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 738 EVIGRSCHGTLYKATLDSGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVS 792
+VIG G + + L +A+K L+ G K + +F E +G HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L+G K ++I+ Y+ SL +L+E D K + LR +A + YL
Sbjct: 70 LEGVV--TKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLR---GIASGMKYL- 122
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRIL--------TSAG------TADQV 896
+E H +L + NIL+ N V ++D+ L R L T G TA +
Sbjct: 123 SEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE- 178
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
A+ YR +F S SDV++FGI++ E+++
Sbjct: 179 ----AIAYR--KFTSA--------SDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
IG+ G ++K + A+K+ L + + ++E E + L + ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
YY + KL ++ Y L L+ R PL D+ R + + L +LH+
Sbjct: 64 -YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLHS 119
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
++ + H ++KS N+ L+A N + D + ++L+ + G Y PE
Sbjct: 120 KKIL-HRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCE-D 175
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
KP KSDV+A G++L E TGK
Sbjct: 176 KPYNE-KSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 62/272 (22%), Positives = 120/272 (44%), Gaps = 60/272 (22%)
Query: 759 LAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
+A+K L++G + + F E + ++HP LV L Y + +I+ Y+ SL
Sbjct: 33 VAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRL---YAVVTQEPIYIITEYMENGSLV 88
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878
+L+ + KL I++ + +A +A + ++ + I H +L++ NIL+ + T+ +
Sbjct: 89 DFLKTPEGIKLT---INKLIDMAAQIAEGMAFIERKNYI-HRDLRAANILV-SETLCCKI 143
Query: 879 TDYSLHRILTSAG-------------TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYA 925
D+ L R++ TA + +N G ++KSDV++
Sbjct: 144 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF---------------TIKSDVWS 188
Query: 926 FGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRI 985
FGI+L E++T G I PG +T+ + LE G+ M +P
Sbjct: 189 FGILLTEIVT---YGRIPY--PG---MTNPEVIQNLER------------GYRMPRPDNC 228
Query: 986 LSDMLQVALRCILPASERPDMMSVFEELSTIV 1017
++ ++ C E+P+ FE L +++
Sbjct: 229 PEELYELMRLC---WKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 734 HAPAEVIGRSCHGTLYKA-TLDSGSILAVKRLR-----EGIAKGKKEFAREV---KKLGN 784
+ P IG +GT+YKA SG +A+K +R +G+ REV K+L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST---VREVALLKRLEA 58
Query: 785 IKHPNLVSLQ---GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVA 841
HPN+V L +E + ++ +++ Q L YL + P LP +I + +R
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMR-- 115
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901
R L++LH I H +LK NIL+ + L D+ L RI + V+
Sbjct: 116 -QFLRGLDFLHANC-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVV--T 170
Query: 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR PE S + D+++ G I E+ K
Sbjct: 171 LWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 15/298 (5%)
Query: 200 SLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNF 259
S + L S +S + L++ S + L + + L D + N L I
Sbjct: 55 SSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLE 114
Query: 260 VFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSS 318
+ +L L L +N ++ +P L+ L ELDLS N++E + + LK ++LS
Sbjct: 115 LTNLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSF 172
Query: 319 NKLSGSLPARVGHCTI---VDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTS 375
N LS LP + + + +DLS N++S DL + +E++ LS+N + + + S
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 376 QFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435
L+ ++SNN LE DLP +G L+ +DLS N + S + T L +L+LSG
Sbjct: 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSG 286
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNN 493
N+ S LPL + NL LT L S +L + N +
Sbjct: 287 NSLSNALPLIALLLLLLE-LLLNLLLTLKALELKLNS--ILLNNNILSNGETSSPEAL 341
|
Length = 394 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 44/264 (16%)
Query: 759 LAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
+A+K + EG A +++F E K + + HP LV L G ++ +++ ++ L
Sbjct: 31 VAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLYIVTEFMENGCLL 87
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878
YL++ + LS D L + DV + YL I H +L + N L+ + + V
Sbjct: 88 NYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNSFI-HRDLAARNCLVSSTGVVKV- 141
Query: 879 TDYSLHRILTSAGTADQ-VLNAGA---LGYRPPEFASTSKPCPSLKSDVYAFGIILLELL 934
+D+ + R + D+ ++GA + + PPE + SK S KSDV++FG+++ E+
Sbjct: 142 SDFGMTRYVLD----DEYTSSSGAKFPVKWSPPEVFNFSKY--SSKSDVWSFGVLMWEVF 195
Query: 935 T-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVA 993
T GK + E +S +I G + +P + +V
Sbjct: 196 TEGK---------------------MPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM 234
Query: 994 LRCILPASERPDMMSVFEELSTIV 1017
C E+P+ F EL +
Sbjct: 235 YSC---WHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 740 IGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVS 792
IG+ G +++A + +++AVK L+E A + +F RE + HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 793 LQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKL-----------------PPLSI 834
L G + + ++ Y+ L +L+ PR PLS
Sbjct: 73 LLGVC---AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG--T 892
E+L +A VA + YL +ER H +L + N L+ M + D+ L R + SA
Sbjct: 130 TEQLCIAKQVAAGMAYL-SERKFVHRDLATRNCLV-GENMVVKIADFGLSRNIYSADYYK 187
Query: 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
A + +A + + PPE ++ + +SDV+A+G++L E+ +
Sbjct: 188 ASEN-DAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G+ +G++YK L A+K L K +++ E++ L ++ HPN++S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY--- 64
Query: 797 YWGPKEHEKLVISN-------YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN 849
E + N Y L+ + + ++ + E R+ + + R L
Sbjct: 65 ------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQ 117
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEF 909
LH E+ I H +LKS NILL A + + D + ++L Q+ G Y PE
Sbjct: 118 ALH-EQKILHRDLKSANILLVANDL-VKIGDLGISKVLKKNMAKTQI---GTPHYMAPEV 172
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
+P S KSD+++ G +L E+ T
Sbjct: 173 WK-GRPY-SYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSILAVKRLRE-GIAKGKKEFAREVKKLGNIKHPNLV 791
E +G G +YK L D ++A+K L++ + EF +E + + HPN+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER------------LR 839
L G +E ++ Y+N L +L P S DE L
Sbjct: 71 CLLGVV--TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+A+ +A + YL + + H +L + NIL+ ++ ++D L R + SA +V
Sbjct: 129 IAIQIAAGMEYLSSHFFV-HKDLAARNILI-GEQLHVKISDLGLSREIYSADYY-RVQPK 185
Query: 900 GALGYR--PPEFASTSKPCPSLKSDVYAFGIILLELLT 935
L R PPE K S SD+++FG++L E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 26/195 (13%)
Query: 760 AVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAV 819
A+K +REG A + +F E K + + HPNLV L G K+ +++ Y+ L
Sbjct: 32 AIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEYMANGCLLN 88
Query: 820 YLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLT 879
YL+E + L + L + DV + YL + I H +L + N L+ + V +
Sbjct: 89 YLRERKGK----LGTEWLLDMCSDVCEAMEYLESNGFI-HRDLAARNCLVGEDNVVKV-S 142
Query: 880 DYSLHR-ILTSAGTADQVLNAGA---LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
D+ L R +L T+ Q G + + PPE S+ S KSDV++FG+++ E+ +
Sbjct: 143 DFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRF--SSKSDVWSFGVLMWEVFS 196
Query: 936 -------GKSSGEIV 943
S+ E+V
Sbjct: 197 EGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 52/269 (19%)
Query: 760 AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
AVK L++ IA GKKEF RE + + HP +V L G G +++ L
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVMELAPLGPLL 83
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878
YL+ R++P + E +A VA + YL ++ + H +L + N+LL A +
Sbjct: 84 KYLK--KRREIPVSDLKE---LAHQVAMGMAYLESKHFV-HRDLAARNVLLVNRH-QAKI 136
Query: 879 TDYSLHRILTSAGTADQVLNAG--ALGYRPPE------FASTSKPCPSLKSDVYAFGIIL 930
+D+ + R L + + AG L + PE F+S KSDV+++G+ L
Sbjct: 137 SDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS--------KSDVWSYGVTL 188
Query: 931 LELLT--GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988
E + K GE+ + V+ + LE+ G + +P +
Sbjct: 189 WEAFSYGAKPYGEMKGAE--VIAM--------LES------------GERLPRPEECPQE 226
Query: 989 MLQVALRC-ILPASERPDMMSVFEELSTI 1016
+ + L C +RP +
Sbjct: 227 IYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKR---LREGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
+ IG G +Y A S S V + L + K K+ +EV L +KHPN+V+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT-- 63
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
++ +E+ +L ++ Y + L ++ + ++ S D+ L V ++ L ++H
Sbjct: 64 -FFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+R I H ++KS NI L M A L D+ + R L + G Y PE +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQ-N 176
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
+P + K+D+++ G +L EL T K
Sbjct: 177 RPYNN-KTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQG 795
E IGR G ++ L + + +AVK RE + K +F +E + L HPN+V L G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
++ ++ + +L+ PR L + E +++ + A + YL ++
Sbjct: 61 VC--TQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYLESKH 114
Query: 856 AIPHGNLKSTNILL-EAPTMNAVLTDYSLHR-----ILTSAGTADQVLNAGALGYRPPEF 909
I H +L + N L+ E + ++D+ + R + S G Q+ + + PE
Sbjct: 115 CI-HRDLAARNCLVTEKNVLK--ISDFGMSREEEDGVYASTGGMKQI----PVKWTAPEA 167
Query: 910 ASTSKPCPSLKSDVYAFGIILLE 932
+ + S +SDV++FGI+L E
Sbjct: 168 LNYGR--YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 739 VIGRSCHG--TLYKATLDSGSILAVK-RLREGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
V+G+ +G +L + D + K LR + +K +E + L +KHPN+V+ +
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
W ++ ++ + L L+E + LP + E V +A L YLH E+
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF---VQIAMALQYLH-EK 121
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H +LK+ N+ L + V D + R+L + L G Y PE S +KP
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKV-GDLGIARVLENQCDMASTL-IGTPYYMSPELFS-NKP 178
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
+ KSDV+A G + E+ T K
Sbjct: 179 Y-NYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 42/194 (21%), Positives = 79/194 (40%), Gaps = 14/194 (7%)
Query: 748 LYKATLDSGSIL--AVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH-- 803
+YK ++ ++ K+ +G E+K L I N++ + G+ +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLK 863
+I Y L L K LS +L +A+D + L L+ P+ NL
Sbjct: 96 RLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 864 STNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDV 923
S + L+ ++ + L +IL+S N + Y + + ++K D+
Sbjct: 151 SVSFLVTENYKLKIIC-HGLEKILSSPPFK----NVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 924 YAFGIILLELLTGK 937
Y+ G++L E+ TGK
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 1/84 (1%)
Query: 95 VSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
+ + N L G I DI ++ L+ ++LS N G IP + S+ +L +L++S NSF G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 154 PSGFGGLGKLKYLDLRANRFGGDI 177
P G L L+ L+L N G +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
EVIG +Y A L + +A+KR+ E E +EV+ + HPN+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---K 63
Query: 796 YYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLH 852
YY ++L ++ Y++ SL ++ + PR +DE + V +V + L YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG----LDEAIIATVLKEVLKGLEYLH 119
Query: 853 NERAIPHGNLKSTNILLEAPT--------MNAVLTDY--SLHRIL-TSAGT----ADQVL 897
+ I H ++K+ NILL ++A L D ++ T GT A +V+
Sbjct: 120 SNGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
GY K+D+++FGI +EL TG
Sbjct: 179 EQVH-GY-------------DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 51/293 (17%)
Query: 738 EVIGRSCHGTLYKATL--DSGSI---LAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLV 791
+V+G GT+YK + + +A+K LRE + K KE E + ++ +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G +I+ + L Y++E + L V +A+ +NYL
Sbjct: 73 RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYL 125
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
ER + H +L + N+L++ P + +TD+ L ++L + G + + S
Sbjct: 126 E-ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHA-EGGKVPIKWMALES 182
Query: 912 TSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENR 964
+ +SDV+++G+ + EL+T G + EI + LE
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------------LEK- 226
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
G + QPP D+ + ++C ++ A RP + E S +
Sbjct: 227 -----------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 16/175 (9%)
Query: 770 KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRK 828
K ++E +EV L N+KHPN+V Q + +E+ L ++ +Y L ++ + ++
Sbjct: 41 KEREESRKEVAVLSNMKHPNIVQYQESF---EENGNLYIVMDYCEGGDL---YKKINAQR 94
Query: 829 LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRI 886
D+ L V + L ++H +R I H ++KS NI L T + L D+ + R+
Sbjct: 95 GVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFL---TKDGTIKLGDFGIARV 150
Query: 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941
L S + G Y PE ++P + KSD++A G +L E+ T K + E
Sbjct: 151 LNSTVELARTC-IGTPYYLSPEICE-NRPYNN-KSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKR-------------LREGIAKGKKEFAREVKKLG 783
E+IG+ +G +Y A + +G ++AVK+ ++ + K + E++ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS---EIETLK 63
Query: 784 NIKHPNLVSLQGYYWGPKEHEKLVIS---NYINAQSLAVYLQETDPRKLPPLSIDERLRV 840
++ H N+V G+ E + +S Y+ S+ L R
Sbjct: 64 DLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCL-----RTYGRFEEQLVRFF 113
Query: 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-A 899
V L YLH+ + I H +LK+ N+L++A + + +D+ + + DQ ++
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKI-SDFGISKKSDDIYDNDQNMSMQ 171
Query: 900 GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
G++ + PE + S K D+++ G ++LE+ G+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 738 EVIGRSCHGTLYKATL-DSGSI---LAVKRL-REGIAKGKKEFAREVKKLGNIKHPNLVS 792
VIG+ G +Y TL DS AVK L R + ++F +E + + HPN++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G P E LV+ Y+ L +++ P ++ + + + VA+ + YL
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIR--SETHNP--TVKDLIGFGLQVAKGMEYLA 115
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR-ILTSAGTADQVLNAGALGYRPPEFAS 911
+++ + H +L + N +L+ + + D+ L R I + L + S
Sbjct: 116 SKKFV-HRDLAARNCMLDE-SFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971
+ KSDV++FG++L EL+T + + VD D+T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDS--FDIT-----------------V 213
Query: 972 LIMDGHDMEQPPRILSDMLQVALRCILPASE-RPDMMSVFEELSTIVLE 1019
++ G + QP + +V L C P E RP + + I
Sbjct: 214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 43/273 (15%)
Query: 759 LAVKRLREGIAKGKK--EFAREVKKLGNIKHPNLVSLQGYYWGPKEHEK----LVISNYI 812
+AVK ++ I + +F E + HPN++ L G E E +VI ++
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 813 NAQSLAVYLQET----DPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNIL 868
L +L + P+ LP + ++ D+A + YL ++ I H +L + N +
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQML---VKFMTDIASGMEYLSSKSFI-HRDLAARNCM 144
Query: 869 LEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEF---ASTSKPCPSLKSDVYA 925
L MN + D+ L + + + Q G + P ++ S + + KSDV++
Sbjct: 145 LNE-NMNVCVADFGLSKKIYNGDYYRQ----GRIAKMPVKWIAIESLADRVYTTKSDVWS 199
Query: 926 FGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRI 985
FG+ + E+ T + PGV EN E +D L G+ ++QPP
Sbjct: 200 FGVTMWEIATRGQTPY-----PGV------------EN--SEIYDYL-RQGNRLKQPPDC 239
Query: 986 LSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
L + + C +L +RP ++ EL +
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 47/186 (25%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 759 LAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSL 817
+A+K L+ G K +++F E +G HPN++ L+G K ++++ Y+ SL
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSKPVMIVTEYMENGSL 92
Query: 818 AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV 877
+L++ D + ++ + + + +A + YL + + H +L + NIL+ + + V
Sbjct: 93 DAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDMGYV-HRDLAARNILVNSNLVCKV 147
Query: 878 LTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSKPCPSLKSDVYAFGIILLELLT 935
+D+ L R+L A G + R PE + K + SDV+++GI++ E++
Sbjct: 148 -SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA--SDVWSYGIVMWEVM- 203
Query: 936 GKSSGE 941
S GE
Sbjct: 204 --SYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 39/241 (16%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVK-----RLREGIAKGKKEFAREVKKLGNIKHPNLVSL 793
IG HG ++KA ++G +A+K RL GI + RE+K L +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ P +++ Y+ L+ L++ + R LP + +R+ + + + Y+H
Sbjct: 65 LDVF--PHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRM---LLKGVAYMHA 117
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
I H +LK N+L+ + + D+ L R+ + YR PE +
Sbjct: 118 NG-IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 914 -KPCPSLKSDVYAFGIILLELL------TGKSSGEIVC------------VDPGVVDLTD 954
K P + D++A G I ELL G++ E + PG+ L D
Sbjct: 176 RKYDPGV--DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 955 W 955
+
Sbjct: 234 Y 234
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 39/201 (19%)
Query: 756 GSILAVKRLREGIAKGKK------------EFAREVKKLGNIKHPNLVSLQGYYWGPKEH 803
GS+ VK + G KK + RE++ + + P +VS G + E+
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NEN 76
Query: 804 EKLVISNYINAQSL-AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNL 862
+ +++ SL +Y +K P+ ++ ++AV V L YL+N I H ++
Sbjct: 77 NICMCMEFMDCGSLDRIY------KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130
Query: 863 KSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA------GALGYRPPEFASTSKPC 916
K +NIL+ + L G + +++N+ G Y PE K
Sbjct: 131 KPSNILVNSRG----------QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGK-- 178
Query: 917 PSLKSDVYAFGIILLELLTGK 937
++KSDV++ GI ++EL GK
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 56/239 (23%), Positives = 108/239 (45%), Gaps = 25/239 (10%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G G ++ ++ + +AVK L+ G + F E + ++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRL--YAVV 70
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVARCLNYLHNERAIP 858
KE +I+ Y+ SL +L+ + K+ P ID + +A + Y+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID----FSAQIAEGMAYIERKNYI- 125
Query: 859 HGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPS 918
H +L++ N+L+ M + D+ L R++ + + + PE + + +
Sbjct: 126 HRDLRAANVLVSESLMCKI-ADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSFT 182
Query: 919 LKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970
+KSDV++FGI+L E++T G S+ ++ + L R+ +EN E +D
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDV------MSALQRGYRMPRMENCPDELYD 235
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVK--RLREGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
+ IG +G +YKA + +G ++A+K +L G + +E+ L +HPN+V+
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYF 66
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
G Y + + ++ Y SL Q T PLS + V + + L YLH
Sbjct: 67 GSYL--RRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHET 120
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--------GALGYRP 906
I H ++K NILL T+ L G + Q+ G +
Sbjct: 121 GKI-HRDIKGANILL---------TEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 907 PEFASTSKPCP-SLKSDVYAFGIILLEL 933
PE A+ + K D++A GI +EL
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 64/267 (23%), Positives = 106/267 (39%), Gaps = 49/267 (18%)
Query: 760 AVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
AVK L+ + ++ +F +E + ++ H NL+ L G H ++++ SL
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV---LTHPLMMVTELAPLGSLL 83
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878
L++ L I AV +A + YL ++R I H +L + NILL + +
Sbjct: 84 DRLRK---DALGHFLISTLCDYAVQIANGMRYLESKRFI-HRDLAARNILLASDDK-VKI 138
Query: 879 TDYSLHRILTSAGTADQ--VLNAG---ALGYRPPEFASTSKPCPSLKSDVYAFGIILLEL 933
D+ L R L + V+ + PE T S SDV+ FG+ L E+
Sbjct: 139 GDFGLMRAL---PQNEDHYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEM 193
Query: 934 LTGKSSGEIVCVDPGVVDLTDWVRLLALE-----NRSGECFDRLIMDGHDMEQPPRILSD 988
T +P W L + ++ GE RL E+P D
Sbjct: 194 FT-------YGEEP-------WAGLSGSQILKKIDKEGE---RL-------ERPEACPQD 229
Query: 989 MLQVALRC-ILPASERPDMMSVFEELS 1014
+ V L+C ++RP ++ E L
Sbjct: 230 IYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 738 EVIGRSCHGTLYKATLDSG----SILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVS 792
EVIG G + + L +A+K L+ G K +++F E +G HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L+G K ++I+ ++ +L +L++ D + + + LR +A + YL
Sbjct: 70 LEGVV--TKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLR---GIAAGMKYL- 122
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP-----P 907
+E H +L + NIL+ + + V +D+ L R L T+D + G P P
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKV-SDFGLSRFLED-DTSDPTYTSSLGGKIPIRWTAP 180
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLT 935
E + K + SDV+++GI++ E+++
Sbjct: 181 EAIAYRKFTSA--SDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSIL----AVKRLREGIA-KGKKEFAREVKKLGNIKHPNLV 791
+V+G GT+YK + G + A+K L E K EF E + ++ HP+LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G P +++ + L Y+ E + L V +A+ + YL
Sbjct: 73 RLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDN----IGSQLLLNWCVQIAKGMMYL 125
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
ER + H +L + N+L+++P + +TD+ L R+L + + G + +
Sbjct: 126 E-ERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALEC 182
Query: 912 TSKPCPSLKSDVYAFGIILLELLT--GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969
+ +SDV+++G+ + EL+T GK I ++ D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-----PTREIPD--------------- 222
Query: 970 DRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
L+ G + QPP D+ V ++C ++ A RP + E S + +D Q
Sbjct: 223 --LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR--MARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 63/238 (26%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKEFA----------------REVKKL 782
+G +G + KA +G I+A+K+++ I + + RE+K +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK--IIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 783 GNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842
IKH N++ L Y V ++IN L + + +D +K+ +D ++R+
Sbjct: 75 NEIKHENIMGLVDVY---------VEGDFIN---LVMDIMASDLKKV----VDRKIRLTE 118
Query: 843 DVARC--------LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR----ILTSA 890
+C LN LH H +L NI + + + + D+ L R S
Sbjct: 119 SQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGI-CKIADFGLARRYGYPPYSD 176
Query: 891 GTADQVLNAG---------ALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ L YR PE + D+++ G I ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 787 HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVA 845
HP LV L + E + Y+N L ++Q RKLP +E R + +++
Sbjct: 55 HPFLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQ--RKLP----EEHARFYSAEIS 106
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR 905
LNYLH ER I + +LK N+LL++ + LTDY + + G G Y
Sbjct: 107 LALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTF-CGTPNYI 163
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943
PE S+ D +A G+++ E++ G+S +IV
Sbjct: 164 APEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 31/132 (23%)
Query: 214 IQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQ 272
I L + L G P+D + +L+ + S N + G IP S + SL +L L N
Sbjct: 420 IDGLGLDNQGLRG-FIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 273 LSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVG-- 330
+GS+P +L G +TS L+ +NL+ N LSG +PA +G
Sbjct: 478 FNGSIPESL----------------------GQLTS--LRILNLNGNSLSGRVPAALGGR 513
Query: 331 --HCTIVDLSNN 340
H + ++N
Sbjct: 514 LLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 43/227 (18%)
Query: 733 SHAPAEVIGRSCHGTLYKA--TLDSGSILAVKRL---REGIAKGKKEFAREVKKLGN--- 784
+A E +G G +YK + ++LA+K + K K+E + + + +
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 785 -----IKHPNLVSLQGYYWGPKEHEKL-VISNYINAQSLAVY---LQETDPRKLPPLSID 835
++HPN+V YY E+++L ++ + I L + L+E R +
Sbjct: 61 IIKEQLRHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR-----FTE 112
Query: 836 ERL-RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR------ILT 888
ER+ + V + L YLH E+ I H +L NI+L +TD+ L + LT
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLT 171
Query: 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
S G + Y PE ++P K+DV+AFG IL ++ T
Sbjct: 172 SV--------VGTILYSCPEIVK-NEPYGE-KADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/215 (23%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799
+G G ++ AT + + +AVK ++ G + + F E + ++H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 70
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVARCLNYLHNERAIP 858
+ +I+ ++ SL +L+ + K P P ID + +A + ++ I
Sbjct: 71 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID----FSAQIAEGMAFIEQRNYI- 124
Query: 859 HGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA---LGYRPPEFASTSKP 915
H +L++ NIL+ A ++ + D+ L R++ + GA + + PE + +
Sbjct: 125 HRDLRAANILVSA-SLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPE--AINFG 178
Query: 916 CPSLKSDVYAFGIILLELLT-------GKSSGEIV 943
++KSDV++FGI+L+E++T G S+ E++
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRL-REGIAKGKKEFAREVK-KLGNIKHPNLVSLQGY 796
IG G +YK +G ++AVK++ R G + K ++ L + P +V GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 797 YWGPKEHEKLVISN---YINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYL 851
+ I++ +I + ++ L + R P I E + ++ V + + L+YL
Sbjct: 83 F----------ITDSDVFICMELMSTCLDKLLKRIQGP--IPEDILGKMTVAIVKALHYL 130
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
+ + H ++K +NILL+A + N L D+ + L + + +AG Y PE
Sbjct: 131 KEKHGVIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKAKTR--SAGCAAYMAPERID 187
Query: 912 TSKPCPS--LKSDVYAFGIILLELLTGK 937
P P +++DV++ GI L+EL TG+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G +G++YKA ++G ++A+K + + + +E +E+ L P +V G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHNE 854
Y+ K + ++ Y A S+ +D K+ ++ E A+ + L YLH+
Sbjct: 67 YF--KNTDLWIVMEYCGAGSV------SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
+ I H ++K+ NILL A L D+ + LT A + G + PE
Sbjct: 119 KKI-HRDIKAGNILLNE-EGQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPEVIQEIG 175
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
+ K+D+++ GI +E+ GK
Sbjct: 176 --YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/186 (26%), Positives = 93/186 (50%), Gaps = 13/186 (6%)
Query: 754 DSGSILAVKRLREGIAKGK-KEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812
++G +AVK L+ + +E++ L N+ H N+V +G + +I ++
Sbjct: 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872
+ SL YL PR +++ ++L+ AV + + ++YL + + + H +L + N+L+E+
Sbjct: 91 PSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLGSRQYV-HRDLAARNVLVESE 145
Query: 873 TMNAVLTDYSLHR-ILTSAG--TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGII 929
+ D+ L + I T T L++ Y PE SK + SDV++FG+
Sbjct: 146 HQVKI-GDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKF--YIASDVWSFGVT 201
Query: 930 LLELLT 935
L ELLT
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 24/225 (10%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKG--KKEFAREVKKLGNIKHPNLVSLQGY 796
IG +G +YKA +G I+A+K+++ K RE+K L + HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ K LV +++ L ++ R LP I L + + L + H+
Sbjct: 67 F-RHKGDLYLVF-EFMD-TDLYKLIK-DRQRGLPESLIKSYL---YQLLQGLAFCHSHGI 119
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA--DQVLNAGALGYRPPEFASTSK 914
+ H +LK N+L+ + L D+ L R S V+ YR PE K
Sbjct: 120 L-HRDLKPENLLINTEGV-LKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELLLGDK 174
Query: 915 PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLL 959
S D+++ G I ELL+ + + PG ++ ++
Sbjct: 175 GY-STPVDIWSVGCIFAELLSRRP------LFPGKSEIDQLFKIF 212
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 739 VIGRSCHGTLYKATLDS-GSILAVKRLREGIAKGKKE----FAREVKKLGNIKHPNLVSL 793
VIG+ G + A + G AVK L++ KKE A L N+KHP LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLH 852
Y + + V+ +Y+N L +LQ R P + R R A ++A L YLH
Sbjct: 62 H-YSFQTADKLYFVL-DYVNGGELFFHLQRE--RSFP----EPRARFYAAEIASALGYLH 113
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883
I + +LK NILL++ + VLTD+ L
Sbjct: 114 -SLNIIYRDLKPENILLDSQG-HVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 35/279 (12%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLR---EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
IGR +Y+AT L G +A+K+++ AK + + +E+ L + HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQ--ETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ +++E ++ +A L+ ++ + R +P ++ + V + L ++H+
Sbjct: 70 SFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV---WKYFVQLCSALEHMHS 124
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
R + H ++K N+ + A T L D L R +S TA L G Y PE
Sbjct: 125 RR-VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE--RIH 179
Query: 914 KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973
+ + KSD+++ G +L E+ +S D + L +L + +C D
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-----------YGDKMNLYSLCKKIEQC-DYPP 227
Query: 974 MDGHDMEQPPRILSDMLQVALRCILPASE-RPDMMSVFE 1011
+ + R L +M CI P E RPD+ V++
Sbjct: 228 LPSDHYSEELRQLVNM------CINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 778 EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER 837
E+ +G ++HPN+V L G E +I YI ++L+ L+ LS + R
Sbjct: 733 EIADMGKLQHPNIVKLIGLC--RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERR 782
Query: 838 LRVAVDVARCLNYLHN--ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-AD 894
++A+ +A+ L +LH A+ GNL I+++ H L+ G
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--------KDEPHLRLSLPGLLCT 834
Query: 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942
+ Y PE T + KSD+Y FG+IL+ELLTGKS +
Sbjct: 835 DTKCFISSAYVAPETRETKDI--TEKSDIYGFGLILIELLTGKSPADA 880
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 190 VDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNH 249
+ L N G + D S + +Q +N+S NS+ G + P G +LEV D S N
Sbjct: 423 LGLDNQGLRGFIP---NDISKLRHLQSINLSGNSIRGNIPPSLGS--ITSLEVLDLSYNS 477
Query: 250 LVGAIP-SFNFVFSLRILRLGSNQLSGSLPVAL 281
G+IP S + SLRIL L N LSG +P AL
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 45/212 (21%)
Query: 746 GTLYKAT-LDSGSILAVKRLREGIAKGKKE---FA--REVKKLGNIKHPNLVSLQGYYWG 799
+YKA ++G I+A+K+++ G K K+ F RE+K L +KHPN++ L
Sbjct: 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL------ 67
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDE---RLRVAVDVA-------RCLN 849
+ + IN L ETD K+ I + L A D+ R L
Sbjct: 68 ---LDVFGHKSNIN---LVFEFMETDLEKV----IKDKSIVLTPA-DIKSYMLMTLRGLE 116
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT--ADQVLNAGALGYRPP 907
YLH+ I H +LK N+L+ A L D+ L R S QV+ YR P
Sbjct: 117 YLHS-NWILHRDLKPNNLLI-ASDGVLKLADFGLARSFGSPNRKMTHQVV---TRWYRAP 171
Query: 908 E--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
E F + + D+++ G I ELL
Sbjct: 172 ELLFGARHY---GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 21/60 (35%), Positives = 30/60 (50%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
+L+ LDLS+N + L NL +L++S N+ P F GL L+ LDL N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 774 EFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQET----DPRKL 829
EF RE+ + H N+V L G + H +I Y + L +L+ T + K
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 830 PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV----LT------ 879
PPLS +++ + +A +++L N R + H +L + N L+ + V L+
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNARFV-HRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 880 DYSLHRILTSAGTADQVLNAGA-LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
+Y R NA L + PE + + S KSDV++FG+++ E+ T
Sbjct: 171 EYYKLR------------NALIPLRWLAPE--AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSL- 793
V+G +G + K +G I+A+K+ E KK REVK L ++H N+V+L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ + + + LV Y+ ++L L+ + P LPP ++ + + + Y H+
Sbjct: 67 EAFRRKGRLY--LVFE-YVE-RTLLELLEAS-PGGLPPDAVR---SYIWQLLQAIAYCHS 118
Query: 854 ERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPEF-- 909
I H ++K NIL+ + + V L D+ R L + + YR PE
Sbjct: 119 HNII-HRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 910 --ASTSKPCPSLKSDVYAFGIILLELLTG 936
+ KP DV+A G I+ ELL G
Sbjct: 175 GDTNYGKPV-----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 54/153 (35%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREGIAKGKKE----FAREVKKLGNIKHPNLVS 792
+VIG+ G + A S GS AVK L++ KKE A L N+KHP LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 793 LQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNY 850
L + EKL + +Y+N L +LQ + L P R R A +VA + Y
Sbjct: 61 LHYSFQTA---EKLYFVLDYVNGGELFFHLQR-ERCFLEP-----RARFYAAEVASAIGY 111
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883
LH+ I + +LK NILL++ + VLTD+ L
Sbjct: 112 LHSLNII-YRDLKPENILLDSQG-HVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 738 EVIGRSCHGTLYKATLDSGSI---LAVKRLREGIAKGK-KEFAREVK---KLGNIKHPNL 790
+VIG G + +A + + A+K L+E ++ ++FA E++ KLG HPN+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG--HHPNI 65
Query: 791 VSLQGYYWGPKEHEKLVIS-NYINAQSLAVYLQ-----ETDPR------KLPPLSIDERL 838
++L G + L I+ Y +L +L+ ETDP L+ + L
Sbjct: 66 INLLG---ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
+ A DVA + YL ++ I H +L + N+L+ + + + D+ L R ++V
Sbjct: 123 QFASDVATGMQYLSEKQFI-HRDLAARNVLV-GENLASKIADFGLSR-------GEEVYV 173
Query: 899 AGALGYRPPEF---ASTSKPCPSLKSDVYAFGIILLELLT 935
+G P + S + + KSDV++FG++L E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS-LQG 795
E IG+ GT++ A + +G +A+K++ K+ E+ + +K+PN+V+ L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHN 853
+ G E V+ Y+ SL + ET +DE AV + + L +LH
Sbjct: 85 FLVG---DELFVVMEYLAGGSLTDVVTET--------CMDEAQIAAVCRECLQALEFLHA 133
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++KS N+LL + LTD+ +T + + G + PE +
Sbjct: 134 NQVI-HRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRK 190
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
P K D+++ GI+ +E++ G+
Sbjct: 191 AYGP--KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
IG+ G + G +AVK L++ + + F E + ++HPNLV L G
Sbjct: 12 ATIGKGEFGDVMLGDY-RGQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 798 WGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ L +++ Y+ SL YL+ R +++ ++L A+DV + YL E+
Sbjct: 70 L---QGNPLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLE-EKN 122
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGAL--GYRPPEFASTSK 914
H +L + N+L+ + + A ++D+ L A A Q ++G L + PE K
Sbjct: 123 FVHRDLAARNVLV-SEDLVAKVSDFGL------AKEASQGQDSGKLPVKWTAPEALREKK 175
Query: 915 PCPSLKSDVYAFGIILLEL 933
S KSDV++FGI+L E+
Sbjct: 176 F--STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 736 PAEV-----IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNL 790
P+E+ IG G ++ +A+K +REG A +++F E + + + HP L
Sbjct: 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKL 61
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
V L G + ++ ++ L+ YL+ + S + L + +DV + Y
Sbjct: 62 VQLYGVCT--ERSPICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAY 115
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL------TSAGTADQVLNAGALGY 904
L + I H +L + N L+ + V +D+ + R + +S GT V +
Sbjct: 116 LESSNVI-HRDLAARNCLVGENQVVKV-SDFGMTRFVLDDQYTSSTGTKFPV------KW 167
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIV 943
PE S SK S KSDV++FG+++ E+ + +S+ E+V
Sbjct: 168 SSPEVFSFSKY--SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 49/218 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA-REVKKLGNIKHPNLVS--- 792
E IG G +YKAT +G +A+K++R + K KE E+ + + KHPN+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 793 ---LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN 849
+ W V+ Y++ SL + + R ++ + V +V + L
Sbjct: 83 SYLVGDELW--------VVMEYMDGGSLTDIITQNFVR----MNEPQIAYVCREVLQGLE 130
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSA--------GTADQVLNA 899
YLH++ I H ++KS NILL + + L D+ LT GT
Sbjct: 131 YLHSQNVI-HRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTP------ 180
Query: 900 GALGY-RPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
Y PE K K D+++ GI+ +E+ G
Sbjct: 181 ----YWMAPEVI-KRKDY-GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 787 HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVA 845
+P LV L + ++ Y+N L ++Q RKLP +E R A ++
Sbjct: 55 NPFLVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQ--RKLP----EEHARFYAAEIC 106
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR 905
LN+LH ER I + +LK N+LL+A + LTDY + + G G Y
Sbjct: 107 IALNFLH-ERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTF-CGTPNYI 163
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDP 947
PE + S+ D +A G+++ E++ G+S +I+ +P
Sbjct: 164 APEILRGEEYGFSV--DWWALGVLMFEMMAGRSPFDIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 772 KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSL-AVY--LQETDPRK 828
+K+ RE++ + K P +V G + + Y SL ++Y +++ R
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR- 101
Query: 829 LPPLSIDER--LRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY--SLH 884
I E+ ++A V + L+YLH R I H ++K +NILL L D+ S
Sbjct: 102 -----IGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGE 154
Query: 885 RILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ + AGT G Y PE KP S+ SDV++ G+ LLE+ +
Sbjct: 155 LVNSLAGTF-----TGTSFYMAPE-RIQGKPY-SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS-LQG 795
E IG+ GT+Y A + +G +A+K++ K+ E+ + KHPN+V+ L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHN 853
Y G E V+ Y+ SL + ET +DE AV + + L +LH+
Sbjct: 85 YLVG---DELWVVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHS 133
Query: 854 ERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
+ I H ++KS NILL M+ LTD+ +T + + G + PE +
Sbjct: 134 NQVI-HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT 188
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
P K D+++ GI+ +E++ G+
Sbjct: 189 RKAYGP--KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 36/220 (16%)
Query: 738 EVIGRSCHGTLYKATLDSGSI---LAVKRLREGIAKGK-KEFAREVKKLGNI-KHPNLVS 792
+VIG G + KA + + A+KR++E +K ++FA E++ L + HPN+++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 793 LQGYYWGPKEHEK---LVISNYINAQSLAVYLQ-----ETDP------RKLPPLSIDERL 838
L G EH L I Y +L +L+ ETDP LS + L
Sbjct: 73 L----LGACEHRGYLYLAIE-YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
A DVAR ++YL ++ I H +L + NIL+ A + D+ L R +V
Sbjct: 128 HFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSR-------GQEVYV 178
Query: 899 AGALGYRPPEF---ASTSKPCPSLKSDVYAFGIILLELLT 935
+G P + S + + SDV+++G++L E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 29/193 (15%)
Query: 754 DSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812
+G ++AVK L+ + + +E+ L + H N+V +G +I Y+
Sbjct: 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872
SL YL P+ L++ + L A + + YLH++ I H +L + N+LL+
Sbjct: 91 PLGSLRDYL----PKH--KLNLAQLLLFAQQICEGMAYLHSQHYI-HRDLAARNVLLDND 143
Query: 873 TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE--------FASTS-KPCP-SLKSD 922
+ + D+ L + + G YR E +A K S SD
Sbjct: 144 RL-VKIGDFGLAKAVPE----------GHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192
Query: 923 VYAFGIILLELLT 935
V++FG+ L ELLT
Sbjct: 193 VWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 22/169 (13%)
Query: 776 AREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSID 835
A E L I HP+++ L+G + K L++ Y L YL R + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNK-FTCLILPRY--KTDLYCYL--AAKRNIA---IC 182
Query: 836 ERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895
+ L + V R + YLH R I H ++K+ NI + P + L D+ + D
Sbjct: 183 DILAIERSVLRAIQYLHENRII-HRDIKAENIFINHPG-DVCLGDFG-----AACFPVDI 235
Query: 896 VLN-----AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSS 939
N AG + PE + P++ D+++ GI+L E+ T S
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAV--DIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS-LQG 795
E IG+ GT+Y A + +G +A+K++ K+ E+ + K+PN+V+ L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHN 853
Y G E V+ Y+ SL + ET +DE AV + + L++LH+
Sbjct: 85 YLVG---DELWVVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALDFLHS 133
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++KS NILL + LTD+ +T + + G + PE +
Sbjct: 134 NQVI-HRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRK 190
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
P K D+++ GI+ +E++ G+
Sbjct: 191 AYGP--KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-06
Identities = 17/45 (37%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCT 63
D +ALL K + DPSG + SW+ S P +W G+TC
Sbjct: 3 DDRDALLAFKSSLNGDPSG-ALSSWN----PSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 31/250 (12%)
Query: 758 ILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816
++AVK LR + K + +F +E+K + +K+PN++ L G + +I+ Y+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC--VSDDPLCMITEYMENGD 103
Query: 817 LAVYLQE-------TDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869
L +L + T +P +SI L +AV +A + YL + + H +L + N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNCLV 162
Query: 870 EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGII 929
+ D+ + R L S G ++ L R + S + SDV+AFG+
Sbjct: 163 GN-HYTIKIADFGMSRNLYS-GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 930 LLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF---DRLIMDGHDMEQPPRIL 986
L E+ T +C + L+D +EN +GE F R I + Q P
Sbjct: 221 LWEMFT-------LCKEQPYSLLSDE---QVIEN-TGEFFRNQGRQIY----LSQTPLCP 265
Query: 987 SDMLQVALRC 996
S + ++ +RC
Sbjct: 266 SPVFKLMMRC 275
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 754 DSGSILAVKRLREGI----AKGKKEFAREVKKLGNIKH-PNLVSLQGYYWGPKEHEKL-V 807
D+G + A+K L++ AK + E + L ++ P LV+L ++ + KL +
Sbjct: 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTL---HYAFQTDTKLHL 82
Query: 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV-DVARCLNYLHNERAIPHGNLKSTN 866
I +Y+N L +L + + +RV + ++ L++LH + I + ++K N
Sbjct: 83 ILDYVNGGELFTHLYQREHFTE------SEVRVYIAEIVLALDHLH-QLGIIYRDIKLEN 135
Query: 867 ILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-AGALGYRPPEFASTSKPCPSLKSDVYA 925
ILL++ + VLTD+ L + A ++ + G + Y PE D ++
Sbjct: 136 ILLDSEG-HVVLTDFGLSKEFL-AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 926 FGIILLELLTGKS 938
G++ ELLTG S
Sbjct: 194 LGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 53/305 (17%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLRE-GIAKGKKEFAREVKKLGNI-KHPN 789
+ +G G + KA + S +AVK L++ K + E++ + I KH N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 790 LVSLQG--YYWGPKEHEKLVISNYINAQSLAVYL-----QETDPRKLPPLSIDERL---- 838
+++L G GP V+ Y +L +L P +E L
Sbjct: 78 IINLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 839 --RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTAD 894
A VAR + +L +++ I H +L + N+L+ T + V+ D+ L R +
Sbjct: 134 LVSFAYQVARGMEFLASKKCI-HRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYR 189
Query: 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD 954
+ N G L + + + +SDV++FG++L E+ T S PG+
Sbjct: 190 KTTN-GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-----PGI----- 238
Query: 955 WVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013
+E E F L+ +G+ ME+P ++ + C S+RP + E+L
Sbjct: 239 -----PVE----ELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
Query: 1014 STIVL 1018
++
Sbjct: 289 DRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 48/271 (17%)
Query: 63 TNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSH 122
+ ++ ++ + N + ++ ++ N+L NI+++ + +L LDL +
Sbjct: 71 SLDLLSPSGISSLDGSENLLNLLPLP-----SLDLNLNRLRSNISELLELTNLTSLDLDN 125
Query: 123 NLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL-- 180
N + P + NL L++S N E + PS L LK LDL N D+ L
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN----DLSDLPK 180
Query: 181 -LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN 239
LS L ++ ++DLS N+ S I+ L+
Sbjct: 181 LLSNLSNLNNLDLSGNKI----------SDLPPEIELLS--------------------A 210
Query: 240 LEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSL-PVALLQESSMMLSELDLSLNQ 298
LE D SNN ++ + S + + +L L L +N+L + L L LDLS NQ
Sbjct: 211 LEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN----LETLDLSNNQ 266
Query: 299 LEGPVGSITSATLKKVNLSSNKLSGSLPARV 329
+ + L++++LS N LS +LP
Sbjct: 267 ISSISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 738 EVIGRSCHGT--LYKATLDSGSILAVKRLREGIAKGKKE----FAREVKKLGNIKHPNLV 791
+VIG+ G L K LD G AVK L++ I +KE A L N+KHP LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLD-GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 792 SLQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLN 849
G ++ + EKL + +++N L +LQ R P + R R A ++A L
Sbjct: 60 ---GLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFP----EPRARFYAAEIASALG 110
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883
YLH+ I + +LK NILL++ + VLTD+ L
Sbjct: 111 YLHSIN-IVYRDLKPENILLDS-QGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
++G +G + K ++G I+A+K+ E KK RE++ L ++H NLV+L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYL 851
+ + ++L ++ +++ L D + P +DE + + R + +
Sbjct: 67 EVF---RRKKRLYLVFEFVDHTVL-------DDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTA--DQVLNAGALGYRPP 907
H+ I H ++K NIL+ + + V L D+ R L + G D V YR P
Sbjct: 117 HSHNII-HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYV---ATRWYRAP 169
Query: 908 EF----ASTSKPCPSLKSDVYAFGIILLELLTG 936
E + D++A G ++ E+LTG
Sbjct: 170 ELLVGDTKYGRAV-----DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 49/286 (17%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLREGI-----AKGKKEFAREVKKLGNIKHPNLVSL 793
IG+ +YKA L G ++A+K+++ I AK +++ +E+ L + HPN++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQ--IFEMMDAKARQDCLKEIDLLKQLDHPNVIK- 66
Query: 794 QGYYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNY 850
Y E+ +L I +A L+ ++ +K I ER + V + L +
Sbjct: 67 --YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTIWKYFVQLCSALEH 121
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
+H++R I H ++K N+ + A T L D L R +S TA L G Y PE
Sbjct: 122 MHSKR-IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERI 178
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970
+ + KSD+++ G +L E+ +S D + L +L + +C
Sbjct: 179 HENG--YNFKSDIWSLGCLLYEMAALQSPFY-----------GDKMNLYSLCKKIEKC-- 223
Query: 971 RLIMDGHDMEQPP---RILSDML-QVALRCILP-ASERPDMMSVFE 1011
+ PP S+ L + RCI P +RPD+ V +
Sbjct: 224 ---------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 11/116 (9%)
Query: 828 KLPPLSIDERL--RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885
L+I E + ++AV + + L YLH++ ++ H ++K +N+L+ L D+ +
Sbjct: 94 YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISG 152
Query: 886 ILTS--AGTADQVLNAGALGYRPPEF--ASTSKPCPSLKSDVYAFGIILLELLTGK 937
L A T D AG Y PE ++ +KSDV++ GI ++EL TG+
Sbjct: 153 YLVDSVAKTID----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 739 VIGRSCHGTLYKATL--DSGSI---LAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVS 792
V+G GT+YK D ++ +A+K LRE + K KE E + + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G +++ + L Y++E R + + L V +A+ ++YL
Sbjct: 74 LLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDR----IGSQDLLNWCVQIAKGMSYLE 126
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
R + H +L + N+L+++P + +TD+ L R+L T + G + + S
Sbjct: 127 EVRLV-HRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHA-DGGKVPIKWMALESI 183
Query: 913 SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972
+ +SDV+++G+ + EL+T + + L
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAK--------------------PYDGIPAREIPDL 223
Query: 973 IMDGHDMEQPPRILSDMLQVALRCILPASE-RPDMMSVFEELSTI 1016
+ G + QPP D+ + ++C + SE RP + +E S +
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 59/264 (22%), Positives = 86/264 (32%), Gaps = 77/264 (29%)
Query: 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172
SL+ L LS N G IP G+ SL G L+ LDL N
Sbjct: 51 PSLKELCLSLN-ETGRIPRGLQSL-----------------LQGLTKGCGLQELDLSDNA 92
Query: 173 FGGDIMHL---LSQLGSVVHVDLSNNQFSG------------------SLDLG------- 204
G D + L + S+ + L+NN L LG
Sbjct: 93 LGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA 152
Query: 205 -----LGDSSFISSIQYLNISENSLVGELFPH--DGMPYFDNLEVFDASNN--------H 249
++ LN++ N + +G+ NLEV D +NN
Sbjct: 153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA 212
Query: 250 LVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLS----ELDLSLNQLEGPVGS 305
L + S SL +L LG N L A L + + + L LS N + G+
Sbjct: 213 LAETLASLK---SLEVLNLGDNNL-TDAGAAALASALLSPNISLLTLSLSCNDI-TDDGA 267
Query: 306 IT-------SATLKKVNLSSNKLS 322
+L +++L NK
Sbjct: 268 KDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 59/274 (21%), Positives = 105/274 (38%), Gaps = 52/274 (18%)
Query: 759 LAVKRLREGIAKGKKE--FAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816
+AVK L E + E F E + H N+V L G + + + ++ +
Sbjct: 39 VAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF--ERLPRFILLELMAGGD 95
Query: 817 LAVYLQETDPRKLPP--LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL--EAP 872
L +L+E PR P L++ + L A DVA+ YL I H ++ + N LL + P
Sbjct: 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI-HRDIAARNCLLTCKGP 154
Query: 873 TMNAVLTDYSLHRILTSAGTADQVLNAG----ALGYRPPE------FASTSKPCPSLKSD 922
A + D+ + R + A G + + PPE F S K+D
Sbjct: 155 GRVAKIADFGMARDIYR---ASYYRKGGRAMLPIKWMPPEAFLDGIFTS--------KTD 203
Query: 923 VYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQP 982
V++FG++L E+ + G + R+ + + G ++ P
Sbjct: 204 VWSFGVLLWEIFS-----------LGYMPYP---------GRTNQEVMEFVTGGGRLDPP 243
Query: 983 PRILSDMLQVALRCILPASE-RPDMMSVFEELST 1015
+ ++ C E RP+ ++ E +
Sbjct: 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 69/303 (22%), Positives = 125/303 (41%), Gaps = 51/303 (16%)
Query: 740 IGRSCHGTLYKATL--------DSGSILAVKRLRE-GIAKGKKEFAREVKKLGNI-KHPN 789
+G C G + +A D +AVK L++ K + E++ + I KH N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDP---------RKLP--PLSIDERL 838
+++L G +E VI Y +L +L+ P K+P LS + +
Sbjct: 80 IINLLGVC--TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
A VAR + YL + R I H +L + N+L+ + + D+ L R + + N
Sbjct: 138 SCAYQVARGMEYLESRRCI-HRDLAARNVLVTEDNVMKI-ADFGLARGVHDIDYYKKTSN 195
Query: 899 AG-ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956
+ + PE + + +SDV++FGI++ E+ T G S + V+
Sbjct: 196 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---------- 243
Query: 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015
E F +L+ +GH M++P ++ + C ++RP + E L
Sbjct: 244 ----------ELF-KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292
Query: 1016 IVL 1018
++
Sbjct: 293 VLA 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 13/193 (6%)
Query: 754 DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH---EKLVISN 810
D +AVK++ + K RE+K + + H N+V + GP E +
Sbjct: 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLT 86
Query: 811 YINAQSLAVYLQETDPRKL---PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNI 867
+N+ + ETD + PLS + + R L Y+H+ + H +LK N+
Sbjct: 87 ELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL-HRDLKPANV 145
Query: 868 LLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG--YRPPEFASTSKPCPSLKS-DVY 924
+ + + D+ L RI+ + L+ G + YR P + P K+ D++
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS--PNNYTKAIDMW 203
Query: 925 AFGIILLELLTGK 937
A G I E+LTGK
Sbjct: 204 AAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 41/210 (19%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL---REGIAKGKK---EFAREVKKLGNIKHPNL 790
+ +G + Y+A + +G+++AVK++ R ++ ++ +E++ + + HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
+ + G H L + ++ S++ L K + + R L+Y
Sbjct: 66 IRMLGAT-CEDSHFNLFVE-WMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSY 118
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA---GALGYRPP 907
LH + I H ++K N+L+++ + D+ L + GT G + + P
Sbjct: 119 LHENQII-HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLTGK 937
E + S DV++ G +++E+ T K
Sbjct: 178 EVLRGEQYGRS--CDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNLV 791
E IG +G +YKA +G ++A+K++R EG+ RE+ L + HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA---IREISLLKELNHPNIV 62
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L E++ ++ +++ Q L ++ + +P I L + + L +
Sbjct: 63 KLLDVI--HTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYL---FQLLQGLAFC 116
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHR---ILTSAGTADQVLNAGALGYRPP 907
H+ R + H +LK N+L+ T A+ L D+ L R + T + V L YR P
Sbjct: 117 HSHRVL-HRDLKPQNLLIN--TEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLTGKS 938
E K S D+++ G I E++T ++
Sbjct: 170 EILLGCK-YYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQG 795
E++G GT+YKA L + ILAVK + I + +K+ E++ L P ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
++ E+ + + +++ SL VY RK+P + R+AV V + L YL + +
Sbjct: 67 AFF--VENRISICTEFMDGGSLDVY------RKIPEHVLG---RIAVAVVKGLTYLWSLK 115
Query: 856 AIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
I H ++K +N+L+ T V L D+ + L ++ V G Y PE S +
Sbjct: 116 -ILHRDVKPSNMLVN--TRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQ 169
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
+ SDV++ GI +EL G+
Sbjct: 170 Y--GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 17/172 (9%)
Query: 771 GKKEFAREVKKLGNIKHPNLVSL-QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL 829
G K RE+ L I H +++L Y W +V+ Y L Y+ + P L
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKSTVC--MVMPKY--KCDLFTYVDRSGPLPL 184
Query: 830 PP-LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888
++I RL A L YLH R I H ++K+ NI L+ P NAVL D+ L
Sbjct: 185 EQAITIQRRLLEA------LAYLH-GRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLD 236
Query: 889 SAGTADQVLN-AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSS 939
+ Q +G L PE + C K+D+++ G++L E+ +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCA--KTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS-LQG 795
E IG+ GT+Y A + +G +A++++ K+ E+ + K+PN+V+ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHN 853
Y G E V+ Y+ SL + ET +DE AV + + L +LH+
Sbjct: 86 YLVG---DELWVVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHS 134
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++KS NILL + LTD+ +T + + G + PE +
Sbjct: 135 NQVI-HRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRK 191
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
P K D+++ GI+ +E++ G+
Sbjct: 192 AYGP--KVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 21/60 (35%), Positives = 26/60 (43%)
Query: 138 NLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
NL L++S+N F GL LK LDL N S L S+ +DLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 755 SGSILAVKRLREGIAKGKKEFAR-EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813
S A+K +R + E +R E L +KHPN+V+ + + + ++ Y +
Sbjct: 24 SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYCD 81
Query: 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT 873
L ++ + P +I L+ V + + ++H +R + H ++KS NI L
Sbjct: 82 GGDLMQKIKLQRGKLFPEDTI---LQWFVQMCLGVQHIHEKRVL-HRDIKSKNIFL-TQN 136
Query: 874 MNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLEL 933
L D+ R+LTS G A G Y PPE + P + KSD+++ G IL EL
Sbjct: 137 GKVKLGDFGSARLLTSPG-AYACTYVGTPYYVPPEIWE-NMPYNN-KSDIWSLGCILYEL 193
Query: 934 LTGK 937
T K
Sbjct: 194 CTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 738 EVIGRSCHGTLYKATLDSGSI---LAVKRLREGIAKGK-KEFAREVK---KLGNIKHPNL 790
+VIG G + KA + + A+KR++E +K ++FA E++ KLG+ HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 791 VSLQGYYWGPKEHEKLVIS-NYINAQSLAVYLQ-----ETDPR------KLPPLSIDERL 838
++L G + L ++ Y +L +L+ ETDP LS + L
Sbjct: 59 INLLG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
A DVAR ++YL +++ H +L + NIL+ A + D+ L R +V
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILV-GENYVAKIADFGLSR-------GQEVYV 166
Query: 899 AGALGYRPPEF---ASTSKPCPSLKSDVYAFGIILLELLT 935
+G P + S + + SDV+++G++L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 758 ILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLV-ISNYINAQS 816
++AVK L++ +K+F RE + L N++H ++V +Y E + L+ + Y+
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK---FYGVCVEGDPLIMVFEYMKHGD 93
Query: 817 LAVYLQETDPRKL------PP--LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNIL 868
L +L+ P + P L+ + L +A +A + YL ++ + H +L + N L
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV-HRDLATRNCL 152
Query: 869 LEAPTMNAVLTDYSLHRILTSAGTADQVLNAG----ALGYRPPEFASTSKPCPSLKSDVY 924
+ + + D+ + R + S D G + + PPE K + +SDV+
Sbjct: 153 V-GENLLVKIGDFGMSRDVYS---TDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVW 206
Query: 925 AFGIILLELLT-GK------SSGEIV-CVDPGVV 950
+ G++L E+ T GK S+ E++ C+ G V
Sbjct: 207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-05
Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 5/125 (4%)
Query: 36 SGQIIDSWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTI----IGLKM 91
G + DS+ +K L + RN F + L + L N I K
Sbjct: 465 FGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 92 LCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFE 150
L ++ +S+NQL G I + L LDLS N G IP + ++++L+ +NIS N
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 151 GTFPS 155
G+ PS
Sbjct: 585 GSLPS 589
|
Length = 968 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAKGKKEFA-REVKKLGNIKHPNLVSLQ 794
E IG +G +YKA +G I+A+K++R E +G A RE+ L + HPN+V L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLH 852
E++ ++ +++ L Y+ P +D L + + + Y H
Sbjct: 65 DVVH--SENKLYLVFEFLD-LDLKKYMD-----SSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR---ILTSAGTADQVLNAGALGYRPPEF 909
+ R + H +LK N+L++ L D+ L R + T + V L YR PE
Sbjct: 117 SHR-VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEI 170
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
S+ S D+++ G I E++ +
Sbjct: 171 LLGSRQY-STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 49/219 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL-----REGIAKGKKEFAREVKKLGNIKHPNLV 791
E IG+ G +YKA + ++A+K + + I + +E++ L + P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE----DIQQEIQFLSQCRSPYIT 62
Query: 792 SLQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
YY + KL +I Y S L+ P KL I LR +V L Y
Sbjct: 63 K---YYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILR---EVLLGLEY 113
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS--------AGT----ADQVLN 898
LH E I H ++K+ NILL + L D+ + LTS GT A +V+
Sbjct: 114 LHEEGKI-HRDIKAANILLSE-EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
K+D+++ GI +EL G+
Sbjct: 172 QSGYDE---------------KADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 739 VIGRSCHGTLYKATL-DSGSILAVKRLREG--IAKGK-KEFAREVKKLGNIKHPNLVSLQ 794
VIG+ G + D+ + A+K + + + KG + E + L + HP LV+L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL- 65
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLHN 853
+Y E ++ + + L +L + +E+++ ++ L YLH+
Sbjct: 66 -WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS------EEQVKFWICEIVLALEYLHS 118
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++K NILL+ + +TD+++ +T +G GY PE
Sbjct: 119 KGII-HRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQ 174
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
S+ D ++ G+ E L GK
Sbjct: 175 GY--SVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFA-REVKKLGNIKHPNLVSLQGYYW 798
+GR +G +YKA G L++ G A RE+ L +KHPN+++LQ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 799 GPKEHEKLVISNYINAQSLAVY------LQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ + ++ +Y + P +LP + L +D ++YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD---GIHYLH 125
Query: 853 NERAIPHGNLKSTNILL--EAPTMNAV-LTDYSLHRILTS--AGTADQVLNAGALGYRPP 907
+ H +LK NIL+ E P V + D R+ S AD YR P
Sbjct: 126 ANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLTGK 937
E ++ + D++A G I ELLT +
Sbjct: 185 ELLLGARHY-TKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 740 IGRSCHGTLYKATLDSGSI---LAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+GR +G +YKA G A+K++ GI+ RE+ L +KHPN++SLQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 65
Query: 796 YYWGPKEHEKLVISNYINAQSLAVY------LQETDPRKLPPLSIDERLRVAVDVARCLN 849
+ + + ++ +Y + P +LP + L +D ++
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD---GIH 122
Query: 850 YLHNERAIPHGNLKSTNILL--EAPTMNAV-LTDYSLHRILTS--AGTADQVLNAGALGY 904
YLH + H +LK NIL+ E P V + D R+ S AD Y
Sbjct: 123 YLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
R PE ++ + D++A G I ELLT +
Sbjct: 182 RAPELLLGARHY-TKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
E+IG G + + +G +AVK ++ + + F E + + H NLV L G
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 798 WGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
H L ++ ++ +L +L+ T R L + + L+ ++DVA + YL +++
Sbjct: 69 L----HNGLYIVMELMSKGNLVNFLR-TRGRALVSVI--QLLQFSLDVAEGMEYLESKKL 121
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPC 916
+ H +L + NIL+ + A ++D+ L R+ S G + L + + PE K
Sbjct: 122 V-HRDLAARNILVSEDGV-AKVSDFGLARV-GSMGVDNSKL---PVKWTAPEALKHKKF- 174
Query: 917 PSLKSDVYAFGIILLELLT 935
S KSDV+++G++L E+ +
Sbjct: 175 -SSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 47/194 (24%), Positives = 91/194 (46%), Gaps = 26/194 (13%)
Query: 758 ILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLV-ISNYINAQS 816
++AVK L++ +K+F RE + L N++H ++V +Y + + L+ + Y+
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK---FYGVCGDGDPLIMVFEYMKHGD 93
Query: 817 LAVYLQETDPRKL-----------PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKST 865
L +L+ P + L + + L +A +A + YL ++ + H +L +
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV-HRDLATR 152
Query: 866 NILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG----ALGYRPPEFASTSKPCPSLKS 921
N L+ A + + D+ + R + S D G + + PPE K + +S
Sbjct: 153 NCLVGANLL-VKIGDFGMSRDVYS---TDYYRVGGHTMLPIRWMPPESIMYRK--FTTES 206
Query: 922 DVYAFGIILLELLT 935
DV++FG+IL E+ T
Sbjct: 207 DVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAKGKK--EFAREVKKLGNIKHPNLVSLQG 795
IG G +Y A + + ++A+K++ G +K + +EV+ L ++HPN + +G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y +EH ++ Y A L E + L + I A+ + L YLH+
Sbjct: 83 CYL--REHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHN 135
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE-FASTSK 914
I H ++K+ NILL P + L D+ I+ A G + PE + +
Sbjct: 136 MI-HRDVKAGNILLSEPGL-VKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDE 188
Query: 915 PCPSLKSDVYAFGIILLEL 933
K DV++ GI +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREV---KKLGNIKHPNLVSL 793
EVIG +G +YKA +G ++A+K + + I ++E E +K N HPN+ +
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSN--HPNIATF 68
Query: 794 QGYYWGP----KEHEKLVISNYINAQSLAVYLQETD--PRKLPPLSIDERLRVAVDVARC 847
G + + + ++ S+ ++ ++L I LR + R
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR---ETLRG 125
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNA--VLTDYSLHRILTSA-GTADQVLNAGALGY 904
L YLH + I H ++K NILL T NA L D+ + L S G + + G +
Sbjct: 126 LAYLHENKVI-HRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYW 179
Query: 905 RPPE-FASTSKPCPSL--KSDVYAFGIILLELLTGK 937
PE A +P S +SDV++ GI +EL GK
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 43/281 (15%)
Query: 759 LAVKRLR-EGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816
+AVK L+ + K + E++ + I KH N+++L G ++ VI Y + +
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGN 110
Query: 817 LAVYLQET---------DPRKLPP--LSIDERLRVAVDVARCLNYLHNERAIPHGNLKST 865
L YL+ +P ++P LS + + A VAR + YL +++ I H +L +
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI-HRDLAAR 169
Query: 866 NILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG-ALGYRPPEFASTSKPCPSLKSDVY 924
N+L+ + + D+ L R + + N + + PE + + +SDV+
Sbjct: 170 NVLVTEDNVMKI-ADFGLARDIHHIDYYKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVW 226
Query: 925 AFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPR 984
+FG++L E+ T S PGV +E E F +L+ +GH M++P
Sbjct: 227 SFGVLLWEIFTLGGSPY-----PGV----------PVE----ELF-KLLKEGHRMDKPSN 266
Query: 985 ILSDMLQVALRC--ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+++ + C +P S+RP + E+L I+ +Q
Sbjct: 267 CTNELYMMMRDCWHAVP-SQRPTFKQLVEDLDRILALTSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 59/282 (20%), Positives = 115/282 (40%), Gaps = 54/282 (19%)
Query: 757 SILAVKRLREGIAKGK-KEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815
+ +AVK L+E + + ++ E L + HP+++ L G ++ L+I Y
Sbjct: 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYG 88
Query: 816 SLAVYLQETDPRKLPP---------------------LSIDERLRVAVDVARCLNYLHNE 854
SL +L+E+ RK+ P L++ + + A ++R + YL E
Sbjct: 89 SLRSFLRES--RKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL-AE 145
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHR-ILTSAGTADQVLNAGALGYRPPEFASTS 913
+ H +L + N+L+ A ++D+ L R + + + + E S
Sbjct: 146 MKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE--SLF 202
Query: 914 KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973
+ +SDV++FG++L E++T + PG+ + L+
Sbjct: 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIAPERLF---------------NLL 242
Query: 974 MDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELST 1015
G+ ME+P +M + L C + PD F ++S
Sbjct: 243 KTGYRMERPENCSEEMYNLMLTC---WKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 48/238 (20%), Positives = 77/238 (32%), Gaps = 57/238 (23%)
Query: 289 LSELDLSLNQLEGPV--------GSITSATLKKVNLSSNKLSGSLPARVGHCT------I 334
L EL LSLN+ G L++++LS N L +
Sbjct: 53 LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQE 112
Query: 335 VDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG-- 392
+ L+NN L R+ G+ L + N LEG
Sbjct: 113 LKLNNNGLGDRGLRL---------------LAKGLKDLP----PALEKLVLGRNRLEGAS 153
Query: 393 --DLPAVLGTYPELKVIDLSLNHLNGF----LLPSFFTSTKLTDLNLSGNNFSGPLPLQE 446
L L +LK ++L+ N + L + L L+L+ NN
Sbjct: 154 CEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN-NNGLTDEGASA 212
Query: 447 IQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHN--------LVYLNLSNNKFE 496
+ ++ SL L+L N+L+ G + + L+ L+LS N
Sbjct: 213 LAETLAS----LKSLEVLNLGDNNLTDA---GAAALASALLSPNISLLTLSLSCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYW 798
IG +G +YKA +++G + A+K ++ + +E+ + + KH N+V+ G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 799 GPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+KL I + SL T PLS + V+ + + L YLH++ +
Sbjct: 77 ---RRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS-KPC 916
H ++K NILL + L D+ + +T A A + G + PE A+ K
Sbjct: 129 -HRDIKGANILL-TDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 917 PSLKSDVYAFGIILLEL 933
+ D++A GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 50/214 (23%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 733 SHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLV 791
S+ +IG G +Y+A +D+ +A+K+ + + + RE+ + N+ H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINII 122
Query: 792 SLQGYYWGP--KEHEKLVISNYIN---AQSLAVYLQ--ETDPRKLPPLSIDERLRVAVDV 844
L+ YY+ K++EK + N + Q++ Y++ + LP + + +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK---LYSYQL 179
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGY 904
R L Y+H+ + I H +LK N+L++ T L D+ + L V + Y
Sbjct: 180 CRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQRSVSYICSRFY 236
Query: 905 RPPE--FASTSKPCPSLKSDVYAFGIILLELLTG 936
R PE +T+ + D+++ G I+ E++ G
Sbjct: 237 RAPELMLGATNY---TTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKK--EFAREVKKLGNIKHPNLVSLQG 795
IG G +Y AT + ++AVK++ G +K + +EVK L +KHPN + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y KEH ++ Y A L E + PL E + + L YLH+
Sbjct: 89 CYL--KEHTAWLVMEYCLGS--ASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN 141
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE-FASTSK 914
I H ++K+ NILL P L D+ + A + G + PE + +
Sbjct: 142 MI-HRDIKAGNILLTEPG-QVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDE 194
Query: 915 PCPSLKSDVYAFGIILLEL 933
K DV++ GI +EL
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 740 IGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSL-QGYY 797
+G G +YKA +LA ++ + ++ + E + E+ L + HPN+V L +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 798 WGPKEHEKLVISNYINAQSL-AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ E+ ++ + ++ AV L+ P P + + V LNYLH +
Sbjct: 73 Y---ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-----VCKQTLEALNYLHENKI 124
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN----AGALGYRPPE--FA 910
I H +LK+ NIL T++ D L SA + G + PE
Sbjct: 125 I-HRDLKAGNILF---TLDG---DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 911 STSKPCP-SLKSDVYAFGIILLEL 933
TSK P K+DV++ GI L+E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRL------REGIAKGKKEFAREVKKLGNIKHPNLV 791
EV+G+ +GT+Y + G ++AVK++ K ++ EV L ++KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 792 SLQGYYWGPKEHEKLV--ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN 849
Y G + + ++ S++ L P LP + + +D +
Sbjct: 66 Q----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILD---GVA 116
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG---TADQVLNA--GALGY 904
YLHN + H ++K N++L P L D+ R L G T +L + G +
Sbjct: 117 YLHNNCVV-HRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE + S KSD+++ G + E+ TGK
Sbjct: 175 MAPEVINESGY--GRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 14/190 (7%)
Query: 754 DSGSILAVKRLREGI----AKGKKEFAREVKKLGNIKH-PNLVSLQGYYWGPKEHEKLVI 808
DSG + A+K L++ AK + E + L +I+ P LV+L +Y + + +I
Sbjct: 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYAFQTDTKLHLI 83
Query: 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNIL 868
+YIN L +L + + K + I + ++ L +LH + I + ++K NIL
Sbjct: 84 LDYINGGELFTHLSQRERFKEQEVQI-----YSGEIVLALEHLH-KLGIIYRDIKLENIL 137
Query: 869 LEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGI 928
L++ + VLTD+ L + G + Y P+ D ++ G+
Sbjct: 138 LDS-NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196
Query: 929 ILLELLTGKS 938
++ ELLTG S
Sbjct: 197 LMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 755 SGSILAVKRLREGIAKG--KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812
+G +A+K++ + + K RE+K L +++H N++SL + P E V
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE--- 90
Query: 813 NAQSLAVYLQETDPRKL---PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869
L TD +L PL + R L Y+H+ + H +LK +NIL+
Sbjct: 91 --------LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVV-HRDLKPSNILI 141
Query: 870 EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGII 929
+ + D+ L RI T YR PE T + ++ D+++ G I
Sbjct: 142 NE-NCDLKICDFGLARIQDPQMTG----YVSTRYYRAPEIMLTWQKY-DVEVDIWSAGCI 195
Query: 930 LLELLTGK 937
E+L GK
Sbjct: 196 FAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 756 GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL-VISNYINA 814
G+ +AVK ++ + F E + ++H NLV L G +E L +++ Y+
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEYMAK 84
Query: 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874
SL YL+ R L D L+ ++DV + YL + H +L + N+L+ +
Sbjct: 85 GSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFV-HRDLAARNVLVSEDNV 140
Query: 875 NAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLEL 933
A ++D+ L T ++ Q + + PE K S KSDV++FGI+L E+
Sbjct: 141 -AKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNLV 791
E IG +G +YK +G I+A+K++R EG+ RE+ L ++HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA---IREISLLKELQHPNIV 62
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRK-LPPLSIDERLRVAVDVARCLNY 850
LQ +E +I ++ + L YL + + + L + + + +
Sbjct: 63 CLQDVLM--QESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY---QILQGILF 116
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR---ILTSAGTADQVLNAGALGYRPP 907
H+ R + H +LK N+L++ L D+ L R I T + V L YR P
Sbjct: 117 CHSRRVL-HRDLKPQNLLIDNKG-VIKLADFGLARAFGIPVRVYTHEVV----TLWYRAP 170
Query: 908 E--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
E S P D+++ G I E+ T K
Sbjct: 171 EVLLGSPRYSTP---VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 3/92 (3%)
Query: 314 VNLSSNKLSGSLP---ARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMV 370
+ L + L G +P +++ H ++LS N + G++ +E + LS N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 371 PNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYP 402
P Q L ++ NSL G +PA LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 31/207 (14%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIK--HPNLVSLQ 794
I + G++Y A +G A+K L++ IAK + + + + I+ P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
Y + K++ LV+ Y+N A ++ L L D + +V + LH +
Sbjct: 64 -YSFQSKDYLYLVM-EYLNGGDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLH-Q 115
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS----AGTADQVLNAGALGYRPPEFA 910
R I H ++K N+L++ T + LTD+ L R GT D Y PE
Sbjct: 116 RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLENKKFVGTPD---------YLAPE-- 163
Query: 911 STSKPCPSLK-SDVYAFGIILLELLTG 936
T K SD ++ G ++ E L G
Sbjct: 164 -TILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 715 AGDLHLFDVSLMFTAEELSHAPAEV--IGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAK 770
AG L +++ +F E+ ++ IG G +Y A + + ++A+K++ G
Sbjct: 6 AGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS 65
Query: 771 GKK--EFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRK 828
+K + +EVK L IKHPN + +G Y +EH ++ Y A L E +
Sbjct: 66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYCLGS--ASDLLEVHKK- 120
Query: 829 LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888
PL E + + L YLH+ I H ++K+ NILL P L D+ I +
Sbjct: 121 --PLQEVEIAAITHGALQGLAYLHSHNMI-HRDIKAGNILLTEPG-QVKLADFGSASIAS 176
Query: 889 SAGTADQVLNAGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLEL 933
A + G + PE + + K DV++ GI +EL
Sbjct: 177 PANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 65/275 (23%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 759 LAVKRLRE-GIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816
+AVK L++ K + E++ + I KH N+++L G ++ V+ Y + +
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGN 104
Query: 817 LAVYLQETDPR---------KLP--PLSIDERLRVAVDVARCLNYLHNERAIPHGNLKST 865
L YL+ P KLP L+ + + A VAR + YL +++ I H +L +
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI-HRDLAAR 163
Query: 866 NILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG-ALGYRPPEFASTSKPCPSLKSDVY 924
N+L+ + + D+ L R + + + N + + PE + + +SDV+
Sbjct: 164 NVLVTEDNVMKI-ADFGLARDVHNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVW 220
Query: 925 AFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPR 984
+FG++L E+ T S PG+ +E E F +L+ +GH M++P
Sbjct: 221 SFGVLLWEIFTLGGSPY-----PGI----------PVE----ELF-KLLKEGHRMDKPAN 260
Query: 985 ILSDMLQVALRC--ILPASERPDMMSVFEELSTIV 1017
++ + C +P S+RP + E+L ++
Sbjct: 261 CTHELYMIMRECWHAVP-SQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 782 LGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVA 841
+ + H +LV G E +++ Y+ SL YL+ + ++I +L VA
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDES--IMVQEYVKFGSLDTYLK----KNKNLINISWKLEVA 106
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILL----EAPTMNAVLTDYSLHRILTSAGTADQVL 897
+A L++L ++ + HGN+ + N+LL + T N L+ G + VL
Sbjct: 107 KQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK------LSDPGISITVL 159
Query: 898 NAGALGYR----PPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
L R PPE + SL +D ++FG L E+ +G
Sbjct: 160 PKEILLERIPWVPPECIENPQNL-SLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 787 HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVA 845
HP LV L + + +++ L ++Q RKLP +E R + +++
Sbjct: 55 HPFLVGLHSCFQTESR--LFFVIEFVSGGDLMFHMQRQ--RKLP----EEHARFYSAEIS 106
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR 905
LN+LH ER I + +LK N+LL+A + LTDY + + G G Y
Sbjct: 107 LALNFLH-ERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTF-CGTPNYI 163
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943
PE S+ D +A G+++ E++ G+S +IV
Sbjct: 164 APEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK-KEFAREVKKLGNIKH---PNLVS 792
E+IGR +G +Y+ + +G ++A+K + + REV L ++ PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAV---YLQETDPRKL-PPLSIDERLRVAV--DVAR 846
Y+G +Y+ L + Y + R L I E+ + +V
Sbjct: 67 ----YYG----------SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV 112
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP 906
L Y+H I H ++K+ NIL+ T N L D+ + +L + G +
Sbjct: 113 ALKYIHKVGVI-HRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMA 169
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTG 936
PE + K K+D+++ GI + E+ TG
Sbjct: 170 PEVITEGKYY-DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 65/280 (23%), Positives = 124/280 (44%), Gaps = 37/280 (13%)
Query: 740 IGRSCHGTLYKAT--LDSGSILAVKRLR--EGI-AKGKKEFAREVKKLGNIKHPNLVSLQ 794
IGR +Y+AT LD + A+K+++ E + AK +++ +E+ L + HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPV-ALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQ--ETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ +++E ++ +A L+ ++ + R +P ++ + V + + ++H
Sbjct: 69 DSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV---WKYFVQLCSAVEHMH 123
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
+ R + H ++K N+ + A T L D L R +S TA L G Y PE
Sbjct: 124 SRR-VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE--RI 178
Query: 913 SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972
+ + KSD+++ G +L E+ +S D + L +L + +C D
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF-----------YGDKMNLFSLCQKIEQC-DYP 226
Query: 973 IMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFE 1011
+ + R L M CI P +RPD+ V +
Sbjct: 227 PLPTEHYSEKLRELVSM------CIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSL-QGYY 797
+G G +YKA ++G A K ++ + ++F E+ L KHPN+V L + Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+ K ++ + + +L + E + L+ + V + LN+LH+ + I
Sbjct: 73 YENK---LWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 858 PHGNLKSTNILLEAPTM--NAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPEF--AS 911
H +LK+ NILL T+ + L D+ + S Q + G + PE
Sbjct: 126 -HRDLKAGNILL---TLDGDVKLADFGVSAKNKS---TLQKRDTFIGTPYWMAPEVVACE 178
Query: 912 TSKPCP-SLKSDVYAFGIILLEL 933
T K P K+D+++ GI L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 21/167 (12%)
Query: 774 EFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLS 833
F + + H +LV L G E +++ Y+ L V+L R+ +S
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRD---ENIMVEEYVKFGPLDVFLH----REKNNVS 99
Query: 834 IDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL------EAPTMNAVLTDYSLHRIL 887
+ +L VA +A L+YL +++ + HGN+ NIL+ E L+D I
Sbjct: 100 LHWKLDVAKQLASALHYLEDKKLV-HGNVCGKNILVARYGLNEGYVPFIKLSDPG---IP 155
Query: 888 TSAGTADQ-VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLEL 933
+ + ++ V + PE + ++ +D ++FG LLE+
Sbjct: 156 ITVLSREERVERIPWI---APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 43/188 (22%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 755 SGSILAVKRLREGIAKGKKEFAR---EVKKLGNIKHPNLVSLQGYYWGPKEHEKLV-ISN 810
+G A+K L++ + K E A E + L N +HP L +L+ + + H++L +
Sbjct: 19 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK---YSFQTHDRLCFVME 75
Query: 811 YINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLHNERAIPHGNLKSTNILL 869
Y N L +L + ++R R ++ L+YLH+E+ + + +LK N++L
Sbjct: 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129
Query: 870 EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGII 929
+ + +TD+ L + G + G Y PE + ++ D + G++
Sbjct: 130 DKDG-HIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVLEDNDYGRAV--DWWGLGVV 185
Query: 930 LLELLTGK 937
+ E++ G+
Sbjct: 186 MYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 739 VIGRSCHGTLYKAT-LDSGSILAVKRLR--EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
V+G +G + K ++ I+A+K+ + E + K+ RE+K L +K N+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 796 YYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV-DVARCLNYLHN 853
+ + KL ++ Y+ L L E P +PP E++R + + + +++ H
Sbjct: 68 AF---RRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP----EKVRSYIYQLIKAIHWCH- 117
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++K N+L+ + L D+ R L+ A+ YR PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 914 KPCPSLKS-DVYAFGIILLELLTGK 937
P K+ D+++ G IL EL G+
Sbjct: 177 ---PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 755 SGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813
SG I+A K + I + + RE++ L P +V G ++ + E + +++
Sbjct: 29 SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMD 86
Query: 814 AQSLAVYLQETDPRKLPPLSIDERL-RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872
SL L+E +++P +E L +V++ V R L YL + I H ++K +NIL+ +
Sbjct: 87 GGSLDQVLKEA--KRIP----EEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR 140
Query: 873 TMNAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPEFASTSKPCPSLKSDVYAFGIIL 930
L D+ + S D + N+ G Y PE + S++SD+++ G+ L
Sbjct: 141 G-EIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSL 192
Query: 931 LELLTGK 937
+EL G+
Sbjct: 193 VELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 18/140 (12%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKK--EFAREVKKLGNIKHPNLVSLQG 795
IG G +Y A + + ++A+K++ G +K + +EV+ L ++HPN + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 796 YYWGPKEHEKLVISNY-INAQS--LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
Y +EH ++ Y + + S L V+ +K PL E + + L YLH
Sbjct: 83 CYL--REHTAWLVMEYCLGSASDILEVH------KK--PLQEVEIAAICHGALQGLAYLH 132
Query: 853 NERAIPHGNLKSTNILLEAP 872
+ I H ++K+ NILL P
Sbjct: 133 SHERI-HRDIKAGNILLTEP 151
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 65/277 (23%), Positives = 125/277 (45%), Gaps = 47/277 (16%)
Query: 759 LAVKRLRE-GIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816
+AVK L++ K + E++ + I KH N+++L G ++ VI Y + +
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGN 107
Query: 817 LAVYLQETDP---------RKLP--PLSIDERLRVAVDVARCLNYLHNERAIPHGNLKST 865
L YL+ P ++P ++ + + VAR + YL +++ I H +L +
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI-HRDLAAR 166
Query: 866 NILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNAG-ALGYRPPEFASTSKPCPSLKSD 922
N+L+ T N V+ D+ L R + + + N + + PE + + +SD
Sbjct: 167 NVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSD 221
Query: 923 VYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQP 982
V++FG+++ E+ T S PG+ +E E F +L+ +GH M++P
Sbjct: 222 VWSFGVLMWEIFTLGGSPY-----PGI----------PVE----ELF-KLLKEGHRMDKP 261
Query: 983 PRILSDMLQVALRC--ILPASERPDMMSVFEELSTIV 1017
+++ + C +P S RP + E+L I+
Sbjct: 262 ANCTNELYMMMRDCWHAIP-SHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQG 795
E IG+ G +YK + + ++A+K + A+ + E +E+ L P + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y K + +I Y+ S L+ P L I LR ++ + L+YLH+ER
Sbjct: 70 SYL--KGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILR---EILKGLDYLHSER 121
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H ++K+ N+LL + + L D+ + LT G + PE S
Sbjct: 122 KI-HRDIKAANVLL-SEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQS-- 176
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
K+D+++ GI +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 739 VIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEF-----AREVKKLGNIKHPNLVS 792
V+G+ G + A L + + AVK L++ + + + V L KHP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYL 851
L + K+ V+ Y+N L ++Q + + + R R A ++ L +L
Sbjct: 61 LHSCF-QTKDRLFFVME-YVNGGDLMFHIQRS--GRFD----EPRARFYAAEIVLGLQFL 112
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSL--------HRILTSAGTADQVLNAGALG 903
H ER I + +LK N+LL++ + + D+ + T GT D
Sbjct: 113 H-ERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCGTPD--------- 161
Query: 904 YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938
Y PE S P++ D +A G++L E+L G+S
Sbjct: 162 YIAPEILSYQPYGPAV--DWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 822 QETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTD 880
QETD PL++++ + + VAR + +L + + I H +L + NILL N V + D
Sbjct: 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCI-HRDLAARNILLSEN--NVVKICD 217
Query: 881 YSLHRILTSAGTADQVLNAGA---LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-G 936
+ L R + D V A L + PE S + +SDV++FG++L E+ + G
Sbjct: 218 FGLARDIYK--DPDYVRKGSARLPLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 937 KSSGEIVCVDPGVVD-LTDWVRLLALENRSGECFDRLIMD---GHDMEQPP-----RILS 987
S V ++ L D R+ A EN + E + R+++ G E+P IL
Sbjct: 274 ASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY-RIMLACWQGDPKERPTFSALVEILG 332
Query: 988 DMLQ 991
D+LQ
Sbjct: 333 DLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 62/259 (23%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 760 AVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA 818
AVK LR + +++F +EVK L + PN+ L G + +I Y+ L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV--CTVDPPLCMIMEYMENGDLN 107
Query: 819 VYLQE------TDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872
+LQ+ LS L +A +A + YL H +L + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCLV-GK 165
Query: 873 TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPP--------------EFASTSKPCPS 918
+ D+ + R L S+ + R P +F +
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYR-------VQGRAPLPIRWMAWESVLLGKFTT------- 211
Query: 919 LKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD-WVRLLALENRSGECFDRLIMDGH 977
KSDV+AFG+ L E+LT +C + LTD V +EN +G F +
Sbjct: 212 -KSDVWAFGVTLWEILT-------LCREQPYEHLTDQQV----IEN-AGHFFRDDGRQIY 258
Query: 978 DMEQPPRILSDMLQVALRC 996
+ +PP D+ ++ L C
Sbjct: 259 -LPRPPNCPKDIYELMLEC 276
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 738 EVIGRSCHGTLYKA-TLDSGSILAVKRLR-EGIAKGKKEFA-REVKKLGNIKHPNLVSLQ 794
E IG +GT++KA ++ I+A+KR+R + +G A RE+ L +KH N+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQ----ETDPRKLPPLSIDERLRVAVDVARCLNY 850
+ + ++ Y + Q L Y + DP + + + L +
Sbjct: 66 DVLHS--DKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMF--------QLLKGLAF 114
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHR---ILTSAGTADQVLNAGALGYR 905
H+ + H +LK N+L+ N L D+ L R I +A+ V L YR
Sbjct: 115 CHSHN-VLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVV----TLWYR 166
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLEL 933
PP+ +K S D+++ G I EL
Sbjct: 167 PPDVLFGAK-LYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNLV 791
E IG +G +YKA + +A+K++R EG+ RE+ L ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA---IREISLLKEMQHGNIV 64
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLN 849
LQ E ++ Y++ L ++ + P + + RL + R +
Sbjct: 65 RLQDVVH--SEKRLYLVFEYLDL-DLKKHMDSS-----PDFAKNPRLIKTYLYQILRGIA 116
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR---ILTSAGTADQVLNAGALGYRP 906
Y H+ R + H +LK N+L++ T L D+ L R I T + V L YR
Sbjct: 117 YCHSHRVL-HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRA 171
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE S+ S D+++ G I E++ K
Sbjct: 172 PEILLGSRHY-STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR---EGIAKGKKEFAREVKKLGNIKHPNLVSL 793
EVIG+ +G + A +G +A+K++ E ++ + RE+K L ++HP++V +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEI 64
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVY-LQETDPRKL----PPLSIDERLRVAVDVARCL 848
+ P E I Y+ V+ L E+D ++ L+ + + R L
Sbjct: 65 KHIMLPPSRREFKDI--YV------VFELMESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLT--DYSLHRI-LTSAGTA----DQVLNAGA 901
Y+H H +LK NIL A + L D+ L R+ TA D V
Sbjct: 117 KYIHTANVF-HRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYV---AT 169
Query: 902 LGYRPPEFAST--SKPCPSLKSDVYAFGIILLELLTGK 937
YR PE + SK P++ D+++ G I E+LTGK
Sbjct: 170 RWYRAPELCGSFFSKYTPAI--DIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-04
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYY 797
IG GT+YK +G + A+K + +++ RE++ L ++ HPN+V +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR----CLNYLHN 853
+H + V L+ D L I + +A DVAR + YLH
Sbjct: 142 ----DH----------NGEIQVLLEFMDGGSLEGTHIADEQFLA-DVARQILSGIAYLH- 185
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-GALGYRPPEFAST 912
R I H ++K +N+L+ + N + D+ + RIL A T D ++ G + Y PE +T
Sbjct: 186 RRHIVHRDIKPSNLLINS-AKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINT 242
Query: 913 S---KPCPSLKSDVYAFGIILLELLTGK 937
D+++ G+ +LE G+
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-AVKRL-REGIAKGKKE---FAREVKKLGNIKHPNLVS 792
+VIG+ G + A + AVK L ++ I K K+E + L N+KHP LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV- 59
Query: 793 LQGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNY 850
G ++ + +KL + +YIN L +LQ ++ R R A ++A L Y
Sbjct: 60 --GLHFSFQTADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGY 111
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883
LH+ I + +LK NILL++ + VLTD+ L
Sbjct: 112 LHSLN-IVYRDLKPENILLDSQG-HIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 741 GRSCHGTLYKATLDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQGYYWG 799
GR +G L + VK +++ ++ + +E L + H N++ +
Sbjct: 20 GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV--C 77
Query: 800 PKEHEK-LVISNYINAQSLAVYLQ---ETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
++ E V+ Y+N +L ++LQ + LS + + +A+ +A ++YLH
Sbjct: 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG 137
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG---YRP-----P 907
I H ++ + N ++ + +TD +L R L + LG RP
Sbjct: 138 VI-HKDIAARNCVI-DEELQVKITDNALSRDLFPM-------DYHCLGDNENRPVKWMAL 188
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLT 935
E S S SDV++FG++L EL+T
Sbjct: 189 E--SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 57/257 (22%), Positives = 109/257 (42%), Gaps = 38/257 (14%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNL 790
E +G G +YK L + +A+K L++ ++EF E ++HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER-----------LR 839
V L G KE +I +Y + L +L P + D++ +
Sbjct: 71 VCLLGVV--TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+ +A + +L + + H +L + N+L+ +N ++D L R + +A + N+
Sbjct: 129 IVTQIAAGMEFLSSHHVV-HKDLATRNVLV-FDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 900 G-ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIV------CV 945
+ + PE K S+ SD++++G++L E+ + G S+ +++ V
Sbjct: 187 LLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244
Query: 946 DPGVVDLTDWVRLLALE 962
P D WV L LE
Sbjct: 245 LPCPDDCPAWVYTLMLE 261
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.003
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 51/232 (21%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIK---------- 786
++IG T+ A ++ A+K L K + KK+ +K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 787 -HPNLVSLQGYYWGPKEHEKL--VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
HP ++ L Y+ ++ E L V+ Y L Y+ RK L A +
Sbjct: 60 GHPGIIKL---YYTFQDEENLYFVLE-YAPNGELLQYI-----RKYGSLDEKCTRFYAAE 110
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS-----AGTADQVLN 898
+ L YLH+ + I H +LK NILL+ M+ +TD+ ++L + D
Sbjct: 111 ILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 899 AGALGYRPPEFAS-------------TSKPCPSLKSDVYAFGIILLELLTGK 937
+ FAS KP SD++A G I+ ++LTGK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 37/219 (16%)
Query: 739 VIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEF----AREVKKLGNIKHPNLVSL 793
IG +G +YKA D+G ++A+K++R + K+ F RE+K L + H N+V+L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 794 QGYYWGPKEHEKLVISNYINAQSL-----AVYL----QETD-----PRKLPPLSIDERLR 839
E ++++ +A A YL + D L S D
Sbjct: 72 ---------KE--IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+ LNY H + H ++K +NILL L D+ L R+ S +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178
Query: 900 GALGYRPPEFA-STSKPCPSLKSDVYAFGIILLELLTGK 937
L YRPPE + P++ DV++ G IL EL T K
Sbjct: 179 ITLWYRPPELLLGEERYGPAI--DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.003
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 739 VIGRSCHGTLYKAT-LDSGSILAVKRLR---EGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
IG +G + A +G +A+K++ + + K+ RE+K L +++H N++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGL- 64
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVY--LQETDPRKL----PPLSIDERLRVAVDVARCL 848
+ L + + + + L ETD K+ PL+ D + R L
Sbjct: 65 --------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 849 NYLHNERA-IPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNAGALG-- 903
YLH A + H +LK +NIL+ + N L D+ L R + L +
Sbjct: 117 KYLH--SANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 904 YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE +S + D+++ G I ELLT K
Sbjct: 172 YRAPELLLSSSRY-TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 50/225 (22%)
Query: 739 VIGRSCHG----TLYKATLDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNLVS 792
+IG+ L K + +++AVK+ L + K +E+ ++HPN++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 793 LQGYYWGP--KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
Y + E V+S + S L+ P LP L+I L+ DV L+Y
Sbjct: 64 ----YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDY 116
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG------------------- 891
+H++ I H ++K+++ILL + VL+ + G
Sbjct: 117 IHSKGFI-HRSVKASHILL-SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
+ +VL GY KSD+Y+ GI EL G
Sbjct: 175 LSPEVLQQNLQGYNE-------------KSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 745 HGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVSLQGYYWG 799
+G +Y+A +G I+A+K+L+ + K K+ F RE+ L ++HPN+V+++ G
Sbjct: 18 YGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 800 PKEHEKLVISNYINAQSLAVYLQETDPRKL-----PPLSIDERLRVAVDVARCLNYLHNE 854
+ ++ Y+ E D + L P E + + + + +LH +
Sbjct: 76 SNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH-D 124
Query: 855 RAIPHGNLKSTNILLEAPTMNA---VLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
I H +LK++N+LL N + D+ L R S L YR PE
Sbjct: 125 NWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRAPELL- 178
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
S D+++ G I ELLT K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 48/211 (22%)
Query: 759 LAVKRLREGIAKG---KKEFAREVKKLGNIKHPNLVSL-----QG---YYWGPKEHEKLV 807
+A+K++RE +++ KK F RE K ++ HP +V + G YY P
Sbjct: 30 VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP------- 82
Query: 808 ISNYINAQSL-----AVYLQETDPRKLP-PLSIDERLRVAVDVARCLNYLHNERAIPHGN 861
YI +L +V+ +E+ ++L S+ L + + + Y+H+ + + H +
Sbjct: 83 ---YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRD 138
Query: 862 LKSTNILL-----------------EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGY 904
LK NILL + + + D I S+ T + G Y
Sbjct: 139 LKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI-VGTPDY 197
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
PE S +D+YA G+IL ++LT
Sbjct: 198 MAPERLLGVP--ASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 50/180 (27%), Positives = 72/180 (40%), Gaps = 43/180 (23%)
Query: 777 REVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLA----VY----LQETDPRK 828
RE+K L KH N++ I + I S VY L ETD K
Sbjct: 52 REIKILRRFKHENIIG---------------ILDIIRPPSFESFNDVYIVQELMETDLYK 96
Query: 829 L---PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885
L LS D + R L Y+H+ + H +LK +N+LL + + D+ L R
Sbjct: 97 LIKTQHLSNDHIQYFLYQILRGLKYIHSANVL-HRDLKPSNLLLNT-NCDLKICDFGLAR 154
Query: 886 ILTSAGTADQVLNAGALG-------YRPPEFASTSKPCPSLKS-DVYAFGIILLELLTGK 937
I + G L YR PE SK K+ D+++ G IL E+L+ +
Sbjct: 155 IADPEHD-----HTGFLTEYVATRWYRAPEIMLNSKG--YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 78/286 (27%)
Query: 740 IGRSCHGTLYKATL------DSGSILAVKRLREGIAKGKK-EFAREVKKLGNIKHPNLVS 792
+G+ G +Y+ + + +A+K + E + ++ EF E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDP-----RKLPPLSIDERLRVAVDVARC 847
L G LV+ + L YL+ P L P ++ + +++A ++A
Sbjct: 74 LLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLT----DYSLHRIL------TSAGTADQVL 897
+ YL + H +L + N ++ LT D+ + R + G
Sbjct: 132 MAYLA-AKKFVHRDLAARNCMV-----AEDLTVKIGDFGMTRDIYETDYYRKGG------ 179
Query: 898 NAGALGYR--PPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPG 948
G L R PE S + KSDV++FG++L E+ T G S+ E++
Sbjct: 180 -KGLLPVRWMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL----- 231
Query: 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQP---PRILSDMLQ 991
+ ++DG ++ P P L ++++
Sbjct: 232 ----------------------KFVIDGGHLDLPENCPDKLLELMR 255
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.004
Identities = 15/37 (40%), Positives = 22/37 (59%), Gaps = 2/37 (5%)
Query: 460 SLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFE 496
+L +LDL+ N ++ LP +S NL L+LS NK
Sbjct: 2 NLETLDLSNNQITD--LPPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 782 LGNIKHPNLVSL-QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV 840
L N+ HP+++ + G +V+ +Y + L YL ++ PL ID+ L +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITC--MVLPHY--SSDLYTYLT----KRSRPLPIDQALII 162
Query: 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG 900
+ L YLH +R I H ++K+ NI + + D + A + AG
Sbjct: 163 EKQILEGLRYLHAQRII-HRDVKTENIFINDVD-QVCIGDLGAAQFPVVA--PAFLGLAG 218
Query: 901 ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELL 934
+ PE + K + K+D+++ GI+L E+L
Sbjct: 219 TVETNAPEVLARDK--YNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 44/193 (22%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 758 ILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLV-ISNYINAQS 816
++AVK L+E +++F RE + L ++H ++V G E L+ + Y+
Sbjct: 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC---TEGRPLLMVFEYMRHGD 93
Query: 817 LAVYLQETDP----------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTN 866
L +L+ P L++ + L +A +A + YL + + H +L + N
Sbjct: 94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFV-HRDLATRN 152
Query: 867 ILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG----ALGYRPPEFASTSKPCPSLKSD 922
L+ + + D+ + R + S D G + + PPE K + +SD
Sbjct: 153 CLV-GQGLVVKIGDFGMSRDIYS---TDYYRVGGRTMLPIRWMPPESILYRK--FTTESD 206
Query: 923 VYAFGIILLELLT 935
+++FG++L E+ T
Sbjct: 207 IWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 740 IGRSCHGTLYKA-TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQG-YY 797
+G G +YKA ++G++ A K + + +++ E++ L HP +V L G +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
W + + ++ + ++ + E D R L I R ++ L YLH+ + I
Sbjct: 80 W---DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEA---LQYLHSMKII 132
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLH-RILTSAGTADQVLNAGALGYRPPE--FASTSK 914
H +LK+ N+LL + L D+ + + + + D + G + PE T K
Sbjct: 133 -HRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMK 188
Query: 915 PCP-SLKSDVYAFGIILLEL 933
P K+D+++ GI L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1025 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.62 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.19 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.95 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.93 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.65 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.62 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.58 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.21 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.19 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.14 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-97 Score=953.58 Aligned_cols=856 Identities=30% Similarity=0.452 Sum_probs=513.2
Q ss_pred HHHHHHhhcCChhhHHHHHHHHhhcCCCCCCCcccCCCCCCCCCCCCCCCccceEcCC-CCEEEEEeCCCCcccccCccc
Q 001700 7 IVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN-GYVTSIMLNDMGLVGNFSFPT 85 (1025)
Q Consensus 7 ~~~~~~~~~~~~~~~~aLl~~k~~~~~d~~~~l~~sW~~~~~~~d~C~~~w~gv~C~~-~~v~~l~l~~~~l~g~~~~~~ 85 (1025)
++.+++.+...++|+.||++||+++ .||.+.+ ++|+.. .|||. |.||+|++ ++|+.|+|+++++.|.++ +.
T Consensus 17 ~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~-~~w~~~---~~~c~--w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~ 88 (968)
T PLN00113 17 FFLFLNFSMLHAEELELLLSFKSSI-NDPLKYL-SNWNSS---ADVCL--WQGITCNNSSRVVSIDLSGKNISGKIS-SA 88 (968)
T ss_pred HHHHHHccCCCHHHHHHHHHHHHhC-CCCcccC-CCCCCC---CCCCc--CcceecCCCCcEEEEEecCCCccccCC-hH
Confidence 3333444555789999999999999 6787766 899753 37886 99999984 799999999999999886 77
Q ss_pred ccCCCCCCEEEccCCcCccCCCC--CCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccc
Q 001700 86 IIGLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKL 163 (1025)
Q Consensus 86 ~~~L~~L~~L~ls~N~l~~~~~~--~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 163 (1025)
+..+++|+.|+|++|++++.++. +..+++|++|||++|++++.+|. +.+++|++|+|++|.+++.+|..|+++++|
T Consensus 89 ~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L 166 (968)
T PLN00113 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166 (968)
T ss_pred HhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCC
Confidence 88899999999999988875553 44677777777777777665553 345555555555555555555555555555
Q ss_pred cEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCC------------
Q 001700 164 KYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPH------------ 231 (1025)
Q Consensus 164 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------ 231 (1025)
++|+|++|.+.+.+|..+.++++|++|+|++|++++.+|..++.+ ++|+.|+|++|.+++.++..
T Consensus 167 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 243 (968)
T PLN00113 167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM---KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243 (968)
T ss_pred CEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCc---CCccEEECcCCccCCcCChhHhcCCCCCEEEC
Confidence 555555555555555555555555555555555555544444332 44555555555544433322
Q ss_pred ----------CCCCCCCCCCEEeccCCcccccCC-cccccccccceecccccccccCChhHHhhcccccCeEEcccccCc
Q 001700 232 ----------DGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300 (1025)
Q Consensus 232 ----------~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~ 300 (1025)
..+..+++|+.|++++|++++.+| .+..+.+|++|+|++|.+++.+|..+.... +|+.|++++|.+.
T Consensus 244 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~--~L~~L~l~~n~~~ 321 (968)
T PLN00113 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ--NLEILHLFSNNFT 321 (968)
T ss_pred cCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCC--CCcEEECCCCccC
Confidence 113344444444444444444333 234444444444444444444444443322 2455555555544
Q ss_pred Ccc--cccCCCCccEEEccCCcccCCCCCCC---CCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhcc
Q 001700 301 GPV--GSITSATLKKVNLSSNKLSGSLPARV---GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTS 375 (1025)
Q Consensus 301 ~~~--~~~~~~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 375 (1025)
+.. ....+++|+.|+|++|++++.+|..+ .+|+.|++++|++++.++..+.....|+.|++++|.+.+.+|..+.
T Consensus 322 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~ 401 (968)
T PLN00113 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401 (968)
T ss_pred CcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHh
Confidence 321 12234455555555555555555433 2344555555555554443333333444444444444444444445
Q ss_pred CCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcC-----------------
Q 001700 376 QFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF----------------- 438 (1025)
Q Consensus 376 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l----------------- 438 (1025)
.+++|+.|++++|.+++.+|..|..+++|+.|+|++|++++.++..+..+++|+.|+|++|++
T Consensus 402 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ 481 (968)
T PLN00113 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLD 481 (968)
T ss_pred CCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEE
Confidence 555555555555555555555454555555555555554444444333344444444443333
Q ss_pred ------cccCCcc----------cccCCCCc-----cccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCcc
Q 001700 439 ------SGPLPLQ----------EIQNNPST-----GSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEG 497 (1025)
Q Consensus 439 ------~~~~p~~----------~~~~~~~~-----~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 497 (1025)
++.+|.. .+..+... ......+|++|+|++|.++|.+|..+..+++|+.|||++|+++|
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 3332211 00000000 00111256666666666666666666666677777777777766
Q ss_pred ccCCCcCC--CCcEEECCCCcccccCCCC--CCCCCCCCCCCCCCC-CCCCCC---CCCCCCCCccccCCCccccccceE
Q 001700 498 SIPDGLPN--GLKEFNVSFNNLSGVVPEN--LRNFPDSAFHPGNSL-LTFPNS---PSQQDVPDLTLRGHGNHMKPATKI 569 (1025)
Q Consensus 498 ~ip~~l~~--~L~~L~ls~N~l~g~~p~~--l~~~~~~~~~~~n~~-c~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 569 (1025)
.+|..+.. +|+.|++++|+++|.+|.. +..+....|. ||+. |+.+.. .+|. . ..+.....
T Consensus 562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~-~n~~lc~~~~~~~~~~c~----------~-~~~~~~~~ 629 (968)
T PLN00113 562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA-GNIDLCGGDTTSGLPPCK----------R-VRKTPSWW 629 (968)
T ss_pred cCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhc-CCccccCCccccCCCCCc----------c-ccccceee
Confidence 66665543 5677777777777766654 3455555666 6664 764321 1111 0 01111112
Q ss_pred EEEEeeeehhHHhHHHHHHHHHHHHHhhcCCcccccccccccccCCCCCccccCCCCCCCCCCCCcceecCCCCCCCccc
Q 001700 570 ALIVGLVCGVTMVALLCMLIYFRALWQRHGRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFTFHQDPLPSSPME 649 (1025)
Q Consensus 570 ~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~k~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (1025)
++++++++++++++++++++++++. + ++...++ . +.. .+.
T Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~------~-~~~------~~~------------------------ 669 (968)
T PLN00113 630 FYITCTLGAFLVLALVAFGFVFIRG--R-NNLELKR------V-ENE------DGT------------------------ 669 (968)
T ss_pred eehhHHHHHHHHHHHHHHHHHHHHh--h-hcccccc------c-ccc------ccc------------------------
Confidence 2222222222222222222222220 0 0000000 0 000 000
Q ss_pred cccccCCccccccCCccccCCCcccCCCCCCCCccccccCCCCCCCCCcccCCccccccCCcccccCCccccccccccCH
Q 001700 650 SAYDAGETSSVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTA 729 (1025)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (1025)
+.... .. .. ....++.
T Consensus 670 ------------------~~~~~------------------~~-~~---------------------------~~~~~~~ 685 (968)
T PLN00113 670 ------------------WELQF------------------FD-SK---------------------------VSKSITI 685 (968)
T ss_pred ------------------ccccc------------------cc-cc---------------------------cchhhhH
Confidence 00000 00 00 0001122
Q ss_pred HHhh--cCCCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeE
Q 001700 730 EELS--HAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 730 ~~l~--~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 806 (1025)
+++. +...++||+|+||.||+|+. .+|..||||+++..... ..+|++++++++|||||+++|+|. .....+
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~ 759 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR--SEKGAY 759 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE--cCCCCE
Confidence 2221 12357899999999999996 57999999998754322 235688999999999999999997 445789
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCEEeecCCCCEEEeccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE--RAIPHGNLKSTNILLEAPTMNAVLTDYSLH 884 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--~~ivHrDlkp~NILl~~~~~~~kl~DfGla 884 (1025)
+||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+. ++|+||||||+||+++. +..+++. ||.+
T Consensus 760 lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~ 829 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLR-LSLP 829 (968)
T ss_pred EEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC-CCceEEE-eccc
Confidence 9999999999999995 378999999999999999999942 68999999999999987 6677765 6655
Q ss_pred cccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 885 RILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 885 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
...... ....||+.|||||++.+.. ++.|+|||||||++|||+||+.||+.... ....+++|++.......
T Consensus 830 ~~~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 830 GLLCTD-----TKCFISSAYVAPETRETKD--ITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCH 900 (968)
T ss_pred cccccC-----CCccccccccCcccccCCC--CCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccc
Confidence 433221 1125889999999998766 58999999999999999999999964332 34568888876655544
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
....+|+.+.... +.+.++..++.+++.+||+.+ ++||+|+||++.|+++....
T Consensus 901 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 901 LDMWIDPSIRGDV--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred hhheeCccccCCC--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 5556666554432 234567788999999999999 99999999999999997643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=435.17 Aligned_cols=280 Identities=37% Similarity=0.634 Sum_probs=238.4
Q ss_pred cccCHHHhhcCC-----CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeec
Q 001700 725 LMFTAEELSHAP-----AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799 (1025)
Q Consensus 725 ~~~~~~~l~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 799 (1025)
..|++.|+..|| .++||+|+||.||+|.+++|..||||++........++|.+|+.++.+++|||+|+++|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 468899998876 479999999999999999999999998876543215669999999999999999999999984
Q ss_pred CCCC-eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCEEeecCCCCE
Q 001700 800 PKEH-EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE--RAIPHGNLKSTNILLEAPTMNA 876 (1025)
Q Consensus 800 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--~~ivHrDlkp~NILl~~~~~~~ 876 (1025)
.. +.++|||||++|+|.++++..... +++|..|++||.++|+||+|||+. +.||||||||+|||+|. ++.+
T Consensus 143 --~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~a 216 (361)
T KOG1187|consen 143 --GGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNA 216 (361)
T ss_pred --CCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCE
Confidence 33 599999999999999999986432 689999999999999999999985 36999999999999998 9999
Q ss_pred EEecccccccccc-CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHH
Q 001700 877 VLTDYSLHRILTS-AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDW 955 (1025)
Q Consensus 877 kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~ 955 (1025)
||+|||+|+.... ....... ..||.+|+|||++..+. .+.|+|||||||+++|++||+.|.+... ..+...+++|
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~--lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w 292 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGK--LTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEW 292 (361)
T ss_pred EccCccCcccCCccccceeee-cCCCCccCChhhhccCC--cCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHH
Confidence 9999999976654 2211111 16999999999998765 5999999999999999999999987654 2334569999
Q ss_pred HHHHHhhccccccchhhhcC-CCCCCCch-HHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 956 VRLLALENRSGECFDRLIMD-GHDMEQPP-RILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 956 ~~~~~~~~~~~~~~d~~~~~-~~~~~~~~-~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
++....++...+++|+.+.. .+ +. +....+.+++.+|++.+ .+||+|.||+++|+.+..
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~----~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEY----PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCC----ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99988888999999999873 33 32 67888999999999999 999999999999977654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=489.18 Aligned_cols=433 Identities=30% Similarity=0.446 Sum_probs=313.7
Q ss_pred CEEEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCC-CCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEc
Q 001700 66 YVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNI 144 (1025)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~-~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 144 (1025)
....|+|+++.+.+.++ ..+.++++|+.|+|++|.+.+..+. ++++++|++|||++|.+++.+|..|+++++|++|+|
T Consensus 141 ~L~~L~Ls~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (968)
T PLN00113 141 NLETLDLSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219 (968)
T ss_pred CCCEEECcCCcccccCC-hHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence 46778888887777766 5677788888888888888766554 778888888888888888777888888888888888
Q ss_pred cCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccc
Q 001700 145 SSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224 (1025)
Q Consensus 145 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 224 (1025)
++|++++.+|..|+++++|++|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+ ++|+.|+|++|.+
T Consensus 220 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~n~l 296 (968)
T PLN00113 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL---QKLISLDLSDNSL 296 (968)
T ss_pred cCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhc---cCcCEEECcCCee
Confidence 8888887788888888888888888888877777777777888888888887777666655543 6677777777776
Q ss_pred cCccCCCCCCCCCCCCCEEeccCCcccccCCc-ccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCcc
Q 001700 225 VGELFPHDGMPYFDNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV 303 (1025)
Q Consensus 225 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~ 303 (1025)
.+.++.. +..+++|+.|++++|.+++.+|. +..+++|+.|+|++|.+++.+|..+.... .|+.|++++|++++..
T Consensus 297 ~~~~p~~--~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~--~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 297 SGEIPEL--VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN--NLTVLDLSTNNLTGEI 372 (968)
T ss_pred ccCCChh--HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC--CCcEEECCCCeeEeeC
Confidence 6554432 44556666666666666655443 55555666666666666655555554332 2555555555554311
Q ss_pred --------------------------cccCCCCccEEEccCCcccCCCCCCC---CCcceeeccCccCCCcccccccCCC
Q 001700 304 --------------------------GSITSATLKKVNLSSNKLSGSLPARV---GHCTIVDLSNNRLSGDLSRMQNWGN 354 (1025)
Q Consensus 304 --------------------------~~~~~~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~Ls~N~l~~~~~~~~~~~~ 354 (1025)
....+++|+.|+|++|++++.+|..+ ..++.|++++|.+++.++..+....
T Consensus 373 p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 452 (968)
T PLN00113 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452 (968)
T ss_pred ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCC
Confidence 12234556666666666666666543 3445677777777766665555566
Q ss_pred ccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecC
Q 001700 355 YVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434 (1025)
Q Consensus 355 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 434 (1025)
+|+.|+|++|++.+.+|..+ ...+|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+..+++|++|+|+
T Consensus 453 ~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 453 SLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 67777777777777777654 34778888888888888888888888899999999999988888888889999999999
Q ss_pred CCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCccccCCCcC-CCCcEEECC
Q 001700 435 GNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLP-NGLKEFNVS 513 (1025)
Q Consensus 435 ~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ip~~l~-~~L~~L~ls 513 (1025)
+|.++|.+|.. +.... +|++|||++|+++|.+|..+..+++|+.|++++|+++|.+|..-. ..+....+.
T Consensus 532 ~N~l~~~~p~~-------~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~ 602 (968)
T PLN00113 532 HNQLSGQIPAS-------FSEMP--VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA 602 (968)
T ss_pred CCcccccCChh-------HhCcc--cCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhc
Confidence 99998887754 33333 899999999999999999999999999999999999999997422 233444455
Q ss_pred CCc
Q 001700 514 FNN 516 (1025)
Q Consensus 514 ~N~ 516 (1025)
+|.
T Consensus 603 ~n~ 605 (968)
T PLN00113 603 GNI 605 (968)
T ss_pred CCc
Confidence 665
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=380.25 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=212.2
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCC
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 803 (1025)
.++..|+++ .+.||+|..|+|||++++ +++.+|+|.+.... ...++++.+|+++++.++||+||++||.|+.+..
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~- 151 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE- 151 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-
Confidence 356667765 478999999999999987 79999999995543 4457889999999999999999999999985333
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
+..++||||++|+|++++...+ .+++...-+|+.+|++||.|||+.++||||||||+|||++. .+.+||||||.
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGV 225 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGV 225 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccc
Confidence 6999999999999999998763 59999999999999999999996689999999999999998 88999999999
Q ss_pred ccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 884 HRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 884 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
++.+... ...+.+||..|||||.+.+.. |+.++||||||++++|+++|+.||.... ..-..|+.
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~-----~~~~~~~~------ 289 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPN-----PPYLDIFE------ 289 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcC-----CCCCCHHH------
Confidence 9988765 223347999999999999887 5999999999999999999999987531 11122322
Q ss_pred cccccchhhhcCCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 964 RSGECFDRLIMDGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.++....+ ..+..+.. +..++..++..|++.+ .+||+++|+++.
T Consensus 290 ----Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 ----LLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----HHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12222222 22233443 8889999999999999 999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=394.65 Aligned_cols=264 Identities=30% Similarity=0.486 Sum_probs=211.7
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccchhc--HHHHHHHHHHHhcCCCCccccccceeecCCCCe
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKG--KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHE 804 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 804 (1025)
+..+++.. .+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|..+.. .
T Consensus 38 i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~ 114 (362)
T KOG0192|consen 38 IDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-S 114 (362)
T ss_pred cChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-c
Confidence 33444433 35599999999999999844449999998654222 5689999999999999999999999974322 6
Q ss_pred eEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCCEEeecCCC-CEEEeccc
Q 001700 805 KLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA-IPHGNLKSTNILLEAPTM-NAVLTDYS 882 (1025)
Q Consensus 805 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-ivHrDlkp~NILl~~~~~-~~kl~DfG 882 (1025)
..+|||||++|+|.++++.... ..+++..++++|.|||+||.|||+ .+ ||||||||+|||++. +. ++||+|||
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFG 189 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFG 189 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCc
Confidence 8999999999999999988411 269999999999999999999998 67 999999999999998 65 99999999
Q ss_pred cccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 883 LHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 883 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
+++...... .......||+.|||||++.+....++.|+|||||||++|||+||+.||..... .+
T Consensus 190 lsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~-------- 253 (362)
T KOG0192|consen 190 LSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQ-------- 253 (362)
T ss_pred cceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HH--------
Confidence 999776532 12222479999999999995311269999999999999999999999985421 11
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+.........+++.+..++..+..++..||+.+ +.||++.+|+..|+.+...
T Consensus 254 -----~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 254 -----VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -----HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 111222233444556668889999999999999 9999999999999988653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=390.11 Aligned_cols=264 Identities=23% Similarity=0.395 Sum_probs=223.3
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCee
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 805 (1025)
.+..+++.. .+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++++|++||+++|+|. .+...
T Consensus 202 ei~r~~l~l--~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~--~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKL--IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT--KQEPI 276 (468)
T ss_pred eecHHHHHH--HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe--cCCce
Confidence 344455544 4789999999999999997779999999876 344678999999999999999999999997 44479
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
+||||||+.|+|.+||+...+. .+...+.+.++.|||+|++||++ +++|||||.++|||+++ +..+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~---~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGG---LLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCC---ccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEccccccc
Confidence 9999999999999999984332 68999999999999999999998 88999999999999998 8899999999999
Q ss_pred ccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
...++.........-...|.|||.+..+.+ +.|+|||||||+||||+| |+.|+..+. ..+
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F--S~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~e---------- 412 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKF--SSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEE---------- 412 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCc--ccccceeehhhhHHHHhccCCCCCCCCC-------HHH----------
Confidence 666555444333334668999999998884 999999999999999999 898876432 111
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccccc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKDS 1022 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~~ 1022 (1025)
+-..+..+++.++|+.|+.++.++|..||+.+ ++|||++.+...|+++....++
T Consensus 413 ----v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 413 ----VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred ----HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 22345667889999999999999999999999 9999999999999999876554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=369.33 Aligned_cols=248 Identities=19% Similarity=0.301 Sum_probs=201.9
Q ss_pred CCCceeeeecceEEEEEE-ecCCCEEEEEEccccchh-------cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeE
Q 001700 735 APAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK-------GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 806 (1025)
...+.||+|+||.|-+|. .++|+.||||++.+.... ......+|+++|++++|||||+++++|. .....|
T Consensus 175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--~~ds~Y 252 (475)
T KOG0615|consen 175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--VPDSSY 252 (475)
T ss_pred EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee--cCCceE
Confidence 346889999999999998 558999999999754211 1234579999999999999999999997 445679
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec--CCCCEEEeccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLH 884 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~--~~~~~kl~DfGla 884 (1025)
||+||++||+|.+.+-... .+.+..-..+++|++.|+.|||+ .||+||||||+|||+.. .+..+||+|||+|
T Consensus 253 mVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999998764 57888889999999999999998 99999999999999965 2477999999999
Q ss_pred cccccCCCccccccCcccccCccccccCCCCCC-CCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 885 RILTSAGTADQVLNAGALGYRPPEFASTSKPCP-SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 885 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
+........ .+.||||.|.|||++......+ ..++|+||+|||+|-+++|.+||.....+. .+
T Consensus 327 K~~g~~sfm--~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl----------- 390 (475)
T KOG0615|consen 327 KVSGEGSFM--KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SL----------- 390 (475)
T ss_pred hccccceeh--hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cH-----------
Confidence 987644332 3459999999999998765433 448899999999999999999998654332 12
Q ss_pred cccccchhhhcCCC--CCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 964 RSGECFDRLIMDGH--DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~--~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.++...+.+ .++...+..++..+++.+++..+ ++|||++|+++
T Consensus 391 -----~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 -----KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 122222222 23456678899999999999999 99999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=382.43 Aligned_cols=245 Identities=23% Similarity=0.420 Sum_probs=209.4
Q ss_pred cCCCceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 734 HAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
|..+++||+|||+.||+++. ++|+.||+|++.+.. ...++...+|+++.+.++|||||+++++|. +....|+|.
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE--Ds~nVYivL 97 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE--DSNNVYIVL 97 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee--cCCceEEEE
Confidence 44578999999999999995 899999999998742 345678999999999999999999999998 556899999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
|+|..++|..+++.+. ++++.+++.+++||+.||.|||+ .+|+|||||..|+++++ +.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecccceeeeecC
Confidence 9999999999998553 79999999999999999999998 88999999999999998 99999999999998876
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.+.. ..+.||||.|.|||++...+ ++..+||||+|||||-|++|++||+... ..+.+
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~--------------------vkety 227 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKT--------------------VKETY 227 (592)
T ss_pred cccc-cceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccch--------------------HHHHH
Confidence 5433 33459999999999999777 5999999999999999999999998421 12233
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+......+. .|.....+..+++.+.++.+ .+|||+++|+..
T Consensus 228 ~~Ik~~~Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 228 NKIKLNEYS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHhcCcc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 333344443 24466788899999999999 999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.00 Aligned_cols=195 Identities=27% Similarity=0.398 Sum_probs=172.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+|+++ ++..||||.+.+. ..+..+.+..|+++|+.++|||||.++++++ .....++|||||.
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~--~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE--DDDFIYLVMEYCN 92 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe--cCCeEEEEEEeCC
Confidence 345999999999999975 7899999999776 4556778899999999999999999999998 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC--C---CCEEEeccccccccc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP--T---MNAVLTDYSLHRILT 888 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~--~---~~~kl~DfGla~~~~ 888 (1025)
||||.+|++.++ .+++.+++.++.|+|.||++||+ ++||||||||.|||++.. . ..+||+|||+|+.+.
T Consensus 93 gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 93 GGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999875 69999999999999999999998 899999999999999762 1 468999999999987
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
...... +.||++.|||||++.... |+.|+|+||.|+++|+|++|+.||+..
T Consensus 167 ~~~~a~--tlcGSplYMAPEV~~~~~--YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGSMAE--TLCGSPLYMAPEVIMSQQ--YDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhHHH--HhhCCccccCHHHHHhcc--ccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 554333 348999999999998776 599999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.02 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=203.3
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.++||+|.||.|||+. ..+|..||.|.+.-+ +.+.+++...|+.+|++++|||||+++++-...+..-.++||||+.
T Consensus 24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 4789999999999998 568999999998743 2455678899999999999999999998544434434899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-C--CCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-R--AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~--~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
.|+|.++++.....+ ..++++++++++.|+++||.++|++ + .|+||||||.||+++. ++.+||+|||+++.+...
T Consensus 104 ~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred ccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccchhHhHhcch
Confidence 999999998653332 3699999999999999999999983 2 3889999999999998 889999999999998765
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
.+... ..+|||+||+||.+.+.+ |+.|+||||+||++|||..-++||... .+.+.-+.
T Consensus 182 ~tfA~-S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~K------------ 239 (375)
T KOG0591|consen 182 TTFAH-SLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKK------------ 239 (375)
T ss_pred hHHHH-hhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHH------------
Confidence 44333 348999999999999888 599999999999999999999999721 22222111
Q ss_pred hhhcCCCCCCCc-hHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 971 RLIMDGHDMEQP-PRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 971 ~~~~~~~~~~~~-~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.-.+++ ++.| ...+..+.+|+..|+..+ +.||+...+++.+..
T Consensus 240 -I~qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 -IEQGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -HHcCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111222 2234 667889999999999999 999996666665554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=348.97 Aligned_cols=235 Identities=26% Similarity=0.330 Sum_probs=193.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
-++||+|+||+||.++. ++++.+|+|++++... +..+...+|..+|.+++||+||+++-.|. +....|+|+||+
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ--t~~kLylVld~~ 107 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ--TEEKLYLVLDYL 107 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc--cCCeEEEEEecc
Confidence 47899999999999985 5799999999987532 34567889999999999999999976665 667899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.||.|..+|++.+ .|++..+..++.+|+.||.|||+ .+||||||||+|||+|. .++++|+|||+++.....+.
T Consensus 108 ~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 108 NGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEeccccchhcccCCC
Confidence 9999999999765 69999999999999999999997 89999999999999999 89999999999996654433
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.. ...|||+.|||||++.+.+ ++.++|+||+||++|||++|.+||... +...|........
T Consensus 181 ~t-~tfcGT~eYmAPEil~~~g--y~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 181 AT-RTFCGTPEYMAPEILLGKG--YDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKILKGK--------- 241 (357)
T ss_pred cc-ccccCCccccChHHHhcCC--CCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHhcCc---------
Confidence 32 2359999999999999887 599999999999999999999999743 3334443333221
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERP 1004 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP 1004 (1025)
....+.-...+..+++..-+..+ ++|-
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11123335566778888888888 8884
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=375.97 Aligned_cols=266 Identities=23% Similarity=0.417 Sum_probs=218.3
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEec------CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeec
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLD------SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWG 799 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 799 (1025)
|+..++.+ .+.||+|+||+||+|+.. +...||||.++..... .+++|+||++++..++|||||+++|+|.
T Consensus 483 i~r~~i~~--~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~- 559 (774)
T KOG1026|consen 483 IPRSDIVF--KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR- 559 (774)
T ss_pred echhheee--hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-
Confidence 44444444 477999999999999843 4568999999987655 7889999999999999999999999998
Q ss_pred CCCCeeEEEEeccccccHHHHHhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEee
Q 001700 800 PKEHEKLVISNYINAQSLAVYLQETDPRK---------LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870 (1025)
Q Consensus 800 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~ 870 (1025)
.+...++|+|||..|||.++|..+.+.. .++++..+.+.||.|||.|++||-+ +.+|||||..+|+||.
T Consensus 560 -~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 560 -EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVG 637 (774)
T ss_pred -cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceec
Confidence 5668999999999999999998754321 2349999999999999999999998 8899999999999999
Q ss_pred cCCCCEEEeccccccccccCCCcccc-ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCC
Q 001700 871 APTMNAVLTDYSLHRILTSAGTADQV-LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPG 948 (1025)
Q Consensus 871 ~~~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~ 948 (1025)
+ +..+||+|||+++..-..+++... ...-.++|||||.+..+. +|+++|||||||||||++| |+.||.....+
T Consensus 638 e-~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~-- 712 (774)
T KOG1026|consen 638 E-NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-- 712 (774)
T ss_pred c-ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchH--
Confidence 8 999999999999976555444322 113367899999999888 4999999999999999999 99998744221
Q ss_pred CcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
|+++- +..+.-.++|+.++.+++.||..||+.. .+||+++||-..|++.....+
T Consensus 713 ------------------EVIe~-i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 ------------------EVIEC-IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ------------------HHHHH-HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 11111 1222225678999999999999999999 999999999999998876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.89 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=203.2
Q ss_pred cCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHH-HHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEe
Q 001700 734 HAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKK-EFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
|...+.||.|.||.||+|+ .++|+.||||++++......+ .=.||++.|+++. |||||++++++.+.+. ..++|||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE 90 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFE 90 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHH
Confidence 3345789999999999999 568999999999887544222 2368999999998 9999999999986443 8999999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|| ..+|++.++++.. .|++.+++.|++||++||+|+|. +|+.|||+||+|||+.. ...+||+|||+||.....
T Consensus 91 ~M-d~NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 91 FM-DCNLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLAREVRSK 163 (538)
T ss_pred hh-hhhHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEecccccccccccC
Confidence 99 4599999998732 79999999999999999999996 99999999999999987 678999999999988765
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc--
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC-- 968 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 968 (1025)
..+.. .+.|.+|+|||++.+..+ |+.+.||||+|||++|+.+-++-|... .++.+..+....-+...+.
T Consensus 164 pPYTe--YVSTRWYRAPEvLLrs~~-Ys~pvD~wA~GcI~aEl~sLrPLFPG~------sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 164 PPYTE--YVSTRWYRAPEVLLRSGY-YSSPVDMWAVGCIMAELYSLRPLFPGA------SEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred CCcch--hhhcccccchHHhhhccc-cCCchHHHHHHHHHHHHHHhcccCCCC------cHHHHHHHHHHHhCCCccccc
Confidence 54433 368999999999998876 799999999999999999999877522 2333322222211111110
Q ss_pred -----chhhhcCCCC-------CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 969 -----FDRLIMDGHD-------MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 969 -----~d~~~~~~~~-------~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+...+.-.+. ...-+.+..+..+++.+|+++| ++|||++|.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111110000 0011236788999999999999 999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.21 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=207.8
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhc-HHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|.||.|..|....+..||||.++....+. +++|.+|+++|.+++|||||+++|+|. .+...++|+|||++|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~--~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV--QDDPLCMITEYMENG 620 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee--cCCchHHHHHHHhcC
Confidence 58899999999999999888999999999876554 589999999999999999999999998 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.++... ...-....+|+.|||.|++||.+ -.+||||+.+.|+|+|. ++++||+|||+++-+-.++.+..
T Consensus 621 DLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 621 DLNQFLSAHELP---TAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCcccccccccCCceee
Confidence 999999987532 23555677899999999999998 88999999999999999 99999999999997655544432
Q ss_pred c-ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc--CCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 896 V-LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT--GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 896 ~-~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt--G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ..+-.+.|||||.+.-+.+ ++++|||+||+++||+++ ...||.....+ +.++=............
T Consensus 696 qgr~vlpiRwmawEsillgkF--ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVENAGEFFRDQGRQV----- 764 (807)
T ss_pred ecceeeeeeehhHHHHHhccc--cchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHhhhhhcCCCCcce-----
Confidence 2 1234678999999887774 999999999999999876 77888754222 12221111111111100
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
-...|.-++..+.+++..||..+ .+||+++++...|++..
T Consensus 765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 12357788999999999999999 99999999999888754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.72 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=200.9
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.++.||+|+||+||++... +|...|||.+........+.+.+|+++|++++|||||+++|.........++++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4688999999999999954 599999999876533336678999999999999999999997543121368999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc--CCC
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS--AGT 892 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~--~~~ 892 (1025)
|+|.+++...+. .+++..++++++||++||+|||+ +|||||||||+|||++..++.+||+|||+++.... ...
T Consensus 101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999998753 49999999999999999999998 99999999999999987457999999999987663 111
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.......||+.|||||++..+.. ...++||||+||++.||+||+.||... .....++-...
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~-~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig------------ 236 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEV-ARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIG------------ 236 (313)
T ss_pred cccccccCCccccCchhhcCCCc-CCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHh------------
Confidence 12223479999999999986321 245999999999999999999998753 11112211111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
.....++.+...+.+..+++.+|+..+ ++|||++++++.-
T Consensus 237 -~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 -REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111122446667888999999999999 9999999998763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.23 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=204.4
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.++||.|..++||+|+ ...++.||||++..+.. ...+++.+|+..|+.++||||++++..|. .+.+.|+||.||.+
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv--v~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV--VDSELWVVMPFMAG 108 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE--ecceeEEeehhhcC
Confidence 5789999999999999 45789999999976543 34588999999999999999999998887 56689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|++.+.+......+ +.+..+..|.+++++||.|||. +|.||||||+.||||+. ++.+||+|||.+..+.+.+...
T Consensus 109 GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCcEEEcCceeeeeecccCcee
Confidence 99999999876553 8999999999999999999997 88899999999999999 9999999999888776554321
Q ss_pred c---cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 895 Q---VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 895 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ...+||+.|||||++.....+|+.|+||||||++..|+++|..||..+.+ +.-... ... +... ..+
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~-tLq-n~pp-~~~- 253 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLL-TLQ-NDPP-TLL- 253 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHH-Hhc-CCCC-Ccc-
Confidence 1 23489999999999776666689999999999999999999999986522 110000 000 0000 000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.....-+........+.+++..|+..| .+|||++++++.
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111223345668999999999999 999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=325.23 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=194.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.++|+|+||+||||+.+ +|+.||||++.+.. ...++-.+||+++|++++|||+|.++++|. .....++|+||++.
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLVFE~~dh 85 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLVFEYCDH 85 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEEeeecch
Confidence 57999999999999965 79999999997643 334567899999999999999999999997 55689999999976
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
.-| +-+..... .++...+.+|++|++.|+.|+|+ ++|+||||||+|||+.. ++.+||||||+|+.+..++. .
T Consensus 86 TvL-~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L~~pgd-~ 157 (396)
T KOG0593|consen 86 TVL-HELERYPN----GVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTLSAPGD-N 157 (396)
T ss_pred HHH-HHHHhccC----CCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhhcCCcc-h
Confidence 444 44444332 48899999999999999999997 88999999999999998 88999999999999875332 2
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc----cccch
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS----GECFD 970 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~d 970 (1025)
.+..+.|.+|+|||.+.+... |+..+||||.||++.||++|.+-|. +.+++.+.......-+.. .+++.
T Consensus 158 YTDYVATRWYRaPELLvGDtq-YG~pVDiWAiGCv~aEl~~G~pL~P------G~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQ-YGKPVDIWAIGCVFAELLTGEPLWP------GRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hhhhhhhhhccChhhhcccCc-CCCcccchhhhHHHHHHhcCCcCCC------CcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 233478999999999988665 6999999999999999999998775 233444333221111111 11111
Q ss_pred ------hhhcCCCCCC-----CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 971 ------RLIMDGHDME-----QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 971 ------~~~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.........+ .-+....-+.+++..|++-| ++|++.+|++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000001000 01233457899999999999 99999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.13 Aligned_cols=244 Identities=21% Similarity=0.365 Sum_probs=207.3
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
-+.||+|+.|.||.|+ ..+++.||||++....+..++-+.+|+.+|+..+|+|||.+++.|. ...+.|+|||||++|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl--v~deLWVVMEym~gg 355 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL--VGDELWVVMEYMEGG 355 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc--ccceeEEEEeecCCC
Confidence 4789999999999998 5679999999998877777788899999999999999999999888 446899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+.+... .+++.++..|+++++.||+|||. .+|+|||||.+|||++. ++.+||+|||++..+..... ..
T Consensus 356 sLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 356 SLTDVVTKT------RMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred chhhhhhcc------cccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeeccccccC-cc
Confidence 999999876 58999999999999999999997 89999999999999998 88899999999998876554 33
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...+||++|||||++.... |++|.||||||++++||+-|++||-.. ..+...... ...+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLI-------------a~ng 485 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLI-------------ATNG 485 (550)
T ss_pred ccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHH-------------hhcC
Confidence 4458999999999998887 589999999999999999999998642 111111110 1112
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+...++.....+.++..+|+..| ++||++.|+++.
T Consensus 486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233446778889999999999999 999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.25 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=210.4
Q ss_pred cccCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccchhc---HHHHHHHHHHHhcCCCCccccccceeec--
Q 001700 725 LMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKG---KKEFAREVKKLGNIKHPNLVSLQGYYWG-- 799 (1025)
Q Consensus 725 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 799 (1025)
..++.+++.......||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.++++++|||||+++|++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 45677777777678999999999999998 48899999997653322 4678899999999999999999999875
Q ss_pred CCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEe
Q 001700 800 PKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLT 879 (1025)
Q Consensus 800 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~ 879 (1025)
......++||||+++|+|.+++.... .+++..+.+++.|++.||+|||+..+++||||||+||+++. ++.+||+
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~ 165 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKII 165 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEc
Confidence 33456899999999999999998653 58999999999999999999997458889999999999998 8899999
Q ss_pred ccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHH
Q 001700 880 DYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLL 959 (1025)
Q Consensus 880 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~ 959 (1025)
|||+++....... ...|+..|+|||++.+....++.++|||||||++|||++|+.||.... ..++....
T Consensus 166 dfg~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i 234 (283)
T PHA02988 166 CHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLI 234 (283)
T ss_pred ccchHhhhccccc----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHH
Confidence 9999987644322 236899999999987632226899999999999999999999997431 11222111
Q ss_pred HhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 960 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.....+...+..++.++.+++.+||+.+ ++|||++||++.|+.+.
T Consensus 235 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 -------------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -------------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111222233456778999999999999 99999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=369.03 Aligned_cols=252 Identities=23% Similarity=0.436 Sum_probs=218.5
Q ss_pred CceeeeecceEEEEEEec----CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
+++||.|.||.||+|+++ ....||||.++.+. ++++.+|+.|+.||.+++||||++|.|+.. +....++|+||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMIiTEy 711 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMIITEY 711 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEEEhhh
Confidence 589999999999999975 24589999999764 567789999999999999999999999986 66678999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
|++|+|+.+|+.+++ .|++.+...+.++||.|++||-+ .++|||||.++|||++. +...|++|||+++.+.++.
T Consensus 712 MENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNs-nLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeecc-ceEEEeccccceeecccCC
Confidence 999999999998864 59999999999999999999997 99999999999999998 9999999999999886655
Q ss_pred CccccccCc--ccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQVLNAG--ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
....+...| ..+|.|||.+....+ +.++|||||||||||.++ |..||-++..+ -
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF--TsASDVWSyGIVmWEVmSyGERPYWdmSNQ---------------------d 842 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF--TSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------------D 842 (996)
T ss_pred CccccccCCccceeecChhHhhhccc--CchhhccccceEEEEecccCCCcccccchH---------------------H
Confidence 333333233 468999999988774 999999999999999776 99998654221 1
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+-..+..+++.+.|.+|+..+.+||..||+.+ .+||.+.||+..|+++...
T Consensus 843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 33456678888999999999999999999999 9999999999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=343.79 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=202.7
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.++||+|.||.||+|+ ..+|+.||+|+++... .....-..|||.||++++||||++|.+..........|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4789999999999999 6789999999998654 333556789999999999999999999988654678999999995
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
. ||.-++....- .|++.++..|+.|++.||+|+|+ +||+|||||.+|||||. ++.+||+|||+|+++......
T Consensus 202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEeccccceeeccCCCCc
Confidence 5 88888876432 69999999999999999999998 99999999999999999 899999999999998877666
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-ccccccchh-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRSGECFDR- 971 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~- 971 (1025)
..+..+-|..|+|||.+.+... |+.+.|+||.||||.||++|++.|... .++ +.+.....- +...+..-+
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~-Yg~aVDlWS~GCIl~El~~gkPI~~G~------tEv-eQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATS-YGTAVDLWSVGCILAELFLGKPILQGR------TEV-EQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred ccccceEEeeccChHHhcCCcc-cccceeehhhhHHHHHHHcCCCCcCCc------cHH-HHHHHHHHHhCCCChhcccc
Confidence 6666788999999999998876 799999999999999999999887632 111 111111111 111111111
Q ss_pred ------hhcCCCC------CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 ------LIMDGHD------MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ------~~~~~~~------~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....... .+.-...+....+++...+..+ ++|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 0001233566788999999999 99999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.02 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=206.2
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCC
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 803 (1025)
.+.++|+.. ++.||+|.||+||+|+|. | .||||.+.... ....+.|+.|+.++++-+|.||+-+.|||.. .
T Consensus 388 eIp~~ev~l--~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~--p- 460 (678)
T KOG0193|consen 388 EIPPEEVLL--GERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN--P- 460 (678)
T ss_pred ccCHHHhhc--cceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--C-
Confidence 455666654 588999999999999986 2 59999997653 3456889999999999999999999999973 3
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
...+|+.+++|.+|+.+++.... .|...+.+.||+|||+|+.|||. ++|||||||..||++.+ +.+|||+|||+
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGL 534 (678)
T ss_pred ceeeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccc
Confidence 34999999999999999997652 68999999999999999999998 88999999999999998 79999999999
Q ss_pred ccccccC-CCccccccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh
Q 001700 884 HRILTSA-GTADQVLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 884 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
+..-..- .........|...|||||+++.+. ..+++.+||||||+|+|||+||..||.+...+. + -|+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----I-ifm----- 604 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----I-IFM----- 604 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----e-EEE-----
Confidence 8753221 111112235888999999987432 226999999999999999999999998432211 0 000
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
.++.--..|. ......+++++.+|+..||..+ ++||.+.+|+..|+.+.++
T Consensus 605 VGrG~l~pd~-------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 605 VGRGYLMPDL-------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ecccccCccc-------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0000000000 1123567889999999999999 9999999999999888763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.41 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=204.4
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeE
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 806 (1025)
+.++++.. -+.||+|+.|.||+|+++ ++.||||+++.-. ..+|+-|++|+||||+.+.|+|. ...-++
T Consensus 121 iPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt--qsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT--QSPCYC 188 (904)
T ss_pred CCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec--CCceeE
Confidence 44555543 378999999999999998 6889999886532 35788999999999999999997 444689
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
||||||..|-|+.+|+... .++......|..+||.|+.|||. +.|||||||.-||||.. +..+||+|||.++.
T Consensus 189 IiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHh
Confidence 9999999999999999875 68888999999999999999997 88999999999999998 77899999999998
Q ss_pred cccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 887 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
..+.. ..+..+||..|||||++.... .+.|+||||||||||||+||..||.+.... ..-|-
T Consensus 262 ~~~~S--TkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwG---------- 322 (904)
T KOG4721|consen 262 LSDKS--TKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWG---------- 322 (904)
T ss_pred hhhhh--hhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcCCCccccchh-----eeEEe----------
Confidence 76652 334458999999999999887 599999999999999999999998754210 00110
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+. ...-..+.+..+++-|.-++..||+.. .+||++++|+..|+-..
T Consensus 323 --VG---sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 323 --VG---SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred --cc---CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 00 001123457888999999999999988 99999999999987554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.36 Aligned_cols=238 Identities=20% Similarity=0.315 Sum_probs=198.0
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCC
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE 802 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 802 (1025)
+++++.+. ...||.|+||.|..++.+ +|..+|+|++.+.. .++.+...+|..+|+.+.||+++++++.|. +.
T Consensus 41 ~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~--d~ 116 (355)
T KOG0616|consen 41 YSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK--DN 116 (355)
T ss_pred cchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec--cC
Confidence 34444433 478999999999999965 78999999998753 344567889999999999999999998887 56
Q ss_pred CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccc
Q 001700 803 HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882 (1025)
Q Consensus 803 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfG 882 (1025)
...++||||++||.|..+++..+ +|+++.++.+|.||+.||+|||+ .+|++||+||+|||+|. ++.+||+|||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKitDFG 189 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKITDFG 189 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEEecc
Confidence 68999999999999999999875 69999999999999999999998 89999999999999999 9999999999
Q ss_pred cccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 883 LHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 883 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
+|+..... ..+.||||.|+|||++...+ +..++|.|||||++|||+.|.+||....
T Consensus 190 FAK~v~~r----T~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~------------------ 245 (355)
T KOG0616|consen 190 FAKRVSGR----TWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDN------------------ 245 (355)
T ss_pred ceEEecCc----EEEecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCC------------------
Confidence 99987543 33459999999999999888 5889999999999999999999997431
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCC
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SER 1003 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~R 1003 (1025)
..++++..+.+.. ..|.....++.+++..-++.| .+|
T Consensus 246 --~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 246 --PIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --hHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1223334444333 235566677788888888887 777
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.67 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=199.0
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
++.||+|+|++||+|+ .+++++||||++.+.. ++..+-+.+|-.+|.+| .||.||+|+-.|. ++...|+|+||
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~~sLYFvLe~ 155 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DEESLYFVLEY 155 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cccceEEEEEe
Confidence 6889999999999998 5589999999997642 23345677899999999 8999999987776 66689999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.++|+..+ .|++..++.++.||+.||+|||+ +|||||||||+|||+|. ++++||.|||.|+.+.+..
T Consensus 156 A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 156 APNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred cCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeeccccccCChhh
Confidence 99999999999875 69999999999999999999998 99999999999999999 9999999999999875432
Q ss_pred Cc----------cc--cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHH
Q 001700 892 TA----------DQ--VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLL 959 (1025)
Q Consensus 892 ~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~ 959 (1025)
.. .. ...+||-.|.+||++.... .+..+|+|+|||++|.|+.|++||... ....-
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~------Neyli----- 295 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAA------NEYLI----- 295 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccc------cHHHH-----
Confidence 11 11 3358999999999998887 488999999999999999999999743 11111
Q ss_pred HhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 960 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+...+.-.+ +.++..+..+.+|+.+-+..+ .+|++.+||-+
T Consensus 296 ---------FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 ---------FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---------HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 111121122 235556677889999999999 99999988754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=349.84 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=198.4
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEcccc----ch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREG----IA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv 808 (1025)
.++.||+|+||+||.|+. .+|..||||++.+. .. ...+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~~~~iv 98 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PTKIYIV 98 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CCeEEEE
Confidence 367899999999999985 47899999987653 11 23456778999999998 9999999999984 4469999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+.+|+|.+++.... ++.+.++..+++|++.|++|+|+ +||+||||||+|||+|....++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999843 68999999999999999999998 8999999999999999832899999999999874
Q ss_pred -cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 889 -SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 889 -~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
... ...+.+||+.|+|||++.+...+.+.++||||+||++|.|++|+.||++. +.....+
T Consensus 173 ~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~---------- 233 (370)
T KOG0583|consen 173 GEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYR---------- 233 (370)
T ss_pred CCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHH----------
Confidence 222 22345899999999999987733578999999999999999999999852 1111111
Q ss_pred cchhhhcCCCCCCCchHH-HHHHHHHHHHccCCC-CCCCCHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRI-LSDMLQVALRCILPA-SERPDMMSVF 1010 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~-~~~~~~l~~~C~~~~-~~RPs~~evl 1010 (1025)
....+.+ ..+... ..++..++.+|+..+ .+|+++.+|+
T Consensus 234 ---ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 234 ---KIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---HHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1112222 233444 788999999999999 9999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=374.60 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=211.1
Q ss_pred CceeeeecceEEEEEEec--CCC----EEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD--SGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~--~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|++. +|. .||||.+++.. .+...+|.+|..+|++++|||||+++|+|.+ ....++++
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~l 774 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILL 774 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEe
Confidence 578999999999999964 343 49999998764 4456889999999999999999999999984 56789999
Q ss_pred eccccccHHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 810 NYINAQSLAVYLQETDPRK--LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|||++|||..||++.+... ...++..+.+.++.|||+|++||++ ..+|||||.++|+|++. ...+||+|||+|+.+
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKIADFGLARDI 852 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEEcccchhHhh
Confidence 9999999999999863221 1368999999999999999999998 77889999999999999 789999999999955
Q ss_pred ccCCCcccccc-CcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccc
Q 001700 888 TSAGTADQVLN-AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 888 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
-....+..... .-...|||||.+.++. ++.|+|||||||++||++| |..||.....
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~i--FtskSDvWsFGVllWEifslG~~PY~~~~n-------------------- 910 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGI--FTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------------------- 910 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcc--cccccchhhhHHHHHHHHhCCCCCCCCcch--------------------
Confidence 44443333222 2346899999999877 4999999999999999999 8899874321
Q ss_pred cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
.+++...+.+ .+.+.|..|+..++++|..||+.+ ++||++..|++++..+...
T Consensus 911 ~~v~~~~~~g-gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 911 FEVLLDVLEG-GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHHHHhC-CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1122222223 367789999999999999999999 9999999999999988754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=352.13 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=199.4
Q ss_pred CCceeeeecceEEEEEEe------cCCCEEEEEEccccch-hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATL------DSGSILAVKRLREGIA-KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
..++||+|+||.||+|.. .++..||||+++.... ...+.+.+|+.++.++ +|||||+++++|.. .....++
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~~l 89 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PNGPLMV 89 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CCCceEE
Confidence 358899999999999974 2356899999975432 3346789999999999 89999999998864 3446899
Q ss_pred EEeccccccHHHHHhhcCCC---------------------------------------------------------CCC
Q 001700 808 ISNYINAQSLAVYLQETDPR---------------------------------------------------------KLP 830 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~ 830 (1025)
||||+++|+|.+++...... ...
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 99999999999999753210 012
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc-cccccCcccccCcccc
Q 001700 831 PLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEF 909 (1025)
Q Consensus 831 ~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~ 909 (1025)
++++.++..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++........ ......+++.|+|||+
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 48899999999999999999998 89999999999999998 789999999999865432221 1112246788999999
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHH
Q 001700 910 ASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988 (1025)
Q Consensus 910 ~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 988 (1025)
+.+.. ++.++|||||||++|||++ |+.||...... ..+... .. .+.....+...+..
T Consensus 248 ~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~-~~-------------~~~~~~~~~~~~~~ 305 (338)
T cd05102 248 IFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQR-LK-------------DGTRMRAPENATPE 305 (338)
T ss_pred hhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHH-Hh-------------cCCCCCCCCCCCHH
Confidence 97766 5889999999999999997 99998743111 111111 11 11111123345567
Q ss_pred HHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 989 MLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 989 ~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+.+++.+||+.+ ++|||+.||++.|+++..+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=306.76 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=204.7
Q ss_pred cCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 734 HAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
|...+++|+|.||.||+|+ .++|+.||||+++....+ -.....||++.|+.++||||+.++++|- ......+|+|
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lVfE 81 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLVFE 81 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEEEE
Confidence 3445789999999999999 568999999999876433 2356789999999999999999999986 5667899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
||+ .+|+..++.... .++..++..++.++++|++|||+ +.|+|||+||.|+|++. ++.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhccCCC
Confidence 995 599999987653 79999999999999999999997 89999999999999998 889999999999998765
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc----
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG---- 966 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~---- 966 (1025)
...... .+-|..|+|||.+.|.+. |+...||||.|||+.||+-|.+-|. +..++.+.......-+...
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~-Yg~~VDmWavGCI~AELllr~P~fp------G~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQ-YGTGVDMWAVGCIFAELLLRVPFFP------GDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchh-cCCcchhhhHHHHHHHHHccCCCCC------CCchHHHHHHHHHHcCCCCcccC
Confidence 443222 367999999999998876 7999999999999999999886554 3345554443332222111
Q ss_pred ----ccchhhhcCCCC----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ----ECFDRLIMDGHD----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ----~~~d~~~~~~~~----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+.-|-.....+. ...-..+..+..+++..++..+ .+|.+++|.+++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111111110 0122345667799999999999 999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=338.30 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
-+.||+|.||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|+++++.++|||||.++++|. ...+.++|.||+.
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vVte~a~ 84 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVVTEYAV 84 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEEehhhh
Confidence 467999999999999955 78999999987642 344567899999999999999999999997 5668999999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
| +|..++.... .++++.++.|+.++..||.|||+ ++|+|||+||.|||++. ++.+|+||||+|+.+.... .
T Consensus 85 g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 85 G-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred h-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhcccCc-e
Confidence 6 9999998764 69999999999999999999998 89999999999999998 8999999999999876543 3
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......|||.|||||++.+.. ++..+|.||+||++||+++|++||... .+.+.++....
T Consensus 156 vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~------------ 214 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILK------------ 214 (808)
T ss_pred eeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhc------------
Confidence 334457999999999999777 589999999999999999999998632 23333333322
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
++. ..+......+..++..-+..| ..|-+-.+++.
T Consensus 215 -d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 -DPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222 235577788899999999888 99998888765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=346.19 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=205.9
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++-||.|+-|.|..|++ .+|+.+|||++.+.. ......+.+|+-+|+-+.||||+++|+++. ...+.|+|.||+
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~lylvlEyv 94 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLYLVLEYV 94 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEEEEEEec
Confidence 57799999999999995 589999999997652 233567899999999999999999999987 566899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|.|.+++-.++ ++++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|. ...+||+|||+|..-..+..
T Consensus 95 ~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 95 PGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred CCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeeccceeecccCCcc
Confidence 9999999998875 69999999999999999999997 89999999999999998 66699999999987655443
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
-. +.||++.|.|||++.+..+ .+.++||||.|||+|.|+||+.||++ +++.... .+.
T Consensus 168 Le--TSCGSPHYA~PEIV~G~pY-dG~~sDVWSCGVILfALLtG~LPFdD-------dNir~LL-------------lKV 224 (786)
T KOG0588|consen 168 LE--TSCGSPHYAAPEIVSGRPY-DGRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLL-------------LKV 224 (786)
T ss_pred cc--ccCCCcccCCchhhcCCCC-CCCccccchhHHHHHHHHhCCCCCCC-------ccHHHHH-------------HHH
Confidence 33 2489999999999999886 69999999999999999999999983 2333222 222
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+.+ +.|...+.+..+++.+|+..| ++|-|+.||++.
T Consensus 225 ~~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 23333 346777888999999999999 999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.90 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=203.1
Q ss_pred cCCCceeeeecceEEEEEE-ecCCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 734 HAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
|...+.||+|.||.||||. .++++.||+|++..... ...+++++|+.++..++++||.++||.|. .+...+++|||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl--~g~~LwiiMey 92 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL--KGTKLWIIMEY 92 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee--ecccHHHHHHH
Confidence 3335789999999999998 45899999999986543 34678999999999999999999999988 56689999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+.+|++.+.+.... .+.+.++.-|++++..||.|||+ .+.+|||||+.|||+.. ++.+|++|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeeeeechh
Confidence 99999999998653 45888899999999999999998 67789999999999998 6899999999999887655
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
... .+.+||+.|||||++.... |+.|+||||||++.+||++|.+|+....+.+ +.-
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~--Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------vlf---- 221 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSG--YDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------VLF---- 221 (467)
T ss_pred hcc-ccccccccccchhhhcccc--ccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------EEE----
Confidence 444 4458999999999999656 6999999999999999999999987542211 110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+-....+.....+...+.+++..|+..+ +.||++.++++.
T Consensus 222 lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11111222233466778999999999999 999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=348.34 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=211.7
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEec--CC--CE-EEEEEcccc---chhcHHHHHHHHHHHhcCCCCcccccccee
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLD--SG--SI-LAVKRLREG---IAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~--~g--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 797 (1025)
.+..+++... ++||+|+||.||+|++. ++ .. ||||..+.. .....++|.+|+++|++++|||||++||++
T Consensus 153 el~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 153 ELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred EEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4444555443 89999999999999965 22 23 899999852 355678999999999999999999999999
Q ss_pred ecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEE
Q 001700 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV 877 (1025)
Q Consensus 798 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~k 877 (1025)
. .....++|||+|.||+|.+||+.... .++..+++.++.+.|+||+|||+ .+++||||-++|+|++. +..+|
T Consensus 231 ~--~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vK 302 (474)
T KOG0194|consen 231 V--LEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVK 302 (474)
T ss_pred c--CCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEE
Confidence 7 45578999999999999999998753 49999999999999999999998 78899999999999998 77789
Q ss_pred EeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHH
Q 001700 878 LTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 878 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~ 956 (1025)
|+|||+++........... ..-...|+|||.+.... ++.++|||||||++||+++ |..||..... .++
T Consensus 303 ISDFGLs~~~~~~~~~~~~-~klPirWLAPEtl~~~~--~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v---- 371 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFL-KKLPIRWLAPETLNTGI--FSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEV---- 371 (474)
T ss_pred eCccccccCCcceeecccc-ccCcceecChhhhccCc--cccccchhheeeeEEeeeccCCCCCCCCCH----HHH----
Confidence 9999998865421111111 12457899999999886 6999999999999999999 8889874311 111
Q ss_pred HHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
.......+++.+.+...+..+..++.+||..+ ++||+|.+|.+.++.+....+
T Consensus 372 ------------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 372 ------------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11222445566667788889999999999999 999999999999999876543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.87 Aligned_cols=399 Identities=22% Similarity=0.197 Sum_probs=289.7
Q ss_pred CCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeC
Q 001700 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDL 192 (1025)
Q Consensus 113 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 192 (1025)
+.-+.||||+|.|+.+-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.+.-++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 34567888888888888888888888888888888888 67776666777888888888888877888888888888888
Q ss_pred ccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCC-cccccccccceecccc
Q 001700 193 SNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSN 271 (1025)
Q Consensus 193 s~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N 271 (1025)
|.|.|+...-..+..- .+|++|+|++|.|+. ...+.|..+.+|..|.|++|+++..++ .|..+.+|+.|+|..|
T Consensus 157 SrN~is~i~~~sfp~~---~ni~~L~La~N~It~--l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN 231 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAK---VNIKKLNLASNRITT--LETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRN 231 (873)
T ss_pred hhchhhcccCCCCCCC---CCceEEeeccccccc--cccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccc
Confidence 8888886554444332 678888888888854 344557777788888888888887665 4666888888888888
Q ss_pred cccccCChhHHhhcccccCeEEcccccCcCcc--cccCCCCccEEEccCCcccCCCCCCCCCcceeeccCccCCCccccc
Q 001700 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPV--GSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRM 349 (1025)
Q Consensus 272 ~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~--~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~Ls~N~l~~~~~~~ 349 (1025)
+|.-.--.+|..+ .+|+.|.|..|.+.... .+..+.+ ++.|+|+.|+++..-..+
T Consensus 232 ~irive~ltFqgL--~Sl~nlklqrN~I~kL~DG~Fy~l~k---------------------me~l~L~~N~l~~vn~g~ 288 (873)
T KOG4194|consen 232 RIRIVEGLTFQGL--PSLQNLKLQRNDISKLDDGAFYGLEK---------------------MEHLNLETNRLQAVNEGW 288 (873)
T ss_pred ceeeehhhhhcCc--hhhhhhhhhhcCcccccCcceeeecc---------------------cceeecccchhhhhhccc
Confidence 8861111122221 22444445555444311 1222333 445555555555444444
Q ss_pred ccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCC
Q 001700 350 QNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLT 429 (1025)
Q Consensus 350 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 429 (1025)
...++.|+.|+||+|.|..+-++.+....+|++|+|++|+|+..-+..|..+..|+.|+|++|+++.+--..|..+++|+
T Consensus 289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~ 368 (873)
T KOG4194|consen 289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH 368 (873)
T ss_pred ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence 45566789999999999998899888899999999999999987888899999999999999999877777888999999
Q ss_pred EEecCCCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCccccCCCcCC-CCc
Q 001700 430 DLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN-GLK 508 (1025)
Q Consensus 430 ~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ip~~l~~-~L~ 508 (1025)
.|||++|.+++.|.... .++.+ ..+|+.|+|.+|+|....-..|..+++|+.|||.+|.|...-|..+.. .|+
T Consensus 369 ~LdLr~N~ls~~IEDaa---~~f~g---l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk 442 (873)
T KOG4194|consen 369 KLDLRSNELSWCIEDAA---VAFNG---LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELK 442 (873)
T ss_pred hhcCcCCeEEEEEecch---hhhcc---chhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhh
Confidence 99999999998765431 11122 348999999999999655567999999999999999998766777755 777
Q ss_pred EEECCCCcccc-----cCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC
Q 001700 509 EFNVSFNNLSG-----VVPENL-RNFPDSAFHPGNSLLTFPNSPSQQ 549 (1025)
Q Consensus 509 ~L~ls~N~l~g-----~~p~~l-~~~~~~~~~~~n~~c~~~~~~~~~ 549 (1025)
.|-+..-.|-+ ..++|+ +.+.+.+ -+..|++|......
T Consensus 443 ~Lv~nSssflCDCql~Wl~qWl~~~~lq~s---v~a~CayPe~Lad~ 486 (873)
T KOG4194|consen 443 ELVMNSSSFLCDCQLKWLAQWLYRRKLQSS---VIAKCAYPEPLADQ 486 (873)
T ss_pred hhhhcccceEEeccHHHHHHHHHhcccccc---eeeeccCCcccccc
Confidence 77665433322 234454 2333322 13359988765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.00 Aligned_cols=240 Identities=19% Similarity=0.271 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
-.+||+|+||.||.|+ .++|..+|+|++++.. ..+.+.+..|-.+|...++|.||+||-.|. +....|+||||+
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ--D~~~LYLiMEyl 223 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ--DKEYLYLIMEYL 223 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec--CCCeeEEEEEec
Confidence 4789999999999999 5589999999998754 234567888999999999999999976665 566899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC--
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA-- 890 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~-- 890 (1025)
+|||+..+|...+ .|++..++.++.+++.|++-+|. .|+|||||||+|+|||. .+++||+|||++..+...
T Consensus 224 PGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 224 PGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred CCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeeccccccchhhhhhh
Confidence 9999999998775 79999999999999999999996 99999999999999999 999999999998643210
Q ss_pred --------------------CCc-----cc-------------------cccCcccccCccccccCCCCCCCCchhHHHH
Q 001700 891 --------------------GTA-----DQ-------------------VLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926 (1025)
Q Consensus 891 --------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSl 926 (1025)
... .. ...+|||.|||||++.+.+ |+..+|+||+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDwWSL 374 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDWWSL 374 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccHHHH
Confidence 000 00 0127999999999999988 5899999999
Q ss_pred HHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCC
Q 001700 927 GIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPD 1005 (1025)
Q Consensus 927 Gvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs 1005 (1025)
|||||||+.|-+||....+..-...++.|..... .+.......+..+++.+|+.+.++|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------------fP~~~~~s~eA~DLI~rll~d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------------------FPEEVDLSDEAKDLITRLLCDPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------------CCCcCcccHHHHHHHHHHhcCHHHhcC
Confidence 9999999999999985543332333444432111 111233447788999999983377754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.93 Aligned_cols=267 Identities=20% Similarity=0.274 Sum_probs=200.2
Q ss_pred hcCCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCC---eeEEE
Q 001700 733 SHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH---EKLVI 808 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---~~~lv 808 (1025)
.+...+++|+|+||.||+|... +++.||||+.-.... .-.+|+++|++++|||||++.-+|....+. ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4445689999999999999954 679999999865422 224799999999999999998777643333 35689
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+|||+. +|.++++..... ...++.-.+.-+++|+.+||+|||+ .+|+||||||.|+|+|.+.+.+||||||.|+.+.
T Consensus 101 leymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 999965 899888853111 1258888999999999999999998 9999999999999999978999999999999987
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc-----
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN----- 963 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~----- 963 (1025)
.+....+ ..-|..|+|||.+.+... |+.+.||||.|||+.||+-|++-|.. +.+...++..++..-...
T Consensus 178 ~~epniS--YicSRyYRaPELifga~~-Yt~~IDiWSaGCV~aELl~g~plFpG---~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 178 KGEPNIS--YICSRYYRAPELIFGATE-YTTSIDIWSAGCVMAELLKGQPLFPG---DSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cCCCcee--EEEeccccCHHHHcCccc-cCceeEEhhhhHHHHHHhcCCcccCC---CCHHHHHHHHHHHhCCCCHHHHh
Confidence 6554332 357889999999998876 79999999999999999999987753 223334444443221110
Q ss_pred --cc--cccchhhhcCCCCCC-CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 964 --RS--GECFDRLIMDGHDME-QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 964 --~~--~~~~d~~~~~~~~~~-~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.. .+.-.+.+...+... .....+.+..+++.+++.++ .+|.++.|++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 111122222222111 23445677899999999999 999999998854
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.39 Aligned_cols=250 Identities=21% Similarity=0.367 Sum_probs=198.0
Q ss_pred CCceeeeecceEEEEEEec----CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 736 PAEVIGRSCHGTLYKATLD----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
..+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++++++||||++++|++. .....++|||
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 86 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTE 86 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCcEEEEE
Confidence 3578999999999999753 46689999998653 233467899999999999999999999987 4557899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..++++|||.+......
T Consensus 87 ~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 87 YMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRRLQEDKSE 160 (266)
T ss_pred eCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCccccccccc
Confidence 9999999999976431 58999999999999999999997 89999999999999988 889999999987654322
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.........++..|+|||++.+.. ++.++|||||||++||+++ |+.||.... ..+.+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~p~~~~~-------~~~~~~~~---------- 221 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMS-------GQDVIKAV---------- 221 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCC--ccchhHHHHHHHHHHHHhcCCCCCcCcCC-------HHHHHHHH----------
Confidence 211111224567899999987766 5889999999999999775 999986431 11111111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
......+.+..++..+.+++.+||+.+ ++||+++||.+.|+++
T Consensus 222 ----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 ----EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111122334556778999999999999 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.32 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=214.2
Q ss_pred CceeeeecceEEEEEEec---CC--CEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD---SG--SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~---~g--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.++||.|.||.||+|.+. .| -.||||..+..+ ....+.|..|.-+|++++|||||+++|+|. +...|+|||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~---e~P~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV---EQPMWIVME 470 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee---ccceeEEEe
Confidence 578999999999999853 23 368999998754 445788999999999999999999999995 457899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
.++.|.|..|++.+.. .++......+++||+.||+|||+ ...|||||..+|||+.. ...+|++|||+++.+.+.
T Consensus 471 L~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSRYLEDD 544 (974)
T ss_pred cccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhhhcccc
Confidence 9999999999998753 68899999999999999999999 77999999999999988 668999999999999887
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
..+......-.+.|||||.+.-.++ +.++|||-|||.|||++. |..||...... +++
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrF--TtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------------DVI 602 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRF--TTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------------DVI 602 (974)
T ss_pred chhhccccccceeecCccccchhcc--cchhhHHHHHHHHHHHHHhcCCcccccccc--------------------ceE
Confidence 7666554445678999999987774 999999999999999987 99999743211 111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
..+..+.+.+.|+.|+..++.++.+||+++ .+||.+.|+...|+++..
T Consensus 603 -~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 234456678899999999999999999999 999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=331.40 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=213.7
Q ss_pred CceeeeecceEEEEEEecC-CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLDS-GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
..+||-|.||.||.|.|+. .-.||||.+++. ....++|++|+.+|+.++|||+|+++|+|. .+...|||+|||.+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT--~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--HEPPFYIITEFMCYG 348 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhc--cCCCeEEEEecccCc
Confidence 5789999999999999873 568999999876 345789999999999999999999999997 555789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+|+++.... .++.-..+.+|.||+.|++||.. ..+|||||.++|+|+.+ +..+|++|||+++++..+.....
T Consensus 349 NLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 349 NLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcCCceecc
Confidence 999999987643 46777788999999999999996 77889999999999998 88999999999999876654433
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....-.+.|.|||-+....+ +.|+|||+|||+|||+.| |..||... ++-+ +-..+.
T Consensus 424 AGAKFPIKWTAPEsLAyNtF--SiKSDVWAFGVLLWEIATYGMsPYPGi-------dlSq--------------VY~LLE 480 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTF--SIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQ--------------VYGLLE 480 (1157)
T ss_pred cCccCcccccCccccccccc--ccchhhHHHHHHHHHHHhcCCCCCCCc-------cHHH--------------HHHHHh
Confidence 32234568999999887774 889999999999999998 88887632 2211 223455
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
.+++++.++.|+..++++|.+||++. .+||++.||-+.++.+..+
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 67788889999999999999999999 9999999999999988754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.35 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=197.6
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccch--------------hcHHHHHHHHHHHhcCCCCccccccceeecCC
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA--------------KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK 801 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 801 (1025)
.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++++|||||+|+++..++.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 56799999999999994 4799999999965311 01257889999999999999999999998888
Q ss_pred CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecc
Q 001700 802 EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY 881 (1025)
Q Consensus 802 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~Df 881 (1025)
....|||+|||..|.+...=.. + +.+++.++++|++++..||+|||. .+||||||||+|+|++. ++++||+||
T Consensus 182 s~~~YlVley~s~G~v~w~p~d----~-~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~-~g~VKIsDF 254 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPD----K-PELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS-DGTVKISDF 254 (576)
T ss_pred cCceEEEEEeccCCccccCCCC----c-ccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC-CCcEEeecc
Confidence 8899999999998876533221 1 249999999999999999999997 89999999999999998 899999999
Q ss_pred ccccccccCCC----ccccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHH
Q 001700 882 SLHRILTSAGT----ADQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDW 955 (1025)
Q Consensus 882 Gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~ 955 (1025)
|.+.....+.. ......+|||.|+|||...++. .+.+.+.||||+||+||.|+.|+.||-...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----------- 323 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----------- 323 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----------
Confidence 99886633211 1111247999999999887632 235789999999999999999999996321
Q ss_pred HHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 956 VRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 956 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+.+++.+...-..+..++....+.+++.+++..| +.|.+..+|...
T Consensus 324 ---------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 324 ---------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ---------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 112344444443334445566788999999999999 999999988643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=335.59 Aligned_cols=248 Identities=20% Similarity=0.318 Sum_probs=205.8
Q ss_pred ceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
-+||+|.||+||-|+ .++...+|||.+........+-+..|+.+-++++|.|||+++|.+- +.+..-+.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCc
Confidence 479999999999999 4567789999998876666677889999999999999999999875 5567889999999999
Q ss_pred HHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 817 LAVYLQETDPRKLPPL--SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|.+.+...-+ ++ .+.++-.+.+||++||.|||+ +.|||||||-.|||++.-.+.+||+|||.++.+..-....
T Consensus 659 LSsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9999987643 55 788899999999999999997 8899999999999998878899999999998775433222
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.+..||..|||||++..+..+|+.++|||||||++.||.||++||....... . . +.+-+ +
T Consensus 734 -ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----A-A----MFkVG----------m 793 (1226)
T KOG4279|consen 734 -ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----A-A----MFKVG----------M 793 (1226)
T ss_pred -cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----H-h----hhhhc----------c
Confidence 2236999999999999887779999999999999999999999997542111 0 0 00000 1
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
....++.|.+...+...++.+|++++ .+||+++++++.
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 11235678889999999999999999 999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.61 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=196.2
Q ss_pred CceeeeecceEEEEEEe------cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEE
Q 001700 737 AEVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
.+.||+|+||.||+|+. +++..||||+++... ....+.+.+|+++++.+ +|||||+++++|. .....++|
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~~~~~lv 117 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--VGGPTLVI 117 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cCCcceee
Confidence 68999999999999973 246689999997543 23456788999999999 8999999999987 45578999
Q ss_pred EeccccccHHHHHhhcCCC-------------------------------------------------------------
Q 001700 809 SNYINAQSLAVYLQETDPR------------------------------------------------------------- 827 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 827 (1025)
|||+++|+|.+++......
T Consensus 118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (375)
T cd05104 118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ 197 (375)
T ss_pred ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence 9999999999999753210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc-ccc
Q 001700 828 ---------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD-QVL 897 (1025)
Q Consensus 828 ---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~-~~~ 897 (1025)
....+++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++......... ...
T Consensus 198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccCcccccccCC
Confidence 01247899999999999999999997 89999999999999997 7889999999998664432211 111
Q ss_pred cCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCC
Q 001700 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 898 ~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
..++..|+|||++.+.. ++.++|||||||++|||++ |..||.....+ ....+++. .+
T Consensus 276 ~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~-----------------~~ 333 (375)
T cd05104 276 ARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIK-----------------EG 333 (375)
T ss_pred CCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHH-----------------hC
Confidence 23567899999997766 5889999999999999998 88888643111 11111111 11
Q ss_pred CCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 977 ~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
.+...+...+.++.+++.+||+.+ ++||+|+||++.|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111112334567899999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.58 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=195.1
Q ss_pred CceeeeecceEEEEEEecC-----------------CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceee
Q 001700 737 AEVIGRSCHGTLYKATLDS-----------------GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYW 798 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 798 (1025)
.+.||+|+||.||+|..++ +..||+|.++... .....++.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 5789999999999997532 3479999987643 334567999999999999999999999987
Q ss_pred cCCCCeeEEEEeccccccHHHHHhhcCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 001700 799 GPKEHEKLVISNYINAQSLAVYLQETDP--------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKS 864 (1025)
Q Consensus 799 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp 864 (1025)
. ....++||||+++|+|.+++..... .....+++.++.+++.||+.||+|||+ .+|+||||||
T Consensus 90 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ivH~dlkp 166 (304)
T cd05096 90 D--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LNFVHRDLAT 166 (304)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccccCcch
Confidence 3 4578999999999999999865321 111247889999999999999999998 8999999999
Q ss_pred CCEEeecCCCCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc--CCCCCC
Q 001700 865 TNILLEAPTMNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT--GKSSGE 941 (1025)
Q Consensus 865 ~NILl~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt--G~~P~~ 941 (1025)
+||+++. ++.+||+|||+++......... .....++..|+|||++.... ++.++|||||||++|||++ |..||.
T Consensus 167 ~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 167 RNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred hheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC--CCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 9999998 8899999999998654332211 11224578899999987665 5889999999999999987 556765
Q ss_pred ccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 942 IVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 942 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
... ......++......... .. ....+..++..+.+++.+||+.+ ++||||.||.+.|++
T Consensus 244 ~~~----~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELT----DEQVIENAGEFFRDQGR-QV---------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCC----HHHHHHHHHHHhhhccc-cc---------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 321 11222222211111000 00 00113345677999999999999 999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=346.11 Aligned_cols=267 Identities=23% Similarity=0.268 Sum_probs=216.7
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEecCC-CEEEEEEccccchhcHHHHHHHHHHHhcCC-CCccccccc-eeec---
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLDSG-SILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQG-YYWG--- 799 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~--- 799 (1025)
.|++........++|.+|||+.||.|+...+ ..||+|++-..++...+.+.+|+++|++|+ |||||.+++ ....
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 4455555556678999999999999996644 999999998777778889999999999997 999999999 3321
Q ss_pred CC-CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCCCCCEEeecCCCCEE
Q 001700 800 PK-EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-RAIPHGNLKSTNILLEAPTMNAV 877 (1025)
Q Consensus 800 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~ivHrDlkp~NILl~~~~~~~k 877 (1025)
.. ..+++|.||||.+|.|-+++..+... .|++.++++|+.|+++|+++||.. +.|||||||-|||||+. +++.|
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~-~g~~K 186 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA-DGNYK 186 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC-CCCEE
Confidence 12 35789999999999999999876543 499999999999999999999974 56999999999999998 88999
Q ss_pred EeccccccccccCCC-c-------cccccCcccccCccccccC-CCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCC
Q 001700 878 LTDYSLHRILTSAGT-A-------DQVLNAGALGYRPPEFAST-SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPG 948 (1025)
Q Consensus 878 l~DfGla~~~~~~~~-~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~ 948 (1025)
|||||.+........ . ......-|+.|+|||++.- .....++|+|||||||+||.|.....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 999998875433221 1 1112357999999998862 222269999999999999999999999984310
Q ss_pred CcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
-+.+.+.+..+..+.....+.+||..|++.+ ++||++-||++.+.++....
T Consensus 264 ---------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1234455665666788999999999999999 99999999999999987653
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=295.97 Aligned_cols=265 Identities=18% Similarity=0.274 Sum_probs=210.4
Q ss_pred hcCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecC---CCCeeEEE
Q 001700 733 SHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP---KEHEKLVI 808 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~~~lv 808 (1025)
.|...+.+|+|||+.||.++ ..++..||+|++.....++.+..++|++..++++||||++++++.... ..++.|++
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 34446889999999999999 668999999999887777888999999999999999999999988631 33568999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
+.|...|+|.+.+.....++ ..+++.+++.|+.+|++||++||+. +.+.||||||.|||+.+ .+.+++.|||.+...
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQA 179 (302)
T ss_pred eehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEeccCcccc
Confidence 99999999999998764333 3699999999999999999999973 34999999999999988 789999999998765
Q ss_pred ccCCC--------ccccccCcccccCccccccCCCCC-CCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHH
Q 001700 888 TSAGT--------ADQVLNAGALGYRPPEFASTSKPC-PSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 888 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
.-... ........|..|+|||.+.-...+ .++++|||||||++|+|+.|..||+.....++...+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL------ 253 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL------ 253 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE------
Confidence 32111 111223578999999998644332 588999999999999999999999866543221111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+...+....+.....++.+.+++.+|++.| .+||++.+++..++.+.
T Consensus 254 ------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011112222334457888999999999999 99999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.10 Aligned_cols=240 Identities=20% Similarity=0.334 Sum_probs=199.3
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhc---HHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKG---KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|.||+|-+|. +..|+.||||.+++..-++ .-.+.+|++||+.++||||+.+|++|. ......+||||.
T Consensus 58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE--NkdKIvivMEYa 135 (668)
T KOG0611|consen 58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE--NKDKIVIVMEYA 135 (668)
T ss_pred HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc--CCceEEEEEEec
Confidence 4679999999999998 5789999999998764333 446789999999999999999999997 556899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.+|.|++|+.+++ .+++.+++.+++||..|+.|+|. +++||||+|.+|||+|. +.++||+|||++-.+.+...
T Consensus 136 S~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 136 SGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred CCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccchhhhhccccH
Confidence 9999999999876 69999999999999999999996 99999999999999998 99999999999998876544
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.. +.||++-|.+||++.+..+ -+..+|-||+||++|.++.|..||+.. +....++..
T Consensus 209 Lq--TFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lvrQI------------- 265 (668)
T KOG0611|consen 209 LQ--TFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLVRQI------------- 265 (668)
T ss_pred HH--HhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCc-------hHHHHHHHh-------------
Confidence 32 3489999999999998876 488999999999999999999999843 233333322
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
-.+.++ .++.+....-++.+++..+ ++|-|+.+|..
T Consensus 266 s~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 266 SRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred hccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 122332 1222334556788888888 99999998875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.18 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=199.5
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCC
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPK 801 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 801 (1025)
++.+++.. ..+||+|+||+|+++..+ +++.+|||++++.. ....+....|.+|+... +||++++++..|. .
T Consensus 365 ~~l~~F~~--l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T 440 (694)
T KOG0694|consen 365 LTLDDFRL--LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--T 440 (694)
T ss_pred ccccceEE--EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--c
Confidence 34444433 478999999999999976 78899999999864 34466788899998877 5999999998886 5
Q ss_pred CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecc
Q 001700 802 EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY 881 (1025)
Q Consensus 802 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~Df 881 (1025)
..+.++||||+.||++..+.+.. .|++..+..|+..|+.||+|||+ ++||+||||.+|||+|. ++++||+||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence 66899999999999955444433 59999999999999999999997 99999999999999999 999999999
Q ss_pred ccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh
Q 001700 882 SLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 882 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
|+++..--.+. ...+.|||+.|||||++.+.. |+.++|+|||||+||||+.|..||....
T Consensus 513 GlcKe~m~~g~-~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----------------- 572 (694)
T KOG0694|consen 513 GLCKEGMGQGD-RTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGDD----------------- 572 (694)
T ss_pred ccccccCCCCC-ccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCCC-----------------
Confidence 99997543332 334469999999999999888 5999999999999999999999997321
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
-.+++|..+..++ .+|.-.+.+...|+.+.+..+ ++|--+
T Consensus 573 ---Eee~FdsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 573 ---EEEVFDSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---HHHHHHHHhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1234565555544 356777888999999999888 888765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.70 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=198.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++.||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|++|-+.++||||+++|+||. +....|+++||.
T Consensus 27 gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riyLilEya 104 (281)
T KOG0580|consen 27 GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIYLILEYA 104 (281)
T ss_pred cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee--ccceeEEEEEec
Confidence 689999999999999955 78899999997642 234577999999999999999999999998 556899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
..|++...+++.... .+++.....+..|+|.||.|+|. +.|+||||||+|+|++. .+..|++|||.+.....
T Consensus 105 ~~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfGwsV~~p~--- 176 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPS--- 176 (281)
T ss_pred CCchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCCceeecCC---
Confidence 999999999965433 58999999999999999999997 88999999999999998 78999999999876542
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....+.|||..|.|||+..+.. ++..+|+|++|++.||++.|.+||+....+ .. +.+ .. ..+.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----et--Ykr-I~----k~~~---- 239 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHS----ET--YKR-IR----KVDL---- 239 (281)
T ss_pred CCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhH----HH--HHH-HH----Hccc----
Confidence 2333458999999999999887 488999999999999999999999854211 11 110 00 0111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+........+++.+|+..+ .+|.+..||++
T Consensus 240 -------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 240 -------KFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -------cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 124556677899999999999 99999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.26 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=195.7
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|++.++..+|+|.++.. ....+++.+|++++++++||||+++++++. .....++||||+++|+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFMENGC 85 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEEEEcCCCCc
Confidence 4679999999999999888889999998754 334567899999999999999999999886 4557899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.++++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||.++...........
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 86 LLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCCCceeccC
Confidence 9999976432 58999999999999999999997 89999999999999988 889999999998865433222222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++||||||+++|||++ |+.||.... ..+.+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~--~~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~~~~~~~i~~~------------- 217 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKKS-------NYEVVEMISRG------------- 217 (256)
T ss_pred CCCCchhhCChhhcccCc--cchhhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCC-------------
Confidence 224567899999987665 5889999999999999999 899986421 11111111110
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.+...+...+.++.+++.+||+.+ ++||+|.|+++.|.
T Consensus 218 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 218 -FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111112334567899999999999 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=335.75 Aligned_cols=240 Identities=19% Similarity=0.289 Sum_probs=192.1
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
++||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++. .....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence 46999999999999854 79999999997643 223456788999999999999999998887 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 79 GGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCCC-
Confidence 999999987653 58999999999999999999997 89999999999999998 88999999999875432221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .........
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~~~------------- 208 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELIL------------- 208 (323)
T ss_pred cccceecCccccChhhhcCCC--CCccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHHHH-------------
Confidence 122236999999999998766 5889999999999999999999996321 111111110
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
... ...+.....++.+++.+|++.+ ++|| ++.++++
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 209 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 011 1123445677899999999999 9999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=304.12 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=199.3
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhc--HHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKG--KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
-+.|++|.||.||+|+. ++++.||+|+++....+. .-...||+.+|.+++|||||.+..+..+.+-...|+||||++
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 47899999999999995 489999999998653221 123579999999999999999999888777778999999995
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
.||...++.... +|...++..++.|+++|++|||+ +.|+|||||++|+|+.. .+.+||+|||+|+.+..+..
T Consensus 161 -hDLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 161 -HDLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred -hhHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecccchhhhhcCCcc-
Confidence 499999987752 69999999999999999999997 99999999999999998 88999999999999877532
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
..+..+-|..|+|||.+.+... |+++.|+||+|||+.||+++++-|.. ...+.+.-+....-+...+.+-+-.
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~t-yst~iDMWSvGCI~aE~l~~kPlf~G------~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKT-YSTAVDMWSVGCIFAELLTQKPLFPG------KSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcc-cCcchhhhhHHHHHHHHHhcCCCCCC------CchHHHHHHHHHHhCCCccccCCCc
Confidence 2333467999999999998876 79999999999999999999987752 2222222222222122222221111
Q ss_pred cCCC-----C-CCCc----------hHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGH-----D-MEQP----------PRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~-----~-~~~~----------~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...+ . ...+ ......-++++...+.++ .+|-|+.|-++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 0 0000 013366778899999999 99999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.85 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=196.6
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
..+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++.+ +|||||+++++|. .....++
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~~~~~~l 119 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--HGGPVLV 119 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--CCCCeEE
Confidence 3588999999999998732 34589999997643 23356788999999999 8999999999987 4457899
Q ss_pred EEeccccccHHHHHhhcCC-------------------------------------------------------------
Q 001700 808 ISNYINAQSLAVYLQETDP------------------------------------------------------------- 826 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 826 (1025)
||||+++|+|.+++.....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 9999999999999864311
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc-ccccCcc
Q 001700 827 ----RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD-QVLNAGA 901 (1025)
Q Consensus 827 ----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt 901 (1025)
....++++.++++|+.||+.||+|||+ .+|+||||||+|||++. +..+||+|||+++......... .....++
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 001247899999999999999999998 89999999999999997 8899999999998654332211 1112356
Q ss_pred cccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCC
Q 001700 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDME 980 (1025)
Q Consensus 902 ~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 980 (1025)
..|||||++.+.. ++.++|||||||++|||++ |+.||....... .+.... .......
T Consensus 278 ~~y~aPE~~~~~~--~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~--------------~~~~~~~ 335 (374)
T cd05106 278 VKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMV--------------KRGYQMS 335 (374)
T ss_pred cceeCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHH--------------HcccCcc
Confidence 7899999987665 5899999999999999997 999987432110 111110 0111111
Q ss_pred CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 981 QPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 981 ~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.+...+.++.+++.+||+.+ ++||++.+|++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12234567899999999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.61 Aligned_cols=249 Identities=20% Similarity=0.365 Sum_probs=199.0
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .....++++||+++++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITEYMAKGS 87 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEecCCCCc
Confidence 57899999999999998888899999987542 34578899999999999999999998876 4557899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++...... .+++.+++.++.|++.||+|||+ .+++||||||+||+++. ++.++|+|||++............
T Consensus 88 L~~~l~~~~~~---~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 88 LLDFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred HHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecCCCceeccC
Confidence 99999764322 58899999999999999999997 89999999999999998 889999999999876543322222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.... ++.++|||||||++|||+| |+.||.... ......++. .
T Consensus 163 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~~-----------------~ 219 (261)
T cd05072 163 GAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMS----NSDVMSALQ-----------------R 219 (261)
T ss_pred CCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCC----HHHHHHHHH-----------------c
Confidence 224677899999987665 5889999999999999999 999986321 111111110 1
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
..+.+.....+.++.+++.+|++.+ ++||++++|.+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1111223345667899999999999 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.78 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=193.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+|++++++++|++|+++++++. .....++|+||+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv~e~~ 82 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLVLTIM 82 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEEEEec
Confidence 47899999999999985 5799999999865422 23346789999999999999999998886 455799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++........
T Consensus 83 ~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEEcCCCCe
Confidence 99999988865432 258999999999999999999997 89999999999999987 78999999999987543322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ....||..|+|||++.+.. ++.++|||||||++|||++|+.||....... ..+- ++..
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~-------------~~~~ 216 (285)
T cd05631 158 V--RGRVGTVGYMAPEVINNEK--YTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREE-------------VDRR 216 (285)
T ss_pred e--cCCCCCCCccCHhhhcCCC--CCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHH-------------HHHH
Confidence 1 2236999999999998766 5889999999999999999999997432110 0000 1111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~ 1011 (1025)
+.. .....+...+.++.+++.+||+.+ .+||+ ++++++
T Consensus 217 ~~~-~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 217 VKE-DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hhc-ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 110 111223445677899999999999 99997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.80 Aligned_cols=247 Identities=30% Similarity=0.532 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEEec-----CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++. .....++|+|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccccc
Confidence 368999999999999966 35689999996543 334688999999999999999999999998 4446899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++..... ..+++.++..|+.||++||+|||+ .+|+|+||+++||+++. ++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccc---cccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccccc
Confidence 9999999999998722 268999999999999999999998 78999999999999998 789999999999876322
Q ss_pred CCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
... ......+...|+|||.+.... ++.++||||||+++||+++ |+.||... +..++.....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~~-------- 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKLK-------- 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHHH--------
T ss_pred ccccccccccccccccccccccccc--cccccccccccccccccccccccccccc-------cccccccccc--------
Confidence 221 112234677899999998776 5899999999999999999 78887643 2222222221
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
...+.+.+..++..+.+++..||+.+ ++||+|++|++.|
T Consensus 220 ------~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 ------QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11122234556778999999999999 9999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.17 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=199.7
Q ss_pred CCCceeeeecceEEEEEEec-CCC----EEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
...+.||+|+||.||+|++. ++. .||||+++... ....+++.+|+.+++.++||||++++|+|.. ...+++
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~~~v 86 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLI 86 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCceee
Confidence 34578999999999999853 444 38999987543 3445778999999999999999999999863 256899
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++...
T Consensus 87 ~e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 87 TQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLG 160 (316)
T ss_pred eecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEcccccccccc
Confidence 999999999999986532 58899999999999999999998 89999999999999988 7889999999998765
Q ss_pred cCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 889 SAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 889 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
...... .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||+... ..++.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slGv~l~el~t~g~~p~~~~~-------~~~~~~~~~------ 225 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILE------ 225 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHh------
Confidence 432211 11123467899999987766 5899999999999999998 999986421 111111111
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
.....+.+..+...+.+++.+||+.+ ++||++.+|+..+.++..+..
T Consensus 226 --------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 226 --------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --------CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 11111223345567899999999999 999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.29 Aligned_cols=253 Identities=23% Similarity=0.414 Sum_probs=198.9
Q ss_pred CceeeeecceEEEEEEecC-C-----CEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLDS-G-----SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|.... + ..||+|.++... ....+++.+|++++++++||||+++++++. .....++++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~ 87 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQPTCMLF 87 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCceEEEE
Confidence 4789999999999998542 2 579999987543 234567899999999999999999999987 445789999
Q ss_pred eccccccHHHHHhhcCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEE
Q 001700 810 NYINAQSLAVYLQETDPRKL-----------PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl 878 (1025)
||+++|+|.+++........ ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~-~~~~~L 165 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKI 165 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEcC-CCcEEE
Confidence 99999999999976532111 358899999999999999999997 89999999999999988 789999
Q ss_pred eccccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHH
Q 001700 879 TDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 879 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~ 956 (1025)
+|||+++........ ......+++.|+|||++.... ++.++|||||||++|||++ |..||..... .++.+++
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~~i 239 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIEMI 239 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 999999865433221 112235688899999987665 5889999999999999998 9999864311 1111111
Q ss_pred HHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
. .....+.+..++.++.+++.+||+.+ .+||+++||++.|+++
T Consensus 240 ~-----------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 R-----------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H-----------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 11112234566788999999999999 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.44 Aligned_cols=265 Identities=23% Similarity=0.406 Sum_probs=202.0
Q ss_pred CCceeeeecceEEEEEEec-----CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 736 PAEVIGRSCHGTLYKATLD-----SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
..+.||+|+||.||+|..+ ++..||+|+++.......+.+.+|++++++++||||+++++++........++|+|
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 3578999999999999742 57899999998765556678999999999999999999999886545557899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 88 YLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred ecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCcccccccCC
Confidence 9999999999976431 58999999999999999999997 89999999999999988 788999999999876543
Q ss_pred CCcccc--ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTADQV--LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
...... ...++..|+|||++.+.. ++.++|||||||++|||++|..|+.... ..|.............
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 231 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYSDKSCSPP--------AEFMRMMGNDKQGQMI 231 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCC--cChHHHHHHHHHHHHHHhhcCCcCCCcc--------hhhhhhcccccccccc
Confidence 221111 112445699999987665 5889999999999999999987754321 1111111111000000
Q ss_pred c---hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 969 F---DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 969 ~---d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
. ...+......+.+...+.++.+++.+||+.+ ++||||+||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0111122222234456678999999999999 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.94 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=199.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|... +++.||+|+++.. ....+++.+|++++++++||||+++++++. .....+++|||++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 87 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYG 87 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEEEEeCCCC
Confidence 478999999999999854 6889999998754 334567899999999999999999999987 445789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||++...........
T Consensus 88 ~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 88 NLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred cHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCccccccccceeecc
Confidence 99999976432 258999999999999999999997 89999999999999987 88999999999987654332222
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....++..|+|||++.+.. ++.++|||||||++|||++ |..||... +..++.... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~-------~~~~~~~~~--------------~ 219 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELL--------------E 219 (263)
T ss_pred CCCCCccccCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHH--------------H
Confidence 2223467899999887666 5889999999999999998 99998632 112221111 1
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
.....+.+...+.++.+++.+||..+ ++||++.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234455678999999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=329.98 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=196.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+++.. +|..||+|.+.... ....+.+.+|++++++++||||+++++++. .....++||||+++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 87 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG 87 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEEEeecCCC
Confidence 578999999999999965 78999999987642 234567999999999999999999999987 45578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|+|.+++.... .+++..+..++.|++.||.|||+.++|+||||||+||+++. ++.+||+|||+++.......
T Consensus 88 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~-- 159 (331)
T cd06649 88 GSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMA-- 159 (331)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccccccccc--
Confidence 99999997653 58999999999999999999997557999999999999988 78999999999886543221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc-----------
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN----------- 963 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~----------- 963 (1025)
....||+.|+|||++.+.. ++.++|||||||++|||+||+.||..... ..+...+.......
T Consensus 160 -~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 160 -NSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred -ccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhcccccccccCCccccCcc
Confidence 2236899999999998766 58899999999999999999999964321 11111110000000
Q ss_pred ---------------c----ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 964 ---------------R----SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 964 ---------------~----~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ..+..+.................++.+++.+||+.+ ++|||++||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000001001111100011235677999999999999 999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.57 Aligned_cols=267 Identities=20% Similarity=0.270 Sum_probs=199.5
Q ss_pred ceeeeecceEEEEEEe-cCCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCc-cccccceeecCC----CCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPN-LVSLQGYYWGPK----EHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----~~~~~lv~ 809 (1025)
+.||+|+||+||+|+. .+|+.||+|+++.... .......+|+.++++++|+| ||.+++++.... ....++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5699999999999994 4899999999986543 23456789999999999999 999999998422 12688999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+ .-+|..++....... ..++...+..+++|+++||+|||+ ++|+||||||.|||++. .+.+||+|||+|+...-
T Consensus 97 e~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLARAFSI 172 (323)
T ss_pred Eee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchHHHhcC
Confidence 999 569999998865321 146778999999999999999998 99999999999999999 89999999999997653
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc------
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN------ 963 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~------ 963 (1025)
+.. ..+..++|..|+|||++.+... |+...||||+||+++||++++.-|... .+..+..+....-+
T Consensus 173 p~~-~yt~evvTlWYRaPEvLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~LFpG~------se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 173 PMR-TYTPEVVTLWYRAPEVLLGSTS-YSTSVDIWSLGCIFAEMFTRRPLFPGD------SEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred Ccc-cccccEEEeeccCHHHhcCCCc-CCCCcchHhHHHHHHHHHhCCCCCCCC------cHHHHHHHHHHHcCCCCccC
Confidence 322 2333478999999999998865 799999999999999999999877632 22222222222111
Q ss_pred cccccchhhhcCCCCCCC-chH-------HHHHHHHHHHHccCCC-CCCCCHHHHHHH--Hhhc
Q 001700 964 RSGECFDRLIMDGHDMEQ-PPR-------ILSDMLQVALRCILPA-SERPDMMSVFEE--LSTI 1016 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~-~~~-------~~~~~~~l~~~C~~~~-~~RPs~~evl~~--L~~i 1016 (1025)
|.....-+.....+.... +.. ......+++.+|++++ .+|.|++..++. +..+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111110010010110000 111 1137889999999999 999999999886 5544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.78 Aligned_cols=239 Identities=20% Similarity=0.236 Sum_probs=192.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....++||||+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 83 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYMLMEYV 83 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEEEEeCC
Confidence 578999999999999965 78999999986532 233566889999999999999999998886 456889999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 84 PGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcchhccCCc-
Confidence 9999999997653 58999999999999999999997 89999999999999987 7899999999998764322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~----------- 212 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILA----------- 212 (291)
T ss_pred ---ccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-----------
Confidence 1236999999999998766 5889999999999999999999986421 1111111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~~ 1012 (1025)
.. ...+......+.+++.+|++.+ .+||+ ++|+++.
T Consensus 213 --~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 213 --GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 1123334567889999999999 99995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=306.77 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=202.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|.++ +|.+||||.+.-. .+.+++.+|+.+|++++.|+||++||.|+ +....|+|||||..|
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhhcCCC
Confidence 367999999999999965 7999999998754 56788999999999999999999999887 566899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+..+.++.+.. ++++.++..|++..++||+|||. ..-+|||||+-|||++. ++.+||+|||.|..+.+.- ...
T Consensus 114 SiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDTM-AKR 186 (502)
T KOG0574|consen 114 SISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDTM-AKR 186 (502)
T ss_pred cHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcc-cchhhhhhccccchhhhhH-Hhh
Confidence 99999987642 79999999999999999999997 45559999999999998 8999999999998876542 334
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
.++.||+.|||||++..-+ |..++||||+|++..||..|++||.+..+- ..++----..
T Consensus 187 NTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------------------RAIFMIPT~P 245 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPM-------------------RAIFMIPTKP 245 (502)
T ss_pred CccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCccccccc-------------------ceeEeccCCC
Confidence 4568999999999998777 588999999999999999999998643211 1111000011
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.+..++....++.+++..|+-.. ++|-|+.++++.
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1223346778899999999999988 999999988764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.53 Aligned_cols=240 Identities=19% Similarity=0.296 Sum_probs=190.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
++||+|+||.||+++.. +|..||+|+++... ......+.+|++++++++||||+++++++. .....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCC
Confidence 46999999999999954 78999999997642 223456778999999999999999999887 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 79 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCCC-
Confidence 999999887653 58999999999999999999997 89999999999999998 88999999999875432221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ....... .
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~-------------~ 208 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELI-------------L 208 (323)
T ss_pred ccccccCCcCcCCcccccCCC--CCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHH-------------h
Confidence 112236999999999998766 58899999999999999999999864211 1111110 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.... ..+...+.++.+++.+|+..+ .+|| ++.++++
T Consensus 209 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 209 MEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0111 113345667889999999999 9998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=329.83 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=198.4
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
.++||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||++++++|.. .+...+++
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~~~~~~v 90 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-PGGPLMVI 90 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CCCCEEEE
Confidence 588999999999999632 35789999987543 22345678899999999 79999999998864 44578899
Q ss_pred EeccccccHHHHHhhcCCCC--------------------------------------------------------CCCC
Q 001700 809 SNYINAQSLAVYLQETDPRK--------------------------------------------------------LPPL 832 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------~~~l 832 (1025)
+||+++++|.+++....... ...+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 99999999999986532100 1258
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc-cccccCcccccCcccccc
Q 001700 833 SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFAS 911 (1025)
Q Consensus 833 ~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 911 (1025)
++..+..++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++.+...... ......++..|+|||++.
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 999999999999999999997 89999999999999998 788999999999876433221 111224677899999988
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHH
Q 001700 912 TSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDML 990 (1025)
Q Consensus 912 ~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 990 (1025)
+.. ++.++|||||||++|||++ |+.||...... . .+.... . .......+.....++.
T Consensus 249 ~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~---~~~~~~-~-------------~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 249 DKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQID---E---EFCRRL-K-------------EGTRMRAPEYATPEIY 306 (337)
T ss_pred CCC--CCccccHHHHHHHHHHHHHcCCCCCCCCCcc---H---HHHHHH-h-------------ccCCCCCCccCCHHHH
Confidence 766 5889999999999999998 99998642111 0 111111 1 1111111334456789
Q ss_pred HHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 991 QVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 991 ~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+++.+||+.+ ++||++.||++.|+++..+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.27 Aligned_cols=238 Identities=18% Similarity=0.250 Sum_probs=190.0
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++. .....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence 699999999999965 68899999987532 233466889999999999999999999886 456899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 79 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~-~~ 150 (312)
T cd05585 79 ELFHHLQREG-----RFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDD-KT 150 (312)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCC-cc
Confidence 9999997643 58999999999999999999997 89999999999999988 88999999999986433221 12
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+...... ..
T Consensus 151 ~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~-------~~~~~~~~~~-------------~~ 208 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPFYDE-------NVNEMYRKIL-------------QE 208 (312)
T ss_pred ccccCCcccCCHHHHcCCC--CCCccceechhHHHHHHHhCCCCcCCC-------CHHHHHHHHH-------------cC
Confidence 2346999999999998766 588999999999999999999999632 1222222111 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCC---HHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPD---MMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs---~~evl~ 1011 (1025)
. ...+.....++.+++.+|++.+ .+||+ +.|++.
T Consensus 209 ~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 209 P--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred C--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1 1123445677899999999999 99985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.50 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=198.5
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|++|.||+|...+++.||||.++... ...+++.+|+.++++++||||+++++++. .....+++|||+++++
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGS 87 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe--cCCCeeeeeecccCCc
Confidence 57899999999999998778899999987643 34677999999999999999999999886 4557899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||+++...........
T Consensus 88 L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 88 LLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred HHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEccCCcccccC
Confidence 9999976532 258999999999999999999997 89999999999999998 889999999999876533222221
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||+..+.. ++.++|||||||++|||+| |+.||..... ..+. .. +..
T Consensus 163 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~---~~--------------~~~ 219 (261)
T cd05068 163 GAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVL---QQ--------------VDQ 219 (261)
T ss_pred CCcCceeccCccccccCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHH---HH--------------HHc
Confidence 112345799999987765 5889999999999999999 9999863210 0000 00 011
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
....+.+...+..+.+++.+|++.+ ++||+|++|++.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111223445678999999999999 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=297.81 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=200.5
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--------hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCee
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--------AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 805 (1025)
..++||+|..++|.++.++ +|..+|+|++.... ....++..+|+.+|+++ .||+|+++.++|. .....
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye--s~sF~ 98 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE--SDAFV 98 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--Ccchh
Confidence 4578999999999999865 78999999985321 12245678899999999 5999999999997 45578
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
++|+|.|+.|.|.+|+...- .+++++.++|++|+.+|++|||. +.|||||+||+|||+|+ +.++||+|||+|.
T Consensus 99 FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~isDFGFa~ 171 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEEeccceee
Confidence 99999999999999998764 69999999999999999999997 89999999999999998 9999999999999
Q ss_pred ccccCCCccccccCcccccCccccccC----CCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFAST----SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
.+..+.... ..||||+|.|||.+.. ...+|+...|+||.||+||.++.|.+||-.. ....
T Consensus 172 ~l~~GekLr--elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------------kQml 235 (411)
T KOG0599|consen 172 QLEPGEKLR--ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------------KQML 235 (411)
T ss_pred ccCCchhHH--HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------------HHHH
Confidence 887665433 3489999999998863 2334788999999999999999999998531 0000
Q ss_pred hccccccchhhhcC--CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 962 ENRSGECFDRLIMD--GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~--~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
++.-.+.+ .++.+...+....+.+++.+|++.| .+|-|++|+++.
T Consensus 236 ------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 ------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 01111122 2334556778889999999999999 999999998763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=334.66 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=199.3
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGIA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 807 (1025)
..++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. |||||+++++|. .....++
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~~~~~~l 118 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--KSGPIYI 118 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCceEE
Confidence 3688999999999999842 234799999975432 33567999999999996 999999999986 4567999
Q ss_pred EEeccccccHHHHHhhcCCC------------------------------------------------------------
Q 001700 808 ISNYINAQSLAVYLQETDPR------------------------------------------------------------ 827 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------ 827 (1025)
||||+++|+|.+++......
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999998753210
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCE
Q 001700 828 -------------------------------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNA 876 (1025)
Q Consensus 828 -------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~ 876 (1025)
....+++.++..++.|+++||+|||+ .+|+||||||+||+++. +..+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nill~~-~~~~ 276 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVLLAQ-GKIV 276 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEEEeC-CCEE
Confidence 01248889999999999999999997 89999999999999998 7889
Q ss_pred EEeccccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHH
Q 001700 877 VLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTD 954 (1025)
Q Consensus 877 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~ 954 (1025)
||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.....+ +
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-------~ 347 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------S 347 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCcccchh-------H
Confidence 99999999865432221 111224678899999987765 5889999999999999997 99998643111 0
Q ss_pred HHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 955 WVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 955 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
... ..+....+...+...+.++.+++.+||+.+ ++||++.+|.+.|+++.+
T Consensus 348 ~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFY-------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH-------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 011111122234455678999999999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.50 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=196.7
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeec---CCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG---PKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~~lv~e 810 (1025)
.+.||+|+||.|+.|.. .+|+.||||++... .....++..||+++|+.++|+||+.+++++.. ..-...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 47899999999999985 48999999999743 33456788999999999999999999998864 23356899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
+| +-+|.+.++... .++...+..+++|+++||+|+|+ .+|+|||+||+|++++. +...||+|||+|+.....
T Consensus 107 lM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceeecccc
Confidence 99 679999998764 59999999999999999999998 89999999999999998 889999999999988543
Q ss_pred CCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh-hcccccc
Q 001700 891 GTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL-ENRSGEC 968 (1025)
Q Consensus 891 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~ 968 (1025)
... ..+..+.|..|+|||++..... |+.+.||||.|||+.||++|++-|... +.++.+..... -+...+.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~-Yt~aiDiWSvGCI~AEmL~gkplFpG~-------d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSE-YTKAIDIWSVGCILAEMLTGKPLFPGK-------DYVHQLQLILELLGTPSEE 250 (359)
T ss_pred CcccchhcceeeeeecCHHHHhcccc-ccchhhhhhhhHHHHHHHcCCCCCCCC-------chHHHHHHHHHhcCCCCHH
Confidence 111 1233468999999999876654 799999999999999999999877521 11111111111 0111100
Q ss_pred ---------chhhhcCCCC-CCC-----chHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 969 ---------FDRLIMDGHD-MEQ-----PPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 969 ---------~d~~~~~~~~-~~~-----~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+.+..-+. +.. -+.......+++.+++.-| .+|+|+.|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111110 011 1234466789999999999 999999998764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.91 Aligned_cols=245 Identities=23% Similarity=0.396 Sum_probs=195.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|+.+++..+|+|++.... ....++.+|++++++++||||+++++++. .....++|+||+++++
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYMANGC 85 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEecCCCCC
Confidence 57899999999999998777789999987542 34567889999999999999999999886 4457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...........
T Consensus 86 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 86 LLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceecccccccccC
Confidence 9999976532 58999999999999999999997 89999999999999998 788999999998866433222211
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++|||||||++|||++ |+.||+.... .... .. +..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~---~~--------------~~~ 216 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVV---ES--------------VSA 216 (256)
T ss_pred CCCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHH---HH--------------HHc
Confidence 123456799999988765 5889999999999999999 8999864311 1111 10 111
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
..+...+...+.++.+++.+||..+ ++||+|.||++.|
T Consensus 217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112223446778999999999999 9999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.86 Aligned_cols=247 Identities=18% Similarity=0.222 Sum_probs=194.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++.+++||||+++++++. .....++||||+
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 83 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYLAMEYV 83 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEEEEeCC
Confidence 578999999999999965 689999999976432 23456889999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 84 PGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCccccc---
Confidence 9999999997653 58999999999999999999997 89999999999999988 88999999999986543
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+........ ...+..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~---~~~~~~- 219 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKG--YDFTVDYWSLGCMLYEFLCGFPPFSGSTP-------NETWENLKYW---KETLQR- 219 (333)
T ss_pred -ccCCcccCccccChhHhcCCC--CCCccceecchHHHhhhhhCCCCCCCCCH-------HHHHHHHHhc---cccccC-
Confidence 112236999999999998775 58999999999999999999999974311 1111111000 000000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..........+.++.+++.+|+..+ ++||+++|+++.
T Consensus 220 ---~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 ---PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001234667889999999988 999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=327.25 Aligned_cols=244 Identities=22% Similarity=0.378 Sum_probs=189.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++. .....++||||+++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 156 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEFMDG 156 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEEecCCC
Confidence 478999999999999965 78999999986543 233567899999999999999999999986 45678999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|+|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccceecccccc-c
Confidence 9986432 35678889999999999999997 89999999999999998 88999999999987643321 1
Q ss_pred ccccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 895 QVLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....||..|+|||++... ....+.++|||||||++|||++|+.||.... ..+|.......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-------~~~~~~~~~~~--------- 288 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-------QGDWASLMCAI--------- 288 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CccHHHHHHHH---------
Confidence 1234699999999987532 1113568999999999999999999997321 11232211110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
........+.....++.+++.+||+.+ ++||++.||++.
T Consensus 289 --~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 --CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111223455677999999999999 999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.28 Aligned_cols=246 Identities=19% Similarity=0.341 Sum_probs=194.2
Q ss_pred eeeeecceEEEEEEec---CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 739 VIGRSCHGTLYKATLD---SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.||+|+||.||+|.+. ++..||+|++..... ...+++.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence 3899999999999753 456799999976532 33567999999999999999999999874 3367999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... .+++.++++++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++.........
T Consensus 79 ~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 79 GPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCccce
Confidence 999999875432 58999999999999999999997 89999999999999988 7899999999998654332211
Q ss_pred c--cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 895 Q--VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 895 ~--~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ....++..|+|||++.... ++.++|||||||++||+++ |+.||..... .++....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~------------ 211 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFI------------ 211 (257)
T ss_pred eccCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHH------------
Confidence 1 1113357899999987665 5889999999999999996 9999874311 1111111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
..+.+...+..++.++.+++.+||..+ ++||++.+|.+.|+++
T Consensus 212 --~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 --EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111112234455778999999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.38 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=195.5
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|+..++..||||.++... ...+++.+|+.++++++||||+++++++. .....+++|||+.+|+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYIVTEYMSNGC 85 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEEEEEcCCCCc
Confidence 46799999999999998777789999987542 34567999999999999999999999986 3446899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... .+++.+++.++.||+.||+|||+ .+|+|+||||+||+++. ++.+||+|||.++...........
T Consensus 86 l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 86 LLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecCCCceeecC
Confidence 9999976432 58999999999999999999997 89999999999999988 789999999998866443322222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||+..+.. ++.++|||||||++|||++ |+.||..... ....+. .. .
T Consensus 160 ~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~---~~--------------~ 216 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEK---VS--------------Q 216 (256)
T ss_pred CCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH---Hh--------------c
Confidence 224567899999997665 5889999999999999999 9999863211 111111 11 0
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
..+...+...+..+.+++.+||+.+ ++||++.+|++.|+
T Consensus 217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111112334678899999999999 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=321.41 Aligned_cols=258 Identities=20% Similarity=0.354 Sum_probs=202.0
Q ss_pred CceeeeecceEEEEEEe------cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL------DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++. .....++|+|
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 87 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDPLIMVFE 87 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccEEEEE
Confidence 57899999999999974 235679999998765556678999999999999999999999987 4557899999
Q ss_pred ccccccHHHHHhhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccc
Q 001700 811 YINAQSLAVYLQETDP--------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfG 882 (1025)
|+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg 165 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFG 165 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-CCcEEeccCC
Confidence 9999999999975431 111258999999999999999999997 89999999999999988 8899999999
Q ss_pred cccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHH
Q 001700 883 LHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLA 960 (1025)
Q Consensus 883 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~ 960 (1025)
+++........ ......+++.|+|||++.+.. ++.++|||||||++|||+| |+.||..... .+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~~i~ 236 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIECIT 236 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 99865432211 111224577899999987765 5889999999999999998 8999863311 11111111
Q ss_pred hhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 961 LENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 961 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
. + .....+...+.++.+++.+||+.+ .+|||+.||.+.|+++....+
T Consensus 237 ~-------------~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 237 Q-------------G-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred c-------------C-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 0 001112234567999999999999 999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.41 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=198.3
Q ss_pred CceeeeecceEEEEEEec----CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||+||+|++. +...||||.++... .....+|.+|+.++++++||||+++++++. .....+++|||
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~ 86 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVMIITEY 86 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceEEEEEc
Confidence 578999999999999864 24589999987543 334567899999999999999999999886 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++..... .+++.+++.++.|++.||+|||+ ++|+||||||+||+++. +..++++|||+++......
T Consensus 87 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 87 MENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccchhhcccccc
Confidence 999999999976532 58999999999999999999997 89999999999999998 8889999999998775211
Q ss_pred -CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 892 -TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 892 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
........++..|+|||.+.+.. ++.++||||||+++|||++ |..||..... ..+.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~------------- 221 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAV------------- 221 (266)
T ss_pred cceeccCCCCCccccChhhhccCC--CccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHHH-------------
Confidence 11111224567899999987765 5889999999999999998 9999864311 1111111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
......+.+..++..+.+++.+||+.+ ++||+++||++.|+++.
T Consensus 222 ----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 222 ----EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ----HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111223445677899999999999 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=329.81 Aligned_cols=241 Identities=20% Similarity=0.301 Sum_probs=192.2
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
++||+|+||.||+++.. +|+.||||+++... ......+.+|+++++.++||||+++++++. .....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 46999999999999854 78999999997642 223457889999999999999999998886 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 79 GGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCccc-
Confidence 999999887643 58999999999999999999997 89999999999999998 88999999999876432211
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+......
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~------------- 208 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELIL------------- 208 (328)
T ss_pred ccccccCCcCccChhhhcCCC--CCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhc-------------
Confidence 112246999999999998766 5889999999999999999999996321 111111110
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~~ 1012 (1025)
... ...+.....++.+++.+|++.+ .+|| ++.|+++.
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 MED--IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCC--ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011 1123345667889999999999 9997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.58 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=200.3
Q ss_pred CceeeeecceEEEEEEe-----cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-----DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||+||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++........+++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 57899999999988653 367899999997643 234567889999999999999999999887544556899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++.....
T Consensus 89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecccccccCCc
Confidence 99999999999754 48999999999999999999997 89999999999999988 789999999999876543
Q ss_pred CCcc--ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTAD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.... .....++..|+|||++.... ++.++|||||||++|||+||+.||...... ......+... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~----~~~~~~ 232 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK--FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQG----QMTVVR 232 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC--CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccc----ccchhh
Confidence 2211 11124567799999987665 588999999999999999999998643211 0011110000 000000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+...+......+.+...+.++.+++..||+.+ ++||++++|++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00111111112234456788999999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.50 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=195.5
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
++||+|+||.||+|..+++..||+|.++.... .....+.+|++++++++||||+++++++. .....++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT--QRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe--cCCccEEEEECCCCCc
Confidence 46899999999999988899999999876532 33457889999999999999999999987 4457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... .+++.+++.++.|++.||.|+|+ ++++||||||+||+++. +..+|++|||++............
T Consensus 79 L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 79 FLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccccCC
Confidence 9999875432 58899999999999999999997 89999999999999987 888999999998765433222222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...+++.|+|||++.+.. ++.++|||||||++||+++ |..||.... ... ..... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~-------~~~-~~~~~-------------~~ 209 (250)
T cd05085 153 LKQIPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMT-------NQQ-AREQV-------------EK 209 (250)
T ss_pred CCCCcccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCC-------HHH-HHHHH-------------Hc
Confidence 224567899999987665 5889999999999999999 999986321 111 11000 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
..+...+...+..+.+++.+|++.+ ++||++.|+++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111223345678999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=297.74 Aligned_cols=243 Identities=19% Similarity=0.250 Sum_probs=197.3
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
-++||+|.|+.||++.+ .+|+.+|+|++.-. ...+.+++.+|++|-+.++|||||++++.+. ..+..++|+|+|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYLVFDLVT 93 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEEEEeccc
Confidence 46899999999999985 48999999987532 2346788999999999999999999998875 5668899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC--CCCEEEeccccccccccCC
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP--TMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~--~~~~kl~DfGla~~~~~~~ 891 (1025)
|++|..-+-.+. .+++..+-.+++||++||.|+|. ++|||||+||+|+++... .-.+||+|||+|....++.
T Consensus 94 G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 94 GGELFEDIVARE-----FYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred chHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 999986555442 58899999999999999999998 999999999999999542 3468999999999887332
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....+|||+|||||++...+ ++..+|||+.|||+|-++.|..||..... .+++.+
T Consensus 168 --~~~G~~GtP~fmaPEvvrkdp--y~kpvDiW~cGViLfiLL~G~~PF~~~~~--------------------~rlye~ 223 (355)
T KOG0033|consen 168 --AWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQ--------------------HRLYEQ 223 (355)
T ss_pred --ccccccCCCcccCHHHhhcCC--CCCcchhhhhhHHHHHHHhCCCCCCCccH--------------------HHHHHH
Confidence 233458999999999999887 58999999999999999999999974211 112233
Q ss_pred hhcCCCC--CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 LIMDGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~--~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+.+.+. .++.+....+..+++.+|+..+ .+|.|+.|.+.
T Consensus 224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 3333332 2345566778899999999998 99999988764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.50 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=190.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|+.+ ++..||+|+++... ......+.+|++++++++||||+++++++. .....++||||++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~- 86 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVFEYLD- 86 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEEeCCC-
Confidence 578999999999999865 78999999987543 223456789999999999999999999886 4557899999997
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 87 ~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 87 SDLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeeccCCCc-c
Confidence 599998875432 57899999999999999999997 89999999999999988 78999999999876543221 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-cc-c----cc-
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NR-S----GE- 967 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~-~----~~- 967 (1025)
.....|++.|+|||++.+... ++.++||||+||++|||+||+.||.... ..+.+...... +. . .+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTE-YSTPIDMWGVGCILYEMATGRPMFPGST-------VKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred ccCceecccccChHHhcCCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCChHHhhcc
Confidence 122368999999998875433 5889999999999999999999996431 11111111100 00 0 00
Q ss_pred ----cchhhhcCCCC----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 ----CFDRLIMDGHD----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ----~~d~~~~~~~~----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+........+ .........+..+++.+|+..+ .+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 0011223456889999999999 99999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.43 Aligned_cols=238 Identities=18% Similarity=0.248 Sum_probs=192.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++. .....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 100 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVYFLLEFV 100 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEEEEEcCC
Confidence 578999999999999965 78999999987542 233467889999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 101 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 101 VGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccCceEcCCCcc
Confidence 9999999998653 58999999999999999999998 89999999999999998 88999999999987643321
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+...... .
T Consensus 174 ----~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~-~---------- 229 (329)
T PTZ00263 174 ----TLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKIL-A---------- 229 (329)
T ss_pred ----eecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHh-c----------
Confidence 236999999999998776 4889999999999999999999986321 111111111 0
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~ 1011 (1025)
+ ....+.....++.+++.+||+.+ .+||+ +++++.
T Consensus 230 --~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 --G--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --C--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 11112334566889999999999 99996 677763
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.72 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=198.1
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
..+.||+|+||.||+|+.+++..||+|+++... ...+++.+|++++++++||||+++++++. ....++||||+++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~ 85 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKG 85 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEEcCCCC
Confidence 357899999999999998766789999997542 34567899999999999999999998764 34579999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||.++..........
T Consensus 86 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 86 SLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccccccccc
Confidence 99999986432 257999999999999999999997 89999999999999998 88899999999987654332222
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....++..|+|||+..+.. ++.++|||||||++|||+| |+.||..... .+.... +.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~~~~~~--------------~~ 217 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQ--------------VE 217 (262)
T ss_pred cCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------HHHHHH--------------Hh
Confidence 2234677899999887666 5889999999999999999 8888863211 010110 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.....+.+...+..+.+++.+|++.+ ++||++.++++.|++..
T Consensus 218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11111223456678899999999999 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=316.59 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=202.7
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
..+.||+|+||.||+|...++..+|+|.+........+++.+|+.+++.++||||+++++++. .....++||||++++
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~ 87 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYIITELMEKG 87 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEEEeecccC
Confidence 357899999999999998879999999998765556678999999999999999999999887 445789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++...... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||.+...........
T Consensus 88 ~L~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 88 SLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred CHHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhcCCcccccc
Confidence 999999865322 58999999999999999999997 89999999999999998 88999999999987654322211
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
...++..|+|||+..+.. ++.++|||||||++|+|++ |+.||..... ....+.+ .
T Consensus 163 -~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~---~-------------- 218 (261)
T cd05148 163 -DKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQI---T-------------- 218 (261)
T ss_pred -CCCCceEecCHHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH---H--------------
Confidence 234677899999987665 5889999999999999998 8999864210 1111111 0
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
...+.+.+..++..+.+++.+||..+ ++|||++++++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11112224455677899999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=323.88 Aligned_cols=261 Identities=17% Similarity=0.219 Sum_probs=192.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++++++||||+++++++. .....++||||++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 83 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLVFEYVE 83 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEEEecCC
Confidence 578999999999999975 68899999987542 233567889999999999999999999987 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++.+..+..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 84 KNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccccccccc
Confidence 887765543321 58999999999999999999997 89999999999999988 789999999999876543322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHH-----------HHHHHHhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD-----------WVRLLALE 962 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~-----------~~~~~~~~ 962 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+.. +.......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCHHHHHhhhcc
Confidence 222346899999999998766 588999999999999999999999743110 00100 00000000
Q ss_pred ccccccchhhhcCCCC--CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 963 NRSGECFDRLIMDGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~--~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
........+....... .......+..+.+++.+|++.+ ++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 0001124567999999999999 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=327.14 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=190.9
Q ss_pred ceeeeecceEEEEEEe----cCCCEEEEEEccccc----hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATL----DSGSILAVKRLREGI----AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++. .+...++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEE
Confidence 5799999999999984 358899999987532 223456788999999999999999999887 455789999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 80 EYLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIH 152 (323)
T ss_pred eCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCeeccc
Confidence 9999999999997653 58899999999999999999997 89999999999999988 88999999999875433
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ........
T Consensus 153 ~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~---------- 212 (323)
T cd05584 153 EGTV-THTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKI---------- 212 (323)
T ss_pred CCCc-ccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHH----------
Confidence 2221 12236999999999998766 4889999999999999999999996421 11111111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.... ...+......+.+++.+|++.+ ++|| ++.++++
T Consensus 213 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 213 ---LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1111 1123345567899999999999 9999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=315.23 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=194.1
Q ss_pred eeeeecceEEEEEEe---cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 739 VIGRSCHGTLYKATL---DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.||+|+||.||+|.+ +++..||+|+++... ....+++.+|+.++++++||||+++++++. ....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 589999999999974 367899999987543 234567899999999999999999999874 336789999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCCCe
Confidence 999999997543 58999999999999999999997 89999999999999998 788999999999876543321
Q ss_pred c--ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 894 D--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 894 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
. .....++..|+|||++.... ++.++|||||||++|||++ |+.||.... ..++......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~i~~--------- 213 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMK-------GNEVTQMIES--------- 213 (257)
T ss_pred eeecCCCCCCccccCHhHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHC---------
Confidence 1 11123467899999887655 5889999999999999998 999987431 1112211111
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
....+.+...+.++.+++.+||+.+ ++||+|++|.+.|++-
T Consensus 214 -----~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 214 -----GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111223445677899999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.13 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=193.4
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++. .....++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCCeEEEEeeccCC
Confidence 46899999999999964 78999999886543 334567999999999999999999999987 445789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++...........
T Consensus 79 ~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 79 DFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccccc
Confidence 9999997543 258999999999999999999997 89999999999999987 77899999999886543211110
Q ss_pred -cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 896 -VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 896 -~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..... .+ ..... .
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~-~~~~~---------~--- 210 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQ-TREAI---------E--- 210 (252)
T ss_pred CCCCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCH-------HH-HHHHH---------H---
Confidence 1112345799999987766 5889999999999999998 8888863211 00 00000 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.....+.+...+..+.+++.+|++.+ ++||+++||+++|++
T Consensus 211 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 211 -QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 01111223445678999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.73 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=203.2
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+.. ++..+|+|.++.......+.+.+|++++++++||||+++++++. .....++|||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 87 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDPLIMVFE 87 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCceEEEEe
Confidence 478999999999999742 35679999998766556678999999999999999999999987 4557899999
Q ss_pred ccccccHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEe
Q 001700 811 YINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLT 879 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~ 879 (1025)
|+++++|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.++|+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~ 165 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA-NLLVKIG 165 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-CCcEEEC
Confidence 99999999999764310 11248999999999999999999997 89999999999999998 8899999
Q ss_pred ccccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHH
Q 001700 880 DYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVR 957 (1025)
Q Consensus 880 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~ 957 (1025)
|||++......... ......++..|+|||++.+.. ++.++|||||||++|||+| |+.||..... .+...
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~ 236 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TEVIE 236 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence 99999765433211 111235678899999987765 5889999999999999999 9999864211 11111
Q ss_pred HHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccccc
Q 001700 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKDS 1022 (1025)
Q Consensus 958 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~~ 1022 (1025)
... .......+...+..+.+++.+||+.+ ++||++++|+++|+++......
T Consensus 237 ~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 237 CIT--------------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred HHh--------------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 110 00111112334667999999999999 9999999999999999765443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.96 Aligned_cols=251 Identities=19% Similarity=0.315 Sum_probs=194.8
Q ss_pred CceeeeecceEEEEEEec-CCC----EEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGS----ILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||+||+|.+. +++ .||+|.+..... ....++..|+..+++++||||+++++++. ....++++|
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~~~i~e 88 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASLQLVTQ 88 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCccEEEEE
Confidence 478999999999999863 454 477888764322 23467888999999999999999999874 335788999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++.....
T Consensus 89 ~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 89 LSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPD 162 (279)
T ss_pred eCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCccceeccCC
Confidence 9999999999976432 58999999999999999999997 89999999999999988 889999999999865433
Q ss_pred CCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
... ......++..|+|||++.+.. ++.++|||||||++||+++ |+.||..... ..+.+++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~----------- 225 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLLE----------- 225 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH-----------
Confidence 221 112235778899999997766 5899999999999999998 9999864311 11111111
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
.+.....+..+...+.+++.+||..+ ++||++.|+++.|..+..+
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 226 ------KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111112234556788999999999 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.61 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=197.3
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|..+++..||+|.++.... ..+.+.+|+.++++++||||+++++++. ....+++|||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~~ 86 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTEYMSKGS 86 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEEecCCCc
Confidence 578999999999999988888899999876432 4567999999999999999999998874 335789999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||.+............
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 87 LLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeeccCccccccc
Confidence 9999976432 258999999999999999999997 89999999999999998 788999999999876543322222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||+..+.. ++.++||||||+++|||++ |+.||.... ..+...... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~--------------~ 218 (260)
T cd05070 162 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMN-------NREVLEQVE--------------R 218 (260)
T ss_pred CCCCCccccChHHHhcCC--CcchhhhHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHH--------------c
Confidence 223567899999987665 5889999999999999999 899986421 111111111 1
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+...+..+.+++.+|+..+ ++|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234455678999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.18 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=204.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+++|+|+||.++.++++ ++..||+|.+.... ...++....|+.++++++|||||.+.+.+.. ++...++||+|++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLLCIVMEYCE 87 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceEEEEEeecC
Confidence 578999999999999876 67899999886543 3345578899999999999999999999874 4444999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
||++.+.+.+..+. .|+++.+..|+.|++.|+.|||+ ..|+|||||+.||++.. +..+||+|||+|+.+......
T Consensus 88 Gg~l~~~i~~~k~~---~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 88 GGDLAQLIKEQKGV---LFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred CCCHHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhhhcCCchhh
Confidence 99999999887532 69999999999999999999996 89999999999999998 778899999999998766522
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
. ...+||+.||.||.+.+.. |..|+|||||||++|||++-+++|+.. ++...+.....
T Consensus 163 a-~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~------------ 220 (426)
T KOG0589|consen 163 A-STVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINR------------ 220 (426)
T ss_pred h-heecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhh------------
Confidence 2 2348999999999999988 599999999999999999999999753 22222221111
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ...+.+.....++..++..|+..+ ..||++.+++.+
T Consensus 221 -~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 -G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 112346677889999999999999 999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=342.93 Aligned_cols=248 Identities=19% Similarity=0.193 Sum_probs=196.1
Q ss_pred CCceeeeecceEEEEEEec-C-CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 736 PAEVIGRSCHGTLYKATLD-S-GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
..+.||+|++|.||+|... + +..||+|.+..........+.+|+.++++++|||||++++++. .....++||||++
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~lv~E~~~ 148 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK--SDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--ECCEEEEEEECCC
Confidence 3578999999999999844 4 6788999876555555567888999999999999999999987 4568999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++....... .++++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEH-LPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCceecCCcccc
Confidence 999999887532211 268999999999999999999997 89999999999999998 889999999999876543221
Q ss_pred -cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 894 -DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 894 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ...+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~Pf~~~-------~~~~~~~~~------------- 283 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGP-------SQREIMQQV------------- 283 (478)
T ss_pred ccccccCCCccccCHhHhCCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHH-------------
Confidence 122346999999999998765 588999999999999999999998632 111111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+.+.. .+.+...+..+.+++..|++.+ ++||++.+++.
T Consensus 284 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 284 LYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111 1123344567899999999999 99999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=329.32 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=198.4
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGIA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 807 (1025)
..+.||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++. |||||+++++|. .....++
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--~~~~~~i 118 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT--KGGPIYI 118 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--cCCCcEE
Confidence 4689999999999999853 346899999976432 22457889999999997 999999999987 4457899
Q ss_pred EEeccccccHHHHHhhcCC-------------------------------------------------------------
Q 001700 808 ISNYINAQSLAVYLQETDP------------------------------------------------------------- 826 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 826 (1025)
|+||+++|+|.++++....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 9999999999999975421
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC
Q 001700 827 --------------------------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874 (1025)
Q Consensus 827 --------------------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~ 874 (1025)
...+.+++..++.|+.|++.||+|||+ .+|+||||||+|||++. +.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~NiLl~~-~~ 276 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARNVLICE-GK 276 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcceEEEeC-CC
Confidence 011247888999999999999999997 89999999999999998 78
Q ss_pred CEEEeccccccccccCCC-ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcch
Q 001700 875 NAVLTDYSLHRILTSAGT-ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDL 952 (1025)
Q Consensus 875 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l 952 (1025)
.+||+|||+++....... .......++..|+|||++.... ++.++|||||||++|||++ |+.||.....
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~~g~~P~~~~~~------- 347 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELPM------- 347 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-------
Confidence 899999999986533221 1111225778899999987665 5889999999999999998 8899864211
Q ss_pred HHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 953 TDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 953 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.+... ..+..+.+...+...+.++.+++.+||..+ .+||+++||++.|+++.
T Consensus 348 ~~~~~-------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFY-------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHH-------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11110 011111112223445678999999999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.29 Aligned_cols=194 Identities=23% Similarity=0.359 Sum_probs=166.7
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
..+.||+|+||.||+|+.. ++..+|+|+++... ....+.+.+|++++++++||||++++++|. .....++||||++
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 86 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMD 86 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE--ECCEEEEEEecCC
Confidence 3578999999999999965 78899999887542 234567899999999999999999999998 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++.... .+++..+..++.|++.||+|||+..+|+||||||+||+++. ++.+||+|||++........
T Consensus 87 ~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~~~- 159 (333)
T cd06650 87 GGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMA- 159 (333)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchhhhhhcc-
Confidence 999999997653 58899999999999999999997457999999999999988 77899999999876543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
....||..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 160 --~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 160 --NSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --ccCCCCccccCHHHhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1236899999999998765 58899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.41 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=192.2
Q ss_pred CceeeeecceEEEEEEe----cCCCEEEEEEccccc----hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 737 AEVIGRSCHGTLYKATL----DSGSILAVKRLREGI----AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
.+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|+.+++++ +||+|+++++++. .....++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~~~l 82 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEAKLHL 82 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCCEEEE
Confidence 57899999999999874 368899999987532 22345678899999999 5999999998876 4557899
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeCcCCccc
Confidence 999999999999997653 58999999999999999999997 89999999999999998 789999999999865
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
............||+.|+|||++.+... ++.++|||||||++|||+||+.||....... ..........
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~------- 224 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGG-HGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRIL------- 224 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCC-CCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHHHHHHHh-------
Confidence 4433322233479999999999876542 4789999999999999999999996431111 1111111100
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.. ..+.+......+.+++.+|++.+ ++|| +++++++
T Consensus 225 ------~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 ------KC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------cC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 11223345667889999999999 9999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=325.12 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=192.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence 46999999999999965 78999999997642 22345678899999998 7999999999887 455889999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 79 SGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccCCC
Confidence 9999999887543 59999999999999999999997 89999999999999998 88999999999875322211
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCC-CCcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDP-GVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||+...... ......++.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 152 -TTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred -ccccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 122347999999999998766 5889999999999999999999997432211 011222332221111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC------HHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD------MMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs------~~evl~ 1011 (1025)
.. ...+...+.++.+++..|++.+ .+||+ +.++++
T Consensus 220 ---~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 220 ---KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 1123345667899999999999 99997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=328.36 Aligned_cols=239 Identities=19% Similarity=0.251 Sum_probs=190.8
Q ss_pred CceeeeecceEEEEEEec-C-CCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-S-GSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.+ + +..||+|++.... ....+.+.+|+.+++.++|||||++++++. .....++||||
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~lv~Ey 112 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLYLVLEF 112 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEEEEEeC
Confidence 478999999999999854 3 3689999986532 233457889999999999999999999987 45679999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 113 ~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 113 VIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecCCCCeecCCCc
Confidence 99999999998653 58999999999999999999997 89999999999999987 8899999999998764321
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....+.. .
T Consensus 186 ----~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~-i------------ 240 (340)
T PTZ00426 186 ----YTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANE------PLLIYQK-I------------ 240 (340)
T ss_pred ----ceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCC------HHHHHHH-H------------
Confidence 2236999999999998765 5889999999999999999999997421 1111110 0
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~~ 1012 (1025)
..+. ...+......+.+++.+|++.+ ++|+ +++|+++.
T Consensus 241 -~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 -LEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -hcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0000 0113334566889999999999 8884 88888753
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.77 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=195.0
Q ss_pred CceeeeecceEEEEEEecC-CC--EEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEE
Q 001700 737 AEVIGRSCHGTLYKATLDS-GS--ILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~l 807 (1025)
+++||+|+||.||+|+..+ +. .||+|.++... ....+.+.+|++++++++||||+++++++.... ....++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 5789999999999999653 33 68999887542 334567899999999999999999999875321 124689
Q ss_pred EEeccccccHHHHHhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 808 ISNYINAQSLAVYLQETD-PRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
++||+++|+|.+++.... ......+++..+..++.|++.||+|||+ ++|+||||||+||+++. +..+||+|||+++.
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 161 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKK 161 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCcccc
Confidence 999999999999875432 1122358999999999999999999997 89999999999999987 88999999999987
Q ss_pred cccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 887 LTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 887 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
........ .....+++.|+|||+..+.. ++.++|||||||++|||++ |+.||.... ..+...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~~-~-- 229 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVE-------NSEIYDYLR-Q-- 229 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCC--cChHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHH-c--
Confidence 65432211 11224567899999987765 5889999999999999999 888886321 111111111 1
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
+...+.+...+..+.+++.+||+.+ ++|||+.+|++.|+++
T Consensus 230 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 -----------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111123345667899999999999 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.00 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=196.3
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|++|.||+|..+.+..||+|++.... ...+.+.+|++++++++|||++++++++. ....+++|||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~ 86 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEcCCCCC
Confidence 46899999999999998777789999987543 34567899999999999999999998874 345789999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||.++...........
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 87 LLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEccCCcccccC
Confidence 9999976432 258999999999999999999997 89999999999999998 888999999999876443222222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||+..+.. ++.++|||||||++|||+| |+.||..... ....++. ..
T Consensus 162 ~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~-----------------~~ 218 (260)
T cd05069 162 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQV-----------------ER 218 (260)
T ss_pred CCccchhhCCHHHhccCC--cChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-----------------Hc
Confidence 224677899999887665 5889999999999999999 8999864211 1111111 01
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+...+..+.+++.+||+.+ ++||++++|++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111223455678999999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=328.97 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=191.4
Q ss_pred ceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
+.||+|+||.||+|+. .+|+.||+|+++... .....++.+|+++++.++||||+++++++. .....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999985 478999999997642 223456788999999999999999998886 4558999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++.... .+++.++..++.||+.||+|||+..+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 79 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCCc-
Confidence 999999887643 58999999999999999999996478999999999999998 88999999999875432221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.||.... ..+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~------------- 209 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELIL------------- 209 (325)
T ss_pred ccccccCCcccCCHHHHccCC--CCCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHh-------------
Confidence 112236999999999998766 5889999999999999999999996321 111111110
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~~ 1012 (1025)
.... ..+.....++.+++.+|++.+ ++|+ ++.++++.
T Consensus 210 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 MEEI--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0001 113344567889999999999 9996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.67 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=189.1
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence 46999999999999965 78899999997642 22345677899988877 7999999999887 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 79 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCCCC
Confidence 9999999887643 58999999999999999999997 89999999999999998 88999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCC-CcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPG-VVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .....+++......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred -ccccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 112246999999999998766 58899999999999999999999964322111 11222232221111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
.. ...+.....++.+++.+|++.+ ++||++
T Consensus 220 ---~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 ---KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1123445667889999999999 999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.47 Aligned_cols=252 Identities=22% Similarity=0.404 Sum_probs=198.0
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|+.. ++..||||.++..... ..+.+.+|++++++++||||+++++++. .....++||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 87 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT--EGDPPIMVF 87 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe--cCCCeEEEE
Confidence 477999999999999863 3478999999765433 4578999999999999999999999987 446799999
Q ss_pred eccccccHHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEec
Q 001700 810 NYINAQSLAVYLQETDP---------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~D 880 (1025)
||+++++|.+++..... .....+++.++..++.|++.|++|||+ .+|+||||||+||+++. +..+||+|
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~kl~d 165 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY-DLVVKIGD 165 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC-CCeEEECC
Confidence 99999999999976532 112358899999999999999999997 89999999999999998 78999999
Q ss_pred cccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHH
Q 001700 881 YSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 881 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
||+++........ ......+++.|+|||++.+.. ++.++|||||||++|||++ |+.||..... ....+.+.
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHH-
Confidence 9998765332211 111224678899999998766 5889999999999999999 9999863211 11111111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.+.....+...+..+.+++.+||+.+ ++||++.||++.|++
T Consensus 239 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 01111123345678999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.88 Aligned_cols=247 Identities=21% Similarity=0.389 Sum_probs=198.2
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++. ....++++||+.+++
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~ 86 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGS 86 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEEcCCCCC
Confidence 57899999999999998889999999987643 34567899999999999999999998864 346899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. +..++++|||++............
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 87 LVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecCCCCccccc
Confidence 9999876432 258999999999999999999997 89999999999999998 889999999999876533222222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++|||||||++||+++ |+.||.... -.+..... ..
T Consensus 162 ~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~--------------~~ 218 (260)
T cd05067 162 GAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMT-------NPEVIQNL--------------ER 218 (260)
T ss_pred CCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHH--------------Hc
Confidence 234677899999987666 4889999999999999999 999986321 11111111 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
..+.+.+...+.++.+++.+|+..+ ++||+++++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111223345677999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=329.78 Aligned_cols=260 Identities=18% Similarity=0.237 Sum_probs=189.5
Q ss_pred cCCCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 734 HAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
|...+.||+|+||.||+|.. .+++.||+|... .+.+.+|++++++++|||||++++++. .....++|+|++
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~lv~e~~ 165 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRY 165 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE--ECCeeEEEEecC
Confidence 34467899999999999985 478999999753 234678999999999999999999987 445789999998
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.++|..++.... .+++.+++.|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 166 -~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 -KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred -CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence 478988887643 58999999999999999999998 89999999999999988 78999999999975433222
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh-hccc------
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL-ENRS------ 965 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~-~~~~------ 965 (1025)
.......||+.|+|||++.+.. ++.++|||||||++|||+||+.||.......+..+...-+..... .+..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 2222347999999999998765 588999999999999999999886432211111111111110000 0000
Q ss_pred --cccchh----hhcCCC-----CCC--CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 --GECFDR----LIMDGH-----DME--QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 --~~~~d~----~~~~~~-----~~~--~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...++. ...... +.. .....+.++.+++.+|++.+ .+|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 000 01134567899999999999 99999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=331.36 Aligned_cols=248 Identities=16% Similarity=0.188 Sum_probs=192.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~~lv~Ey~ 125 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYLYMVMEYM 125 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEEEEEEcCC
Confidence 578999999999999965 78999999986532 223455788999999999999999998886 556899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 126 ~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 126 PGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEeccceeeccCCCc
Confidence 999999998754 47899999999999999999998 89999999999999998 88999999999987654332
Q ss_pred ccccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 893 ADQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.... ............
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~------- 263 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHK------- 263 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCC-------
Confidence 2223347999999999986532 125789999999999999999999997421 111111111000
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CC--CCCHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SE--RPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~--RPs~~evl~~ 1012 (1025)
.....+.....+.++.+++..|+..+ .+ ||++.|+++.
T Consensus 264 ----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 ----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00011112234677889999999876 65 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=328.68 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=212.6
Q ss_pred HHhhcCCCceeeeecceEEEEEEe-cCCC----EEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCC
Q 001700 730 EELSHAPAEVIGRSCHGTLYKATL-DSGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 730 ~~l~~~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 803 (1025)
+|.+....++||+|+||+||||.+ ..|+ +||+|++.... .+...++.+|+-+|.+++|||+++++|+|..+
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--- 770 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--- 770 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---
Confidence 344445578999999999999984 4444 68999887643 44567899999999999999999999999742
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
...+|++||+.|.|.+|++.++. .+-....+.|..|||+||.|||. .++|||||-.+|||+.. -..+|+.|||+
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgl 844 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGL 844 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecch
Confidence 47899999999999999998653 68889999999999999999996 88999999999999988 56899999999
Q ss_pred ccccccCCCccccc-cCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHh
Q 001700 884 HRILTSAGTADQVL-NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 884 a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
++............ ..-.+.|||-|.+.... ++.++|||||||++||++| |..|++....
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------------- 906 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------------- 906 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------
Confidence 99887655433221 12356799999888766 5999999999999999999 9999874321
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+.+...+..+.+.++|+.+..+++.++.+||..| +.||+++++...+.++..+
T Consensus 907 -----~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 907 -----EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1233344455567789999999999999999999 9999999999999988754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.05 Aligned_cols=239 Identities=19% Similarity=0.271 Sum_probs=187.1
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 68899999997542 22344566677777654 8999999999887 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 79 NGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCCCC
Confidence 9999999987653 58999999999999999999998 89999999999999998 78999999999986433221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~----------- 210 (316)
T cd05592 152 -KASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSILN----------- 210 (316)
T ss_pred -ccccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHc-----------
Confidence 222346999999999998766 5889999999999999999999997421 1111111110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH-HHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM-SVF 1010 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~-evl 1010 (1025)
. ....+.....++.+++.+|++.+ ++||++. +++
T Consensus 211 --~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 211 --D--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 11123345567889999999999 9999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=331.11 Aligned_cols=250 Identities=16% Similarity=0.194 Sum_probs=192.5
Q ss_pred CCCceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
...+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++. .....++|||
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~~lv~E 123 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYLYMVME 123 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEc
Confidence 34578999999999999965 68899999986532 223456789999999999999999999887 4568999999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 124 YMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFGTCMKMDET 195 (370)
T ss_pred CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecccceecccC
Confidence 99999999999754 47899999999999999999997 89999999999999998 889999999999876543
Q ss_pred CCccccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
........+||+.|+|||++.+.. ..++.++||||+||++|||++|+.||... +............
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-------~~~~~~~~i~~~~----- 263 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-------SLVGTYSKIMDHK----- 263 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCC-----
Confidence 332233447999999999987542 12578999999999999999999999632 1111111111000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-C--CCCCHHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-S--ERPDMMSVFEE 1012 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~--~RPs~~evl~~ 1012 (1025)
.....+.....+..+.+++..|+..+ . .||++.|+++.
T Consensus 264 ------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 ------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00111112234566788888998755 3 38999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.97 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=196.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|..+ |..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. .....++++||+++++
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEECCCCCc
Confidence 578999999999999876 788999998754 235678999999999999999999998754 4456899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||+++.......
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~---- 157 (256)
T cd05082 87 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQD---- 157 (256)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceeccccCC----
Confidence 9999986532 248999999999999999999997 89999999999999988 88999999999886543221
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++|||||||++|||++ |+.||... ...+..... ..
T Consensus 158 ~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~--------------~~ 214 (256)
T cd05082 158 TGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRV--------------EK 214 (256)
T ss_pred CCccceeecCHHHHccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH--------------hc
Confidence 123567899999987665 5889999999999999998 99998632 222222211 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
......+..++..+.+++.+|++.+ ++|||+.++++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111223455678999999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=335.04 Aligned_cols=247 Identities=16% Similarity=0.208 Sum_probs=187.4
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++|||||++++++. +....++||||+
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv~E~~ 83 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFVMDYI 83 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEEEecC
Confidence 57899999999999985 478999999997542 233467889999999999999999999987 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 84 PGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcccccccc
Confidence 9999999997653 58999999999999999999997 89999999999999998 78999999999764311000
Q ss_pred ----------------------------------------------ccccccCcccccCccccccCCCCCCCCchhHHHH
Q 001700 893 ----------------------------------------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926 (1025)
Q Consensus 893 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSl 926 (1025)
......+||+.|+|||++.+.. ++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCCccceeeh
Confidence 0001236999999999997765 5889999999
Q ss_pred HHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHH--ccCCC-CCC
Q 001700 927 GIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALR--CILPA-SER 1003 (1025)
Q Consensus 927 Gvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~--C~~~~-~~R 1003 (1025)
||++|||+||+.||...... .......... .....+.......++.+++.+ |+..+ ..|
T Consensus 235 G~il~elltG~~Pf~~~~~~------~~~~~i~~~~------------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT------ETQLKVINWE------------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH------HHHHHHHccc------------cccCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 99999999999999743110 0011100000 000111122234567777776 54445 669
Q ss_pred CCHHHHHHH
Q 001700 1004 PDMMSVFEE 1012 (1025)
Q Consensus 1004 Ps~~evl~~ 1012 (1025)
|++.||++.
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.88 Aligned_cols=195 Identities=20% Similarity=0.274 Sum_probs=165.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.++.+++||||+++++.+. +....++||||+
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~lv~E~~ 83 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYLIMEFL 83 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEEEEcCC
Confidence 578999999999999854 78999999997542 223456788999999999999999999887 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 84 PGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCccccccccc
Confidence 9999999997653 58999999999999999999997 89999999999999998 78999999999876432110
Q ss_pred c----------------------------------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCC
Q 001700 893 A----------------------------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938 (1025)
Q Consensus 893 ~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~ 938 (1025)
. .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHHHHHHhCCC
Confidence 0 011247999999999998766 5889999999999999999999
Q ss_pred CCCc
Q 001700 939 SGEI 942 (1025)
Q Consensus 939 P~~~ 942 (1025)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.43 Aligned_cols=246 Identities=18% Similarity=0.262 Sum_probs=190.6
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||+||+|... +|+.||||.+..... ...+.+..|++++++++||||+++.+++. .....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence 689999999999854 789999999875422 22356788999999999999999988876 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++......... .
T Consensus 79 ~L~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~-~ 154 (280)
T cd05608 79 DLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK-T 154 (280)
T ss_pred CHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc-c
Confidence 999888643221 1368999999999999999999998 89999999999999988 788999999999866443221 2
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....... .....
T Consensus 155 ~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~-------------~~~~~ 216 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQ-------------RILND 216 (280)
T ss_pred cccCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHH-------------hhccc
Confidence 2236899999999998776 5889999999999999999999996431110 0001000 00000
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
....+...+..+.+++..|++.+ ++|| +++++++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 217 --SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11123445677899999999999 9999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.90 Aligned_cols=235 Identities=21% Similarity=0.306 Sum_probs=186.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.+ +++.||||+++... ....+.+.+|..++..+ +||||+++++++. .....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 68999999987542 23345677888988877 6999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 79 NGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred CCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcCCC
Confidence 9999999987653 58999999999999999999997 89999999999999998 88999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~----------- 210 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILN----------- 210 (320)
T ss_pred -cccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhc-----------
Confidence 122346999999999998765 5889999999999999999999997421 1112111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
.. ...+.....++.+++.+|++.+ ++||++
T Consensus 211 --~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 211 --DE--VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CC--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 1112334567899999999999 999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.88 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=201.8
Q ss_pred CCceeeeecceEEEEEEecC-----CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLDS-----GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..++||+|+||.||+|.... +..||+|+++... ....+.+.+|+.++++++||||+++++++.. .....++++
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~~~~~ 88 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE-DGEPPFVLY 88 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCCEEEE
Confidence 35889999999999999764 6889999987542 3345678899999999999999999998864 345789999
Q ss_pred eccccccHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 810 NYINAQSLAVYLQETDPR---KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||+||+++. +..+|++|||+++.
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kl~d~g~~~~ 166 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVKITDNALSRD 166 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEEECCCCCccc
Confidence 999999999999765321 11368999999999999999999997 89999999999999987 78999999999986
Q ss_pred cccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 887 LTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 887 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
+....... .....++..|+|||++.... ++.++|||||||++||+++ |+.||.... ...+..++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~------- 233 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAYLK------- 233 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCC--CCchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHHHHHHH-------
Confidence 64332211 11124677899999987665 5889999999999999999 999986421 111211111
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
.......+..++.++.+++.+||..+ ++|||+.||++.|+++..
T Consensus 234 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 ----------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111123334567899999999999 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.68 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=196.4
Q ss_pred ceeeeecceEEEEEEec-C---CCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-S---GSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|... . +..||+|.++.... ...+++.+|++++++++|||||++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence 46999999999999753 2 26899999986543 34567899999999999999999999875 34679999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecCCc
Confidence 9999999998653 58999999999999999999997 89999999999999988 88999999999987644332
Q ss_pred ccc--cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 ADQ--VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
... ....++..|+|||+..+.. ++.++|||||||++|||++ |+.||.... ...+..++..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~~~----------- 213 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAMLES----------- 213 (257)
T ss_pred ccccccCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHc-----------
Confidence 211 1112456899999987666 5889999999999999998 999986431 1122222210
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
....+.+...+..+.+++.+||..+ ++||++.+|++.|+++.
T Consensus 214 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 ------GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0111223445678999999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=324.62 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=191.1
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC---CeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE---HEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~~lv~ 809 (1025)
..+.||+|+||.||+|+.. +|..||||+++... ......+.+|++++++++||||+++++++..... ...++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 3578999999999999954 78999999987432 2234568899999999999999999998864222 3479999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+. ++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 84 e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 84 ELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAFN 155 (338)
T ss_pred ecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCcccccccc
Confidence 9995 78999887643 58999999999999999999998 89999999999999998 88999999999986533
Q ss_pred CCCc--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh------
Q 001700 890 AGTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL------ 961 (1025)
Q Consensus 890 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~------ 961 (1025)
.... ......||+.|+|||++.+....++.++|||||||++|||+||+.||..... ....+++.....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCHHH
Confidence 2211 1122369999999999865322358899999999999999999999964211 111111100000
Q ss_pred -----hccccccchhhhcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 962 -----ENRSGECFDRLIMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 962 -----~~~~~~~~d~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.....+.+.. +......+ ..+.....+.+++.+|++.+ ++||+++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000 00123456789999999999 999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.50 Aligned_cols=240 Identities=20% Similarity=0.298 Sum_probs=189.5
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence 46999999999999965 68899999997642 23345677899998876 7999999999987 455799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 79 NGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccCCc
Confidence 9999999987653 58999999999999999999997 89999999999999998 88999999999876433222
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 ~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~----------- 210 (321)
T cd05591 152 T-TTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILH----------- 210 (321)
T ss_pred c-ccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHc-----------
Confidence 1 22336999999999998766 5889999999999999999999997431 1111111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-------CHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERP-------DMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-------s~~evl~ 1011 (1025)
... ..+.....++.+++..|++.+ ++|| ++.++++
T Consensus 211 --~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 211 --DDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111 112234567889999999999 9999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=316.79 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=189.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++. .....++||||+.
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~- 86 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTLVFEYVH- 86 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe--cCCeEEEEEECCC-
Confidence 578999999999999965 789999999875432 23456788999999999999999999987 4557899999995
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 87 ~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~-~ 159 (303)
T cd07869 87 TDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSH-T 159 (303)
T ss_pred cCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceeccCCCc-c
Confidence 688888765432 58899999999999999999998 89999999999999988 78999999999875433221 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-cccc-------
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRSG------- 966 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~~------- 966 (1025)
.....||+.|+|||++.+... ++.++||||+||++|||++|+.||.... +..+........ +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTE-YSTCLDMWGVGCIFVEMIQGVAAFPGMK------DIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CCCCcccCCCCChHHHcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCc------cHHHHHHHHHHHhCCCChhhccch
Confidence 222468999999999875443 5889999999999999999999997431 121111111100 0000
Q ss_pred ---ccchhhhcCCCCCCCc------hHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 967 ---ECFDRLIMDGHDMEQP------PRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 967 ---~~~d~~~~~~~~~~~~------~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+++........... ......+.+++.+|++.+ .+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000 012356789999999999 99999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=314.33 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=197.9
Q ss_pred CceeeeecceEEEEEEe-cCCC----EEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-DSGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.++||+|+||+||+|++ .+|. .||+|+++... ....+++.+|+.+++.++||||+++++++.. ...++++|
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~l~~~ 88 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQ 88 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCcEEEEE
Confidence 47899999999999985 3555 48999987543 3345678899999999999999999999863 35689999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++.....
T Consensus 89 ~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 89 LMPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDFGLARLLDID 162 (279)
T ss_pred cCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCCCceeecccc
Confidence 9999999999976431 58999999999999999999998 89999999999999987 778999999999876533
Q ss_pred CCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.... .....+++.|+|||...+.. ++.++|||||||++|||++ |..||+.... ..+..++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~----------- 225 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE----------- 225 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH-----------
Confidence 2211 11123567899999987766 5889999999999999998 8999864311 11222211
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
.....+.+...+..+.+++.+||+.+ ++||++.++++.|+++....
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 ------KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11111223345667899999999999 99999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=338.53 Aligned_cols=251 Identities=20% Similarity=0.227 Sum_probs=196.7
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC------CeeE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE------HEKL 806 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------~~~~ 806 (1025)
..++||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++..++|+||+++++.+..... ...+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 357899999999999984 579999999986542 3345678899999999999999999877653211 1367
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DFGls~~ 192 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKM 192 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEecccCee
Confidence 999999999999999764322 1368999999999999999999998 89999999999999998 88999999999987
Q ss_pred cccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc
Q 001700 887 LTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 887 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+++....
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~-------~~~~~~~~~~----- 258 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGE-------NMEEVMHKTL----- 258 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHh-----
Confidence 6432211 122347999999999998766 589999999999999999999999632 2222222111
Q ss_pred cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.. .+.+...+.++.+++.+||+.+ .+||++.++++.
T Consensus 259 --------~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 --------AGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------cCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 1223455677999999999999 999999999863
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.98 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=198.9
Q ss_pred CceeeeecceEEEEEEecC----CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLDS----GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~lv~e~ 87 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVWIVMEL 87 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcEEEEEc
Confidence 5789999999999998542 3478999987654 3456689999999999999999999998853 357899999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++. +..+|++|||+++......
T Consensus 88 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 88 APLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCceeeeccccc
Confidence 999999999976432 58999999999999999999997 89999999999999998 7899999999998765443
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
........++..|+|||.+.... ++.++|||||||++||+++ |+.||..... .....++.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~------------- 222 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIE------------- 222 (270)
T ss_pred ceecCCCCccccccChhhhccCC--CCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHH-------------
Confidence 22222223556899999887665 5889999999999999986 9999864311 11111110
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
...+.+.+..++..+.+++.+|+..+ ++|||+.++++.|+++..+
T Consensus 223 ----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 ----NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111223455678999999999999 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=310.86 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=200.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc---chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG---IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|++++++++||||+++++++.. ....++++||+
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~ 84 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNIVLELA 84 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEEEEEec
Confidence 578999999999999954 7899999987542 22334578899999999999999999998873 45789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++....... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccceeccchhH
Confidence 9999999886532211 258899999999999999999997 89999999999999988 78899999999887654322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||.... .+..++......
T Consensus 162 ~-~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~~~~~----------- 222 (267)
T cd08228 162 A-AHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQKIEQ----------- 222 (267)
T ss_pred H-HhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHHHHhc-----------
Confidence 1 11235888999999987765 5889999999999999999999985321 122222221110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
...........+..+.+++.+||..+ ++||++.+|++.++.+.
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 --CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01111112345677999999999999 99999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.17 Aligned_cols=421 Identities=28% Similarity=0.349 Sum_probs=249.6
Q ss_pred EEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCC
Q 001700 68 TSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147 (1025)
Q Consensus 68 ~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N 147 (1025)
+.+++.++.++. ++ |+++.+..+..|+.++|+++..+++++.+.+|+.||.++|.+. .+|++++.+..|+.|+..+|
T Consensus 71 ~vl~~~~n~l~~-lp-~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N 147 (565)
T KOG0472|consen 71 TVLNVHDNKLSQ-LP-AAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN 147 (565)
T ss_pred eEEEeccchhhh-CC-HHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc
Confidence 444444444432 22 4555555555555555555555555555555555555555555 23455555555555555555
Q ss_pred ccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCc
Q 001700 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGE 227 (1025)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 227 (1025)
+++ ..|+.++++.+|..|++.+|++....|..+. ++.|++||...|.+... |..++.+ .+|..|+|.+|++.
T Consensus 148 ~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tl-P~~lg~l---~~L~~LyL~~Nki~-- 219 (565)
T KOG0472|consen 148 QIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETL-PPELGGL---ESLELLYLRRNKIR-- 219 (565)
T ss_pred ccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcC-Chhhcch---hhhHHHHhhhcccc--
Confidence 555 4555555555555555555555543333333 55555555555555432 3333332 55555566666553
Q ss_pred cCCCCCCCCCCCCCEEeccCCcccccCCc-ccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCccccc
Q 001700 228 LFPHDGMPYFDNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSI 306 (1025)
Q Consensus 228 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~ 306 (1025)
..|. |..+..|.+|.++.|.+...+.+ ...+.+|.+|||.+|+++ ..|+.++.+.+ |..||+|+|.|++.+...
T Consensus 220 ~lPe--f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs--L~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 220 FLPE--FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS--LERLDLSNNDISSLPYSL 294 (565)
T ss_pred cCCC--CCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhh--hhhhcccCCccccCCccc
Confidence 2222 45555555556665555544333 235555666666666665 55555544333 556666666665533322
Q ss_pred CCCCccEEEccCCcccC-------------------------------------CCCCC-------CCCcceeeccCccC
Q 001700 307 TSATLKKVNLSSNKLSG-------------------------------------SLPAR-------VGHCTIVDLSNNRL 342 (1025)
Q Consensus 307 ~~~~L~~L~Ls~N~l~~-------------------------------------~~p~~-------l~~l~~L~Ls~N~l 342 (1025)
....|+.|-+.+|.+.. ..|.+ +.+.++|+++.-++
T Consensus 295 gnlhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql 374 (565)
T KOG0472|consen 295 GNLHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL 374 (565)
T ss_pred ccceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence 22255556666655421 00000 01223455555555
Q ss_pred CCcccccccCCC--ccceEEecCCCCCCCCchhccCCCCC-CEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCc
Q 001700 343 SGDLSRMQNWGN--YVEDIHLSSNFLTGMVPNQTSQFLRL-TSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLL 419 (1025)
Q Consensus 343 ~~~~~~~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 419 (1025)
+.++.+.|.... -+...+++.|++. .+|..+..++.+ +.+.+++|.++ .+|..++.+++|..|+|++|-+.. +|
T Consensus 375 t~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP 451 (565)
T KOG0472|consen 375 TLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LP 451 (565)
T ss_pred ccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cc
Confidence 555554443321 2566777777776 456555555544 34556666664 788888999999999999999875 67
Q ss_pred ccccCCCCCCEEecCCCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCcccc
Q 001700 420 PSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSI 499 (1025)
Q Consensus 420 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~i 499 (1025)
..++.+..|+.||+|+|+|.- +|.. ..... .|+.+-.++|++...-|..+.++.+|..|||.+|.|. .|
T Consensus 452 ~e~~~lv~Lq~LnlS~NrFr~-lP~~-------~y~lq--~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~I 520 (565)
T KOG0472|consen 452 EEMGSLVRLQTLNLSFNRFRM-LPEC-------LYELQ--TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QI 520 (565)
T ss_pred hhhhhhhhhheeccccccccc-chHH-------HhhHH--HHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hC
Confidence 888888889999999998863 3322 11111 4666767778988655566999999999999999998 88
Q ss_pred CCCcCC--CCcEEECCCCccc
Q 001700 500 PDGLPN--GLKEFNVSFNNLS 518 (1025)
Q Consensus 500 p~~l~~--~L~~L~ls~N~l~ 518 (1025)
|..+.+ +|++|++++|+|.
T Consensus 521 Pp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 521 PPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ChhhccccceeEEEecCCccC
Confidence 888876 8999999999997
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=316.17 Aligned_cols=256 Identities=22% Similarity=0.368 Sum_probs=198.3
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|+.. ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+. .....++++
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 82 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPLLLIV 82 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCcEEEE
Confidence 578999999999999842 235789998875432 33467889999999999999999999886 445789999
Q ss_pred eccccccHHHHHhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEee
Q 001700 810 NYINAQSLAVYLQETDP-------------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~ 870 (1025)
||+.+|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~nill~ 161 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLVA 161 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhheEEEc
Confidence 99999999999875321 011258899999999999999999997 8999999999999998
Q ss_pred cCCCCEEEeccccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCC
Q 001700 871 APTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPG 948 (1025)
Q Consensus 871 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~ 948 (1025)
. +..+||+|||+++........ ......++..|+|||++.+.. ++.++||||||+++|||+| |+.||.....
T Consensus 162 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 162 E-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred C-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 8 789999999999865332221 112224677899999887665 5889999999999999999 9999863211
Q ss_pred CcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
..+..++ . .....+.+...+.++.+++..|++.+ ++||++.||++.|+++..+
T Consensus 236 -~~~~~~~----~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 -ERLFNLL----K-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHHH----h-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111111 0 11111223445677999999999999 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.62 Aligned_cols=250 Identities=23% Similarity=0.437 Sum_probs=197.4
Q ss_pred CceeeeecceEEEEEEec-CC---CEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SG---SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. ++ ..+|+|.++... ....+++..|++++++++||||+++++++. .....++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~ 87 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPAMIITEY 87 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCcEEEEEc
Confidence 578999999999999864 33 379999987652 334567899999999999999999999987 44578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++..... .+++.++..++.|++.|++|||+ .+|+||||||+||+++. +..+|++|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 88 MENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccceeccccc
Confidence 999999999976432 58999999999999999999997 89999999999999987 8899999999988664332
Q ss_pred Ccccc--ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQV--LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
..... ....+..|+|||++.... ++.++|||||||++|||++ |+.||.... ..++......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~il~ell~~g~~p~~~~~-------~~~~~~~i~~------- 225 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMS-------NHEVMKAIND------- 225 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCC--cChHhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHHhc-------
Confidence 21111 112345799999987665 5889999999999999997 999986321 1122222111
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
....+.+...+..+.+++.+||+.+ ++||+|.+|++.|++++
T Consensus 226 -------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 226 -------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111223345677999999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=316.93 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=196.6
Q ss_pred CceeeeecceEEEEEEec-CCC--EEEEEEcccc-chhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGS--ILAVKRLREG-IAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.++||+|+||.||+|..+ ++. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++. .....++++||
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~lv~e~ 84 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLYIAIEY 84 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcceEEEEe
Confidence 578999999999999865 343 4788888753 233456789999999999 7999999999886 44578999999
Q ss_pred cccccHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEec
Q 001700 812 INAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~D 880 (1025)
+++++|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. +..+||+|
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~d 162 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE-NLASKIAD 162 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-CCeEEECC
Confidence 9999999999764211 11258899999999999999999997 89999999999999988 88899999
Q ss_pred cccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHH
Q 001700 881 YSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLL 959 (1025)
Q Consensus 881 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~ 959 (1025)
||++........ ......+..|+|||+..+.. ++.++|||||||++|||++ |+.||.... ..++....
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~~-------~~~~~~~~ 231 (297)
T cd05089 163 FGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAELYEKL 231 (297)
T ss_pred cCCCccccceec--cCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHH
Confidence 999874322111 11112356799999987665 5889999999999999998 999986431 11111111
Q ss_pred HhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 960 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
. .+...+.+..++..+.+++.+||+.+ .+||++.+|++.|+.+..+..
T Consensus 232 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 232 P--------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred h--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 11111223345677899999999999 999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.42 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=188.4
Q ss_pred CCceeeeecceEEEEEEe-c-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcC---CCCccccccceeec---CCCCee
Q 001700 736 PAEVIGRSCHGTLYKATL-D-SGSILAVKRLREGI--AKGKKEFAREVKKLGNI---KHPNLVSLQGYYWG---PKEHEK 805 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---~~~~~~ 805 (1025)
..+.||+|+||.||+|+. . ++..||||+++... ......+.+|+.+++++ +||||++++++|.. ......
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 357899999999999985 3 46889999986532 22234566788777766 69999999998852 133468
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
++|+||+. ++|.+++...... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 158 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLAR 158 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccceE
Confidence 99999996 6999998764322 58999999999999999999997 89999999999999998 7899999999998
Q ss_pred ccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHH----h
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA----L 961 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~----~ 961 (1025)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+....+.... .
T Consensus 159 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 159 IYSFQM--ALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 230 (290)
T ss_pred eccCCc--ccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCCh
Confidence 764432 122336899999999987665 58899999999999999999999974321 11111111000 0
Q ss_pred hcccccc-chhh-hcCCCCC---CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 962 ENRSGEC-FDRL-IMDGHDM---EQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 962 ~~~~~~~-~d~~-~~~~~~~---~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+..+. .... ....... ...+.....+.+++.+|++.+ ++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0000 0000000 001234566789999999999 99999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=335.72 Aligned_cols=247 Identities=19% Similarity=0.201 Sum_probs=188.3
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++. +....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~E~~ 83 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYLIMEFL 83 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEEEEeCC
Confidence 57899999999999985 479999999986532 223456889999999999999999999987 455799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 84 PGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeecccccccccccc
Confidence 9999999997643 58999999999999999999997 89999999999999988 88999999999864321100
Q ss_pred ------------c----------------------------------cccccCcccccCccccccCCCCCCCCchhHHHH
Q 001700 893 ------------A----------------------------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926 (1025)
Q Consensus 893 ------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSl 926 (1025)
. .....+||+.|+|||++.+.. ++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSl 234 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CCCceeeEec
Confidence 0 000136999999999998766 5889999999
Q ss_pred HHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CC--C
Q 001700 927 GIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SE--R 1003 (1025)
Q Consensus 927 Gvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~--R 1003 (1025)
||++|||+||+.||..... .+....... . . .....+.......++.+++.+|+..+ ++ |
T Consensus 235 Gvil~elltG~~Pf~~~~~-------~~~~~~i~~-~-~---------~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r 296 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS-------HETYRKIIN-W-R---------ETLYFPDDIHLSVEAEDLIRRLITNAENRLGR 296 (377)
T ss_pred chhhhhhhcCCCCCCCCCH-------HHHHHHHHc-c-C---------CccCCCCCCCCCHHHHHHHHHHhcCHhhcCCC
Confidence 9999999999999963211 111111100 0 0 00000111223566888999999754 33 7
Q ss_pred CCHHHHHHH
Q 001700 1004 PDMMSVFEE 1012 (1025)
Q Consensus 1004 Ps~~evl~~ 1012 (1025)
|++.|+++.
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 899998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.72 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=192.3
Q ss_pred ceeeeecceEEEEEEec----CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. .+...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-SEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec-CCCCcEEEEecC
Confidence 46899999999999853 24579999986432 3345678899999999999999999998764 334578999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.+|+|.+++..... ..++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCCcc
Confidence 99999999976432 46788899999999999999997 89999999999999998 78899999999986543221
Q ss_pred c---cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcC-CCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 893 A---DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG-KSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 893 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
. ......++..|+|||++.+.. ++.++|||||||++|||++| .+||... +..+.......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~------- 217 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQ------- 217 (262)
T ss_pred eeecccccCcCCccccChhHhccCc--cchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhc-------
Confidence 1 111224677899999987665 58899999999999999995 5555422 11112111110
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
......+...+..+.+++..||+.+ ++||++.||++.|+++..
T Consensus 218 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 -------GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0111112334567999999999999 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.18 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=200.3
Q ss_pred CCCceeeeecceEEEEEEe-----cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 735 APAEVIGRSCHGTLYKATL-----DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
...+.||+|+||.||+|++ .++..||+|.++... ....+.+.+|++++++++||||+++++++........++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 3457899999999999974 257899999987553 3345679999999999999999999998875444578999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 87 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 87 MEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccccccc
Confidence 99999999999997543 158999999999999999999997 89999999999999988 7889999999998764
Q ss_pred cCCCc--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccC--------CCCcchHHHHHH
Q 001700 889 SAGTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVD--------PGVVDLTDWVRL 958 (1025)
Q Consensus 889 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~--------~~~~~l~~~~~~ 958 (1025)
..... ......|+..|+|||++.+.. ++.++|||||||++|||+|++.|+...... ........++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSK--FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCC--CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 43221 111234677899999987665 588999999999999999988765322110 000011111111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+......+.+..++.++.+++.+|++.+ ++||++.+|++.|+++.
T Consensus 239 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 --------------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred --------------HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111112223446778999999999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=316.92 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=200.9
Q ss_pred CCCceeeeecceEEEEEEec--------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCe
Q 001700 735 APAEVIGRSCHGTLYKATLD--------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHE 804 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 804 (1025)
...+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++. ....
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~ 95 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGP 95 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--cCCc
Confidence 34688999999999999741 34579999987543 33456789999999999 8999999999987 4457
Q ss_pred eEEEEeccccccHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC
Q 001700 805 KLVISNYINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT 873 (1025)
Q Consensus 805 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~ 873 (1025)
.++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++. +
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Nili~~-~ 173 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-N 173 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccceEEEcC-C
Confidence 89999999999999999864321 01258899999999999999999997 89999999999999987 7
Q ss_pred CCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcc
Q 001700 874 MNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVD 951 (1025)
Q Consensus 874 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 951 (1025)
+.+||+|||.++......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||... .
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~-------~ 244 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGI-------P 244 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccC-------C
Confidence 899999999998765432221 11224677899999987765 5889999999999999998 78887532 2
Q ss_pred hHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 952 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
..++...... ..+...+..++..+.+++.+||+.+ ++||+|.||++.|+++..-
T Consensus 245 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2222222111 1111123445677999999999998 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=309.11 Aligned_cols=239 Identities=20% Similarity=0.324 Sum_probs=184.8
Q ss_pred ceeeeecceEEEEEEecC-------------CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCe
Q 001700 738 EVIGRSCHGTLYKATLDS-------------GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHE 804 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 804 (1025)
+.||+|+||.||+|++.+ ...||+|.+..........+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV--RDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCC
Confidence 468999999999998532 2358999887655555567889999999999999999999987 3457
Q ss_pred eEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC-------CEE
Q 001700 805 KLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM-------NAV 877 (1025)
Q Consensus 805 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~-------~~k 877 (1025)
.++||||+++|+|..++..... .+++..+++++.||+.||+|||+ .+|+||||||+|||++. ++ .++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCceeE
Confidence 7999999999999998875432 58999999999999999999997 89999999999999976 33 289
Q ss_pred EeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHH-cCCCCCCccccCCCCcchHHHH
Q 001700 878 LTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELL-TGKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 878 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ell-tG~~P~~~~~~~~~~~~l~~~~ 956 (1025)
++|||++....... ...|+..|+|||++..... ++.++|||||||++|||+ +|+.||.... ..+..
T Consensus 153 l~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~ 219 (262)
T cd05077 153 LSDPGIPITVLSRQ-----ECVERIPWIAPECVEDSKN-LSIAADKWSFGTTLWEICYNGEIPLKDKT-------LAEKE 219 (262)
T ss_pred eCCCCCCccccCcc-----cccccccccChhhhcCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCcc-------hhHHH
Confidence 99999987653221 1257889999998864433 588999999999999997 5888875321 11110
Q ss_pred HHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
. . .. .... .......++.+++.+||+.+ .+||++.+|++.+
T Consensus 220 ~-~-~~------------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 R-F-YE------------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred H-H-Hh------------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0 00 0000 01123456889999999999 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.18 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=200.7
Q ss_pred CCCceeeeecceEEEEEEec--------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCe
Q 001700 735 APAEVIGRSCHGTLYKATLD--------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHE 804 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 804 (1025)
...+.||+|+||.||+|+.. ++..||+|.++... .....++.+|+.+++++ +||||+++++++. ....
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~~~~ 98 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGP 98 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCc
Confidence 34688999999999999742 23579999997542 33456788999999999 7999999999987 4457
Q ss_pred eEEEEeccccccHHHHHhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC
Q 001700 805 KLVISNYINAQSLAVYLQETDPRK-----------LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT 873 (1025)
Q Consensus 805 ~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~ 873 (1025)
.++|+||+++|+|.+++....... ...+++.++++++.|++.||+|||+ .+|+||||||+||+++. +
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Nill~~-~ 176 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-D 176 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHheEEcC-C
Confidence 899999999999999998653211 1258999999999999999999997 89999999999999998 7
Q ss_pred CCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcc
Q 001700 874 MNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVD 951 (1025)
Q Consensus 874 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 951 (1025)
+.+||+|||.++......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||... .
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~~g~~p~~~~-------~ 247 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGV-------P 247 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCC--CCcHHHHHHHHHHHHHHHcCCCCCCCcC-------C
Confidence 899999999988654322111 11123456899999987765 5889999999999999998 88887532 1
Q ss_pred hHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 952 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
..+...... .....+.+...+.++.+++.+|+..+ ++||+|.+|++.|+++.+..
T Consensus 248 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 VEELFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHH--------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 222222111 11111223455678999999999998 99999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=321.89 Aligned_cols=240 Identities=21% Similarity=0.281 Sum_probs=187.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHH---hcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKL---GNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++. .....++||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~lv~ 81 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVCFVM 81 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEEEEE
Confidence 468999999999999865 78999999997543 12234566676655 5678999999999987 456899999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++|+|..++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCCccCCC
Confidence 999999999888643 58999999999999999999997 89999999999999998 88999999999875432
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
... .....+|++.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+......
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~--------- 214 (324)
T cd05589 154 FGD-RTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIV--------- 214 (324)
T ss_pred CCC-cccccccCccccCHhHhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH---------
Confidence 221 122346999999999998766 5889999999999999999999986421 111111111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.... ..+...+..+.+++.+|++.+ .+|| ++.++++
T Consensus 215 ----~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 ----NDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----hCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111 123345677889999999999 9999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.66 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=198.7
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
..+.||+|+||.||+|... ....||+|.++... .....++.+|+.+++++ +||||+++++++. .....++
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~~l 93 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--QEGPLYV 93 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--CCCCeEE
Confidence 3578999999999999853 23689999987542 23446688999999999 8999999999987 4457899
Q ss_pred EEeccccccHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCE
Q 001700 808 ISNYINAQSLAVYLQETDP-----------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNA 876 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~ 876 (1025)
+|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil~~~-~~~~ 171 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVLVTE-DHVM 171 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEEEcC-CCeE
Confidence 9999999999999975321 112368999999999999999999997 89999999999999988 8899
Q ss_pred EEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHH
Q 001700 877 VLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTD 954 (1025)
Q Consensus 877 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~ 954 (1025)
||+|||+++......... .....++..|+|||++.+.. ++.++|||||||++||+++ |..||.... ..+
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~ 242 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------VEE 242 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCC--cCcccceeehhhHHHHHhcCCCCCCCCCC-------HHH
Confidence 999999998765432211 11123567899999987665 5889999999999999998 999886321 111
Q ss_pred HHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 955 WVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 955 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.... +......+.+...+..+.+++.+|+..+ ++||||.||++.|+++.
T Consensus 243 ~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKL--------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH--------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1110 1111111224455677999999999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.11 Aligned_cols=240 Identities=22% Similarity=0.334 Sum_probs=193.0
Q ss_pred ceeeeecceEEEEEE-ecCCCEEEEEEcccc---chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREG---IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
..||.|+||.||-|+ ..+.++||||++.-. ......++.+|++.|++++|||+|.+.|+|. .++..|+|||||
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL--re~TaWLVMEYC- 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL--REHTAWLVMEYC- 108 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee--ccchHHHHHHHH-
Confidence 569999999999999 457899999998643 2233568999999999999999999999998 667899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
-|+-.+.+.-.. .++.+.++..|+.+.+.||+|||+ .+.||||||+-|||+.+ .+.|||+|||.|.+..+..+
T Consensus 109 lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~~PAns- 181 (948)
T KOG0577|consen 109 LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIMAPANS- 181 (948)
T ss_pred hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhcCchhc-
Confidence 567777776543 278999999999999999999999 77889999999999998 88999999999988765433
Q ss_pred cccccCcccccCccccccC--CCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 894 DQVLNAGALGYRPPEFAST--SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.+|||+|||||++.. .+. |+-|+||||+|++..|+.-.++|...+. .+-. +-.
T Consensus 182 ----FvGTPywMAPEVILAMDEGq-YdgkvDvWSLGITCIELAERkPPlFnMN------AMSA--------------LYH 236 (948)
T KOG0577|consen 182 ----FVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNMN------AMSA--------------LYH 236 (948)
T ss_pred ----ccCCccccchhHheeccccc-cCCccceeeccchhhhhhhcCCCccCch------HHHH--------------HHH
Confidence 379999999998863 232 6889999999999999999999965431 0101 111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
........-...+....|..++..|++.. .+|||..+++..
T Consensus 237 IAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 237 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11111111235577889999999999998 999999988753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.89 Aligned_cols=240 Identities=19% Similarity=0.315 Sum_probs=187.7
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence 46999999999999965 68899999997642 22345567788888764 8999999999887 455799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 79 NGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCCCC
Confidence 9999999997643 58999999999999999999997 89999999999999998 78999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~----------- 210 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSIRM----------- 210 (316)
T ss_pred -ceeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-----------
Confidence 122236999999999998766 5889999999999999999999996421 1111111100
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH-HHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM-SVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~-evl~ 1011 (1025)
... ..+.....++.+++.+|++.+ ++||++. ++.+
T Consensus 211 --~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 --DNP--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCC--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 112234566889999999999 9999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.59 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=195.0
Q ss_pred CceeeeecceEEEEEEe-----cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-----DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+. .++..||+|.++... ....+++.+|++++++++||||+++++++. .....+++||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e 87 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT--QEQPVCMLFE 87 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCceEEEEE
Confidence 47899999999999984 256789999997543 233467899999999999999999999987 4557899999
Q ss_pred ccccccHHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEE
Q 001700 811 YINAQSLAVYLQETDP------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl 878 (1025)
|+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~-~~~~kl 165 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGE-QLHVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEcC-CCcEEe
Confidence 9999999999864321 001258899999999999999999997 89999999999999998 788999
Q ss_pred eccccccccccCCC-ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHH
Q 001700 879 TDYSLHRILTSAGT-ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 879 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~ 956 (1025)
+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.... ...+.+.+
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~~~~~~~ 239 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQEVIEMV 239 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH
Confidence 99999986543321 1112224677899999987665 5889999999999999999 998985321 11111111
Q ss_pred HHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
. . ....+.+..++.++.+++.+||+.+ ++||++.+|.+.|..
T Consensus 240 ~----~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R----K-------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----c-------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 0 1111223345677899999999999 999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=321.18 Aligned_cols=239 Identities=19% Similarity=0.293 Sum_probs=187.6
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++... +||||+++++++. .....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence 46999999999999965 78999999997642 22345567788888765 8999999999887 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.+|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 79 NGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccCCC
Confidence 9999999987653 58999999999999999999997 89999999999999998 78999999999875322211
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~~~~----------- 210 (316)
T cd05620 152 -RASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRV----------- 210 (316)
T ss_pred -ceeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-----------
Confidence 122346999999999998766 5889999999999999999999996321 1111111110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH-HHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM-SVF 1010 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~-evl 1010 (1025)
.. ...+.....++.+++.+|++.+ ++||++. ++.
T Consensus 211 --~~--~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 --DT--PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 1112234567889999999999 9999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=331.80 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=187.2
Q ss_pred CCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecC------CCCeeEE
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP------KEHEKLV 807 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~~~l 807 (1025)
...++||+|+||.||+|... +++.||||++.... ....+|+.++++++|||||++++++... .....++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34688999999999999964 78999999886432 2345799999999999999999887531 1124668
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
||||+++ ++.+++...... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++..+..+||+|||+|+..
T Consensus 145 vmE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 9999974 777776542211 1268999999999999999999998 899999999999999874567999999999876
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
...... ....||+.|+|||++.+... ++.++|||||||++|||++|.+||..... ...+...+.... ....+
T Consensus 222 ~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~--~p~~~ 293 (440)
T PTZ00036 222 LAGQRS--VSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMILGYPIFSGQSS---VDQLVRIIQVLG--TPTED 293 (440)
T ss_pred cCCCCc--ccCCCCcCccCHHHhcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC--CCCHH
Confidence 543222 22368999999999876543 58899999999999999999999964211 111111111000 00000
Q ss_pred c---chhh--------hc-CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 968 C---FDRL--------IM-DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 968 ~---~d~~--------~~-~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ..+. +. .......+...+.++.+++.+|+..+ .+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000 00 00000012234567899999999999 999999999843
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=312.19 Aligned_cols=253 Identities=18% Similarity=0.315 Sum_probs=194.8
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
..+.||+|+||.||+|... ++..||||++.... .....++.+|+.+++.++||||+++++++. .....++|
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~lv 87 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVI 87 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCeEEE
Confidence 3578999999999999753 35689999986532 234567899999999999999999999886 45578999
Q ss_pred EeccccccHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 809 SNYINAQSLAVYLQETDPR-----KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||+++. ++.++++|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~~~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CCCEEECCCCC
Confidence 9999999999999764221 01246889999999999999999997 89999999999999998 88999999999
Q ss_pred ccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHh
Q 001700 884 HRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 884 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
++........ ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.... ..+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~ 236 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRFVME 236 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHc
Confidence 8765432221 111224578899999987765 5889999999999999999 788886321 1111111111
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
. .....+...+..+.+++.+|++.+ ++||++.|+++.|++
T Consensus 237 ~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 G--------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C--------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 001123345667999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.18 Aligned_cols=246 Identities=18% Similarity=0.237 Sum_probs=190.1
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||.||+++.+ +|+.||+|++..... ...+.+..|++++++++||||+++++++. .....++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 689999999999854 799999999865322 12345667999999999999999998886 456789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||++........ .
T Consensus 79 ~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~--~ 151 (277)
T cd05607 79 DLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKT--I 151 (277)
T ss_pred CHHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCce--e
Confidence 999988654322 48899999999999999999997 89999999999999998 88899999999887654322 1
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||++.+.. ++.++||||+||++|||++|+.||....... ...+..+... ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~-------------~~ 213 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTL-------------ED 213 (277)
T ss_pred eccCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhh-------------cc
Confidence 2236899999999998766 5889999999999999999999986432111 1111111110 00
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
... ......+.++.+++.+|++.+ ++||++.|+++.+
T Consensus 214 ~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 214 EVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 000 011234567899999999999 9999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.54 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=196.6
Q ss_pred CCCceeeeecceEEEEEEe------cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeE
Q 001700 735 APAEVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 806 (1025)
...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++++++ +||||+++++++. .....+
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~ 115 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--IGGPIL 115 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--cCCceE
Confidence 3468999999999999973 135589999987643 23346789999999999 7999999999987 445789
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+++||+.+|+|.++++..... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++. +..++++|||+++.
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~dfg~~~~ 190 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKICDFGLARD 190 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEECCCccccc
Confidence 999999999999999764321 38999999999999999999997 89999999999999987 78899999999986
Q ss_pred cccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 887 LTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 887 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
....... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||...... ..... ...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~-~~~--- 258 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYK-LIK--- 258 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHH-HHH---
Confidence 5433221 111124577899999987766 5889999999999999998 99998643110 01111 000
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
.......+...+.++.+++.+|++.+ ++||++.||++.|++.
T Consensus 259 ----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ----------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111112334567999999999998 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.41 Aligned_cols=240 Identities=21% Similarity=0.301 Sum_probs=190.8
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|.+++..+ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 68899999998642 22345677899999888 6999999999887 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 79 NGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcCCC
Confidence 9999999987653 58999999999999999999997 89999999999999998 88999999999875322221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~----------- 210 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILE----------- 210 (318)
T ss_pred -cccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHc-----------
Confidence 112236899999999998766 5889999999999999999999996321 1111111110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH-----HHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM-----MSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~-----~evl~ 1011 (1025)
.. ...+...+.++.+++.+|+..+ .+||++ .++++
T Consensus 211 --~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 211 --DE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00 1113345667899999999999 999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=317.89 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=196.1
Q ss_pred CceeeeecceEEEEEEec-CCC--EEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGS--ILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.+ ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++. .....++|+||
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~ 89 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEY 89 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCceEEEEe
Confidence 478999999999999964 454 45788776532 33456788999999999 8999999999986 45578999999
Q ss_pred cccccHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEec
Q 001700 812 INAQSLAVYLQETDP-----------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~D 880 (1025)
+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +..+||+|
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~-~~~~kl~d 167 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIAD 167 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecC-CCcEEeCc
Confidence 999999999976431 111358999999999999999999997 89999999999999998 78999999
Q ss_pred cccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHH
Q 001700 881 YSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLL 959 (1025)
Q Consensus 881 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~ 959 (1025)
||+++...... ......++..|+|||++.+.. ++.++|||||||++|||+| |..||.... ..+.....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~ 236 (303)
T cd05088 168 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKL 236 (303)
T ss_pred cccCcccchhh--hcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHhcCCCCcccCC-------hHHHHHHH
Confidence 99986432111 111123467899999887665 5889999999999999998 999986321 11111111
Q ss_pred HhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 960 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
. .....+.+...+..+.+++.+||+.+ ++||+++++++.|+++.....
T Consensus 237 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 P--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred h--------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 11111122334567899999999999 999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=310.91 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=193.1
Q ss_pred ceeeeecceEEEEEEec-CCC--EEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGS--ILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++. .....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeC
Confidence 46899999999999965 444 46888887532 34456789999999999 7999999999987 445689999999
Q ss_pred ccccHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecc
Q 001700 813 NAQSLAVYLQETDP-----------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY 881 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~Df 881 (1025)
++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+|++||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl~df 156 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADF 156 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEECCC
Confidence 99999999976431 111258899999999999999999997 89999999999999998 889999999
Q ss_pred ccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHH
Q 001700 882 SLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLA 960 (1025)
Q Consensus 882 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~ 960 (1025)
|++....... .......+..|+|||++.... ++.++|||||||++|||++ |..||.... ..+......
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~~~~~~~ 225 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLP 225 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCccccC-------HHHHHHHHh
Confidence 9986432111 111113456799999987665 5889999999999999997 999986321 111111111
Q ss_pred hhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 961 LENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 961 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
. ....+.+...+.++.+++.+||..+ .+||++.|+++.|+++.
T Consensus 226 ~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 Q--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C--------------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 1111123334567899999999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.49 Aligned_cols=201 Identities=24% Similarity=0.321 Sum_probs=162.5
Q ss_pred CceeeeecceEEEEEEec---CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD---SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
+..||+|+||.||+|+.. +++.||+|.++.. .....+.+|++++++++||||+++++++........++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999854 5678999998754 22345789999999999999999999887555567899999985
Q ss_pred cccHHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec---CCCCEEEeccccccc
Q 001700 814 AQSLAVYLQETDP----RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA---PTMNAVLTDYSLHRI 886 (1025)
Q Consensus 814 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~---~~~~~kl~DfGla~~ 886 (1025)
++|.+++..... .+...+++..+..++.||+.||+|||+ .+|+||||||+|||++. ..+.+||+|||+++.
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 588888764321 111258999999999999999999997 89999999999999942 256899999999987
Q ss_pred cccCCC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 887 LTSAGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 887 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
...... .......||+.|+|||++.+... ++.++||||+||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCC-cCchhhHHHHHHHHHHHHhCCCCccC
Confidence 654321 11223468999999999876543 58899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=321.09 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=197.0
Q ss_pred CCCceeeeecceEEEEEEe------cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeE
Q 001700 735 APAEVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 806 (1025)
...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++.. .....+
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~~ 88 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLM 88 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec-CCCceE
Confidence 3468899999999999973 357899999997643 22345788999999999 68999999998864 344678
Q ss_pred EEEeccccccHHHHHhhcCCCC----------------------------------------------------------
Q 001700 807 VISNYINAQSLAVYLQETDPRK---------------------------------------------------------- 828 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------------- 828 (1025)
++|||+++|+|.+++.......
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999987532100
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC-ccccccCcccc
Q 001700 829 ----LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-ADQVLNAGALG 903 (1025)
Q Consensus 829 ----~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~ 903 (1025)
...+++.++..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++....... .......++..
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0147889999999999999999997 89999999999999997 78999999999986533221 11111245678
Q ss_pred cCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCc
Q 001700 904 YRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQP 982 (1025)
Q Consensus 904 y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 982 (1025)
|+|||++.+.. ++.++|||||||++|||++ |..||...... ...... ... +.....+
T Consensus 247 y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~-------------~~~~~~~ 304 (343)
T cd05103 247 WMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRR-LKE-------------GTRMRAP 304 (343)
T ss_pred eECcHHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHH-Hhc-------------cCCCCCC
Confidence 99999987665 5889999999999999997 99998643110 011111 111 1111112
Q ss_pred hHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 983 PRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 983 ~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
.....++.+++..||+.+ ++||++.||++.|+.+...
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 223456899999999999 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=325.69 Aligned_cols=237 Identities=19% Similarity=0.292 Sum_probs=188.8
Q ss_pred ceeeeecceEEEEEEe----cCCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 738 EVIGRSCHGTLYKATL----DSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++. .....++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence 5799999999999874 3689999999976432 23456778999999999999999999887 45688999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccCCCC
Confidence 99999999997643 58999999999999999999998 89999999999999998 7899999999988654332
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+......
T Consensus 153 ~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~----------- 211 (318)
T cd05582 153 K-KAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMIL----------- 211 (318)
T ss_pred C-ceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHH-----------
Confidence 2 122346999999999998765 4889999999999999999999997421 111111111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMS 1008 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~e 1008 (1025)
... ...+...+..+.+++.+|++.+ ++||++.+
T Consensus 212 --~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 212 --KAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --cCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 010 1123345567889999999999 99999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.60 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=188.7
Q ss_pred eeeeecceEEEEEEec---CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 739 VIGRSCHGTLYKATLD---SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++. .....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCCC
Confidence 5899999999999854 346799999876432 23457889999999999999999999886 44568999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|+|.+++...........++..++.++.|++.|++|||+ .+++||||||+||+++. +..+|++|||.++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCcceee
Confidence 999999976432222246788889999999999999997 89999999999999998 8899999999987543322211
Q ss_pred -ccccCcccccCccccccCCC-----CCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 895 -QVLNAGALGYRPPEFASTSK-----PCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 895 -~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.....|+..|+|||++.... ..++.++|||||||++|||++ |+.||..... .....+. .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~~---~~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTYT---VR-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHH---hh-cccCC
Confidence 11235788899999886432 124779999999999999996 9999964311 1111110 00 00000
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHHHHh
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELS 1014 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~~L~ 1014 (1025)
..++ .........+.+++..||..+++|||++||++.|+
T Consensus 230 ~~~~--------~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKP--------RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC--------ccCCCCChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 1111 11123345688899999953499999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.53 Aligned_cols=246 Identities=19% Similarity=0.284 Sum_probs=194.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++..++||||+++++++. .....++||||+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYLVMEYM 83 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEEEEcCC
Confidence 578999999999999965 799999999975421 33567889999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC-
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG- 891 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~- 891 (1025)
++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 84 PGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCccCcccCc
Confidence 9999999998752 58999999999999999999998 99999999999999998 8899999999998765433
Q ss_pred ---------------------------CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccc
Q 001700 892 ---------------------------TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVC 944 (1025)
Q Consensus 892 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~ 944 (1025)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC--CCCceeeEecchhhhhhccCCCCCCCCC
Confidence 01122346999999999998775 5899999999999999999999997431
Q ss_pred cCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-HHHHHHH
Q 001700 945 VDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-MMSVFEE 1012 (1025)
Q Consensus 945 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-~~evl~~ 1012 (1025)
....+.. ... +. .....+.....+.++.+++.+|+. + .+||+ +.|+++.
T Consensus 235 ------~~~~~~~-i~~--~~---------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ------LQETYNK-IIN--WK---------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHH-Hhc--cC---------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111 100 00 001111122246778899999998 6 99999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.88 Aligned_cols=249 Identities=23% Similarity=0.431 Sum_probs=196.5
Q ss_pred CceeeeecceEEEEEEec-C---CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-S---GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. + +..||+|.++... ....+.+.+|+.++++++||||+++++++. .....++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~ 86 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVMIVTEY 86 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccEEEEEc
Confidence 578999999999999853 2 3479999987543 334567899999999999999999999986 44578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..++++|||+++......
T Consensus 87 ~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 87 MENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCccccccccc
Confidence 999999999976532 58999999999999999999997 89999999999999988 7899999999998765433
Q ss_pred Ccccc--ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQV--LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
..... ...++..|+|||++.+.. ++.++|||||||++||+++ |+.||..... .....++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~----------- 223 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIKAIE----------- 223 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCc--cCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHHHHh-----------
Confidence 21111 112356899999998765 5889999999999999886 9999864311 11111111
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
...+.+.+...+..+.+++.+|++.+ .+||+|.+|++.|+++
T Consensus 224 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111223345667899999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.01 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=197.0
Q ss_pred CceeeeecceEEEEEEec-C---CCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC----CeeE
Q 001700 737 AEVIGRSCHGTLYKATLD-S---GSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE----HEKL 806 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~~ 806 (1025)
.+.||+|+||.||+|... + +..||+|+++... ....+.+.+|+..++.++||||+++++++..... ...+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 578999999999999864 2 3689999987542 2334678999999999999999999998864221 2378
Q ss_pred EEEeccccccHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 807 VISNYINAQSLAVYLQETDPR-KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
+++||+++|+|..++...... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~ 161 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSK 161 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcccee
Confidence 999999999999998654211 12368999999999999999999997 89999999999999988 7899999999998
Q ss_pred ccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 886 ILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 886 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
......... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.... ...+.+++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~SlG~il~el~~~g~~p~~~~~----~~~~~~~~~------ 229 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVE----NHEIYDYLR------ 229 (273)
T ss_pred eccccccccccccccCCccccCHhhcccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH------
Confidence 765433221 11123567899999987665 5889999999999999999 888886321 111111111
Q ss_pred cccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
.+.....+..++.++.+++.+||+.+ ++||++.||++.|+++
T Consensus 230 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -----------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111223455678999999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=313.53 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=195.5
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.++++++||||+++++++. .....++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~~~~ 87 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT--KEQPLSMIF 87 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCCceEEEE
Confidence 467999999999999853 257899999975432 23467889999999999999999999987 445689999
Q ss_pred eccccccHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEE
Q 001700 810 NYINAQSLAVYLQETDP-----------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl 878 (1025)
||+.+++|.+++..... .....+++..+.+++.|++.||+|||+ ++|+||||||+||+++. +..+||
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~kl 165 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD-KLNVKI 165 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC-CCceEe
Confidence 99999999999864311 011258899999999999999999997 89999999999999987 778999
Q ss_pred eccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHH
Q 001700 879 TDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 879 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~ 956 (1025)
+|||+++......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||... ...++.
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~-------~~~~~~ 236 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGY-------SNQDVI 236 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCC-------CHHHHH
Confidence 9999988654332211 11224678899999987665 5889999999999999998 88887632 111222
Q ss_pred HHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
..... ....+.+..++..+.+++..||+.+ ++||+++||++.|+.
T Consensus 237 ~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRN--------------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHc--------------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 21111 1111224556778999999999999 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=328.76 Aligned_cols=246 Identities=19% Similarity=0.243 Sum_probs=189.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.++..++||||+++++++. .....++||||+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~E~~ 83 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYLIMEYL 83 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEEEECCC
Confidence 578999999999999965 78999999997542 223456788999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 84 PGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccceecccccc
Confidence 9999999997653 58999999999999999999997 89999999999999998 88999999999876432110
Q ss_pred c-------------------------------------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc
Q 001700 893 A-------------------------------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935 (1025)
Q Consensus 893 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt 935 (1025)
. .....+||+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC--CCCeeeeecchhHHHHhhc
Confidence 0 001236999999999987766 5889999999999999999
Q ss_pred CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCC---HHHHHH
Q 001700 936 GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPD---MMSVFE 1011 (1025)
Q Consensus 936 G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs---~~evl~ 1011 (1025)
|+.||..... .+....... . ......+........+.+++.+|+..+.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~-------~~~~~~i~~-~----------~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP-------QETYRKIIN-W----------KETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH-------HHHHHHHHc-C----------CCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhc
Confidence 9999974311 111111100 0 00000111123355678889999874477776 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.74 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=202.1
Q ss_pred CceeeeecceEEEEEEec--CCC--EEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD--SGS--ILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.|+||+|.||+|++|.|+ .|+ .||||+++..... ...+|.+|+.+|.+|+|||+++|||+..+ ....+|+|.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~EL 191 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFEL 191 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhh
Confidence 378999999999999976 344 6899999876544 56889999999999999999999999863 467899999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
++.|+|.+.|+... . ..|-......|+.|||.||.||.+ .+.|||||..+|+|+.. ...+||+|||+.+.+....
T Consensus 192 aplGSLldrLrka~-~--~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK-K--AILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhcc-c--cceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccceeccCCCC
Confidence 99999999998822 1 368888999999999999999998 78899999999999988 7789999999999887765
Q ss_pred Ccccccc--CcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQVLN--AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
....+.. .-...|.|||.+....+ +.++|||+|||++|||+| |+.||.... ...+ .+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF--ShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qI-------------L~~ 327 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF--SHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQI-------------LKN 327 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc--cccchhhhhhhhHHhhhccCCCCCCCCC----HHHH-------------HHh
Confidence 5443321 23557999999998885 899999999999999999 788875321 0111 111
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
+| .+.+.+.+..|++.+++++..||... ++|||+..|.+.+
T Consensus 328 iD----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 ID----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cc----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22 34455678899999999999999999 9999999998543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.76 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=200.2
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+. .+++.||||.+.... .....++.+|+++++.++||||+++++++. .....+++|||+
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v~e~~ 84 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNIVLELA 84 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeEEEEEEec
Confidence 46799999999999995 489999999876432 233467889999999999999999999987 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++....... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++. ++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhhccccCCc
Confidence 9999999987532211 258999999999999999999997 89999999999999988 78999999999887644322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. .....|+..|+|||++.+.. ++.++||||||+++|||++|..||.... ....++.....
T Consensus 162 ~-~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~------------ 221 (267)
T cd08229 162 A-AHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIE------------ 221 (267)
T ss_pred c-cccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCccccc-----chHHHHhhhhh------------
Confidence 1 12236889999999987765 5889999999999999999999985321 11112211110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
............+.++.+++.+||..+ ++||||.+|++.++++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 -QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 001111112346678999999999999 99999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=322.67 Aligned_cols=236 Identities=25% Similarity=0.300 Sum_probs=184.5
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHH-HHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVK-KLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||+||+|+.. +|+.||||++..... ...+++.+|.. +++.++||||+++++++. .....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence 46999999999999965 799999999875421 22334555554 567899999999998886 455889999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 79 NGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccCCC
Confidence 9999999987643 58999999999999999999997 89999999999999998 88999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~-------~~~~~~~~i~------------ 209 (323)
T cd05575 152 -TTSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSR-------DTAEMYDNIL------------ 209 (323)
T ss_pred -ccccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCCC-------CHHHHHHHHH------------
Confidence 122236999999999998766 588999999999999999999998642 1112211111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM 1007 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~ 1007 (1025)
.... ..+...+..+.+++.+|++.+ .+||++.
T Consensus 210 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 210 -NKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -cCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111 112334667899999999999 9999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.92 Aligned_cols=246 Identities=20% Similarity=0.317 Sum_probs=194.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcc--c--cchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLR--E--GIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.++||+|+|-+||||... +|..||=-.++ . ......++|..|+++|+.|+|||||++|.++.+.+.....+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 478999999999999854 67777732222 1 123345789999999999999999999999987777778999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|..|+|..|+++.+ .+..+.+..|++||++||.|||++ ++|+|||||..||+|+...+.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999875 588999999999999999999986 789999999999999987899999999999987654
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
.... ..|||.|||||++... |...+||||||++|+||+|+.+||..-. .-.+-.+. +..+...+.+.
T Consensus 200 ~aks---vIGTPEFMAPEmYEE~---YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKK-V~SGiKP~sl~ 266 (632)
T KOG0584|consen 200 HAKS---VIGTPEFMAPEMYEEN---YNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKK-VTSGIKPAALS 266 (632)
T ss_pred ccce---eccCccccChHHHhhh---cchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHH-HHcCCCHHHhh
Confidence 3322 4799999999999743 5999999999999999999999987431 11111111 11111111111
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~~ 1012 (1025)
.-...++.+|+.+|+....+|||+.|++..
T Consensus 267 ------------kV~dPevr~fIekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 ------------KVKDPEVREFIEKCLATKSERLSAKELLKD 296 (632)
T ss_pred ------------ccCCHHHHHHHHHHhcCchhccCHHHHhhC
Confidence 011356889999999988999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.06 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=195.0
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|...++..+|+|.++... ....++.+|++++++++||||+++++++. .....++|+||+++++
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEFMEHGC 85 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEcCCCCc
Confidence 47899999999999997778899999987542 33567899999999999999999999886 4457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... .++++.+..++.|++.|++|||+ .+|+||||||+||+++. +..+||+|||.++...........
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 86 LSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred HHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeecccCcccccC
Confidence 9999976432 58899999999999999999997 89999999999999987 778999999998865433222122
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++|||||||++|||++ |+.||.... ..+.......
T Consensus 160 ~~~~~~~~~aPe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~-------------- 216 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRS-------NSEVVETINA-------------- 216 (256)
T ss_pred CCccchhhcCHhHhccCC--cChHHHHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHhC--------------
Confidence 223567899999987665 5889999999999999998 999986421 1122221111
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
..+...+...+..+.+++.+||+.+ ++||++.||++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111112234577999999999998 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.13 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=197.1
Q ss_pred ceeeeecceEEEEEEecC--C--CEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLDS--G--SILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 468999999999998642 3 3699999987655 556789999999999999999999999873 6789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccccc
Confidence 99999999987542 258999999999999999999997 89999999999999998 78999999999987654322
Q ss_pred c--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 A--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
. ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||... ...+........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~~~~~~~~~~~------- 216 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGL-------SGSQILKKIDKE------- 216 (257)
T ss_pred ceecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhc-------
Confidence 1 111235778999999987666 5889999999999999999 99998632 111111111110
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
......+...+..+.+++.+|++.+ ++||++.||++.|.
T Consensus 217 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 ------GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111123345678999999999999 99999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=326.44 Aligned_cols=249 Identities=16% Similarity=0.189 Sum_probs=192.7
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....++||||
T Consensus 47 i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~~lv~Ey 124 (371)
T cd05622 47 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRYLYMVMEY 124 (371)
T ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEEEEEEcC
Confidence 3578999999999999965 78899999986432 223456788999999999999999998886 45689999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 125 ~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 125 MPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCCceeEcCcCC
Confidence 9999999998754 48899999999999999999997 89999999999999998 8899999999998765443
Q ss_pred CccccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 892 TADQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.......+||+.|+|||++.... ..++.++|||||||++|||++|+.||... +............
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~------ 263 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-------SLVGTYSKIMNHK------ 263 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCC------
Confidence 33333447999999999987542 12578999999999999999999999732 1111111111000
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CC--CCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SE--RPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~--RPs~~evl~~ 1012 (1025)
.....+.....+..+.+++..|+..+ .+ ||++.||++.
T Consensus 264 -----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 -----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00111122345677889999999865 43 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.53 Aligned_cols=246 Identities=19% Similarity=0.247 Sum_probs=192.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++. .....++||||+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~ 82 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVLTLM 82 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEEEecc
Confidence 478999999999999954 789999999875422 22345778999999999999999999886 445799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 83 NGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCceecCCCCc
Confidence 99999998865432 258999999999999999999998 89999999999999988 78999999999987543322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ....|++.|+|||++.+.. ++.++||||+||++|||++|+.||...... ...+.+...
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~--~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~------------- 216 (285)
T cd05605 158 I--RGRVGTVGYMAPEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERR------------- 216 (285)
T ss_pred c--ccccCCCCccCcHHhcCCC--CCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHH-------------
Confidence 1 2236899999999997665 588999999999999999999999742111 111111100
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
+.. .....+...+..+.+++.+|++.+ ++|| +++++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 217 VKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 000 011123445677899999999999 9999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=294.90 Aligned_cols=271 Identities=19% Similarity=0.313 Sum_probs=208.3
Q ss_pred CHHHhhcCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCee
Q 001700 728 TAEELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 728 ~~~~l~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 805 (1025)
+++|+..-++++||+|+|+.|-.+. +.+|..||||++.+.....+.++.||++++.+++ |+||++++++|. ++...
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~F 151 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRF 151 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceE
Confidence 4678888889999999999999998 7899999999998876667888999999999995 999999999997 55578
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC--CCEEEecccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT--MNAVLTDYSL 883 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~--~~~kl~DfGl 883 (1025)
|+|||-|.||.|..+++++. .|++.++.++..+|+.||.|||. +||.|||+||+|||...++ ..+|||||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999875 69999999999999999999997 9999999999999997644 3589999988
Q ss_pred ccccccC------CCccccccCcccccCcccccc---CCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHH
Q 001700 884 HRILTSA------GTADQVLNAGALGYRPPEFAS---TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD 954 (1025)
Q Consensus 884 a~~~~~~------~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~ 954 (1025)
+..+... .+....+.+|+..|||||+.. +....|+.++|.||+|||+|-|++|.+||...+.+.-+
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----- 300 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----- 300 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC-----
Confidence 7654322 122334568999999999864 34444789999999999999999999999877664311
Q ss_pred HHHHHHhhccccccchhhhcCCCCCC--CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 955 WVRLLALENRSGECFDRLIMDGHDME--QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 955 ~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
|-+...-..--...+.....+.+.++ .......+..+++..-+..+ ..|-++.+|+.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 21100000000112222222323221 12344566777787777778 88888888876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=284.74 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=196.4
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCC
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 803 (1025)
.++.|++. ...||.|..|.|++++++ +|..+|||.+++... ...++++..+.++.+.+ .|.||+.+|||. ...
T Consensus 89 ~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi--~n~ 164 (391)
T KOG0983|consen 89 ADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI--TNT 164 (391)
T ss_pred cChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe--eCc
Confidence 34455544 357999999999999966 689999999987543 34567888888887775 899999999998 455
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
..++.||.| ...++..+..... ++++.-+-++..-+..||.||.++++|+|||+||+|||+|+ .+.+|+||||+
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFGI 238 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFGI 238 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeecccc
Confidence 678889988 4456666665432 68888888999999999999999999999999999999999 88999999999
Q ss_pred ccccccCCCccccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 884 HRILTSAGTADQVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 884 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
+..+.++..+.. .+|.+.|||||.+.-. ...|+.++||||||++++|++||+.||..... +.. .......+
T Consensus 239 sGrlvdSkAhtr--sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-----dFe-~ltkvln~ 310 (391)
T KOG0983|consen 239 SGRLVDSKAHTR--SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-----DFE-VLTKVLNE 310 (391)
T ss_pred cceeeccccccc--ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-----cHH-HHHHHHhc
Confidence 998876654433 3799999999998743 33478899999999999999999999974321 111 11111111
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. .| ..+........+.+++..|+..| .+||...++++
T Consensus 311 e------PP------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 311 E------PP------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C------CC------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 0 11 11122336778999999999999 99999998775
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.40 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=198.0
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|..+++..||||.+.... ...+++.+|+.++++++||||+++++++. .....++||||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEEEeccCCCC
Confidence 57899999999999998878899999987542 34577999999999999999999999886 4457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++.++..++.|++.|++|||+ .+|+|+||||+||+++. +..+|++|||.++...........
T Consensus 88 L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 88 LLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred HHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceeccchhhhhhh
Confidence 9999986532 258999999999999999999997 89999999999999988 889999999998876542222111
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||.+.+.. ++.++|||||||++||++| |+.||.... -....... ..
T Consensus 163 ~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~--------------~~ 219 (261)
T cd05034 163 GAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQV--------------ER 219 (261)
T ss_pred ccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH--------------Hc
Confidence 223567899999988665 5889999999999999999 999985321 01111110 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+...+.++.+++.+|+..+ ++||+++++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111223344678999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=323.42 Aligned_cols=248 Identities=19% Similarity=0.252 Sum_probs=193.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYLVMEYQ 83 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEEEECCC
Confidence 578999999999999854 789999999976432 24566889999999999999999998886 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 84 PGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCeECCCCCc
Confidence 99999999987532 58999999999999999999997 89999999999999998 88999999999987654433
Q ss_pred ccccccCcccccCccccccCC----CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 893 ADQVLNAGALGYRPPEFASTS----KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.......||+.|+|||++... ...++.++|||||||++|||++|+.||.... ............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~----- 225 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-------SAKTYNNIMNFQ----- 225 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-------HHHHHHHHHcCC-----
Confidence 322334699999999998631 1125789999999999999999999996421 111111111100
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.....+.....+.++.+++..|+. + .+||++.++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 ------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000111122345678899999998 6 99999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=323.97 Aligned_cols=241 Identities=24% Similarity=0.295 Sum_probs=185.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHH-HHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVK-KLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||+||+|+.. +|+.||||++.... ....+++.+|.. +++.++||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence 46999999999999854 79999999987542 123345556655 467789999999998887 455889999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 79 NGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCCCC
Confidence 9999999887543 58999999999999999999997 89999999999999998 88999999999875432211
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~-------~~~~~~~~~~~----------- 210 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPFYCR-------DVAEMYDNILH----------- 210 (325)
T ss_pred -CcccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCCCCC-------CHHHHHHHHHc-----------
Confidence 122346999999999998766 588999999999999999999998632 11111111110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
... ...+.....+.+++.+|++.+ .+||++++.++.
T Consensus 211 --~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 211 --KPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --CCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 000 112234566889999999999 999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.82 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=197.3
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhc--CCCCccccccceeecC--CCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGN--IKHPNLVSLQGYYWGP--KEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~--~~~~~~lv~e~~~ 813 (1025)
++||+|.||.||||.+. ++.||||++... .++.|..|-+|.+- ++|+||++++++-... ...++++|++|.+
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 67999999999999987 589999999753 45668888888765 5899999998876421 2457999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE--------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
.|+|.+||..+ .++|.+..+|+.-+++||+|||+. ++|+|||||++|||+.. +.++.|+|||+|.
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDFGLAl 364 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADFGLAL 364 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeeccceeE
Confidence 99999999987 699999999999999999999984 67999999999999988 9999999999999
Q ss_pred ccccCCC-ccccccCcccccCccccccCCCCC----CCCchhHHHHHHHHHHHHcCCCCCC--------ccccCC--CCc
Q 001700 886 ILTSAGT-ADQVLNAGALGYRPPEFASTSKPC----PSLKSDVYAFGIILLELLTGKSSGE--------IVCVDP--GVV 950 (1025)
Q Consensus 886 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~DVwSlGvvl~elltG~~P~~--------~~~~~~--~~~ 950 (1025)
.+..... .+....+||.+|||||++.+.-.- .=.+.||||+|.|+|||++.-.-++ ..+.++ ...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 8865432 223345899999999999764320 0136799999999999999654332 111111 111
Q ss_pred chHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 951 DLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 951 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
.+.+.-...+.++....+-+.-. ....+..+.+.+..||..| +.|-|+.=|-+++.++....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~--------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWR--------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhh--------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 22222222222111111111111 1245778999999999999 99999999999988876543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=323.91 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=192.9
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC---CCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK---EHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~lv~ 809 (1025)
..+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++.... ....++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999995 479999999986532 233467889999999999999999999987422 12689999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeeccc
Confidence 9996 67888876542 58999999999999999999997 89999999999999998 88999999999986544
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc---
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG--- 966 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~--- 966 (1025)
..........+|+.|+|||++.+... ++.++|||||||++|||++|+.||...... ...+-+..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRH-YTSAVDIWSVGCIFAELLGRRILFQAQSPI----QQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCC-CCcHHHHHhHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHHcCCCCHHHHH
Confidence 33222223368899999999876543 588999999999999999999999643110 0000000000000000
Q ss_pred ---ccchhhh-cCCCCC-------CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ---ECFDRLI-MDGHDM-------EQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ---~~~d~~~-~~~~~~-------~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+.....+ ...... ........++.+++.+|++.+ .+|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 000000 011223567889999999999 999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.08 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=197.6
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.. ....++||||+++++
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~ 86 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAKGS 86 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEecCCCc
Confidence 578999999999999876 78999999987644 56789999999999999999999999873 567899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||.++.......
T Consensus 87 L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 87 LVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred HHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccccccc----
Confidence 99999865422 58999999999999999999997 89999999999999998 88999999999987643222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++||||||+++||+++ |+.||..... ..+...+ ..
T Consensus 158 ~~~~~~~~~ape~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~-----------------~~ 214 (256)
T cd05039 158 SGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHV-----------------EK 214 (256)
T ss_pred cCCCcccccCchhhcCCc--CCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH-----------------hc
Confidence 123567899999987665 4889999999999999997 9999863211 1111111 11
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
......+...+..+.+++.+|+..+ ++||++.|+++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111223345678899999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=309.68 Aligned_cols=249 Identities=22% Similarity=0.434 Sum_probs=196.1
Q ss_pred CceeeeecceEEEEEEec-CC---CEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SG---SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. ++ ..||||+++... ....++|..|+.++++++||||+++++++. .....++|+||
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~ 86 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVMIITEF 86 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceEEEEec
Confidence 578999999999999864 33 369999987642 344678999999999999999999999886 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++. +..+|++|||+++......
T Consensus 87 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 87 MENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccccccccCc
Confidence 999999999976532 58999999999999999999997 89999999999999987 7899999999988654332
Q ss_pred Cccc-ccc---CcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 892 TADQ-VLN---AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 892 ~~~~-~~~---~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
.... ... ..+..|+|||++.+.. ++.++|||||||++||+++ |..||.... ..+..+++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~e~l~~g~~p~~~~~----~~~~~~~i~--------- 225 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVINAIE--------- 225 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCc--ccchhhhhhhHHHHHHHhcCCCCCCCCCC----HHHHHHHHH---------
Confidence 2111 111 1245799999987766 5889999999999999886 999986431 111222211
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
...+.+.+.+++..+.+++..||+.+ ++||+|.+|+..|+++
T Consensus 226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 --------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111223455677899999999999 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.06 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=189.3
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++.++ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence 46999999999999964 688999999986432 2345688999999888 6999999999886 455799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 79 NGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCCCC
Confidence 9999999887543 58999999999999999999998 89999999999999998 78999999999875332221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||+...... .....+++......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~---------- 217 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILE---------- 217 (327)
T ss_pred -ceecccCCcccCCHHHHCCCC--CCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHh----------
Confidence 122347999999999998766 5889999999999999999999996432211 11222222211111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM 1007 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~ 1007 (1025)
.. ...+...+..+.+++.+|++.+ .+||++.
T Consensus 218 --~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 --KP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11 1123344567889999999999 9999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.37 Aligned_cols=243 Identities=19% Similarity=0.258 Sum_probs=201.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh---cHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK---GKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|.||.||+|+.+ +|+.+|+|++.+.... ..+.+.+|+++|+++. |||||.+++.|. .....++|||+
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e--~~~~~~lvmEL 117 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE--DPDSVYLVMEL 117 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE--cCCeEEEEEEe
Confidence 478999999999999966 6999999999776443 3468999999999998 999999999998 44589999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC---CCEEEeccccccccc
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT---MNAVLTDYSLHRILT 888 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~---~~~kl~DfGla~~~~ 888 (1025)
+.||.|.+.+... .+++..+..++.|++.|++|||+ .||+|||+||+|+|+.... ..+|++|||++....
T Consensus 118 ~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 118 CEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred cCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999875 28999999999999999999998 9999999999999997632 479999999999887
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. ......+||+.|+|||++.... ++..+||||+||++|.|++|..||....... ...
T Consensus 191 ~~--~~~~~~~Gtp~y~APEvl~~~~--y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------~~~------------ 248 (382)
T KOG0032|consen 191 PG--ERLHTIVGTPEYVAPEVLGGRP--YGDEVDVWSIGVILYILLSGVPPFWGETEFE------IFL------------ 248 (382)
T ss_pred CC--ceEeeecCCccccCchhhcCCC--CCcccchhHHHHHHHHHhhCCCCCcCCChhH------HHH------------
Confidence 62 2334458999999999998766 5899999999999999999999997542211 111
Q ss_pred chhhhcC--CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 969 FDRLIMD--GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 969 ~d~~~~~--~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
....+ .+..+..+.......+++..|+..+ .+|+|+.++++.
T Consensus 249 --~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 --AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 1222345666888999999999999 999999999983
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.06 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=196.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. +++.||+|.+... .....+++.+|++++++++||||+++++++. .....++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 82 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVMEYAE 82 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEEEeCC
Confidence 478999999999999965 7899999998643 2345677899999999999999999999987 4558899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++. +..++|+|||+++........
T Consensus 83 ~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 83 NGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceeccCccch
Confidence 9999999987532 268999999999999999999997 89999999999999998 789999999998876543322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
. ....|++.|+|||+..+.. ++.++|||||||++|||++|+.||.... -....... .
T Consensus 158 ~-~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~-------------~ 214 (256)
T cd08529 158 A-NTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKI-------------I 214 (256)
T ss_pred h-hccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH-------------H
Confidence 2 2236889999999998766 5889999999999999999999986431 01111110 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+ ...+.+...+.++.+++.+||+.+ ++||+|.+|++.
T Consensus 215 ~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 111223355678999999999999 999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.29 Aligned_cols=247 Identities=21% Similarity=0.390 Sum_probs=197.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|...++..+|+|.++.. ....+.+.+|++++++++|+||+++++++.. ...+++|||+++++
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~~~~~~ 86 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMAKGS 86 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEeCCCCc
Confidence 5789999999999999777888999998754 2345678999999999999999999988763 46899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++. +..+||+|||.+............
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 87 LLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred HHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeeccCCCccccc
Confidence 9999976432 258899999999999999999997 89999999999999988 889999999999866443222222
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.... ++.++|||||||++||++| |+.||.... ...+..+.. .
T Consensus 162 ~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~~-----------------~ 218 (260)
T cd05073 162 GAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRALE-----------------R 218 (260)
T ss_pred CCcccccccCHhHhccCC--cCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHh-----------------C
Confidence 224567899999987665 5889999999999999999 999986321 111111111 1
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+...+.++.+++.+|++.+ ++||++.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223445677999999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.95 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=194.5
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++. .....++|+||+++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS--ENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec--cCCEEEEEEecCCCCC
Confidence 57999999999999854 68899999988765556678999999999999999999999987 4567899999999999
Q ss_pred HHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 817 LAVYLQETDPRKLPPL--SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|.+++..... .+ ++..+..++.|++.||+|||+ .+|+||||||+||+++..+..++|+|||.+.........
T Consensus 92 L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~- 165 (268)
T cd06624 92 LSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC- 165 (268)
T ss_pred HHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence 9999986432 34 788999999999999999997 899999999999999875678999999998765432221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|++.|+|||++.+....++.++|||||||++|||++|+.||..... .....|... ..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~~~~~~~~--------------~~ 227 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQAAMFKVG--------------MF 227 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hhhhHhhhh--------------hh
Confidence 112358899999999876543358899999999999999999999864211 111111100 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+.....++.+++.+||+.+ ++||++.||++
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011123445677899999999999 99999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.54 Aligned_cols=240 Identities=19% Similarity=0.331 Sum_probs=184.4
Q ss_pred eeeeecceEEEEEEecC-------------------------CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccc
Q 001700 739 VIGRSCHGTLYKATLDS-------------------------GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSL 793 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 793 (1025)
.||+|+||.||+|.+.. ...||+|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544445678899999999999999999
Q ss_pred cceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC-
Q 001700 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP- 872 (1025)
Q Consensus 794 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~- 872 (1025)
++++. .....++||||+++|+|..++..... .+++..++.++.||++||+|||+ .+|+||||||+||+++..
T Consensus 82 ~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCV--RGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEE--eCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccC
Confidence 99997 44578999999999999999875432 58999999999999999999997 899999999999999752
Q ss_pred -----CCCEEEeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHH-HcCCCCCCccccC
Q 001700 873 -----TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLEL-LTGKSSGEIVCVD 946 (1025)
Q Consensus 873 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~el-ltG~~P~~~~~~~ 946 (1025)
...+|++|||.+....... ...++..|+|||.+.+... ++.++|||||||++||+ ++|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKERTP- 227 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCccccCh-
Confidence 1237999999876543221 1257888999998876432 58899999999999998 579999864311
Q ss_pred CCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 947 PGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 947 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.....+.. . ... .+......+.+++.+||+.+ ++||+|.+|++.|+
T Consensus 228 ---~~~~~~~~-------------~----~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERFYE-------------K----KHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHHH-------------h----ccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110 0 000 11122346889999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.43 Aligned_cols=253 Identities=19% Similarity=0.355 Sum_probs=197.5
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++. .....++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v 87 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TGQPTLVV 87 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CCCCcEEE
Confidence 3578999999999999854 24689999987543 234567889999999999999999999987 44578999
Q ss_pred EeccccccHHHHHhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 809 SNYINAQSLAVYLQETDPRK-----LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
|||+++|+|.+++....... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~~kl~dfg~ 165 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLTVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCCEEECCccc
Confidence 99999999999997643211 1247899999999999999999997 89999999999999998 88999999999
Q ss_pred ccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHh
Q 001700 884 HRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 884 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
++........ ......++..|+|||.+.+.. ++.++|||||||++||++| |+.||.... .....++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~~~~~~~---- 235 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGLS----NEEVLKFVI---- 235 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCC--CCcccchHHHHHHHHHhhccCCCCCccCC----HHHHHHHHh----
Confidence 8865443221 112235678999999987665 5889999999999999998 999986321 111111111
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.......+...+.++.+++.+||+.+ ++|||+.++++.|++
T Consensus 236 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -------------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111223445778999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.21 Aligned_cols=250 Identities=20% Similarity=0.231 Sum_probs=193.5
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++. .....++|+||+++
T Consensus 13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~--~~~~~~iv~e~~~~ 90 (267)
T cd06646 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL--SREKLWICMEYCGG 90 (267)
T ss_pred hhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE--eCCEEEEEEeCCCC
Confidence 357899999999999995 578999999997654445567889999999999999999999987 45578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 91 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 91 GSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceeeccccc-c
Confidence 99999987543 58999999999999999999997 89999999999999987 77899999999987643221 1
Q ss_pred ccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 895 QVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....|++.|+|||.+... ...++.++|||||||++|||++|+.||........ ... ......
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~-------------~~~~~~ 226 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFL-------------MSKSNF 226 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---hee-------------eecCCC
Confidence 1223688999999987532 11247899999999999999999999853311100 000 000000
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ..........+..+.+++.+||..+ ++||++++|++.
T Consensus 227 ~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 227 Q-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred C-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0 0001112234577899999999999 999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.18 Aligned_cols=241 Identities=20% Similarity=0.353 Sum_probs=186.6
Q ss_pred ceeeeecceEEEEEEec-C-------CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATLD-S-------GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
+.||+|+||.||+|... . ...||+|.+........+++.+|+.+++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEE
Confidence 46999999999999853 2 23488888876544556778999999999999999999999874 44689999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCC-------EEEeccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMN-------AVLTDYS 882 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~-------~kl~DfG 882 (1025)
||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++..+.. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999986532 58999999999999999999997 899999999999999873322 6999999
Q ss_pred cccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCC-CCCCccccCCCCcchHHHHHHHHh
Q 001700 883 LHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK-SSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 883 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~-~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
.+....... ...+++.|+|||++.+... ++.++|||||||++|||++|. .||.... -...... .
T Consensus 154 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~~~~~~~~-------~~~~~~~--~ 218 (258)
T cd05078 154 ISITVLPKE-----ILLERIPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALD-------SQKKLQF--Y 218 (258)
T ss_pred cccccCCch-----hccccCCccCchhccCCCC-CCchhhHHHHHHHHHHHHcCCCCChhhcc-------HHHHHHH--H
Confidence 887553321 2357889999999976443 588999999999999999995 5544211 0011100 0
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
. . +...+.....++.+++.+||+.+ ++|||+++|++.|+
T Consensus 219 ~------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 E------------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred H------------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 01112334467899999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=321.35 Aligned_cols=240 Identities=24% Similarity=0.279 Sum_probs=185.3
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHH-HHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVK-KLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||+||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++++. .....++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence 46999999999999965 678999999875421 22234444544 567889999999999887 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 79 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccCCC
Confidence 9999999997643 58899999999999999999997 89999999999999988 78999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~----------- 210 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILN----------- 210 (325)
T ss_pred -CcccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHh-----------
Confidence 122346999999999998766 5889999999999999999999996321 1111111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.. ...++..+..+.+++.+|++.+ .+||++.+.+.
T Consensus 211 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 211 --KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 00 0112344567889999999999 99999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.96 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=190.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++. .....++||||+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYLVMDYY 83 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEEEEecC
Confidence 578999999999999965 68999999987532 223456889999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++........
T Consensus 84 ~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 84 VGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCceeecCCCCC
Confidence 99999999976421 58999999999999999999997 89999999999999987 88999999999876654333
Q ss_pred ccccccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 ADQVLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.......||+.|+|||++... ...++.++|||||||++|||++|+.||... ...+......... ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-------~~~~~~~~i~~~~---~~~ 227 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHK---EHF 227 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-------CHHHHHHHHHcCC---Ccc
Confidence 333334699999999998631 112578999999999999999999998632 1222211111100 000
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC---CCCCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA---SERPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~---~~RPs~~evl~~ 1012 (1025)
. . .......+..+.+++.+|+..+ ..||++.++++.
T Consensus 228 ~------~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q------F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c------C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0 0111224566778888876554 348899988765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.86 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=201.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++. .....++||||+
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 84 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNELNIVLELA 84 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEEEEEecC
Confidence 578999999999999976 89999999886422 233567899999999999999999999987 445789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++....... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||++........
T Consensus 85 ~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccC-CCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceeeeccCCCc
Confidence 9999999987532211 258999999999999999999997 89999999999999988 78899999999886543322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||... ..+..++......
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~----------- 222 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNLYSLCKKIEK----------- 222 (267)
T ss_pred c-cceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccC-----CccHHHHHhhhhc-----------
Confidence 1 12236889999999987665 588999999999999999999998532 1222222221110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+..........+..+.+++.+||..+ ++||++.+|+++|+++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 --CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00110112245678999999999999 99999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.50 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=195.5
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
++||+|+||.||+|...+++.||+|.++..... ..+.+.+|++++++++||||+++++++. .....++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence 468999999999999766999999998765433 4568999999999999999999999887 4557899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc-
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ- 895 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~- 895 (1025)
|.+++..... .+++..++.++.+++.||+|||+ .+|+||||||+||+++. +..+||+|||.+...........
T Consensus 79 l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 79 LLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcceecc
Confidence 9999976432 57899999999999999999997 89999999999999988 78999999999886543221111
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....++..|+|||.+.+.. ++.++|||||||++|||+| |..||..... ..+.... .
T Consensus 153 ~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~--------------~ 209 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERI--------------E 209 (251)
T ss_pred ccCcceeccCChHhhccCC--CCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHH--------------h
Confidence 1113456799999987665 5889999999999999999 8888853211 1111110 0
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.......+...+.++.+++.+|+..+ ++||++.||++.|++
T Consensus 210 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11111224455678999999999998 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.74 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=197.1
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|... ++..+|+|.++.......+.+.+|++++++++||||+++++++. .....++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 87 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT--EGRPLLMVFE 87 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe--cCCceEEEEe
Confidence 578999999999999632 46689999988766666778999999999999999999999887 4456899999
Q ss_pred ccccccHHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEec
Q 001700 811 YINAQSLAVYLQETDPR----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~D 880 (1025)
|+++++|.+++...... ....+++.+++.++.|++.|++|||+ .+|+||||||+||+++. +..+||+|
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~-~~~~kL~d 165 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ-GLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-CCCEEECC
Confidence 99999999999765321 11258999999999999999999997 89999999999999987 88999999
Q ss_pred cccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHH
Q 001700 881 YSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 881 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
||+++......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||..... .+.+..
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~ 236 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------TEAIEC 236 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCccCCH-------HHHHHH
Confidence 99987654322111 11124577899999987766 5889999999999999998 8999863211 111111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
. ... .....+..++..+.+++.+||+.+ ++||++.||++.|++
T Consensus 237 ~-------------~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 I-------------TQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-------------HcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 000 011123345667899999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.60 Aligned_cols=252 Identities=21% Similarity=0.377 Sum_probs=193.9
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++. .....++||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 88 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF--ERLPRFILL 88 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCcEEEE
Confidence 478999999999999864 35789999887543 333567899999999999999999999886 344679999
Q ss_pred eccccccHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC--CCCEEEecccccc
Q 001700 810 NYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP--TMNAVLTDYSLHR 885 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~--~~~~kl~DfGla~ 885 (1025)
||+++++|.+++...... ....+++.++++++.||+.||+|||+ .+++||||||+||+++.. +..+||+|||+++
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 999999999999765321 11258999999999999999999998 899999999999999752 2368999999998
Q ss_pred ccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 886 ILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 886 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
......... .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||+.... .+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~--- 235 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QEVMEFVT--- 235 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHH---
Confidence 763322211 11113456799999997666 5899999999999999997 9999864211 11111111
Q ss_pred cccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
...+.+.+...+.++.+++.+|++.+ ++||++.+|++.|+
T Consensus 236 -----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111223445678999999999999 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=338.68 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=196.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|+.++++++|||||+++++|........++||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 578999999999999964 67899999986532 234567899999999999999999999887555567899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCcccCCCCCCEEeecC---------------
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE------RAIPHGNLKSTNILLEAP--------------- 872 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~ivHrDlkp~NILl~~~--------------- 872 (1025)
+|+|.+++...... ...+++..++.|+.||+.||+|||+. .+||||||||+|||++..
T Consensus 98 gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 99999999764211 12689999999999999999999972 249999999999999641
Q ss_pred -CCCEEEeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcc
Q 001700 873 -TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVD 951 (1025)
Q Consensus 873 -~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~ 951 (1025)
...+||+|||++......... ....||+.|+|||++.+....++.++|||||||++|||+||+.||... ..
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~--~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~------~~ 248 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA------NN 248 (1021)
T ss_pred CCCceEEccCCccccccccccc--cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC------Cc
Confidence 234899999999876433221 223699999999998654433688999999999999999999999632 12
Q ss_pred hHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHH--HHHhhcc
Q 001700 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVF--EELSTIV 1017 (1025)
Q Consensus 952 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl--~~L~~i~ 1017 (1025)
...++..... ....+ ....+.++.+|+..||..+ .+||++.|++ ..+..+.
T Consensus 249 ~~qli~~lk~--------------~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 249 FSQLISELKR--------------GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHhc--------------CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 2222221110 01000 1223567899999999999 9999999998 4455443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.40 Aligned_cols=255 Identities=18% Similarity=0.325 Sum_probs=196.2
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|..+ .+..||+|.+.... .....++.+|+.++++++||||+++++++. .....++||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 88 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KGQPTLVVM 88 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEE
Confidence 578999999999999743 24589999986543 233456889999999999999999999886 445789999
Q ss_pred eccccccHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccc
Q 001700 810 NYINAQSLAVYLQETDPR-----KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLH 884 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla 884 (1025)
||+++|+|.+++...... ..+..++..+..++.|++.||+|||+ ++|+||||||+||+++. +..++++|||++
T Consensus 89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~~~~L~Dfg~~ 166 (288)
T cd05061 89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMT 166 (288)
T ss_pred eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CCcEEECcCCcc
Confidence 999999999999764211 12356788999999999999999997 89999999999999998 889999999998
Q ss_pred cccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 885 RILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 885 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
+......... .....++..|+|||.+.+.. ++.++|||||||++|||++ |+.||... +..++......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~-------~~~~~~~~~~~- 236 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGL-------SNEQVLKFVMD- 236 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHc-
Confidence 8654322211 11124567899999987766 5889999999999999999 78888632 11122211111
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
......+...+..+.+++.+|++.+ ++||++.++++.|++...
T Consensus 237 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 -------------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred -------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 0111122344578999999999999 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.48 Aligned_cols=243 Identities=17% Similarity=0.264 Sum_probs=202.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
++-||+|.|.+|-.|++- +|+.||||++.+.. ......+.+|++.|+-++|||||++|++.. .....|+|.|.-+
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD--TQTKlyLiLELGD 100 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID--TQTKLYLILELGD 100 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc--ccceEEEEEEecC
Confidence 467999999999999854 89999999997653 233567889999999999999999999875 5557999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|++|+-.+.. .+.+.-+.+|+.||+.|+.|+|. -.+||||+||+||.+-+.-+-+||.|||++-.+.++...
T Consensus 101 ~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 101 GGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred CchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999999987653 58999999999999999999996 789999999999999776788999999999877665433
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.+.||+..|-|||++.+..+ ..+++||||+|||+|.+++|+.||+...+.+ ...-++|-
T Consensus 176 --~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------TLTmImDC-- 234 (864)
T KOG4717|consen 176 --TTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------TLTMIMDC-- 234 (864)
T ss_pred --hcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccccchh----------------hhhhhhcc--
Confidence 34589999999999999886 5789999999999999999999998542211 01111221
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....|.....++.+++..|+..+ .+|.+..||+.
T Consensus 235 ----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 ----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11347788899999999999999 99999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.31 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=199.7
Q ss_pred ceeeeecceEEEEEEec-C---CCEEEEEEccccchhc-HHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-S---GSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|... . +..||+|+++...... .+.+.+|++.++.++|+||+++++++. .....++|+||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEEEec
Confidence 46899999999999965 3 8899999998754333 678999999999999999999999987 456899999999
Q ss_pred ccccHHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 813 NAQSLAVYLQETDPR----KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
++++|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||.+....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSRDVY 156 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEcccccccccc
Confidence 999999999875211 01268999999999999999999997 89999999999999998 7899999999998775
Q ss_pred cCCC-ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 889 SAGT-ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 889 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
.... .......++..|+|||.+.... ++.++||||+||++|||++ |+.||.... ..+......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~------ 221 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLR------ 221 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCC--cchhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHH------
Confidence 4321 1122235788999999987765 5889999999999999999 699987431 111111111
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.......+...+.++.+++.+|+..+ ++||++.|+++.|+
T Consensus 222 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 --------KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122234455778999999999999 99999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=319.68 Aligned_cols=236 Identities=24% Similarity=0.295 Sum_probs=184.0
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHH-HHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVK-KLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
++||+|+||.||+|+.. +++.||+|++..... ....++.+|.. +++.++||||+++++++. .....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 47999999999999965 789999999875421 22344555554 578899999999998886 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|..++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 79 NGGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCCCC
Confidence 9999998887543 58899999999999999999997 89999999999999998 88999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +.........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~------------ 209 (321)
T cd05603 152 -TTSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSR-------DVSQMYDNIL------------ 209 (321)
T ss_pred -ccccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCC-------CHHHHHHHHh------------
Confidence 122346999999999987765 588999999999999999999999632 1112211111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM 1007 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~ 1007 (1025)
.. ....+......+.+++.+|++.+ .+||++.
T Consensus 210 -~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 -HK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -cC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 01123344567899999999999 9999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.59 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=187.6
Q ss_pred eeeeecceEEEEEEec---CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 739 VIGRSCHGTLYKATLD---SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++++. .....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCCC
Confidence 5899999999999753 34578899876543 233467889999999999999999999887 45578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc-
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA- 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~- 893 (1025)
|+|.+++...........++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccchhee
Confidence 999999987543222246788899999999999999997 89999999999999998 889999999998754332211
Q ss_pred cccccCcccccCccccccCC-----CCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 894 DQVLNAGALGYRPPEFASTS-----KPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
......+++.|+|||++... ...++.++|||||||++|||++ |..||..... ... ........ ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~-~~~~~~~~-~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQV-LKQVVREQ-DIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHH-HHHHhhcc-Ccc
Confidence 11222467789999987531 1125789999999999999999 7888763311 100 01001110 000
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHHHHh
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELS 1014 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~~L~ 1014 (1025)
.. .+..+...+..+.+++..||.++++||+++||++.|.
T Consensus 230 ~~--------~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LP--------KPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred CC--------CCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 00 1112334566778899999964499999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=338.31 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.||+|+.. +|+.||||+++... ....+++.+|++++++++||||+++++++. +....++||||+
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyLVMEY~ 84 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYYTMPYI 84 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEEEEEcC
Confidence 578999999999999864 68999999997542 223567999999999999999999999887 455789999999
Q ss_pred ccccHHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 813 NAQSLAVYLQETDPR------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
++|+|.+++...... ....+++..++.++.||++||+|||+ .+|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKLiDFGLAk~ 162 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVILDWGAAIF 162 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEEEecCccee
Confidence 999999998753111 01246778899999999999999997 89999999999999998 88999999999986
Q ss_pred cccCCC-----------------ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCC
Q 001700 887 LTSAGT-----------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGV 949 (1025)
Q Consensus 887 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~ 949 (1025)
...... ......+||+.|||||++.+.. ++.++|||||||++|||+||+.||.....
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~~PF~~~~~---- 236 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFPYRRKKG---- 236 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCCCCCCCcch----
Confidence 621110 0011136999999999998776 58899999999999999999999964211
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-CHHHHHHHHhhccc
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-DMMSVFEELSTIVL 1018 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-s~~evl~~L~~i~~ 1018 (1025)
..+.. .. ...++.- .......+..+.+++.+|++.+ ++|| +++++.+.|+....
T Consensus 237 ~ki~~-------~~---~i~~P~~-----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RKISY-------RD---VILSPIE-----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh-------hh---hccChhh-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 00 0001100 0011234567889999999999 9995 77888888887754
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.04 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
..+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++. .....++|+||+++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~--~~~~~~lv~e~~~~ 101 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAG 101 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE--eCCEEEEeecccCC
Confidence 357899999999999985 478999999987665555677899999999999999999999887 45589999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.........
T Consensus 102 ~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 102 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhccccccc-
Confidence 9999998653 47899999999999999999997 89999999999999988 789999999998865432211
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|++.|+|||.+.+.. ++.++|||||||++|||++|+.||..... ...+.... ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~-~~------------ 231 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIA-TN------------ 231 (296)
T ss_pred cCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHh-cC------------
Confidence 12236889999999987665 48899999999999999999999964311 11111100 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.......+...+..+.+++.+||..+ ++||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00011123345677899999999999 999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.33 Aligned_cols=267 Identities=22% Similarity=0.350 Sum_probs=202.7
Q ss_pred CceeeeecceEEEEEEec-----CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-----SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+++ ++..||||+++..... ..+++.+|++++++++||||+++++++........++++|
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 378999999999999854 3689999999865433 4678999999999999999999999887545667899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||.+......
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGLAKVLPED 162 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccccccccccC
Confidence 9999999999986532 58999999999999999999997 89999999999999998 789999999999876532
Q ss_pred CCcc--ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GTAD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.... .....++..|+|||+..+.. ++.++|||||||++|||+||+.|+....... ..++... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~-~~~~~~~~ 234 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSK--FSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIA-QGQMIVTR 234 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCC--CCcccchHHHhhhhheeeccCCCcccccchh-----ccccccc-cccccHHH
Confidence 2211 11123566799999987665 5889999999999999999999986432111 0000000 00000000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+...+....+.+.+..++.++.+++.+||+.+ ++||+|.||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111111222223445678999999999999 99999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=318.30 Aligned_cols=236 Identities=19% Similarity=0.277 Sum_probs=186.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. +++.||||++++... ...+.+..|..++..+ +|++|+++++++. .....++||||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~ 82 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYFVMEY 82 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEEEEcC
Confidence 578999999999999865 688999999876432 2334567788888877 5899999998886 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 83 VNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCceecCCCC
Confidence 99999999987653 58999999999999999999997 89999999999999998 8899999999987543222
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.. .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||..... .+.......
T Consensus 156 ~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~---------- 215 (323)
T cd05616 156 VT-TKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIME---------- 215 (323)
T ss_pred Cc-cccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHh----------
Confidence 11 12246999999999998766 58999999999999999999999974311 111111110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
.. ...+.....++.+++.+|++.+ ++|++.
T Consensus 216 ---~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 ---HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 1123345667899999999999 999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.32 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=196.6
Q ss_pred CCceeeeecceEEEEEEec-CCC----EEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGS----ILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.++++++||||++++|+|.. ...++++
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~ 87 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVT 87 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCceeee
Confidence 3578999999999999853 454 478998875432 234578899999999999999999999863 2467899
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++....
T Consensus 88 e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 88 QLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFGLARLLEG 161 (303)
T ss_pred hhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEccccccccccC
Confidence 99999999999876532 58999999999999999999997 89999999999999987 77899999999987643
Q ss_pred CCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 890 AGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||.... .....+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~~~~---------- 225 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPDLLE---------- 225 (303)
T ss_pred cccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH----------
Confidence 3221 111224577899999987665 5889999999999999997 899986321 111222211
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
.....+.+..++..+.+++..||..+ ++||+|++|++.|+++..+.+
T Consensus 226 -------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 226 -------KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 01111122334567899999999999 999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.66 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=193.3
Q ss_pred CCceeeeecceEEEEEEecC---------------CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeec
Q 001700 736 PAEVIGRSCHGTLYKATLDS---------------GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWG 799 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 799 (1025)
..+.||+|+||.||+|+... ...||+|.++... ....+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~- 87 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV- 87 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc-
Confidence 35789999999999987532 2358999987642 334567999999999999999999999987
Q ss_pred CCCCeeEEEEeccccccHHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC
Q 001700 800 PKEHEKLVISNYINAQSLAVYLQETDPR-------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872 (1025)
Q Consensus 800 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~ 872 (1025)
.....++||||+++++|.+++...... ..+.+++.+++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nill~~- 164 (295)
T cd05097 88 -SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNCLVGN- 164 (295)
T ss_pred -CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChhhEEEcC-
Confidence 455789999999999999999654211 11247899999999999999999997 89999999999999987
Q ss_pred CCCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc--CCCCCCccccCCCC
Q 001700 873 TMNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT--GKSSGEIVCVDPGV 949 (1025)
Q Consensus 873 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt--G~~P~~~~~~~~~~ 949 (1025)
+..+||+|||++.......... .....++..|+|||+..+.. ++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---- 238 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---- 238 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHHcCCCCCCcccCh----
Confidence 7889999999988654332211 11124577899999987666 5899999999999999998 5667653211
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
......+....... .... + ...+...+..+.+++.+||+.+ ++||+|++|++.|++
T Consensus 239 ~~~~~~~~~~~~~~------~~~~---~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQ------GRQI---Y-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhc------cccc---c-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000 0000 0 0112334568999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.60 Aligned_cols=236 Identities=18% Similarity=0.278 Sum_probs=185.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCC-ccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHP-NLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..++|+ +|+++++++. .....++||||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~ 82 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYFVMEY 82 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEEEEcC
Confidence 478999999999999865 67899999997542 23456688899999999765 6888888776 45579999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcceecCCCC
Confidence 99999999987653 58999999999999999999997 89999999999999998 7899999999987532221
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||..... .+......
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~----------- 214 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIM----------- 214 (324)
T ss_pred C-ceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH-----------
Confidence 1 122346999999999998766 48899999999999999999999964211 11111110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
.. ....+.....++.+++.+|+..+ .+||+.
T Consensus 215 --~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 --EH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --cC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 01123345567889999999999 999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.95 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=197.2
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCC
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKE 802 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 802 (1025)
.|+.++++. ...||.|+||+|+|-.++ .|+..|||+++... .+..++++.|.+...+- +.||||++||.+. .+
T Consensus 60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~E 135 (361)
T KOG1006|consen 60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SE 135 (361)
T ss_pred ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cC
Confidence 355555544 367999999999999866 79999999998754 35677888898876555 6899999999987 56
Q ss_pred CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccc
Q 001700 803 HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882 (1025)
Q Consensus 803 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfG 882 (1025)
+..|+.||.| .-++..+...........+++.-.-.|+.-...||.||-.+..|+||||||+|||+|. .+.+||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeeccc
Confidence 6899999999 4466554332111111258888888999999999999998788999999999999998 8899999999
Q ss_pred cccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 883 LHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 883 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
++..+.++- ..+..+|...|||||.+.....+++.++||||+|++|||++||+.|+... .+..+.+......
T Consensus 214 IcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svfeql~~Vv~g 285 (361)
T KOG1006|consen 214 ICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVFEQLCQVVIG 285 (361)
T ss_pred chHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHHHHHHHHHcC
Confidence 998775432 22334799999999999866555799999999999999999999998632 1122222222111
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.. |.+.... ........+..++..|+..+ ..||.++++.+.
T Consensus 286 dp------p~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DP------PILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CC------CeecCcc---cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 10 1111100 12235677999999999999 999999988653
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.22 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=194.1
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccch-----hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA-----KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..+.||+|++|.||+|.. ++++.||+|.++.... ...+.+.+|++++++++||||+++++++. .....++|+
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~ 83 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR--DDETLSIFM 83 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc--cCCeEEEEE
Confidence 368899999999999985 4789999999864321 12356889999999999999999999987 445899999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceeccc
Confidence 9999999999987653 58899999999999999999997 89999999999999997 88999999999876543
Q ss_pred CCCccc--cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 890 AGTADQ--VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
...... ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||.... ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~-~------- 220 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFE------AMAAIFKI-A------- 220 (263)
T ss_pred cccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccc------hHHHHHHH-h-------
Confidence 221111 2235788999999998766 5889999999999999999999986421 11111000 0
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
........+......+.+++..||..+ ++||++.|+++.
T Consensus 221 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 ------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111223455677899999999998 999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.15 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=197.6
Q ss_pred CCceeeeecceEEEEEEec--------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCee
Q 001700 736 PAEVIGRSCHGTLYKATLD--------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 805 (1025)
..+.||+|+||.||+|+.. ....||+|.++... .....++.+|+++++++ +||||+++++++. .....
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~ 93 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--QEGPL 93 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--cCCce
Confidence 4689999999999999742 24579999987542 23456788999999999 6999999999886 44578
Q ss_pred EEEEeccccccHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC
Q 001700 806 LVISNYINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~ 874 (1025)
++++||+++|+|.+++...... ....+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Nill~~-~~ 171 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DN 171 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccceeEEEcC-CC
Confidence 9999999999999999764310 11258999999999999999999997 89999999999999987 78
Q ss_pred CEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcch
Q 001700 875 NAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDL 952 (1025)
Q Consensus 875 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l 952 (1025)
.+||+|||.++......... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.... .
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~~g~~p~~~~~-------~ 242 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIP-------V 242 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCC--cCccchhhHHHHHHHHHHhCCCCCCCCCC-------H
Confidence 99999999998664322211 11113456799999987665 5889999999999999999 888886321 1
Q ss_pred HHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 953 TDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 953 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
.+...... .....+.+..++.++.+++.+|+..+ ++||++.||++.|+++..
T Consensus 243 ~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 EELFKLLR--------------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHH--------------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111 11111223445667889999999999 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.67 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=195.8
Q ss_pred CceeeeecceEEEEEEecC-----------------CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceee
Q 001700 737 AEVIGRSCHGTLYKATLDS-----------------GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYW 798 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 798 (1025)
.+.||+|+||.||+|+... +..||+|++.... ....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 5789999999999997542 2468999987653 334678899999999999999999999987
Q ss_pred cCCCCeeEEEEeccccccHHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC
Q 001700 799 GPKEHEKLVISNYINAQSLAVYLQETDPRK------LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872 (1025)
Q Consensus 799 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~ 872 (1025)
.....++++||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 90 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp~Nili~~- 165 (296)
T cd05051 90 --VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLATRNCLVGK- 165 (296)
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccchhceeecC-
Confidence 3457899999999999999997654211 1258999999999999999999997 89999999999999998
Q ss_pred CCCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc--CCCCCCccccCCCC
Q 001700 873 TMNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT--GKSSGEIVCVDPGV 949 (1025)
Q Consensus 873 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt--G~~P~~~~~~~~~~ 949 (1025)
+..++|+|||+++......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.... .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~~~~~p~~~~~----~ 239 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLT----D 239 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC--CCccchhhhhHHHHHHHHhcCCCCCCCCcC----h
Confidence 7899999999988654332211 11234678899999987655 5889999999999999998 677775321 1
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+........ . ....+.+..++.++.+++.+|++.+ ++||+++||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~------~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDG------R----QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhcccccc------c----cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111100000 0 0001113344578999999999999 999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=315.46 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=201.2
Q ss_pred hcCCCceeeeecceEEEEEEec--------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCC
Q 001700 733 SHAPAEVIGRSCHGTLYKATLD--------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKE 802 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 802 (1025)
.+...+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|+++++++ +||||++++++|. ..
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~ 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QD 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--cC
Confidence 3445689999999999999742 12378999887542 23456789999999999 7999999999987 44
Q ss_pred CeeEEEEeccccccHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec
Q 001700 803 HEKLVISNYINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA 871 (1025)
Q Consensus 803 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~ 871 (1025)
...++++||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE 169 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC
Confidence 5789999999999999999764311 11258899999999999999999997 89999999999999988
Q ss_pred CCCCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCC
Q 001700 872 PTMNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGV 949 (1025)
Q Consensus 872 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~ 949 (1025)
+..+||+|||+++......... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...
T Consensus 170 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~------ 240 (334)
T cd05100 170 -DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGI------ 240 (334)
T ss_pred -CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHhcCCCCCCCC------
Confidence 7899999999998664432211 11123457899999997766 5889999999999999998 88888632
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccccc
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~ 1020 (1025)
+..++...... ....+.+...+.++.+++.+||+.+ ++||+|.|+++.|+++....
T Consensus 241 -~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 241 -PVEELFKLLKE--------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -CHHHHHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 22233222111 1111223345667999999999999 99999999999999988443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.27 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=199.5
Q ss_pred CCceeeeecceEEEEEEec-CCC----EEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGS----ILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..+.||+|+||.||+|... +|. .||+|.++.... ....++.+|+.++++++||||+++++++.. ...++|+
T Consensus 11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 87 (279)
T cd05057 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLIT 87 (279)
T ss_pred EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEEE
Confidence 3588999999999999854 343 689998876532 345678999999999999999999999873 5789999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||.++....
T Consensus 88 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLDV 161 (279)
T ss_pred ecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCcccccccC
Confidence 99999999999986532 58999999999999999999998 99999999999999987 77899999999987653
Q ss_pred CCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 890 AGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
..... .....++..|+|||.+.... ++.++|||||||++||+++ |+.||+... ..++.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~------- 225 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AVEIPDLLE------- 225 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCC--cCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHh-------
Confidence 32211 11112456899999887655 5889999999999999999 999986431 112221111
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccccc
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~~~ 1021 (1025)
.....+.+..+...+.+++.+||..+ .+||++.++++.|+++..+..
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 226 -------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred -------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 11111223344567899999999999 999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.65 Aligned_cols=239 Identities=21% Similarity=0.255 Sum_probs=192.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchh---cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK---GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
+.||+|.-|+||+++.+ ++..+|+|++.+.... ...+.+.|-+||+.++||.++.||+.+. .++..+++||||+
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe--t~~~~cl~meyCp 160 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE--TDKYSCLVMEYCP 160 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee--ccceeEEEEecCC
Confidence 67999999999999976 5689999999876433 3456778999999999999999999997 5668999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC--
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG-- 891 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~-- 891 (1025)
||+|....+.+..+ .|++..++.++.+|+.||+|||- .|||.|||||+||||.+ ++++-|+||.++.......
T Consensus 161 GGdL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CccHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeeccccccCCCCCee
Confidence 99999998876543 69999999999999999999996 99999999999999988 9999999999866431100
Q ss_pred -------------------------------C----------------------ccccccCcccccCccccccCCCCCCC
Q 001700 892 -------------------------------T----------------------ADQVLNAGALGYRPPEFASTSKPCPS 918 (1025)
Q Consensus 892 -------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 918 (1025)
. ......+||..|.|||++.+.++ +
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH--g 313 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH--G 313 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC--C
Confidence 0 00112379999999999999884 8
Q ss_pred CchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccC
Q 001700 919 LKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCIL 998 (1025)
Q Consensus 919 ~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 998 (1025)
.++|+|+|||++|||+.|+.||...... . .+...+......+..+..+..+.+++..-+.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~---~-----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK---E-----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch---h-----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 8999999999999999999999743211 1 1222222333333344677889999999998
Q ss_pred CC-CCCCC
Q 001700 999 PA-SERPD 1005 (1025)
Q Consensus 999 ~~-~~RPs 1005 (1025)
.| .+|--
T Consensus 374 KdP~kRlg 381 (459)
T KOG0610|consen 374 KDPSKRLG 381 (459)
T ss_pred cChhhhhc
Confidence 88 98987
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.76 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=196.9
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
..||.|+||+||+|..+ ++-..|.|++.-......++|.-|++||..++||+||++++.|+ .++..|++.|||.||-
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy--~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY--FENKLWILIEFCGGGA 115 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh--ccCceEEEEeecCCch
Confidence 45899999999999965 45566788887776777889999999999999999999999887 4568999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
...++-+-+. .+++.++..+++|++.||.|||+ ..|||||||+-|||+.- ++.++|+|||.+........ ...
T Consensus 116 VDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~~t~q-kRD 188 (1187)
T KOG0579|consen 116 VDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNKSTRQ-KRD 188 (1187)
T ss_pred HhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccchhHHh-hhc
Confidence 9998877653 79999999999999999999998 78999999999999998 88999999999875443221 222
Q ss_pred ccCcccccCccccccCCCC---CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 897 LNAGALGYRPPEFASTSKP---CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~---~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
...|||+|||||+.....+ .|++++||||||+++.||..+.+|-... +-.+ ++-...
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMR-------------VllKia 248 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMR-------------VLLKIA 248 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHH-------------HHHHHh
Confidence 3479999999998864221 2688999999999999999999995532 1111 111111
Q ss_pred c-CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 M-DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~-~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. ..+..-.|......|.++...|+..+ ..||++.++++
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 11223356778889999999999999 99999999886
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=317.31 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=189.1
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC----CeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE----HEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~~lv 808 (1025)
..+.||+|+||.||+|+.. +|..||||++.... ....+.+.+|+.+++.++||||+++++++..... ...++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 3578999999999999854 78999999986532 2345678899999999999999999998863221 347999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++ ++.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAC 174 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCccccc
Confidence 999965 56666642 47899999999999999999997 89999999999999998 8899999999998653
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc--
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG-- 966 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~-- 966 (1025)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....|......-+...
T Consensus 175 ~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~------~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 175 TNFM--MTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKGSVIFQGTD------HIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred cCcc--CCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCcHH
Confidence 3221 12236899999999998766 5889999999999999999999997431 1122221111100000
Q ss_pred ------ccchhhhcCC------------------CCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ------ECFDRLIMDG------------------HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ------~~~d~~~~~~------------------~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+....... ...........++.+++.+|+..+ ++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 000011123467899999999999 999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=330.77 Aligned_cols=247 Identities=16% Similarity=0.175 Sum_probs=187.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++.+. .....++||||+
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~E~~ 83 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFVMDYI 83 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEEEEeCC
Confidence 578999999999999954 78999999987542 123456889999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC-
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG- 891 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~- 891 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++..+....
T Consensus 84 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 84 PGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcccccccc
Confidence 9999999997653 58899999999999999999997 89999999999999998 8899999999975321000
Q ss_pred -----------------------------------------CccccccCcccccCccccccCCCCCCCCchhHHHHHHHH
Q 001700 892 -----------------------------------------TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIIL 930 (1025)
Q Consensus 892 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl 930 (1025)
.......+||+.|||||++.+.. ++.++|||||||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil 234 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCcceeeeecccee
Confidence 00001236999999999998766 58899999999999
Q ss_pred HHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCC---CHH
Q 001700 931 LELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERP---DMM 1007 (1025)
Q Consensus 931 ~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RP---s~~ 1007 (1025)
|||++|+.||..... .++...... +. .....+.......++.+++.+|+..+.+|+ ++.
T Consensus 235 yell~G~~Pf~~~~~-------~~~~~~i~~--~~---------~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ 296 (376)
T cd05598 235 YEMLVGQPPFLADTP-------AETQLKVIN--WE---------TTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGAD 296 (376)
T ss_pred eehhhCCCCCCCCCH-------HHHHHHHhc--cC---------ccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHH
Confidence 999999999974311 111111100 00 000011122344556777777765338898 888
Q ss_pred HHHHH
Q 001700 1008 SVFEE 1012 (1025)
Q Consensus 1008 evl~~ 1012 (1025)
|+++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.21 Aligned_cols=376 Identities=20% Similarity=0.204 Sum_probs=269.0
Q ss_pred CCCCCCCCccceEcCCCCEEEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCC-CCCCCCCCEEeccCCcCcc
Q 001700 49 SSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHG 127 (1025)
Q Consensus 49 ~~d~C~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~-~~~l~~L~~LdLs~N~l~~ 127 (1025)
|+-.|.|.-.-..|+..++..++ ...|.|.++ ..-+.||+|+|.+.....+ |.++++|+.++|..|.++
T Consensus 46 cpa~c~c~~~lldcs~~~lea~~--~~~l~g~lp-------~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt- 115 (873)
T KOG4194|consen 46 CPATCPCNTRLLDCSDRELEAID--KSRLKGFLP-------SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT- 115 (873)
T ss_pred CCCcCCCCceeeecCcccccccc--ccccCCcCc-------cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-
Confidence 45557665666667655544443 233455444 2345678888887766544 777888888888888877
Q ss_pred cCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCC
Q 001700 128 LIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207 (1025)
Q Consensus 128 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 207 (1025)
.+|.......+|+.|+|.+|.|+.+-.+.+..++.|+.||||.|.|+......|..-.++++|+|++|.|+..-.. .
T Consensus 116 ~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~---~ 192 (873)
T KOG4194|consen 116 RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG---H 192 (873)
T ss_pred hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccc---c
Confidence 4566555566688888888888777677777788888888888888766666676667788888888888744333 3
Q ss_pred CcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCccccc-CCcccccccccceecccccccccCChhHHhhcc
Q 001700 208 SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGA-IPSFNFVFSLRILRLGSNQLSGSLPVALLQESS 286 (1025)
Q Consensus 208 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~ 286 (1025)
+..+.+|..|.|+.|+++. .|...|.+++.|+.|+|..|+|... .-.|.++.+|+.|.|..|.++..-...|..+.
T Consensus 193 F~~lnsL~tlkLsrNritt--Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~- 269 (873)
T KOG4194|consen 193 FDSLNSLLTLKLSRNRITT--LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE- 269 (873)
T ss_pred ccccchheeeecccCcccc--cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec-
Confidence 3344677788888888753 4445677778888888888877654 33577777888888888887733333333332
Q ss_pred cccCeEEcccccCcCc--ccccCCCCccEEEccCCcccCCCCCCC---CCcceeeccCccCCCcccccccCCCccceEEe
Q 001700 287 MMLSELDLSLNQLEGP--VGSITSATLKKVNLSSNKLSGSLPARV---GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHL 361 (1025)
Q Consensus 287 ~~L~~L~ls~N~l~~~--~~~~~~~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L 361 (1025)
.+++|+|+.|+++.. .+...++.|+.|+||+|.|...-++.. ..|+.|||++|+|+...+..+..+..|++|+|
T Consensus 270 -kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 -KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred -ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 377888888887652 245567778888888888765434332 35678888888888777777777788889999
Q ss_pred cCCCCCCCCchhccCCCCCCEEEecCcccCCCcc---cccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcC
Q 001700 362 SSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLP---AVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF 438 (1025)
Q Consensus 362 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 438 (1025)
++|+++..-...|..+++|+.|||++|.|+..+- ..|..++.|+.|+|.+|+|+.+.-..|..+.+|++|||.+|.+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 9999887777788888999999999999886653 3577888999999999999887777888999999999999987
Q ss_pred ccc
Q 001700 439 SGP 441 (1025)
Q Consensus 439 ~~~ 441 (1025)
...
T Consensus 429 aSI 431 (873)
T KOG4194|consen 429 ASI 431 (873)
T ss_pred eee
Confidence 643
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=328.31 Aligned_cols=195 Identities=19% Similarity=0.232 Sum_probs=164.4
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|||||++++.+. .....++||||+
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv~E~~ 83 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFVMDYI 83 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEEEeCC
Confidence 57899999999999985 478999999987542 233457889999999999999999999987 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 84 PGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcccccccc
Confidence 9999999997653 58899999999999999999997 89999999999999998 88999999999753210000
Q ss_pred ----------------------------------------------ccccccCcccccCccccccCCCCCCCCchhHHHH
Q 001700 893 ----------------------------------------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926 (1025)
Q Consensus 893 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSl 926 (1025)
......+||+.|+|||++.+.. ++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSl 234 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCCeeeEEec
Confidence 0001236999999999998766 5889999999
Q ss_pred HHHHHHHHcCCCCCCc
Q 001700 927 GIILLELLTGKSSGEI 942 (1025)
Q Consensus 927 Gvvl~elltG~~P~~~ 942 (1025)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=311.69 Aligned_cols=202 Identities=23% Similarity=0.307 Sum_probs=162.1
Q ss_pred CceeeeecceEEEEEEec---CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD---SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
+..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++........++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 45789999987542 2346789999999999999999999887555667899999986
Q ss_pred cccHHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec---CCCCEEEeccccccc
Q 001700 814 AQSLAVYLQETDP----RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA---PTMNAVLTDYSLHRI 886 (1025)
Q Consensus 814 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~---~~~~~kl~DfGla~~ 886 (1025)
++|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++.. .++.+||+|||+++.
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 578887753211 111258999999999999999999998 89999999999999942 256899999999987
Q ss_pred cccCCCc--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 887 LTSAGTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 887 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
....... ......||+.|+|||++.+... ++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCc-cCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6543221 1122368999999999876443 588999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=311.04 Aligned_cols=258 Identities=20% Similarity=0.297 Sum_probs=194.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||++... ++..||+|.++... ....+++.+|++++++++||||+++++++. .....++|+||+++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ey~~~ 83 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG 83 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEeeccCC
Confidence 578999999999999855 78899999987542 233466889999999999999999999987 45689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++.... .+++..+..++.|++.||.|||+..+|+||||||+||+++. ++.+||+|||++........
T Consensus 84 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~-- 155 (308)
T cd06615 84 GSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMA-- 155 (308)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCccccccccc--
Confidence 99999997653 58999999999999999999997468999999999999988 78899999999876543222
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc---------
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS--------- 965 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~--------- 965 (1025)
....|+..|+|||++.+.. ++.++|||||||++|||++|+.||..... .....+..........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 156 -NSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred -ccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcCccccccccCCcccccC
Confidence 1236899999999987655 58899999999999999999999863311 1111111100000000
Q ss_pred -----------cccchhhhcCCCCCCC-chHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 966 -----------GECFDRLIMDGHDMEQ-PPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 966 -----------~~~~d~~~~~~~~~~~-~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+..+..... ..+.. ......++.+++.+|+..+ ++||++.||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111111 11111 1124567999999999999 999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.71 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=190.8
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.++||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++. .....++|+||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 83 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF--VENRISICTEFMDG 83 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--ECCEEEEEEecCCC
Confidence 47899999999999985 478999999986542 334567899999999999999999999987 44578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++. ++.++|+|||++........
T Consensus 84 ~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~~~~~-- 150 (279)
T cd06619 84 GSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIA-- 150 (279)
T ss_pred CChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecccccc--
Confidence 9997552 47889999999999999999997 89999999999999998 88999999999986543321
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....||..|+|||++.+.. ++.++|||||||++|||++|+.||..............+......
T Consensus 151 -~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 214 (279)
T cd06619 151 -KTYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD------------- 214 (279)
T ss_pred -cCCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-------------
Confidence 1236899999999998766 588999999999999999999999753322111111111111100
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.............++.+++.+|++.+ ++||+++|+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000011224456899999999999 999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.73 Aligned_cols=239 Identities=21% Similarity=0.371 Sum_probs=186.7
Q ss_pred ceeeeecceEEEEEEecC-C----------CEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeE
Q 001700 738 EVIGRSCHGTLYKATLDS-G----------SILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 806 (1025)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence 468999999999999753 3 25788887654333 6788999999999999999999999874 4679
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC-------CEEEe
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM-------NAVLT 879 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~-------~~kl~ 879 (1025)
+|+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++. +. .+|++
T Consensus 77 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEeC
Confidence 99999999999999986532 58999999999999999999997 89999999999999987 44 69999
Q ss_pred ccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHH
Q 001700 880 DYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 880 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
|||++....... ...++..|+|||++.+....++.++|||||||++|||++ |..||..... ..+...
T Consensus 151 Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-------~~~~~~ 218 (259)
T cd05037 151 DPGIPITVLSRE-----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-------SEKERF 218 (259)
T ss_pred CCCccccccccc-----ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-------hhHHHH
Confidence 999988654311 124678899999987762236889999999999999999 5777654311 111111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
... .... +......+.+++.+||..+ ++||++.||++.|+
T Consensus 219 ~~~--------------~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQD--------------QHRL--PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred Hhc--------------CCCC--CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100 0000 1111267899999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.38 Aligned_cols=236 Identities=18% Similarity=0.274 Sum_probs=185.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.++||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++..+. |++|+++++++. .....++||||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~Ey 82 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYFVMEY 82 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEEEEcC
Confidence 478999999999999854 78999999987542 223456788999998885 577888888876 44578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeccccccccCCCC
Confidence 99999999987653 58999999999999999999997 89999999999999998 8899999999988643322
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ........
T Consensus 156 ~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~----------- 214 (323)
T cd05615 156 VT-TRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIM----------- 214 (323)
T ss_pred cc-ccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH-----------
Confidence 21 12236999999999998766 58899999999999999999999974311 11111111
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM 1006 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~ 1006 (1025)
.... ..+...+.++.+++.+|++.+ .+|++.
T Consensus 215 --~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 215 --EHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --hCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111 123344567889999999999 999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.19 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=193.9
Q ss_pred CceeeeecceEEEEEEec-----------------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceee
Q 001700 737 AEVIGRSCHGTLYKATLD-----------------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYW 798 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 798 (1025)
.+.||+|+||.||++... ++..||+|+++... ....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 578999999999998532 24479999997643 334578999999999999999999999987
Q ss_pred cCCCCeeEEEEeccccccHHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC
Q 001700 799 GPKEHEKLVISNYINAQSLAVYLQETDPRK------LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872 (1025)
Q Consensus 799 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~ 872 (1025)
.....+++|||+++|+|.+++....... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 90 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~Nili~~- 165 (296)
T cd05095 90 --TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATRNCLVGK- 165 (296)
T ss_pred --cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChheEEEcC-
Confidence 4457899999999999999997643211 1247889999999999999999997 89999999999999987
Q ss_pred CCCEEEeccccccccccCCCcc-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc--CCCCCCccccCCCC
Q 001700 873 TMNAVLTDYSLHRILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT--GKSSGEIVCVDPGV 949 (1025)
Q Consensus 873 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt--G~~P~~~~~~~~~~ 949 (1025)
+..++|+|||+++......... .....+++.|+|||+..+.. ++.++|||||||++|||++ |..||.....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~---- 239 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLSD---- 239 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC--ccchhhhhHHHHHHHHHHHhCCCCCccccCh----
Confidence 8899999999998654332211 11123467899999877665 5889999999999999998 6778753211
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.+++..... .+........ .+.+..++..+.+++.+||+.+ .+||+|.||++.|++
T Consensus 240 ---~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ---EQVIENTGE------FFRDQGRQVY-LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHH------HHhhcccccc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111000 0000000000 1123345578999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.75 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=190.6
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
..+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++. .....++||||++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 87 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH--TDKSLTLVFEYLD 87 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe--eCCeEEEEEeCCC
Confidence 3578999999999999865 688999999875432 23456788999999999999999999987 4557899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+ +|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++........
T Consensus 88 ~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 88 K-DLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred C-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECccccceecCCCccc
Confidence 4 88888865432 58899999999999999999997 89999999999999998 789999999998765332221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-ccc-----c-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRS-----G- 966 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~-----~- 966 (1025)
.....+|+.|+|||++.+... ++.++|||||||++|||+||+.||..... .+........ +.. .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSE-YSTQIDMWGVGCIFFEMASGRPLFPGSTV-------EDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred -cccccccccccCCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHhCCCCHHHHhh
Confidence 122368899999998875443 58899999999999999999999964311 1111111000 000 0
Q ss_pred ----ccchhhhcCCCC----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 967 ----ECFDRLIMDGHD----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 967 ----~~~d~~~~~~~~----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+...-...+. .........++.+++.+|++.+ .+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 0011234567889999999999 99999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=316.83 Aligned_cols=257 Identities=17% Similarity=0.194 Sum_probs=189.5
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv 808 (1025)
..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 3578999999999999854 68999999987542 233467789999999999999999999886322 2357999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++ ++.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAG 170 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCcccccCC
Confidence 999965 67776653 47899999999999999999997 89999999999999988 8899999999998654
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc----
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR---- 964 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~---- 964 (1025)
..... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....|......-+.
T Consensus 171 ~~~~~--~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 171 TSFMM--TPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred Ccccc--CCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHH
Confidence 33221 2236899999999997766 5889999999999999999999996321 11122111100000
Q ss_pred ------------------ccccchhhhcCCC----CCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 965 ------------------SGECFDRLIMDGH----DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 965 ------------------~~~~~d~~~~~~~----~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
......+...... ..........++.+++.+|+..+ ++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000 00112223567899999999999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=306.96 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=193.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++. .....++|+||++++
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~~v~e~~~~~ 87 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFCAGG 87 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe--eCCEEEEEEEecCCC
Confidence 467999999999999965 68889999987665556678899999999999999999999987 455889999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||++........ ..
T Consensus 88 ~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 88 AVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEcccccccccccccc-cc
Confidence 9999886532 158999999999999999999997 89999999999999988 78899999999876543221 12
Q ss_pred cccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 896 VLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....|++.|+|||++... ...++.++|||||||++|||++|+.||..... .+.+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~--------- 224 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE--------- 224 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcC---------
Confidence 223689999999998421 11257899999999999999999999864311 11111110000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
......+...+.++.+++.+||+.+ ++||++.+|++.
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 ---PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123345677899999999999 999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=308.32 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=191.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++++++|++|+++++.+. .....++||||+
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 82 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVLTLM 82 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe--cCCEEEEEEEec
Confidence 478999999999999854 789999999865422 22345778999999999999999998886 445789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++. +..++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 83 NGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceeecCCCcc
Confidence 99999999865432 258999999999999999999997 89999999999999998 77899999999876543322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||....... ....+ ..... .
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~-~~~~~---------~- 219 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEV-ERLVK---------E- 219 (285)
T ss_pred c--cCCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHH-Hhhhh---------h-
Confidence 1 1236899999999998766 5889999999999999999999997432110 00000 00000 0
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~ 1011 (1025)
... ..+.....++.+++..|++.+ ++||| +.|+++
T Consensus 220 ~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 112334566889999999999 99999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=308.18 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=196.0
Q ss_pred CCceeeeecceEEEEEEec------CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
..+.||+|+||.||+|... ++..||+|+++... ....+++.+|+.++++++||||+++++++. .+...+++
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~~~~~lv 86 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VGKPMCLL 86 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCccEEE
Confidence 3578999999999999853 46789999987643 234567999999999999999999999887 44578999
Q ss_pred EeccccccHHHHHhhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec
Q 001700 809 SNYINAQSLAVYLQETDP-----------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA 871 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~ 871 (1025)
+||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~nil~~~ 165 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRNCLVGE 165 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccHhheEecC
Confidence 999999999999975321 111257899999999999999999997 89999999999999988
Q ss_pred CCCCEEEeccccccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCC
Q 001700 872 PTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGV 949 (1025)
Q Consensus 872 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~ 949 (1025)
++.++|+|||+++........ ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||...
T Consensus 166 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~~~~p~~~~------ 236 (288)
T cd05050 166 -NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPYYGM------ 236 (288)
T ss_pred -CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC------
Confidence 889999999998765332211 111123567799999987665 5889999999999999998 88887532
Q ss_pred cchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 950 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
...++...... . ...+.+...+.++.+++.+|++.+ ++||++.||++.|++
T Consensus 237 -~~~~~~~~~~~-~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -AHEEVIYYVRD-G-------------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -CHHHHHHHHhc-C-------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11222221111 0 111123345678999999999998 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.14 Aligned_cols=251 Identities=17% Similarity=0.206 Sum_probs=189.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++..++|++|+++++++. .....++||||+
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~lv~Ey~ 83 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYLVMDYY 83 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEeCC
Confidence 578999999999999965 78899999987532 223455788999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 84 VGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEeccceeeccCCCc
Confidence 99999999986421 58999999999999999999997 89999999999999987 78999999999987654433
Q ss_pred ccccccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 ADQVLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||... +..+.........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-------~~~~~~~~i~~~~------ 224 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHE------ 224 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-------CHHHHHHHHHcCC------
Confidence 3333346999999999987521 12478999999999999999999999632 1111111111100
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CC--CCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SE--RPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~--RPs~~evl~~ 1012 (1025)
... .. +......+.++.+++.+|+..+ .+ |++++++++.
T Consensus 225 -~~~--~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 -ERF--QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -Ccc--cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 00 0111234567888999988765 33 6788888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.80 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=193.4
Q ss_pred ceeeeecceEEEEEEecC-------CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATLDS-------GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
+.||+|+||.||+|+..+ +..||||.+.... .....++.+|+.++++++||||+++++++. .....++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEE
Confidence 368999999999998542 2579999886543 234567899999999999999999999987 445789999
Q ss_pred eccccccHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC-----CEEEeccc
Q 001700 810 NYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM-----NAVLTDYS 882 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~-----~~kl~DfG 882 (1025)
||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++. +. .++++|||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~dfg 156 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIGDFG 156 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEECCcc
Confidence 999999999999764221 11258899999999999999999997 89999999999999987 44 79999999
Q ss_pred cccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHH
Q 001700 883 LHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLA 960 (1025)
Q Consensus 883 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~ 960 (1025)
+++........ ......++..|+|||++.+.. ++.++|||||||++|||+| |+.||.... .......+ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~----~~~~~~~~---~ 227 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALN----NQEVLQHV---T 227 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccC----HHHHHHHH---h
Confidence 98765432211 111224567899999998766 5889999999999999998 999986321 11111111 0
Q ss_pred hhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 961 LENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 961 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
.......+...+..+.+++.+||..+ ++||++++|++.|++
T Consensus 228 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 --------------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01111223445678899999999999 999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=307.93 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=195.9
Q ss_pred CCCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 735 APAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....++||||++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~ 99 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLA 99 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEeecccC
Confidence 3457899999999999995 579999999997655555677889999999999999999999987 4558899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 100 GGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceEccCCccC
Confidence 99999998653 48899999999999999999997 89999999999999987 789999999998865433221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....|++.|+|||.+.+.. ++.++|||||||++|++++|+.||....... .. .....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slGvil~~l~tg~~pf~~~~~~~------~~-------------~~~~~ 229 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------AL-------------YLIAT 229 (297)
T ss_pred -cCcccCCccccCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCcch------he-------------eeecc
Confidence 12236889999999987765 4889999999999999999999996431110 00 00000
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+......+...+..+.+++.+||..+ ++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111123345567889999999999 99999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=322.20 Aligned_cols=194 Identities=20% Similarity=0.272 Sum_probs=155.9
Q ss_pred CCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCC------CccccccceeecCCCCeeEE
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKH------PNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~~~~~~l 807 (1025)
...++||+|+||+||+|... +++.||||+++... ...+++..|+++++.++| ++++++++++.. .....++
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~~~~~~i 209 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-ETGHMCI 209 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-CCceEEE
Confidence 34578999999999999854 68899999997532 233456667777776654 458888888864 3447889
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC--------------
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT-------------- 873 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~-------------- 873 (1025)
|||++ +++|.+++.... .+++..+..|+.||+.||+|||++.+||||||||+|||++..+
T Consensus 210 v~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 99988 788998887653 5899999999999999999999645999999999999998622
Q ss_pred -CCEEEeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 874 -MNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 874 -~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
..+||+|||.+...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||+.
T Consensus 284 ~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CceEEECCCCccccCccc----cccccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 14999999987643221 22347999999999998776 58899999999999999999999974
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.54 Aligned_cols=245 Identities=21% Similarity=0.302 Sum_probs=195.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc-chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|+.++++++||||+++++.+. .....++++||+++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 82 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVMEYCDG 82 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEeeCCC
Confidence 578999999999999865 7899999998643 2344567889999999999999999999887 45689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++. ++.++++|||.+..........
T Consensus 83 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 83 GDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeeccccccc
Confidence 999998875432 258999999999999999999997 89999999999999988 7899999999998765432221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||... +.........
T Consensus 158 -~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~-------~~~~~~~~~~-------------- 213 (255)
T cd08219 158 -CTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQAN-------SWKNLILKVC-------------- 213 (255)
T ss_pred -ccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCC-------CHHHHHHHHh--------------
Confidence 1236889999999987765 588999999999999999999998632 1111111110
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+...+.+...+..+.+++.+||+.+ ++||++.||+..
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 214 QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01111123345567889999999999 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=303.65 Aligned_cols=248 Identities=18% Similarity=0.305 Sum_probs=191.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCC----CCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPK----EHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~----~~~~~lv~e 810 (1025)
.+.||+|+||.||+|... +++.||+|++... .....++.+|+.+++++ +||||+++++++.... ....+++||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 467999999999999854 6889999998654 33456788999999998 6999999999986422 235899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+.+++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||+++.....
T Consensus 90 ~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 90 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCceecccc
Confidence 9999999999986432 258999999999999999999998 89999999999999998 788999999999865432
Q ss_pred CCccccccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.. ......|+..|+|||++... ...++.++|||||||++|||++|+.||.... ....+... ...
T Consensus 165 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~------~~~~~~~~--~~~---- 231 (272)
T cd06637 165 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLI--PRN---- 231 (272)
T ss_pred cc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC------HHHHHHHH--hcC----
Confidence 21 22234689999999998632 1125789999999999999999999986431 11111110 000
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+.......+..+.+++.+||..+ .+||++.||++
T Consensus 232 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 --------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000112234567899999999999 99999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=307.26 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=195.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....++|+||++++
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~ 101 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEEecCCC
Confidence 57899999999999984 578999999987655555678899999999999999999999987 455899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++......... .
T Consensus 102 ~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 102 SLTDVVTET------CMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred cHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhccccccc-C
Confidence 999998653 58999999999999999999998 89999999999999988 889999999998865443221 1
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||.+.+.. ++.++|||||||++|||++|+.||.... .. +........ .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~~lltg~~pf~~~~------~~-~~~~~~~~~------------~ 231 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNEN------PL-RALYLIATN------------G 231 (296)
T ss_pred CCcCCCccccCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC------HH-HHHHHHHhc------------C
Confidence 2236889999999987765 4889999999999999999999986431 11 111111000 0
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
......+...+..+.+++.+||..+ ++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0011123345567889999999999 999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=307.78 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=196.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++. .....++|+||+++
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 87 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNICMCMEFMDC 87 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEEEEEEecCCC
Confidence 478999999999999854 78999999886543 334578899999999999999999999987 44689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++.... .+++..+..++.+++.||.|||+..+|+||||||+||+++. +..++|+|||++........
T Consensus 88 ~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~~~~~~~-- 159 (284)
T cd06620 88 GSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIA-- 159 (284)
T ss_pred CCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccchhhhcc--
Confidence 99999987643 58999999999999999999996568999999999999988 78999999999875533221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCC----cchHHHHHHHHhhccccccch
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGV----VDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~----~~l~~~~~~~~~~~~~~~~~d 970 (1025)
....|+..|+|||++.+.. ++.++|||||||++||++||+.||......... ..+.+++....
T Consensus 160 -~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 226 (284)
T cd06620 160 -DTFVGTSTYMSPERIQGGK--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------- 226 (284)
T ss_pred -CccccCcccCCHHHHccCC--CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh----------
Confidence 1236899999999987665 588999999999999999999999754322110 11112222111
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
............+..+.+++.+|++.+ ++||++.||++..
T Consensus 227 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 ---QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111100011235667899999999999 9999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=304.28 Aligned_cols=242 Identities=20% Similarity=0.312 Sum_probs=193.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 86 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIMEYLGG 86 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEEccCC
Confidence 366999999999999854 68899999987442 334567899999999999999999999987 45578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... .+++..+..++.|+++|+.|||+ .+|+|+||+|+||+++. ++.++++|||++........ .
T Consensus 87 ~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 87 GSALDLLKPG------PLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccccCcch-h
Confidence 9999998643 58999999999999999999997 89999999999999988 78999999999987654322 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|+..|+|||++.+.. ++.++|||||||++|||+||+.||...... .+... +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~--------------~~ 214 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSA--YDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFL--------------IP 214 (277)
T ss_pred hhcccCcccccCHHHhCcCC--CchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhh--------------hh
Confidence 12235888999999998765 588999999999999999999998643111 01100 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...........+.++.+++.+||+.+ ++||+|.+|++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00111123345677899999999999 999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.14 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=171.0
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+. .+|+.||||.++... ....+...+|+++|++++|||||+++++-.... .....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 57899999999999995 589999999998754 345677899999999999999999998765433 446789999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC---CCCEEEecccccccc
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP---TMNAVLTDYSLHRIL 887 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~---~~~~kl~DfGla~~~ 887 (1025)
||.+|||+.++.+-.... .|++.+.+.+..+++.||.|||+ ++||||||||.||++-.. ....||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~--GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAY--GLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCccccc--CCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999998654332 69999999999999999999996 999999999999998431 234789999999998
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
.++.. ....+||..|.+||++....+ ++..+|.|||||++||++||..||...
T Consensus 175 ~d~s~--~~S~vGT~~YLhPel~E~q~~-y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 175 DDNSL--FTSLVGTEEYLHPELYERQKK-YTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCe--eeeecCchhhcChHHHhhccC-cCceeehhhhhhHHHHHhccCCCCCcC
Confidence 87653 334589999999999986343 688999999999999999999999754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=301.71 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=189.7
Q ss_pred CCCceeeeecceEEEEEEe-cCCCEEEEEEccccc-----hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 735 APAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-----AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
...+.||+|+||.||+|.. .++..||+|+++... .+..+.+.+|+.++++++||||+++++++........+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 3468899999999999985 468999999886432 1234568899999999999999999998875445678899
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 85 MEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQ 157 (266)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCCccccc
Confidence 99999999999997643 58899999999999999999997 89999999999999987 7889999999988654
Q ss_pred cCCCc--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 889 SAGTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 889 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
..... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||.... .. ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~-~~~~~~~------ 222 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYE------AM-AAIFKIA------ 222 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCC--CCchhhhHHHHHHHHHHHHCCCCccccc------hH-HHHHHHh------
Confidence 32111 111235889999999997765 5889999999999999999999986431 11 1111000
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.....+..+......+.+++ .||..+ ++||+|+||++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 -------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011112333445566666 688778 99999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=310.87 Aligned_cols=199 Identities=20% Similarity=0.243 Sum_probs=162.1
Q ss_pred Cceeeee--cceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRS--CHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.++||+| +||+||+++. .+|+.||+|+++... ....+.+.+|+++++.++||||++++++|. .+...++|+||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~ 80 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTSF 80 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEEEec
Confidence 3679999 6889999985 489999999997542 223456788999999999999999999997 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++...... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 81 MAYGSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred cCCCcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhcccccc
Confidence 9999999999764322 48999999999999999999997 89999999999999998 7789999998654432211
Q ss_pred Ccc------ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 892 TAD------QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 892 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
... .....++..|+|||++.+....++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 100 111256788999999876432358899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=314.39 Aligned_cols=251 Identities=18% Similarity=0.221 Sum_probs=190.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.||+++.+ +++.||+|++.+.. ....+.+.+|+.++..++|++|+++++++. .....++||||+
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ey~ 83 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYLVMDYY 83 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEEEEecc
Confidence 478999999999999965 67899999986532 222345888999999999999999998887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++........
T Consensus 84 ~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 84 VGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchheecccCCc
Confidence 99999999976422 58999999999999999999997 89999999999999997 88999999999876544333
Q ss_pred ccccccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 ADQVLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.......||+.|+|||++... ...++.++|||||||++|||++|+.||... +..+.......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-------~~~~~~~~i~~~~~--~-- 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHKE--R-- 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-------CHHHHHHHHhCCCc--c--
Confidence 223334799999999998631 112588999999999999999999999632 12222221111000 0
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC---CCCCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA---SERPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~---~~RPs~~evl~~ 1012 (1025)
. ..+......+.++.+++.+|+..+ ..||++.|+++.
T Consensus 227 ---~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 ---F---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---c---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000112234567888888887554 347899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=307.00 Aligned_cols=257 Identities=19% Similarity=0.230 Sum_probs=196.1
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEecCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCC-CCccccccceeecCCCC
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 803 (1025)
+.+.+-+|...+.||+||.+.||++...+.+.||+|++... +.+...-|..|+..|.+++ |.+||++++|-. .+.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--TDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--cCc
Confidence 33444445556889999999999999888889999987543 3455678999999999995 999999999987 466
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
..||||||- ..+|..+|..... ..+.-.++.|..|++.|+.++|. +||||.||||.|+|+- .+.+||+|||+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeech
Confidence 899999986 5699999988653 23323889999999999999997 9999999999999997 45899999999
Q ss_pred ccccccCCCc-cccccCcccccCccccccCCCC---------CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchH
Q 001700 884 HRILTSAGTA-DQVLNAGALGYRPPEFASTSKP---------CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLT 953 (1025)
Q Consensus 884 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~---------~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~ 953 (1025)
|..+....+. .....+||+.||+||.+..... ..+.++||||+|||+|+|+.|+.||.... .
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------n 577 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------N 577 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------H
Confidence 9987655432 2223489999999998864322 15789999999999999999999997431 1
Q ss_pred HHHHHHHhhccccccchhhhcCCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 954 DWVRLLALENRSGECFDRLIMDGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 954 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.|.+... +.|+ +...+.+.. ...++.++|..|++.+ .+||++.|+++.
T Consensus 578 ~~aKl~a-------I~~P----~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 QIAKLHA-------ITDP----NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHh-------hcCC----CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3333211 2222 111111111 1223899999999999 999999999863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.59 Aligned_cols=195 Identities=24% Similarity=0.313 Sum_probs=166.1
Q ss_pred hcCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-C-----CccccccceeecCCCCee
Q 001700 733 SHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-H-----PNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~~ 805 (1025)
.|...++||+|+||.|-||. +++++.||||+++.... -..+...|+.+|..++ | -|+|++++||. ...+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~--fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY--FRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc--cccce
Confidence 44557899999999999998 56899999999987632 3445678999999996 4 38999999998 66789
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec-CCCCEEEeccccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA-PTMNAVLTDYSLH 884 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~-~~~~~kl~DfGla 884 (1025)
++|+|.+ .-+|+++++..... .|+...++.++.||+.||.+||. .+|||+||||||||+.. ....+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999 56999999987654 59999999999999999999996 99999999999999964 2357999999999
Q ss_pred cccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 885 RILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 885 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
........ ..+-+..|+|||++.+.. |+.+.||||||||++||++|.+-|.
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccC
Confidence 87654433 235678999999999998 5999999999999999999976654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=300.47 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=192.6
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
..+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++.. ...+++|||++++
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~~~~~ 83 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMELMSKG 83 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEECCCCC
Confidence 358899999999999975 57889999987542 34678999999999999999999998853 3478999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||+++.......
T Consensus 84 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~~~~--- 155 (254)
T cd05083 84 NLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVD--- 155 (254)
T ss_pred CHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceeccccCC---
Confidence 99999976532 258999999999999999999997 89999999999999988 78999999999876433211
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....+..|+|||++.+.. ++.++|||||||++|||++ |+.||... +..++.....
T Consensus 156 -~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~-------~~~~~~~~~~-------------- 211 (254)
T cd05083 156 -NSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRAPYPKM-------SLKEVKECVE-------------- 211 (254)
T ss_pred -CCCCCceecCHHHhccCC--cCchhhHHHHHHHHHHHHhCCCCCCccC-------CHHHHHHHHh--------------
Confidence 113456899999987665 5889999999999999998 99998632 1122211111
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
...+.+.+...+..+.+++.+||+.+ ++||++++|++.|++
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111223445677899999999999 999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=302.46 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=185.7
Q ss_pred eeeeecceEEEEEEecCC---CEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 739 VIGRSCHGTLYKATLDSG---SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.||+|+||.||+|+..++ ..+++|.++... ....+.+.+|+.+++.++||||++++++|. .....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCC
Confidence 589999999999975433 356677766433 334578999999999999999999999987 44578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC-c
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-A 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~-~ 893 (1025)
|+|.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcchhhh
Confidence 9999999864321 1256788889999999999999997 89999999999999988 88899999999864322111 1
Q ss_pred cccccCcccccCccccccCCC-----CCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 894 DQVLNAGALGYRPPEFASTSK-----PCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
......|+..|+|||++.... ..++.++|||||||++|||++ |..||.... -.+.......+. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~~-~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-------DREVLNHVIKDQ-QVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhhc-ccc
Confidence 112236788999999875321 114679999999999999997 566775321 111222111111 111
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHHHHh
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFEELS 1014 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~~L~ 1014 (1025)
..++.+ .......+.+++..||..+++||+++||++.|.
T Consensus 229 ~~~~~~--------~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQL--------ELPYSERWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCcc--------CCCCcHHHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 122211 223456688899999954599999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=314.34 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=189.5
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv 808 (1025)
..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 3578999999999999854 68899999997542 233567889999999999999999999875321 2357999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++ +|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAG 177 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCccccC
Confidence 999964 77777753 47899999999999999999997 89999999999999998 8899999999998654
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc--
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG-- 966 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~-- 966 (1025)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....|......-+...
T Consensus 178 ~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 178 TSFM--MTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTD------HIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCCc--ccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHH
Confidence 3322 12236899999999998766 5889999999999999999999996431 1112211111000000
Q ss_pred --------------------c-cchhhh---cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 --------------------E-CFDRLI---MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 --------------------~-~~d~~~---~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ...... ..............++.+++.+|+..+ .+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000 000000111123457889999999999 999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.16 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=191.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-----hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-----AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.++.....++++|
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 578999999999999854 68999999875321 123457888999999999999999999876544456889999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++.... .+++..+++++.|++.||+|||+ .+|+|+||||+||+++. ++.++|+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTI 159 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCccccccccc
Confidence 999999999987653 57899999999999999999997 89999999999999987 889999999998865432
Q ss_pred CC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 891 GT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. .......|+..|+|||++.+.. ++.++|||||||++|||++|+.||.... ....... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~-~--------- 221 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAAIFK-I--------- 221 (265)
T ss_pred cccccccccCCCCccccChhhhcCCC--CCcchhHHHHHHHHHHHhhCCCCCCccc------hHHHHHH-H---------
Confidence 11 1112235889999999987665 5889999999999999999999986321 1111100 0
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~ 1011 (1025)
.........+......+.+++.+|+..+++||+++||++
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ----ATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLR 260 (265)
T ss_pred ----hcCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhc
Confidence 001111223455667788999999964499999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.00 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=195.5
Q ss_pred CceeeeecceEEEEEEec------CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
...||+|+||.||+|+.+ +...||+|.+...... ..+++.+|++++++++||||+++++++. .....++||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 87 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEPHYMIL 87 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCcceEEE
Confidence 467999999999999854 3467999988754333 4567999999999999999999999886 445789999
Q ss_pred eccccccHHHHHhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 810 NYINAQSLAVYLQETDPRK----LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||+++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~~~~~~~ 165 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVKVSLLSLSK 165 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEEEccccccc
Confidence 9999999999997654211 1258999999999999999999997 89999999999999988 7899999999987
Q ss_pred ccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
..............++..|+|||.+.+.. ++.++|||||||++|||++ |..||..... . +.+..... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~---~~~~~~~~-~- 234 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSD----E---EVLNRLQA-G- 234 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccch----H---HHHHHHHc-C-
Confidence 54332222222235678899999987665 4789999999999999999 7888853211 1 11111110 0
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
....+.+...+..+.+++.+|++.+ ++||++.|+++.|.+
T Consensus 235 -----------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 -----------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -----------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0001112345678999999999999 999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.48 Aligned_cols=263 Identities=24% Similarity=0.302 Sum_probs=188.1
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcC---CCCccccccceeecC---CCCeeE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNI---KHPNLVSLQGYYWGP---KEHEKL 806 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~---~~~~~~ 806 (1025)
..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++... .....+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 3578999999999999865 789999999875322 1234566777777665 699999999987632 234578
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+++||+. ++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.
T Consensus 84 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~~ 157 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARI 157 (288)
T ss_pred EEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCcccc
Confidence 9999997 589888876432 248999999999999999999998 89999999999999988 78999999999987
Q ss_pred cccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHH---hhc
Q 001700 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA---LEN 963 (1025)
Q Consensus 887 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~---~~~ 963 (1025)
....... ....||..|+|||++.+.. ++.++|||||||++|||++|++||...... ..+........ ...
T Consensus 158 ~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 158 YSCQMAL--TPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccCcccC--CCccccccccCchHhhCCC--CCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChhh
Confidence 6433221 2236899999999997765 588999999999999999999998632111 11111111000 000
Q ss_pred cccccc--hhhhcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 964 RSGECF--DRLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 964 ~~~~~~--d~~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+..... ......... ....+.....+.+++.+|++.+ ++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000000 0011234567889999999999 99999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.98 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=193.4
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccc------hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGI------AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..+.||+|+||.||+|...+++.+|||.++... ....+.+.+|++++++++|+||+++++++. .....++++
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeEEEEE
Confidence 467899999999999998889999999886432 122356889999999999999999999987 446899999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++. ++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 82 EFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAW 154 (265)
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchhhHhhhh
Confidence 9999999999997643 58899999999999999999997 89999999999999997 88999999999886532
Q ss_pred CCC-----ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 890 AGT-----ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 890 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
... .......|+..|+|||++.+.. ++.++|||||||++|||++|+.||.... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~-- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMD------RLAAMFYIGAHR-- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCC------hHHHHHHhhhcc--
Confidence 111 1111235889999999987765 5889999999999999999999996421 111111000000
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....+.+.....++.+++.+||+.+ ++||++.||++
T Consensus 225 -----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -----------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001123345677899999999999 99999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.52 Aligned_cols=240 Identities=21% Similarity=0.252 Sum_probs=182.5
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcC---CCCccccccceeecCCCCeeEEEEecc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNI---KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
||+|+||+||+|+.. +++.||||++..... .....+..|..++.+. +||||+++++++. .....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 699999999999854 789999999865322 1223455677777665 6999999998886 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 79 SGGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CCChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCCCC
Confidence 9999999987643 58999999999999999999998 89999999999999998 78999999999875432221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+... ++.++|||||||++|||+||+.||... +..+.......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslGvil~elltG~~Pf~~~-------~~~~~~~~i~~----------- 211 (330)
T cd05586 152 -TTNTFCGTTEYLAPEVLLDEKG-YTKHVDFWSLGVLVFEMCCGWSPFYAE-------DTQQMYRNIAF----------- 211 (330)
T ss_pred -CccCccCCccccCHHHHcCCCC-CCCccceeccccEEEEeccCCCCCCCC-------CHHHHHHHHHc-----------
Confidence 1223469999999999876543 588999999999999999999998632 11111111111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC----HHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD----MMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs----~~evl~ 1011 (1025)
+..+.+ ......++.+++.+|+..+ .+||+ +.|+++
T Consensus 212 --~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 --GKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 001100 1123566789999999999 99984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=305.86 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=191.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++. .+...+++|||+
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 82 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE--TKDALCLVLTIM 82 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe--cCCEEEEEEEec
Confidence 467999999999999864 789999999865422 22345788999999999999999988876 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++. +..+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 83 NGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred cCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCcceecCCCCc
Confidence 99999998875432 258999999999999999999997 89999999999999988 77899999999876543222
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...... .....+.. .
T Consensus 158 ~--~~~~g~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~--------------~ 216 (285)
T cd05632 158 I--RGRVGTVGYMAPEVLNNQR--YTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDR--------------R 216 (285)
T ss_pred c--cCCCCCcCccChHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH--------------h
Confidence 1 2236899999999997765 588999999999999999999999743110 00011111 0
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~~ 1012 (1025)
+... ....+...+.++.+++..|++.+ ++||+ +++++..
T Consensus 217 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 217 VLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred hhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0000 00113344567889999999999 99999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=308.76 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++||||+++++++. .....++|+||++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~e~~~- 87 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVFEYLD- 87 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEEeccc-
Confidence 478999999999999865 68899999987543 233456788999999999999999999987 4557899999996
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.........
T Consensus 88 ~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 88 KDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhccCCCCCc-
Confidence 689988876432 58899999999999999999998 89999999999999998 789999999998765432211
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh---hccccccchh
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL---ENRSGECFDR 971 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~ 971 (1025)
.....+++.|+|||++.+... ++.++|||||||++|||+||+.||..... ......+..... ........+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTD-YSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred ccccceeecccCcHHHhCCCC-CccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChhhchhhhcc
Confidence 122357899999998876443 58899999999999999999999974311 111111110000 0000000000
Q ss_pred ---------hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 ---------LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ---------~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..............+..+.+++.+|+..+ .+|||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000011234567889999999999 99999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=319.92 Aligned_cols=195 Identities=21% Similarity=0.278 Sum_probs=165.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||+|+++++.+. .....++||||+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~lv~E~~ 83 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYLIMEFL 83 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEeCC
Confidence 478999999999999865 78999999997532 223456888999999999999999999887 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 84 PGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCcccccccc
Confidence 9999999997653 58999999999999999999997 89999999999999988 88999999999875432110
Q ss_pred c----------------------------------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCC
Q 001700 893 A----------------------------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938 (1025)
Q Consensus 893 ~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~ 938 (1025)
. .....+||+.|+|||++.+.. ++.++|||||||++|||+||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC--CCCcceeccccceeeecccCCC
Confidence 0 011236999999999998766 5889999999999999999999
Q ss_pred CCCc
Q 001700 939 SGEI 942 (1025)
Q Consensus 939 P~~~ 942 (1025)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=311.64 Aligned_cols=189 Identities=22% Similarity=0.326 Sum_probs=157.3
Q ss_pred hcCCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 733 SHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.|...+.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++||||+++++++. .....++|+||
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 138 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPH 138 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE--eCCeeEEEEEc
Confidence 3445688999999999999965 6789999985433 2356999999999999999999987 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+ .++|.+++.... ..+++.+++.|+.||+.||+|||+ .+|+||||||+|||++. +..+||+|||+++......
T Consensus 139 ~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred c-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCc
Confidence 9 568888887543 268999999999999999999997 89999999999999988 7889999999987543222
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSG 940 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~ 940 (1025)
. .....||+.|+|||++.+.. ++.++|||||||++|||+++..|+
T Consensus 212 ~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 A--FLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--cccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 12236999999999998766 588999999999999999966554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.21 Aligned_cols=243 Identities=22% Similarity=0.364 Sum_probs=192.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh---------cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK---------GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 806 (1025)
+..||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 82 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--DADHLN 82 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCccE
Confidence 578999999999999854 6889999988653221 2356889999999999999999999987 455789
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+++||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||.++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~dfg~~~~ 155 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKK 155 (267)
T ss_pred EEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecccCCCcc
Confidence 9999999999999997653 58999999999999999999997 89999999999999987 88999999999887
Q ss_pred cccCCCc-----cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh
Q 001700 887 LTSAGTA-----DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 887 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
....... ......|+..|+|||++.+.. ++.++|||||||++|||++|+.||.... .... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~-~~~~-- 224 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGKHPFPDCT------QLQA-IFKI-- 224 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCC--CCchhhhHHHHHHHHHHhhCCCCCCCcc------HHHH-HHHH--
Confidence 6532111 111125788999999987765 4889999999999999999999997421 1000 0000
Q ss_pred hccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
........+...+..+.+++.+||+.+ .+||++.||++
T Consensus 225 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 ------------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------------hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111223445678899999999999 99999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=318.06 Aligned_cols=262 Identities=15% Similarity=0.177 Sum_probs=187.9
Q ss_pred cCCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 734 HAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+...+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|||||++++++. .....++|||++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~~~lv~e~~ 242 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV--VGGLTCLVLPKY 242 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEEEEcc
Confidence 344578999999999999965 688999996432 23578999999999999999999887 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.++|.+++..... .+++.+++.|+.|++.||+|||+ .+|+||||||+|||++. +..+||+|||+++.......
T Consensus 243 -~~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 -RSDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred -CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 5789988875432 58999999999999999999997 89999999999999988 78899999999986543221
Q ss_pred c-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCC----CcchHHHHHHHHhh--ccc
Q 001700 893 A-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPG----VVDLTDWVRLLALE--NRS 965 (1025)
Q Consensus 893 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~----~~~l~~~~~~~~~~--~~~ 965 (1025)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ ...+.+.+...... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1 112346999999999998766 58899999999999999998876532211111 11122222111100 000
Q ss_pred c----ccchh---hh----cCCCCCCCch---HHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 966 G----ECFDR---LI----MDGHDMEQPP---RILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 966 ~----~~~d~---~~----~~~~~~~~~~---~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. +.... .. .......... .....+.+++.+|++.+ .+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000 00 0000000001 22346889999999999 999999999863
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.10 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=189.8
Q ss_pred cCCCceeeeecceEEEEEEec---CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 734 HAPAEVIGRSCHGTLYKATLD---SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
|...+.||+|+||.||+|... .+..||||.+... +...+|++++++++|||||++++++. .....+++||
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~e 166 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR--WKSTVCMVMP 166 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe--eCCEEEEEeh
Confidence 444678999999999999743 4678999988653 23568999999999999999999886 4557899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
++. ++|.+++.... .+++.+++.|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 167 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCcc
Confidence 985 68888885432 68999999999999999999997 89999999999999998 789999999999866543
Q ss_pred CCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc------
Q 001700 891 GTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN------ 963 (1025)
Q Consensus 891 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~------ 963 (1025)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+..-++......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 221 122346999999999998766 58899999999999999999999864332211111111111100000
Q ss_pred cccc---cch---hhhcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 964 RSGE---CFD---RLIMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 964 ~~~~---~~d---~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.... .+. .........+ .......++.+++.+|+..+ ++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 000 0000000000 00122456788999999999 999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=299.58 Aligned_cols=242 Identities=20% Similarity=0.301 Sum_probs=195.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||||+++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 86 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIMEYLGG 86 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEEEEecCCC
Confidence 467999999999999864 68899999987542 334567899999999999999999999987 45689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... ++++.++..++.|++.||+|||+ .+++|+||+|+||+++. +..++++|||++.........
T Consensus 87 ~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 87 GSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceeccCCccc-
Confidence 9999998643 58899999999999999999997 89999999999999998 788999999999876443221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....++..|+|||++.+.. ++.++|||||||++|||+||+.||...... ..... +.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~--------------~~ 214 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFL--------------IP 214 (277)
T ss_pred cccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhhh--------------hh
Confidence 12235788999999987665 588999999999999999999998643211 00000 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...........+..+.+++.+||+.+ ++||++.+|++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11111234567788999999999999 999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.90 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=194.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|+.. ++..||+|.++.... .+++.+|++++++++||||+++++++. .....++++||++++
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~ 83 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF--KNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee--cCCcEEEEEecCCCC
Confidence 567999999999999976 488999999876532 678999999999999999999999987 446789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||+++. ++.+||+|||++........ ..
T Consensus 84 ~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 84 SVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred cHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccCcc-cc
Confidence 9999997543 268999999999999999999997 89999999999999998 78899999999987654332 12
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||++.+.. ++.++|||||||++|||++|+.||....... .... ... ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~--~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~~-----------~~~--~~ 215 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIG--YNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIFM-----------IPN--KP 215 (256)
T ss_pred ccccCCccccCHHHHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhhh-----------hcc--CC
Confidence 2235889999999987765 5889999999999999999999987432111 0000 000 00
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+......+.+++.+||+.+ ++||++.||++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0011123344567899999999998 99999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.75 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=194.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. .....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~~~ 83 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVMGFCE 83 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEecccC
Confidence 578999999999999854 68899999986532 2345678899999999999999999987653 3446789999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++..... ..+++.++..++.|++.|++|||+ .+|+||||||+||+++. ++.++|+|||++........
T Consensus 84 ~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 84 GGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEecccCC-
Confidence 9999999986432 258999999999999999999997 89999999999999998 88999999999987643322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......|++.|+|||+..+.. ++.++|||||||++|||++|+.||+.. +...+...... +
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~-------~~~~~~~~~~~-~---------- 217 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAK-------DMNSLVYRIIE-G---------- 217 (257)
T ss_pred ccccccCCcCccChhHhcCCC--CCchhhhHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHh-c----------
Confidence 122236889999999987765 588999999999999999999998632 12222221111 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.....+...+.++.+++.+|++.+ ++||++.++++
T Consensus 218 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 218 ---KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011123445678999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.24 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=187.7
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv~ 809 (1025)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.... ....++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 57899999999999985 4788999999875422 23456789999999999999999999875321 23578999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
+++ +++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLARQADD 170 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccceecCC
Confidence 988 78998887643 58999999999999999999997 89999999999999998 88999999999987543
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.. ....||+.|+|||++.+... ++.++|||||||++|||++|+.||..... ...+..+..... ....+..
T Consensus 171 ~~----~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~--~~~~~~~ 240 (343)
T cd07878 171 EM----TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVG--TPSPEVL 240 (343)
T ss_pred Cc----CCccccccccCchHhcCCcc-CCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhC--CCCHHHH
Confidence 22 22368999999999876433 58899999999999999999999864211 011111111000 0000000
Q ss_pred --------hhhhcCCCCCCC------chHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 970 --------DRLIMDGHDMEQ------PPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 970 --------d~~~~~~~~~~~------~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...+......+. .......+.+++.+|+..+ .+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 0112345789999999999 999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=302.63 Aligned_cols=247 Identities=19% Similarity=0.292 Sum_probs=193.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++||||+++++++. .+...++||||++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 94 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY--WDGKLWIMIEFCPGG 94 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--eCCeEEEEEecCCCC
Confidence 467999999999999965 68999999998766566778899999999999999999999887 445799999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|..++.+... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++........ ..
T Consensus 95 ~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~~~~-~~ 167 (292)
T cd06644 95 AVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNVKTLQ-RR 167 (292)
T ss_pred cHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceecccccc-cc
Confidence 99988765432 58999999999999999999997 89999999999999987 78999999999875433221 11
Q ss_pred cccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 896 VLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....+++.|+|||++.+.. ..++.++|||||||++|||++|+.||..... ...+......
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~---------- 230 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKS---------- 230 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcC----------
Confidence 2235889999999985321 1147799999999999999999999864211 1111111000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.......+...+.++.+++.+||..+ ++||++.||++
T Consensus 231 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 --EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011123345567899999999999 99999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.78 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=195.2
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..+.||+|+||.||+|.. .+++.+|||.+.... ....+.+.+|++++++++||||+++++++. .....++|+||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 81 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVMEYA 81 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEEecC
Confidence 357899999999999985 478899999986542 234567899999999999999999999886 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++..+..+|++|||.+........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999986532 258999999999999999999997 89999999999999987566789999999987654322
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.... ....+......
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~---------- 216 (256)
T cd08220 158 A--YTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSG---------- 216 (256)
T ss_pred c--cccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhc----------
Confidence 1 1236889999999998765 5889999999999999999999986421 11222111110
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...+.+...+..+.+++..||+.+ ++|||+.|+++
T Consensus 217 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 217 ----TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011123345667899999999999 99999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.06 Aligned_cols=239 Identities=21% Similarity=0.290 Sum_probs=193.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
-++||+|+||.||-++. .+|+.||+|.+.+.. .+.....+.|-.+|.+++.++||.+--.|. .....++|+..|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe--Tkd~LClVLtlM 267 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE--TKDALCLVLTLM 267 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec--CCCceEEEEEee
Confidence 37899999999999985 489999999986543 234556788999999999999999843333 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.||+|.-+|...+. +.|++..++.++.+|+.||++||. .+||.||+||+|||+|+ .++++|+|.|+|..+.....
T Consensus 268 NGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred cCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeeccceEEecCCCCc
Confidence 99999999887654 369999999999999999999997 89999999999999999 99999999999998877654
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
... .+||.+|||||++.... |+...|.||+||++|||+.|+.||.... +....+.+|++
T Consensus 343 ~~~--rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~K-----------------eKvk~eEvdrr 401 (591)
T KOG0986|consen 343 IRG--RVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRK-----------------EKVKREEVDRR 401 (591)
T ss_pred ccc--ccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhh-----------------hhhhHHHHHHH
Confidence 433 47999999999999887 5889999999999999999999997431 11112334555
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERP 1004 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP 1004 (1025)
+.... .++++....+..++...-+..+ .+|-
T Consensus 402 ~~~~~-~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 402 TLEDP-EEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred Hhcch-hhcccccCHHHHHHHHHHHccCHHHhc
Confidence 54433 2345666777777777777777 6665
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.31 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=195.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+.++++++||||+++++++. .....++|+||+++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~ 83 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEEEEEeecCC
Confidence 478999999999999965 78999999887542 233567899999999999999999999887 45688999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|..++...... ..+++..+..++.|++.||.|||+..+|+||||||+||+++. +..+||+|||.+........
T Consensus 84 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 84 GSLDKLYAGGVAT--EGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCHHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccccCCcc--
Confidence 9999998764221 258999999999999999999996468999999999999998 88999999999876543222
Q ss_pred ccccCcccccCccccccCCCC----CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 895 QVLNAGALGYRPPEFASTSKP----CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~----~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
....|++.|+|||++.+... .++.++|||||||++|||++|+.||..... ..+.....
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~---------- 220 (286)
T cd06622 159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-------ANIFAQLS---------- 220 (286)
T ss_pred -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-------hhHHHHHH----------
Confidence 12358889999999864331 147799999999999999999999964211 11111100
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. +........+.....++.+++.+|++.+ ++||++.+++..
T Consensus 221 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 A-IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred H-HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 0011111224456788899999999999 999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=305.77 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=193.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|++++++++||||+++++++. .....++|+||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 83 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLVFEFVD 83 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEEEecCC
Confidence 578999999999999975 6899999998654322 3467889999999999999999999986 4568999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++++.++..... .+++.+++.++.|++.||+|||+ .+|+|||++|+||+++. ++.++|+|||++........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 84 HTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeeccCCcc-
Confidence 999988775432 48999999999999999999998 89999999999999988 88999999999887544322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc----ccc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG----ECF 969 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~ 969 (1025)
......++..|+|||++.+... ++.++|||||||++|||++|+.||... .....+.+......... +..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~el~~g~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGD------SDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred ccCcccceeeccCcHHhccccc-cCchHhHHHHHHHHHHHHcCCCCCCCC------chHHHHHHHHHHhCCCchhhHHHh
Confidence 2222358899999999875443 578999999999999999999998632 11222221111100000 000
Q ss_pred h------hhhcCCCC-----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 970 D------RLIMDGHD-----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 d------~~~~~~~~-----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+ ........ ....+..+..+.+++.+||..+ ++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000000 0011234677999999999999 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.79 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=197.9
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||.|+||.||+|.. .++..||+|++.... ....+++..|++++++++||||+++++++........++++||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 46799999999999985 478999999986432 334567889999999999999999999887555567899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH-----NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+++|.+++...... ...+++.+++.++.|++.||+||| + .+|+|+||||+||+++. ++.+|++|||++....
T Consensus 85 ~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 85 GGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFGLAKILG 161 (265)
T ss_pred CCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccccccccc
Confidence 99999999764211 136899999999999999999999 7 78999999999999998 8899999999998765
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
..... .....|++.|+|||++.... ++.++||||||+++|+|++|+.||.... ...+.....
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~-------- 223 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARN-------QLQLASKIK-------- 223 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcC-------HHHHHHHHh--------
Confidence 43321 12236899999999987766 5889999999999999999999987431 111111110
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.......+...+.++.+++.+|++.+ ++||++.+|++.
T Consensus 224 ------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01111223455678999999999999 999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.84 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=194.2
Q ss_pred CceeeeecceEEEEEEec----CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC----CeeE
Q 001700 737 AEVIGRSCHGTLYKATLD----SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE----HEKL 806 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~~ 806 (1025)
.++||+|+||.||+|... ++..||||+++... ....+++.+|++++++++||||+++++++..... ...+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 468999999999999853 46889999987542 3345678899999999999999999998864222 1247
Q ss_pred EEEeccccccHHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 807 VISNYINAQSLAVYLQETDP-RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
++++|+.+|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+|++|||.++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg~~~ 161 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSK 161 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECcccccc
Confidence 88999999999988764321 121257899999999999999999997 89999999999999987 8899999999998
Q ss_pred ccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 886 ILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 886 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
........ ......+++.|++||.+.... ++.++|||||||++|||++ |+.||..... ..+..++. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~---~-- 230 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLI---K-- 230 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHH---c--
Confidence 66433211 111224567899999987665 4889999999999999999 8888763211 11111111 0
Q ss_pred cccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
......+...+..+.+++.+|++.+ ++||++.||++.|+++
T Consensus 231 ------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 ------------GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011112345568999999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.75 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=191.0
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++. .....++|+||++++
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~e~~~~~ 91 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICMEFCGGG 91 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEEeccCCC
Confidence 46799999999999985 478999999987654444567889999999999999999999887 456889999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++........ ..
T Consensus 92 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06645 92 SLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQITATIA-KR 163 (267)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEccCccc-cc
Confidence 9999987653 58999999999999999999997 89999999999999987 78899999999876543221 12
Q ss_pred cccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....|+..|+|||++... ...++.++|||||||++|||++|+.||....... .+....... ...+..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~----~~~~~~- 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFLMTKSN----FQPPKL- 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHhhhccC----CCCCcc-
Confidence 223689999999987421 1125789999999999999999999985321100 000000000 000000
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+..+.+++.+|++.+ ++||++++|++
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001123456889999999999 99999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.79 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=191.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++. .+...++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~ 82 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIFEFLS 82 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEEecCC
Confidence 468999999999999965 78999999986532 223467889999999999999999999987 4557899999997
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++...... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++........
T Consensus 83 -~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 83 -MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred -CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecCCCcc-
Confidence 6898888754322 268999999999999999999997 89999999999999988 88999999999876543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh---hcc--ccc-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL---ENR--SGE- 967 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~---~~~--~~~- 967 (1025)
......+++.|+|||++.+... ++.++|||||||++|||+||+.||...... ..+......... ..+ ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cccCCcccccccChHHhcCCCC-cCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhcchhh
Confidence 1122357889999998866543 588999999999999999999998632110 001111000000 000 000
Q ss_pred -cchhhhc---CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 -CFDRLIM---DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 -~~d~~~~---~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....... .............++.+++.+|+..+ ++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000011224567889999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.73 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=195.6
Q ss_pred CceeeeecceEEEEEEec-C----CCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-S----GSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+.. . +..||+|+++..... ..+.+..|+++++.++|+||+++++++.. ....+++||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i~e 81 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIVME 81 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEEEe
Confidence 478999999999999965 3 388999999765433 56789999999999999999999998873 457899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++...... .+++.++..++.|++.||+|||+ .+++||||||+||+++. +..++++|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCceecccc
Confidence 99999999999865421 28999999999999999999997 89999999999999998 779999999999876554
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.........+++.|+|||...+.. ++.++||||+||++|||++ |+.||... +..+.......
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~~~-------- 219 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGK--FTSKSDVWSFGVLLWEIFTLGESPYPGM-------SNEEVLEYLKK-------- 219 (258)
T ss_pred cccccccCCCcccccChHHhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhc--------
Confidence 332221224778999999986554 5889999999999999998 78887632 11122111111
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
......+...+.++.+++.+|+..+ ++|||+.|+++.|
T Consensus 220 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 ------GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111123335677999999999999 9999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.19 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=195.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|... ++..||+|+++.......+.+.+|++++++++||||+++++++. .....++||||++++
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 87 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILIEFCDGG 87 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEeeccCCC
Confidence 467999999999999964 68999999997665556678999999999999999999999987 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++......... .
T Consensus 88 ~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~-~ 160 (280)
T cd06611 88 ALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKNKSTLQK-R 160 (280)
T ss_pred cHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhhcccccc-c
Confidence 99999876432 58999999999999999999997 89999999999999988 889999999998765432221 1
Q ss_pred cccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 896 VLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....|++.|+|||++.... ..++.++|||||||++|||++|+.||..... .+........
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~---------- 223 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKS---------- 223 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcC----------
Confidence 2236899999999875321 1247799999999999999999999864311 1111111000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.......+...+.++.+++..||+.+ ++||++.+|++.
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 --EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00011123345667899999999999 999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=295.55 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=196.8
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..++||+|+||.||.++. ++++.+++|.+.... ....+++.+|++++++++|+||+++++++. .....+++|||+
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~~~e~~ 81 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLLIEMEYA 81 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe--cCCeEEEEEEec
Confidence 357899999999999984 478999999876532 344567889999999999999999999997 456789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||+++. +..+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEcccccc
Confidence 99999999986532 258999999999999999999997 89999999999999998 78899999999987654332
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......|++.|+|||+..+.. ++.++||||||+++|||++|+.||+.. ...+.+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~------------ 214 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDAT-------NPLNLVVKIV------------ 214 (256)
T ss_pred -cccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHH------------
Confidence 122336899999999987665 488999999999999999999998632 1112221111
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.. .+.+...+.++.+++.+||..+ ++||++.|+++.
T Consensus 215 -~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 215 -QGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -cCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111 1122345677899999999998 999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.81 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=191.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcH--HHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGK--KEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++||||+++++++. .....++||||++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ--DDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE--ESSEEEEEEEEET
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc--ccccccccccccc
Confidence 578999999999999965 677999999987643322 23456999999999999999999987 4568899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++.... .+++.++..++.|+++||+|||+ .+|+||||||+||+++. ++.++|+|||.+...... ..
T Consensus 82 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 82 GGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEESTST-TS
T ss_pred cccccccccccc-----ccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccccc-cc
Confidence 999999998433 68999999999999999999998 89999999999999997 889999999998764211 12
Q ss_pred cccccCcccccCcccccc-CCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 894 DQVLNAGALGYRPPEFAS-TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......++..|+|||++. +.. ++.++||||+|+++|+|++|+.||.... ..+........... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~~~~p~~~~~----~~~~~~~~~~~~~~-----~~~~~ 222 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKK--YTRKSDIWSLGIILYELLTGKLPFEESN----SDDQLEIIEKILKR-----PLPSS 222 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSS--BSTHHHHHHHHHHHHHHHHSSSSSTTSS----HHHHHHHHHHHHHT-----HHHHH
T ss_pred cccccccccccccccccccccc--cccccccccccccccccccccccccccc----chhhhhhhhhcccc-----ccccc
Confidence 222346899999999987 444 5899999999999999999999987530 01111111111000 00000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.. .......++.+++..|++.+ ++||++.++++
T Consensus 223 ~~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TT------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 01112378999999999999 99999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=296.93 Aligned_cols=249 Identities=18% Similarity=0.328 Sum_probs=195.0
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc------hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI------AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
.++.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++. .....++|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~v 81 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHFNLF 81 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeEEEE
Confidence 457899999999999984 578999999986432 123467899999999999999999999987 45578999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++..+..+||+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999997643 58999999999999999999998 8999999999999998744569999999988765
Q ss_pred cCCCcc---ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc
Q 001700 889 SAGTAD---QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 889 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
...... .....|+..|+|||++.+.. ++.++||||+||++|||++|+.||..... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~------ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKI------ 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHH------
Confidence 432111 11235888999999987655 58899999999999999999999863311 1111111100
Q ss_pred cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.......+.+.....++.+++.+|+..+ ++||++.|+++
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 -------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011112234556778999999999999 99999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.25 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=192.7
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
..||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+. .....++||||+++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGGA 105 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeCCCCCc
Confidence 56999999999999864 68999999987655555677899999999999999999999987 4557899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++... .+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||++........ ...
T Consensus 106 L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 106 LTDIVTHT------RMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhcccccc-cCc
Confidence 99988543 48899999999999999999998 89999999999999998 78999999999876543222 112
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...|+..|+|||+..+.. ++.++|||||||++|||++|+.||..... . +-+.... ..+.+.+
T Consensus 177 ~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~el~~g~~p~~~~~~------~-~~~~~~~------~~~~~~~--- 238 (292)
T cd06658 177 SLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPP------L-QAMRRIR------DNLPPRV--- 238 (292)
T ss_pred eeecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH------H-HHHHHHH------hcCCCcc---
Confidence 236899999999987655 58899999999999999999999864211 1 1011000 0011111
Q ss_pred CCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 977 ~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.........+.+++..|+..+ .+|||+.||++.
T Consensus 239 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 ---KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112234556889999999999 999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=295.38 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=195.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.++++++||||+++++++. .....+++|||++++
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~e~~~~~ 85 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEEeCCCCC
Confidence 478999999999999864 68899999998665556678999999999999999999999886 456799999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++. ++.+||+|||.+......... .
T Consensus 86 ~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~-~ 158 (262)
T cd06613 86 SLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQLTATIAK-R 158 (262)
T ss_pred cHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhhhhhhhc-c
Confidence 99999876521 58999999999999999999997 89999999999999998 788999999998865443211 1
Q ss_pred cccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....++..|+|||.+.+.. ..++.++|||||||++|||+||+.||...... .. ...... . .+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~-~~~~~~-~----~~~---- 222 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RA-LFLISK-S----NFP---- 222 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHh-c----cCC----
Confidence 2236888999999987651 11578999999999999999999998643110 00 000000 0 000
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..........+.++.+++.+||..+ .+||++.+|+.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 -PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011123345677999999999999 99999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.17 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=193.0
Q ss_pred CCCceeeeecceEEEEEEe-cCCCEEEEEEccccch----------hcHHHHHHHHHHHhcCCCCccccccceeecCCCC
Q 001700 735 APAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA----------KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 803 (1025)
...+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 81 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--TEE 81 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--cCC
Confidence 3467899999999999985 4789999998864211 11346788999999999999999999887 455
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEeeccc
Confidence 7899999999999999997653 58999999999999999999997 89999999999999997 88999999999
Q ss_pred ccccccCCCc-cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh
Q 001700 884 HRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 884 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
++........ ......|+..|+|||++......++.++||||||+++||+++|+.||... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------EAIAAMFKLGN-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc------chHHHHHHhhc--
Confidence 8865432111 11223588999999998765423588999999999999999999998632 11111111000
Q ss_pred ccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......++ .......+..+.+++..|+..+ ++||++.+|++
T Consensus 227 ~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KRSAPPIP--------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cccCCcCC--------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000000 0112234678999999999999 99999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=297.62 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=194.0
Q ss_pred CceeeeecceEEEEEEecC--CCEEEEEEccccc----------hhcHHHHHHHHHHHhc-CCCCccccccceeecCCCC
Q 001700 737 AEVIGRSCHGTLYKATLDS--GSILAVKRLREGI----------AKGKKEFAREVKKLGN-IKHPNLVSLQGYYWGPKEH 803 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~ 803 (1025)
.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++. ...
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~ 82 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--END 82 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--cCC
Confidence 4679999999999999654 7889999875321 2234557788988875 79999999999987 456
Q ss_pred eeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccc
Q 001700 804 EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL 883 (1025)
Q Consensus 804 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGl 883 (1025)
..+++|||+++++|.+++....... ..+++..++.++.|++.||.|||+..+|+||||||+||+++. ++.+||+|||.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEEEecccc
Confidence 8999999999999999886532111 268999999999999999999996478999999999999988 88999999999
Q ss_pred ccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc
Q 001700 884 HRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN 963 (1025)
Q Consensus 884 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 963 (1025)
+....... ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||... +...........
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~~~- 228 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPFYST-------NMLSLATKIVEA- 228 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCC--CchHHHHHHHHHHHHHHHhCCCccccc-------CHHHHHHHHhhc-
Confidence 98765433 222336899999999998765 588999999999999999999998632 112222111110
Q ss_pred cccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 964 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
..........+..+.+++.+||+.+ ++||++.||..++++
T Consensus 229 ------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 ------------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ------------cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0000011234567899999999999 999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.96 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=194.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++. .+...++|+||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 83 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL--KGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE--ECCeEEEEEEeeCC
Confidence 467999999999999955 78999999987543 334567889999999999999999999887 44689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... .+++..+..++.|++.|+.|||+ .+|+||||+|+||+++. ++.++++|||+++....... .
T Consensus 84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceeeccccc-c
Confidence 9999999754 58999999999999999999997 89999999999999998 88999999999987754322 2
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|++.|+|||++.+.. ++.++|||||||++|||+||+.||..... ......... .
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~-~----------- 213 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFLIPK-N----------- 213 (274)
T ss_pred cccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHHhhh-c-----------
Confidence 22236888999999998766 58999999999999999999999864311 111111000 0
Q ss_pred CCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.....+.. .+.++.+++.+|+..+ ++||+++++++.
T Consensus 214 --~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 214 --NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00001111 4567899999999998 999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=297.97 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=194.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++. .....++|+||+
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e~~- 81 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFVLVMEYM- 81 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeEEEeccc-
Confidence 578999999999999964 78999999987643 233567899999999999999999999987 456789999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+|+||||+||+++. ++.++++|||.+.........
T Consensus 82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeecccccCCCCC
Confidence 999999987643 268999999999999999999998 89999999999999998 888999999999876544322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc--------
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS-------- 965 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-------- 965 (1025)
......|+..|+|||++.+... ++.++||||+||++|||+||++||... .+...+.+....-+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~tg~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARK-YDPGVDLWAVGCIFAELLNGSPLFPGE------NDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred ccccccCcccccCceeeecccc-CCchhHHHHHHHHHHHHHcCCcCcCCC------CHHHHHHHHHHHcCCCChHHHhhc
Confidence 2223468999999999876543 588999999999999999998777532 1111221111100000
Q ss_pred cccch--hhhcCCCC----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 GECFD--RLIMDGHD----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 ~~~~d--~~~~~~~~----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+..+ ........ .+...+....+.+++.+|+..+ ++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 00000000 0001234578999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=335.91 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=200.3
Q ss_pred CCCceeeeecceEEEEEE-ecCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 735 APAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
..+..||.|.||.||.|. .++|+..|||-++... .+..+.+.+|+.++..++|||+|++||+-. +....++.|||
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~IFMEy 1315 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVYIFMEY 1315 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee--cHHHHHHHHHH
Confidence 346889999999999998 6789999999887543 344567889999999999999999999876 56678999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
|++|+|.+.+...+ ..++.....+..|++.|++|||+ .|||||||||+||+++. ++.+|++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccceeEecCch
Confidence 99999999998654 46777788899999999999997 99999999999999998 7799999999999876542
Q ss_pred -Ccc--ccccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 892 -TAD--QVLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 892 -~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
+.. .....||+.|||||++.+.. .+...++||||+|||+.||+||+.||...+. +|.-+...
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V------ 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHV------ 1454 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHH------
Confidence 111 11237999999999997643 2346789999999999999999999976532 24322211
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+..+..|.....+-.+++.+|++.| .+|-++.|+++
T Consensus 1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 122334556778888999999999998 99977776654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=302.96 Aligned_cols=243 Identities=20% Similarity=0.288 Sum_probs=192.7
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
..||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++. .+...++++||+++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGA 104 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEEEecCCCCC
Confidence 46999999999999854 78999999987654455677889999999999999999999887 4567899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++........ ...
T Consensus 105 L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT------RLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcccccc-ccc
Confidence 99987653 58999999999999999999997 89999999999999988 88999999999876543222 122
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...|+..|+|||++.+.. ++.++|||||||++|||++|+.||..... .+-+..... . . ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~-~----~~----- 235 (297)
T cd06659 176 SLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRD-S-P----PP----- 235 (297)
T ss_pred ceecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc-c-C----CC-----
Confidence 246899999999997765 58899999999999999999999863211 111111000 0 0 00
Q ss_pred CCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 977 ~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...........+.+++..|++.+ ++||++.+|++.
T Consensus 236 -~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 -KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112233456889999999999 999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=294.03 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=193.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-----hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-----AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|++|.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. .....++++|
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e 82 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLYIFLE 82 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEEEEEE
Confidence 578999999999999965 78999999886532 224567899999999999999999999887 4557899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++. ++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 83 LVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEF 155 (258)
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccceecccc
Confidence 999999999997653 58999999999999999999997 89999999999999988 889999999998875443
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
. ......|+..|+|||.+.... .++.++|||||||++|+|++|+.||.... -.+........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~-------- 217 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRS-------- 217 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhc--------
Confidence 3 112236889999999886554 25889999999999999999999987431 11111111000
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+......+.+++.+||+.+ ++||++.++++
T Consensus 218 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 -----KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0011123345677889999999999 99999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=295.40 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=195.1
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+++. .+|+.||+|++... .....+++.+|+.++++++||||+++++++. .....++|+||++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~ 82 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVMDYCE 82 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEEecCC
Confidence 57899999999999985 47899999998643 2234567899999999999999999999886 4568999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++..... ..+++.++++++.|++.|++|||+ .+++|+||+|+||+++. +..++++|||.+.........
T Consensus 83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 83 GGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeecCcchhh
Confidence 9999999876432 147899999999999999999997 89999999999999988 778999999999866443221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....|++.|+|||+..+.. ++.++|||||||++|||++|+.||... +..+.+... +
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~-------------~ 214 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKI-------------I 214 (256)
T ss_pred -hhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHH-------------h
Confidence 11235888999999987765 588999999999999999999998632 112222111 1
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+.. .+.+.....++.+++.+||+.+ ++||+|+||++
T Consensus 215 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 215 RGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 1223445677999999999999 99999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=299.64 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=194.9
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
..+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++. .....++|+||+++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~~ 100 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL--VGDELWVVMEYLAG 100 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee--eCCcEEEEEecCCC
Confidence 357899999999999985 478899999987654555677899999999999999999999987 34578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||++.........
T Consensus 101 ~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 101 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceecccccccc-
Confidence 9999999754 47899999999999999999997 89999999999999988 789999999988765443321
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|++.|+|||++.... ++.++|||||||++||+++|+.||....... .+.... ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~~~------------~~ 230 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIA------------TN 230 (293)
T ss_pred cccccCChhhcCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heeehh------------cC
Confidence 12236889999999987665 4889999999999999999999997432110 000000 00
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+......+...+..+.+++..||..+ ++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111123345667889999999998 999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=298.62 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=190.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeec---CCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWG---PKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. +++.+|+|+++.. ....+++.+|+.+++++ +||||+++++++.. ..+...++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 478999999999999864 6889999988653 22346688899999999 69999999998753 234568999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++....... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRG-ERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccC-ccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCceeecccCC
Confidence 99999999886432111 258999999999999999999997 89999999999999998 7789999999988764432
Q ss_pred CccccccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQVLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. .....|++.|+|||++.... ..++.++|||||||++|||++|+.||..... ...+... . ...
T Consensus 179 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------~~~~~~~-~-~~~---- 245 (286)
T cd06638 179 LR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------MRALFKI-P-RNP---- 245 (286)
T ss_pred Cc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------hHHHhhc-c-ccC----
Confidence 21 22236899999999875321 1257899999999999999999999864311 1111100 0 000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. .....+.....++.+++.+||+.+ ++||++.||++.
T Consensus 246 -~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 -P------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -C------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000012223456899999999999 999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.30 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||||++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v~e~~~ 83 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLVFEYCD 83 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEEEeccC
Confidence 467999999999999965 68999999986532 223456889999999999999999999987 4557899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++.+..++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 84 HTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceecCCCcc-
Confidence 998888765432 58999999999999999999997 89999999999999998 77899999999987654332
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc--cccccch-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN--RSGECFD- 970 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d- 970 (1025)
......++..|+|||++.+... ++.++|||||||++|||++|+.||...... ..+..+.. ..... ...+.++
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~ 230 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQ-YGPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLIRK-TLGDLIPRHQQIFST 230 (286)
T ss_pred cccCcccccccCCHHHHhCCCC-cCchhhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHH-HhCCCChHHhhhccc
Confidence 1112357889999999876432 578999999999999999999999643211 01111111 00000 0000000
Q ss_pred -----hhhcCCCCCCC-----chHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 971 -----RLIMDGHDMEQ-----PPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 971 -----~~~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
........... ....+..+.+++.+|++.+ ++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000 1123567899999999999 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-36 Score=314.58 Aligned_cols=436 Identities=28% Similarity=0.368 Sum_probs=335.0
Q ss_pred ccceEcCCCCEEEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCC
Q 001700 57 WFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSL 136 (1025)
Q Consensus 57 w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 136 (1025)
|+-|.- ..+.++.+.+.-. . +.+.+|..|+.|++++|++...+++++.+..++.|+.|+|+++ .+|..++++
T Consensus 42 W~qv~l-----~~lils~N~l~~l-~-~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~ 113 (565)
T KOG0472|consen 42 WEQVDL-----QKLILSHNDLEVL-R-EDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSL 113 (565)
T ss_pred hhhcch-----hhhhhccCchhhc-c-HhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhh
Confidence 555542 3445555554432 2 6778899999999999999999999999999999999999999 679999999
Q ss_pred CCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccE
Q 001700 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQY 216 (1025)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~ 216 (1025)
.+|..|+.++|.+. .+|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++..+|..+. ++.|+.
T Consensus 114 ~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~----m~~L~~ 187 (565)
T KOG0472|consen 114 ISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA----MKRLKH 187 (565)
T ss_pred hhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH----HHHHHh
Confidence 99999999999999 68889999999999999999998 5778889999999999999999987765544 489999
Q ss_pred EecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcccccCeEEccc
Q 001700 217 LNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296 (1025)
Q Consensus 217 L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~ 296 (1025)
||...|-+. .+|+. ++.+.+|+.|+|..|++... |+|.++..|++|+++.|+|. .+|...+.. ...+..|||..
T Consensus 188 ld~~~N~L~-tlP~~--lg~l~~L~~LyL~~Nki~~l-Pef~gcs~L~Elh~g~N~i~-~lpae~~~~-L~~l~vLDLRd 261 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPE--LGGLESLELLYLRRNKIRFL-PEFPGCSLLKELHVGENQIE-MLPAEHLKH-LNSLLVLDLRD 261 (565)
T ss_pred cccchhhhh-cCChh--hcchhhhHHHHhhhcccccC-CCCCccHHHHHHHhcccHHH-hhHHHHhcc-cccceeeeccc
Confidence 999999995 45555 77899999999999999855 58999999999999999998 788888732 23489999999
Q ss_pred ccCcC-cccccCCCCccEEEccCCcccCCCCCCCCCc--ceeeccCccCCCcccccccC---------------------
Q 001700 297 NQLEG-PVGSITSATLKKVNLSSNKLSGSLPARVGHC--TIVDLSNNRLSGDLSRMQNW--------------------- 352 (1025)
Q Consensus 297 N~l~~-~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~Ls~N~l~~~~~~~~~~--------------------- 352 (1025)
|++.. |...+.+.+|++||+|+|.++ .+|.+++++ ..|-+.+|.+...-.++...
T Consensus 262 Nklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s 340 (565)
T KOG0472|consen 262 NKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS 340 (565)
T ss_pred cccccCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence 99988 445666788999999999999 578788865 47778888774211111000
Q ss_pred --------------------CCccceEEecCCCCCCCCchhccCCCC---CCEEEecCcccCCCcccccCCCCCCCE-ee
Q 001700 353 --------------------GNYVEDIHLSSNFLTGMVPNQTSQFLR---LTSFKVSNNSLEGDLPAVLGTYPELKV-ID 408 (1025)
Q Consensus 353 --------------------~~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~ 408 (1025)
....+.|+++.-+++. +|.....-.. .+..+++.|++. ++|..+..++.+.. ++
T Consensus 341 e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 341 EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred cccccccCCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 1135667777777774 4444333333 677888888887 67777666665554 44
Q ss_pred cCCCcccccCcccccCCCCCCEEecCCCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEe
Q 001700 409 LSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYL 488 (1025)
Q Consensus 409 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L 488 (1025)
+++|.+ +++|..++.+++|+.|+|++|-+. .+|.+ .+... .|+.||+|+|+|. .+|..+-.+..|+.+
T Consensus 419 lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e-------~~~lv--~Lq~LnlS~NrFr-~lP~~~y~lq~lEtl 486 (565)
T KOG0472|consen 419 LSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEE-------MGSLV--RLQTLNLSFNRFR-MLPECLYELQTLETL 486 (565)
T ss_pred hhcCcc-ccchHHHHhhhcceeeecccchhh-hcchh-------hhhhh--hhheecccccccc-cchHHHhhHHHHHHH
Confidence 555554 467777888888999999888765 34544 33333 6888999999887 677777777777777
Q ss_pred eCcCCcCccccCCCcCC--CCcEEECCCCcccccCCCCCCCC
Q 001700 489 NLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRNF 528 (1025)
Q Consensus 489 dLs~N~l~g~ip~~l~~--~L~~L~ls~N~l~g~~p~~l~~~ 528 (1025)
-.++|++...-|+++.. +|..|||.+|.|.. ||..++++
T Consensus 487 las~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~-IPp~Lgnm 527 (565)
T KOG0472|consen 487 LASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQ-IPPILGNM 527 (565)
T ss_pred HhccccccccChHHhhhhhhcceeccCCCchhh-CChhhccc
Confidence 77788887444444654 89999999999974 45455443
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=293.08 Aligned_cols=247 Identities=20% Similarity=0.291 Sum_probs=193.7
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEcccc-----chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREG-----IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+......++++
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 367899999999999985 47999999987532 122345788999999999999999999988754556788999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+++++|.+++.... .+++..+.+++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||+++....
T Consensus 86 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQT 158 (264)
T ss_pred EeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccccccccc
Confidence 9999999999987643 58899999999999999999997 89999999999999987 78899999999986543
Q ss_pred CCC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 890 AGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
... .......|+..|+|||++.+.. ++.++|||||||++||+++|+.||.... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~------------ 218 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAI------------ 218 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccC------HHHHH------------
Confidence 111 1111235889999999988765 5889999999999999999999986421 11100
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCCHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPASERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs~~evl~ 1011 (1025)
............+.....++.+++.+|+..+.+||+..+++.
T Consensus 219 --~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~ 260 (264)
T cd06653 219 --FKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLR 260 (264)
T ss_pred --HHHHcCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhc
Confidence 011111111223555677899999999996699999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=300.18 Aligned_cols=258 Identities=21% Similarity=0.237 Sum_probs=189.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++. .....++|+||++
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 82 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVFEYCD 82 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEEecCC
Confidence 468999999999999965 79999999986532 223456788999999999999999999987 4557899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++..... .+++..++.++.||++||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 83 -QDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred -CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccCCCCC-
Confidence 588888765431 58999999999999999999997 89999999999999998 78999999999986543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-ccc-------
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRS------- 965 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~------- 965 (1025)
......++..|+|||++.+... ++.++|||||||++|||+||+.|+.... +..+........ +..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGN------DVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred CcCCCccccCCcChHHHhCCcc-cCcHHHHHHHHHHHHHHHhcCCCCcCCC------CHHHHHHHHHHHhCCCChHHhHH
Confidence 1122357889999999876543 5889999999999999999999864321 111111111100 000
Q ss_pred -cccchhhhcCCCC-----CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 -GECFDRLIMDGHD-----MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 -~~~~d~~~~~~~~-----~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+..+........ ....+....++.+++.+|++.+ .+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000 0011234567889999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=293.95 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=196.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||++++++|........++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 468999999999999964 689999999875432 345678999999999999999999999875555678999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++. +..++|+|||++.........
T Consensus 86 ~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~- 161 (287)
T cd06621 86 GSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGELVNSLAG- 161 (287)
T ss_pred CCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccccccccc-
Confidence 9999987653221 1258999999999999999999997 89999999999999998 778999999998765432221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCC-CCcchHHHHHHHHhhccccccchhhh
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDP-GVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
...++..|+|||.+.+.. ++.++|||||||++|||++|+.||+....+. ...++..|+... . .+.+
T Consensus 162 --~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~-----~~~~ 228 (287)
T cd06621 162 --TFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----P-----NPEL 228 (287)
T ss_pred --cccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----C-----chhh
Confidence 225788999999987665 5889999999999999999999997542211 111222222110 0 0011
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.... ......+..+.+++.+||..+ ++|||+.||++
T Consensus 229 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1000 111234677899999999999 99999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=296.91 Aligned_cols=248 Identities=18% Similarity=0.283 Sum_probs=190.1
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecC----CCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGP----KEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +||||+++++++... .....+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 46899999999999996 478999999986542 3345688999999998 699999999988531 2457899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++|+|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 100 FCGAGSVTDLVKNTKGN---ALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred eCCCCcHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhhhhcc
Confidence 99999999999764322 48899999999999999999997 89999999999999998 788999999998765432
Q ss_pred CCccccccCcccccCccccccCC---CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.. ......|++.|+|||++... ...++.++|||||||++|||++|+.||...... .....
T Consensus 175 ~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~---------- 237 (282)
T cd06636 175 VG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------RALFL---------- 237 (282)
T ss_pred cc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------hhhhh----------
Confidence 21 11223689999999987532 112578999999999999999999998643110 00000
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. .............+.++.+++.+||+.+ .+||++.||++
T Consensus 238 -~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -I---PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -H---hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000000112245677999999999999 99999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=303.31 Aligned_cols=242 Identities=20% Similarity=0.317 Sum_probs=199.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
...||+|.|++|..|++. ++..||||.+.+.... ..+.+.+|+++|+.++|||||+++.+.. .....|+||||+.
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~~lylV~eya~ 138 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEATLYLVMEYAS 138 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecceeEEEEEecc
Confidence 478999999999999965 7999999999876432 3345889999999999999999999987 4568999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|.+++|+...+ .+.+.++..++.|+.+|++|||+ ..|||||||++|||++. ++++||+|||++..+......
T Consensus 139 ~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 139 GGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred CchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeeccccceeecccccc
Confidence 999999999876 45668999999999999999998 89999999999999998 889999999999988755443
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
. ..+|++.|.|||++.+..+ .+.++|+||+|+++|-|+.|..||+...- .+.-++.+
T Consensus 212 q--t~cgsppyAaPEl~~g~~y-~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~Lr~rvl 268 (596)
T KOG0586|consen 212 Q--TFCGSPPYAAPELFNGKKY-DGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KELRPRVL 268 (596)
T ss_pred c--ccCCCCCccChHhhcCccc-CCcceehhhhhhhheeeeecccccCCccc--------------------ccccchhe
Confidence 3 3489999999999998885 69999999999999999999999984311 11222333
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.++. +.-...++.+++.+.+..+ .+|+++++|.+.
T Consensus 269 ~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 333332 3334556778888888888 889998888653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=295.45 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=192.8
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCC---CCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIK---HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|.. .+++.||+|.++... ....+++.+|+.++++++ |||++++++++. .....++||||
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~lv~e~ 83 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWIIMEY 83 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEEEEec
Confidence 46799999999999995 478999999987542 334567889999999996 999999999887 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++... .+++..++.++.|++.||.|||+ .+|+||||+|+||+++. ++.++++|||.+.......
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 84 AEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred CCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCceeecCCCc
Confidence 9999999998653 58999999999999999999997 89999999999999998 8899999999998765443
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.. .....|+..|+|||++.+... ++.++|||||||++|+|++|+.||..... ..+..... ....+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~------~~~~~ 220 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMMLIP------KSKPP 220 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCc-cccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhhccc------cCCCC
Confidence 22 223368999999998865443 58899999999999999999999864311 11111000 00000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+ .....+.++.+++.+||..+ ++||++.|+++.
T Consensus 221 ~~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RL-------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CC-------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00 01124567899999999999 999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=300.16 Aligned_cols=259 Identities=21% Similarity=0.267 Sum_probs=192.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh-----cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK-----GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|... +|+.||||.++..... ....+..|++++++++|+||+++++++.. ....++|||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 82 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLVFE 82 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEEEc
Confidence 468999999999999964 7899999999765322 24557789999999999999999999974 568899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+ +|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+||+++. ++.++|+|||+++.....
T Consensus 83 ~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 83 FM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSP 155 (298)
T ss_pred cc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeeeeccCC
Confidence 99 999999997643 158999999999999999999997 89999999999999998 889999999999876543
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc-c---
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS-G--- 966 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-~--- 966 (1025)
... .....+++.|+|||.+.+... ++.++|||||||++|||++|..||.... +..........-... .
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~e~~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLRVPFLPGDS------DIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCC-CCcHHHHHHHHHHHHHHHcCCccccCCc------cHHHHHHHHHHcCCCchhhh
Confidence 221 122256888999998865443 5889999999999999999987775321 111111110000000 0
Q ss_pred ---ccchhhhcCCCCCC-----CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ---ECFDRLIMDGHDME-----QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ---~~~d~~~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.............. .......++.+++.+|++.+ ++||++.||++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11233577899999999999 999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.03 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=195.0
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++++++|+||+++++++. .....++|+||+
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 81 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFMEYC 81 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEEecC
Confidence 3578999999999999854 789999999876543 25678999999999999999999999876 456899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++. ++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEcccccccccCCCCC
Confidence 9999999997643 47899999999999999999997 89999999999999998 88999999999887654332
Q ss_pred cccc---ccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 893 ADQV---LNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 893 ~~~~---~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.... ...+++.|+|||++.+.. ...+.++||||||+++||+++|+.||.... . .|........
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~------~--~~~~~~~~~~----- 221 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD------N--EFQIMFHVGA----- 221 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc------c--hHHHHHHHhc-----
Confidence 2111 235788999999987654 224789999999999999999999996431 0 1111000000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+........+.+++.+||+.+ ++||++.|++.
T Consensus 222 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -----GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111112233667889999999998 99999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=297.68 Aligned_cols=251 Identities=23% Similarity=0.288 Sum_probs=191.1
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCC---CCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPK---EHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|.. ++++.+|+|++.... ....++.+|+.+++++ +||||+++++++...+ ....++|+||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 46899999999999996 478999999986542 2345678899999999 7999999999986432 2468999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.++++..... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.......
T Consensus 106 ~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchhccccc
Confidence 9999999988753211 1268999999999999999999997 89999999999999988 7789999999988754332
Q ss_pred CccccccCcccccCccccccCCCC---CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQVLNAGALGYRPPEFASTSKP---CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. .....|+..|+|||++..... .++.++|||||||++|||++|+.||...... ..+.++. . ...
T Consensus 183 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~~----~-~~~--- 250 (291)
T cd06639 183 LR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKIP----R-NPP--- 250 (291)
T ss_pred cc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHh----c-CCC---
Confidence 21 122368899999998764321 1478999999999999999999998643110 0111110 0 000
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.....+......+.+++.+|++.+ ++||++.|+++
T Consensus 251 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 --------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000112334567899999999999 99999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.95 Aligned_cols=242 Identities=20% Similarity=0.319 Sum_probs=193.2
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|.. .++..||+|+..... ....+.+.+|+.++++++||||+++++++. .....++|+||+++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 86 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGG 86 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEEeCCC
Confidence 46799999999999985 478999999986432 234567889999999999999999999987 45578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++... .+++..+..++.|++.|++|||+ .+|+|+||||+||+++. ++.++++|||++........ .
T Consensus 87 ~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 87 GSALDLLEPG------PLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecccchh-h
Confidence 9999998643 58999999999999999999997 89999999999999988 78899999999876543321 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|+..|+|||.+.+.. .+.++|||||||++|||++|..||.... -..+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~-------------- 214 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELH-------PMKVLFLIP-------------- 214 (277)
T ss_pred hccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCccc-------hHHHHHHHh--------------
Confidence 12235888999999987665 4889999999999999999999986321 111111110
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.......+...+.++.+++.+|++.+ ++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111123345677899999999998 999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=299.78 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|..+ +++.||||+++... ....+.+.+|++++++++|+||+++++++. .....++++||++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~ 83 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLYLVFEYVE 83 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE--ECCEEEEEEecCC
Confidence 578999999999999965 68899999987542 233567899999999999999999999997 4557999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++.+..+..... .+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 84 RTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeecccccCCCccc
Confidence 877776654432 58999999999999999999997 89999999999999998 889999999998876554322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc--cccc--c
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR--SGEC--F 969 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~--~ 969 (1025)
......++..|+|||++.+... ++.++||||||+++|||++|+.||..... .+............. .... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccCcccccCCcCCchhcCCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHhhhccc
Confidence 2223468899999999987632 58899999999999999999999864211 110000000000000 0000 0
Q ss_pred hhhhcC-CC-C--------CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 970 DRLIMD-GH-D--------MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~-~~-~--------~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
++.... .. . ...+...+.++.+++.+||..+ ++||++++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 00 0 0012234678999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=295.21 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=183.8
Q ss_pred eeeeecceEEEEEEe-cCCCEEEEEEccccch---hcHHHHHHHHHHHh---cCCCCccccccceeecCCCCeeEEEEec
Q 001700 739 VIGRSCHGTLYKATL-DSGSILAVKRLREGIA---KGKKEFAREVKKLG---NIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
+||+|+||.||++.. .+++.||+|.+..... .....+.+|..+++ ..+||||+.+++++. .....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence 489999999999985 4789999998865421 11233445544433 347999999988886 44578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++++|||++.......
T Consensus 79 ~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 79 MNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccccC
Confidence 99999999987653 58999999999999999999998 89999999999999988 7899999999987654322
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ....|+..|+|||...+... ++.++|||||||++|||++|+.||...... . .........
T Consensus 152 ~---~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~-~~~~~~~~~---------- 212 (279)
T cd05633 152 P---HASVGTHGYMAPEVLQKGTA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTK----D-KHEIDRMTL---------- 212 (279)
T ss_pred c---cCcCCCcCccCHHHhcCCCC-CCchhhhHHHHHHHHHHHhCCCCcCCCCCc----C-HHHHHHHhh----------
Confidence 2 12368999999998864332 588999999999999999999999743211 1 111111000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~~ 1012 (1025)
......+...+.++.+++.+|+..+ ++|| +++|+++.
T Consensus 213 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 ----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011123445678899999999999 9999 69988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=293.74 Aligned_cols=243 Identities=18% Similarity=0.297 Sum_probs=193.9
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++. .....++++||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e~~~~~ 101 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFLEGG 101 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEeccCCC
Confidence 36899999999999985 478999999987654455667889999999999999999999887 456789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||.+........ ..
T Consensus 102 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 102 ALTDIVTHT------RMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhccCCc-cc
Confidence 999998762 58999999999999999999997 89999999999999998 88999999998876543221 11
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|++.|+|||+..+.. ++.++|||||||++|||++|+.||... +...+....... ..+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~-------~~~~~~~~~~~~------~~~---- 233 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNE-------PPLQAMKRIRDN------LPP---- 233 (285)
T ss_pred ccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCC-------CHHHHHHHHHhc------CCC----
Confidence 2236899999999987765 588999999999999999999998632 111222211111 000
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
........+..+.+++.+||..+ ++||++.++++
T Consensus 234 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 --KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --CCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112234567999999999999 99999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=293.35 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=196.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++. .....++++||+++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~ 83 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY--NNGDISICMEYMDG 83 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee--cCCEEEEEEEecCC
Confidence 467999999999999965 78999999987653 334567899999999999999999999987 44689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++.... ..+++..+.+++.|++.||+|||+..+|+||||||+||+++. ++.++|+|||.+..........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 84 GSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhhHHHHhhc
Confidence 99999998653 268999999999999999999996478999999999999998 8889999999987664322211
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
..|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...... .....+.+.....
T Consensus 159 ---~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------------- 218 (265)
T cd06605 159 ---FVGTSSYMAPERIQGND--YSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVN------------- 218 (265)
T ss_pred ---ccCChhccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhc-------------
Confidence 46889999999987765 588999999999999999999998643211 1122222221111
Q ss_pred CCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. .....+.. ...++.+++.+||..+ ++||++.|++..
T Consensus 219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 E-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 11111222 5677999999999999 999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=294.65 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=190.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++. .....++||||+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~ 82 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVFEFLH 82 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEeeccc
Confidence 468999999999999864 78999999987543 223457889999999999999999999987 4557899999995
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||++........
T Consensus 83 -~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 83 -QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred -cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcccCcc-
Confidence 689998876432 258999999999999999999997 89999999999999998 88999999999886543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL- 972 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~- 972 (1025)
......++..|+|||++.+... ++.++|||||||++|||+||+.||..... ...+.+..... +...+...+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~ 228 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTL---GTPDEVVWPGV 228 (284)
T ss_pred ccccccccccccCCeEEecCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHh---CCCChhhhhhh
Confidence 1122357889999998876543 47899999999999999999999863211 11111111100 0000000000
Q ss_pred ---------hcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 ---------IMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ---------~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...... .........++.+++.+|++.+ ++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 0001123456789999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=275.88 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=193.9
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecC--CCCeeEEEEec
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGP--KEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~~~lv~e~ 811 (1025)
+.++||-|-.|.|..+.++ +|+.+|+|++... ....+|++.--+. .|||||.++++|... ...-.++|||.
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 3588999999999999865 8999999998643 2356788875555 599999999998642 22347789999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec--CCCCEEEecccccccccc
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~--~~~~~kl~DfGla~~~~~ 889 (1025)
|+||.|...+++++.. .|+++++-.|++||+.|+.|||+ ..|.||||||+|+|... .+..+||+|||+|+....
T Consensus 141 meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred ccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999987643 59999999999999999999998 89999999999999964 356789999999997654
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.. ...+.+-|++|.|||++.... ++..+|+||+||+||-|++|-+||...... .+..-++
T Consensus 217 ~~--~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk------------ 276 (400)
T KOG0604|consen 217 PG--DLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMK------------ 276 (400)
T ss_pred Cc--cccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHH------------
Confidence 32 233457899999999997776 588999999999999999999999754221 1111111
Q ss_pred hhhhcCCCC--CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 970 DRLIMDGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~--~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+...+.+. .+.....++...+++...+..+ .+|-|+.|++.
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111222232 3345567788888888888888 99999999975
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=299.51 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=192.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLVMDYC 83 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEEEEec
Confidence 478999999999999965 689999999876432 24467889999999999999999999886 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.+++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 84 PGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhhccccccc
Confidence 99999999875432 258999999999999999999997 89999999999999998 78999999999876532211
Q ss_pred c----------------------------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccc
Q 001700 893 A----------------------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVC 944 (1025)
Q Consensus 893 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~ 944 (1025)
. ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC--CCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0 011125888999999998766 5889999999999999999999986431
Q ss_pred cCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC----HHHHHH
Q 001700 945 VDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD----MMSVFE 1011 (1025)
Q Consensus 945 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs----~~evl~ 1011 (1025)
. ...+.... ......+.....+.++.+++.+|++.+ ++||+ +.|++.
T Consensus 237 ~------~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R------DETFSNIL--------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h------HHHHHHHh--------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111110 011111112225778999999999999 99999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=296.83 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=187.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++||||++++++|. .....++|+||+
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~ 97 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYC 97 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--eCCeEEEEHHhh
Confidence 478999999999999864 78999999986432 223457889999999999999999999997 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
. |++.+++..... .+++.++..++.|++.||.|||+ .+|+||||+|+||+++. ++.++|+|||++.......
T Consensus 98 ~-g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 98 L-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred C-CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCcceecCCCC-
Confidence 6 677777764321 58999999999999999999997 89999999999999998 7899999999987654322
Q ss_pred ccccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
...|++.|+|||++.+. ...++.++||||||+++|||+||+.||..... .........
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~~~~~---------- 228 (307)
T cd06607 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ---------- 228 (307)
T ss_pred ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhc----------
Confidence 23588899999987531 11257899999999999999999999864311 111110000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...........+..+.+++.+||+.+ ++||+|.+|+..
T Consensus 229 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 ---NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000112345677999999999999 999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=290.85 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=196.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+. .....++|+||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~~ 83 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVMPYLSG 83 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEEeccCC
Confidence 578999999999999954 78899999986532 234577899999999999999999999886 45688999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc-
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA- 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~- 893 (1025)
++|.+++....... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++|+|||++.........
T Consensus 84 ~~l~~~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 84 GSLLDIMKSSYPRG--GLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CcHHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHhccCcccc
Confidence 99999998653211 58999999999999999999997 89999999999999998 788999999998876544322
Q ss_pred --cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 894 --DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 894 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
......|+..|+|||++..... ++.++|||||||++|||++|+.||...... ....+... . ..+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~----~------~~~ 225 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQ----N------DPP 225 (267)
T ss_pred ccccccccCChhhcChHHHccccC-cCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhc----C------CCC
Confidence 1122368899999999876622 588999999999999999999998743211 01111110 0 000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..... ......+.++.+++.+|+..+ ++||++.||++
T Consensus 226 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 001245677899999999999 99999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=297.79 Aligned_cols=195 Identities=25% Similarity=0.376 Sum_probs=161.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++. .....++||||+.
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~- 86 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVFEYLD- 86 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEEecCC-
Confidence 578999999999999965 789999999875432 22345778999999999999999999987 4558899999997
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 87 ~~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 87 TDLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECccccccccCCCCc-c
Confidence 599998876532 58999999999999999999997 89999999999999998 78999999999875432211 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
.....++..|+|||++.+... ++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ccccccccccCCcHHhhcCcc-cCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 112246889999998875432 58899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=294.99 Aligned_cols=249 Identities=21% Similarity=0.387 Sum_probs=186.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHH-HhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKK-LGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.+ ++..+||||+++++++. .....++++||++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv~e~~~ 83 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWICMEVMD 83 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEEhhhhc
Confidence 468999999999999965 79999999987643 2234456667665 56678999999999987 4557899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
|+|.+++....... ..+++..++.++.|++.||+|||+..+|+||||||+||+++. +..+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-CCCEEEeecccccccccccc-
Confidence 78888886543222 368999999999999999999997338999999999999998 88999999999886643221
Q ss_pred cccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 894 DQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....|+..|+|||++.+.. ..++.++|||||||++|||++|+.||..... ..... .....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~---------- 222 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQL-KQVVE---------- 222 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHH-HHHHh----------
Confidence 12235889999999886421 1247899999999999999999999864211 11111 10000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...........+.++.+++.+|+..+ ++||++.+|++
T Consensus 223 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 ---EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000001234567899999999999 99999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=285.58 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=196.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcC--CCCccccccceeecCCC--CeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNI--KHPNLVSLQGYYWGPKE--HEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~~--~~~~lv~e~~ 812 (1025)
.+.||+|.||.||+|.++ |+.||||++... +++.+.||.++.+.+ +|+||+.+++.-....+ .+.|+|++|-
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 478999999999999998 889999999653 455678888888764 99999999875432111 3689999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
+.|+|+|||... .++....++++.-+|.||+|||-+ +.|.|||||+.|||+.. ++...|+|+|+|.
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IADLGLAv 364 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAV 364 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEeeceeeE
Confidence 999999999975 699999999999999999999973 78999999999999988 8999999999998
Q ss_pred ccccCCC---ccccccCcccccCccccccCCCC----CCCCchhHHHHHHHHHHHHcC----------CCCCCccccCCC
Q 001700 886 ILTSAGT---ADQVLNAGALGYRPPEFASTSKP----CPSLKSDVYAFGIILLELLTG----------KSSGEIVCVDPG 948 (1025)
Q Consensus 886 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DVwSlGvvl~elltG----------~~P~~~~~~~~~ 948 (1025)
....... ......+||.+|||||++...-. ..=..+||||||.|+||++.. +.||.+.-+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~-- 442 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS-- 442 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC--
Confidence 7654421 22334589999999999975321 012368999999999999863 3566543221
Q ss_pred CcchHHHHHHHHhhccccccchhhhcCCC-CCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGH-DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+.+..++... -+++ .++... ..-...++...+.++|..||..+ ..|-|+=.|-+.|.++...
T Consensus 443 DPs~eeMrkV--------VCv~-~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKV--------VCVQ-KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcc--------eeec-ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 1112111110 0111 111111 00124578899999999999999 9999999999999888743
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=297.66 Aligned_cols=249 Identities=21% Similarity=0.216 Sum_probs=192.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+. .....++||||+
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCMVMEYV 83 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEEEEecC
Confidence 478999999999999965 688999999876532 23457889999999999999999999886 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||+++.......
T Consensus 84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 84 EGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCccccCcCcc
Confidence 9999999997653 58999999999999999999997 89999999999999988 88999999999874211100
Q ss_pred --------------ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHH
Q 001700 893 --------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 893 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
.......|+..|+|||.+.... ++.++|||||||++|||++|+.||... ...++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~vl~el~~g~~pf~~~-------~~~~~~~~ 227 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQ 227 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence 0001125788999999987665 588999999999999999999998632 11122221
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhh
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~ 1015 (1025)
..... .. .+......+.++.+++.+||+.+ ++||++.++.+.|+.
T Consensus 228 ~~~~~----~~--------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD----IE--------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc----cC--------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11100 00 00111234667899999999999 999997777666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=295.89 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=187.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++. .....+++|||+.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~~e~~~ 86 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWICMELMD 86 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEEEeccc
Confidence 367999999999999954 68999999987543 234567889999999996 999999999887 4457889999985
Q ss_pred cccHHHH---HhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 814 AQSLAVY---LQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 814 ~gsL~~~---l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
. ++.++ +..... ..+++..+..++.|++.||+|||+..+|+||||||+||+++. +..+||+|||+++.....
T Consensus 87 ~-~l~~l~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 87 I-SLDKFYKYVYEVLK---SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDS 161 (288)
T ss_pred C-CHHHHHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHHhccC
Confidence 4 55443 322211 268999999999999999999997568999999999999988 778999999999865433
Q ss_pred CCccccccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
... ....|++.|+|||++.+.. ..++.++|||||||++|||++|+.||.... ...+-+...... .
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~------~ 227 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKG------D 227 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCC------C
Confidence 221 2235889999999987651 125889999999999999999999986431 111111100000 0
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.+.. ......+.++.+++.+|++.+ ++||++.+|++.
T Consensus 228 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSN----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCC----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011110 112345678999999999999 999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.05 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=194.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+. .....++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~ 82 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVMEYCD 82 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEEecCC
Confidence 578999999999999965 68899999986532 234567889999999999999999999886 4557899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++..... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++..+..+|++|||.+.........
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 83 GGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999976432 257999999999999999999997 899999999999999874456799999998876543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....|++.|+|||+..+.. ++.++|||||||++|||++|+.||... ...+++.......
T Consensus 159 -~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~---------- 218 (257)
T cd08225 159 -AYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQGY---------- 218 (257)
T ss_pred -ccccCCCccccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHhccc----------
Confidence 12235889999999887665 588999999999999999999998632 2233333221110
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+.....+.++.+++.+|+..+ ++|||+.||++
T Consensus 219 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 219 ----FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112334567899999999998 99999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=292.16 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|||++++++++. .....++++||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e~~~ 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFEFLD 81 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEeccC
Confidence 478999999999999864 79999999987543 223467889999999999999999999987 4568999999994
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||+|+||+++. ++.++|+|||+++.......
T Consensus 82 -~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 82 -LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCCCcc-
Confidence 689999876542 258999999999999999999997 89999999999999998 88999999999976543221
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc----
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF---- 969 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 969 (1025)
......++..|+|||++.+... ++.++|||||||++|||++|+.||..... ...+.+..+. .....+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~---~~~~~~~~~~~~ 227 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRT---LGTPDEDVWPGV 227 (283)
T ss_pred ccCccccccCCCCCceeecCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH---hCCCChHHhhhh
Confidence 1122256889999998866443 47899999999999999999999863211 0111111110 00000000
Q ss_pred ------hhhhcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 970 ------DRLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 ------d~~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......... .......+..+.+++.+|++.+ ++||+++||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0011233467889999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.38 Aligned_cols=258 Identities=18% Similarity=0.199 Sum_probs=189.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +++.||+|+++.... .......+|+.++.++. ||||+++++++.+......++|+||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 467999999999999854 789999999876422 22334557999999985 999999999998644467899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. +.+||+|||+++........
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEecccccccccCCCc
Confidence 58888876543 258999999999999999999997 89999999999999987 78999999999876443222
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
. ...++..|+|||++..... ++.++|||||||++|||++|+.||.... ..+...+....... ..+.+....
T Consensus 156 ~--~~~~~~~y~aPE~~~~~~~-~~~~~Di~slGv~l~el~~~~~p~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~ 226 (282)
T cd07831 156 T--EYISTRWYRAPECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTN----ELDQIAKIHDVLGT--PDAEVLKKF 226 (282)
T ss_pred C--CCCCCcccCChhHhhcCCC-CCcchhHHHHHHHHHHHHcCCcCCCCCC----HHHHHHHHHHHcCC--CCHHHHHhh
Confidence 1 2357899999998755433 5889999999999999999999996431 11222222111100 000000000
Q ss_pred c----CCCCC---------CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 M----DGHDM---------EQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~----~~~~~---------~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. ..... ......+..+.+++.+|++.+ ++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 00000 001234688999999999999 99999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.22 Aligned_cols=241 Identities=20% Similarity=0.239 Sum_probs=192.1
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. .+...++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence 689999999999965 68999999987542 233567899999999999999999999887 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.++|+|||.+........ .
T Consensus 79 ~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~--~ 149 (262)
T cd05572 79 ELWTILRDRG-----LFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQK--T 149 (262)
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCcccc--c
Confidence 9999997653 58999999999999999999997 89999999999999998 88999999999987654321 1
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||++.+.. ++.++||||||+++|||++|+.||..... +..+...... .+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-------------~~ 209 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDIL-------------KG 209 (262)
T ss_pred ccccCCcCccChhHhcCCC--CCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHh-------------cc
Confidence 2236889999999987655 58899999999999999999999975421 1112221111 01
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCC-----HHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-----~~evl~ 1011 (1025)
......+...+.++.+++.+||+.+ ++||+ +.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111223344678999999999999 99999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=293.09 Aligned_cols=266 Identities=17% Similarity=0.212 Sum_probs=190.6
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCC-CCccccccceeecCCC---CeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKE---HEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~---~~~~lv 808 (1025)
..+.||+|+||.||+|+.. +++.||||.++.... ...+.+.+|+.++++++ ||||+++++++..... ...++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3578999999999999965 789999998865432 23457888999999995 6999999998863221 137999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++ +|.+++..........+++..++.++.||+.||+|||+ .+|+||||||+||+++..+..+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence 999975 89888876533212368999999999999999999997 8999999999999998757789999999988654
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc-c
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG-E 967 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~-~ 967 (1025)
.... ......+++.|+|||++.+... ++.++|||||||++|||++|..||... ................. +
T Consensus 163 ~~~~-~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~------~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 163 IPVK-SYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGD------SELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred CCcc-ccCCcccccCCCChHHhhCCCC-CCchHHHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHHHhCCCChh
Confidence 3211 1112257889999998865443 588999999999999999999998632 11222211111100000 0
Q ss_pred cchh-------hhcCCCCC----CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 CFDR-------LIMDGHDM----EQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~-------~~~~~~~~----~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.... ........ ...+....++.+++.+|+..+ .+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000000 001234567899999999999 99999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.32 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=192.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCC----CCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPK----EHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~----~~~~~lv~e 810 (1025)
.+.||+|++|.||+|... +++.||+|++..... ..+++.+|+.+++++ +||||+++++++.... ....++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 578999999999999965 688999999876533 356789999999999 6999999999987422 345899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++...... ...+++..+..++.|++.||+|||+ .+|+|+||+|+||+++. ++.+||+|||.+......
T Consensus 90 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 90 LCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGVSAQLDST 166 (275)
T ss_pred cCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCccceecccc
Confidence 99999999998754311 1268999999999999999999997 89999999999999998 788999999998765432
Q ss_pred CCccccccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 891 GTADQVLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.. ......|+..|+|||++.... ..++.++|||||||++|||++|+.||..... ...... ... .
T Consensus 167 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~-~---- 233 (275)
T cd06608 167 LG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------MRALFK-IPR-N---- 233 (275)
T ss_pred hh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch------HHHHHH-hhc-c----
Confidence 22 122236899999999875421 2247789999999999999999999863211 111100 000 0
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.. .....+......+.+++.+|+..+ ++|||+.||++
T Consensus 234 -~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 -PP------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -CC------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 011112335677899999999999 99999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=295.17 Aligned_cols=264 Identities=19% Similarity=0.206 Sum_probs=189.0
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
+.+|.|+++.||+++. +++.||||+++.. .....+.+.+|++++++++||||+++++++. .....+++|||+++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCC
Confidence 3344555555555544 6899999998754 2344578999999999999999999999887 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc--
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA-- 893 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~-- 893 (1025)
+|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+|++|||.+.........
T Consensus 85 ~l~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFPE---GLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeecccccccc
Confidence 999999865322 48899999999999999999997 89999999999999997 789999999988755332211
Q ss_pred ----cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh--------
Q 001700 894 ----DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL-------- 961 (1025)
Q Consensus 894 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~-------- 961 (1025)
......++..|+|||++......++.++|||||||++|||++|+.||...... ..+.+-......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccccCch
Confidence 11123577889999998765333688999999999999999999999743111 011110000000
Q ss_pred --h-ccccc----cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 962 --E-NRSGE----CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 962 --~-~~~~~----~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
. ....+ ..++................++.+++.+||..+ ++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00000 001111111111223345678899999999999 999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.85 Aligned_cols=238 Identities=20% Similarity=0.281 Sum_probs=191.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~ 83 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYLVMEYV 83 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEEEEecC
Confidence 578999999999999965 68999999986532 233567889999999999999999999987 456789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||+|+||+++. ++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 84 PGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCccccCCC--
Confidence 9999999997653 58999999999999999999997 89999999999999988 788999999999876543
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....|++.|+|||.+.+.. .+.++||||||+++|||++|+.||.... ....+.. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~-~------------- 210 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEK-I------------- 210 (290)
T ss_pred --CCCCCCCccccChhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH-H-------------
Confidence 12236899999999987665 5889999999999999999999986421 0000000 0
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
..+ ....+......+.+++.+||..+ .+|| +++|+++
T Consensus 211 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 211 LEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred hcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 000 11123344677899999999999 9999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=291.49 Aligned_cols=195 Identities=24% Similarity=0.323 Sum_probs=160.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|.. .+|..||+|+++.... .....+.+|+.++++++|+||+++++++. .....++|+||+.
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~- 86 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEEEEeccc-
Confidence 47899999999999985 4789999999875432 23346788999999999999999999987 4557899999995
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
+++.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++........
T Consensus 87 ~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 TDLAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEeccccccccCCCCCC-
Confidence 677777654321 47889999999999999999997 89999999999999988 789999999998765332211
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
.....+++.|+|||++.+... ++.++|||||||++|||++|+.||+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCccccccccCCceeecCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 122357899999999875432 57899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=290.62 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=192.0
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++.+. .....++++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 589999999999976 599999999875433 34567889999999999999999999886 456789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc--
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA-- 893 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~-- 893 (1025)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||+|+||+++. +..++|+|||++.........
T Consensus 79 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 79 DLASLLENVG-----SLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccccc
Confidence 9999998653 58999999999999999999997 89999999999999998 889999999998865433110
Q ss_pred -----cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 894 -----DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 894 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
......++..|+|||+..... .+.++||||||+++||+++|+.||.... ..+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~-------- 214 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNIL-------- 214 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHh--------
Confidence 112235788999999987766 5889999999999999999999986431 111111111
Q ss_pred chhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.+....+.....+..+.+++.+|++.+ ++|||+.+|.+.|+
T Consensus 215 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 -----NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -----cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111111111113677899999999999 99999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=287.30 Aligned_cols=247 Identities=23% Similarity=0.397 Sum_probs=198.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|+..+.+++||||+++++++. .....++|+||+++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~ 83 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEEEEEEecCC
Confidence 478999999999999966 699999999876543 44678999999999999999999999987 44689999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++.... .+++..+..++.|+++|++|||+..+++||||+|+||+++. ++.++|+|||.+..........
T Consensus 84 ~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 84 GSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS-KGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC-CCCEEEccCccceecccCCCcc
Confidence 99999998652 68999999999999999999995378999999999999998 8899999999988765433221
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..... ....+......
T Consensus 158 -~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~-------------- 216 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGES--YSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAIC-------------- 216 (264)
T ss_pred -cceeecccccCHhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHh--------------
Confidence 1235889999999987765 58899999999999999999999874421 01111111110
Q ss_pred CCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 975 DGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.......+.. .+..+.+++.+|++.+ ++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111112233 5678999999999999 999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.12 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=192.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++........++|+||+.
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 478999999999999965 689999999875432 22345778999999999999999999987544468999999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~- 161 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLAREYGSPLK- 161 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceeeccCCcc-
Confidence 599998876432 58999999999999999999997 89999999999999998 78999999999987654321
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchH---------HHHHHHHhh--
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLT---------DWVRLLALE-- 962 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~---------~~~~~~~~~-- 962 (1025)
......+++.|+|||++.+... .+.++|||||||++|||++|+.||...........+. .|.......
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCcc-ccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 1122357889999998876543 4789999999999999999999986431100000000 010000000
Q ss_pred --ccccccchhhhcCCCCCCCchH-HHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 963 --NRSGECFDRLIMDGHDMEQPPR-ILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 963 --~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....+.....+.... +.. ....+.+++..|++.+ ++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKF----PALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccc----cccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000011111 111 3667889999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=299.72 Aligned_cols=264 Identities=21% Similarity=0.239 Sum_probs=189.1
Q ss_pred eeeee--cceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 739 VIGRS--CHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 739 ~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.||+| +||+||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|. .....++|+||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe--cCCceEEEEeccc
Confidence 46666 89999999964 79999999987532 233467889999999999999999999997 4557899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++++.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhccCcc
Confidence 99999998875322 48999999999999999999997 89999999999999998 788999999865433221111
Q ss_pred c------ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHH---------
Q 001700 894 D------QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL--------- 958 (1025)
Q Consensus 894 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~--------- 958 (1025)
. .....++..|+|||++.+....++.++|||||||++|||++|+.||....... .+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDIT 234 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCcccc
Confidence 0 00113566799999997654335889999999999999999999997532110 00000000
Q ss_pred -------HHh------hccccccchh-----hhc-CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 959 -------LAL------ENRSGECFDR-----LIM-DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 959 -------~~~------~~~~~~~~d~-----~~~-~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
... +....+.... .+. ...+.+....+...+.+++.+|+..+ ++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000000000 000 00111223456778999999999999 999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=294.45 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=188.6
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|++++++++|||++++++++. .....++||||+
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~ 107 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYC 107 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--eCCeEEEEEeCC
Confidence 46799999999999995 478999999986432 223457889999999999999999999987 455789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
. |++.+++..... .+++.++..++.|++.||.|||+ .+|+||||+|+||+++. ++.+||+|||++.......
T Consensus 108 ~-g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~~~~~- 179 (317)
T cd06635 108 L-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIASPAN- 179 (317)
T ss_pred C-CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCccccCCcc-
Confidence 6 578777764421 58999999999999999999997 89999999999999988 7899999999987654321
Q ss_pred ccccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
...|++.|+|||++... ...++.++|||||||++|||++|+.||.... .. ........
T Consensus 180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~-~~~~~~~~---------- 238 (317)
T cd06635 180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AM-SALYHIAQ---------- 238 (317)
T ss_pred ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HH-HHHHHHHh----------
Confidence 23588999999987421 1125889999999999999999999986321 11 11111110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
...........+..+.+++.+|++.+ .+||++.+|++..-
T Consensus 239 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 239 ---NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ---ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00111112345567899999999998 99999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=295.59 Aligned_cols=204 Identities=24% Similarity=0.296 Sum_probs=165.0
Q ss_pred CceeeeecceEEEEEEec---CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD---SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++........++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 467999999999999964 47899999998743 333466788999999999999999999998654468999999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec---CCCCEEEecccccccc
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA---PTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~---~~~~~kl~DfGla~~~ 887 (1025)
|+++ ++.+++..........+++..+..++.|++.||+|||+ .+|+||||||+||+++. .++.+||+|||+++..
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 9964 67777654433222368999999999999999999997 89999999999999975 2467999999999876
Q ss_pred ccCCC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 888 TSAGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 888 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
..... .......++..|+|||++.+... ++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 44322 11122367889999998866443 588999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=291.32 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=193.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++|||++++++++........++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999965 68999999998653 334567889999999999999999999987532368999999997
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++. ++.+|++|||.+.........
T Consensus 84 -~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 84 -HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred -ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccCCCcc
Confidence 48988887542 268999999999999999999997 89999999999999998 889999999999877554322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh----hcc--c--
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL----ENR--S-- 965 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~----~~~--~-- 965 (1025)
......++..|+|||.+.+... ++.++||||||+++|||+||+.||+.... ......+..... ..+ .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATR-YGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccCCceeeEcccc-CChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchhhcccccc
Confidence 2223357889999998765432 58899999999999999999999864321 111111100000 000 0
Q ss_pred ---------cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 ---------GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 ---------~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.......+.... ...++..+.+++..|+..+ ++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFF----KHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHh----cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000 0112667899999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=293.38 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=190.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|++++++++|+||+++++++.+......++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 578999999999999964 7999999998754322 2335678999999999999999999987544456899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||.+........
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceeeecCCccC-
Confidence 58888887543 268999999999999999999998 89999999999999998 78999999999987654321
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-ccc-ccc---
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRS-GEC--- 968 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~-~~~--- 968 (1025)
......++..|+|||++.+... ++.++||||+||++|||++|+.||..... .+.+...... +.. ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~il~el~~g~~~f~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTT-YTTAIDMWAVGCILAELLAHKPLLPGKSE-------IEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CCCcccccccccChhhhcCCCC-cCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCCChhhchh
Confidence 1112246788999999876443 58899999999999999999999864311 1111111110 000 000
Q ss_pred chh-hhcCCCC-----CC----CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDR-LIMDGHD-----ME----QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~-~~~~~~~-----~~----~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
++. ....... .. ........+.+++.+|++.+ ++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 00 00123566789999999999 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.45 Aligned_cols=243 Identities=20% Similarity=0.279 Sum_probs=195.0
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
..+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. .....++|+||
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~ 81 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLVVDL 81 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEEEeC
Confidence 3578999999999999965 689999999975432 34567899999999999999999999886 45579999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+.+++|.+++.... .+++.++..++.|+++||.|||+ .+|+|+||||+||+++. ++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccccCCCc
Confidence 99999999997652 58999999999999999999997 89999999999999998 8899999999988765432
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. .....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ..++.......
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------- 216 (258)
T cd05578 155 L--TTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET--------- 216 (258)
T ss_pred c--ccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc---------
Confidence 1 12236888999999987766 588999999999999999999998743211 12222111110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH--HHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM--MSVF 1010 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~--~evl 1010 (1025)
.....+...+..+.+++.+||..+ .+||++ +|++
T Consensus 217 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111223445678999999999999 999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=299.00 Aligned_cols=257 Identities=17% Similarity=0.234 Sum_probs=190.1
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv 808 (1025)
..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+++++++.... ....++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 3578999999999999954 79999999986532 233456788999999999999999999886322 1357999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+. ++|.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAG 169 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccceeCC
Confidence 99995 588888753 37899999999999999999997 89999999999999998 7899999999998764
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc---
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS--- 965 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~--- 965 (1025)
.... .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.... ....|......-+..
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 170 TSFM--MTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTVLFPGTD------HIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CCCC--CCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHhcCCCCHH
Confidence 4322 12235889999999998766 5889999999999999999999986321 111221111100000
Q ss_pred ------------------------cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 966 ------------------------GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 966 ------------------------~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+.+................+..+.+++.+|++.+ ++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000000012234667899999999999 999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=292.58 Aligned_cols=255 Identities=15% Similarity=0.149 Sum_probs=177.5
Q ss_pred CCceeeeecceEEEEEEecC----CCEEEEEEccccchhc-----------HHHHHHHHHHHhcCCCCccccccceeecC
Q 001700 736 PAEVIGRSCHGTLYKATLDS----GSILAVKRLREGIAKG-----------KKEFAREVKKLGNIKHPNLVSLQGYYWGP 800 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 800 (1025)
..++||+|+||+||+|...+ +..+|+|+........ ......+...+..++|++|+++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 46789999999999999653 4566777643221111 11123344556677899999999866432
Q ss_pred CC--CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEE
Q 001700 801 KE--HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878 (1025)
Q Consensus 801 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl 878 (1025)
.. ...+++++++. .++.+.+.... ..++..+..|+.|++.||+|||+ .+|+||||||+|||++. +..++|
T Consensus 96 ~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~~~l 167 (294)
T PHA02882 96 RCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNRGYI 167 (294)
T ss_pred cCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCcEEE
Confidence 21 23467777763 46666665432 36788899999999999999997 89999999999999987 788999
Q ss_pred eccccccccccCCC------ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcch
Q 001700 879 TDYSLHRILTSAGT------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDL 952 (1025)
Q Consensus 879 ~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l 952 (1025)
+|||+|+....... .......||+.|+|||+..+.. ++.++|||||||++|||++|+.||...... ..+
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g~~P~~~~~~~---~~~ 242 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGIKLPWKGFGHN---GNL 242 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCccccc---hHH
Confidence 99999987643221 1112236999999999988766 589999999999999999999999753111 111
Q ss_pred HHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 953 TDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 953 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
..-.... .+.+...+.. ....++..+.+++..|+..+ ++||++.++++.++
T Consensus 243 ~~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCD--------FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHH--------HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111100 0011000100 12234577999999999999 99999999998763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=317.22 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=211.4
Q ss_pred ccCHHHhhcCCCceeeeecceEEEEEEec----C----CCEEEEEEccccch-hcHHHHHHHHHHHhcC-CCCccccccc
Q 001700 726 MFTAEELSHAPAEVIGRSCHGTLYKATLD----S----GSILAVKRLREGIA-KGKKEFAREVKKLGNI-KHPNLVSLQG 795 (1025)
Q Consensus 726 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~ 795 (1025)
.+..+.+.. .+.+|+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|||||.++|
T Consensus 292 e~~~~~l~~--~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKL--GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccc--cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 444555532 359999999999999743 1 45799999987543 4567899999999999 6999999999
Q ss_pred eeecCCCCeeEEEEeccccccHHHHHhhcC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 001700 796 YYWGPKEHEKLVISNYINAQSLAVYLQETD---------PRKLP--PLSIDERLRVAVDVARCLNYLHNERAIPHGNLKS 864 (1025)
Q Consensus 796 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp 864 (1025)
+|.. ....++|+||+..|+|.++++..+ ..... .++..+.+.++.|||.|++||++ ..+||||+-+
T Consensus 370 ~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAA 446 (609)
T ss_pred eecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhh
Confidence 9974 668999999999999999999875 11111 38999999999999999999998 7789999999
Q ss_pred CCEEeecCCCCEEEeccccccccccCCCccccccCc--ccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 001700 865 TNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG--ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGE 941 (1025)
Q Consensus 865 ~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~ 941 (1025)
+|||+.. +..+||+|||+|+..............| ...|||||.+.... ++.|+|||||||++||++| |..||.
T Consensus 447 RNVLi~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~--ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 447 RNVLITK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV--FTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhEEecC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc--ccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999998 8899999999999765544433222233 34599999998855 6999999999999999999 888876
Q ss_pred ccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 942 IVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 942 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
.... .. +. -..+..+.+.+.|..+..+++++|..||+.+ ++||++.|+++.++...
T Consensus 524 ~~~~---~~----------------~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 524 GIPP---TE----------------EL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCc---HH----------------HH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3210 01 11 1234556677778889999999999999999 99999999999999854
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=290.71 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=188.4
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||+||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++. .....++|+||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence 689999999999854 78999999986532 223455678999999999999999998886 455789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||.+........ .
T Consensus 79 ~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~--~ 151 (277)
T cd05577 79 DLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKK--I 151 (277)
T ss_pred cHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCc--c
Confidence 99999976543 258999999999999999999997 89999999999999998 78999999999886543221 1
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||....... . .+.+.. ....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-~~~~~~-------------~~~~ 212 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---E-KEELKR-------------RTLE 212 (277)
T ss_pred ccccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccc---c-HHHHHh-------------cccc
Confidence 2235788999999987766 5889999999999999999999986432111 0 000000 0000
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.....+......+.+++.+||+.+ ++|| ++.+++.
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 011123344677899999999999 9999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=288.83 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=183.4
Q ss_pred eeeeecceEEEEEEe-cCCCEEEEEEccccch---hcHHHHHHHH---HHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 739 VIGRSCHGTLYKATL-DSGSILAVKRLREGIA---KGKKEFAREV---KKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
+||+|+||.||+|+. .+++.||+|.+..... .....+..|. +.++...||+|+++++++. .....++|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence 489999999999985 4689999999865421 1122233443 3445567999999998887 44578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+.+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||++.......
T Consensus 79 ~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 79 MNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCccC
Confidence 99999999887542 68999999999999999999998 89999999999999998 7889999999987654322
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ....|+..|+|||++.+... ++.++||||+||++|||++|+.||...... .......
T Consensus 152 ~---~~~~~~~~y~aPE~~~~~~~-~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~~~~~-------------- 209 (278)
T cd05606 152 P---HASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDR-------------- 209 (278)
T ss_pred C---cCcCCCcCCcCcHHhcCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCcc----chHHHHH--------------
Confidence 2 12368999999999875432 588999999999999999999999743111 1111000
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
... ....+.+...+.++.+++.+|+..+ .+|| ++.|+++
T Consensus 210 ~~~-~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 210 MTL-TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred Hhh-ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000 0011223344678999999999999 9999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=297.96 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=191.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc--chhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG--IAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||+++++++...+....++|+||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 478999999999999965 6889999988543 223345677899999999 999999999998654555789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
. ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFGLARSLSELEE 162 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccchhccccccc
Confidence 6 5999988754 47899999999999999999997 89999999999999998 88999999999987644322
Q ss_pred c----cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHH--------
Q 001700 893 A----DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA-------- 960 (1025)
Q Consensus 893 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~-------- 960 (1025)
. ......|+..|+|||++.+... ++.++|||||||++|||+||+.||...... .....+....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~sDi~slG~~l~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL----NQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccCcchhcccccccccCceeeecccc-ccccchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHH
Confidence 1 1122358999999998865433 578999999999999999999998643111 0000000000
Q ss_pred ---hhccccccchhhhcCCCC--CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 961 ---LENRSGECFDRLIMDGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 961 ---~~~~~~~~~d~~~~~~~~--~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
......+.++........ .......+.++.+++.+||+.+ ++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000011100000000 0011124677899999999999 999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=290.82 Aligned_cols=248 Identities=22% Similarity=0.300 Sum_probs=192.1
Q ss_pred CceeeeecceEEEEEEe----cCCCEEEEEEccccch----hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 737 AEVIGRSCHGTLYKATL----DSGSILAVKRLREGIA----KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
.+.||+|+||.||+|+. .+|..||+|+++.... ...+.+.+|+++++++ +|+||+++++++. .....++
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~~~l 82 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDTKLHL 82 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCCeEEE
Confidence 47899999999999985 3689999999875322 2346788999999999 5999999998876 4557899
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 155 (290)
T cd05613 83 ILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEF 155 (290)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeCccceec
Confidence 999999999999997653 58899999999999999999997 89999999999999998 789999999999876
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
............|+..|+|||++......++.++||||||+++|||++|+.||..... .....++......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~------ 226 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILK------ 226 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhc------
Confidence 4433222223468999999999875433357899999999999999999999863211 1112222211110
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCC-----CHHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFE 1011 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RP-----s~~evl~ 1011 (1025)
.. .+.+......+.+++.+|++.+ ++|| ++.+++.
T Consensus 227 -------~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 -------SE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------cC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 1123445667889999999999 9997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=316.29 Aligned_cols=200 Identities=16% Similarity=0.261 Sum_probs=152.8
Q ss_pred cCCCceeeeecceEEEEEEec--CCCEEEEEE--------------ccc---cchhcHHHHHHHHHHHhcCCCCcccccc
Q 001700 734 HAPAEVIGRSCHGTLYKATLD--SGSILAVKR--------------LRE---GIAKGKKEFAREVKKLGNIKHPNLVSLQ 794 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~ 794 (1025)
|...+.||+|+||+||+|..+ ++..+++|. +.+ ........+.+|+.++++++|||||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 334578999999999998754 222222221 111 1112345688999999999999999999
Q ss_pred ceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC
Q 001700 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874 (1025)
Q Consensus 795 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~ 874 (1025)
+++. .....++|+|++ .+++.+++..............++..|+.|++.||+|||+ .+||||||||+|||++. ++
T Consensus 230 ~~~~--~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~~-~~ 304 (501)
T PHA03210 230 EILR--SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNC-DG 304 (501)
T ss_pred EEEE--ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CC
Confidence 9987 445788999998 4678777765422111134467788999999999999998 89999999999999988 78
Q ss_pred CEEEeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 001700 875 NAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSG 940 (1025)
Q Consensus 875 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~ 940 (1025)
.+||+|||+++.+............||+.|+|||++.+.. ++.++|||||||++|||++|..++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999876544333233347999999999998766 588999999999999999998643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=285.02 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=195.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++||||+++++++. .....++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~ 82 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLCIVMEYAP 82 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEEEEehhcC
Confidence 578999999999999854 78899999987542 234567889999999999999999999887 4468999999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++...... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++. +..+|++|||+++.......
T Consensus 83 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~~~~~~- 158 (256)
T cd08530 83 FGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVLKKNMA- 158 (256)
T ss_pred CCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhhccCCc-
Confidence 99999998764321 1368999999999999999999997 89999999999999998 78899999999987755421
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
....|+..|+|||.+.+.. ++.++|+||||+++|||++|+.||.... ..+.... +
T Consensus 159 --~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~--------------~ 213 (256)
T cd08530 159 --KTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDLRYK--------------V 213 (256)
T ss_pred --ccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH--------------H
Confidence 1235889999999987765 4889999999999999999999986431 1111111 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+.+.....++.+++.+|++.+ ++||++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111223456778999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=297.47 Aligned_cols=267 Identities=19% Similarity=0.217 Sum_probs=191.8
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCC---CCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK---EHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++.... ....++++||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 57899999999999985 478999999986432 233456888999999999999999999875322 2357999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+. +++.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEH 160 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceeeccccc
Confidence 96 5888887643 58999999999999999999997 89999999999999998 8899999999988654332
Q ss_pred Ccc--ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc---c
Q 001700 892 TAD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS---G 966 (1025)
Q Consensus 892 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~---~ 966 (1025)
... .....||..|+|||.+.+... ++.++|||||||++|||++|+.||..... .....++......... .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslGvil~el~~G~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNRPLFPGKDY----LHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCHHHHH
Confidence 211 112368999999998765432 58899999999999999999999864211 0101111000000000 0
Q ss_pred ccchhh-------hcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH--Hhhcc
Q 001700 967 ECFDRL-------IMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 967 ~~~d~~-------~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~--L~~i~ 1017 (1025)
.+.+.. .......+ ..+....++.+++.+|++.+ ++||++.|+++. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 00000000 01123567899999999999 999999999986 55444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=290.80 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=194.6
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|++|.||+|..+ ++..||+|++..... ..+.+.+|++++++++|+||+++++++.. ....++++||++++
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 100 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEYMDGG 100 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEEEeccCCC
Confidence 367999999999999976 789999999976543 56778999999999999999999999874 46899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++. ++.++|+|||.+........ ..
T Consensus 101 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~-~~ 173 (286)
T cd06614 101 SLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQLTKEKS-KR 173 (286)
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhhccchh-hh
Confidence 9999998764 158999999999999999999997 99999999999999997 88999999998876543321 11
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... . ..........
T Consensus 174 ~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~-~~~~~~~~~~------------ 232 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPP------L-RALFLITTKG------------ 232 (286)
T ss_pred ccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCH------H-HHHHHHHhcC------------
Confidence 2235788999999987665 58899999999999999999999863211 1 1111100000
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..........+..+.+++.+|++.+ .+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0001112235677899999999999 99999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=287.34 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=191.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|++|.||+|+.. +|..||||+++.... ...+.+.+|+.++++++||||+++++++. .....++||||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~- 81 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH--TENKLMLVFEYMD- 81 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe--eCCcEEEEEecCC-
Confidence 578999999999999965 789999999876532 23466788999999999999999999987 3457899999997
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||+++....... .
T Consensus 82 ~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcCCcc-c
Confidence 4899888765422 268999999999999999999997 89999999999999997 78999999999976543221 1
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh--hccccccch-h
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL--ENRSGECFD-R 971 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d-~ 971 (1025)
.....++..|+|||++.+... ++.++|||||||++|||++|+.||....... ....-...... ........+ +
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccChHHhcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcCc
Confidence 122357889999998866543 5889999999999999999999986432110 00000000000 000000000 0
Q ss_pred hhcCCCC-------CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 972 LIMDGHD-------MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~-------~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....... ....+..+..+.+++..|++.+ .+||++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0001233567889999999999 99999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=292.77 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=188.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. +|+.||+|.++.... ...+.+.+|++++++++||||+++++++. .....++||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLVFEYLD 84 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEEEeccc
Confidence 478999999999999965 789999999865422 23467889999999999999999999987 4558999999995
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++..+..+|++|||++........
T Consensus 85 -~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 85 -LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred -ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 588888765432 136888999999999999999997 89999999999999986466799999999976533211
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc-cccc----
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR-SGEC---- 968 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~---- 968 (1025)
......+++.|+|||++.+... ++.++|||||||++|+|+||+.||..... ...........+. ..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~i~~~l~tg~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDSE------IDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ccccCceeecccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChhhcccc
Confidence 1122357889999998866443 58899999999999999999999864311 1111111000000 0000
Q ss_pred ---chhhh-cCCCCCC----CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 ---FDRLI-MDGHDME----QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ---~d~~~-~~~~~~~----~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+... ....... ..+....++.+++.+|++.+ ++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000000 01223566889999999999 99999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.87 Aligned_cols=242 Identities=18% Similarity=0.292 Sum_probs=191.7
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+||+|+||.||++... +++.||||.+........+.+.+|+.++++++||||+++++++. .....++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEecCCCCc
Confidence 57999999999999864 78999999987654455667899999999999999999999987 4558999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~ 896 (1025)
|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||.+........ ...
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 104 LTDIVTHT------RMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceecccccc-ccc
Confidence 99987543 48999999999999999999998 89999999999999998 78899999998876543221 122
Q ss_pred ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCC
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...|++.|+|||+..+.. ++.++|||||||++|||++|+.||.... ..+.+...... ....+
T Consensus 175 ~~~~~~~y~~pE~~~~~~--~~~~~Dv~slGvil~el~tg~~p~~~~~-------~~~~~~~~~~~------~~~~~--- 236 (292)
T cd06657 175 SLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDN------LPPKL--- 236 (292)
T ss_pred ccccCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhh------CCccc---
Confidence 236889999999887655 4889999999999999999999986321 11111111100 00000
Q ss_pred CCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 977 ~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+..+.+++.+|+..+ .+||++.+|++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 237 ---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112234556788999999999 99999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=290.49 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=188.6
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..+.||+|+||.||+|+.+ +++.||||+++... .....++.+|+.++.+.. ||||+++++++. .....+++|||+
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~~ 96 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFICMELM 96 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEEEeecc
Confidence 3589999999999999976 48999999997543 223456777888777775 999999999997 455789999998
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
. +++.+++..... .+++..+..++.|++.||+|||+..+|+||||+|+||+++. +..+||+|||++........
T Consensus 97 ~-~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 S-TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred C-cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccchhccCCCc
Confidence 4 577777665332 68999999999999999999997468999999999999987 88999999999886644322
Q ss_pred ccccccCcccccCccccccCCC--CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 893 ADQVLNAGALGYRPPEFASTSK--PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
. ....++..|+|||++.+.. ..++.++||||||+++|||++|+.||..... -.+.........
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~------- 235 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEE------- 235 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCC-------
Confidence 2 1225788999999987543 2247899999999999999999999864211 011111111100
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
....+.....+.++.+++.+|++.+ ++||++.++++.
T Consensus 236 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 -----PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001112234567899999999999 999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=291.60 Aligned_cols=243 Identities=21% Similarity=0.298 Sum_probs=191.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
+++||+|.||+||-|+++ +|+.||||++.+.. .++...+.+|++||.+++||.||.+.-.|. .....++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E--T~ervFVVMEKl- 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE--TPERVFVVMEKL- 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec--CCceEEEEehhh-
Confidence 689999999999999965 89999999997642 345577899999999999999999977776 555899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec--CCCCEEEeccccccccccCC
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~--~~~~~kl~DfGla~~~~~~~ 891 (1025)
.|+..+++-....+ ++++.....+..||+.||.|||. .+|||+|+||+|||+.. +...+||||||+|+++.+..
T Consensus 646 ~GDMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 646 HGDMLEMILSSEKG---RLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred cchHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 56777766554322 69999999999999999999997 89999999999999964 23579999999999998765
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.... .+||+.|.|||+++.++ |...-|+||.|||+|--++|..||.. +.++.+.+..+
T Consensus 722 FRrs--VVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNE------dEdIndQIQNA------------ 779 (888)
T KOG4236|consen 722 FRRS--VVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNE------DEDINDQIQNA------------ 779 (888)
T ss_pred hhhh--hcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCC------ccchhHHhhcc------------
Confidence 5444 47999999999999888 58889999999999999999999973 23333333211
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVF 1010 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl 1010 (1025)
..+. .+....+......+++..-++.. .+|-+.+.-+
T Consensus 780 aFMy--Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 780 AFMY--PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccc--CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1111 11234555666777777777777 7787776543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=291.47 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=195.8
Q ss_pred CceeeeecceEEEEEEe----cCCCEEEEEEccccc----hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEE
Q 001700 737 AEVIGRSCHGTLYKATL----DSGSILAVKRLREGI----AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 807 (1025)
.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+. .....++
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 82 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDTKLHL 82 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCCEEEE
Confidence 47899999999999974 257899999987532 22345688999999999 5999999998876 4557899
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
||||+++|+|.+++.... .+++..+..++.|+++||+|||+ .+++||||||+||+++. +..++++|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEECcccccc
Confidence 999999999999987543 58999999999999999999997 89999999999999988 788999999998875
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
............|+..|+|||...+.....+.++||||||+++|||++|+.||..... .....++.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~------- 225 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSEISRRIL------- 225 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHHHHHHHH-------
Confidence 4433222222358899999999876543357899999999999999999999863211 111111111110
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
.. ..+.+......+.+++.+|++.+ ++|||+.+|.+.|+..
T Consensus 226 ------~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 ------KS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------cc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 01223345567899999999999 9999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.29 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=196.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|++|.||++... +++.|++|++........+.+.+|++++++++||+|+++++++. .....++++||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~ 82 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL--KKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe--cCCeEEEEEecCCCC
Confidence 578999999999999965 78999999998765556678999999999999999999999887 346789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++. ++.++|+|||.+........ .
T Consensus 83 ~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 83 SLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred cHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeecccccccccccc--c
Confidence 9999987653 268999999999999999999997 89999999999999998 88999999999887655432 2
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.... ..+....... . .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~-----------~ 213 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIAT-N-----------G 213 (253)
T ss_pred cceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHh-c-----------C
Confidence 2236889999999987766 5889999999999999999999986421 1111111100 0 0
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..........+..+.+++.+|+..+ ++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000112223567999999999999 99999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.41 Aligned_cols=263 Identities=23% Similarity=0.243 Sum_probs=190.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC--------CCee
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK--------EHEK 805 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--------~~~~ 805 (1025)
.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.... ....
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 578999999999999965 68999999987543 223456788999999999999999999886432 2368
Q ss_pred EEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
++|+||+++ ++.+.+.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||.+.
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~ 164 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLAR 164 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCcccccc
Confidence 999999975 7777766542 258999999999999999999997 89999999999999998 8899999999998
Q ss_pred ccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcc-
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR- 964 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~- 964 (1025)
..............++..|+|||++.+... ++.++|||||||++|||++|+.||..... ...+..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~-~~~~~~~ 239 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISR-LCGSPCP 239 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH-HhCCCCh
Confidence 765433222222346788999998865433 47899999999999999999999874211 111111111 000000
Q ss_pred --ccccc--------hhhhcCCCC-CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 965 --SGECF--------DRLIMDGHD-MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 965 --~~~~~--------d~~~~~~~~-~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+.. ++......+ .......+..+.+++..||+.+ ++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 000000000 0001123677999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=273.21 Aligned_cols=203 Identities=23% Similarity=0.338 Sum_probs=171.8
Q ss_pred cCHHHhhcCCCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcH---HHHHHHHHHHhcCCCCccccccceeecCCC
Q 001700 727 FTAEELSHAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGK---KEFAREVKKLGNIKHPNLVSLQGYYWGPKE 802 (1025)
Q Consensus 727 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 802 (1025)
.+.++..+ -++||+|.||+|-.++- .+|+.+|+|++++..-..+ .....|-++|+..+||.+..+.-.|. ..
T Consensus 165 vTm~dFdf--LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~ 240 (516)
T KOG0690|consen 165 VTMEDFDF--LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQ 240 (516)
T ss_pred eccchhhH--HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cC
Confidence 44555544 37899999999999984 4899999999988654333 34567999999999999998865554 55
Q ss_pred CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccc
Q 001700 803 HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882 (1025)
Q Consensus 803 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfG 882 (1025)
...++||||+.||.|.-++.+.. .|+++..+.+-.+|..||.|||+ ++||.||+|.+|.|+|. ++++||.|||
T Consensus 241 drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFG 313 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFG 313 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeecc
Confidence 68999999999999999888754 69999999999999999999998 89999999999999999 9999999999
Q ss_pred cccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 883 LHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 883 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
+++.--..+. .....||||.|.|||++.... |+.+.|.|.+|||||||++|+.||...
T Consensus 314 LCKE~I~~g~-t~kTFCGTPEYLAPEVleDnD--YgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 314 LCKEEIKYGD-TTKTFCGTPEYLAPEVLEDND--YGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cchhcccccc-eeccccCChhhcCchhhcccc--ccceeehhhhhHHHHHHHhccCccccc
Confidence 9986433322 223459999999999999887 589999999999999999999999753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-34 Score=310.20 Aligned_cols=389 Identities=23% Similarity=0.286 Sum_probs=263.7
Q ss_pred CCCCCEEEccCCcCccC--CCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEe
Q 001700 89 LKMLCNVSVSNNQLMGN--ITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYL 166 (1025)
Q Consensus 89 L~~L~~L~ls~N~l~~~--~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 166 (1025)
|+..+-.|+++|.|+|. |.+...+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-+.+..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 44566677888888753 334777888888888888887 57888888888888888888888 466777888888888
Q ss_pred ecccCCCCC-CchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEec
Q 001700 167 DLRANRFGG-DIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDA 245 (1025)
Q Consensus 167 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~L 245 (1025)
++.+|++.+ -+|..+..|..|..||||+|+++.. |..+ ....++-.|+||+|+|. .+|...|.++..|-.|||
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~Ev-P~~L---E~AKn~iVLNLS~N~Ie--tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREV-PTNL---EYAKNSIVLNLSYNNIE--TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhhhc-chhh---hhhcCcEEEEcccCccc--cCCchHHHhhHhHhhhcc
Confidence 888888864 4677777888888888888888743 3333 23367788888888883 345545667888888899
Q ss_pred cCCcccccCCcccccccccceecccccccccCChhHHhhcc-cccCeEEcccccCcCcccccCCCCccEEEccCCcccCC
Q 001700 246 SNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESS-MMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGS 324 (1025)
Q Consensus 246 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~ 324 (1025)
|+|+|...+|.+..+..|++|+|++|.|.- ..+.++++ .+|+.|.+++.+=+- ..
T Consensus 158 S~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~h---fQLrQLPsmtsL~vLhms~TqRTl---------------------~N 213 (1255)
T KOG0444|consen 158 SNNRLEMLPPQIRRLSMLQTLKLSNNPLNH---FQLRQLPSMTSLSVLHMSNTQRTL---------------------DN 213 (1255)
T ss_pred ccchhhhcCHHHHHHhhhhhhhcCCChhhH---HHHhcCccchhhhhhhcccccchh---------------------hc
Confidence 999988888888888888888888887751 01111111 124444444433221 12
Q ss_pred CCCCC---CCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCC
Q 001700 325 LPARV---GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTY 401 (1025)
Q Consensus 325 ~p~~l---~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 401 (1025)
+|.++ .+|..+|||.|.|...+ +......+|+.|+||+|+|+. +.-......+|+.|+||.|+++ .+|++++.+
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp~vP-ecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLPIVP-ECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCCchhhhhhhhhccccccCCCcch-HHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 33322 23334445555444322 222233457778888888773 3344455677888889999888 788888888
Q ss_pred CCCCEeecCCCcccc-cCcccccCCCCCCEEecCCCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhh
Q 001700 402 PELKVIDLSLNHLNG-FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS 480 (1025)
Q Consensus 402 ~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~ 480 (1025)
+.|+.|++.+|+++- -+|..++.+.+|+.+..++|++. ..|.. .+....|+.|.|++|+|- .+|+.|.
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEg---------lcRC~kL~kL~L~~NrLi-TLPeaIH 359 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEG---------LCRCVKLQKLKLDHNRLI-TLPEAIH 359 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchh---------hhhhHHHHHhccccccee-echhhhh
Confidence 888888888888752 25778888888888888888876 33432 222337888888888887 6788888
Q ss_pred cCCCCCEeeCcCCcCccccCCC--cCCCCcEEECCC---C--cccccCCC
Q 001700 481 KFHNLVYLNLSNNKFEGSIPDG--LPNGLKEFNVSF---N--NLSGVVPE 523 (1025)
Q Consensus 481 ~l~~L~~LdLs~N~l~g~ip~~--l~~~L~~L~ls~---N--~l~g~~p~ 523 (1025)
-|+.|+.|||.+|.=--..|.- -...|++-|+.. + +|.|..|.
T Consensus 360 lL~~l~vLDlreNpnLVMPPKP~da~~~lefYNIDFSLq~QlrlAG~~pa 409 (1255)
T KOG0444|consen 360 LLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNIDFSLQHQLRLAGQMPA 409 (1255)
T ss_pred hcCCcceeeccCCcCccCCCCcchhhhcceeeecceehhhHHhhccCCcc
Confidence 8888888898888644233321 112555544432 1 34565554
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=288.60 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=191.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch-hcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA-KGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++.. ....++||||+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~- 80 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFEYM- 80 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEecC-
Confidence 468999999999999965 688999999876432 22334567999999998 9999999999874 56889999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++. ++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccCCCCc
Confidence 8899998876542 258999999999999999999997 89999999999999998 889999999999876543222
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCC---------cchHHHHHHHHhhcc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGV---------VDLTDWVRLLALENR 964 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~---------~~l~~~~~~~~~~~~ 964 (1025)
. ...|+..|+|||++..... ++.++||||||+++|||++|+.||......... ..-..|.........
T Consensus 156 ~--~~~~~~~~~aPE~~~~~~~-~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 156 T--DYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred C--CCCCcccccCceeeecCcC-cCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 2358889999998865443 588999999999999999999998643110000 000011111111111
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
....+........ ..........+.+++.+||+.+ ++||++.||+.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1000000000000 0001112467899999999999 99999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=281.45 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=195.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++. .....++++||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~ 82 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLYIILEYAE 82 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEEecCC
Confidence 578999999999999855 688999999976543 34567999999999999999999999887 4468899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 83 NGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceecCCCccc
Confidence 999999997652 68999999999999999999997 89999999999999998 789999999999876544321
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....|+..|+|||...+.. ++.++||||+|+++|+|++|+.||.... ......... .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~-~------------ 213 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIV-Q------------ 213 (254)
T ss_pred -ccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-c------------
Confidence 12236889999999987665 5889999999999999999999986431 111111100 0
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+...+..+.+++.+|+..+ ++||++.+++.
T Consensus 214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0011123345677899999999999 99999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=299.60 Aligned_cols=271 Identities=20% Similarity=0.268 Sum_probs=193.8
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC---CeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE---HEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~~lv~ 809 (1025)
..+.||+|+||+||+|+. .+++.||||.++... ......+.+|+.++++++||||+++++++..... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 357899999999999985 478999999987532 2334567889999999999999999998864221 3479999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 89 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 89 ELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSE 160 (337)
T ss_pred eCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccccCC
Confidence 9995 78998887543 68999999999999999999997 89999999999999988 78999999999987644
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-------
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE------- 962 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~------- 962 (1025)
... ......++..|+|||++..... ++.++|||||||++|||++|+.||...........+.+.......+
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KGD-FMTEYVVTRWYRAPELLLNCSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Ccc-cccccccccCccChHHHhcCCC-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 321 1122357889999998865432 5889999999999999999999996431100000000000000000
Q ss_pred ccccccchhhhcCCCCC---CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH--Hhhcc
Q 001700 963 NRSGECFDRLIMDGHDM---EQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~---~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~--L~~i~ 1017 (1025)
....+.+. .+...... ...+..+.++.+++.+|++.+ ++||+++|+++. ++.+.
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 239 EKARRYIR-SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhhHHHH-hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 00000000 011234677899999999999 999999999876 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=280.95 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=198.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++++........++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 478999999999999966 789999999876542 44678899999999999999999999887432267899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++.... .+++.++..++.|++.||+|||+ .+++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEeccccccc
Confidence 999999998653 58999999999999999999998 89999999999999998 889999999999877654321
Q ss_pred -cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 894 -DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 894 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......++..|+|||...+.. .+.++||||||+++|+|++|+.||.... +....+...
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~------------- 216 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKI------------- 216 (260)
T ss_pred ccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhc-------------
Confidence 112236889999999987766 5889999999999999999999987432 111111000
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.........+...+..+.+++.+|++.+ ++||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0001111224445778999999999999 99999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=296.54 Aligned_cols=260 Identities=19% Similarity=0.207 Sum_probs=188.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhc--------------HHHHHHHHHHHhcCCCCccccccceeecCC
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKG--------------KKEFAREVKKLGNIKHPNLVSLQGYYWGPK 801 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 801 (1025)
.+.||+|+||.||+|+.. +++.||||.++...... ...+.+|++++++++||||+++++++. .
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 91 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV--E 91 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe--c
Confidence 467999999999999854 78999999986542211 125778999999999999999999987 4
Q ss_pred CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecc
Q 001700 802 EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY 881 (1025)
Q Consensus 802 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~Df 881 (1025)
....++||||+. |+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. +..++++||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~-~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS-KGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC-CCCEEECCc
Confidence 557899999996 69999987543 58999999999999999999997 89999999999999988 789999999
Q ss_pred ccccccccCC-------------CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCC
Q 001700 882 SLHRILTSAG-------------TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPG 948 (1025)
Q Consensus 882 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~ 948 (1025)
|.++...... ........++..|+|||++.+... ++.++|||||||++|||++|+.||.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~--- 239 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFPGENE--- 239 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 9988654111 111112246888999999876543 58899999999999999999999874321
Q ss_pred CcchHHHHHHHHhhcc---ccccchhhhcCCCC---C----CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 949 VVDLTDWVRLLALENR---SGECFDRLIMDGHD---M----EQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~---~~~~~d~~~~~~~~---~----~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
......+........ ..+..+........ . ........++.+++.+|++.+ ++||++.||+.
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111111100000 00000000000000 0 001123567889999999999 99999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=295.30 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=192.3
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecC--CCCeeEEEEe
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGP--KEHEKLVISN 810 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~lv~e 810 (1025)
..+.||+|+||.||+|... +|..||+|++..... ...+.+.+|+.++++++||||+++++++... .....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 3578999999999999854 799999999875422 3356678899999999999999999987532 2346899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 89 ~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 89 LME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSS 160 (334)
T ss_pred hhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEecccccceeeccc
Confidence 995 68998886543 58999999999999999999997 89999999999999998 889999999999865433
Q ss_pred CCcc---ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-----
Q 001700 891 GTAD---QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE----- 962 (1025)
Q Consensus 891 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~----- 962 (1025)
.... .....|+..|+|||++..... ++.++|||||||++|||++|+.||..... ......+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLILSVLGSPSEEV 235 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcc-cccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHHHHhCCChhHh
Confidence 2211 112368899999999865433 58899999999999999999999964311 1111111100000
Q ss_pred ------ccccccchhhhcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 963 ------NRSGECFDRLIMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 963 ------~~~~~~~d~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+..+..+. .......+ .....+.++.+++.+|++.+ ++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 00000000 01234678999999999999 999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.47 Aligned_cols=243 Identities=19% Similarity=0.195 Sum_probs=185.2
Q ss_pred ceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHH-hcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKL-GNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||.||+|... +|+.||||+++.... .....+..|..++ ...+||||+++++++. .....++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence 46899999999999864 689999999875432 1223344555544 4558999999999987 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++. +..+||+|||+++.....
T Consensus 80 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~-- 150 (260)
T cd05611 80 NGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLEN-- 150 (260)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceecccc--
Confidence 9999999997653 58999999999999999999998 89999999999999988 789999999998764331
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....|+..|+|||.+.+.. ++.++||||||+++|||++|..||.... ............ .
T Consensus 151 ---~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~------- 210 (260)
T cd05611 151 ---KKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRR-I------- 210 (260)
T ss_pred ---ccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcc-c-------
Confidence 1235888999999987765 5889999999999999999999986321 111111111000 0
Q ss_pred hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.........++..+.+++.+|++.+ ++||++.++.+.|.
T Consensus 211 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 211 ---NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0001112245677999999999999 99998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=294.65 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=189.2
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCC------------
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE------------ 802 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------------ 802 (1025)
..+.||.|+||.||+|.. .+|..||+|.+........+.+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 357899999999999985 4789999999876655556778899999999999999999987653221
Q ss_pred CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccc
Q 001700 803 HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882 (1025)
Q Consensus 803 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfG 882 (1025)
...++|+||++ ++|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++..+..+|++|||
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 24689999996 5898888643 58999999999999999999997 8999999999999998656779999999
Q ss_pred cccccccCCCcc--ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHH
Q 001700 883 LHRILTSAGTAD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA 960 (1025)
Q Consensus 883 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~ 960 (1025)
.++......... .....|+..|+|||++..... ++.++|||||||++|||++|+.||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~ 236 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN-YTKAIDMWAAGCIFAEMLTGKPLFAGAHEL---EQMQLILESVP 236 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccc-cCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 997653321111 112257889999998765333 588999999999999999999999643110 00000000000
Q ss_pred hh-----ccccccchhhhc-CCCCCCC-----chHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 961 LE-----NRSGECFDRLIM-DGHDMEQ-----PPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 961 ~~-----~~~~~~~d~~~~-~~~~~~~-----~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.. ............ ....... ......++.+++..|+..+ .+||++.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 000000000000 0000000 1123467889999999999 99999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=280.89 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=197.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||.||++... ++..||+|++..... ...+++.+|++++++++|||++++++.+.. ....++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~e~~~ 82 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVMEYAD 82 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEEEecC
Confidence 578999999999999965 789999999876432 456778999999999999999999998873 468899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+++|.+++...... ...+++.++..++.+++.||.|||+ .+++|+||+|+||+++. +..++|+|||.+........
T Consensus 83 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 83 GGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred CCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeecccCcc-
Confidence 99999999875311 1369999999999999999999997 89999999999999998 78999999999987655431
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhh
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......|++.|+|||...+.. ++.++||||+|+++|+|++|+.||+... ..+.......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~------------ 217 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILK------------ 217 (258)
T ss_pred eecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhc------------
Confidence 112236889999999987666 5889999999999999999999986431 1121111111
Q ss_pred cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. ...+.+...+.++.+++.+|+..+ ++||++.|+++
T Consensus 218 -~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 -G-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -C-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 011123345677899999999999 99999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=311.78 Aligned_cols=247 Identities=17% Similarity=0.221 Sum_probs=197.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.++||+|+||.|..++++ ++++||+|++.+.. ......|..|-.+|..-+.+=||.++-.|. +..+.|+|||||
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ--D~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ--DERYLYLVMDYM 157 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc--CccceEEEEecc
Confidence 478999999999999975 79999999998742 233456889999999999999999976665 667899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
+||+|-..+.... +++++.++.|+.+|.-||.-||+ .|+|||||||+|||+|. .+++||+|||.+-.+...+.
T Consensus 158 pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~-~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDK-SGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred cCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecc-cCcEeeccchhHHhcCCCCc
Confidence 9999999998764 59999999999999999999997 99999999999999999 99999999999998887777
Q ss_pred ccccccCcccccCccccccCC--C-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccc
Q 001700 893 ADQVLNAGALGYRPPEFASTS--K-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~--~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
..+...+|||.|.+||++... . ..|+..+|+||+||++|||+.|..||.. ..+++-.... .
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-------dslveTY~KI---------m 294 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-------DSLVETYGKI---------M 294 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-------HHHHHHHHHH---------h
Confidence 777777999999999998632 1 2378999999999999999999999963 2233221111 1
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCCCCCCC---HHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPASERPD---MMSVF 1010 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~~~RPs---~~evl 1010 (1025)
+. .....+|...+.+.+..+++.+-+...+.|-. +.++-
T Consensus 295 ~h--k~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 295 NH--KESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIK 336 (1317)
T ss_pred ch--hhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHH
Confidence 11 01112222345677788888887766555554 66654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=265.64 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=166.9
Q ss_pred CCceeeeecceEEEEEEec---C--CCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD---S--GSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
....||+|.||.||+|.-. + ...+|+|.++..... ......||+.+++.++|||||.+..++.. .+...+++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~-~d~~v~l~ 106 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS-HDKKVWLL 106 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-cCceEEEE
Confidence 3567999999999999632 2 237999999765221 13456799999999999999999999875 36689999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC---CCCEEEecccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP---TMNAVLTDYSLHR 885 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~---~~~~kl~DfGla~ 885 (1025)
+||.+. +|.+.++.+...+...++...+..|+.||+.|+.|||+ +.|+|||+||.|||+..+ .+.+||+|||+++
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 999965 89999887655554578999999999999999999998 899999999999999761 2889999999999
Q ss_pred ccccCCC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 886 ILTSAGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 886 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
.+...-. .....++-|..|+|||.+.+... |+.+.||||.|||+.||+|-++-|.
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h-YT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARH-YTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhccccc-ccchhhhHHHHHHHHHHHccCcccc
Confidence 8865432 22233467999999999999886 7999999999999999999877664
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=281.66 Aligned_cols=234 Identities=19% Similarity=0.227 Sum_probs=179.9
Q ss_pred eeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEeccccccH
Q 001700 740 IGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINAQSL 817 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL 817 (1025)
||+|+||.||+++. .++..+|+|.+........ |+.+...+ +||||+++++++.. ....++||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCCCCcH
Confidence 69999999999985 4788999999865422111 22222222 79999999999874 4589999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccc
Q 001700 818 AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL 897 (1025)
Q Consensus 818 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~ 897 (1025)
.+++.... .+++.++..++.|+++||+|||+ .+|+||||||+||+++.....++++|||+++...... .
T Consensus 97 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~ 165 (267)
T PHA03390 97 FDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----C 165 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----c
Confidence 99997653 58999999999999999999997 8999999999999999833389999999988654322 1
Q ss_pred cCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCC
Q 001700 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977 (1025)
Q Consensus 898 ~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 977 (1025)
..|+..|+|||++.+.. ++.++|||||||++|||++|+.||.....+ ..+...|..... .
T Consensus 166 ~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----------------~ 225 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQQ----------------K 225 (267)
T ss_pred CCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhhc----------------c
Confidence 25889999999998766 488999999999999999999999743211 112223322110 0
Q ss_pred CCCCchHHHHHHHHHHHHccCCC-CCCCC-HHHHHH
Q 001700 978 DMEQPPRILSDMLQVALRCILPA-SERPD-MMSVFE 1011 (1025)
Q Consensus 978 ~~~~~~~~~~~~~~l~~~C~~~~-~~RPs-~~evl~ 1011 (1025)
........+..+.+++.+|++.+ .+||+ ++|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11123345677899999999999 99995 688874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=287.21 Aligned_cols=243 Identities=24% Similarity=0.300 Sum_probs=186.6
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEec
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
..+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++|||++++++++. +....++||||
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 102 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHTAWLVMEY 102 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE--eCCEEEEEEec
Confidence 3567999999999999854 789999999864322 23456889999999999999999999987 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+. |++.+++..... .+++.+++.++.|++.|++|||+ .+|+||||||+||+++. ++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCcccCCC-
Confidence 95 678887765431 58999999999999999999997 89999999999999987 788999999988653221
Q ss_pred CccccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 892 TADQVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
....|+..|+|||++... ...++.++|||||||++|||++|+.||.... ....+.......
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~------- 236 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQND------- 236 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-------
Confidence 123688999999998531 1125789999999999999999999986431 111111111100
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.........+..+.+++.+|++.+ .+||++.+++..
T Consensus 237 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 ------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112233456889999999999 999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=284.02 Aligned_cols=258 Identities=19% Similarity=0.256 Sum_probs=192.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|... +++.+|+|+++..... ....+.+|++++++++||||+++++++. .....++|+||++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~ 81 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFEFMD 81 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEeccC
Confidence 467999999999999864 7899999998764322 4567889999999999999999999987 4467899999996
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
+ ++.+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++. ++.++|+|||.+........
T Consensus 82 ~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 82 T-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred C-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCCCcc-
Confidence 5 8888887643 168999999999999999999997 89999999999999997 78999999999987654431
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc-----ccc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS-----GEC 968 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~ 968 (1025)
......++..|+|||.+.+... ++.++||||||+++|+|+||+.||.... ....+......-+.. ...
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~-~~~~~Di~slG~~l~~l~tg~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRRPLFPGKS------EIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cccCccCcccccCcHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCchHhcccc
Confidence 1122357889999999876522 6889999999999999999999986421 111111100000000 000
Q ss_pred ch------hhhcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FD------RLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d------~~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+ ........ ....+..+.++.+++..||+.+ .+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00000000 0112345678999999999999 99999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=287.93 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=187.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEcccc---chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREG---IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|+++++.++|+|++++++++. .....++|+||+
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~ 97 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYC 97 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCeeEEEEEcc
Confidence 467999999999999954 6889999988642 2233456889999999999999999999987 445789999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
. |++.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.++++|||++.......
T Consensus 98 ~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~- 169 (308)
T cd06634 98 L-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN- 169 (308)
T ss_pred C-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCcccceeecCcc-
Confidence 6 68887776432 158999999999999999999997 89999999999999988 7899999999987654321
Q ss_pred ccccccCcccccCccccccCC-CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTS-KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
...|++.|+|||++.+. ...++.++|||||||++|||++|+.||..... .........
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~---------- 228 (308)
T cd06634 170 ----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ---------- 228 (308)
T ss_pred ----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhh----------
Confidence 22588999999987531 11147899999999999999999999864211 111111110
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..............+.+++.+||..+ ++||++.+|++.
T Consensus 229 ---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 ---NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00000112345677899999999998 999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=289.45 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=186.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCC------CCeeEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK------EHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~~~l 807 (1025)
.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++.... ....++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 578999999999999965 789999998864322 22345678999999999999999999886432 234699
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|+||+. +++.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++...
T Consensus 97 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 169 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADFGLARAF 169 (310)
T ss_pred EEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcCCCcccc
Confidence 999995 58888876543 158999999999999999999997 89999999999999988 789999999999866
Q ss_pred ccCCCc---cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh--
Q 001700 888 TSAGTA---DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-- 962 (1025)
Q Consensus 888 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-- 962 (1025)
...... ......++..|+|||++.+... ++.++||||||+++|||+||+.||..... ......+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~el~t~~~~~~~~~~----~~~~~~~~~~~~~~~ 244 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWTRSPIMQGNTE----QHQLTLISQLCGSIT 244 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcc-cCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCC
Confidence 433211 1112357889999998866543 47899999999999999999999864311 1111111110000
Q ss_pred -ccc-----cccchhhhc-CCCCCC-----CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 963 -NRS-----GECFDRLIM-DGHDME-----QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 963 -~~~-----~~~~d~~~~-~~~~~~-----~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
... .+..+.... ...... .+......+.+++.+|+..+ ++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000000 000000 00012345678999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.38 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=206.6
Q ss_pred CceeeeecceEEEEEEecC------CCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLDS------GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
..++-+|.||.||+|.+.+ .+.|-||.++... +-+...+..|...+..+.|||+.++.+++.. +....+++|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-ccCcceEEE
Confidence 4567899999999997543 3456677776543 3456778999999999999999999999975 455789999
Q ss_pred eccccccHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 810 NYINAQSLAVYLQETDPR---KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
.++.-|+|..++...+.. ....++-.+...++.|++.|++|||+ ++|||.||.++|.+||+ ...+||+|=.+++.
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKLTDSALSRD 445 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEeccchhccc
Confidence 999999999999844322 12357777888999999999999997 99999999999999998 78999999999998
Q ss_pred cccCCCcccc-ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHHHHHHhhcc
Q 001700 887 LTSAGTADQV-LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 887 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
+-+.+.+... .......||+||.+.... ++.++|||||||+||||.| |+.|+...++.+
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfE----------------- 506 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----------------- 506 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----------------
Confidence 7665543211 123567899999998887 5999999999999999998 999986442211
Q ss_pred ccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
+...++++++..+|-.|++++..+|.-||+.. ++||+++|++.-|.+.-
T Consensus 507 ----m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 ----MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 23445667777888999999999999999999 99999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=251.37 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=164.3
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc-hhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..+.||+|+||.|-+-++ .+|...|||+++... .+..++..+|+.+..+. ..|.+|++||.+. .....++.||.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwIcME~M 127 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWICMELM 127 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEEeHHHh
Confidence 357799999999998885 489999999998653 23456778899887665 7999999999876 556799999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.-+|..+..+.-. +...+++..+-+||..|.+||.|||++..|+|||+||+|||++. ++++|+||||++..+.++-.
T Consensus 128 -~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEcccccceeehhhhH
Confidence 5577776554321 12368999999999999999999999888999999999999999 89999999999998765432
Q ss_pred ccccccCcccccCccccccCC--CCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 893 ADQVLNAGALGYRPPEFASTS--KPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
. +...|...|||||.+..+ ...|+.|+||||+|+++.||.+++.||+..
T Consensus 205 k--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 K--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred H--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 2 223688999999988642 223789999999999999999999998754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=285.08 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=188.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch--hcHHHHHHHHHHHhcC---CCCccccccceeecCCC---CeeEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA--KGKKEFAREVKKLGNI---KHPNLVSLQGYYWGPKE---HEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~---~~~~l 807 (1025)
.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++++ +||||+++++++..... ...++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 468999999999999976 589999999975322 2234566788777666 59999999999874221 23899
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
+|||+. ++|.+++..... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++. ++.+||+|||.+...
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~~ 157 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIY 157 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCcceec
Confidence 999996 589998876432 158999999999999999999997 89999999999999998 789999999999876
Q ss_pred ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh---cc
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE---NR 964 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~---~~ 964 (1025)
....... ...++..|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+..+....... .+
T Consensus 158 ~~~~~~~--~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 158 SFEMALT--SVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred cCCcccc--cccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCChHhc
Confidence 5432221 224788999999998766 58899999999999999999999864311 11111111110000 00
Q ss_pred ccccc-hh-hhcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 965 SGECF-DR-LIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 965 ~~~~~-d~-~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..... .. ....... ....+.....+.+++.+||+.+ ++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 00 0000000 0011234577889999999999 99999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=296.25 Aligned_cols=248 Identities=20% Similarity=0.325 Sum_probs=201.0
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeec---CCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWG---PKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~~~~lv~e~ 811 (1025)
.++||.|.+|.||+++ .++|+.+|||++... ....+++..|.++++.. .|||++.++|+|.. ..+.+.|+||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 4789999999999999 558999999998765 44567788999999888 69999999999873 234689999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
|.+|+..++++...+ ..+.|..+..|+++++.|+.|||. +.++|||||-.|||++. ++.+|++|||.+..++..-
T Consensus 103 C~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred cCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeeeeeeeeccc
Confidence 999999999987653 269999999999999999999997 78889999999999998 8999999999999876543
Q ss_pred CccccccCcccccCccccccCCCC---CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 892 TADQVLNAGALGYRPPEFASTSKP---CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
. ...+..||+.|||||++..... .++.++|+||+|++..||.-|.+|+-++.+-. .+
T Consensus 178 g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------aL--------- 237 (953)
T KOG0587|consen 178 G-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------AL--------- 237 (953)
T ss_pred c-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----------hh---------
Confidence 2 3334589999999999864322 25779999999999999999999987542210 00
Q ss_pred chhhh-cCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDRLI-MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~-~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+ +.. ...+....+.....++.+++..|+..+ ++||++.++++
T Consensus 238 F-~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 F-LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred c-cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 011 111122346778899999999999999 99999998875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=294.11 Aligned_cols=268 Identities=20% Similarity=0.266 Sum_probs=199.1
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC---CCeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK---EHEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~lv~ 809 (1025)
..+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....+++|
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 3578999999999999965 68999999987653 334567899999999999999999999987432 23689999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+. ++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++.....
T Consensus 84 e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 84 ELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVDP 155 (330)
T ss_pred cchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeecc
Confidence 9997 58988887543 68999999999999999999998 89999999999999998 78999999999987655
Q ss_pred CCC--ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-cc-c
Q 001700 890 AGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NR-S 965 (1025)
Q Consensus 890 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~-~ 965 (1025)
... .......++..|+|||++.+... ++.++||||||+++|+|++|+.||..... .+..+..... +. .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~sDi~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~ 227 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSR-YTKAIDIWSVGCIFAELLTRKPLFPGRDY-------IDQLNLIVEVLGTPS 227 (330)
T ss_pred cccccccccccccccCcCCceeeecccC-CCcchhHHHHHHHHHHHHcCCCCcCCCCH-------HHHHHHHHHhcCCCC
Confidence 431 11222357889999999987632 58899999999999999999999964321 1111111100 00 0
Q ss_pred c--------ccchhhhc---CCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH--Hhhcccc
Q 001700 966 G--------ECFDRLIM---DGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIVLE 1019 (1025)
Q Consensus 966 ~--------~~~d~~~~---~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~--L~~i~~~ 1019 (1025)
. ......+. .... ....+..+..+.+++.+||+.+ ++||++.++++. ++.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0 00000000 0000 0011224677899999999999 999999999984 6666544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=290.25 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=188.7
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv 808 (1025)
..+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.++++++||||+++++++.... ....++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 357899999999999995 479999999987532 223456889999999999999999999886321 1356899
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+. .++..+... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 99 ~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 99 MPYMQ-TDLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARHAD 168 (342)
T ss_pred ecccc-cCHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcCCC
Confidence 99995 477766531 48999999999999999999997 89999999999999998 8899999999988653
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccccc
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
... ....++..|+|||++.+... ++.++|||||||++|||++|+.||.... ....+.......+.....
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slGvil~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 169 AEM----TGYVVTRWYRAPEVILNWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCC----CCceeeecccChhhhcCccc-cCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHH
Confidence 221 12357889999999876432 5889999999999999999999996321 111111110000000000
Q ss_pred chh--------h-hcCCCCCC------CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH--Hhhccc
Q 001700 969 FDR--------L-IMDGHDME------QPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIVL 1018 (1025)
Q Consensus 969 ~d~--------~-~~~~~~~~------~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~--L~~i~~ 1018 (1025)
+.. . .......+ ..+.....+.+++.+|++.+ ++||+++|++.. ++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 0 00000000 00123456889999999999 999999999954 666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=279.13 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=187.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc-----hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-----AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+.||+|+||.||+++.. .+..+++|.++... .....++.+|+.++++++||||+++++++. .....++|+|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFCIITE 82 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceEEEEE
Confidence 578999999999999854 45556666655321 123345778999999999999999999886 3456899999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|+++++|.+++....... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++. ..++++|||.++.....
T Consensus 83 ~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCceeecCCC
Confidence 999999999987532111 268999999999999999999997 89999999999999975 45999999998876443
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
... .....|++.|+|||...+.. ++.++||||||+++|+|++|..||... ..........
T Consensus 159 ~~~-~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~~---------- 218 (260)
T cd08222 159 CDL-ATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQ-------NFLSVVLRIV---------- 218 (260)
T ss_pred ccc-ccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHH----------
Confidence 221 12235888999999887655 478999999999999999999998632 1111111110
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.......+...+.++.+++.+||..+ ++||++.|+++
T Consensus 219 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 ----EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11111224456678999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=285.08 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=186.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh--cHHHHHHHHHHHhcCCCCccccccceeecCC------CCeeEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQGYYWGPK------EHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~~~l 807 (1025)
.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.... ....++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 578999999999999965 7899999998654322 2345778999999999999999999876422 234799
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|+||+.+ ++...+.... ..+++.++..++.|+++||+|||+ .+|+||||||+||+++. ++.++|+|||+++..
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 165 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPY 165 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCccchhc
Confidence 9999964 6777766432 258999999999999999999998 89999999999999998 889999999999865
Q ss_pred ccCCCc----------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHH
Q 001700 888 TSAGTA----------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVR 957 (1025)
Q Consensus 888 ~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~ 957 (1025)
...... ......|++.|+|||++.+... ++.++|||||||++|||++|+.||...... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~~~~~~ 241 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQLHLIFK 241 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCc-cCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH
Confidence 432211 1112357888999998865432 588999999999999999999998642110 00111000
Q ss_pred HHHh--h-c-----cccccchhhhcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 958 LLAL--E-N-----RSGECFDRLIMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 958 ~~~~--~-~-----~~~~~~d~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.... . . ......+.......... ........+.+++.+|++.+ ++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0 0 00000000000000000 00122356889999999999 99999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=289.57 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=189.5
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC----CeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE----HEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~~lv~ 809 (1025)
.+.||+|+||.||+|.. .+|..||||++.... ....+.+.+|++++++++||||+++++++..... ...++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 57899999999999984 479999999986432 2234568899999999999999999998864221 2468999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+ +++|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||++.....
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQTDS 170 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccccccccc
Confidence 998 77999888643 58999999999999999999997 89999999999999998 78899999999886543
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-cccccc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRSGEC 968 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 968 (1025)
.. ....+++.|+|||++.+... ++.++|||||||++|++++|+.||..... .......... ......
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 171 EM----TGYVVTRWYRAPEVILNWMH-YTQTVDIWSVGCIMAEMLTGKPLFKGHDH-------LDQLMEIMKVTGTPSKE 238 (343)
T ss_pred Cc----cccccCCcccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCCCHH
Confidence 22 12357889999999875432 58899999999999999999999864211 1111110000 000000
Q ss_pred chhhh---------cCCCCC------CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH--HHhhc
Q 001700 969 FDRLI---------MDGHDM------EQPPRILSDMLQVALRCILPA-SERPDMMSVFE--ELSTI 1016 (1025)
Q Consensus 969 ~d~~~---------~~~~~~------~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~--~L~~i 1016 (1025)
+...+ ...... ........++.+++.+|++.+ ++|||+.++++ .++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000 000000 001233456889999999999 99999999983 34444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=305.17 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=183.2
Q ss_pred CHHHhhcCCCceeeeecceEEEEEEec-CCCEEEEEEccccc-hhcHHHHHHHHHHHhcCCCCccccccceeecC-----
Q 001700 728 TAEELSHAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP----- 800 (1025)
Q Consensus 728 ~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 800 (1025)
+++|+ ++||+||||.|||++.+ ||+.||||++.... ......+.+|++.+++++|||||++|..+...
T Consensus 480 DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 480 DFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45666 57999999999999976 89999999998663 23345688999999999999999986432100
Q ss_pred -------------------------------------------------C------------------------------
Q 001700 801 -------------------------------------------------K------------------------------ 801 (1025)
Q Consensus 801 -------------------------------------------------~------------------------------ 801 (1025)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -------------------------C--------CeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 001700 802 -------------------------E--------HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848 (1025)
Q Consensus 802 -------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL 848 (1025)
+ ...|+=||||+.-.++++++..... -.....++++++|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHH
Confidence 0 2357778999988888888765311 03678899999999999
Q ss_pred HHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc----c-------------CCCccccccCcccccCcccccc
Q 001700 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT----S-------------AGTADQVLNAGALGYRPPEFAS 911 (1025)
Q Consensus 849 ~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~ 911 (1025)
+|+|+ .|||||||||.||++|. +..+||+|||+|.... . ......+..+||.-|+|||++.
T Consensus 711 aYIH~-~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 711 AYIHD-QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHh-CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99998 88999999999999998 8899999999998721 0 0111234458999999999998
Q ss_pred CCCC-CCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHH
Q 001700 912 TSKP-CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDML 990 (1025)
Q Consensus 912 ~~~~-~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 990 (1025)
+... .|+.|+|+||+|||++||+. ||... +. -+... ...-+..+-.. ..........-+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------ME-Ra~iL------~~LR~g~iP~~--~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------ME-RASIL------TNLRKGSIPEP--ADFFDPEHPEEA 848 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCch--------HH-HHHHH------HhcccCCCCCC--cccccccchHHH
Confidence 6652 36999999999999999985 56422 00 00000 00001111110 011223344457
Q ss_pred HHHHHccCCC-CCCCCHHHHHH
Q 001700 991 QVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 991 ~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.++.++++.+ .+|||+.|++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8899999998 99999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=316.55 Aligned_cols=396 Identities=27% Similarity=0.383 Sum_probs=249.7
Q ss_pred CCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccC
Q 001700 92 LCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171 (1025)
Q Consensus 92 L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 171 (1025)
|+.||+++|++..-+..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|+|..|++. ..|..+..+++|++||+|.|
T Consensus 47 L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N 124 (1081)
T KOG0618|consen 47 LKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFN 124 (1081)
T ss_pred eEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchh
Confidence 66667777766665556666666777777777666 34666666666777777766666 56666666667777777776
Q ss_pred CCCCCchhHhhhcccCcE-------------------EeCccCccccccCCCCCCCcccccccEEecccccccCccCCCC
Q 001700 172 RFGGDIMHLLSQLGSVVH-------------------VDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHD 232 (1025)
Q Consensus 172 ~l~~~~~~~~~~l~~L~~-------------------L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 232 (1025)
.+. .+|..+..++.++. ++|..|.+.+.++..+..+ +. .|+|.+|.+.. .
T Consensus 125 ~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l---~~--~ldLr~N~~~~--~--- 193 (1081)
T KOG0618|consen 125 HFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNL---TH--QLDLRYNEMEV--L--- 193 (1081)
T ss_pred ccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhh---he--eeecccchhhh--h---
Confidence 665 44444444444444 4444444444444433322 22 47888887741 1
Q ss_pred CCCCCCCCCEEeccCCcccccCC-------------------cccccccccceecccccccccCChhHHhhcccccCeEE
Q 001700 233 GMPYFDNLEVFDASNNHLVGAIP-------------------SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELD 293 (1025)
Q Consensus 233 ~~~~l~~L~~L~Ls~N~l~~~~~-------------------~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ 293 (1025)
....+.+|+.|.+..|++....- ......+|+++++++|+++ .+|.++..... |+.|+
T Consensus 194 dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~n--le~l~ 270 (1081)
T KOG0618|consen 194 DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACAN--LEALN 270 (1081)
T ss_pred hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhccc--ceEec
Confidence 13345555555555555543211 0112234555566666655 34555544332 55556
Q ss_pred cccccCcC-cccccCCCCccEEEccCCcccCCCCCC---CCCcceeeccCccCCCcccccccCCCc-cceEEecCCCCCC
Q 001700 294 LSLNQLEG-PVGSITSATLKKVNLSSNKLSGSLPAR---VGHCTIVDLSNNRLSGDLSRMQNWGNY-VEDIHLSSNFLTG 368 (1025)
Q Consensus 294 ls~N~l~~-~~~~~~~~~L~~L~Ls~N~l~~~~p~~---l~~l~~L~Ls~N~l~~~~~~~~~~~~~-L~~L~Ls~N~l~~ 368 (1025)
..+|+|.. +.......+|+.|.+..|.+. -+|.. +.+++.|||..|+|...+...+..... |+.|+.+.|.+..
T Consensus 271 ~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~ 349 (1081)
T KOG0618|consen 271 ANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST 349 (1081)
T ss_pred ccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc
Confidence 66665543 223344455555555555555 23332 334556667666666555443333322 5555666666653
Q ss_pred CCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcCcccCCccccc
Q 001700 369 MVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQ 448 (1025)
Q Consensus 369 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 448 (1025)
..--.-..+..|+.|++.+|.|+...-..+.++++|++|+|++|+|..+....+.++..|++|+||+|+++. +|..
T Consensus 350 lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~t--- 425 (1081)
T KOG0618|consen 350 LPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDT--- 425 (1081)
T ss_pred cccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHH---
Confidence 332222234568889999999988766678889999999999999988777778889999999999999984 4432
Q ss_pred CCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCc-cccCCCcC-CCCcEEECCCCc
Q 001700 449 NNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFE-GSIPDGLP-NGLKEFNVSFNN 516 (1025)
Q Consensus 449 ~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~-g~ip~~l~-~~L~~L~ls~N~ 516 (1025)
...+. .|++|...+|+|. ..| .+..+++|+.+|||.|+|+ +.+|...+ ++|++|||++|.
T Consensus 426 ----va~~~--~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 426 ----VANLG--RLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ----HHhhh--hhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 22233 7899999999997 455 8899999999999999996 46787777 699999999997
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=281.60 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++ ||||+++++++. .....++||||
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv~e~ 83 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLYFVLEY 83 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEEEEEcC
Confidence 568999999999999965 79999999987532 233467889999999998 999999999887 45578999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.++++|||++.......
T Consensus 84 ~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 84 APNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccccccCCcc
Confidence 99999999998653 59999999999999999999997 89999999999999987 7899999999988764432
Q ss_pred C-------------------ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcch
Q 001700 892 T-------------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDL 952 (1025)
Q Consensus 892 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l 952 (1025)
. .......|+..|+|||+..... ++.++||||||++++++++|+.||.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSN------EY 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCcc------HH
Confidence 1 1112235788999999887665 5889999999999999999999987431 00
Q ss_pred HHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCH----HHHHH
Q 001700 953 TDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDM----MSVFE 1011 (1025)
Q Consensus 953 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~----~evl~ 1011 (1025)
.. ..... .. ....+...+..+.+++.+|++.+ ++||++ .|+++
T Consensus 229 ~~-~~~~~-------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LT-FQKIL-------------KL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH-HHHHH-------------hc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 00000 00 01123344677899999999999 999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=287.32 Aligned_cols=260 Identities=19% Similarity=0.258 Sum_probs=189.3
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.. .....++++||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~~lv~e~~ 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLEDIYFVTELL 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCCcEEEEeehh
Confidence 3578999999999999854 79999999886432 2335678899999999999999999998864 344688999998
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
+++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||+++. ++.++|+|||.+.......
T Consensus 93 -~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~~~~~~~- 162 (328)
T cd07856 93 -GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLARIQDPQM- 162 (328)
T ss_pred -ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCccccccccCCCc-
Confidence 66899888643 57888999999999999999997 89999999999999987 8899999999987543221
Q ss_pred ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcch--------HHHHHHHHhhcc
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDL--------TDWVRLLALENR 964 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l--------~~~~~~~~~~~~ 964 (1025)
....++..|+|||++.+... ++.++|||||||++|||+||+.||...........+ .+|........
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQK-YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN- 237 (328)
T ss_pred ---CCCcccccccCceeeeccCC-cCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-
Confidence 12257889999998765332 588999999999999999999998643210000000 11111110000
Q ss_pred ccccchhhhcCCCCCC---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 965 SGECFDRLIMDGHDME---QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+.+.. .......+ ..+.....+.+++.+|++.+ ++||++.+++..
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000000 01123577999999999999 999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=274.06 Aligned_cols=235 Identities=23% Similarity=0.291 Sum_probs=189.0
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
||+|+||.||++... +++.||+|+++.... .....+.+|+.++++++||||+++++.+. .....++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence 689999999999965 689999999876532 23567889999999999999999999886 456789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||.+........ ..
T Consensus 79 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~-~~ 150 (250)
T cd05123 79 ELFSHLSKEG-----RFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGS-RT 150 (250)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCC-cc
Confidence 9999998653 58999999999999999999997 89999999999999998 78899999999887644321 12
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|+..|+|||...+.. .+.++|+||||+++||+++|+.||..... ........ .
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~-------------~- 207 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKIL-------------K- 207 (250)
T ss_pred cCCcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHh-------------c-
Confidence 2236888999999987765 48899999999999999999999864311 11111111 0
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMS 1008 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~e 1008 (1025)
...+.+...+.++.+++.+|+..+ ++||++.+
T Consensus 208 -~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 -DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111223444677899999999999 99999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=276.62 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=195.1
Q ss_pred ceeeeecceEEEEEE-ecCCCEEEEEEccccc-------hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGI-------AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.+||+|||+.||+|. +...+.||||+-.... ....+...+|.+|-+.++||.||++|+|+.- +.+..+-|.
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-DtdsFCTVL 547 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DTDSFCTVL 547 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-ccccceeee
Confidence 579999999999998 5678899999854221 1123457789999999999999999999975 455789999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCCCCCEEeec--CCCCEEEeccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-RAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~ivHrDlkp~NILl~~--~~~~~kl~DfGla~~ 886 (1025)
||++|.+|.-|++.+. -+++++++.|+.||+.||.||... +.|||-||||.|||+.. ..+.+||.|||++++
T Consensus 548 EYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999999999875 589999999999999999999964 78999999999999954 246799999999999
Q ss_pred cccCCCcc------ccccCcccccCccccccCC--CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHH
Q 001700 887 LTSAGTAD------QVLNAGALGYRPPEFASTS--KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 887 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
+.+..... .....||.+|.+||++.-+ .+..+.|+||||.|||+|..+.|+.||.....+. ++.+.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqe--- 696 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQE--- 696 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhh---
Confidence 87654321 1223799999999987644 4456889999999999999999999997542221 11111
Q ss_pred HHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 959 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
..+ +.+ ....++..+....+...++.+|+++. ++|-...++..
T Consensus 697 ----NTI---lkA---tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 ----NTI---LKA---TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----hch---hcc---eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 000 01112334556677889999999999 99998888764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=285.71 Aligned_cols=259 Identities=19% Similarity=0.216 Sum_probs=185.7
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCC----CCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~~lv~ 809 (1025)
.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.... ....++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 46899999999999984 578999999987542 223466888999999999999999999875321 12467788
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
+++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLARHTDD 172 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccccccc
Confidence 776 78998888643 58999999999999999999997 89999999999999998 78999999999886533
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh--cc---
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE--NR--- 964 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~--~~--- 964 (1025)
.. ....|+..|+|||++.+... ++.++|||||||++|||++|+.||...... ..+....+..... ..
T Consensus 173 ~~----~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 173 EM----TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc----cccccCCCccCHHHHhCccC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHhh
Confidence 21 22358899999998865332 588999999999999999999998642110 0111100000000 00
Q ss_pred cccc----chhhhcCCCCC---CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 965 SGEC----FDRLIMDGHDM---EQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 965 ~~~~----~d~~~~~~~~~---~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+. +-..+...... ........++.+++..|++.+ .+||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000000000 000123456889999999999 999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=281.61 Aligned_cols=260 Identities=24% Similarity=0.294 Sum_probs=191.7
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++|+||++
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e~~~ 81 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFEYCD 81 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEecCcC
Confidence 467999999999999965 69999999998653 333467889999999999999999999987 3468899999997
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||+|+||+++. ++.++|+|||.++.......
T Consensus 82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCCCcc-
Confidence 59999998753 158999999999999999999998 89999999999999998 88999999999987644322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh----hcc--ccc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL----ENR--SGE 967 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~----~~~--~~~ 967 (1025)
......++..|+|||++.+... ++.++|||||||++||+++|+.||..... ......+..... ..+ ..+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKH-YSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred ccCccccCcCcCChHHhcCCcC-CCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHHhCCCcHHHHHhhcc
Confidence 1112246788999999876532 58899999999999999999999864321 000001000000 000 000
Q ss_pred c--chhhhcCCCC---CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 968 C--FDRLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 968 ~--~d~~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. .+........ ....+.....+.+++..|+..+ ++||++.+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000 0001123567999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=301.34 Aligned_cols=394 Identities=22% Similarity=0.311 Sum_probs=261.6
Q ss_pred CEEEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEcc
Q 001700 66 YVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145 (1025)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 145 (1025)
-|.++|++++..+|..-...+..++.++.|.|..-++...|.+++.|.+|++|.+++|++.. +-..++.|+.|+.+++.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhh
Confidence 35666777777774422255666777777777777776666667777777777777777663 45566677777777777
Q ss_pred CCcccc-CCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccc
Q 001700 146 SNSFEG-TFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224 (1025)
Q Consensus 146 ~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 224 (1025)
+|++.. -+|..+..|..|..||||+|++. +.|..+....++..|+||+|+|..++..-+-+ |+.|-+||||+|++
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfin---LtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFIN---LTDLLFLDLSNNRL 162 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHh---hHhHhhhccccchh
Confidence 777642 35666667777777777777776 56666666777777777777776543332222 36666777777777
Q ss_pred cCccCCCCCCCCCCCCCEEeccCCccccc-CCcccccccccceeccccccc-ccCChhHHhhcccccCeEEcccccCcC-
Q 001700 225 VGELFPHDGMPYFDNLEVFDASNNHLVGA-IPSFNFVFSLRILRLGSNQLS-GSLPVALLQESSMMLSELDLSLNQLEG- 301 (1025)
Q Consensus 225 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~~~~~~L~~L~ls~N~l~~- 301 (1025)
. .+||. +..+..|+.|+|++|.|.-. +..+..+++|++|.+++.+-+ ..+|.++-.+. +|..+|+|.|.+..
T Consensus 163 e-~LPPQ--~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~--NL~dvDlS~N~Lp~v 237 (1255)
T KOG0444|consen 163 E-MLPPQ--IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLH--NLRDVDLSENNLPIV 237 (1255)
T ss_pred h-hcCHH--HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhh--hhhhccccccCCCcc
Confidence 3 22332 44566677777777766532 223445667777777775533 34566654433 36677777777665
Q ss_pred cccccCCCCccEEEccCCcccCCCCCCCCCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCC
Q 001700 302 PVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLT 381 (1025)
Q Consensus 302 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 381 (1025)
|.....+.+|+.|+||+|+|+.. -.. ...+ .+|+.|+||+|+++ .+|.++..+++|+
T Consensus 238 Pecly~l~~LrrLNLS~N~iteL-~~~-----------------~~~W----~~lEtLNlSrNQLt-~LP~avcKL~kL~ 294 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKITEL-NMT-----------------EGEW----ENLETLNLSRNQLT-VLPDAVCKLTKLT 294 (1255)
T ss_pred hHHHhhhhhhheeccCcCceeee-ecc-----------------HHHH----hhhhhhccccchhc-cchHHHhhhHHHH
Confidence 33444567788888888877621 100 0111 24788899999998 7899999999999
Q ss_pred EEEecCcccCC-CcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcCcccCCcccccCCCCcccccccc
Q 001700 382 SFKVSNNSLEG-DLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460 (1025)
Q Consensus 382 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~ 460 (1025)
.|++.+|+++- -+|..++.+.+|+++..++|++. ..|..++.+..|+.|.|++|++-. +|.. +..+. .
T Consensus 295 kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPea-------IHlL~--~ 363 (1255)
T KOG0444|consen 295 KLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEA-------IHLLP--D 363 (1255)
T ss_pred HHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee-chhh-------hhhcC--C
Confidence 99999999873 38999999999999999999997 689999999999999999999863 3433 33333 7
Q ss_pred ccEEEccCCcCcccCChhhhcCCCCCEeeCcC---C--cCccccCCCc
Q 001700 461 LTSLDLAYNSLSGRLLPGISKFHNLVYLNLSN---N--KFEGSIPDGL 503 (1025)
Q Consensus 461 L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~---N--~l~g~ip~~l 503 (1025)
|+.|||..|.=---.|..-..-+.|+.-++.. + +|.|..|.+.
T Consensus 364 l~vLDlreNpnLVMPPKP~da~~~lefYNIDFSLq~QlrlAG~~pasv 411 (1255)
T KOG0444|consen 364 LKVLDLRENPNLVMPPKPNDARKKLEFYNIDFSLQHQLRLAGQMPASV 411 (1255)
T ss_pred cceeeccCCcCccCCCCcchhhhcceeeecceehhhHHhhccCCcccc
Confidence 99999999964322222222224565544432 2 4557666544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=240.13 Aligned_cols=194 Identities=25% Similarity=0.355 Sum_probs=165.4
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
-++||+|.||+||+|+ .++++.||+|+++... +.......+|+.+++.++|.|||+++++.. .+....+|+||+
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvfe~c- 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVFEFC- 83 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeHHHh-
Confidence 3689999999999999 5689999999987643 333567889999999999999999999886 455789999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
..+|..|.....+ .++.+.++.++.|+++||.|+|+ +.+.|||+||.|.||+. +++.|++|||+++.+.-+...
T Consensus 84 dqdlkkyfdslng----~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 84 DQDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hHHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcCCceEe
Confidence 5689999887653 68999999999999999999998 88999999999999998 999999999999987654322
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGE 941 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt-G~~P~~ 941 (1025)
....+-|..|++|+++.+... |++..|+||-||++.|+.. |++-|.
T Consensus 158 -ysaevvtlwyrppdvlfgakl-y~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred -eeceeeeeeccCcceeeeeeh-hccchHhhhcchHHHHHhhcCCCCCC
Confidence 223367999999999998876 6899999999999999987 555454
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=286.25 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=187.8
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecCCC----CeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE----HEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~~lv~ 809 (1025)
.+.||+|++|.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++..... ...++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 578999999999999965 68899999986532 2234567889999999999999999987753221 2489999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
||+ +++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLARHTDD 170 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEccccccccccc
Confidence 998 67999998753 58999999999999999999998 89999999999999998 78999999999986643
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhh-cccc--
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRSG-- 966 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~~-- 966 (1025)
.. ....++..|+|||.+.+... ++.++|||||||++||+++|+.||..... .+.+...... +...
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslGv~l~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 171 EM----TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDH-------IDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cc----cCCcccccccCHHHHhCCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCHH
Confidence 21 22357889999998865432 58899999999999999999999863211 1111111100 0000
Q ss_pred -------ccchhhhcCCCCC---C---CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 967 -------ECFDRLIMDGHDM---E---QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 967 -------~~~d~~~~~~~~~---~---~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+.....+...... . .......++.+++.+|++.+ ++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000 0 00123567899999999999 99999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=282.90 Aligned_cols=265 Identities=18% Similarity=0.189 Sum_probs=186.4
Q ss_pred CceeeeecceEEEEEEec-C--CCEEEEEEccccc--hhcHHHHHHHHHHHhcC-CCCccccccceeecC--CCCeeEEE
Q 001700 737 AEVIGRSCHGTLYKATLD-S--GSILAVKRLREGI--AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGP--KEHEKLVI 808 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~~~lv 808 (1025)
.+.||+|+||.||+|+.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++... .....+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 468999999999999964 4 7899999987532 22345688899999999 599999999875421 22457888
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+||+. ++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCceecc
Confidence 88885 68999886543 58999999999999999999997 89999999999999998 7899999999998654
Q ss_pred cCCCc---cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcch--------HHHHH
Q 001700 889 SAGTA---DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDL--------TDWVR 957 (1025)
Q Consensus 889 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l--------~~~~~ 957 (1025)
..... ......||..|+|||+..+... ++.++|||||||++|+|++|+.||...........+ .++..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQS-YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 32211 1122368999999998765432 588999999999999999999998643110000000 00000
Q ss_pred HHHhhccccccchhhhcCCCCC---CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 958 LLALENRSGECFDRLIMDGHDM---EQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 958 ~~~~~~~~~~~~d~~~~~~~~~---~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
...... ..... ......... .........+.+++.+|++.+ .+|||+.|++..
T Consensus 236 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPK-AQNYI-RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhh-HHHHH-HhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000 000000000 001123567899999999999 999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=270.31 Aligned_cols=195 Identities=22% Similarity=0.316 Sum_probs=166.3
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
..+||+|+||+|.+|..+ +.+.+|||++++... .+.+..+.|-++|.-- +-|.+++++..|. .....|+||||
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ--TmDRLyFVMEy 431 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ--TMDRLYFVMEY 431 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh--hhhheeeEEEE
Confidence 368999999999999865 678999999987532 2344556778888776 5789999998886 45589999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+.||+|..++++.+ .+.++.+..+|.+||-||-|||+ .||+.||||..|||+|. ++++||+|||+++.---.+
T Consensus 432 vnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIFDG 504 (683)
T ss_pred ecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeeecccccccccCC
Confidence 99999999998765 58899999999999999999998 99999999999999999 8999999999998653333
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
... .+.+||+.|+|||++.... |+..+|+|||||++|||+.|++||+..
T Consensus 505 ~TT-kTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 505 VTT-KTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred cce-eeecCCCcccccceEEecc--cccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 222 2348999999999998887 588999999999999999999999843
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=247.78 Aligned_cols=258 Identities=17% Similarity=0.260 Sum_probs=201.3
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.+|+|.|+.||.|. ..+.+.++||+++.. ..+.+.||+.+|..++ ||||++++++..++......+|+||+.+
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 4679999999999998 567889999999854 3567899999999997 9999999999998888889999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
.+...... .++..+++.++.+++.||.|+|+ .||+|||+||.|++||......+|+|+|+|.++.......
T Consensus 120 ~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 120 TDFKQLYP--------TLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred ccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 88876654 58888999999999999999999 9999999999999999878889999999999887654332
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhc------ccccc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALEN------RSGEC 968 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~------~~~~~ 968 (1025)
.++.+..|.-||.+..... ++..-|+|||||++..|+..+.||-.. ..+...++..++..-.+. ...-.
T Consensus 191 --VRVASRyfKGPELLVdy~~-YDYSLD~WS~GcmlA~miFrkepFFhG--~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 191 --VRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred --eeeehhhcCCchheeechh-ccccHHHHHHHHHHHHHHhccCcccCC--CCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3467888999999887665 688999999999999999999998643 233445555444322221 00111
Q ss_pred chhhhcC---CC-CC--------CCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 969 FDRLIMD---GH-DM--------EQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 969 ~d~~~~~---~~-~~--------~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+|+.... .+ +. +...-...+..+++..-+.+| ++|||++|.+.
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2322211 11 10 111123467888999999999 99999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=268.77 Aligned_cols=219 Identities=21% Similarity=0.210 Sum_probs=172.8
Q ss_pred ecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccccHHHHH
Q 001700 743 SCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYL 821 (1025)
Q Consensus 743 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l 821 (1025)
|.+|.||+++. .+++.||+|+++... .+.+|...+....||||+++++++. .....++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHH
Confidence 88999999995 478999999997643 2344555556667999999999987 456889999999999999998
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccccCcc
Q 001700 822 QETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901 (1025)
Q Consensus 822 ~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 901 (1025)
.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++++|||.+....... ....++
T Consensus 77 ~~~~-----~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~~----~~~~~~ 145 (237)
T cd05576 77 SKFL-----NIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDSC----DGEAVE 145 (237)
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhcccccc----ccCCcC
Confidence 7653 58999999999999999999997 89999999999999998 7789999999876654321 122467
Q ss_pred cccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCC
Q 001700 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQ 981 (1025)
Q Consensus 902 ~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 981 (1025)
..|+|||+..+.. ++.++||||+||++|||++|+.|+....... . .......
T Consensus 146 ~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~----~~~~~~~ 197 (237)
T cd05576 146 NMYCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------N----THTTLNI 197 (237)
T ss_pred ccccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------c----cccccCC
Confidence 7899999987665 4889999999999999999998875321100 0 0000011
Q ss_pred chHHHHHHHHHHHHccCCC-CCCCCHH
Q 001700 982 PPRILSDMLQVALRCILPA-SERPDMM 1007 (1025)
Q Consensus 982 ~~~~~~~~~~l~~~C~~~~-~~RPs~~ 1007 (1025)
+......+.+++.+|++.+ ++||++.
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 2334567899999999999 9999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=279.10 Aligned_cols=193 Identities=20% Similarity=0.246 Sum_probs=170.3
Q ss_pred ceeeeecceEEEEEEecC-CCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.-||-|+||.|-.+.... ...+|+|++++.. .++.+.+..|-++|..++.|.||++|..|. +....|+.||-|-
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYmLmEaCl 503 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYMLMEACL 503 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhhhHHhhc
Confidence 458999999999998663 3358999987653 345677888999999999999999999987 5568899999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
||.++..+..++ .|+..++..|+..+++|++|||+ ++||.|||||+|.++|. ++-+||.|||+|+.+..+.
T Consensus 504 GGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFAKki~~g~-- 574 (732)
T KOG0614|consen 504 GGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFAKKIGSGR-- 574 (732)
T ss_pred CchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhHHHhccCC--
Confidence 999999998875 69999999999999999999998 89999999999999999 8899999999999987654
Q ss_pred cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCcc
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~ 943 (1025)
...+.|||+.|.|||++...++ +.++|.||+|+++||+++|.+||...
T Consensus 575 KTwTFcGTpEYVAPEIILnKGH--D~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGH--DRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred ceeeecCCcccccchhhhccCc--chhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 3445699999999999998874 88999999999999999999999743
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=304.26 Aligned_cols=140 Identities=22% Similarity=0.319 Sum_probs=123.5
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~lVmEy~ 86 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYLVMEYL 86 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEEEEeCC
Confidence 578999999999999965 78999999997542 223467889999999999999999998876 455899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccc
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~ 885 (1025)
.+++|.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCCc
Confidence 9999999997643 58899999999999999999997 89999999999999987 7899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.83 Aligned_cols=213 Identities=24% Similarity=0.383 Sum_probs=179.9
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccch---hcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
-.+||+|+|++|..+++. +.+.||+|++++... .+....+.|-.+..+. +||.+|.++.+|. .+...++|.||
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrlffviey 332 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRLFFVIEY 332 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceEEEEEEE
Confidence 378999999999999965 789999999987542 3345567788888777 6999999998886 56689999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
++||+|.-++++.+ .++++.++.+..+|+-||.|||+ +||+.||+|..|||+|. .+++|+.|||+++.--.++
T Consensus 333 v~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred ecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeecccchhhcCCCCC
Confidence 99999987777654 59999999999999999999997 99999999999999999 8899999999999754433
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHh
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
... .+.+|||.|.|||++.+.. |+...|+|++||+|+||+.|+.||++...+..+.+..++.-....
T Consensus 406 d~t-stfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil 472 (593)
T KOG0695|consen 406 DTT-STFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL 472 (593)
T ss_pred ccc-ccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence 322 3459999999999999988 588999999999999999999999987666556666666654443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=283.41 Aligned_cols=232 Identities=18% Similarity=0.241 Sum_probs=185.4
Q ss_pred ceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEeccccc
Q 001700 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
..+|.|+|+.|-++.. .+++..+||++.+. ..+..+|+.++.+. .||||+++++.|. +..+.++|||++.++
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLVMELLDGG 401 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceec--CCceeeeeehhcccc
Confidence 4599999999999985 47899999999765 22345677777766 6999999999997 566899999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
-+.+.+.... .+. .++..|+.+|+.|+.|||+ .||||||+||+|||++...++++|+|||.++..... .
T Consensus 402 ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 402 ELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred HHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 8888776543 233 7888999999999999998 899999999999999533788999999999987654 2
Q ss_pred cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcC
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...+-|..|.|||++.... ++.++||||||++||+|++|+.||.....+ ..+ .. ++..
T Consensus 471 ~tp~~t~~y~APEvl~~~~--yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei----------------~~-~i~~ 528 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQE--YTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEI----------------HT-RIQM 528 (612)
T ss_pred cccchhhcccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCccccCCch---HHH----------------HH-hhcC
Confidence 2336688999999998655 699999999999999999999999754221 111 11 1111
Q ss_pred CCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
+......+.+..+++..|++.+ .+||+|+++..
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1123556778899999999999 99999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-31 Score=306.68 Aligned_cols=400 Identities=26% Similarity=0.325 Sum_probs=269.2
Q ss_pred CCCCEEEccCCcCccCCCC-CCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeec
Q 001700 90 KMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDL 168 (1025)
Q Consensus 90 ~~L~~L~ls~N~l~~~~~~-~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 168 (1025)
..+..|+++.|.+-..|-+ +...-+|+.||||+|.+. ..|..+..+.+|+.|+++.|.|. ..|....++.+|++|.|
T Consensus 21 ~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL 98 (1081)
T KOG0618|consen 21 EALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL 98 (1081)
T ss_pred HHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence 3477888999987665544 555566999999999998 57999999999999999999999 68899999999999999
Q ss_pred ccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCc----------------ccccccEEecccccccCccCCCC
Q 001700 169 RANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSS----------------FISSIQYLNISENSLVGELFPHD 232 (1025)
Q Consensus 169 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~----------------~l~~L~~L~Ls~N~l~~~~~~~~ 232 (1025)
.+|++. ..|..+..+.+|+.||+|+|+|... |..+..+. .-..++.++|..|.+.+.++..
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~-Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~- 175 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFGPI-PLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLID- 175 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccCCC-chhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcc-
Confidence 999998 7899999999999999999999844 32222110 0012555666666665544432
Q ss_pred CCCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCcccccCCCCcc
Q 001700 233 GMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLK 312 (1025)
Q Consensus 233 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~ 312 (1025)
...+.. .|||..|.+. .-.+..+.+|+.|....|+++. +- .....|+.|+.++|.+..........+|+
T Consensus 176 -i~~l~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~-l~-----~~g~~l~~L~a~~n~l~~~~~~p~p~nl~ 244 (1081)
T KOG0618|consen 176 -IYNLTH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSE-LE-----ISGPSLTALYADHNPLTTLDVHPVPLNLQ 244 (1081)
T ss_pred -hhhhhe--eeecccchhh--hhhhhhccchhhhhhhhcccce-EE-----ecCcchheeeeccCcceeeccccccccce
Confidence 223333 4888888887 2224455556666666666652 11 11123555555555555333333334566
Q ss_pred EEEccCCcccCCCCCCCC---CcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcc
Q 001700 313 KVNLSSNKLSGSLPARVG---HCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389 (1025)
Q Consensus 313 ~L~Ls~N~l~~~~p~~l~---~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 389 (1025)
++++++|+++ .+|.+++ +++.++..+|+|+..+.+++. ..+|+.|.+.+|.+. .+|....+++.|+.|+|..|+
T Consensus 245 ~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~-~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~ 321 (1081)
T KOG0618|consen 245 YLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISR-ITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNN 321 (1081)
T ss_pred eeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhh-hhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcc
Confidence 6666666665 3444443 334555556655443332221 223444555555554 233344445555555555555
Q ss_pred cCCCcccc--------------------------cCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcCcccCC
Q 001700 390 LEGDLPAV--------------------------LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP 443 (1025)
Q Consensus 390 l~~~~p~~--------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 443 (1025)
|. ..|+. =..++.|+.|++.+|.|+....+.+.+..+|+.|+|++|+|.. +|
T Consensus 322 L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~-fp 399 (1081)
T KOG0618|consen 322 LP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS-FP 399 (1081)
T ss_pred cc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc-CC
Confidence 54 22221 1234568889999999998888888899999999999999873 45
Q ss_pred cccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcCCcCccccCCCc-CCCCcEEECCCCccccc
Q 001700 444 LQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGL-PNGLKEFNVSFNNLSGV 520 (1025)
Q Consensus 444 ~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ip~~l-~~~L~~L~ls~N~l~g~ 520 (1025)
...+.+ ...|+.|+||+|+|+ .+|..+.++..|++|...+|+|. .+|.-. .+.|+++|||.|+|+-.
T Consensus 400 as~~~k--------le~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 400 ASKLRK--------LEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred HHHHhc--------hHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhh
Confidence 443332 226899999999999 78899999999999999999998 677422 24899999999999753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=290.06 Aligned_cols=263 Identities=17% Similarity=0.134 Sum_probs=167.5
Q ss_pred CceeeeecceEEEEEEec-C----CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceee----cCCCCeeEE
Q 001700 737 AEVIGRSCHGTLYKATLD-S----GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYW----GPKEHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~~~l 807 (1025)
.+.||+|+||.||+|+.. + +..||||++..... .+.+..| .+....+.+++.++..+. .....+.++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 578999999999999965 5 78999998764321 1111111 122222333333322211 124557899
Q ss_pred EEeccccccHHHHHhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC
Q 001700 808 ISNYINAQSLAVYLQETDPR---------------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~ 872 (1025)
|+||+.+++|.+++...... .........+..|+.|++.||+|||+ .+|+||||||+|||++..
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHHEEEeCC
Confidence 99999999999998754210 00012234566899999999999997 899999999999999865
Q ss_pred CCCEEEeccccccccccCCCccccccCcccccCccccccCCCC--------------------CCCCchhHHHHHHHHHH
Q 001700 873 TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP--------------------CPSLKSDVYAFGIILLE 932 (1025)
Q Consensus 873 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~~~~~DVwSlGvvl~e 932 (1025)
++.+||+|||+|+..............|++.|||||.+..... .++.++|||||||++||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence 6789999999998664433322233478999999996643221 12346799999999999
Q ss_pred HHcCCCCCCcccc------CCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCC
Q 001700 933 LLTGKSSGEIVCV------DPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD 1005 (1025)
Q Consensus 933 lltG~~P~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs 1005 (1025)
|+++..|++.... .....+...|....... ..+.+...+ +..........+++.+|++.+ .+|||
T Consensus 372 l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~--~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 372 MAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGF--EVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhh--hhccccchHHHHHHHHHccCCcccCCC
Confidence 9998877542100 00111223332211110 000000000 011112334568999999999 99999
Q ss_pred HHHHHHH
Q 001700 1006 MMSVFEE 1012 (1025)
Q Consensus 1006 ~~evl~~ 1012 (1025)
++|+++.
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=278.18 Aligned_cols=259 Identities=15% Similarity=0.146 Sum_probs=176.7
Q ss_pred CceeeeecceEEEEEEe-----------------cCCCEEEEEEccccchhcHHH--------------HHHHHHHHhcC
Q 001700 737 AEVIGRSCHGTLYKATL-----------------DSGSILAVKRLREGIAKGKKE--------------FAREVKKLGNI 785 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~l 785 (1025)
.++||+|+||+||+|.. ..++.||||++........++ +..|+..+.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 58899999999999963 235689999987543322233 34467777777
Q ss_pred CCCcc-----ccccceeecC------CCCeeEEEEeccccccHHHHHhhcCCC-------------------CCCCCCHH
Q 001700 786 KHPNL-----VSLQGYYWGP------KEHEKLVISNYINAQSLAVYLQETDPR-------------------KLPPLSID 835 (1025)
Q Consensus 786 ~hpni-----v~l~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~ 835 (1025)
+|.++ ++++++|... .....++||||+++++|.++++..... ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66544 6777777531 234689999999999999998753210 00135788
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccccCcccccCccccccCCCC
Q 001700 836 ERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915 (1025)
Q Consensus 836 ~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 915 (1025)
.+..++.|++.||+|||+ .+|+||||||+||+++. +..+||+|||+++..............+|+.|+|||.+.....
T Consensus 310 ~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 899999999999999997 89999999999999998 7899999999997654332222222245889999998754221
Q ss_pred --------------------CCCCchhHHHHHHHHHHHHcCCC-CCCccccCC-----CCcchHHHHHHHHhhccccccc
Q 001700 916 --------------------CPSLKSDVYAFGIILLELLTGKS-SGEIVCVDP-----GVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 916 --------------------~~~~~~DVwSlGvvl~elltG~~-P~~~~~~~~-----~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
....+.||||+||++|||++|.. ||....... ...++..|...
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~----------- 456 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY----------- 456 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-----------
Confidence 11235799999999999999985 664321100 01122222210
Q ss_pred hhhhcCCCCCCCchHHHHHHHHHHHHccCCC----CCCCCHHHHHH
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA----SERPDMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~----~~RPs~~evl~ 1011 (1025)
..................+++.+++..+ .+|+|++|+++
T Consensus 457 ---~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 ---KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ---cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0011111223344667888999999753 47999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=270.87 Aligned_cols=210 Identities=18% Similarity=0.252 Sum_probs=171.4
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccch---hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+-||-|+||.|.+++ .++...||+|.+++.+. .+......|-.||...+.+=||+||-.|. +....|+||||+
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ--DkdnLYFVMdYI 711 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFVMDYI 711 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec--cCCceEEEEecc
Confidence 3569999999999997 66788999999987643 23445678999999999999999976655 556899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc----
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT---- 888 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~---- 888 (1025)
+||++..+|-+.+ .|.+..++.++.++.+|+++.|. .|+|||||||.|||||. ++++||.|||++.-+.
T Consensus 712 PGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDr-dGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred CCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEcc-CCceeeeeccccccceeccc
Confidence 9999999988765 69999999999999999999996 99999999999999999 9999999999986431
Q ss_pred -----cCCCc--------c------------------------ccccCcccccCccccccCCCCCCCCchhHHHHHHHHH
Q 001700 889 -----SAGTA--------D------------------------QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILL 931 (1025)
Q Consensus 889 -----~~~~~--------~------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ 931 (1025)
.+... . ....+||+.|+|||++...+ ++.-+|+||.|||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--YTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--ccccchhhHhhHHHH
Confidence 10000 0 00127999999999998777 589999999999999
Q ss_pred HHHcCCCCCCccccCCCCcchHHHHH
Q 001700 932 ELLTGKSSGEIVCVDPGVVDLTDWVR 957 (1025)
Q Consensus 932 elltG~~P~~~~~~~~~~~~l~~~~~ 957 (1025)
||+.|+.||......+....+..|-.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhh
Confidence 99999999976544443334445543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=257.30 Aligned_cols=236 Identities=26% Similarity=0.371 Sum_probs=188.6
Q ss_pred cceEEEEEEec-CCCEEEEEEccccchhc-HHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccccHHHHH
Q 001700 744 CHGTLYKATLD-SGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYL 821 (1025)
Q Consensus 744 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l 821 (1025)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++. .....++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHHHHH
Confidence 58999999976 58999999998765444 678999999999999999999999987 345789999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccccCcc
Q 001700 822 QETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901 (1025)
Q Consensus 822 ~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 901 (1025)
.... .+++..+..++.+++.|+.|||+ .+|+|+||+|+||+++. ++.++++|||.+........ .....++
T Consensus 79 ~~~~-----~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 149 (244)
T smart00220 79 KKRG-----RLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGL--LTTFVGT 149 (244)
T ss_pred Hhcc-----CCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccc--cccccCC
Confidence 7653 38899999999999999999997 89999999999999998 78999999999987755421 1223688
Q ss_pred cccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCC-
Q 001700 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDME- 980 (1025)
Q Consensus 902 ~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~- 980 (1025)
..|++||...+.. .+.++||||||+++|++++|..||... .+.......... ......
T Consensus 150 ~~~~~pE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~------~~~~~~~~~~~~-------------~~~~~~~ 208 (244)
T smart00220 150 PEYMAPEVLLGKG--YGKAVDVWSLGVILYELLTGKPPFPGD------DQLLELFKKIGK-------------PKPPFPP 208 (244)
T ss_pred cCCCCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHHhc-------------cCCCCcc
Confidence 8999999987655 477999999999999999999998642 111111111110 000000
Q ss_pred CchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 981 QPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 981 ~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
.....+.++.+++.+|+..+ ++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 01115678999999999998 99999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-30 Score=249.97 Aligned_cols=197 Identities=23% Similarity=0.321 Sum_probs=161.0
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeec------CCCCeeEE
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWG------PKEHEKLV 807 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~~~~l 807 (1025)
-.+||+|.||.||+|+.+ +|+.||+|++-... +.-.....+|+++|..++|+|++.+++.|.. ......++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 468999999999999965 68888988764321 2223456899999999999999999998853 12235899
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|+++++ .+|...+..... .++..++.+++.++..||.|+|+ ..|+|||+||+|+||+. ++.+||+|||+++.+
T Consensus 102 Vf~~ce-hDLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGlar~f 174 (376)
T KOG0669|consen 102 VFDFCE-HDLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGLARAF 174 (376)
T ss_pred eHHHhh-hhHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeeccccccce
Confidence 999995 488888876532 68999999999999999999998 88999999999999998 889999999999876
Q ss_pred ccCCC---ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 888 TSAGT---ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 888 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
..... ...+.++-|..|++||.+.+... ++.+.|||+.|||+.||.||.+-+.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~-yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDRE-YGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccc-cCCcchhHhHHHHHHHHHccCcccc
Confidence 43321 11223456999999999998876 7999999999999999999997665
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=281.99 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=182.9
Q ss_pred CCCceeeeecceE-EEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecc
Q 001700 735 APAEVIGRSCHGT-LYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 735 ~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.+++|.|+.|+ ||+|.++ |+.||||++-... ..-..+|+..|+.- +|||||++|+. ..+....|+..|.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIalELC 585 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIALELC 585 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEEehHh
Confidence 3456789999875 8999997 7899999986543 34567999999988 59999999544 44677899999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec----CCCCEEEeccccccccc
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA----PTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~----~~~~~kl~DfGla~~~~ 888 (1025)
..+|.+++.... .......--..+.+..|++.||+|||+ -+||||||||.||||+. ...+++|+|||+++.+.
T Consensus 586 -~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 -ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 569999998741 111111214567889999999999998 89999999999999976 23679999999999886
Q ss_pred cCCCc--cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcC-CCCCCccccCCCCcchHHHHHHHHhhccc
Q 001700 889 SAGTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG-KSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 889 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
.+... ......||-+|+|||++..... +.++||||+|||+|+.++| ..||.+.... -+.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~--~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~---- 728 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK--TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTG---- 728 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcccc--CcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcC----
Confidence 55432 2334579999999999988774 7799999999999999996 8999754221 1111000
Q ss_pred cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...++. .....++ +..+++.++++.+ ..||++.+|+.
T Consensus 729 ~~~L~~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 NYTLVH-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccceee-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000100 0112222 7889999999999 99999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=261.30 Aligned_cols=256 Identities=18% Similarity=0.240 Sum_probs=190.3
Q ss_pred CceeeeecceEEEEEEe-cCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-C-C----ccccccceeecCCCCeeEEEE
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-H-P----NLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~l~~~~~~~~~~~~~lv~ 809 (1025)
...+|+|.||.|.++.. +.+..||||+++.. .+..+..+-|++++.++. + | -+|.+.+||. ..++.++|+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yrghiCivf 170 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YRGHICIVF 170 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--ccCceEEEE
Confidence 46799999999999984 46899999999864 445667788999999993 2 2 3778878775 556889999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC-----------------
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP----------------- 872 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~----------------- 872 (1025)
|.+ |-++++++..... .+++...++.+++|++++++|||+ .+++|-||||+|||+...
T Consensus 171 ell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 171 ELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred ecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 998 7799999987643 379999999999999999999998 899999999999998441
Q ss_pred --CCCEEEeccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCc
Q 001700 873 --TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVV 950 (1025)
Q Consensus 873 --~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~ 950 (1025)
+..+|++|||.|....... ...+.|..|+|||++.+-+ ++.++||||+||||.|+.||..-|..... ..
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqtHen---~E 316 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQTHEN---LE 316 (415)
T ss_pred CCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceecccCCc---HH
Confidence 2357999999998754433 2346899999999999887 69999999999999999999988864321 11
Q ss_pred chHHHHHHHHhhccccc--------------cch-------h---hhcCCCC-----CCCchHHHHHHHHHHHHccCCC-
Q 001700 951 DLTDWVRLLALENRSGE--------------CFD-------R---LIMDGHD-----MEQPPRILSDMLQVALRCILPA- 1000 (1025)
Q Consensus 951 ~l~~~~~~~~~~~~~~~--------------~~d-------~---~~~~~~~-----~~~~~~~~~~~~~l~~~C~~~~- 1000 (1025)
.+ ..+..... ..... .+| . ...+... .-....+..++.+++..++..|
T Consensus 317 HL-aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 317 HL-AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HH-HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 11 11111110 00000 000 0 0000000 1123456678999999999999
Q ss_pred CCCCCHHHHHH
Q 001700 1001 SERPDMMSVFE 1011 (1025)
Q Consensus 1001 ~~RPs~~evl~ 1011 (1025)
.+|+|+.|+++
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=249.50 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=166.5
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEccccch--hcHHHHHHHHHHHhcCCCCccccccceeecCCC---CeeEEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE---HEKLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~~lv~ 809 (1025)
..+.||.|+||+||-++. ++|+.||.|++..... ...+.+.+|+++|..++|.|++..++....+.. .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 467899999999999984 5899999999875432 345778899999999999999999887643222 2577888
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
|.| ..+|...+-.-. .++.+.+.-+.+||++||+|||+ .+|.||||||-|.|++. +...||||||+++....
T Consensus 137 ELm-QSDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDFGLARTWDQ 208 (449)
T ss_pred HHH-HhhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEecccccccccch
Confidence 888 558887776543 68899999999999999999998 89999999999999998 99999999999998766
Q ss_pred CCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
......+..+-|.+|+|||++.+.+. |+.+.||||.||++.|++-.+.-|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRh-Ys~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARR-YTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchh-hcCccceehhhHHHHHHHhhhhhhhc
Confidence 55544445567899999999999886 79999999999999999998887764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=259.02 Aligned_cols=194 Identities=16% Similarity=0.234 Sum_probs=164.3
Q ss_pred CCCceeeeecceEEEEEEec-CCCEEEEEEccccch----h----cHHHHHHHHHHHhcCC---CCccccccceeecCCC
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA----K----GKKEFAREVKKLGNIK---HPNLVSLQGYYWGPKE 802 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~ 802 (1025)
.+-+.+|.|+||.|+.|.++ +...|+||.+.+..- . ....+--|++||.+++ |+||++++++|. ++
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE--dd 641 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE--DD 641 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee--cC
Confidence 44578999999999999976 567899999876421 0 1122456999999997 999999999998 45
Q ss_pred CeeEEEEecc-ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecc
Q 001700 803 HEKLVISNYI-NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDY 881 (1025)
Q Consensus 803 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~Df 881 (1025)
..+|++||-- ++-+|.+++..+. .+++.++..|++||+.|+++||+ .+|||||||-+||.++. ++-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~-~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDS-NGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccc-cCceecccccccEEEec-CCeEEEeec
Confidence 5788888864 5679999998763 79999999999999999999998 89999999999999998 889999999
Q ss_pred ccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 882 SLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 882 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
|.|.....+.... .+||..|.|||++.+..+ .+..-|||++|+++|.++....||.
T Consensus 715 gsaa~~ksgpfd~---f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGPFDV---FVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCCcce---eeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCc
Confidence 9998876654432 379999999999988876 5888899999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=240.08 Aligned_cols=133 Identities=21% Similarity=0.294 Sum_probs=113.3
Q ss_pred hcCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-----C---Cccccccceee--cCC
Q 001700 733 SHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-----H---PNLVSLQGYYW--GPK 801 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~--~~~ 801 (1025)
.|...++||-|.|++||+|. .++.+.||+|+.+.. +.-.+....||++|++++ | .+||+|+++|. ++.
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 34456899999999999998 557889999998754 334567789999999984 3 37999999996 467
Q ss_pred CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEee
Q 001700 802 EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870 (1025)
Q Consensus 802 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~ 870 (1025)
+.+.+||+|++ |.+|..+|.....+ .++...+.+|++||+.||.|||++.||||-||||+|||+-
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 77899999999 77899999876554 4899999999999999999999999999999999999983
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=235.20 Aligned_cols=258 Identities=17% Similarity=0.221 Sum_probs=192.6
Q ss_pred cCCCceeeeecceEEEEEEec-CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCCCCccccccceeecC----CCCeeE
Q 001700 734 HAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP----KEHEKL 806 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~~~ 806 (1025)
++.-..+|.|.- .|..|... .++.||+|++.... ....++..+|..++..+.|+||++++.+|... ...+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 333456777776 45555432 58899999886543 23356778999999999999999999988631 123579
Q ss_pred EEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+||||| .++|.+.++. .++-.++..|.+|+++|++|||+ .||+||||||+||++.. +..+||.|||+|+.
T Consensus 98 ~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 98 LVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLART 167 (369)
T ss_pred HHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhcc
Confidence 999999 6799998883 47888999999999999999998 99999999999999988 88999999999986
Q ss_pred cccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 887 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
.... ...+..+.|..|+|||++.+.. +...+||||.||++.||++|+.-|. +...+.+|.+....-+...
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~------g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFP------GKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEec------CchHHHHHHHHHHHhcCCC
Confidence 5433 2233347899999999999887 5889999999999999999998765 3456777776554433322
Q ss_pred ccchhhh----------------------cCC--CC--CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ECFDRLI----------------------MDG--HD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ~~~d~~~----------------------~~~--~~--~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
+.+-..+ ..+ +. .+.++-......+++.+++-.+ ++|-+++++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111000 000 00 1112234566788999999998 999999998863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=231.05 Aligned_cols=196 Identities=29% Similarity=0.412 Sum_probs=166.2
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++. .....++++||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~~~~ 81 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLVMEYCEG 81 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEEEeccCC
Confidence 478999999999999976 4899999999876544 5678999999999999999999999886 34578999999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
++|.+++..... .+++..+..++.+++.++.|||+ .+++|+|++|+||+++. +..++|+|||.+..........
T Consensus 82 ~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEecCccccc
Confidence 999999986531 17899999999999999999997 89999999999999998 6899999999998775543111
Q ss_pred ccccCcccccCcccccc-CCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 895 QVLNAGALGYRPPEFAS-TSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~-~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
.....++..|++||... ... ++.++|||+||++++||++|+.||+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~--~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKG--YGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCC--CCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12235788899999984 333 57799999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-26 Score=256.50 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=194.3
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
...+|.|.||.|||++ ..+++..|||+++.....+..-++.|+-+++.++|||||.++|-|. .....++.|||+.+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl--r~dklwicMEycggg 97 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL--RRDKLWICMEYCGGG 97 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh--hhcCcEEEEEecCCC
Confidence 3679999999999999 4589999999999876667777889999999999999999999887 556789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~ 895 (1025)
+|.+..+..+ ++++.++..++++.++||+|||+ .+-+|||||-.||++.+ .+.+|++|||.+..++..-.. .
T Consensus 98 slQdiy~~Tg-----plselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqitati~K-r 169 (829)
T KOG0576|consen 98 SLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQITATIAK-R 169 (829)
T ss_pred cccceeeecc-----cchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhhhhhhhh-h
Confidence 9999887664 79999999999999999999998 67669999999999988 889999999998877654332 2
Q ss_pred cccCcccccCcccccc-CCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 896 VLNAGALGYRPPEFAS-TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~-~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....||++|||||+.. +...+|..++|||+.|++..|+.--++|-.+ +...-..... .+..+++-
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd---------lhpmr~l~Lm---TkS~~qpp-- 235 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD---------LHPMRALFLM---TKSGFQPP-- 235 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc---------cchHHHHHHh---hccCCCCC--
Confidence 2347999999999874 2222368999999999999999887777321 1111100000 01112221
Q ss_pred CCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 975 DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 975 ~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...-.......|.++++.|+-.. .+||++..+++
T Consensus 236 ---~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 ---TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11123455677899999999888 99999987654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=225.28 Aligned_cols=211 Identities=30% Similarity=0.482 Sum_probs=177.5
Q ss_pred eeeecceEEEEEEec-CCCEEEEEEccccchh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccccH
Q 001700 740 IGRSCHGTLYKATLD-SGSILAVKRLREGIAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSL 817 (1025)
Q Consensus 740 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL 817 (1025)
||+|.+|.||+++.. +++.+++|++...... ..+.+.+|++.++.++|++|+++++++. .....++++||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCCCcH
Confidence 689999999999975 4899999999865332 3567999999999999999999999987 34678999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccc
Q 001700 818 AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL 897 (1025)
Q Consensus 818 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~ 897 (1025)
.+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++..+..++|+|||.+........ ....
T Consensus 79 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 79 KDLLKENE----GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 99998653 158999999999999999999997 89999999999999986356899999999987654321 1122
Q ss_pred cCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCC
Q 001700 898 NAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977 (1025)
Q Consensus 898 ~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 977 (1025)
..+...|++||...... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~-~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKG-YYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccC-CCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 35788899999987651 258899999999999998
Q ss_pred CCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 978 DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 978 ~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
..+.+++..|++.+ ++||++.++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 34778999999999 999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=221.94 Aligned_cols=206 Identities=18% Similarity=0.284 Sum_probs=162.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.+|+|.||.+-+|+++ +.+.+++|.+... ....++|.+|...--.+ .|.||+.-|++... ....+++++||++.
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~YvF~qE~aP~ 106 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYVFVQEFAPR 106 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEEEeeccCcc
Confidence 567999999999999976 6788999998765 34567899999887777 48999999887654 34478899999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec-CCCCEEEeccccccccccCCCc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA-PTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~-~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
|+|.+-+... .+.+....+++.|++.|+.|||+ ..+||||||.+||||-. +..++|+||||..+..+.....
T Consensus 107 gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 107 GDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred chhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999988764 37788999999999999999999 78999999999999943 3568999999998765332111
Q ss_pred cccccCcccccCccccccC---CCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHH
Q 001700 894 DQVLNAGALGYRPPEFAST---SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVR 957 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~ 957 (1025)
..-+..|.|||.... +.+......|||.||++++.++||+.||+... ..+...++|..
T Consensus 180 ----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 180 ----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQ 240 (378)
T ss_pred ----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHH
Confidence 124567999997653 23334667899999999999999999997321 22344555554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=242.03 Aligned_cols=194 Identities=19% Similarity=0.198 Sum_probs=162.9
Q ss_pred CCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCC------CCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIK------HPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~~~~~~lv 808 (1025)
.....|+|-|++|.+|... .|..||||+++.. +...+.=++|+++|++|. --|+++++..|. ..++.+||
T Consensus 436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--hknHLClV 512 (752)
T KOG0670|consen 436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--HKNHLCLV 512 (752)
T ss_pred EEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--hcceeEEE
Confidence 3455799999999999854 5889999999875 334556678999999994 248899988886 56789999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
+|-+ .-+|.++++..+..- .|....+..|+.|+.-||.+|-. .+|+|.||||.|||+++.....||||||.|....
T Consensus 513 FE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred ehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccccccc
Confidence 9988 568999998865433 58899999999999999999996 8999999999999999877889999999998877
Q ss_pred cCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 889 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
....... .-+..|+|||++.+-. |+...|+||.||+|||+.||+.-|.
T Consensus 589 eneitPY---LVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 589 ENEITPY---LVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccccHH---HHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecC
Confidence 6554433 2456799999999988 5889999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=228.72 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=191.5
Q ss_pred CCceeeeecceEEEEEEec----CCCEEEEEEccccchhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEe
Q 001700 736 PAEVIGRSCHGTLYKATLD----SGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
..++||.|.|++||++... ..+.||+|.+... .....+.+|++.|..+. +.||+++.+.+. ......+|+|
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nnd~v~ivlp 115 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFR--NNDQVAIVLP 115 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhc--cCCeeEEEec
Confidence 4689999999999999843 4678999998765 34566899999999995 999999998886 5668999999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
|++.....++.. .++..++..+++.+..||+|+|. .|||||||||+|+|.+....+-.|+|||+|......
T Consensus 116 ~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999998886 47789999999999999999997 999999999999999987788899999998821100
Q ss_pred ------------------CC-------------------------ccccccCcccccCccccccCCCCCCCCchhHHHHH
Q 001700 891 ------------------GT-------------------------ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFG 927 (1025)
Q Consensus 891 ------------------~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlG 927 (1025)
+. .......||++|+|||++...+. .+.+.||||.|
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~-QttaiDiws~G 265 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR-QTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-cCCccceeecc
Confidence 00 00012379999999999987665 48899999999
Q ss_pred HHHHHHHcCCCCCCccccCCCCcchHHHHHHHH---------hhcc--ccc---------------cch-hhhcCCC---
Q 001700 928 IILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA---------LENR--SGE---------------CFD-RLIMDGH--- 977 (1025)
Q Consensus 928 vvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~---------~~~~--~~~---------------~~d-~~~~~~~--- 977 (1025)
||++-+++++.||-....+- ..+.+.+...- ..++ ..+ -++ ..+....
T Consensus 266 VI~Lslls~~~PFf~a~dd~--~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDA--DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ceeehhhccccccccCcccc--chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999986543221 22222221100 0111 000 000 0011100
Q ss_pred -C-CCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 978 -D-MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 978 -~-~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
. ....+..+..+.++..+|++.+ .+|-|++|.++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 0111223457899999999999 99999998875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=247.50 Aligned_cols=262 Identities=25% Similarity=0.262 Sum_probs=166.3
Q ss_pred CCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeC
Q 001700 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDL 192 (1025)
Q Consensus 113 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 192 (1025)
..-..|||+.|.|+ .+|..+. ++|+.|+|++|+|+. +|.. +++|++|+|++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 34667888888888 4576665 378888888888884 5542 4778888888888874 3432 357778888
Q ss_pred ccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceeccccc
Q 001700 193 SNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQ 272 (1025)
Q Consensus 193 s~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~ 272 (1025)
++|+|+.... . .++|+.|+|++|+++. ++. .+++|+.|+|++|+|++.++ + ..+|+.|++++|+
T Consensus 270 s~N~L~~Lp~-l------p~~L~~L~Ls~N~Lt~-LP~-----~p~~L~~LdLS~N~L~~Lp~-l--p~~L~~L~Ls~N~ 333 (788)
T PRK15387 270 FSNPLTHLPA-L------PSGLCKLWIFGNQLTS-LPV-----LPPGLQELSVSDNQLASLPA-L--PSELCKLWAYNNQ 333 (788)
T ss_pred cCCchhhhhh-c------hhhcCEEECcCCcccc-ccc-----cccccceeECCCCccccCCC-C--cccccccccccCc
Confidence 8887774322 1 2567777888887753 221 24567777777777776432 1 2356677777777
Q ss_pred ccccCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEccCCcccCCCCCCCCCcceeeccCccCCCcccccccC
Q 001700 273 LSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNW 352 (1025)
Q Consensus 273 l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~Ls~N~l~~~~~~~~~~ 352 (1025)
|+ .+|... ..|+.|+|++|+|++.+.. ..+|+.|++++|+|++ +|...
T Consensus 334 L~-~LP~lp-----~~Lq~LdLS~N~Ls~LP~l--p~~L~~L~Ls~N~L~~-LP~l~----------------------- 381 (788)
T PRK15387 334 LT-SLPTLP-----SGLQELSVSDNQLASLPTL--PSELYKLWAYNNRLTS-LPALP----------------------- 381 (788)
T ss_pred cc-cccccc-----cccceEecCCCccCCCCCC--Ccccceehhhcccccc-Ccccc-----------------------
Confidence 76 355311 1255555555555542221 1234444444444442 33222
Q ss_pred CCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEe
Q 001700 353 GNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLN 432 (1025)
Q Consensus 353 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 432 (1025)
..|+.|+|++|.|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+. +|..+..+++|+.|+
T Consensus 382 -~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~Ld 451 (788)
T PRK15387 382 -SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVN 451 (788)
T ss_pred -cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEE
Confidence 346677777777774 4432 2567888888888874 5653 3467788888888874 677788888888888
Q ss_pred cCCCcCcccCC
Q 001700 433 LSGNNFSGPLP 443 (1025)
Q Consensus 433 Ls~N~l~~~~p 443 (1025)
|++|+|++..+
T Consensus 452 Ls~N~Ls~~~~ 462 (788)
T PRK15387 452 LEGNPLSERTL 462 (788)
T ss_pred CCCCCCCchHH
Confidence 88888887654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=246.59 Aligned_cols=267 Identities=24% Similarity=0.226 Sum_probs=204.0
Q ss_pred CCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecc
Q 001700 90 KMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLR 169 (1025)
Q Consensus 90 ~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (1025)
..-..|+|++|.|+..|+.+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+. +|.. .++|+.|+|+
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCCcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 456789999999998777665 489999999999996 464 35899999999999994 5653 4689999999
Q ss_pred cCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCc
Q 001700 170 ANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNH 249 (1025)
Q Consensus 170 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 249 (1025)
+|.|+. +|..+ .+|+.|+|++|+++..+. .+++|+.|+|++|+|++ ++. ...+|+.|++++|+
T Consensus 271 ~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~-------~p~~L~~LdLS~N~L~~-Lp~-----lp~~L~~L~Ls~N~ 333 (788)
T PRK15387 271 SNPLTH-LPALP---SGLCKLWIFGNQLTSLPV-------LPPGLQELSVSDNQLAS-LPA-----LPSELCKLWAYNNQ 333 (788)
T ss_pred CCchhh-hhhch---hhcCEEECcCCccccccc-------cccccceeECCCCcccc-CCC-----CcccccccccccCc
Confidence 999984 44433 578899999999986432 13789999999999975 222 13468899999999
Q ss_pred ccccCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEccCCcccCCCCCCC
Q 001700 250 LVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARV 329 (1025)
Q Consensus 250 l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l 329 (1025)
|++.+ .+ ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+..+.. ..+|+.|+|++|+|++ +|...
T Consensus 334 L~~LP-~l--p~~Lq~LdLS~N~Ls-~LP~lp-----~~L~~L~Ls~N~L~~LP~l--~~~L~~LdLs~N~Lt~-LP~l~ 401 (788)
T PRK15387 334 LTSLP-TL--PSGLQELSVSDNQLA-SLPTLP-----SELYKLWAYNNRLTSLPAL--PSGLKELIVSGNRLTS-LPVLP 401 (788)
T ss_pred ccccc-cc--ccccceEecCCCccC-CCCCCC-----cccceehhhccccccCccc--ccccceEEecCCcccC-CCCcc
Confidence 98744 32 258999999999999 466532 2488999999999874432 3579999999999984 55433
Q ss_pred CCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeec
Q 001700 330 GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDL 409 (1025)
Q Consensus 330 ~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 409 (1025)
.+ |+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..++.+++|+.|+|
T Consensus 402 s~------------------------L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 402 SE------------------------LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cC------------------------CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 33 5556666666664 4432 245778889999988 68888888999999999
Q ss_pred CCCcccccCcccccC
Q 001700 410 SLNHLNGFLLPSFFT 424 (1025)
Q Consensus 410 s~N~l~~~~~~~~~~ 424 (1025)
++|+|++..+..+..
T Consensus 453 s~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 453 EGNPLSERTLQALRE 467 (788)
T ss_pred CCCCCCchHHHHHHH
Confidence 999998877666533
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=265.64 Aligned_cols=197 Identities=20% Similarity=0.209 Sum_probs=137.2
Q ss_pred cCCC-Cccccccceeec----C-CCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 001700 784 NIKH-PNLVSLQGYYWG----P-KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857 (1025)
Q Consensus 784 ~l~h-pniv~l~~~~~~----~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~i 857 (1025)
.++| +||++++++|.. . .....+.++||+ +++|.+++.... ..+++.+++.|++||++||+|||+ .+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~-~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS-QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 4455 588888887721 1 122456778877 679999997532 259999999999999999999997 899
Q ss_pred cccCCCCCCEEeec------------------CCCCEEEeccccccccccCCC---------------ccccccCccccc
Q 001700 858 PHGNLKSTNILLEA------------------PTMNAVLTDYSLHRILTSAGT---------------ADQVLNAGALGY 904 (1025)
Q Consensus 858 vHrDlkp~NILl~~------------------~~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 904 (1025)
+||||||+|||++. .+..+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999953 244567777777764321000 001123589999
Q ss_pred CccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchH
Q 001700 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPR 984 (1025)
Q Consensus 905 ~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 984 (1025)
||||++.+.. ++.++|||||||++|||++|..|+... .......... .+++. ...
T Consensus 182 ~APE~~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~---------~~~~~~~~~~-----~~~~~---------~~~ 236 (793)
T PLN00181 182 TSPEEDNGSS--SNCASDVYRLGVLLFELFCPVSSREEK---------SRTMSSLRHR-----VLPPQ---------ILL 236 (793)
T ss_pred EChhhhccCC--CCchhhhhhHHHHHHHHhhCCCchhhH---------HHHHHHHHHh-----hcChh---------hhh
Confidence 9999998776 589999999999999999998886421 0111111000 01110 111
Q ss_pred HHHHHHHHHHHccCCC-CCCCCHHHHHH
Q 001700 985 ILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 985 ~~~~~~~l~~~C~~~~-~~RPs~~evl~ 1011 (1025)
...+..+++.+|++.+ .+||+|.||++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 2334567889999999 99999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=204.70 Aligned_cols=168 Identities=22% Similarity=0.202 Sum_probs=124.2
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcc
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~ 894 (1025)
|+|.+++..... .+++.+++.|+.||+.||+|||+ .+ ||+||+++. ++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeecccc---
Confidence 689999986431 59999999999999999999997 44 999999988 778888 99988764422
Q ss_pred ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhc
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
..||+.|||||++.+.. ++.++|||||||++|||+||+.||.... ................ ++
T Consensus 64 ---~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~------~~~~~~~~~~~~~~~~---~~--- 126 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEER------ELSAILEILLNGMPAD---DP--- 126 (176)
T ss_pred ---CCCcccccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccc------hhcHHHHHHHHHhccC---Cc---
Confidence 15899999999998776 5889999999999999999999986431 1111111111110000 00
Q ss_pred CCCCCCCchHHHH--HHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 975 DGHDMEQPPRILS--DMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 975 ~~~~~~~~~~~~~--~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
.....+..... ++.+++.+|+..+ .+||++.|+++.+..+..
T Consensus 127 --~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 127 --RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00011222333 6999999999999 999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-24 Score=223.84 Aligned_cols=286 Identities=20% Similarity=0.193 Sum_probs=165.1
Q ss_pred CCCEEEccCCcCccCCCC-CCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccC-CccccCCCccccccccccEeec
Q 001700 91 MLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISS-NSFEGTFPSGFGGLGKLKYLDL 168 (1025)
Q Consensus 91 ~L~~L~ls~N~l~~~~~~-~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 168 (1025)
.-++++|-.|+|+.+++. |+.+++|+.||||+|+|+.+-|..|..|.+|..|-+-+ |+|+.+.-..|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 346788888888888775 88888888888888888888888888888887776655 8888777778888888888888
Q ss_pred ccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCC
Q 001700 169 RANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248 (1025)
Q Consensus 169 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 248 (1025)
.-|++.-...+.|..|++|..|.|..|.+....-..+.. +.+++.+.+..|.+.. ..+++-+.. ++..|
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~---l~~i~tlhlA~np~ic-------dCnL~wla~-~~a~~ 216 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQG---LAAIKTLHLAQNPFIC-------DCNLPWLAD-DLAMN 216 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccc---hhccchHhhhcCcccc-------ccccchhhh-HHhhc
Confidence 888888888888888888888888888887443333333 4777888888777522 112222211 22222
Q ss_pred cccccCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcC--cc-cccCCCCccEEEccCCcccCCC
Q 001700 249 HLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PV-GSITSATLKKVNLSSNKLSGSL 325 (1025)
Q Consensus 249 ~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~--~~-~~~~~~~L~~L~Ls~N~l~~~~ 325 (1025)
.+. +++.....-..|.++++...-+..+.. ....+..-..+.....+ |. .+..+++|+.|+|++|++++.
T Consensus 217 ~ie-----tsgarc~~p~rl~~~Ri~q~~a~kf~c-~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i- 289 (498)
T KOG4237|consen 217 PIE-----TSGARCVSPYRLYYKRINQEDARKFLC-SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI- 289 (498)
T ss_pred hhh-----cccceecchHHHHHHHhcccchhhhhh-hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh-
Confidence 221 344444445555566665222222211 10001000011111111 11 122344555555555555543
Q ss_pred CCCCCCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCC
Q 001700 326 PARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405 (1025)
Q Consensus 326 p~~l~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 405 (1025)
-+..|.....+++|+|..|+|..+-...|.++..|+.|+|.+|+|+...|.+|..+..|.
T Consensus 290 --------------------~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 290 --------------------EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred --------------------hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 333333444445555555555444444444555555555555555544455555555555
Q ss_pred EeecCCCcc
Q 001700 406 VIDLSLNHL 414 (1025)
Q Consensus 406 ~L~Ls~N~l 414 (1025)
.|+|-.|.+
T Consensus 350 ~l~l~~Np~ 358 (498)
T KOG4237|consen 350 TLNLLSNPF 358 (498)
T ss_pred eeehccCcc
Confidence 555544443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=247.45 Aligned_cols=334 Identities=19% Similarity=0.254 Sum_probs=192.4
Q ss_pred ccccCCCCCCEEEccCCcc------ccCCCccccccc-cccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCC
Q 001700 131 SGIVSLKNLMLLNISSNSF------EGTFPSGFGGLG-KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203 (1025)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l------~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 203 (1025)
..|..+.+|+.|.+..+.+ ...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|++|++... +.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L-~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKL-WD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccc-cc
Confidence 3455566666666654432 223445554443 3555655555554 333333 234555555555555421 22
Q ss_pred CCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHh
Q 001700 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQ 283 (1025)
Q Consensus 204 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 283 (1025)
++.. +++|+.|+|+++.. ...+|.+..+++|+.|+|++|.....+|..+..
T Consensus 629 ~~~~---l~~Lk~L~Ls~~~~--------------------------l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~ 679 (1153)
T PLN03210 629 GVHS---LTGLRNIDLRGSKN--------------------------LKEIPDLSMATNLETLKLSDCSSLVELPSSIQY 679 (1153)
T ss_pred cccc---CCCCCEEECCCCCC--------------------------cCcCCccccCCcccEEEecCCCCccccchhhhc
Confidence 2222 24555555554433 233333444444444444444333344444433
Q ss_pred hcccccCeEEcccc-cCcCcccccCCCCccEEEccCCcccCCCCCCCCCcceeeccCccCCCcccccccCCCccceEEec
Q 001700 284 ESSMMLSELDLSLN-QLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLS 362 (1025)
Q Consensus 284 ~~~~~L~~L~ls~N-~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls 362 (1025)
+.. |+.|++++| .++..+....+.+|+.|+|++|...+.+|....+++.|++++|.+...+... ...+|+.|++.
T Consensus 680 L~~--L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~--~l~~L~~L~l~ 755 (1153)
T PLN03210 680 LNK--LEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNL--RLENLDELILC 755 (1153)
T ss_pred cCC--CCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCccccccccc--ccccccccccc
Confidence 222 444444443 2222222224455666666665544455555556666666666655433221 13445666665
Q ss_pred CCC-------CCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCC
Q 001700 363 SNF-------LTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435 (1025)
Q Consensus 363 ~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 435 (1025)
++. +....|..+...++|+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+|++
T Consensus 756 ~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~ 834 (1153)
T PLN03210 756 EMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSG 834 (1153)
T ss_pred ccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCC
Confidence 532 222223333445689999999998877899999999999999999875444566555 788999999998
Q ss_pred CcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCCCCCEeeCcC-CcCccccCCCcCC--CCcEEEC
Q 001700 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSN-NKFEGSIPDGLPN--GLKEFNV 512 (1025)
Q Consensus 436 N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~~L~~LdLs~-N~l~g~ip~~l~~--~L~~L~l 512 (1025)
|..-..+|.. . .+|++|+|++|.++ .+|.++..+++|++|+|++ |+|. .+|..+.. .|+.+++
T Consensus 835 c~~L~~~p~~----------~--~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l 900 (1153)
T PLN03210 835 CSRLRTFPDI----------S--TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDF 900 (1153)
T ss_pred CCcccccccc----------c--cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeec
Confidence 7654333321 1 26899999999998 6888999999999999988 6666 46655443 7888888
Q ss_pred CCC
Q 001700 513 SFN 515 (1025)
Q Consensus 513 s~N 515 (1025)
+++
T Consensus 901 ~~C 903 (1153)
T PLN03210 901 SDC 903 (1153)
T ss_pred CCC
Confidence 776
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-21 Score=246.73 Aligned_cols=343 Identities=22% Similarity=0.244 Sum_probs=208.3
Q ss_pred CCCCCCCCEEeccCCc------CcccCcccccCCC-CCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHh
Q 001700 109 IGSIQSLEFLDLSHNL------FHGLIPSGIVSLK-NLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLL 181 (1025)
Q Consensus 109 ~~~l~~L~~LdLs~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 181 (1025)
|..+.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|++|++. .++..+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 4455555555554432 2223444554443 4666666666555 455555 3456666666666655 344445
Q ss_pred hhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccc
Q 001700 182 SQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF 261 (1025)
Q Consensus 182 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~ 261 (1025)
..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|.. +.++++|+.|++++|..-..+|....++
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip~----ls~l~~Le~L~L~~c~~L~~lp~s--i~~L~~L~~L~L~~c~~L~~Lp~~i~l~ 704 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIPD----LSMATNLETLKLSDCSSLVELPSS--IQYLNKLEDLDMSRCENLEILPTGINLK 704 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCCc----cccCCcccEEEecCCCCccccchh--hhccCCCCEEeCCCCCCcCccCCcCCCC
Confidence 5566666666665543333331 223466666666665544444332 4556666666666654333344333566
Q ss_pred cccceecccccccccCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEccCCcccCCCCCCCCCcceeeccCcc
Q 001700 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNR 341 (1025)
Q Consensus 262 ~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~Ls~N~ 341 (1025)
+|+.|+|++|...+.+|... .+|+.|++++|.++..+....+.+|+.|++.++... .++..+
T Consensus 705 sL~~L~Lsgc~~L~~~p~~~-----~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~-~l~~~~------------ 766 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDIS-----TNISWLDLDETAIEEFPSNLRLENLDELILCEMKSE-KLWERV------------ 766 (1153)
T ss_pred CCCEEeCCCCCCcccccccc-----CCcCeeecCCCccccccccccccccccccccccchh-hccccc------------
Confidence 67777777665444454321 236666666666655444444556666666553321 111111
Q ss_pred CCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccCccc
Q 001700 342 LSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPS 421 (1025)
Q Consensus 342 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 421 (1025)
....+.......+|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|..+ .+++|+.|+|++|..-..+|..
T Consensus 767 -~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~ 844 (1153)
T PLN03210 767 -QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI 844 (1153)
T ss_pred -cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc
Confidence 01111112233568999999998888899999999999999999986555788766 7899999999997654444432
Q ss_pred ccCCCCCCEEecCCCcCcccCCcccccCCCCccccccccccEEEccC-CcCcccCChhhhcCCCCCEeeCcCCc
Q 001700 422 FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAY-NSLSGRLLPGISKFHNLVYLNLSNNK 494 (1025)
Q Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~-N~l~~~~p~~~~~l~~L~~LdLs~N~ 494 (1025)
..+|+.|+|++|.++. +|.. +..+. +|++|+|++ |+|. .+|..+..+++|+.|+++++.
T Consensus 845 ---~~nL~~L~Ls~n~i~~-iP~s-------i~~l~--~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 845 ---STNISDLNLSRTGIEE-VPWW-------IEKFS--NLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ---ccccCEeECCCCCCcc-ChHH-------HhcCC--CCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 4689999999999974 4432 23333 899999998 5666 578888999999999999874
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=233.63 Aligned_cols=355 Identities=18% Similarity=0.204 Sum_probs=179.0
Q ss_pred ChhhHHHHHHHHhhcCCCCCCCcccC----CCCCCCCCCCCCC--------------CccceEcCCCCEEEEEeCCCCcc
Q 001700 17 GQSDFEALLQLKKGIAKDPSGQIIDS----WDTKSLSSDGCPR--------------NWFGITCTNGYVTSIMLNDMGLV 78 (1025)
Q Consensus 17 ~~~~~~aLl~~k~~~~~d~~~~l~~s----W~~~~~~~d~C~~--------------~w~gv~C~~~~v~~l~l~~~~l~ 78 (1025)
+++|.+.+++..+.+. .|. .. ++ |++++ |+|.. .-.-|.|..+.||.+...+....
T Consensus 61 ~~~~~~~~~~~~~~l~-~p~-~~-~~~~~~~~~~~---~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~ 134 (754)
T PRK15370 61 SPEEIKSKFECLRMLA-FPA-YA-DNIQYSRGGAD---QYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQA 134 (754)
T ss_pred CHHHHHHHHHHHHHhc-CCc-hh-hccccccCCCC---cccccCCcchhhheeeecCCceEEecCCCccccccccccccc
Confidence 4678999999999984 332 23 56 87753 88942 12348898888888776542221
Q ss_pred cccC----c---------------c-------------cccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCc
Q 001700 79 GNFS----F---------------P-------------TIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFH 126 (1025)
Q Consensus 79 g~~~----~---------------~-------------~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~ 126 (1025)
...+ . + .-+-..+.+.|++++++++..+..+. ++|+.|+|++|+|+
T Consensus 135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELK 212 (754)
T ss_pred ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCC
Confidence 1110 0 0 00112334555555555554443332 34555555555555
Q ss_pred ccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCC
Q 001700 127 GLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206 (1025)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 206 (1025)
. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|++|+|+. +|..+.
T Consensus 213 s-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~ 282 (754)
T PRK15370 213 S-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP 282 (754)
T ss_pred c-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC
Confidence 3 333332 35555555555555 2343332 24555555555554 3333332 245555555555542 222211
Q ss_pred CCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcc
Q 001700 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESS 286 (1025)
Q Consensus 207 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~ 286 (1025)
++|+.|+|++|+| ++.++.+. .+|+.|+|++|+|+ .+|..+.
T Consensus 283 -----~sL~~L~Ls~N~L--------------------------t~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~---- 324 (754)
T PRK15370 283 -----EELRYLSVYDNSI--------------------------RTLPAHLP--SGITHLNVQSNSLT-ALPETLP---- 324 (754)
T ss_pred -----CCCcEEECCCCcc--------------------------ccCcccch--hhHHHHHhcCCccc-cCCcccc----
Confidence 3455555555544 43322221 24445555555554 2333221
Q ss_pred cccCeEEcccccCcCcccccCCCCccEEEccCCcccCCCCCCC-CCcceeeccCccCCCcccccccCCCccceEEecCCC
Q 001700 287 MMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNF 365 (1025)
Q Consensus 287 ~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~ 365 (1025)
.+|+.|++++|.+++.+... ..+|+.|+|++|+|+ .+|..+ ..|+.|+|++|.|+..++.+. ..|+.|++++|+
T Consensus 325 ~sL~~L~Ls~N~Lt~LP~~l-~~sL~~L~Ls~N~L~-~LP~~lp~~L~~LdLs~N~Lt~LP~~l~---~sL~~LdLs~N~ 399 (754)
T PRK15370 325 PGLKTLEAGENALTSLPASL-PPELQVLDVSKNQIT-VLPETLPPTITTLDVSRNALTNLPENLP---AALQIMQASRNN 399 (754)
T ss_pred ccceeccccCCccccCChhh-cCcccEEECCCCCCC-cCChhhcCCcCEEECCCCcCCCCCHhHH---HHHHHHhhccCC
Confidence 12555555555554422211 245555666666555 233322 245666666666665443322 247778888888
Q ss_pred CCCC---CchhccCCCCCCEEEecCcccCCCcccccCCCCCCCEeecCCCcccccC-cccccCCCCCCEEecCCCcCc
Q 001700 366 LTGM---VPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFL-LPSFFTSTKLTDLNLSGNNFS 439 (1025)
Q Consensus 366 l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 439 (1025)
|+.. +|.....++++..|++.+|.|+. ..+.+|+.| ++.+.+.|.. +...+...+++....-.+.+.
T Consensus 400 L~~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~ 470 (754)
T PRK15370 400 LVRLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ 470 (754)
T ss_pred cccCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence 8742 23344455788999999999872 345556666 5556665533 223333444444333344433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=214.98 Aligned_cols=158 Identities=18% Similarity=0.206 Sum_probs=122.0
Q ss_pred CCceeeeecceEEEEEEec--CCCEEEEEEcccc-----chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATLD--SGSILAVKRLREG-----IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
..++||+|+||+||+|+++ +++.||||++... .....+.+.+|++++++++|+|+++.+..+ ...++|
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----~~~~LV 96 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----GKDGLV 96 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----CCcEEE
Confidence 3678999999999999864 5788899987533 122356789999999999999998532111 257999
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCC-CCCCEEeecCCCCEEEecccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNL-KSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDl-kp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
|||+++++|... .. .. ...++.|+++||+|||+ .||+|||| ||+|||++. ++.+||+|||+|+..
T Consensus 97 mE~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 97 RGWTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEAAVIDFQLASVF 162 (365)
T ss_pred EEccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCEEEEECccceec
Confidence 999999999632 11 11 14678999999999998 89999999 999999987 778999999999977
Q ss_pred ccCCCccc-------cccCcccccCccccccC
Q 001700 888 TSAGTADQ-------VLNAGALGYRPPEFAST 912 (1025)
Q Consensus 888 ~~~~~~~~-------~~~~gt~~y~aPE~~~~ 912 (1025)
........ ....+++.|+|||++..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 55432111 23468889999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-21 Score=212.15 Aligned_cols=260 Identities=18% Similarity=0.191 Sum_probs=187.9
Q ss_pred CCCceeeeecceEEEEEEecC--CCEEEEEEccccchhcHHHHHHHHHHHhcCCC----CccccccceeecCCCCeeEEE
Q 001700 735 APAEVIGRSCHGTLYKATLDS--GSILAVKRLREGIAKGKKEFAREVKKLGNIKH----PNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~~~~~~~~~~lv 808 (1025)
.....||+|+||.||+|.... ...+|+|............+..|+.++..+.. +++..+++... ......++|
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iV 99 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIV 99 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEE
Confidence 346889999999999999654 35789888765433322367889999988863 57777776653 244567899
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC----CCEEEeccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT----MNAVLTDYSLH 884 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~----~~~kl~DfGla 884 (1025)
|+.+ |.+|.++...... ..++..++++|+.|++.||++||+ .|++||||||+|+++.... ..+++.|||++
T Consensus 100 M~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred Eecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9887 8899998866542 269999999999999999999998 9999999999999998633 56899999999
Q ss_pred c--ccccCCC----c--c-ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHH
Q 001700 885 R--ILTSAGT----A--D-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDW 955 (1025)
Q Consensus 885 ~--~~~~~~~----~--~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~ 955 (1025)
+ .+..... . . .....||..|+++.+..+.. .+.+.|+||++.++.|+..|..||....... . ..-
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~---~-~~~ 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTD---L-KSK 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccc---h-HHH
Confidence 9 3221111 0 1 12235999999999988877 4889999999999999999999996432111 1 111
Q ss_pred HHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 956 VRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 956 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
+....... .... .....+.++.++...+-..+ .++|....+...++....+
T Consensus 249 ~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 FEKDPRKL----LTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHhhhh----cccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111100 0000 12233456666777776778 9999999999998877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=197.11 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=186.4
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEcccc--chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+|.+...|..|+|+++ |..+++|++.-. .....++|..|.-.|+-+.||||..++|.|.. .....++..||+.|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~mp~g 272 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYMPFG 272 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeeeccch
Confidence 45778889999999998 445666776532 23345679999999999999999999999974 35789999999999
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cccCCCCCCEEeecCCCCEEEe--ccccccccccCCC
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI-PHGNLKSTNILLEAPTMNAVLT--DYSLHRILTSAGT 892 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~i-vHrDlkp~NILl~~~~~~~kl~--DfGla~~~~~~~~ 892 (1025)
+|+..+++...- ..+..++.+++.+||+|++|||+-..+ .--.+.+..|++|+ +.+++|. |--++..
T Consensus 273 slynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfsfq------ 342 (448)
T KOG0195|consen 273 SLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFSFQ------ 342 (448)
T ss_pred HHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceeeee------
Confidence 999999986432 467789999999999999999985343 34468889999998 8787764 3222211
Q ss_pred ccccccCcccccCccccccCCCCC-CCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchh
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPC-PSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....-.+.||+||.++..... --.++|+|||.+++||+.|...||.+... +++--+
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--------------------mecgmk 400 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--------------------MECGMK 400 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--------------------hhhhhh
Confidence 1112346789999999865431 13578999999999999999999975421 111112
Q ss_pred hhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcc
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~ 1017 (1025)
...++-+...++.....+.+++.-|+..| .+||.++.|+-.|+++.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22334455567788888999999999999 99999999999999874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-20 Score=190.70 Aligned_cols=260 Identities=14% Similarity=0.205 Sum_probs=192.4
Q ss_pred hcCCCceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEe
Q 001700 733 SHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 733 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.+..+++||+|.||+++.|+ +-+++.||||.-...+. ..++..|.+..+.|. .+.|..+ ||+++.+.+-.+|+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~v--YYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQV--YYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCce--eeeccccchhhhhhh
Confidence 45668999999999999998 56799999998765432 234667888887774 6788877 455667778889999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecC----CCCEEEeccccccc
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAP----TMNAVLTDYSLHRI 886 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~----~~~~kl~DfGla~~ 886 (1025)
.+ |.+|++...-.++ .|+.+++..||.|++.-++|+|+ +.+|.|||||+|+||..+ ...+.++|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 8899999887653 69999999999999999999998 788999999999999653 23578999999999
Q ss_pred cccCCCcccc------ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHH
Q 001700 887 LTSAGTADQV------LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA 960 (1025)
Q Consensus 887 ~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~ 960 (1025)
+.++.+.... ...||..||+--...+... +.+.|.-|+|-+++..+-|..||....-+ ...+-....-
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ--SRRDDLEaLGHvFmYFLRGsLPWQGLKA~----tnK~kYeKIG 252 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKAD----TNKEKYEKIG 252 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchh--hhhhhHHHhhhhhhhhccCCCccccccCc----chHHHHHHhc
Confidence 9877653322 2369999999988887774 88999999999999999999999743211 1111111111
Q ss_pred hhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhccc
Q 001700 961 LENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 961 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~ 1018 (1025)
...+...+ ..+ ....+.++..-+...-..+ .+-|..+-+...+.++.+
T Consensus 253 e~Kr~T~i--~~L--------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 253 ETKRSTPI--EVL--------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred cccccCCH--HHH--------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11111111 011 1223555666665555678 899998888777776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=181.01 Aligned_cols=257 Identities=15% Similarity=0.192 Sum_probs=188.1
Q ss_pred CceeeeecceEEEEEE-ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCC-CccccccceeecCCCCeeEEEEecccc
Q 001700 737 AEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKH-PNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.+|.|. ..+|+.||||.-+... ....+..|.++.+.++| ..|..+.-|.. +...-.+||+.. |
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLVMDLL-G 94 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc--ccccceeeeecc-C
Confidence 4789999999999998 6789999999876542 22357788999998875 44555543433 556789999998 8
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec--CCCCEEEeccccccccccCCC
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~--~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.+|++.+.-... .|+.++++-.+-|++.-++|+|. ++++||||||+|+|..- ....+.++|||+|+.+.+..+
T Consensus 95 PsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 95 PSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999998876543 69999999999999999999997 88999999999999854 234678999999998766443
Q ss_pred ccc------cccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 893 ADQ------VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 893 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
... ..-.||..|.+--...+.. .+.+.|+-|+|.++...--|..||+........ +-..... +..+
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----QKyEkI~-EkK~- 241 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----QKYEKIS-EKKM- 241 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHH----HHHHHHH-Hhhc-
Confidence 221 1236999999888776655 378999999999999999999999854221100 0001111 1101
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhcccc
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i~~~ 1019 (1025)
...-..+.. ..|.++.-.+..|-..- ++-|...-+.+...-+...
T Consensus 242 s~~ie~LC~--------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 242 STPIEVLCK--------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred CCCHHHHhC--------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 111112222 34677888899999988 9999998888777666543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-22 Score=206.63 Aligned_cols=272 Identities=21% Similarity=0.210 Sum_probs=193.4
Q ss_pred CCCCCCCCCc---cceEcCC-----------CCEEEEEeCCCCcccccCcccccCCCCCCEEEccCCcCccCCCC-CCCC
Q 001700 48 LSSDGCPRNW---FGITCTN-----------GYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSI 112 (1025)
Q Consensus 48 ~~~d~C~~~w---~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~-~~~l 112 (1025)
.|+.+|.|+- .-|.|+. ...++|+|..++++- +|..++..|++|+.||||+|+|+.+.++ |..|
T Consensus 36 ~CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~-iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL 114 (498)
T KOG4237|consen 36 ACPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISS-IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL 114 (498)
T ss_pred cCCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCccc-CChhhccchhhhceecccccchhhcChHhhhhh
Confidence 4677787765 5678974 246889999998875 4547888999999999999999998775 9999
Q ss_pred CCCCEEecc-CCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEe
Q 001700 113 QSLEFLDLS-HNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVD 191 (1025)
Q Consensus 113 ~~L~~LdLs-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 191 (1025)
.+|..|-+- +|+|+.+....|++|..|+.|.+.-|++.-+....|..|++|..|.|..|.+....-..|..+..++.+.
T Consensus 115 ~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlh 194 (498)
T KOG4237|consen 115 ASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLH 194 (498)
T ss_pred HhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHh
Confidence 998776555 5999988778999999999999999999998899999999999999999999865555899999999999
Q ss_pred CccCcccc------------ccCCCCCCCcc-------------------cccccEE--ecccccccCccCCCCCCCCCC
Q 001700 192 LSNNQFSG------------SLDLGLGDSSF-------------------ISSIQYL--NISENSLVGELFPHDGMPYFD 238 (1025)
Q Consensus 192 Ls~N~l~~------------~~~~~~~~~~~-------------------l~~L~~L--~Ls~N~l~~~~~~~~~~~~l~ 238 (1025)
+..|.+-. ..|..++.+.. .-.++.+ .++.+..-..+-|..-|..++
T Consensus 195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 99998421 11222211100 0011111 111111111222333466778
Q ss_pred CCCEEeccCCcccccCC-cccccccccceecccccccccCChhHHhhcccccCeEEcccccCcC--cccccCCCCccEEE
Q 001700 239 NLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVN 315 (1025)
Q Consensus 239 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~--~~~~~~~~~L~~L~ 315 (1025)
+|+.|+|++|+|+.+-+ +|..+.++++|+|..|+|. .+....++. ...|+.|+|.+|+|+. +..+-....|..|+
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~-ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQG-LSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhc-cccceeeeecCCeeEEEecccccccceeeeee
Confidence 88888888888887655 4777788888888888886 333322221 2347778888888875 33344456677777
Q ss_pred ccCCccc
Q 001700 316 LSSNKLS 322 (1025)
Q Consensus 316 Ls~N~l~ 322 (1025)
|-.|.+.
T Consensus 353 l~~Np~~ 359 (498)
T KOG4237|consen 353 LLSNPFN 359 (498)
T ss_pred hccCccc
Confidence 7777764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-20 Score=221.38 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=170.2
Q ss_pred CCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEe
Q 001700 139 LMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLN 218 (1025)
Q Consensus 139 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~ 218 (1025)
.+.|+|+++.++ .+|..+. ++|+.|+|++|+|+. +|..+. .+|+.|+|++|+|+.. |..+ ..+|+.|+
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsL-P~~l-----~~~L~~L~ 247 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSI-PATL-----PDTIQEME 247 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccC-Chhh-----hccccEEE
Confidence 344444444444 2333321 244455555555442 222221 2455555555555422 2221 13466666
Q ss_pred cccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcccccCeEEccccc
Q 001700 219 ISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298 (1025)
Q Consensus 219 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~ 298 (1025)
|++|.+. .+|.. + ..+|+.|++++|+|+..+..+. .+|+.|+|++|+|+ .+|..+. ..|+.|++++|+
T Consensus 248 Ls~N~L~-~LP~~--l--~s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp----~sL~~L~Ls~N~ 315 (754)
T PRK15370 248 LSINRIT-ELPER--L--PSALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIR-TLPAHLP----SGITHLNVQSNS 315 (754)
T ss_pred CcCCccC-cCChh--H--hCCCCEEECcCCccCccccccC--CCCcEEECCCCccc-cCcccch----hhHHHHHhcCCc
Confidence 6666664 22221 1 2467777777777775443343 48999999999998 5676543 248999999999
Q ss_pred CcCcccccCCCCccEEEccCCcccCCCCCCC-CCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCC
Q 001700 299 LEGPVGSITSATLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQF 377 (1025)
Q Consensus 299 l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 377 (1025)
++..+... ..+|+.|++++|.+++ +|..+ .+|+.|++++|+|+..+..+ ...|+.|+|++|+|+. +|..+.
T Consensus 316 Lt~LP~~l-~~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~L~~LP~~l---p~~L~~LdLs~N~Lt~-LP~~l~-- 387 (754)
T PRK15370 316 LTALPETL-PPGLKTLEAGENALTS-LPASLPPELQVLDVSKNQITVLPETL---PPTITTLDVSRNALTN-LPENLP-- 387 (754)
T ss_pred cccCCccc-cccceeccccCCcccc-CChhhcCcccEEECCCCCCCcCChhh---cCCcCEEECCCCcCCC-CCHhHH--
Confidence 98744322 3689999999999985 66544 47899999999998654333 3579999999999996 455443
Q ss_pred CCCCEEEecCcccCCCcccc----cCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcCcccC
Q 001700 378 LRLTSFKVSNNSLEGDLPAV----LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPL 442 (1025)
Q Consensus 378 ~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 442 (1025)
..|+.|++++|+|+ .+|.. +..++.+..|+|.+|.|+. ..+.+|+.| ++.|.+.|++
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~ 448 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPR 448 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCc
Confidence 36999999999998 45543 4556889999999999973 244555666 5667776654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-20 Score=220.11 Aligned_cols=253 Identities=16% Similarity=0.199 Sum_probs=184.7
Q ss_pred CCceeeeecceEEEEEEe-cCCCEEEEEEcc----cc-chh-cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEE
Q 001700 736 PAEVIGRSCHGTLYKATL-DSGSILAVKRLR----EG-IAK-GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 808 (1025)
..+++|.|++|.|+.+.. ...+.++.|..+ .. ... ....+..|+.+-..++|||++.....+.. .....-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchhh
Confidence 468899999998887763 344445555433 11 111 11226678888889999999888777653 2234444
Q ss_pred EeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccc
Q 001700 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|||+++ +|...+.... .++..++..++.|++.|++|+|+ .||.|||+|++|+++.. ++.+||+|||.+....
T Consensus 400 mE~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFGAASVFR 471 (601)
T ss_pred hhcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecCcceeec
Confidence 999999 9999998753 48888999999999999999998 99999999999999998 8899999999988765
Q ss_pred cCCC---ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccc
Q 001700 889 SAGT---ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 889 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
.+.. ......+|+..|+|||++.+..+ .....||||.|++++.|++|+.||.....+.... .......+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~y-dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~ 544 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEY-DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQR 544 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCccccccccc-CcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccc
Confidence 4433 33445589999999999988876 5778899999999999999999998654432110 000000000
Q ss_pred cccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.+..++ .......+.+...++.++++.+ .+|-||.+|++.
T Consensus 545 ------~~~~~~-~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 ------NIFEGP-NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ------ccccCh-HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000 0123456777888999999999 999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-18 Score=193.68 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=188.9
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchh---cHHHHHHHHHHHhcCCCC-ccccccceeecCCCCeeEEEEecc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK---GKKEFAREVKKLGNIKHP-NLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++++++. .....+++++|+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~ 80 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVMEYV 80 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEEecC
Confidence 467899999999999976 78999999765433 367899999999999988 7999999885 444579999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~ 892 (1025)
.++++.+++...... ..++......++.|++.+++|+|+ .+++|||+||+||+++.....++++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999777654321 158899999999999999999997 88999999999999998333799999999986554332
Q ss_pred c-----cccccCcccccCccccccCCC-CCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhcccc
Q 001700 893 A-----DQVLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 893 ~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
. ......||..|+|||.+.+.. ...+...|+||+|++++++++|..||.............+.+.... ..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP----TP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC----Cc
Confidence 1 123457999999999998741 1258899999999999999999999664321100011111111100 00
Q ss_pred ccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHH
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~ 1012 (1025)
.................+.+++..|+..+ ..|.++.+....
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000222356888999999888 999988877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=183.78 Aligned_cols=140 Identities=17% Similarity=0.229 Sum_probs=108.8
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchh--c------------------------HHHHHHHHHHHhcCCCCcc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK--G------------------------KKEFAREVKKLGNIKHPNL 790 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni 790 (1025)
.+.||+|++|.||+|...+|+.||||+++..... . .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999878999999999754211 1 1122459999999988877
Q ss_pred ccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCcccCCCCCCEEe
Q 001700 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL-HNERAIPHGNLKSTNILL 869 (1025)
Q Consensus 791 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~ivHrDlkp~NILl 869 (1025)
.....+.. . ..++||||++++++........ .+++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEE
Confidence 54433322 2 3489999999887765433221 588999999999999999999 56 899999999999999
Q ss_pred ecCCCCEEEeccccccccc
Q 001700 870 EAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 870 ~~~~~~~kl~DfGla~~~~ 888 (1025)
+. ..++|+|||+|....
T Consensus 152 ~~--~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 HD--GKLYIIDVSQSVEHD 168 (190)
T ss_pred EC--CcEEEEEccccccCC
Confidence 84 579999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-19 Score=182.13 Aligned_cols=169 Identities=14% Similarity=0.211 Sum_probs=127.7
Q ss_pred cCCCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHH---------HHHHHHHHhcCCCCccccccceeecCC---
Q 001700 734 HAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKE---------FAREVKKLGNIKHPNLVSLQGYYWGPK--- 801 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpniv~l~~~~~~~~--- 801 (1025)
+...+++|.|+||.||.+.. ++..+|||.++.......+. +.+|++.+.++.||+|..+.+++....
T Consensus 33 y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred eEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 34568999999999999765 46789999997654333222 689999999999999999988866322
Q ss_pred ---CCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEE
Q 001700 802 ---EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL 878 (1025)
Q Consensus 802 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl 878 (1025)
....+++|||++|.+|.++.. ++. ....+++.++..+|+ .||+|||+||+||+++. ++ +++
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g-i~l 175 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG-LRI 175 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-EEE
Confidence 235789999999999988732 333 245699999999997 89999999999999987 65 999
Q ss_pred eccccccccccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHH
Q 001700 879 TDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELL 934 (1025)
Q Consensus 879 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ell 934 (1025)
+|||..+.......... +..... +..++|+||||+++....
T Consensus 176 iDfg~~~~~~e~~a~d~-------------~vler~--y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKDR-------------IDLERH--YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHHH-------------HHHHhH--hcccccccceeEeehHHH
Confidence 99998876533221111 222223 357899999999987653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=172.72 Aligned_cols=185 Identities=14% Similarity=0.079 Sum_probs=137.2
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchh----cHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEe
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK----GKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
....|++|+||+||.+.- .+..++.+.+...... ....+.+|+++|+++. |++|++++++. ..+++||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvme 78 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDRS 78 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEEe
Confidence 357899999999997765 5777887777654321 1235889999999995 58899987752 4589999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCC-CCCCEEeecCCCCEEEecccccccccc
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNL-KSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDl-kp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
|+.|.+|.+.... ....++.|++.+|+++|+ .||+|||| ||+|||++. ++.++|+|||+|.....
T Consensus 79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCceecCC
Confidence 9999998754321 113578899999999997 89999999 799999987 77899999999986544
Q ss_pred CCCc----c--------ccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 890 AGTA----D--------QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 890 ~~~~----~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
.... . ......++.|++|+...--....-.+.+.++-|+-+|.++||+.|.-
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 3310 0 11124678888888544322111256789999999999999998753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=176.32 Aligned_cols=141 Identities=20% Similarity=0.254 Sum_probs=111.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchh---------------------c-----HHHHHHHHHHHhcCCCCcc
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK---------------------G-----KKEFAREVKKLGNIKHPNL 790 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~hpni 790 (1025)
...||+|++|.||+|+..+|+.||||+++..... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999778999999998764211 0 1224679999999999987
Q ss_pred ccccceeecCCCCeeEEEEeccccccHHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEe
Q 001700 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVY-LQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869 (1025)
Q Consensus 791 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl 869 (1025)
.....+.. . ..++||||++++++... +... .++..++..++.|++.++.|+|+..||+||||||+||++
T Consensus 82 ~~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILL--K--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEe--c--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence 65544432 1 34899999988855433 3322 478889999999999999999965799999999999999
Q ss_pred ecCCCCEEEecccccccccc
Q 001700 870 EAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 870 ~~~~~~~kl~DfGla~~~~~ 889 (1025)
+ ++.++|+|||+++....
T Consensus 152 ~--~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H--DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E--CCCEEEEEcccceecCC
Confidence 8 56899999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-20 Score=170.86 Aligned_cols=176 Identities=26% Similarity=0.417 Sum_probs=136.4
Q ss_pred CCcccccCcccccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCC
Q 001700 75 MGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFP 154 (1025)
Q Consensus 75 ~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 154 (1025)
.+++.-..++.++++++.+.|.||+|.++..+|.|..|.+|+.|++++|+|+ .+|.+++++++|+.|+++-|++. +.|
T Consensus 18 rgiSsf~~~~gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lp 95 (264)
T KOG0617|consen 18 RGISSFEELPGLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILP 95 (264)
T ss_pred cccccHhhcccccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCc
Confidence 3343333346778888999999999999999999999999999999999998 46889999999999999999999 899
Q ss_pred ccccccccccEeecccCCCCC-CchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCC
Q 001700 155 SGFGGLGKLKYLDLRANRFGG-DIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDG 233 (1025)
Q Consensus 155 ~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 233 (1025)
..|+.++.|+.|||++|++.. ..|..|..++.|+.|+|+.|.|. .+|..
T Consensus 96 rgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~d----------------------------- 145 (264)
T KOG0617|consen 96 RGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPD----------------------------- 145 (264)
T ss_pred cccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChh-----------------------------
Confidence 999999999999999999874 55666666666666666666654 22222
Q ss_pred CCCCCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHh
Q 001700 234 MPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQ 283 (1025)
Q Consensus 234 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 283 (1025)
.+.+++|+.|.+..|.+-..+..++.++.|++|++.+|+++ .+|..+++
T Consensus 146 vg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 146 VGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred hhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 34555666666666666555556788888888888888888 66766654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-18 Score=173.23 Aligned_cols=138 Identities=19% Similarity=0.196 Sum_probs=106.6
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcC-----CCCccccccceeecCCC-Ce-eEEE
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-----KHPNLVSLQGYYWGPKE-HE-KLVI 808 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~-~~-~~lv 808 (1025)
..++||+|+||.||. +......+||++........+.+.+|+.+++.+ .||||++++|++....+ .. ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 443333479988765444567899999999999 57999999999975332 23 3378
Q ss_pred Eec--cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCcccCCCCCCEEeec---CCCCEEEeccc
Q 001700 809 SNY--INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL-NYLHNERAIPHGNLKSTNILLEA---PTMNAVLTDYS 882 (1025)
Q Consensus 809 ~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~ivHrDlkp~NILl~~---~~~~~kl~DfG 882 (1025)
+|| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+ ++|+||||||+|||++. .+..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5579999999653 35555 36688888888 99997 89999999999999974 23479999954
Q ss_pred cc
Q 001700 883 LH 884 (1025)
Q Consensus 883 la 884 (1025)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=190.01 Aligned_cols=221 Identities=26% Similarity=0.309 Sum_probs=164.1
Q ss_pred HhcCCCCccccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccC
Q 001700 782 LGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGN 861 (1025)
Q Consensus 782 l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrD 861 (1025)
|+.+.|.|+.+++|.+.+ +...++|.+|+..|+|.+.+..... .+++.....+.++|+.||+|+|+-+...|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNSPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence 457889999999999984 4688999999999999999987432 5899999999999999999999743338999
Q ss_pred CCCCCEEeecCCCCEEEeccccccccccCC-CccccccCcccccCccccccCCCCC-----CCCchhHHHHHHHHHHHHc
Q 001700 862 LKSTNILLEAPTMNAVLTDYSLHRILTSAG-TADQVLNAGALGYRPPEFASTSKPC-----PSLKSDVYAFGIILLELLT 935 (1025)
Q Consensus 862 lkp~NILl~~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~DVwSlGvvl~ellt 935 (1025)
++++|.++|. .+.+|+.|||+........ ........-..-|.|||.+...... .+.++||||||++++|+++
T Consensus 75 l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 75 LKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9999999998 8999999999988764310 1111111234569999998764111 2678999999999999999
Q ss_pred CCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 936 GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 936 G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
.+.||+..........++.+++. .....+.|.+.. ..+...++..++..||..+ ++||++++|...++
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred ccCccccccccCChHHHHHHHHh-----cCCCCcCcchhh------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 99999865433322333333322 011111111111 1133447999999999999 99999999999999
Q ss_pred hccccc
Q 001700 1015 TIVLEK 1020 (1025)
Q Consensus 1015 ~i~~~~ 1020 (1025)
.+....
T Consensus 223 ~~~~~~ 228 (484)
T KOG1023|consen 223 TINKGG 228 (484)
T ss_pred hhcccc
Confidence 887643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-19 Score=198.00 Aligned_cols=186 Identities=24% Similarity=0.329 Sum_probs=155.8
Q ss_pred eeeeecceEEEEEE----ecCCCEEEEEEccccchhc--HHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEec
Q 001700 739 VIGRSCHGTLYKAT----LDSGSILAVKRLREGIAKG--KKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
++|+|+||.|+.++ .+.|..+|+|++++..... +.....|..++..++ ||.+|+++-.+. .+...+++.+|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhh
Confidence 36899999999875 3468889999987654322 224566888888887 999999976555 55678999999
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
..+|++...+.... .+++.....+...++-|++++|. .+|+|||+|++||+++. ++++++.|||+++..-...
T Consensus 79 ~rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhhh
Confidence 99999998887664 58888889999999999999997 99999999999999999 8999999999999765443
Q ss_pred CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
.. |||..|||||++.+ ...++|.||||++++||+||..||..
T Consensus 152 ~~-----cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 IA-----CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hc-----ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch
Confidence 22 89999999999982 36689999999999999999999873
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-18 Score=196.43 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=170.4
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccc-hhcHHHHHHHHHH--HhcCCCCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGI-AKGKKEFAREVKK--LGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
-.+.+|++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ....+|||++++.-+-. .....|+|-+|.
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylvRqyv 103 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLVRQYV 103 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHHHHHH
Confidence 3578999999999999999887 8899886654 2333444433333 45558999999865543 444667788887
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc--cccC
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI--LTSA 890 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~--~~~~ 890 (1025)
..+|+|.+..+. -+..-+.+.|+.|++.||.-+|. .||+|+|||.+|||+.. -.-+.|+||..-+. +.++
T Consensus 104 -khnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 -KHNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred -hhhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCCccCCCC
Confidence 558998887663 57888899999999999999997 99999999999999987 66789999965442 2222
Q ss_pred CCccccc----cCcccccCccccccCCCC---------CCCCchhHHHHHHHHHHHHc-CCCCCCccccCCCCcchHHHH
Q 001700 891 GTADQVL----NAGALGYRPPEFASTSKP---------CPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWV 956 (1025)
Q Consensus 891 ~~~~~~~----~~gt~~y~aPE~~~~~~~---------~~~~~~DVwSlGvvl~ellt-G~~P~~~~~~~~~~~~l~~~~ 956 (1025)
....... ...-..|.|||.+..... ..+.+-||||+||++.|+++ |++||+.. .+..+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHh
Confidence 2211111 122346999998754210 02568899999999999998 78888632 222221
Q ss_pred HHHHhhccccccchhh-hcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHh
Q 001700 957 RLLALENRSGECFDRL-IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELS 1014 (1025)
Q Consensus 957 ~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~ 1014 (1025)
+. ...++. ..+. -....+..++..|++.+ ++|-++++.++.=.
T Consensus 249 ~~--------~~~~~e~~Le~-------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 249 SG--------NADDPEQLLEK-------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred cc--------CccCHHHHHHh-------CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11 011111 1100 01124788999999999 99999999998743
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=168.13 Aligned_cols=233 Identities=17% Similarity=0.260 Sum_probs=144.1
Q ss_pred CceeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCC----------Cccccccceee----
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKH----------PNLVSLQGYYW---- 798 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~~---- 798 (1025)
++.||.|+++.||.++.. +|+.+|||+..... ....+++.+|.-....+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999965 69999999875332 2335667776655555332 11111111111
Q ss_pred -----c-CCCC-----eeEEEEeccccccHHHHHhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCC
Q 001700 799 -----G-PKEH-----EKLVISNYINAQSLAVYLQE---TDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKS 864 (1025)
Q Consensus 799 -----~-~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp 864 (1025)
. ++.. ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++||+ .||||+||||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~~ 173 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIKP 173 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-SG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh-cceEecccce
Confidence 0 0111 235677766 6788887553 2211 1124455667788999999999998 8999999999
Q ss_pred CCEEeecCCCCEEEeccccccccccCCCccccccCcccccCccccccCC------CCCCCCchhHHHHHHHHHHHHcCCC
Q 001700 865 TNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS------KPCPSLKSDVYAFGIILLELLTGKS 938 (1025)
Q Consensus 865 ~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DVwSlGvvl~elltG~~ 938 (1025)
+|++++. ++.++|+||+.....+..... ...+..|.+||..... ...++.+.|.|++|+++|.|.+|+.
T Consensus 174 ~nfll~~-~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 174 ENFLLDQ-DGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGEEE-T-TS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeEEEcC-CCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999 899999999876654432211 2355789999976432 1125889999999999999999999
Q ss_pred CCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCC
Q 001700 939 SGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SER 1003 (1025)
Q Consensus 939 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~R 1003 (1025)
||+....+.... | .+. .+. +.++.+.+++...++.+ .+|
T Consensus 249 Pf~~~~~~~~~~----~----------------~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPE----W----------------DFS-----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSG----G----------------GGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccc----c----------------cch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 998653222110 0 111 123 77888999999999888 766
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=191.11 Aligned_cols=190 Identities=17% Similarity=0.193 Sum_probs=149.4
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCC---CCccccccceeecCCCCeeEEEEecc
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK---HPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
....||+|+||+||+|...+|+.||+|+-+...... |---.+++.||+ -+.|.++...+. .....++|+||.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~--~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV--FQNASVLVSEYS 776 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc--cCCcceeeeecc
Confidence 457899999999999998889999999987654432 222234445554 234555554444 233678999999
Q ss_pred ccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec------CCCCEEEeccccccc
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA------PTMNAVLTDYSLHRI 886 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~------~~~~~kl~DfGla~~ 886 (1025)
+.|+|.+++.... .++|.-++.+..|+++-+++||. .+|||+||||+|.|+.. +...++|+|||.+..
T Consensus 777 ~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 777 PYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred ccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999998443 68999999999999999999997 89999999999999943 245689999999876
Q ss_pred cccCCC-ccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCC
Q 001700 887 LTSAGT-ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938 (1025)
Q Consensus 887 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~ 938 (1025)
+.--.. ......++|-.+-.+|+..+.. +++.+|-|.++.+++-|+.|++
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHH
Confidence 643222 2333457888999999999887 6999999999999999999985
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.4e-18 Score=189.14 Aligned_cols=105 Identities=24% Similarity=0.268 Sum_probs=65.2
Q ss_pred EEEccCCcCccC-CCC-CCCCCCCCEEeccCCcCccc----CcccccCCCCCCEEEccCCcccc------CCCccccccc
Q 001700 94 NVSVSNNQLMGN-ITD-IGSIQSLEFLDLSHNLFHGL----IPSGIVSLKNLMLLNISSNSFEG------TFPSGFGGLG 161 (1025)
Q Consensus 94 ~L~ls~N~l~~~-~~~-~~~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 161 (1025)
.|+|.++.+++. ... +..+..|+.|+|++|.++.. ++..+...++|++|++++|.+.+ .++..|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 355666666532 122 45566677777777777432 44555666777777777777652 2234556667
Q ss_pred cccEeecccCCCCCCchhHhhhccc---CcEEeCccCccc
Q 001700 162 KLKYLDLRANRFGGDIMHLLSQLGS---VVHVDLSNNQFS 198 (1025)
Q Consensus 162 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~ 198 (1025)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 7777777777776656666655555 666666666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=164.99 Aligned_cols=139 Identities=19% Similarity=0.241 Sum_probs=106.7
Q ss_pred CCceeeeecceEEEEEE--ecCCCEEEEEEccccchh------------------------cHHHHHHHHHHHhcCCCCc
Q 001700 736 PAEVIGRSCHGTLYKAT--LDSGSILAVKRLREGIAK------------------------GKKEFAREVKKLGNIKHPN 789 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~hpn 789 (1025)
..+.||+|++|.||+|. ..+|+.||||+++..... ....+.+|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 35789999999999998 568999999998753210 1123568999999997532
Q ss_pred --cccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CcccCCCCCC
Q 001700 790 --LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA-IPHGNLKSTN 866 (1025)
Q Consensus 790 --iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-ivHrDlkp~N 866 (1025)
+.+++++ . ..++||||++++++..+..... .+...++..++.|++.+++|||+ .+ |+||||||+|
T Consensus 112 i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~N 179 (237)
T smart00090 112 VPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYN 179 (237)
T ss_pred CCCCeeeEe----c--CceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhh
Confidence 3333322 1 3489999999988876543221 35666778999999999999997 78 9999999999
Q ss_pred EEeecCCCCEEEeccccccccc
Q 001700 867 ILLEAPTMNAVLTDYSLHRILT 888 (1025)
Q Consensus 867 ILl~~~~~~~kl~DfGla~~~~ 888 (1025)
|+++ +..++++|||.+....
T Consensus 180 Ili~--~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH--DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE--CCCEEEEEChhhhccC
Confidence 9998 5689999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=159.22 Aligned_cols=200 Identities=22% Similarity=0.245 Sum_probs=139.2
Q ss_pred CCCccccccceeecC-------------------------CCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHH
Q 001700 786 KHPNLVSLQGYYWGP-------------------------KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV 840 (1025)
Q Consensus 786 ~hpniv~l~~~~~~~-------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 840 (1025)
+|||||++.++|.++ .....|+||.-+ ..+|.+|+..+ ..+...+.-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC------CCchHHHHHH
Confidence 699999998877531 234678888877 45999999876 3567778889
Q ss_pred HHHHHHHHHHHhcCCCCcccCCCCCCEEeecC-C--CCEEEeccccccccccCCC-----ccccccCcccccCccccccC
Q 001700 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAP-T--MNAVLTDYSLHRILTSAGT-----ADQVLNAGALGYRPPEFAST 912 (1025)
Q Consensus 841 ~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~-~--~~~kl~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 912 (1025)
+.|+++|+.|||. +||.|||+|++|||+.-+ + ....++|||++-..+..+. .......|.-.-||||+...
T Consensus 347 laQlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999996 999999999999999421 2 3467899998764332111 11112246667899999864
Q ss_pred CCCC----CCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHH
Q 001700 913 SKPC----PSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988 (1025)
Q Consensus 913 ~~~~----~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 988 (1025)
.... .-.|+|.|+.|.+.||+++...||... .+...+...+- +..-+..++.++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~Yq------------------e~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRTYQ------------------ESQLPALPSRVPPV 485 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheechhhhh------------------hhhCCCCcccCChH
Confidence 3321 124899999999999999999998641 00001111110 00112235666777
Q ss_pred HHHHHHHccCCC-CCCCCHHHHHHHH
Q 001700 989 MLQVALRCILPA-SERPDMMSVFEEL 1013 (1025)
Q Consensus 989 ~~~l~~~C~~~~-~~RPs~~evl~~L 1013 (1025)
+.+++..-++.+ ++||+.+-....|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHH
Confidence 889999999999 9999987655544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=158.05 Aligned_cols=134 Identities=19% Similarity=0.366 Sum_probs=110.3
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccchh--------cHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAK--------GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|++++..++|++|+....++.+ ....+++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEE
Confidence 5789999999999987 5778999986543211 12457889999999999998877666653 34678999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
||++|++|.+++... .+ ++..++.+++.+|.++|+ .+++|||++|.||+++ +..++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999998643 12 888999999999999997 8999999999999998 56799999998765
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-17 Score=184.21 Aligned_cols=156 Identities=21% Similarity=0.160 Sum_probs=104.9
Q ss_pred EEeCCCCcccccCcccccCCCCCCEEEccCCcCccC-----CCCCCCCCCCCEEeccCCcCcc------cCcccccCCCC
Q 001700 70 IMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGN-----ITDIGSIQSLEFLDLSHNLFHG------LIPSGIVSLKN 138 (1025)
Q Consensus 70 l~l~~~~l~g~~~~~~~~~L~~L~~L~ls~N~l~~~-----~~~~~~l~~L~~LdLs~N~l~~------~~p~~~~~l~~ 138 (1025)
|+|....+.+.--...+..+..|+.|+++++.++.. ...+...++|++|+++.|.+.+ .++..|..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455555555433324445577799999999998542 2236678889999999998872 34567788999
Q ss_pred CCEEEccCCccccCCCcccccccc---ccEeecccCCCCCC----chhHhhhc-ccCcEEeCccCccccccCCCC-CCCc
Q 001700 139 LMLLNISSNSFEGTFPSGFGGLGK---LKYLDLRANRFGGD----IMHLLSQL-GSVVHVDLSNNQFSGSLDLGL-GDSS 209 (1025)
Q Consensus 139 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~-~~~~ 209 (1025)
|+.|+|++|.+.+..+..|..+.+ |++|++++|++++. +...+..+ ++|+.|+|++|.+++.....+ ..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 999999999998777777777766 99999999999842 33345556 778888888888773211111 0111
Q ss_pred ccccccEEeccccccc
Q 001700 210 FISSIQYLNISENSLV 225 (1025)
Q Consensus 210 ~l~~L~~L~Ls~N~l~ 225 (1025)
.+++|+.|+|++|.++
T Consensus 163 ~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 163 ANRDLKELNLANNGIG 178 (319)
T ss_pred hCCCcCEEECcCCCCc
Confidence 2244555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.1e-18 Score=156.57 Aligned_cols=160 Identities=28% Similarity=0.424 Sum_probs=122.2
Q ss_pred CCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccC
Q 001700 108 DIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSV 187 (1025)
Q Consensus 108 ~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 187 (1025)
.+..+.+.+.|.||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++.|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3556677788888888888 56778888888888888888888 67888888888888888888886 566667777666
Q ss_pred cEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCccccccccccee
Q 001700 188 VHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILR 267 (1025)
Q Consensus 188 ~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 267 (1025)
+.|||.+|++. ....| ..|.++..|+.|+|+.|.+...+|.++.+++|+.|.
T Consensus 105 evldltynnl~---------------------------e~~lp-gnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 105 EVLDLTYNNLN---------------------------ENSLP-GNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILS 156 (264)
T ss_pred hhhhccccccc---------------------------cccCC-cchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEe
Confidence 66666666654 22222 224566778888888888888888999999999999
Q ss_pred cccccccccCChhHHhhcccccCeEEcccccCcC
Q 001700 268 LGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG 301 (1025)
Q Consensus 268 L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~ 301 (1025)
+..|.+- .+|..++.+.. |++|++.+|+++-
T Consensus 157 lrdndll-~lpkeig~lt~--lrelhiqgnrl~v 187 (264)
T KOG0617|consen 157 LRDNDLL-SLPKEIGDLTR--LRELHIQGNRLTV 187 (264)
T ss_pred eccCchh-hCcHHHHHHHH--HHHHhcccceeee
Confidence 9999987 78988877654 6666666666653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-15 Score=180.63 Aligned_cols=156 Identities=26% Similarity=0.437 Sum_probs=95.1
Q ss_pred hcCChhhHHHHHHHHhhcCCCCCCCcccCCCCCCCCCCCC--CCCccceEcCCCCEEEEEeCCCCcccccCcccccCCCC
Q 001700 14 NALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGC--PRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKM 91 (1025)
Q Consensus 14 ~~~~~~~~~aLl~~k~~~~~d~~~~l~~sW~~~~~~~d~C--~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~ 91 (1025)
....+.|..||++||+.+ .+|.. .+|+.+ .|| .+.|.||.|.....+ + ...
T Consensus 367 ~~t~~~~~~aL~~~k~~~-~~~~~---~~W~g~----~C~p~~~~w~Gv~C~~~~~~----------~---------~~~ 419 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSL-GLPLR---FGWNGD----PCVPQQHPWSGADCQFDSTK----------G---------KWF 419 (623)
T ss_pred cccCchHHHHHHHHHHhc-CCccc---CCCCCC----CCCCcccccccceeeccCCC----------C---------ceE
Confidence 345678999999999998 44432 479652 222 135999999621000 0 001
Q ss_pred CCEEEccCCcCccCCC-CCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeeccc
Q 001700 92 LCNVSVSNNQLMGNIT-DIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRA 170 (1025)
Q Consensus 92 L~~L~ls~N~l~~~~~-~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (1025)
++.|+|++|.+.|.++ +++.+++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|++|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 2334444455544433 366666666777777777666666667777777777777777766676666777777777777
Q ss_pred CCCCCCchhHhhhc-ccCcEEeCccCc
Q 001700 171 NRFGGDIMHLLSQL-GSVVHVDLSNNQ 196 (1025)
Q Consensus 171 N~l~~~~~~~~~~l-~~L~~L~Ls~N~ 196 (1025)
|+++|.+|..+..+ .++..+++.+|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCc
Confidence 77766666665542 234445555554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-15 Score=154.80 Aligned_cols=137 Identities=18% Similarity=0.194 Sum_probs=106.2
Q ss_pred cCCCceeeeecceEEEEEEecCCCEEEEEEccccch----------------------hcHHHHHHHHHHHhcCCCCc--
Q 001700 734 HAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIA----------------------KGKKEFAREVKKLGNIKHPN-- 789 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hpn-- 789 (1025)
+...+.||+|+||.||+|..++|+.||||+++.... .....+.+|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 334688999999999999988899999998754320 01123678899999998774
Q ss_pred cccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEe
Q 001700 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869 (1025)
Q Consensus 790 iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl 869 (1025)
+++.++. ...++||||+++++|...... .....++.+++.++.++|+ .+|+||||||+||++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILV 158 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEE
Confidence 3333321 245899999999998765321 2356788999999999997 899999999999999
Q ss_pred ecCCCCEEEecccccccccc
Q 001700 870 EAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 870 ~~~~~~~kl~DfGla~~~~~ 889 (1025)
+. +..++|+|||.+.....
T Consensus 159 ~~-~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DD-DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cC-CCcEEEEECCccccCCC
Confidence 98 88999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-16 Score=181.95 Aligned_cols=160 Identities=25% Similarity=0.323 Sum_probs=114.7
Q ss_pred CCCceeeeecceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccc
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 735 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.+.|..|+||.||.++++ +.+.+|+|+-++. .+.|- ++.....|.+|
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------- 135 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------- 135 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee----------------------
Confidence 34688999999999999976 5778898554332 11111 23333333333
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCc
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~ 893 (1025)
||-...++..+ +++. +++.|++|+|+ .+|||||+||+|.+|.. -+++|+.|||+++.....-..
T Consensus 136 -gDc~tllk~~g-----~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIG-----PLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCC-----CCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhhhccc
Confidence 33333443322 2332 23788999998 89999999999999998 889999999998864221110
Q ss_pred --------------cccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCc
Q 001700 894 --------------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEI 942 (1025)
Q Consensus 894 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~ 942 (1025)
.....+||+.|+|||++...+ |+..+|+|++|+|+||.+-|+.||..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHHHHheeeeeccC
Confidence 011248999999999998877 58899999999999999999999873
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=175.68 Aligned_cols=133 Identities=20% Similarity=0.320 Sum_probs=105.6
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEE-cccc-ch------hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEE
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKR-LREG-IA------KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 807 (1025)
..+.||+|+||+||+|.+.... +++|+ ..+. .. ...+++.+|++++++++|++++..+.++.. ....++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCEE
Confidence 4688999999999999876443 33333 2221 11 123568899999999999999887666653 345789
Q ss_pred EEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
||||+++++|.+++. ....++.+++++|.|||+ .+|+|||+||+||+++ +..++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 999999999998875 346789999999999997 8999999999999994 668999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.5e-15 Score=153.44 Aligned_cols=130 Identities=18% Similarity=0.313 Sum_probs=103.5
Q ss_pred eeeeecceEEEEEEecCCCEEEEEEccccch--------hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEe
Q 001700 739 VIGRSCHGTLYKATLDSGSILAVKRLREGIA--------KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 810 (1025)
.||+|++|.||+|.+. |..|++|+...... ...+++.+|++++..++|+++.....++. .....++|||
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV--DPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE--ECCCCEEEEE
Confidence 4899999999999964 77899998653211 11356788999999999887655444444 3345689999
Q ss_pred ccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
|+++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ +..++++|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN------D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH------H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 999999998875421 1 889999999999997 8999999999999998 56899999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-15 Score=165.89 Aligned_cols=188 Identities=23% Similarity=0.267 Sum_probs=130.3
Q ss_pred eeeeecceEEEEEEecC----CCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccc-------eeec---CCCCe
Q 001700 739 VIGRSCHGTLYKATLDS----GSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQG-------YYWG---PKEHE 804 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-------~~~~---~~~~~ 804 (1025)
..++.+++.+....... .+.++.++.............+++-.+....|.+..-+.+ .... .....
T Consensus 251 ~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~ 330 (516)
T KOG1033|consen 251 SSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVY 330 (516)
T ss_pred cccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccc
Confidence 34555555555544221 2344444444333223333445555555554433332222 0000 01224
Q ss_pred eEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccc
Q 001700 805 KLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLH 884 (1025)
Q Consensus 805 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla 884 (1025)
.++.|+++...+|.+|+..+.... .-++...+.++.|++.|++| ++.+|||+||.||.... +..+||.|||+.
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFGLV 403 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhhhe
Confidence 789999999999999998654333 56788999999999999999 46779999999999977 668999999998
Q ss_pred cccccCC-----CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHc
Q 001700 885 RILTSAG-----TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935 (1025)
Q Consensus 885 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ellt 935 (1025)
....... ....+...||..||+||.+.+.. ++.|+||||+|++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHH
Confidence 8766554 23344458999999999999887 5999999999999999997
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=147.00 Aligned_cols=140 Identities=20% Similarity=0.255 Sum_probs=107.2
Q ss_pred CCCceee-eecceEEEEEEecCCCEEEEEEccccc-------------hhcHHHHHHHHHHHhcCCCCcc--ccccceee
Q 001700 735 APAEVIG-RSCHGTLYKATLDSGSILAVKRLREGI-------------AKGKKEFAREVKKLGNIKHPNL--VSLQGYYW 798 (1025)
Q Consensus 735 ~~~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~ 798 (1025)
..+.+|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3467898 8999999999886 6789999885421 1223567889999999998775 66666644
Q ss_pred cCCC--CeeEEEEecccc-ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCC
Q 001700 799 GPKE--HEKLVISNYINA-QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMN 875 (1025)
Q Consensus 799 ~~~~--~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~ 875 (1025)
.... ...++|+||+++ .+|.+++... .++.. .+.+++.++.+||+ .||+||||||+|||++. +..
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~ 180 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGK 180 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCC
Confidence 2121 123599999997 6999888643 35543 35789999999997 99999999999999987 668
Q ss_pred EEEecccccccc
Q 001700 876 AVLTDYSLHRIL 887 (1025)
Q Consensus 876 ~kl~DfGla~~~ 887 (1025)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.2e-14 Score=143.07 Aligned_cols=138 Identities=18% Similarity=0.288 Sum_probs=97.3
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchh--cHHH----------------------HHHHHHHHhcCCCCc--c
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK--GKKE----------------------FAREVKKLGNIKHPN--L 790 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--i 790 (1025)
.+.||+|+||+||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999878999999998753211 1111 134556666654332 3
Q ss_pred ccccceeecCCCCeeEEEEeccccccHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEe
Q 001700 791 VSLQGYYWGPKEHEKLVISNYINAQSLAV-YLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869 (1025)
Q Consensus 791 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl 869 (1025)
.+.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|+..+|+|||+||+||++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 333322 14589999999854321 111110 11 56789999999999999965889999999999999
Q ss_pred ecCCCCEEEecccccccccc
Q 001700 870 EAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 870 ~~~~~~~kl~DfGla~~~~~ 889 (1025)
+ +..++++|||.+.....
T Consensus 149 ~--~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D--DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E--CCcEEEEECcccccccC
Confidence 8 66899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.41 E-value=8e-13 Score=130.34 Aligned_cols=131 Identities=17% Similarity=0.167 Sum_probs=108.1
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCC--CccccccceeecCCCCeeEEEEeccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKH--PNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv~e~~~~g 815 (1025)
+.||+|.++.||++..++ ..+++|....... ...+.+|+.+++.++| .+++++++++. .....++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEEecCCe
Confidence 579999999999999764 7899999876533 5678899999999976 58888877665 335789999999887
Q ss_pred cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE--RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
.+..+ +......++.+++++++++|.. .+++|+|++|+||+++. ...++++|||.++.
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 66533 4566778899999999999963 36999999999999987 77899999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.7e-14 Score=166.10 Aligned_cols=248 Identities=19% Similarity=0.209 Sum_probs=178.7
Q ss_pred ceeeeecceEEEEEEec--CCCEEEEEEccccc--hhcHHHHHHHHHHHhcCC-CCccccccceeecCCCCeeEEEEecc
Q 001700 738 EVIGRSCHGTLYKATLD--SGSILAVKRLREGI--AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+|+.|-.+... ....+|+|.+.... ....+....|..+-..+. |+|++++++... .....+++.+|.
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~~~~~~~s 103 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSYLLSLSYS 103 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCcccccccCcc
Confidence 45899999999887643 45567777765442 223345556888877886 999999999876 455789999999
Q ss_pred ccccHHHHHh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC-CEEEecccccccccc-
Q 001700 813 NAQSLAVYLQ-ETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM-NAVLTDYSLHRILTS- 889 (1025)
Q Consensus 813 ~~gsL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~-~~kl~DfGla~~~~~- 889 (1025)
.++++.+.+. ... ...+......++.|+..|+.|+|...++.|||+||+|.+++. .. ..+++|||+|..+..
T Consensus 104 ~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~-s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 104 DGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE-SGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc-CCCcccCCCchhhcccccc
Confidence 9999998883 321 135667788999999999999993389999999999999998 55 899999999998766
Q ss_pred CC-CccccccCc-ccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccc
Q 001700 890 AG-TADQVLNAG-ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~-~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
.+ .......+| ++.|+|||...+..+ .....|+||.|+++.-+++|..|++...... .....|....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~-~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~-------- 247 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAY-RGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK-------- 247 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhh-cCCCcccccccccccccccCCCCcccccccc--ccceeecccc--------
Confidence 32 233334578 999999999887543 4778999999999999999999987553322 2222232211
Q ss_pred cchhhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHH
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVF 1010 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl 1010 (1025)
................++..+++..+ +.|.+.+++-
T Consensus 248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00001112333445666777777666 8888877664
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=155.24 Aligned_cols=103 Identities=33% Similarity=0.540 Sum_probs=69.3
Q ss_pred CCEeecCCCcccccCcccccCCCCCCEEecCCCcCcccCCcccccCCCCccccccccccEEEccCCcCcccCChhhhcCC
Q 001700 404 LKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFH 483 (1025)
Q Consensus 404 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~LdLs~N~l~~~~p~~~~~l~ 483 (1025)
++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|.. ++.+. +|+.|||++|+|+|.+|..++.++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~-------~~~l~--~L~~LdLs~N~lsg~iP~~l~~L~ 490 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-------LGSIT--SLEVLDLSYNSFNGSIPESLGQLT 490 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChH-------HhCCC--CCCEEECCCCCCCCCCchHHhcCC
Confidence 566777777777777777777777777777777777766643 22333 677777777777777777777777
Q ss_pred CCCEeeCcCCcCccccCCCcCC---CCcEEECCCC
Q 001700 484 NLVYLNLSNNKFEGSIPDGLPN---GLKEFNVSFN 515 (1025)
Q Consensus 484 ~L~~LdLs~N~l~g~ip~~l~~---~L~~L~ls~N 515 (1025)
+|+.|||++|+|+|.+|..+.. .+..+++++|
T Consensus 491 ~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred CCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 7777777777777777766543 2334444444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4e-12 Score=146.65 Aligned_cols=143 Identities=23% Similarity=0.359 Sum_probs=102.1
Q ss_pred CceeeeecceEEEEEEecCCCEEEEEEccccchhc----------------------------------------HHHHH
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKG----------------------------------------KKEFA 776 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~ 776 (1025)
.+.||.|++|.||+|++++|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999986542111 00245
Q ss_pred HHHHHHhcC----CCCccccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 001700 777 REVKKLGNI----KHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR-CLNYL 851 (1025)
Q Consensus 777 ~E~~~l~~l----~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-aL~yL 851 (1025)
+|++.+.++ +|.+-|.+-.+|+. .....++||||++|++|.++...... .. .+.+++.+++. .+..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~-~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD-RTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh-hcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHH
Confidence 566666555 23333333334432 22357999999999999887654211 12 24456666666 46788
Q ss_pred hcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 852 H~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
|. .|++|+|+||.||+++. ++.++++|||++..+..
T Consensus 274 ~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLSE 309 (437)
T ss_pred Hh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECCH
Confidence 96 89999999999999987 78999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.7e-14 Score=153.10 Aligned_cols=180 Identities=27% Similarity=0.410 Sum_probs=107.3
Q ss_pred CCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEe
Q 001700 112 IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVD 191 (1025)
Q Consensus 112 l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 191 (1025)
|+.-...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|..+.+|..|.+|||+.|+++ ..|..+..| -|+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEE
Confidence 444556666666666 45666666666666666666666 56666666666666666666666 344444444 366666
Q ss_pred CccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccc
Q 001700 192 LSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSN 271 (1025)
Q Consensus 192 Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 271 (1025)
+++|+++ .+|..++. +..|..||.+.|.+.. +++. +.++.+|+.|.+..|++...++.+. .-.|..||+|.|
T Consensus 150 ~sNNkl~-~lp~~ig~---~~tl~~ld~s~nei~s-lpsq--l~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScN 221 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGL---LPTLAHLDVSKNEIQS-LPSQ--LGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCN 221 (722)
T ss_pred EecCccc-cCCccccc---chhHHHhhhhhhhhhh-chHH--hhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccC
Confidence 6666665 23444442 2556666666666642 2222 4456666666666666666655555 334666666666
Q ss_pred cccccCChhHHhhcccccCeEEcccccCcCccccc
Q 001700 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSI 306 (1025)
Q Consensus 272 ~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~ 306 (1025)
+++ .||..|..+.. |++|-|.+|-|+.|+..+
T Consensus 222 kis-~iPv~fr~m~~--Lq~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRH--LQVLQLENNPLQSPPAQI 253 (722)
T ss_pred cee-ecchhhhhhhh--heeeeeccCCCCCChHHH
Confidence 666 66666665544 666666666666655433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-11 Score=143.40 Aligned_cols=198 Identities=32% Similarity=0.429 Sum_probs=98.2
Q ss_pred EEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccc-cccEeecccCCCCCCchhHhhhcccCcEEeCccC
Q 001700 117 FLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLG-KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195 (1025)
Q Consensus 117 ~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 195 (1025)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 344444444221 222333344444555555444 3333344442 4555555555444 22333444455555555555
Q ss_pred ccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCcccccccccceecccccccc
Q 001700 196 QFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSG 275 (1025)
Q Consensus 196 ~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g 275 (1025)
+++...+. .+ .+++|+.|++++|++.. ++.. ......|++|++++|.+...+..+..+.++..|.+.+|++.
T Consensus 174 ~l~~l~~~-~~---~~~~L~~L~ls~N~i~~-l~~~--~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~- 245 (394)
T COG4886 174 DLSDLPKL-LS---NLSNLNNLDLSGNKISD-LPPE--IELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE- 245 (394)
T ss_pred hhhhhhhh-hh---hhhhhhheeccCCcccc-Cchh--hhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-
Confidence 54432221 10 12455555555555531 1111 11233466666666654444444566666666666666665
Q ss_pred cCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEccCCcccCCCCC
Q 001700 276 SLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPA 327 (1025)
Q Consensus 276 ~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 327 (1025)
.++..+..... ++.|++++|+++.........+++.|++++|.++..+|.
T Consensus 246 ~~~~~~~~l~~--l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 246 DLPESIGNLSN--LETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred eccchhccccc--cceeccccccccccccccccCccCEEeccCccccccchh
Confidence 22344433322 667777777776655555567788888888887765554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.6e-11 Score=135.06 Aligned_cols=211 Identities=20% Similarity=0.230 Sum_probs=160.0
Q ss_pred ccccccccCHHHhhcCCCceeee--ecceEEEEEEe--c-CCCEEEEEEccccch--hcHHHHHHHHHHHhcCC-CCccc
Q 001700 720 LFDVSLMFTAEELSHAPAEVIGR--SCHGTLYKATL--D-SGSILAVKRLREGIA--KGKKEFAREVKKLGNIK-HPNLV 791 (1025)
Q Consensus 720 ~~~~~~~~~~~~l~~~~~~~lG~--G~~g~Vy~~~~--~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv 791 (1025)
.++....+++.+-.+....-+|. |.+|.||.+.. . ++..+|+|+-+.... .....=.+|+....+++ |++.|
T Consensus 102 ~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v 181 (524)
T KOG0601|consen 102 IYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPV 181 (524)
T ss_pred ccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcccccc
Confidence 34444556666666667788999 99999999986 3 688899998543322 33333456777777774 99999
Q ss_pred cccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCcccCCCCCCE
Q 001700 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR----CLNYLHNERAIPHGNLKSTNI 867 (1025)
Q Consensus 792 ~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~ivHrDlkp~NI 867 (1025)
+.+..+. .....++-+|++ +.++.++.+.... .++....+.+..+... ||.++|+ ..|+|-|+||.||
T Consensus 182 ~~~~~~e--~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 182 RDSPAWE--GSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANI 253 (524)
T ss_pred ccCcccc--cCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhhe
Confidence 9776665 445677777777 6788888876532 3677788888888888 9999998 8999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCCcccc----ccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 001700 868 LLEAPTMNAVLTDYSLHRILTSAGTADQV----LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGE 941 (1025)
Q Consensus 868 Ll~~~~~~~kl~DfGla~~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~ 941 (1025)
....+....+++|||+...+.+....... ...|...|++||...+.. +.+.|+|++|.+..|..+|..+..
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~---~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA---TFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc---chHhhhcchhhhhHhhHhhccccc
Confidence 99883378899999998887765532211 125777899999987664 889999999999999999887643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-11 Score=141.23 Aligned_cols=194 Identities=36% Similarity=0.468 Sum_probs=109.6
Q ss_pred EEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCC-CCCEEEccCCccccCCCccccccccccEeecccCC
Q 001700 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLK-NLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172 (1025)
Q Consensus 94 ~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 172 (1025)
.|+++.|.+...+..+..++.++.|++.+|.++. +|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 4566666665544445555666666666666663 455555553 6666666666666 455556666666666666666
Q ss_pred CCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCcccc
Q 001700 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVG 252 (1025)
Q Consensus 173 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 252 (1025)
++ .+|...+.+++|+.|++++|+++...+. ++ ....|++|.+++|.+. ..+. .+..+.++..+.+.+|++..
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~-~~---~~~~L~~l~~~~N~~~-~~~~--~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKISDLPPE-IE---LLSALEELDLSNNSII-ELLS--SLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccccCchh-hh---hhhhhhhhhhcCCcce-ecch--hhhhcccccccccCCceeee
Confidence 65 3444444566666666666666643221 11 1244666666666421 1111 24455566666666666665
Q ss_pred cCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcC
Q 001700 253 AIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG 301 (1025)
Q Consensus 253 ~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~ 301 (1025)
.+..+..+.+|+.|++++|+++ .++. +.. ...++.|++++|.+..
T Consensus 247 ~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~--~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 247 LPESIGNLSNLETLDLSNNQIS-SISS-LGS--LTNLRELDLSGNSLSN 291 (394)
T ss_pred ccchhccccccceecccccccc-cccc-ccc--cCccCEEeccCccccc
Confidence 4444556666777777777766 3333 222 2336677777766654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-12 Score=141.12 Aligned_cols=171 Identities=31% Similarity=0.381 Sum_probs=103.1
Q ss_pred CCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEc
Q 001700 237 FDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNL 316 (1025)
Q Consensus 237 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~L 316 (1025)
+.--...||+.|++...+..+..+..|+.|.|..|.+. .+|..+.++.. |++|||+.|+++..+..++..-|+.|-+
T Consensus 74 ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~--lt~l~ls~NqlS~lp~~lC~lpLkvli~ 150 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEA--LTFLDLSSNQLSHLPDGLCDLPLKVLIV 150 (722)
T ss_pred ccchhhhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhH--HHHhhhccchhhcCChhhhcCcceeEEE
Confidence 33345567777777766656666677777777777776 67777766554 7777777777776555555556778888
Q ss_pred cCCcccCCCCCCCCCc---ceeeccCccCCCcccccccCCCccceEEecCCCCCCCCchhccCCCCCCEEEecCcccCCC
Q 001700 317 SSNKLSGSLPARVGHC---TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGD 393 (1025)
Q Consensus 317 s~N~l~~~~p~~l~~l---~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 393 (1025)
++|+++ .+|..++.+ ..||.+.|++.. +|..++.+.+|+.|++..|++. .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-------------------------lpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-------------------------LPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhhh-------------------------chHHhhhHHHHHHHHHhhhhhh-h
Confidence 888887 566666532 244455555443 4444455555555555555554 3
Q ss_pred cccccCCCCCCCEeecCCCcccccCcccccCCCCCCEEecCCCcCc
Q 001700 394 LPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS 439 (1025)
Q Consensus 394 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 439 (1025)
+|..++.++ |..||+|.|+++. +|-.|..|+.|++|-|.+|.|.
T Consensus 204 lp~El~~Lp-Li~lDfScNkis~-iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 204 LPEELCSLP-LIRLDFSCNKISY-LPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CCHHHhCCc-eeeeecccCceee-cchhhhhhhhheeeeeccCCCC
Confidence 444444332 5555555555553 4555555555555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.1e-12 Score=123.23 Aligned_cols=109 Identities=27% Similarity=0.367 Sum_probs=29.5
Q ss_pred ccCCCCCCEEEccCCcCccCCCCCC-CCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccc-cccccc
Q 001700 86 IIGLKMLCNVSVSNNQLMGNITDIG-SIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGF-GGLGKL 163 (1025)
Q Consensus 86 ~~~L~~L~~L~ls~N~l~~~~~~~~-~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L 163 (1025)
+.+...+++|+|++|+|+.+ ..++ .+.+|+.||||+|.|+.+ ..|..+++|++|+|++|+|+. +++.+ ..+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred cccccccccccccccccccc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence 33444566666666666643 3344 356666666666666643 235566666666666666663 33333 346666
Q ss_pred cEeecccCCCCCC-chhHhhhcccCcEEeCccCccc
Q 001700 164 KYLDLRANRFGGD-IMHLLSQLGSVVHVDLSNNQFS 198 (1025)
Q Consensus 164 ~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~ 198 (1025)
++|+|++|+|... .-..+..+++|+.|+|.+|.++
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 6666666666532 1234455566666666666554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-10 Score=135.57 Aligned_cols=141 Identities=14% Similarity=0.221 Sum_probs=94.4
Q ss_pred ceeeeecceEEEEEEecC-CCEEEEEEccccchhc----------------------------------H------HHHH
Q 001700 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREGIAKG----------------------------------K------KEFA 776 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~------~~~~ 776 (1025)
+.||+|++|.||+|++++ |+.||||+.+.+.... . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 689999999999999876 9999999997542110 0 1245
Q ss_pred HHHHHHhcCC----CCccccccceeecCCCCeeEEEEeccccccHHHHH--hhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 001700 777 REVKKLGNIK----HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYL--QETDPRKLPPLSIDERLRVAVDVARCLNY 850 (1025)
Q Consensus 777 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~aL~y 850 (1025)
+|+..+.+++ +...+.+-.+|++ .....++||||++|+.+.++- ...+. ....+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHHH-----
Confidence 5665555552 4444444444543 234678999999999998752 22210 001233333444444443
Q ss_pred HhcCCCCcccCCCCCCEEeecCCC----CEEEecccccccccc
Q 001700 851 LHNERAIPHGNLKSTNILLEAPTM----NAVLTDYSLHRILTS 889 (1025)
Q Consensus 851 LH~~~~ivHrDlkp~NILl~~~~~----~~kl~DfGla~~~~~ 889 (1025)
. .|++|+|+||.||+++. ++ .+++.|||+...++.
T Consensus 278 --~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 3 68999999999999987 55 899999999887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-10 Score=120.55 Aligned_cols=156 Identities=24% Similarity=0.388 Sum_probs=114.4
Q ss_pred HHHHhcCCCCccccccceeecC---CCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 001700 779 VKKLGNIKHPNLVSLQGYYWGP---KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE- 854 (1025)
Q Consensus 779 ~~~l~~l~hpniv~l~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~- 854 (1025)
..-+-++.|-|||+++.|+.+. +..+..++.|||..|++.++|++..... ..+......+|+-||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3445666799999999987642 2245789999999999999998754221 2577888899999999999999985
Q ss_pred CCCcccCCCCCCEEeecCCCCEEEecccccccc---ccCCCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHH
Q 001700 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL---TSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILL 931 (1025)
Q Consensus 855 ~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~ 931 (1025)
+.|+|+++...-|++.. ++-+|+.----.... ............|-++|.|||.-.... .+.++|||+||...+
T Consensus 197 PpiihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn--~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN--TTGASDIYKFGMCAL 273 (458)
T ss_pred CccccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc--cccchhhhhhhHHHH
Confidence 78999999999999985 776775321111100 000111222335778999999876554 377899999999999
Q ss_pred HHHcCCC
Q 001700 932 ELLTGKS 938 (1025)
Q Consensus 932 elltG~~ 938 (1025)
||..|..
T Consensus 274 emailEi 280 (458)
T KOG1266|consen 274 EMAILEI 280 (458)
T ss_pred HHHHhee
Confidence 9998875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.4e-10 Score=114.10 Aligned_cols=127 Identities=15% Similarity=0.169 Sum_probs=93.5
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccc-cccceeecCCCCeeEEEEecccccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLV-SLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~lv~e~~~~gs 816 (1025)
+.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+++ +++++. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~----~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD----PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe----CCCCeEEEEecCCCc
Confidence 56888999999999876 77899999865432 223467899999988655544 444332 123589999999987
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----CcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA-----IPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-----ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
+.+. . . ....++.+++++|+.||+ .+ ++|+|++|.||+++ +..++++|||.+..
T Consensus 78 l~~~---~-------~---~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE---D-------F---SDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---c-------c---cCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 7543 0 1 113456789999999997 55 49999999999998 34789999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.6e-11 Score=123.43 Aligned_cols=139 Identities=24% Similarity=0.286 Sum_probs=99.6
Q ss_pred ccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCC
Q 001700 127 GLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206 (1025)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 206 (1025)
|..-..+..-..|++||||+|.|+ .+..+..-+++++.|++|+|.|... +.+..|++|+.||||+|.++...-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gw--- 347 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGW--- 347 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhh---
Confidence 433344555567888888888888 5666777778888888888888632 3377788888888888887743221
Q ss_pred CCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccCCccccc--CCcccccccccceeccccccccc
Q 001700 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGA--IPSFNFVFSLRILRLGSNQLSGS 276 (1025)
Q Consensus 207 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~L~~N~l~g~ 276 (1025)
-..+-+++.|.|+.|.+.. . .++..+-+|..||+++|+|... ...+++++.|++|.|.+|.|.+.
T Consensus 348 -h~KLGNIKtL~La~N~iE~--L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 348 -HLKLGNIKTLKLAQNKIET--L--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred -HhhhcCEeeeehhhhhHhh--h--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 1234678888888888732 2 2355677888889999988753 34688899999999999999853
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=123.45 Aligned_cols=167 Identities=19% Similarity=0.260 Sum_probs=125.7
Q ss_pred ecCCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCC
Q 001700 753 LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPL 832 (1025)
Q Consensus 753 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l 832 (1025)
..++.+|.|...+...........+-++.|+.+|||||+++++.+. .....|+|+|-+. .|..++.+ +
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~--Pl~~~lk~--------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVR--PLETVLKE--------L 101 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeeccc--cHHHHHHH--------h
Confidence 4478888888887655433455778889999999999999998876 4558899999874 57777764 3
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCccccccCcccccCccccccC
Q 001700 833 SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912 (1025)
Q Consensus 833 ~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 912 (1025)
........++||+.||.|||+..+++|++|.-..|+++. .+..||++|-++.......... ....--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~-~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPA-KSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCccc-ccchhhhcccChhhcCc
Confidence 456677788999999999997789999999999999998 8899999998776543322100 00112234667775533
Q ss_pred CCCCCCCchhHHHHHHHHHHHHcCC
Q 001700 913 SKPCPSLKSDVYAFGIILLELLTGK 937 (1025)
Q Consensus 913 ~~~~~~~~~DVwSlGvvl~elltG~ 937 (1025)
.. ...|.|-|||+++|++.|.
T Consensus 180 s~----~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE----WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc----cchhhhhHHHHHHHHhCcc
Confidence 22 2469999999999999993
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-10 Score=113.32 Aligned_cols=89 Identities=29% Similarity=0.363 Sum_probs=29.0
Q ss_pred CCCCCCCCCCEEeccCCcCcccCccccc-CCCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcc
Q 001700 107 TDIGSIQSLEFLDLSHNLFHGLIPSGIV-SLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLG 185 (1025)
Q Consensus 107 ~~~~~l~~L~~LdLs~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 185 (1025)
+.+.+..++++|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+.+ + .+..+++|+.|+|++|+|+...+.....++
T Consensus 13 ~~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp 88 (175)
T PF14580_consen 13 AQYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLP 88 (175)
T ss_dssp -------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-T
T ss_pred cccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCC
Confidence 4466777899999999999854 3466 588999999999999954 3 588899999999999999864333335689
Q ss_pred cCcEEeCccCcccc
Q 001700 186 SVVHVDLSNNQFSG 199 (1025)
Q Consensus 186 ~L~~L~Ls~N~l~~ 199 (1025)
+|+.|+|++|+|..
T Consensus 89 ~L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 89 NLQELYLSNNKISD 102 (175)
T ss_dssp T--EEE-TTS---S
T ss_pred cCCEEECcCCcCCC
Confidence 99999999999874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=107.66 Aligned_cols=137 Identities=15% Similarity=0.186 Sum_probs=98.0
Q ss_pred ceeeeecceEEEEEEecC-------CCEEEEEEccccc----------------------hhcHHHH----HHHHHHHhc
Q 001700 738 EVIGRSCHGTLYKATLDS-------GSILAVKRLREGI----------------------AKGKKEF----AREVKKLGN 784 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~ 784 (1025)
..||.|.=+.||.|.-.+ +..+|||+.+-.. ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4799999874210 0012223 389999999
Q ss_pred CCC--CccccccceeecCCCCeeEEEEeccccccHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCccc
Q 001700 785 IKH--PNLVSLQGYYWGPKEHEKLVISNYINAQSLAV-YLQETDPRKLPPLSIDERLRVAVDVARCLNYL-HNERAIPHG 860 (1025)
Q Consensus 785 l~h--pniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~ivHr 860 (1025)
+.. -++.+.+++ ...++||||+.++.+.. .+... .++..+...+..+++.+|.+| |. .+|||+
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~-~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKE-CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 853 456666543 24589999997654422 22221 355567778889999999999 65 899999
Q ss_pred CCCCCCEEeecCCCCEEEecccccccccc
Q 001700 861 NLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 861 Dlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
|+++.||+++. +.++++|||.+.....
T Consensus 150 DLs~~NIL~~~--~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWHD--GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEEC--CcEEEEECCCceeCCC
Confidence 99999999974 4799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.7e-10 Score=124.04 Aligned_cols=206 Identities=24% Similarity=0.222 Sum_probs=114.4
Q ss_pred CCCCCCEEEccCCcCccCCC--CCCCCCCCCEEeccCCcCcccCc--ccccCCCCCCEEEccCCccccCCCccc-ccccc
Q 001700 88 GLKMLCNVSVSNNQLMGNIT--DIGSIQSLEFLDLSHNLFHGLIP--SGIVSLKNLMLLNISSNSFEGTFPSGF-GGLGK 162 (1025)
Q Consensus 88 ~L~~L~~L~ls~N~l~~~~~--~~~~l~~L~~LdLs~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 162 (1025)
+++.|++..|.+........ ....|++++.||||.|-|....| .-...|++|+.|+|+.|++.....+.. ..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 46777777777776654432 35667788888888887764322 344567788888888887763322221 24667
Q ss_pred ccEeecccCCCCC-CchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCC
Q 001700 163 LKYLDLRANRFGG-DIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLE 241 (1025)
Q Consensus 163 L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~ 241 (1025)
|+.|.|+.+.|+- .+...+...++|+.|+|..|..-+.-.. ....+..|+.|||++|++... ..-.....++.|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~---~~~i~~~L~~LdLs~N~li~~-~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKAT---STKILQTLQELDLSNNNLIDF-DQGYKVGTLPGLN 274 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecc---hhhhhhHHhhccccCCccccc-ccccccccccchh
Confidence 7778887777763 2333445667777777777742111010 112235566666666666321 1011123455555
Q ss_pred EEeccCCccccc-CCc------ccccccccceecccccccccCChhHHhhcccccCeEEcccccCcCcc---cccCCCCc
Q 001700 242 VFDASNNHLVGA-IPS------FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV---GSITSATL 311 (1025)
Q Consensus 242 ~L~Ls~N~l~~~-~~~------~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~---~~~~~~~L 311 (1025)
.|+++.+.+... .|. ...+++ |++|+++.|++..-. ....+.+|
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~k--------------------------L~~L~i~~N~I~~w~sl~~l~~l~nl 328 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPK--------------------------LEYLNISENNIRDWRSLNHLRTLENL 328 (505)
T ss_pred hhhccccCcchhcCCCccchhhhccccc--------------------------ceeeecccCccccccccchhhccchh
Confidence 555555555432 111 122333 555555555553311 22345678
Q ss_pred cEEEccCCcccC
Q 001700 312 KKVNLSSNKLSG 323 (1025)
Q Consensus 312 ~~L~Ls~N~l~~ 323 (1025)
+.|....|.|+.
T Consensus 329 k~l~~~~n~ln~ 340 (505)
T KOG3207|consen 329 KHLRITLNYLNK 340 (505)
T ss_pred hhhhcccccccc
Confidence 888888888874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.2e-10 Score=132.59 Aligned_cols=243 Identities=25% Similarity=0.289 Sum_probs=118.4
Q ss_pred CCCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCccccccc
Q 001700 136 LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQ 215 (1025)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 215 (1025)
+..++.+++..|.|.. +-..+..+++|+.|+|..|+|... ...+..+++|++|+|++|+|+...+ +..++.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~-----l~~l~~L~ 143 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG-----LSTLTLLK 143 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc-----hhhccchh
Confidence 3334444444444442 222234444444444444444421 1113444555555555555543221 22234466
Q ss_pred EEecccccccCccCCCCCCCCCCCCCEEeccCCcccccCCc-ccccccccceecccccccccCChhHHhhcccccCeEEc
Q 001700 216 YLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDL 294 (1025)
Q Consensus 216 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~l 294 (1025)
.|++++|.+.. +. .+..+.+|+.+++++|.++...+. ...+.+|+.+++++|.+...-...... .+..+++
T Consensus 144 ~L~l~~N~i~~--~~--~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~----~l~~~~l 215 (414)
T KOG0531|consen 144 ELNLSGNLISD--IS--GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEGLDLLK----KLVLLSL 215 (414)
T ss_pred hheeccCcchh--cc--CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccchHHHH----HHHHhhc
Confidence 66666666532 11 233456666666666666654332 356667777777777776222221111 1344466
Q ss_pred ccccCcCcccccCCCC--ccEEEccCCcccCC--CCCCCCCcceeeccCccCCCcccccccCCCccceEEecCCCCCCCC
Q 001700 295 SLNQLEGPVGSITSAT--LKKVNLSSNKLSGS--LPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMV 370 (1025)
Q Consensus 295 s~N~l~~~~~~~~~~~--L~~L~Ls~N~l~~~--~p~~l~~l~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 370 (1025)
..|.++...+...... |+.+++++|.+... ....+.. +..|++.+|++...-
T Consensus 216 ~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~------------------------l~~l~~~~n~~~~~~ 271 (414)
T KOG0531|consen 216 LDNKISKLEGLNELVMLHLRELYLSGNRISRSPEGLENLKN------------------------LPVLDLSSNRISNLE 271 (414)
T ss_pred ccccceeccCcccchhHHHHHHhcccCcccccccccccccc------------------------ccccchhhccccccc
Confidence 6666654333333333 66667777666521 1112223 344444444444321
Q ss_pred chhccCCCCCCEEEecCcccCCC---cccc-cCCCCCCCEeecCCCcccccCc
Q 001700 371 PNQTSQFLRLTSFKVSNNSLEGD---LPAV-LGTYPELKVIDLSLNHLNGFLL 419 (1025)
Q Consensus 371 p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~~ 419 (1025)
.+.....+..+.+..|.+... .... ....+.++.+.+..|.+....+
T Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 272 --GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred --cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 122334455566666665422 1121 4567788888888888876443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-10 Score=131.62 Aligned_cols=241 Identities=26% Similarity=0.281 Sum_probs=146.9
Q ss_pred CCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEee
Q 001700 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLD 167 (1025)
Q Consensus 88 ~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (1025)
.+..++.+++..|.+......+..+++|+.|+|..|+|..+ ...+..+++|++|+|++|+|+.+. .+..++.|+.|+
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 45666677777777766444577778888888888887753 333677778888888888887543 345666688888
Q ss_pred cccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCCEEeccC
Q 001700 168 LRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASN 247 (1025)
Q Consensus 168 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 247 (1025)
+++|.|+.. ..+..+.+|+.+++++|.++...+. . ...+.+|+.++++.|.+.. + ..+..+..+..+++..
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~--~-~~~~~~l~~l~l~~n~i~~--i--~~~~~~~~l~~~~l~~ 217 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND--E-LSELISLEELDLGGNSIRE--I--EGLDLLKKLVLLSLLD 217 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhh--h-hhhccchHHHhccCCchhc--c--cchHHHHHHHHhhccc
Confidence 888877632 3344577788888888877744331 0 2334777777888887742 1 1233344555557777
Q ss_pred CcccccCCcccccc--cccceecccccccccCChhHHhhcccccCeEEcccccCcCcccccCCCCccEEEccCCcccCCC
Q 001700 248 NHLVGAIPSFNFVF--SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSL 325 (1025)
Q Consensus 248 N~l~~~~~~~~~l~--~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~ 325 (1025)
|.++..-+ +..+. .|+.+++++|++. .++..+.. ...+..|++.+|++......-....+..+.+..|.+....
T Consensus 218 n~i~~~~~-l~~~~~~~L~~l~l~~n~i~-~~~~~~~~--~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 218 NKISKLEG-LNELVMLHLRELYLSGNRIS-RSPEGLEN--LKNLPVLDLSSNRISNLEGLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred ccceeccC-cccchhHHHHHHhcccCccc-cccccccc--cccccccchhhccccccccccccchHHHhccCcchhcchh
Confidence 77764433 22222 3778888888876 33222211 2237778888887776554444556666677777665221
Q ss_pred ---C----CCCCCcceeeccCccCCC
Q 001700 326 ---P----ARVGHCTIVDLSNNRLSG 344 (1025)
Q Consensus 326 ---p----~~l~~l~~L~Ls~N~l~~ 344 (1025)
. .....++.+.+..|.+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred hhhccccccccccccccccccCcccc
Confidence 0 112244566666666654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-08 Score=97.88 Aligned_cols=142 Identities=16% Similarity=0.279 Sum_probs=100.7
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEc-ccc-------chhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRL-REG-------IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
++|-+|+-+.|+++.+. |+...||.- .+. ..-.+++..+|++++.+++--.|.--.=++.+ ...-.++|
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCeEEE
Confidence 67889999999999987 777667643 221 11235677889999999864333222223443 33457889
Q ss_pred ecccc-ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCC--CEEEeccccccc
Q 001700 810 NYINA-QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM--NAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~--~~kl~DfGla~~ 886 (1025)
||+++ .++.+++...... ..........+.+|-+.+.-||. ++|+|+||..+||++..++. .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4788888775432 22233337889999999999998 89999999999999976444 358999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.4e-09 Score=123.20 Aligned_cols=242 Identities=19% Similarity=0.219 Sum_probs=163.4
Q ss_pred CceeeeecceEEEEEEec--CCCEEEEEEccccchhcHHH--HHHHHHHHhcC-CCCccccccceeecCCCCeeEEEEec
Q 001700 737 AEVIGRSCHGTLYKATLD--SGSILAVKRLREGIAKGKKE--FAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 811 (1025)
...||.|.|+.|+++..+ ++..|++|.+.+.......+ -..|+-+...+ .|.+++.++..+. .....++=.||
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--ccccccCchhh
Confidence 367999999999998743 68899999987765433222 24566666666 4888888765544 23355688899
Q ss_pred cccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCC
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~ 891 (1025)
+++++......-.. .+++..++++..|++.|+.++|+ ..++|+|+||+||++..+++.-++.|||++..+.-..
T Consensus 348 ~~~~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hcCcchhhhhHHHH-----hcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccccccceec
Confidence 99998877663322 57888999999999999999997 8999999999999998744778899999886432111
Q ss_pred CccccccCcccccC-ccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccch
Q 001700 892 TADQVLNAGALGYR-PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
.. ..+.-+++ ..|++..... +-.+.|+||||..+.|.++|..--. ..+.|...
T Consensus 422 ---~~-~~~~~r~~p~~~~~~e~~~-~~~~~~~~sl~~~~~e~~~~~~ls~---------~~~~~~~i------------ 475 (524)
T KOG0601|consen 422 ---GV-FHHIDRLYPIAEILLEDYP-HLSKADIFSLGLSVDEAITGSPLSE---------SGVQSLTI------------ 475 (524)
T ss_pred ---cc-ccccccccccchhhccccc-cccccccccccccccccccCcccCc---------ccccceee------------
Confidence 11 12223344 2454443332 4779999999999999999885311 11222211
Q ss_pred hhhcCCCCCCCchHHHHHHHHHHHHccCCC-CCCCCHHHHHHHHhhc
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~-~~RPs~~evl~~L~~i 1016 (1025)
+.+. .+.......++..++......+ ..||.+.+.....+..
T Consensus 476 ---~~~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ---RSGD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---eccc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1110 0112222366777777788888 8899988876655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=98.99 Aligned_cols=131 Identities=22% Similarity=0.322 Sum_probs=94.3
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccch--------hcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEE
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIA--------KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 809 (1025)
.++++|+=+.+|.+.+. |..+++|.-..+.. -..++..+|++++.+++--.|..-+=|.. +.....++|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence 35788999999999775 44466664322111 12356788999999886433322221333 444678999
Q ss_pred eccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccc
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~ 886 (1025)
||++|..|.+++... ...++..+-.-+.-||. .||||+|+.++||++.. ..+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA------------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence 999999999898753 24667777788888997 99999999999999975 3499999999874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.5e-10 Score=116.41 Aligned_cols=134 Identities=22% Similarity=0.235 Sum_probs=72.6
Q ss_pred ccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCC
Q 001700 157 FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPY 236 (1025)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 236 (1025)
+...+.|+.||||+|.|+ .+.++..-++.++.|++|+|.+. .++++..+++|+.||||+|.++.-. .+ -..
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-----~v~nLa~L~~L~~LDLS~N~Ls~~~-Gw--h~K 350 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-----TVQNLAELPQLQLLDLSGNLLAECV-GW--HLK 350 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-----eehhhhhcccceEeecccchhHhhh-hh--Hhh
Confidence 334456666666666665 44555555666666666666665 2344555566666666666664210 00 123
Q ss_pred CCCCCEEeccCCcccccCCcccccccccceecccccccccCChhHHhhcccccCeEEcccccCcC
Q 001700 237 FDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG 301 (1025)
Q Consensus 237 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~ 301 (1025)
+-+++.|.|+.|.|.. ...+..+-+|..||+++|+|. .+...-.-.....|+.+.|.+|.+.+
T Consensus 351 LGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 351 LGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccc
Confidence 5566666666666653 222455566666666666665 22211111122336666666666655
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.5e-09 Score=108.93 Aligned_cols=143 Identities=20% Similarity=0.264 Sum_probs=106.4
Q ss_pred ceeeeecceEEEEEEecCCCEEEEEEccccch-hcHHHHHHHHHHHhcCCCC--ccccccceeecCC-CCeeEEEEeccc
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHP--NLVSLQGYYWGPK-EHEKLVISNYIN 813 (1025)
Q Consensus 738 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~-~~~~~lv~e~~~ 813 (1025)
+.|+.|..+.||+++..+|+.+++|....... ....++.+|+++++.+++. .+.+++.+..... ....++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56889999999999987778999999865432 1345788999999999753 4566666554211 124689999999
Q ss_pred cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE--------------------------------------- 854 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------- 854 (1025)
+.++.+.+... .++..++..++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLRP------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCCC------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 98887654321 467778888888888888888841
Q ss_pred ----------------CCCcccCCCCCCEEeecC-CCCEEEeccccccc
Q 001700 855 ----------------RAIPHGNLKSTNILLEAP-TMNAVLTDYSLHRI 886 (1025)
Q Consensus 855 ----------------~~ivHrDlkp~NILl~~~-~~~~kl~DfGla~~ 886 (1025)
..++|+|+.|.||+++.. +..+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235899999999999863 34578999987764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-10 Score=121.55 Aligned_cols=187 Identities=22% Similarity=0.186 Sum_probs=135.9
Q ss_pred ccCCCCCCEEEccCCcCccCCC--C-CCCCCCCCEEeccCCcCcccCccc-ccCCCCCCEEEccCCccccC-CCcccccc
Q 001700 86 IIGLKMLCNVSVSNNQLMGNIT--D-IGSIQSLEFLDLSHNLFHGLIPSG-IVSLKNLMLLNISSNSFEGT-FPSGFGGL 160 (1025)
Q Consensus 86 ~~~L~~L~~L~ls~N~l~~~~~--~-~~~l~~L~~LdLs~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l 160 (1025)
.-.+++++.||||.|-|....+ . ...|++|+.|+||.|.+....... -..+++|+.|.|+.+.|+.. +-.....+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 3458999999999999887543 2 567999999999999988543332 23678999999999999842 22334567
Q ss_pred ccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCC----CCCC
Q 001700 161 GKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHD----GMPY 236 (1025)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~~~ 236 (1025)
++|+.|+|..|............+..|+.|||++|++-..... .....++.|+.|+++.+.+...-.++. ....
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~--~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQG--YKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccc--cccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 9999999999964444455566778899999999998643211 112235899999999999965333332 1246
Q ss_pred CCCCCEEeccCCcccc--cCCcccccccccceeccccccc
Q 001700 237 FDNLEVFDASNNHLVG--AIPSFNFVFSLRILRLGSNQLS 274 (1025)
Q Consensus 237 l~~L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~L~~N~l~ 274 (1025)
+++|++|+++.|++.. ....+..+.+|+.|....|.|+
T Consensus 300 f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 300 FPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 8899999999999964 2233555667777777777776
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.6e-09 Score=88.25 Aligned_cols=61 Identities=38% Similarity=0.595 Sum_probs=41.0
Q ss_pred CCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCC
Q 001700 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173 (1025)
Q Consensus 113 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 173 (1025)
++|++|+|++|+|+.+.+..|..+++|++|++++|+|+.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566667777766666556666677777777777777666666667777777777766654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.2e-09 Score=86.44 Aligned_cols=61 Identities=33% Similarity=0.413 Sum_probs=54.0
Q ss_pred CCCCEEEccCCccccCCCccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCcc
Q 001700 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197 (1025)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 197 (1025)
++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999988778999999999999999999888888889988888888888875
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=101.52 Aligned_cols=152 Identities=16% Similarity=0.148 Sum_probs=106.1
Q ss_pred HHhhcCCCceeeeecceEEEEEEecCCCEEEEEEccccchh-----------cHHHHHHHHHHHhcCCCCcc--ccccce
Q 001700 730 EELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAK-----------GKKEFAREVKKLGNIKHPNL--VSLQGY 796 (1025)
Q Consensus 730 ~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpni--v~l~~~ 796 (1025)
+.+....++++-.-....|+++.+. |+.|.||+....... ....+.+|...+.++..-+| ++.+++
T Consensus 20 ~~~~~~~~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 20 EEVKTLQGEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred HHHHhcCCcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 3444444566766566667787775 778999977433211 11247889999988843333 334444
Q ss_pred eec---CCCCeeEEEEeccccc-cHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeec-
Q 001700 797 YWG---PKEHEKLVISNYINAQ-SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA- 871 (1025)
Q Consensus 797 ~~~---~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~- 871 (1025)
... ......++|+|++++. +|.+++..... .+.+...+..++.+++..+.-||. .||+|+|++++|||++.
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLP 174 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEecc
Confidence 432 1133578999999876 89999864321 135667788999999999999997 99999999999999974
Q ss_pred -----CCCCEEEeccccccc
Q 001700 872 -----PTMNAVLTDYSLHRI 886 (1025)
Q Consensus 872 -----~~~~~kl~DfGla~~ 886 (1025)
.+..+.++||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 246789999998764
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.9e-10 Score=116.04 Aligned_cols=87 Identities=34% Similarity=0.405 Sum_probs=45.5
Q ss_pred CCCCCCEEeccCCcCccc----CcccccCCCCCCEEEccCCcccc----CCCc-------cccccccccEeecccCCCCC
Q 001700 111 SIQSLEFLDLSHNLFHGL----IPSGIVSLKNLMLLNISSNSFEG----TFPS-------GFGGLGKLKYLDLRANRFGG 175 (1025)
Q Consensus 111 ~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~-------~~~~l~~L~~L~Ls~N~l~~ 175 (1025)
....++.|+||+|.|... +...+.+.++|+.-++|.- ++| .+|+ ++-..++|++||||.|-|..
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 345555555555555422 2334455555666655542 222 2232 23345577777777777764
Q ss_pred CchhH----hhhcccCcEEeCccCccc
Q 001700 176 DIMHL----LSQLGSVVHVDLSNNQFS 198 (1025)
Q Consensus 176 ~~~~~----~~~l~~L~~L~Ls~N~l~ 198 (1025)
.-+.. +.++..|++|.|.||.+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCC
Confidence 33333 345566666666666554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.1e-08 Score=98.39 Aligned_cols=126 Identities=21% Similarity=0.289 Sum_probs=83.7
Q ss_pred EEEEEEecCCCEEEEEEccccch--------------------------hcHHHHHHHHHHHhcCCCC--ccccccceee
Q 001700 747 TLYKATLDSGSILAVKRLREGIA--------------------------KGKKEFAREVKKLGNIKHP--NLVSLQGYYW 798 (1025)
Q Consensus 747 ~Vy~~~~~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~hp--niv~l~~~~~ 798 (1025)
.||.|...+|..+|||+.+.... .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998753210 0123567899999999755 566665442
Q ss_pred cCCCCeeEEEEeccc--cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCcccCCCCCCEEeecCCCC
Q 001700 799 GPKEHEKLVISNYIN--AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL-HNERAIPHGNLKSTNILLEAPTMN 875 (1025)
Q Consensus 799 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~ivHrDlkp~NILl~~~~~~ 875 (1025)
..++||||++ |..+..+.... ++..+...++.+++..+..+ |. .||+|+|+.+.||+++. + .
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~-~ 144 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G-K 144 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T-C
T ss_pred -----CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c-e
Confidence 3489999998 65554433321 22345667788888866665 65 89999999999999987 4 8
Q ss_pred EEEeccccccccc
Q 001700 876 AVLTDYSLHRILT 888 (1025)
Q Consensus 876 ~kl~DfGla~~~~ 888 (1025)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.8e-07 Score=103.43 Aligned_cols=172 Identities=19% Similarity=0.258 Sum_probs=127.4
Q ss_pred ceEEEEEEec-CCCEEEEEEccccchhcHHHHHHHHHHHhcCCCCccccccceeec--CCCCeeEEEEecccc-ccHHHH
Q 001700 745 HGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWG--PKEHEKLVISNYINA-QSLAVY 820 (1025)
Q Consensus 745 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~~~lv~e~~~~-gsL~~~ 820 (1025)
..+.||+... ||..|+.|++.............-+++++++.|+|||++.+++.. -.+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578999854 899999999954333333233456788999999999999988762 234568999999875 677776
Q ss_pred HhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC
Q 001700 821 LQETDPR----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 821 l~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~ 890 (1025)
.-..... .....++...+.++.|+..||.++|+ .|..-+-|.+.+|+++. +.+++|+..|+.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecCC
Confidence 4432211 12357889999999999999999998 88988999999999988 668888888877655433
Q ss_pred CCccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCC
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~ 938 (1025)
.. |-+.. -.+-|.=.||.+++-+.||..
T Consensus 447 ~~---------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPLES-----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cchhH-----HhhhhHHHHHHHHHHHhhccc
Confidence 21 11211 235688899999999999953
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.7e-07 Score=96.92 Aligned_cols=270 Identities=16% Similarity=0.197 Sum_probs=159.9
Q ss_pred CCceeeeecceEEEEEEecCCCEEEEEEccccchhcHHHHHHHHHHHhcC-CCCcccc----ccceeecCCCCe-eEEEE
Q 001700 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVS----LQGYYWGPKEHE-KLVIS 809 (1025)
Q Consensus 736 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~----l~~~~~~~~~~~-~~lv~ 809 (1025)
.+..||+|+.+.+|-.--- +.. +.|+.......... +.+..|.+. .||-+-. -....++.+... .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3678999999999964311 122 34666544322221 123334444 5664332 111112223333 55667
Q ss_pred ecccccc-HHHHHh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccc
Q 001700 810 NYINAQS-LAVYLQ-ETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 810 e~~~~gs-L~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~ 887 (1025)
..+.+.- ...++. ..+.+..+...|...+++++.+|.|.+-||. .|.+-+|+.++|+|+.+ +..+.|.|-..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceeec
Confidence 6665542 222222 1233456789999999999999999999997 88889999999999988 778888875432222
Q ss_pred ccCCCccccccCcccccCccccccCCC---CCCCCchhHHHHHHHHHHHHcC-CCCCCccccCCCC-cchHHHHHHHHhh
Q 001700 888 TSAGTADQVLNAGALGYRPPEFASTSK---PCPSLKSDVYAFGIILLELLTG-KSSGEIVCVDPGV-VDLTDWVRLLALE 962 (1025)
Q Consensus 888 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DVwSlGvvl~elltG-~~P~~~~~~~~~~-~~l~~~~~~~~~~ 962 (1025)
.. + ......+|...|.+||.-.-.. +..+...|-|.+||++++++.| +.||......... ..+.. ....
T Consensus 168 ~n-g-~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia~ 241 (637)
T COG4248 168 AN-G-TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIAH 241 (637)
T ss_pred cC-C-ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhhc
Confidence 21 1 1223347899999999765211 1136678999999999999987 9998643221110 01110 0011
Q ss_pred ccccccchhhh--cCCCCCCCchHHHHHHHHHHHHccCCC---CCCCCHHHHHHHHhhccc
Q 001700 963 NRSGECFDRLI--MDGHDMEQPPRILSDMLQVALRCILPA---SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 963 ~~~~~~~d~~~--~~~~~~~~~~~~~~~~~~l~~~C~~~~---~~RPs~~evl~~L~~i~~ 1018 (1025)
+.....-++.. +..++.....-.+..+..+..+|+... .-||+++.-+..|.++..
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 11111111111 011111112334567888999999876 469999999988887754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.5e-09 Score=113.89 Aligned_cols=88 Identities=27% Similarity=0.320 Sum_probs=44.5
Q ss_pred CCCCCCCCEEeccCCcccccCC-----cccccccccceecccccccccCChhHHh---hcccccCeEEcccccCcCc---
Q 001700 234 MPYFDNLEVFDASNNHLVGAIP-----SFNFVFSLRILRLGSNQLSGSLPVALLQ---ESSMMLSELDLSLNQLEGP--- 302 (1025)
Q Consensus 234 ~~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~g~~p~~~~~---~~~~~L~~L~ls~N~l~~~--- 302 (1025)
+.++++|+.|||..|-++..-. .+..+++|+.|+++++.++..--.++.. .....|+.|.+.+|.++..
T Consensus 209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~ 288 (382)
T KOG1909|consen 209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL 288 (382)
T ss_pred HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence 4455666666666666553211 2445556677777776665333333322 1123466666666665421
Q ss_pred ---ccccCCCCccEEEccCCcc
Q 001700 303 ---VGSITSATLKKVNLSSNKL 321 (1025)
Q Consensus 303 ---~~~~~~~~L~~L~Ls~N~l 321 (1025)
......+.|..|+|++|.+
T Consensus 289 ~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 289 ALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhcchhhHHhcCCcccc
Confidence 1112244566666666666
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-08 Score=73.87 Aligned_cols=43 Identities=47% Similarity=0.941 Sum_probs=29.6
Q ss_pred ChhhHHHHHHHHhhcCCCCCCCcccCCCCCCCCCCCCCCCccceEcC
Q 001700 17 GQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCT 63 (1025)
Q Consensus 17 ~~~~~~aLl~~k~~~~~d~~~~l~~sW~~~~~~~d~C~~~w~gv~C~ 63 (1025)
.++|++|||+||+++..||.+.+ .+|+.+. ..+||. |.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l-~~W~~~~-~~~~C~--W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVL-SSWNPSS-DSDPCS--WSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCC-TT--TT---S-CCC--STTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCccc-ccCCCcC-CCCCee--eccEEeC
Confidence 36899999999999966776655 9998763 248997 9999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-08 Score=120.83 Aligned_cols=196 Identities=18% Similarity=0.204 Sum_probs=135.6
Q ss_pred eeeeecceEEEEEEec-CCCEEEEEEccccc---hhcHHHHHHHHHHHhcCCCCccccccceeecCCCCeeEEEEecccc
Q 001700 739 VIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 739 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 814 (1025)
-+-+|.++.++.+.-. .|...++|...... ..+.+....+-.+.-..+||.++...--+ +.....+++++|..+
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcchhhHHhcc
Confidence 4567777877776532 34444444433221 11223334444444445667777654332 244567899999999
Q ss_pred ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccC----
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA---- 890 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~---- 890 (1025)
++|...++... ..+..-.+.....+..+++|||+ ..+.|||++|.|++... +++.++.|||.......-
T Consensus 889 ~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCC-----CcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCccccccccccccCcC
Confidence 99999998764 35555666777788899999997 55889999999999987 888999999843321100
Q ss_pred -----------------C---------CccccccCcccccCccccccCCCCCCCCchhHHHHHHHHHHHHcCCCCCCccc
Q 001700 891 -----------------G---------TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVC 944 (1025)
Q Consensus 891 -----------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DVwSlGvvl~elltG~~P~~~~~ 944 (1025)
. ........||+.|.+||...+... ...+|+|++|++++|.++|..||....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h--gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH--GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC--CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 001122368999999999988874 778999999999999999999998654
Q ss_pred c
Q 001700 945 V 945 (1025)
Q Consensus 945 ~ 945 (1025)
.
T Consensus 1040 p 1040 (1205)
T KOG0606|consen 1040 P 1040 (1205)
T ss_pred h
Confidence 4
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-08 Score=120.39 Aligned_cols=136 Identities=22% Similarity=0.227 Sum_probs=91.0
Q ss_pred cccccCCCCCCEEEccCCcCccCCCCCCCCCCCCEEeccCCc--CcccCcccccCCCCCCEEEccCCccccCCCcccccc
Q 001700 83 FPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNL--FHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGL 160 (1025)
Q Consensus 83 ~~~~~~L~~L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 160 (1025)
.|...+....+...+-+|.+........ .++|++|-+..|. +....+..|..++.|++||||+|.=-+.+|..++.|
T Consensus 516 ~~~~~~~~~~rr~s~~~~~~~~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L 594 (889)
T KOG4658|consen 516 IPQVKSWNSVRRMSLMNNKIEHIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL 594 (889)
T ss_pred cccccchhheeEEEEeccchhhccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh
Confidence 3455555667777777777655443322 2367777777775 444444557778888888888776666788888888
Q ss_pred ccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEeccccc
Q 001700 161 GKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENS 223 (1025)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 223 (1025)
-+|++|+|++..+. .+|..+.+|..|.+||+..+.....++.. ...+++|++|.+..-.
T Consensus 595 i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i---~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 595 VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGI---LLELQSLRVLRLPRSA 653 (889)
T ss_pred hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccch---hhhcccccEEEeeccc
Confidence 88888888888877 67777888888888888777654333222 2235777777765543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5e-08 Score=120.53 Aligned_cols=179 Identities=25% Similarity=0.288 Sum_probs=121.6
Q ss_pred CCCCEEEccCCc--CccCCCC-CCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEe
Q 001700 90 KMLCNVSVSNNQ--LMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYL 166 (1025)
Q Consensus 90 ~~L~~L~ls~N~--l~~~~~~-~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 166 (1025)
+.|+.|-+..|. +.....+ |..++.|++||||+|.=-+.+|.+++.|-+|++|+|++..++ .+|..+++|.+|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 368889999886 4444444 788999999999998766678999999999999999999999 799999999999999
Q ss_pred ecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCCCCCCCCC----E
Q 001700 167 DLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLE----V 242 (1025)
Q Consensus 167 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~----~ 242 (1025)
++.++.-...+|.....|++|++|.|..-..... ...++.+..+..|+.|....... .+... +..+..|. .
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~-~~~l~el~~Le~L~~ls~~~~s~--~~~e~--l~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSND-KLLLKELENLEHLENLSITISSV--LLLED--LLGMTRLRSLLQS 698 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccc-hhhHHhhhcccchhhheeecchh--HhHhh--hhhhHHHHHHhHh
Confidence 9999887667788888899999999876652211 11223333345555554433222 00000 11112221 2
Q ss_pred EeccCCcccccCCcccccccccceeccccccc
Q 001700 243 FDASNNHLVGAIPSFNFVFSLRILRLGSNQLS 274 (1025)
Q Consensus 243 L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 274 (1025)
+.+..+.....++++..+.+|+.|.+.+..++
T Consensus 699 l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 699 LSIEGCSKRTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hhhcccccceeecccccccCcceEEEEcCCCc
Confidence 22233444444555677777888887777765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.2e-09 Score=118.72 Aligned_cols=177 Identities=24% Similarity=0.263 Sum_probs=121.4
Q ss_pred cccCCCCCCEEEccCCcCccCCCCCCC-CCCCCEEeccCCcCcc---cCcccccCC------CCCCEEEccCCccccCCC
Q 001700 85 TIIGLKMLCNVSVSNNQLMGNITDIGS-IQSLEFLDLSHNLFHG---LIPSGIVSL------KNLMLLNISSNSFEGTFP 154 (1025)
Q Consensus 85 ~~~~L~~L~~L~ls~N~l~~~~~~~~~-l~~L~~LdLs~N~l~~---~~p~~~~~l------~~L~~L~Ls~N~l~~~~p 154 (1025)
.|+.+..|+.|.|.+..|... ..+.. -..|++|- -+|.++. .+....+.. -.|.+.+.++|++. ...
T Consensus 104 ~ifpF~sLr~LElrg~~L~~~-~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 104 SIFPFRSLRVLELRGCDLSTA-KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred eeccccceeeEEecCcchhhh-hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 466677778888777776531 11111 12233332 2233221 111222221 25778888999988 677
Q ss_pred ccccccccccEeecccCCCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccccCccCCCCCC
Q 001700 155 SGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGM 234 (1025)
Q Consensus 155 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 234 (1025)
.++.-++.|+.|||++|+++. .+.+..++.|++|||++|.++...-.+...+ .|+.|+|++|.++.- .++
T Consensus 181 ~SLqll~ale~LnLshNk~~~--v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc----~L~~L~lrnN~l~tL----~gi 250 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTK--VDNLRRLPKLKHLDLSYNCLRHVPQLSMVGC----KLQLLNLRNNALTTL----RGI 250 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhh--hHHHHhcccccccccccchhccccccchhhh----hheeeeecccHHHhh----hhH
Confidence 788888999999999999974 3478889999999999999986655444432 489999999988531 346
Q ss_pred CCCCCCCEEeccCCcccccC--Ccccccccccceeccccccc
Q 001700 235 PYFDNLEVFDASNNHLVGAI--PSFNFVFSLRILRLGSNQLS 274 (1025)
Q Consensus 235 ~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~L~~N~l~ 274 (1025)
.++.+|+-|||++|-|.+.- ..+..+.+|+.|+|.+|.+-
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 78889999999999988742 33677888999999999885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1e-06 Score=90.96 Aligned_cols=135 Identities=21% Similarity=0.233 Sum_probs=97.0
Q ss_pred cCCCceeeeecceEEEEEEecCCCEEEEEEccccc----------------------hhcHHHHHHHHHHHhcCCCC--c
Q 001700 734 HAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGI----------------------AKGKKEFAREVKKLGNIKHP--N 789 (1025)
Q Consensus 734 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp--n 789 (1025)
.+.++.||-|.=+.||.|..+.|..+|||.=+.+. ...+....+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44578999999999999999999999999643211 01134467899999999644 6
Q ss_pred cccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEe
Q 001700 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILL 869 (1025)
Q Consensus 790 iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl 869 (1025)
|.+.+++- ...+||||++|-.|...- ++....-.|+..|++-+..+-. .||||+|+.+-||++
T Consensus 173 VP~P~~~n------RHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAWN------RHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCccccc------cceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEE
Confidence 77776542 458999999886665432 1223333444445544444443 799999999999999
Q ss_pred ecCCCCEEEeccccccc
Q 001700 870 EAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 870 ~~~~~~~kl~DfGla~~ 886 (1025)
++ ++.+.++||--+..
T Consensus 236 ~~-dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TE-DGDIVVIDWPQAVP 251 (304)
T ss_pred ec-CCCEEEEeCccccc
Confidence 98 88999999965543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.6e-06 Score=86.62 Aligned_cols=110 Identities=24% Similarity=0.305 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHhcCCCCc--cccccceeecCC--CCeeEEEEecccc-ccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH
Q 001700 772 KKEFAREVKKLGNIKHPN--LVSLQGYYWGPK--EHEKLVISNYINA-QSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846 (1025)
Q Consensus 772 ~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~--~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 846 (1025)
.....+|...+.++..-. +.+.+++..... ....++|+|++++ .+|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 345778888887774332 344444443211 1346899999987 48999988643 2556678899999999
Q ss_pred HHHHHhcCCCCcccCCCCCCEEeecCC--CCEEEecccccccc
Q 001700 847 CLNYLHNERAIPHGNLKSTNILLEAPT--MNAVLTDYSLHRIL 887 (1025)
Q Consensus 847 aL~yLH~~~~ivHrDlkp~NILl~~~~--~~~kl~DfGla~~~ 887 (1025)
.++-||+ .||+|+|+++.|||++..+ ..+.++||+-++..
T Consensus 130 ~i~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999997 9999999999999998733 36889999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.2e-06 Score=82.37 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=102.1
Q ss_pred eeecceEEEEEEecCCCEEEEEEccccc------hhcHHHHHHHHHHHhcCCCC--ccccccceee---cCCCCeeEEEE
Q 001700 741 GRSCHGTLYKATLDSGSILAVKRLREGI------AKGKKEFAREVKKLGNIKHP--NLVSLQGYYW---GPKEHEKLVIS 809 (1025)
Q Consensus 741 G~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~---~~~~~~~~lv~ 809 (1025)
|+||-+.|++..++ |..+=+|+-.... ...+..|.+|+..+.++..- .+.+.. ++. .+.....++|+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888889998876 4468888765211 33567899999999998532 244444 332 12234578899
Q ss_pred eccc-cccHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcccCCCCCCEEeecCC-CCEEEeccccccc
Q 001700 810 NYIN-AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT-MNAVLTDYSLHRI 886 (1025)
Q Consensus 810 e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~-~~~kl~DfGla~~ 886 (1025)
|-++ .-+|.+++..... .+.+...+..+..+|+..++-||+ .|+.|+|+-+.||+++..+ ..++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9664 3689999865422 146778889999999999999998 9999999999999998522 2499999976654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.1e-08 Score=113.94 Aligned_cols=126 Identities=29% Similarity=0.323 Sum_probs=71.5
Q ss_pred CCEEEccCCcCccCCCCCCCCCCCCEEeccCCcCcccCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccC
Q 001700 92 LCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171 (1025)
Q Consensus 92 L~~L~ls~N~l~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 171 (1025)
|...+.+.|.+.....++.-++.|+.||||+|+++.. ..+..|++|++|||++|++....--...++. |+.|.|++|
T Consensus 166 L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN 242 (1096)
T KOG1859|consen 166 LATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNN 242 (1096)
T ss_pred HhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeeccc
Confidence 4555666666665555566666677777777776643 2566666777777777776632222233333 666777776
Q ss_pred CCCCCchhHhhhcccCcEEeCccCccccccCCCCCCCcccccccEEecccccc
Q 001700 172 RFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224 (1025)
Q Consensus 172 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 224 (1025)
.++. -..+.+|.+|+.|||++|-|.+--. +.-+..|..|+.|+|.+|.+
T Consensus 243 ~l~t--L~gie~LksL~~LDlsyNll~~hse--L~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 243 ALTT--LRGIENLKSLYGLDLSYNLLSEHSE--LEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred HHHh--hhhHHhhhhhhccchhHhhhhcchh--hhHHHHHHHHHHHhhcCCcc
Confidence 6652 2235566666666676666653211 11122235566666666665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.3e-07 Score=104.56 Aligned_cols=150 Identities=17% Similarity=0.262 Sum_probs=99.1
Q ss_pred HHHHHHHHHHhcCCCCcccCCCCCCEEeecCCCCEEEeccccccccccCCCcccc--------ccCcccccCccccccCC
Q 001700 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV--------LNAGALGYRPPEFASTS 913 (1025)
Q Consensus 842 ~~ia~aL~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~ 913 (1025)
.+++.|+.|+|...++||++|.|++|.+++ ++..|++.|+.+.....+...... ...-...|.|||++...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 345599999998889999999999999998 889999999987765442111100 01234579999999875
Q ss_pred CCCCCCchhHHHHHHHHHHHHcCCCCCCccccCCCCcchHHHHHHHHhhccccccchhhhcCCCCCCCchHHHHHHHHHH
Q 001700 914 KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVA 993 (1025)
Q Consensus 914 ~~~~~~~~DVwSlGvvl~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l~ 993 (1025)
. .+.++|+||+||++|.+..|..+--...... ..+.. .....+-....+....+.++.+=+
T Consensus 185 ~--~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~------------~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 185 T--NTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSF------------SRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred c--ccccccceeeeeEEEEEecCCcchhhccCCc-----chhhh------------hhcccccccccccccCcHHHHHHH
Confidence 4 4889999999999999995554432111110 00000 000000011112345667777778
Q ss_pred HHccCCC-CCCCCHHHHHH
Q 001700 994 LRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 994 ~~C~~~~-~~RPs~~evl~ 1011 (1025)
.+.+..+ .-||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 8888888 89998887754
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-07 Score=95.02 Aligned_cols=87 Identities=26% Similarity=0.280 Sum_probs=53.4
Q ss_pred CCCCCEEeccCCcCcc--cCcccccCCCCCCEEEccCCccccCCCccccccccccEeecccCCCCC-CchhHhhhcccCc
Q 001700 112 IQSLEFLDLSHNLFHG--LIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG-DIMHLLSQLGSVV 188 (1025)
Q Consensus 112 l~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~ 188 (1025)
.+.++.|||.+|.|+. .+-.-+.+|+.|++|||+.|++...|-..=..+.+|+.|-|.+-.+.- .....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 5667777777777763 233445677777777777777775433222455677777777766652 2233445566666
Q ss_pred EEeCccCccc
Q 001700 189 HVDLSNNQFS 198 (1025)
Q Consensus 189 ~L~Ls~N~l~ 198 (1025)
.|.+|.|.+.
T Consensus 150 elHmS~N~~r 159 (418)
T KOG2982|consen 150 ELHMSDNSLR 159 (418)
T ss_pred hhhhccchhh
Confidence 6666666443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.4e-05 Score=93.06 Aligned_cols=150 Identities=23% Similarity=0.335 Sum_probs=96.5
Q ss_pred HHHhhcCC-CceeeeecceEEEEEEecCCCEEEEEEccccchhc------------------------------------
Q 001700 729 AEELSHAP-AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKG------------------------------------ 771 (1025)
Q Consensus 729 ~~~l~~~~-~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------------ 771 (1025)
++|+.... .+.|+.++-|.||+|++++|+.||||+.+.+....
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 34443333 37899999999999999999999999986432110
Q ss_pred ----HHHHHHHHHHHhcCC-----CCccccccceeecCCCCeeEEEEeccccccHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 001700 772 ----KKEFAREVKKLGNIK-----HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842 (1025)
Q Consensus 772 ----~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~ 842 (1025)
+=++.+|..-+.+++ .|.| ++=.+|++ -.....++|||++|-.+.+...-... .++.+. ++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~ 271 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAE 271 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCe-Eeceeehh-ccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHH
Confidence 012455666665552 2322 22224442 23467999999999998887432221 244333 333
Q ss_pred HHHHH-HHHHhcCCCCcccCCCCCCEEeecCCCCEEEecccccccccc
Q 001700 843 DVARC-LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 843 ~ia~a-L~yLH~~~~ivHrDlkp~NILl~~~~~~~kl~DfGla~~~~~ 889 (1025)
.++++ +..+-. .|+.|.|..|-||+++. ++++.+.|||+...+.+
T Consensus 272 ~~~~~f~~q~~~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 272 LLVRAFLRQLLR-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHh-cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence 33222 122222 57999999999999998 78999999999887654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1025 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-29 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-28 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-24 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-23 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-24 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 7e-04 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 8e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 8e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 3e-91
Identities = 144/520 (27%), Positives = 226/520 (43%), Gaps = 74/520 (14%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLV 78
+ L+ K + D + ++ W + + + C + G+TC + VTSI L+ L
Sbjct: 12 REIHQLISFKDVL-PDKN--LLPDWSS---NKNPC--TFDGVTCRDDKVTSIDLSSKPLN 63
Query: 79 GNFSF--PTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSG--IV 134
FS +++ L L ++ +SN+ + G+++ SL LDLS N G + + +
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 135 SLKNLMLLNISSNSFEGTFP-SGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLS 193
S L LN+SSN+ + SG L L+ L DLS
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL------------------------DLS 159
Query: 194 NNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGA 253
N SG+ +G S +++L IS N + G++ NLE D S+N+
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCV---NLEFLDVSSNNFSTG 215
Query: 254 IPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKK 313
IP +L+ L + N+LSG A+ + L L++S NQ GP+ + +L+
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTE--LKLLNISSNQFVGPIPPLPLKSLQY 273
Query: 314 VNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
++L+ NK +G +P LSG + + LS N G VP
Sbjct: 274 LSLAENKFTGEIPD-------------FLSGACDTLTG-------LDLSGNHFYGAVPPF 313
Query: 374 TSQFLRLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHLNGFLLPSFF-TSTKLTDL 431
L S +S+N+ G+LP L LKV+DLS N +G L S S L L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373
Query: 432 NLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLS 491
+LS NNFSGP+ P+ +L L L N +G++ P +S LV L+LS
Sbjct: 374 DLSSNNFSGPIL-------PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 492 NNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRNFP 529
N G+IP L + L++ + N L G +P+ L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = 3e-90
Identities = 131/483 (27%), Positives = 207/483 (42%), Gaps = 36/483 (7%)
Query: 68 TSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHG 127
+ ++ + G+ + L+ L VS+N I +G +L+ LD+S N G
Sbjct: 181 KHLAISGNKISGDVDVSRCVNLEFL---DVSSNNFSTGIPFLGDCSALQHLDISGNKLSG 237
Query: 128 LIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI-MHLLSQLGS 186
I + L LLNISSN F G P L L+YL L N+F G+I L +
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 187 VVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDAS 246
+ +DLS N F G++ G S ++ L +S N+ GEL P D + L+V D S
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGS---CSLLESLALSSNNFSGEL-PMDTLLKMRGLKVLDLS 351
Query: 247 NNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV- 303
N G +P N SL L L SN SG + L Q L EL L N G +
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 304 GSITSAT-LKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGN--YVE 357
++++ + L ++LS N LSG++P+ +G + + L N L G++ Q +E
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP--QELMYVKTLE 469
Query: 358 DIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGF 417
+ L N LTG +P+ S L +SNN L G++P +G L ++ LS N +G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 418 LLPSFFTSTKLTDLNLSGNNFSGPLP------LQEIQNNPSTGST-------QNLSLTSL 464
+ L L+L+ N F+G +P +I N G
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG 589
Query: 465 DLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVP 522
G +++ N+++ + G N + ++S+N LSG +P
Sbjct: 590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649
Query: 523 ENL 525
+ +
Sbjct: 650 KEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-68
Identities = 109/457 (23%), Positives = 178/457 (38%), Gaps = 94/457 (20%)
Query: 92 LCNVSVSNNQLMGNI-TDIGSIQ--SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNS 148
L + +S+N G I ++ +L+ L L +N F G IP + + L+ L++S N
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 149 FEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS 208
GT PS G L KL+ L L N G+I L + ++ + L N +G + GL +
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 209 SFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILR 267
+ NL SNN L G IP + +L IL+
Sbjct: 490 T-----------------------------NLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 268 LGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPA 327
L +N SG++P L G S L ++L++N +G++PA
Sbjct: 521 LSNNSFSGNIPAEL----------------------GDCRS--LIWLDLNTNLFNGTIPA 556
Query: 328 RVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSN 387
+ + ++ N ++G ++ H + N
Sbjct: 557 AMFKQS-GKIAANFIAGKRYVYIKNDGMKKECHGAGN----------------------L 593
Query: 388 NSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEI 447
+G L +++ G P+F + + L++S N SG +P +EI
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP-KEI 652
Query: 448 QNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN-- 505
L L+L +N +SG + + L L+LS+NK +G IP +
Sbjct: 653 --------GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 506 GLKEFNVSFNNLSGVVPEN--LRNFPDSAFHPGNSLL 540
L E ++S NNLSG +PE FP + F N L
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFL-NNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-47
Identities = 86/317 (27%), Positives = 134/317 (42%), Gaps = 25/317 (7%)
Query: 84 PTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
++ L L ++ + N L G I ++ +++LE L L N G IPSG+ + NL +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLD 202
++S+N G P G L L L L N F G+I L S++ +DL+ N F+G++
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 203 LGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFS 262
+ S I+ N + G+ + + + G S
Sbjct: 556 AAMFKQS-------GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 263 -LRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV-GSITS-ATLKKVNLSSN 319
+ S G SM LD+S N L G + I S L +NL N
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSM--MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 320 KLSGSLPARVGHCT---IVDLSNNRLSGD----LSRMQNWGNYVEDIHLSSNFLTGMVPN 372
+SGS+P VG I+DLS+N+L G +S + + +I LS+N L+G +P
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL----TMLTEIDLSNNNLSGPIP- 721
Query: 373 QTSQFLRLTSFKVSNNS 389
+ QF K NN
Sbjct: 722 EMGQFETFPPAKFLNNP 738
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 5e-57
Identities = 91/466 (19%), Positives = 154/466 (33%), Gaps = 48/466 (10%)
Query: 96 SVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFP 154
++++NQL + L LD+ N L P L L +LN+ N
Sbjct: 31 NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90
Query: 155 SGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSI 214
F L L L +N + + +++ +DLS+N S + ++
Sbjct: 91 KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL---ENL 147
Query: 215 QYLNISENSLVGELFPHDGMPYFDN--LEVFDASNNHLVGAIP-SFNFVFSLRILRLGSN 271
Q L +S N + + + F N L+ + S+N + P F+ + L L L +
Sbjct: 148 QELLLSNNKIQA--LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 272 QLSGSLPVALLQESSMM-LSELDLSLNQLEGP----VGSITSATLKKVNLSSNKLSGSLP 326
QL SL L E + + L LS +QL + L ++LS N L+
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 327 ARVGHCT---IVDLSNNRLSG-------DLSRMQ--NWGNYVEDIHLSSNFLTGMVPNQT 374
L N + L ++ N +S L +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPS----FFTSTKLTD 430
L + +N + G + LK + LS + + L + + L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 431 LNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPG-ISKFHNLVYL 488
LNL+ N S + L L LDL N + L N+ +
Sbjct: 386 LNLTKNKISKIES----------DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 489 NLSNNKFEGSIPD---GLPNGLKEFNVSFNNLSGV--VPENLRNFP 529
LS NK+ + +P+ L+ + L V P +
Sbjct: 436 YLSYNKYLQLTRNSFALVPS-LQRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-50
Identities = 86/429 (20%), Positives = 162/429 (37%), Gaps = 41/429 (9%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
S E D SH +P + N+ +LN++ N + F +L LD+ N
Sbjct: 5 SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDG 233
L +L + ++L +N+ S D +++ L++ NS+ ++
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC---TNLTELHLMSNSIQK--IKNNP 116
Query: 234 MPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSEL 292
NL D S+N L + + +L+ L L +N++ L ++ L +L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 293 DLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQ 350
+LS NQ++ G + L + L++ +L SL ++ +L+N +
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL----ELANTSI-------- 224
Query: 351 NWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV---SNNSLEGDLPAVLGTYPELKVI 407
++ LS++ L+ N T L+ T+ + S N+L P+L+
Sbjct: 225 ------RNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDL 466
L N++ S + LNL + + L + S Q L L L++
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD-FSFQWLKCLEHLNM 336
Query: 467 AYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGL------PNGLKEFNVSFNNLSGV 520
N + G + NL YL+LSN+ + L N++ N +S +
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 521 VPENLRNFP 529
+
Sbjct: 397 ESDAFSWLG 405
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-44
Identities = 85/421 (20%), Positives = 147/421 (34%), Gaps = 53/421 (12%)
Query: 98 SNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF--- 153
S N L D + LE+ L +N L + L N+ LN+ + + +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 154 ------PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFS-GSLDLGLG 206
F L L++L++ N G ++ + L ++ ++ LSN+ S +L
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF--SLR 264
S S + LN+++N + D + +LEV D N + + + ++
Sbjct: 376 VSLAHSPLHILNLTKNKISK--IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 265 ILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-----LKKVNLSSN 319
+ L N+ + S L L L L+ V S S L ++LS+N
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPS--LQRLMLRRVALKN-VDSSPSPFQPLRNLTILDLSNN 490
Query: 320 KLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQ 376
++ + I+DL +N L+ L + G
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKG 534
Query: 377 FLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGN 436
L + +N + V ELK+IDL LN+LN F L LNL N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 437 NFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFE 496
+ +LT LD+ +N I+ F N ++N ++
Sbjct: 595 LITSV--------EKKVFGPAFRNLTELDMRFNPFDC-TCESIAWFVN--WINETHTNIP 643
Query: 497 G 497
Sbjct: 644 E 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-14
Identities = 26/133 (19%), Positives = 50/133 (37%), Gaps = 10/133 (7%)
Query: 80 NFSFPTIIGLKMLCNVSVSNNQL---------MGNITDIGSIQSLEFLDLSHNLFHGLIP 130
N + + GL+ L + + +N L G I + + L L+L N F +
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 131 SGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG-DIMHLLSQLGSVVH 189
L L ++++ N+ S F LK L+L+ N + ++
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 190 VDLSNNQFSGSLD 202
+D+ N F + +
Sbjct: 614 LDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 16/108 (14%)
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHN 484
+ + S L ++ P T ++T L+L +N L +++
Sbjct: 3 TVSHEVADCSHLK------LTQV---PDDLPT---NITVLNLTHNQLRRLPAANFTRYSQ 50
Query: 485 LVYLNLSNNKFEGSIPD---GLPNGLKEFNVSFNNLSGVVPENLRNFP 529
L L++ N P+ LP LK N+ N LS + +
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPM-LKVLNLQHNELSQLSDKTFAFCT 97
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-56
Identities = 92/456 (20%), Positives = 163/456 (35%), Gaps = 38/456 (8%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNI--TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNL--- 139
I LK L ++V++N + ++ +LE LDLS N + + + L +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 140 -MLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIM-HLLSQLGSVVHVDLSNNQF 197
+ L++S N P F + +L L LR N ++M + L + L +F
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 198 SGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMP----YFDNLEVFDASNNHLVGA 253
+L D S + + L I E L + D + N+ F + +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER- 296
Query: 254 IPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKK 313
+ F++ F + L L + + + L L L + N+ + +L+
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKS-----LKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 314 VNLSSNKLS--GSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTG 368
++LS N LS G T +DLS N + S +E + + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ-LEHLDFQHSNLKQ 410
Query: 369 MVPNQTSQFLR-LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS-T 426
M LR L +S+ + L+V+ ++ N LP FT
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 427 KLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLV 486
LT L+LS L + S L L++++N+ ++L
Sbjct: 471 NLTFLDLSQCQLEQ-LSPTAFNSLSS--------LQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 487 YLNLSNNKFEGSIPD---GLPNGLKEFNVSFNNLSG 519
L+ S N S P+ L N++ N+ +
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 8e-52
Identities = 71/460 (15%), Positives = 139/460 (30%), Gaps = 33/460 (7%)
Query: 88 GLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISS 146
L + +S ++ S+ L L L+ N L L +L L
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 147 NSFEGTFPSGFGGLGKLKYLDLRANRF-GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGL 205
+ G L LK L++ N + S L ++ H+DLS+N+ L
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 206 GD-SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP--SFNFVFS 262
L++S N + G L NN + +
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNF---IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 263 LRILRLGSNQLSGSLPVALLQESSMM----LSELDLSLNQLEGPVGSITSA-----TLKK 313
L + RL + + +S++ L+ + L L+ + I +
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 314 VNLSSNKLSGSLP-ARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPN 372
+L S + + ++L N + + + V
Sbjct: 287 FSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 373 QTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLN 432
+ +FL L+ + S +G LK +DLS N + + +F +L L+
Sbjct: 347 PSLEFLDLSR---NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 433 LSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSN 492
+N + + L LD+++ + +L L ++
Sbjct: 403 FQHSNLKQMSEFSVFLSLRN--------LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 493 NKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFP 529
N F+ + + L ++S L + P +
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-50
Identities = 81/454 (17%), Positives = 155/454 (34%), Gaps = 50/454 (11%)
Query: 98 SNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG 156
S N L S L+ LDLS + SL +L L ++ N +
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 157 FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS-SFISSIQ 215
F GL L+ L + L ++ +++++N L + S +++++
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS---FKLPEYFSNLTNLE 152
Query: 216 YLNISENSLVGELFPHDGMPYFDNLEVF----DASNNHLVGAIPSFNFVFSLRILRLGSN 271
+L++S N + + + + D S N + P L L L +N
Sbjct: 153 HLDLSSNKIQS--IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPV----------GSITSATLKKVNLSSNKL 321
S ++ +Q + L L L + + + T+++ L+
Sbjct: 211 FDSLNVMKTCIQGLA-GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 322 SGSLPARVGHC----TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQF 377
+ +C + L + + N+G + + L + +
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLKLKSL 327
Query: 378 LRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLN--GFLLPSFFTSTKLTDLNLSG 435
RLT S +G P L+ +DLS N L+ G S F +T L L+LS
Sbjct: 328 KRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNK 494
N S+ L LD +++L + NL+YL++S+
Sbjct: 383 NGVIT----------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 495 FEGSIPD---GLPNGLKEFNVSFNNLSGVVPENL 525
+ GL + L+ ++ N+ ++
Sbjct: 433 TRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-17
Identities = 33/150 (22%), Positives = 57/150 (38%), Gaps = 4/150 (2%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNI--TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
GL L + ++ N N +++L FLDLS L P+ SL +L +L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQL-GSVVHVDLSNNQFSGSL 201
N+S N+F + L L+ LD N L S+ ++L+ N F+ +
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 559
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPH 231
+ +I + L + +
Sbjct: 560 EH-QSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-54
Identities = 101/319 (31%), Positives = 159/319 (49%), Gaps = 32/319 (10%)
Query: 704 DVLNACSPEKLAGDLHLFDVSLMFTAEELSHA-----PAEVIGRSCHGTLYKATLDSGSI 758
DV PE G L F + EL A ++GR G +YK L G++
Sbjct: 3 DVPAEEDPEVHLGQLKRF------SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL 56
Query: 759 LAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSL 817
+AVKRL+E +G + +F EV+ + H NL+ L+G+ E+L++ Y+ S+
Sbjct: 57 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC--MTPTERLLVYPYMANGSV 114
Query: 818 AVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIP---HGNLKSTNILLEAPTM 874
A L+E + PPL +R R+A+ AR L YLH + P H ++K+ NILL+
Sbjct: 115 ASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDE-EF 171
Query: 875 NAVLTDYSLHRILTSAGT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLE 932
AV+ D+ L +++ T V G +G+ PE+ ST K S K+DV+ +G++LLE
Sbjct: 172 EAVVGDFGLAKLMDYKDTHVTTAV--RGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLE 227
Query: 933 LLTGKSSGEIVCVDPG-VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQ 991
L+TG+ + ++ + V L DWV+ L E + D + + E+ + ++Q
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQ 283
Query: 992 VALRCILP-ASERPDMMSV 1009
VAL C ERP M V
Sbjct: 284 VALLCTQSSPMERPKMSEV 302
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-53
Identities = 75/486 (15%), Positives = 157/486 (32%), Gaps = 55/486 (11%)
Query: 72 LNDMGLVGNFSFPTIIGLKMLC----NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHG 127
L + + +I + + +N + + + L + ++ F
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 128 LIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSV 187
+N T + L L +++ + L L +
Sbjct: 221 ENICEAWENENSEYAQQY-----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 188 VHVDLSNNQFSGSLDL-----GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEV 242
++++ N+ L L D+ IQ + I N+L + L +
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGM 334
Query: 243 FDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG- 301
+ N L G +P+F L L L NQ++ +P + + L + N+L+
Sbjct: 335 LECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQ-VENLSFAHNKLKYI 392
Query: 302 -PVGSITSAT-LKKVNLSSNKLSG-------SLPARVGHCT---IVDLSNNRLSGDLSRM 349
+ S + + ++ S N++ L ++LSNN++S +
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
Query: 350 QNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDL 409
+ G+ + I+L N LT + N D L IDL
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLK-----------------DENENFKNTYLLTSIDL 495
Query: 410 SLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTS-LDLA 467
N L T+ L ++LS N+FS P + N+ + + + + D
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FP-TQPLNSSTL---KGFGIRNQRDAQ 550
Query: 468 YNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRN 527
N GI+ +L L + +N + + + + ++ N + +
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLSYVCP 609
Query: 528 FPDSAF 533
+ ++
Sbjct: 610 YIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-49
Identities = 65/479 (13%), Positives = 145/479 (30%), Gaps = 77/479 (16%)
Query: 98 SNNQLMGNITD-IGSIQSLEFLDLSHNLFHG----LIPSGIVSLKNLMLLNISSNSFEGT 152
G + D IG + LE L L + P GI + + ++ T
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 153 FPSGFGGLG--KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSF 210
F L + ++ I + +N + + +
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMR--- 204
Query: 211 ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLG 269
++ ++ + + V E + E ++ ++ + L + +
Sbjct: 205 LTKLRQFYMGNSPFVAE-------NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 270 SNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT----------LKKVNLSSN 319
+ LP L + ++++ N+ ++ + + N
Sbjct: 258 NCPNLTKLPTFLKALPE--MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 320 KL-SGSLPARVGHCT---IVDLSNNRLSG---DLSRMQNWGNYVEDIHLSSNFLTGMVPN 372
L + + + +++ N+L G + ++L+ N +T +P
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIK----LASLNLAYNQITE-IPA 370
Query: 373 QTSQFLR-LTSFKVSNNSLEGDLPAVLGTY--PELKVIDLSLNHLNGF-------LLPSF 422
F + + ++N L+ +P + + ID S N + L P+
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 423 FTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG-------RL 475
F ++ +NLS N S P + L+S++L N L+
Sbjct: 430 FKGINVSSINLSNNQISK-FPKELFSTGS--------PLSSINLMGNMLTEIPKNSLKDE 480
Query: 476 LPGISKFHNLVYLNLSNNKFEGSIPDGLPNG----LKEFNVSFNNLSGVVPE--NLRNF 528
+ L ++L NK + D L ++S+N+ S + N
Sbjct: 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTL 538
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-44
Identities = 64/460 (13%), Positives = 141/460 (30%), Gaps = 90/460 (19%)
Query: 109 IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEG----TFPSGFGGLGKLK 164
+ S + L L G +P I L L +L + S+ + P G +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 165 YLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224
+ + DL + + I + + + +
Sbjct: 137 QKQKMRMHYQKTF---VDYDPREDFSDLIKDCINSDPQQK-----SIKKSSRITLKDTQI 188
Query: 225 VGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQE 284
+N++ + + LR +G++ +
Sbjct: 189 -------------------GQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
Query: 285 SSM----MLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDL 337
+ DL + L+ L V + + LP + ++++
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKD---------LTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
Query: 338 SNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSL-EGDLPA 396
+ NR +W + + + N+L +
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEK----------------IQIIYIGYNNLKTFPVET 324
Query: 397 VLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP--------LQEIQ 448
L +L +++ N L G LP+F + KL LNL+ N + ++ +
Sbjct: 325 SLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 449 --NN-----PSTGSTQNL-SLTSLDLAYNSLSG-------RLLPGISKFHNLVYLNLSNN 493
+N P+ +++ ++++D +YN + L P K N+ +NLSNN
Sbjct: 384 FAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443
Query: 494 KFEGSIPD--GLPNGLKEFNVSFNNLSGVVPENLRNFPDS 531
+ + + L N+ N L+ + +L++ ++
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-10
Identities = 20/141 (14%), Positives = 46/141 (32%), Gaps = 11/141 (7%)
Query: 392 GDLPAV-LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNN 450
G P V L + + + L +G + + T+L L L + L +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG- 128
Query: 451 PSTGSTQNLSLTSLDLAYNSLSGRLLPGISK--FHNLVYLNLSNNKFEGSIPD--GLPNG 506
+ N+S + + F +L+ ++++ + SI +
Sbjct: 129 ----ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 507 LKEFNVSFNNLSGVVPENLRN 527
+ NN++ V + +
Sbjct: 185 DTQIGQLSNNITF-VSKAVMR 204
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 85/339 (25%), Positives = 134/339 (39%), Gaps = 49/339 (14%)
Query: 18 QSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN----GYVTSIMLN 73
D +ALLQ+KK + + + SW ++D C R W G+ C V ++ L+
Sbjct: 5 PQDKQALLQIKKDLGNPTT---LSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 74 DMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSH-NLFHGLIPSG 132
+ L + P+ + ++ L FL + N G IP
Sbjct: 59 GLNLPKPYPIPS----------------------SLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 133 IVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDL 192
I L L L I+ + G P + L LD N G + +S L ++V +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 193 SNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVG 252
N+ SG++ G SF + IS N L G++ P NL D S N L G
Sbjct: 157 DGNRISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTFAN---LNLAFVDLSRNMLEG 211
Query: 253 AIP-SFNFVFSLRILRLGSNQLSGSLP-VALLQESSMMLSELDLSLNQLEGPV-GSITSA 309
F + + + L N L+ L V L + L+ LDL N++ G + +T
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK----NLNGLDLRNNRIYGTLPQGLTQL 267
Query: 310 T-LKKVNLSSNKLSGSLPA--RVGHCTIVDLSNNR-LSG 344
L +N+S N L G +P + + +NN+ L G
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-44
Identities = 78/289 (26%), Positives = 122/289 (42%), Gaps = 39/289 (13%)
Query: 271 NQLSGSLPVALLQESSMMLSELDLSLNQLEGP------VGSITSATLKKVNLSS-NKLSG 323
G L Q ++ LDLS L P + ++ L + + N L G
Sbjct: 36 RTWLGVLCDTDTQTYR--VNNLDLSGLNLPKPYPIPSSLANLPY--LNFLYIGGINNLVG 91
Query: 324 SLPARVGHCT---IVDLSNNRLSG----DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQ 376
+P + T + +++ +SG LS+++ + + S N L+G +P S
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT----LVTLDFSYNALSGTLPPSISS 147
Query: 377 FLRLTSFKVSNNSLEGDLPAVLGTYPEL-KVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435
L N + G +P G++ +L + +S N L G + P F + L ++LS
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI-PPTFANLNLAFVDLSR 206
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKF 495
N G GS +N + LA NSL+ L + NL L+L NN+
Sbjct: 207 NMLEGDAS-------VLFGSDKNT--QKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRI 256
Query: 496 EGSIPDGLPN--GLKEFNVSFNNLSGVVPE--NLRNFPDSAFHPGNSLL 540
G++P GL L NVSFNNL G +P+ NL+ F SA+ N L
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA-NNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (393), Expect = 6e-42
Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 37/294 (12%)
Query: 244 DASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLP----VALLQESSMMLSELDLS-LN 297
D N +G + + + + L L L P +A L L+ L + +N
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY----LNFLYIGGIN 87
Query: 298 QLEGPV-GSITSAT-LKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSG----DLSR 348
L GP+ +I T L + ++ +SG++P + +D S N LSG +S
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 349 MQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRL-TSFKVSNNSLEGDLPAVLGTYPELKVI 407
+ N + I N ++G +P+ F +L TS +S N L G +P L +
Sbjct: 148 LPN----LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFV 202
Query: 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLA 467
DLS N L G F + ++L+ N+ + L ++ + + L LDL
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--KVGLSKN--------LNGLDLR 252
Query: 468 YNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLP-NGLKEFNVSFNN-LSG 519
N + G L G+++ L LN+S N G IP G + N L G
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 53/254 (20%), Positives = 104/254 (40%), Gaps = 28/254 (11%)
Query: 290 SELDLSLNQLEGPV-GSITSAT-LKKVNLSSNKLSGS--LPARVGHCT---IVDLSN-NR 341
D G + + T + ++LS L +P+ + + + + N
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 342 LSG----DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAV 397
L G ++++ + ++++ ++G +P+ SQ L + S N+L G LP
Sbjct: 89 LVGPIPPAIAKLTQ----LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 398 LGTYPELKVIDLSLNHLNGFLLPSFFTSTKL-TDLNLSGNNFSGPLPLQEIQNNPSTGST 456
+ + P L I N ++G + S+ + +KL T + +S N +G +P P+
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP-------PTFA-- 195
Query: 457 QNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPD-GLPNGLKEFNVSFN 515
NL+L +DL+ N L G N ++L+ N + GL L ++ N
Sbjct: 196 -NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 516 NLSGVVPENLRNFP 529
+ G +P+ L
Sbjct: 255 RIYGTLPQGLTQLK 268
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 75/317 (23%), Positives = 116/317 (36%), Gaps = 47/317 (14%)
Query: 191 DLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFD-ASNNH 249
D N + G L + + L++S +L + L N+
Sbjct: 32 DCCNRTWLGVLCDTDTQTY---RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 250 LVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV----G 304
LVG IP + + L L + +SG++P L Q + L LD S N L G +
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT--LVTLDFSYNALSGTLPPSIS 146
Query: 305 SITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSN 364
S+ + L + N++SG++P G + + +S N
Sbjct: 147 SLPN--LVGITFDGNRISGAIPDSYGSFS--------------------KLFTSMTISRN 184
Query: 365 FLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
LTG +P + L L +S N LEGD + G+ + I L+ N L L
Sbjct: 185 RLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGL 242
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISKFH 483
S L L+L N G LP L L SL++++N+L G + P
Sbjct: 243 SKNLNGLDLRNNRIYGTLP----------QGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQ 291
Query: 484 NLVYLNLSNNKFEGSIP 500
+NNK P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-49
Identities = 83/450 (18%), Positives = 146/450 (32%), Gaps = 33/450 (7%)
Query: 98 SNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG 156
S N L T + +L FLDL+ + + S L L +++N +
Sbjct: 41 SFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA 100
Query: 157 FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQY 216
G LK+L L ++ + L +N S S+ L G + ++
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPT--EKLKV 157
Query: 217 LNISENSLVGELFPHDGMPYFDNLEV--FDASNNHLVGAIPSFNFVFSLRILRLGSNQLS 274
L+ N++ + M + + N + G P + L G Q
Sbjct: 158 LDFQNNAIHY--LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 275 GSLPVALLQESSMMLSELDLSLNQL----EGPVGSITSATLKKVNLSSNKLSGSLPARVG 330
+ L + L + +++ +NL +
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275
Query: 331 HCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSN 387
+ +DL+ LS S + ++ + LS+N + S F LT +
Sbjct: 276 CFSGLQELDLTATHLSELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 388 NSLEGDL-PAVLGTYPELKVIDLSLNHLN--GFLLPSFFTSTKLTDLNLSGNNFSGPLPL 444
N+ +L L L+ +DLS + + + L LNLS N L
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKT 393
Query: 445 QEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPD-- 501
+ + P L LDLA+ L + H L LNLS++ + S
Sbjct: 394 EAFKECP--------QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
Query: 502 -GLPNGLKEFNVSFNNLSGVVPENLRNFPD 530
GLP L+ N+ N+ + +
Sbjct: 446 DGLPA-LQHLNLQGNHFPKGNIQKTNSLQT 474
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-47
Identities = 71/461 (15%), Positives = 143/461 (31%), Gaps = 34/461 (7%)
Query: 88 GLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISS 146
L L + ++ Q+ D S L+ L L+ N + + + K L L
Sbjct: 55 RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114
Query: 147 NSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206
L+ L L +N + + +D NN +
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174
Query: 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP---SFNFVFSL 263
+++ LN++ N + G G + + + I + + SL
Sbjct: 175 SLQQATNL-SLNLNGNDIAGI---EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKL 321
+ P M + ++L + + + L++++L++ L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 322 SGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFL 378
S LP+ + + + LS N+ + + + + N + + L
Sbjct: 291 S-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 379 R-LTSFKVSNNSLE--GDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435
L +S++ +E L L+ ++LS N +F +L L+L+
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNK 494
QN L L+L+++ L + L +LNL N
Sbjct: 410 TRLKVKDAQSPFQNLH--------LLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNH 460
Query: 495 FEGSIPD------GLPNGLKEFNVSFNNLSGVVPENLRNFP 529
F L L+ +SF +LS + +
Sbjct: 461 FPKGNIQKTNSLQTLGR-LEILVLSFCDLSSIDQHAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-46
Identities = 84/464 (18%), Positives = 146/464 (31%), Gaps = 60/464 (12%)
Query: 95 VSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFP 154
+ N L + + S E L+ S N+ + + L NL L+++
Sbjct: 17 YNCENLGLNEIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74
Query: 155 SGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSI 214
F +L L L AN LS ++ H+ S + L + ++
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN---QKTL 131
Query: 215 QYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS 274
+ L + N + P E L++L +N +
Sbjct: 132 ESLYLGSNHISSIKLPK-----GFPTE--------------------KLKVLDFQNNAIH 166
Query: 275 GSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSATLKKVNLSSNKLSGSLPARVGHCT 333
+ L+L+ N + G G+ SA + +N + + + + T
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 334 IVDLSNNRLSG----DLSRMQNWG---NYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVS 386
I L D+S G VE I+L ++ + N F L ++
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 387 NNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQE 446
L +LP+ L LK + LS N S LT L++ GN L
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 447 IQNNPS-----------------TGSTQNL-SLTSLDLAYNSLSGRLLPGISKFHNLVYL 488
++N + +NL L SL+L+YN + L L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 489 NLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFP 529
+L+ + + LK N+S + L + P
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 73/447 (16%), Positives = 143/447 (31%), Gaps = 51/447 (11%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIV--SLKNLMLLNISSNSFEGTFPS 155
+ N + G + L+ +I G+ ++++L L E P+
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 156 GFGGLGK--LKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISS 213
F GL + ++ ++L+ + F + + +DL+ S L GL +S+
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG---LST 302
Query: 214 IQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSN 271
++ L +S N E F +L N + + + +LR L L +
Sbjct: 303 LKKLVLSANKF--ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV 329
+ S L + L L+LS N+ + L+ ++L+ +L
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA--- 417
Query: 330 GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+L ++ ++LS + L L + N
Sbjct: 418 -QSPFQNLHL----------------LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460
Query: 390 LEG---DLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQE 446
L T L+++ LS L+ +F + + ++LS N +
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--- 517
Query: 447 IQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP-DGLPN 505
+ +L L+LA N +S L + +NL N + +
Sbjct: 518 -------EALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLE 570
Query: 506 GLKEFNVSFNNLSGVV---PENLRNFP 529
KE + + P LR
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVR 597
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-35
Identities = 66/367 (17%), Positives = 130/367 (35%), Gaps = 26/367 (7%)
Query: 77 LVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSL 136
+ TI L + + + + + + S+E ++L + F + +
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
Query: 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQ 196
L L++++ PSG GL LK L L AN+F S S+ H+ + N
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 197 FSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP- 255
LG G + +++ L++S + + + + +L+ + S N +
Sbjct: 337 KRLE--LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 256 SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKK 313
+F L +L L +L + Q +L L+LS + L+ L+
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLH-LLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 314 VNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
+NL N N L L R++ + LS L+ + +
Sbjct: 454 LNLQGNHFPK----------GNIQKTNSLQT-LGRLEI-------LVLSFCDLSSIDQHA 495
Query: 374 TSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNL 433
+ + +S+N L L + ++L+ NH++ L ++ +NL
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554
Query: 434 SGNNFSG 440
N
Sbjct: 555 RQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 24/198 (12%)
Query: 334 IVDLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSL 390
+ N L+ G L N E + S N L + S+ + LT ++ +
Sbjct: 16 TYNCENLGLNEIPGTLP------NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI 69
Query: 391 EGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNN 450
+ L + L+ N L + L L S + + N
Sbjct: 70 YWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQ 128
Query: 451 PSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLK-- 508
+L SL L N +S LP L L+ NN + + L+
Sbjct: 129 K--------TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQA 179
Query: 509 ---EFNVSFNNLSGVVPE 523
N++ N+++G+ P
Sbjct: 180 TNLSLNLNGNDIAGIEPG 197
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 17/68 (25%), Positives = 33/68 (48%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNI 144
LKM+ +V +S+N+L + + S +L+L+ N ++PS + L +N+
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINL 554
Query: 145 SSNSFEGT 152
N + T
Sbjct: 555 RQNPLDCT 562
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 90/333 (27%), Positives = 157/333 (47%), Gaps = 41/333 (12%)
Query: 697 SRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHA-----PAEVIGRSCHGTLYKA 751
S+++K ++ +N S +L A +IG G +YK
Sbjct: 3 SKYSKATNSINDALSSSYLVPFE----SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 752 TLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811
L G+ +A+KR ++G +EF E++ L +HP+LVSL G+ + +E ++I Y
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--ERNEMILIYKY 116
Query: 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA 871
+ +L +L +D + +S ++RL + + AR L+YLH RAI H ++KS NILL+
Sbjct: 117 MENGNLKRHLYGSDLPTM-SMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDE 174
Query: 872 PTMNAVLTDYSLHRILTSAG-----TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926
+TD+ + + T T V G LGY PE+ + + KSDVY+F
Sbjct: 175 -NFVPKITDFGISKKGTELDQTHLST--VV--KGTLGYIDPEYFIKGR--LTEKSDVYSF 227
Query: 927 GIILLELLTGKSSGEIVCVDP----GVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQ- 981
G++L E+L +S+ + +V+L +W N ++ I+D + ++
Sbjct: 228 GVVLFEVLCARSA-----IVQSLPREMVNLAEWAVES-HNNGQ---LEQ-IVDPNLADKI 277
Query: 982 PPRILSDMLQVALRCILP-ASERPDMMSVFEEL 1013
P L A++C+ + +RP M V +L
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-46
Identities = 69/449 (15%), Positives = 141/449 (31%), Gaps = 60/449 (13%)
Query: 84 PTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLN 143
I L L + +N+ + + E + + + +LK+L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 144 ISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203
+ + P L +L+ L++ N + S + + +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACN-----------RGISAAQLKADWTRLADDE-- 544
Query: 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSL 263
IQ + N+L E + L + D +N + + +F L
Sbjct: 545 -----DTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSAT-LKKVNLSSNK 320
L+L NQ+ +P + + L S N+L+ + + S + V+ S NK
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTD-QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNK 655
Query: 321 LSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRL 380
+ N + LS N + + +
Sbjct: 656 IGSEGRNISCSMDDYKGIN----------------ASTVTLSYNEIQKFPTELFATGSPI 699
Query: 381 TSFKVSNNSLE-------GDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS-TKLTDLN 432
++ +SNN + L IDL N L T+ L++++
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759
Query: 433 LSGNNFSGPLPLQEIQNNPSTGSTQNLSLTS-LDLAYNSLSGRLLPGISKFHNLVYLNLS 491
+S N FS P + N+ + + D N + + GI+ +L+ L +
Sbjct: 760 VSYNCFSS-FP-TQPLNSS---QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 492 NNKFEGSIPDGLPNGLKEFNVSFNNLSGV 520
+N + + L L +++ N +
Sbjct: 815 SNDIR-KVDEKLTPQLYILDIADNPNISI 842
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-44
Identities = 82/589 (13%), Positives = 179/589 (30%), Gaps = 109/589 (18%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSS----DGCPRNWFGITCT----NGYVTSI 70
D++AL + + + + + S + W NG VT +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 71 MLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIG-------------------- 110
L G G I L L +S + + G
Sbjct: 329 SLAGFGAKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 111 ------SIQSLEFLDLSHNLFHG------LIPSGIVSLKNLMLLNISSNSFEGTFPSGFG 158
Q L DL + + + +SLK+ + N+++
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQ 445
Query: 159 GLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLN 218
L KL+ + + F D + + + + + + +L + + + +
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSN---LKDLTDVE 497
Query: 219 ISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF----------SLRILRL 268
+ + +L P D + L+ + + N + A ++I +
Sbjct: 498 LYNCPNMTQL-P-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 269 GSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSSNKLSGSLPA 327
G N L P + + + L LD N++ + + + L + L N++ +P
Sbjct: 556 GYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIE-EIPE 612
Query: 328 RVGHCT----IVDLSNNRLSG-----DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTS--- 375
T + S+N+L + + + + S N + N +
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV----MGSVDFSYNKIGSEGRNISCSMD 668
Query: 376 --QFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHL-------NGFLLPSFFTST 426
+ + ++ +S N ++ + T + I LS N + ++ +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 427 KLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLV 486
LT ++L N + L +T L+++D++YN S L
Sbjct: 729 LLTTIDLRFNKLTS-LS-------DDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLK 779
Query: 487 YLNL------SNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRN 527
+ N+ P G+ L + + N++ V +
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ 828
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-37
Identities = 53/459 (11%), Positives = 139/459 (30%), Gaps = 44/459 (9%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGF 157
N + + + +++ + + + L+++ +G P
Sbjct: 284 KNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAI 343
Query: 158 GGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYL 217
G L +LK L + + + + ++ D +
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY--DQRLNLS 401
Query: 218 NISENSLVGEL----FPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQL 273
++ ++++ D + + N + + + L+I+ ++
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 274 SGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT 333
+ ++ S+ E ++ L V L + LP +
Sbjct: 461 TYDNIAVDWED---ANSDYAKQYENEELSWSNLKD--LTDVELYNCPNMTQLPDFLYDLP 515
Query: 334 ---IVDLSNNRLSGDLSRMQNWGNYVEDI---------HLSSNFLTGMVPNQT-SQFLRL 380
++++ NR +W +D ++ N L + + + ++L
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL 575
Query: 381 TSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSG 440
+N + L A GT +L + L N + + ++ L S N
Sbjct: 576 GLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 441 PLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSG-----RLLPGISKFHNLVYLNLSNNK 494
P+ + +++ + S+D +YN + K N + LS N+
Sbjct: 634 I---------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 495 FEGSIPDGLPNG--LKEFNVSFNNLSGVVPENLRNFPDS 531
+ + G + +S N ++ + +L+ +
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-35
Identities = 59/398 (14%), Positives = 127/398 (31%), Gaps = 60/398 (15%)
Query: 84 PTIIGLKMLCNVSVSNNQLMGNIT----------DIGSIQSLEFLDLSHNLFHGLIPS-G 132
+ L L +++++ N+ + D + ++ + +N S
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 133 IVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDL 192
+ + L LL+ N FG KL L L N+ + V +
Sbjct: 569 LQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGF 626
Query: 193 SNNQFSGSLDLGLGDSSFISSIQYLNISENSLVG---ELFPHDGMPYFDNLEVFDASNNH 249
S+N+ ++ S + + ++ S N + + N S N
Sbjct: 627 SHNKLKYIPNIFNAKS--VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 250 LVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSM------MLSELDLSLNQLEGP 302
+ F + + L +N ++ S+P L+ +L+ +DL N+L
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSL 743
Query: 303 VGSITSAT---LKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYV 356
+ T L +++S N S S P + + + + + R
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD-------------- 788
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
N + P + L ++ +N + + L P+L ++D++ N
Sbjct: 789 ----AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYILDIADNPNIS 841
Query: 417 FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTG 454
+ S + L + Q+I+ + G
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDK------TQDIRGCDALG 873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 80/323 (24%), Positives = 136/323 (42%), Gaps = 36/323 (11%)
Query: 710 SPEKLAGDLHLFDVSLMFTA-----EELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRL 764
S E H F + E +G G +YK ++ + +AVK+L
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKL 62
Query: 765 REGIAK----GKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVY 820
+ K++F +E+K + +H NLV L G+ + ++ Y+ SL
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS--DGDDLCLVYVYMPNGSLLDR 120
Query: 821 LQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880
L + PPLS R ++A A +N+LH E H ++KS NILL+ A ++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDE-AFTAKISD 176
Query: 881 YSLHRILTSAGTAD---QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ L R ++ G Y PE A + + KSD+Y+FG++LLE++TG
Sbjct: 177 FGLARASEKFAQTVMTSRI--VGTTAYMAPE-ALRGEI--TPKSDIYSFGVVLLEIITGL 231
Query: 938 SSGEIVCVDPG--VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALR 995
+ VD L D + E ++ + +D + + M VA +
Sbjct: 232 PA-----VDEHREPQLLLDIKEEIEDEEKT---IED-YIDKKMNDADSTSVEAMYSVASQ 282
Query: 996 CILP-ASERPDMMSVFEELSTIV 1017
C+ ++RPD+ V + L +
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-45
Identities = 92/459 (20%), Positives = 156/459 (33%), Gaps = 50/459 (10%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNL--- 139
I L L ++V++N + ++ +L +DLS+N + + + L+
Sbjct: 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182
Query: 140 -MLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIM-HLLSQLGSVVHVDLSNNQF 197
+ L++S N + F G+ KL L LR N +IM L L + L +F
Sbjct: 183 NLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 198 SGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFD---NLEVFDASNNHLVGAI 254
+L + + S + + + I E L D + F N+ + + +
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-L 300
Query: 255 PSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKV 314
F + L + QL P L L L L++N+ + +L +
Sbjct: 301 EDVPKHFKWQSLSIIRCQLK-QFPTLDLPF----LKSLTLTMNKGSISFKKVALPSLSYL 355
Query: 315 NLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQT 374
+LS N LS G C+ DL N L + LS N M
Sbjct: 356 DLSRNALSF-----SGCCSYSDLGTNSL--------------RHLDLSFNGAIIM-SANF 395
Query: 375 SQFLRLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNL 433
L +++L+ + +L +D+S + F T L L +
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 434 SGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSN 492
+GN+F N + LT LDL+ L + G+ H L LN+S+
Sbjct: 456 AGNSFKDNTLSNVFANTTN--------LTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSH 506
Query: 493 NKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRNFP 529
N L + SFN +
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-41
Identities = 70/450 (15%), Positives = 139/450 (30%), Gaps = 68/450 (15%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
S + +DLS N L + L L++S E + GL L L L N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDG 233
S L S+ ++ + + +G + +++ LN++ N + P
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ---LITLKKLNVAHNFIHSCKLP--- 146
Query: 234 MPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVAL--LQESSMMLSE 291
YF NL +L + L N + L L+E+ +
Sbjct: 147 -AYFSNLT--------------------NLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185
Query: 292 LDLSLNQLEG-PVGSITSATLKKVNLSSNKLSGSLPARVG----HCTIVDLSNNRLSG-- 344
LD+SLN ++ + L ++ L N S ++ + L
Sbjct: 186 LDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 345 -----DLSRMQNWGN-YVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVL 398
+ S M+ + +++ L+ + +++ ++ S++ +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--V 303
Query: 399 GTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQE--------IQNN 450
+ + + + + L F L L L+ N S + N
Sbjct: 304 PKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
Query: 451 P----STGSTQNL---SLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP--- 500
S +L SL LDL++N + L +L+ ++ +
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 501 -DGLPNGLKEFNVSFNNLSGVVPENLRNFP 529
L L ++S+ N
Sbjct: 420 FLSLEK-LLYLDISYTNTKIDFDGIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 65/381 (17%), Positives = 105/381 (27%), Gaps = 50/381 (13%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVS-LKNLMLLNISSNSFEGTF--- 153
S N + L L L N I + L L + + F+
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 154 ---PSGFGGLGKLKY--LDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS 208
PS GL + L D + L +V + L+ L D
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-----LEDV 303
Query: 209 SFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRL 268
Q L+I L + FP +P L+ + N + SL L L
Sbjct: 304 PKHFKWQSLSIIRCQL--KQFPTLDLP---FLKSLTLTMNKGSI-SFKKVALPSLSYLDL 357
Query: 269 GSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSSNKLSGSLPA 327
N LS S + + L LDLS N + L+ ++ + L
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 328 RVGHC----TIVDLSNNRLSG---------------DLSRMQNWGNYVEDI--------- 359
+D+S ++ N + ++
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 360 -HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFL 418
LS L + RL +S+N+L + L +D S N +
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537
Query: 419 LPSFFTSTKLTDLNLSGNNFS 439
L NL+ N+ +
Sbjct: 538 GILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-16
Identities = 40/206 (19%), Positives = 69/206 (33%), Gaps = 25/206 (12%)
Query: 333 TIVDLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+ +LS D+ ++I LS N L + S F L +S
Sbjct: 14 ITYQCMDQKLSKVPDDIPS------STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCE 67
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
+E L + L+ N + F SF T L +L + L I
Sbjct: 68 IETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQ 126
Query: 450 NPSTGSTQNLSLTSLDLAYNSLSGRLLPG-ISKFHNLVYLNLSNNKFEGSIPD------G 502
+L L++A+N + LP S NLV+++LS N + +
Sbjct: 127 LI--------TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 503 LPNGLKEFNVSFNNLSGVVPENLRNF 528
P ++S N + + + +
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGI 204
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-16
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 5/150 (3%)
Query: 77 LVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDI-GSIQSLEFLDLSHNLFHGLIPSGIVS 135
L F + L+ L + +S + I + SL L ++ N F S + +
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 136 -LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSN 194
NL L++S E F L +L+ L++ N +QL S+ +D S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 195 NQFSGSLDLGLGDSSFISSIQYLNISENSL 224
N+ F S+ + N++ NS+
Sbjct: 531 NRIET---SKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-14
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 2/116 (1%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
+GL L + ++ N N + +L FLDLS + +L L LL
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFS 198
N+S N+ S + L L LD NR L S+ +L+NN +
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 82/465 (17%), Positives = 169/465 (36%), Gaps = 56/465 (12%)
Query: 92 LCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEG 151
L + +++ + + I ++ L + L + L +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS 60
Query: 152 TFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGLGDSS 209
G L L ++ N+ + + L L +V + ++NNQ + L
Sbjct: 61 --IDGVEYLNNLTQINFSNNQ----LTDITPLKNLTKLVDILMNNNQIADITPLA----- 109
Query: 210 FISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLG 269
++++ L + N + D + NL + S+N + I + + + SL+ L
Sbjct: 110 NLTNLTGLTLFNNQITD----IDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSF- 163
Query: 270 SNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARV 329
NQ++ P+A L L LD+S N++ L+ + ++N++S P +
Sbjct: 164 GNQVTDLKPLANLTT----LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--L 217
Query: 330 GHCT---IVDLSNNRLSG--DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFK 384
G T + L+ N+L L+ + N + D+ L++N ++ + P S +LT K
Sbjct: 218 GILTNLDELSLNGNQLKDIGTLASLTN----LTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 385 VSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPL 444
+ N + ++ L L ++L+ N L + LT L L NN S P+
Sbjct: 272 LGANQIS-NISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPV 327
Query: 445 QEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLP 504
+ L L N +S + ++ N+ +L+ +N+ P
Sbjct: 328 SSLTK-----------LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANL 374
Query: 505 NGLKEFNVSFNNLSGVVPENLRNFP-DSAFHPGNSLLTFPNSPSQ 548
+ + ++ + N + L P + S
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISD 419
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-34
Identities = 81/427 (18%), Positives = 165/427 (38%), Gaps = 55/427 (12%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ L L ++ ++NNQ+ +IT + ++ +L L L +N + P + +L NL
Sbjct: 82 DITPLKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNR 138
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
L +SSN+ S GL L+ L L+ L ++ +D+S+N+ S
Sbjct: 139 LELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNKVSD-- 191
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF 261
+ + +++++ L + N + + NL+ + N L I + +
Sbjct: 192 ---ISVLAKLTNLESLIATNNQISDI----TPLGILTNLDELSLNGNQLKD-IGTLASLT 243
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSN 319
+L L L +NQ+S P++ L + L+EL L NQ+ P+ +T+ L + L+ N
Sbjct: 244 NLTDLDLANNQISNLAPLSGLTK----LTELKLGANQISNISPLAGLTA--LTNLELNEN 297
Query: 320 KLSGSLPARVGHCT---IVDLSNNRLSG--DLSRMQNWGNYVEDIHLSSNFLTGMVPNQT 374
+L P + + + L N +S +S + ++ + +N ++ +
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK----LQRLFFYNNKVSD--VSSL 349
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434
+ + +N + DL L + + L+ + ++ N
Sbjct: 350 ANLTNINWLSAGHNQIS-DLTP-LANLTRITQLGLNDQAWTNAPVNYK---ANVSIPNTV 404
Query: 435 GNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGIS-KFHNLVYLNLSNN 493
N + I + S T D+ +N S +S F V +
Sbjct: 405 KNVTGALIAPATISDGG--------SYTEPDITWNLPSY--TNEVSYTFSQPVTIGKGTT 454
Query: 494 KFEGSIP 500
F G++
Sbjct: 455 TFSGTVT 461
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 36/301 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY- 796
EV R G ++KA L +AVK K + EV L +KH N++ G
Sbjct: 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 797 YWGPKEH-EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
G + +I+ + SL+ +L+ +S +E +A +AR L YLH +
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDI 141
Query: 856 ---------AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-AGALGYR 905
AI H ++KS N+LL+ + A + D+ L + +A G Y
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 906 PPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE 962
PE + + L+ D+YA G++L EL + ++ + VD ++ + + +
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEYMLPFEEEIG----Q 255
Query: 963 NRSGECFDRLIM-DGHDMEQPPRILSD-----MLQVALRCILP-ASERPDMMSVFEELST 1015
+ S E +++ + + C A R V E ++
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
Query: 1016 I 1016
+
Sbjct: 316 M 316
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 104/571 (18%), Positives = 189/571 (33%), Gaps = 82/571 (14%)
Query: 88 GLKMLCNVSVSNNQLMGNITD---IGSIQSLEFLDLSHNLFHGLIPSGIVS-LKNLMLLN 143
GL L + + L + ++++L LDLS N L L +L ++
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 144 ISSNSFEGTFPSGFGGLG--KLKYLDLRANRFGGDIMHLLSQLGSVVH------VDLSNN 195
SSN L L + L AN + + + +D+S N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 196 QFS----GSLDLGLGDSSFIS-----SIQYLNISENSLVG---ELFPHDGMPYFDNLEVF 243
++ G+ + S S I +++ F ++
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS---SVRHL 271
Query: 244 DASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG 301
D S+ + ++ S F + L++L L N+++ A + L L+LS N L
Sbjct: 272 DLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN--LQVLNLSYNLLGE 328
Query: 302 -PVGSITS-ATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLSGDLSRMQNWGNY 355
+ + ++L N ++ + + +DL +N L+ + + +
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-TIHFIPS---- 382
Query: 356 VEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG-DLPAVLGTYPELKVIDLSLNHL 414
+ DI LS N L + L +S N LE D+ L P L+++ L+ N
Sbjct: 383 IPDIFLSGNKLVTL----PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 415 NGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG 473
+ + L L L N L L L +N L+
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLA----WETELCWDVFEGLSHLQVLYLNHNYLN- 493
Query: 474 RLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPE--------- 523
L PG+ S L L+L++N+ + LP L+ ++S N L P+
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLD 553
Query: 524 ----------NLRNFPDSAFHPGNSLLTFPNS------PSQQDVPDLTLRGHG-NHMKPA 566
L F + H ++ P S V +L G + +
Sbjct: 554 ITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVL 613
Query: 567 TKIALIVGLVCGVTMVALLCMLIYFRALWQR 597
+ + +VC VT+ L ++
Sbjct: 614 KSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-37
Identities = 85/486 (17%), Positives = 158/486 (32%), Gaps = 59/486 (12%)
Query: 88 GLKMLCNVSVSNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGI-VSLKNLMLLNIS 145
L + +S N + + ++ L+ L+L I +L NL +L++
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 146 SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH--LLSQLGSVVHVDLSNNQFSGSLDL 203
S+ P F GL L L L ++ L ++ +DLS NQ SL L
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYL 140
Query: 204 GLGDSSFISSIQYLNISENSLVG---ELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
++S++ ++ S N + L F + N L +
Sbjct: 141 H-PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK---TLSFFSLAANSLYSRVSVDWGK 196
Query: 261 F-------SLRILRLGSNQLSGSLPVALLQE----------SSMMLSELDLSLNQLEGPV 303
L IL + N + + + + + ++
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK--- 253
Query: 304 GSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSS 363
T L+ + + +DLS+ + SR+ ++ ++L+
Sbjct: 254 -DPDQNTFA--GLARSSV-----------RHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 364 NFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFF 423
N + + L +S N L + P++ IDL NH+ +F
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 424 TSTKLTDLNLSGNNFS---GPLPLQEI---QNNPSTGSTQNLSLTSLDLAYNSLSG-RLL 476
KL L+L N + + +I N T NL+ + L+ N L +L
Sbjct: 360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDIL 419
Query: 477 PGISKFHNLVYLNLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFPDSAF 533
+ + +L L L+ N+F D P+ L++ + N L F
Sbjct: 420 YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA---WETELCWDVF 476
Query: 534 HPGNSL 539
+ L
Sbjct: 477 EGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-32
Identities = 102/557 (18%), Positives = 181/557 (32%), Gaps = 109/557 (19%)
Query: 64 NGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMG---NITDIGSIQSLEFLDL 120
NG+ I N + ++I + + + N + S+ LDL
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273
Query: 121 SHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL 180
SH L +LK+L +LN++ N F GL L+ L+L N G
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 181 LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNL 240
L V ++DL N + + F+ +Q L++ +N
Sbjct: 334 FYGLPKVAYIDLQKNHIA---IIQDQTFKFLEKLQTLDLRDN------------------ 372
Query: 241 EVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
A+ + +F+ S+ + L N+L L + ++ + + LS N+LE
Sbjct: 373 ------------ALTTIHFIPSIPDIFLSGNKLVT------LPKINLTANLIHLSENRLE 414
Query: 301 GPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
NL +P H I+ L+ NR S
Sbjct: 415 --------------NLDILYFLLRVP----HLQILILNQNRFS----------------S 440
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGD-----LPAVLGTYPELKVIDLSLNHLN 415
S + P+ L + N L+ V L+V+ L+ N+LN
Sbjct: 441 CSGDQTPSENPS-------LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 416 GFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRL 475
F T L L+L+ N + L ++ N L LD++ N L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLPAN----------LEILDISRNQLLA-- 540
Query: 476 LPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHP 535
P F +L L++++NKF + + N P ++ +F
Sbjct: 541 -PNPDVFVSLSVLDITHNKFICECE---LSTFINWLNHTNVTIAGPPADIYCVYPDSFS- 595
Query: 536 GNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLVCGVTMVALLCMLIYFRALW 595
G SL + ++ +L+ + + L + L+ +T+
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIV---CTVTLTLFLMTILTVTKFRGFCFICYKTA 652
Query: 596 QRHGRDSFKRDGEQKAF 612
QR + E +
Sbjct: 653 QRLVFKDHPQGTEPDMY 669
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-23
Identities = 71/377 (18%), Positives = 126/377 (33%), Gaps = 82/377 (21%)
Query: 179 HLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFD 238
+ L + + LS N ++ +S +
Sbjct: 18 QVPQVLNTTERLLLSFNYIR-------------------TVTASSFPF----------LE 48
Query: 239 NLEVFDASNNHLVGAIP--SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
L++ + + + I +F + +LRIL LGS+++ L Q L EL L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQ-GLFHLFELRLYF 106
Query: 297 NQLEGPVGSITS----ATLKKVNLSSNKLSGSLPAR-----VGHCTIVDLSNNRLS---- 343
L V L +++LS N++ SL + +D S+N++
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 344 GDLSRMQNWGNYVEDIHLSSNFLTGMVPN------QTSQFLRLTSFKVSNNSLEGDLPAV 397
+L +Q + L++N L V + + L VS N D+
Sbjct: 166 HELEPLQG--KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT-- 221
Query: 398 LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQ 457
N ++ S + + +N +++ N G
Sbjct: 222 ----------GNFSNAISKSQAFSLILAHHIMGAGFGFHN------IKDPDQNTFAGL-A 264
Query: 458 NLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPD----GLPNGLKEFNV 512
S+ LDL++ + L + +L LNL+ NK I D GL N L+ N+
Sbjct: 265 RSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDN-LQVLNL 321
Query: 513 SFNNLSGVVPENLRNFP 529
S+N L + N P
Sbjct: 322 SYNLLGELYSSNFYGLP 338
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 34/165 (20%), Positives = 53/165 (32%), Gaps = 27/165 (16%)
Query: 386 SNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQ 445
+L +P VL + + LS N++ SF +L L L + +
Sbjct: 12 RFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 446 EIQNNPS---------------TGSTQNL-SLTSLDLAYNSLSGRLLPG--ISKFHNLVY 487
+N P+ + Q L L L L + LS +L L
Sbjct: 68 AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 488 LNLSNNKF----EGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNF 528
L+LS N+ L + LK + S N + V L
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNS-LKSIDFSSNQIFLVCEHELEPL 171
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-37
Identities = 81/472 (17%), Positives = 162/472 (34%), Gaps = 62/472 (13%)
Query: 92 LCNVSVSNNQLM---GNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNS 148
+ +T +++ LDLS N + + + NL +L + S+
Sbjct: 7 SGVCDGRSRSFTSIPSGLTA-----AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 149 FEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSG--------- 199
F LG L++LDL N L S+ +++L N +
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 200 -----SLDLG-------LGDSSF--ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDA 245
+L +G + F ++S+ L I SL + + ++
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL--RNYQSQSLKSIRDIHHLTL 179
Query: 246 SNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVG 304
+ + + + S+R L L L+ Q S + + E+ + +L
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLAR------FQFSPLPVDEVSSPMKKLAFRGS 233
Query: 305 SITSATLKKVNLSSNKLSGSLPARVGHCTI-----VDLSNNRLSGDLSRMQNWGNYVEDI 359
+T + ++ + CT+ + S + + +L +++ + +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET--VTIRRL 291
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLL 419
H+ +L + S ++ V N+ + + L+ +DLS N + L
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 420 PS---FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRL 475
+ L L LS N+ L+ +Q L +LTSLD++ N+ +
Sbjct: 352 KNSACKGAWPSLQTLVLSQNH------LRSMQKTG--EILLTLKNLTSLDISRNTFH-PM 402
Query: 476 LPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRN 527
+ +LNLS+ + +P L+ +VS NNL L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-33
Identities = 81/458 (17%), Positives = 164/458 (35%), Gaps = 48/458 (10%)
Query: 88 GLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVS-LKNLMLLNI 144
L L ++ +S+N L +++ G + SL++L+L N + L + + L NL L I
Sbjct: 72 SLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 145 SSNSFEGTFPSG-FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203
+ F GL L L+++A L + + H+ L ++ + L
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA---FL 187
Query: 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSL 263
+ +SS++YL + + +L + + + V SFN + L
Sbjct: 188 LEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSG 323
L +++ + L + + S + + +G + + T++++++ L
Sbjct: 247 LRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 324 SLPARVGHCT---IVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQ 376
L + + N+++ +++ +E + LS N + ++
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS----LEFLDLSENLMVEEYLKNSAC 356
Query: 377 FLRLTS---FKVSNNSLE--GDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDL 431
S +S N L +L T L +D+S N + + S K+ L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 432 NLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLS 491
NLS ++ ++ +L LD++ N+L L L +S
Sbjct: 416 NLSSTG------IRVVKTCIPQ------TLEVLDVSNNNLDS--FS--LFLPRLQELYIS 459
Query: 492 NNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFP 529
NK + L L +S N L V
Sbjct: 460 RNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 68/411 (16%), Positives = 130/411 (31%), Gaps = 49/411 (11%)
Query: 88 GLKMLCNVSVSNNQLMGNI--TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
L L + + N + I D + SL L++ + S++++ L +
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 146 SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGL 205
+ L ++YL+LR L + + S D
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 206 GD----SSFISSIQYLNISENSLVG---------ELFPHDGMPYFDNLEVFDASNNHLVG 252
+ +I + + + +L G ++ G + +L
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 253 AIPSFNFVF-SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL-----EGPVGSI 306
+ + + ++ + + ++++ +P + Q L LDLS N + +
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS-LEFLDLSENLMVEEYLKNSACKG 358
Query: 307 TSATLKKVNLSSNKLSGSLPARVGHC------TIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
+L+ + LS N L S+ T +D+S N Q ++
Sbjct: 359 AWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRF-LN 416
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LSS + +V L VSNN+L+ L P L+ + +S N L LP
Sbjct: 417 LSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLKT--LP 467
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSL 471
L + +S N +P S L + L N
Sbjct: 468 DASLFPVLLVMKISRNQLKS-VPDGIFDRLTS--------LQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 49/269 (18%), Positives = 90/269 (33%), Gaps = 16/269 (5%)
Query: 80 NFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNL 139
F + + + L + + D + + + G V +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 140 MLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSG 199
L+I + + L K+K + + ++ L S+ +DLS N
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 200 SLDLGLGDSSFISSIQYLNISEN---SLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
S+Q L +S+N S+ + NL D S N S
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK---NLTSLDISRNTFHPMPDS 405
Query: 257 FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNL 316
+ +R L L S + + + Q L LD+S N L+ + L+++ +
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCIPQ----TLEVLDVSNNNLDSFSLFLPR--LQELYI 458
Query: 317 SSNKLSGSLPARVGHC--TIVDLSNNRLS 343
S NKL +LP ++ +S N+L
Sbjct: 459 SRNKLK-TLPDASLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-21
Identities = 67/380 (17%), Positives = 128/380 (33%), Gaps = 39/380 (10%)
Query: 85 TIIGLKMLCNVSVSNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLN 143
GL L + + L + SI+ + L L + L+ L ++ L
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 144 ISSNSFEGTFPSGFGG---LGKLKYLDLRANRFG----GDIMHLLSQLGSVVHVDLSNNQ 196
+ + S +K L R + +++ LL + + V+ +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 197 FSGSLDLGLGDSSFIS--------SIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+G D +S +S +I+ L+I + L + ++ N+
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--FYDLSTVYSLLEKVKRITVENS 320
Query: 249 HLVGAIPS--FNFVFSLRILRLGSNQLSG-SLPVALLQESSMMLSELDLSLNQL---EGP 302
+ +P + SL L L N + L + + + L L LS N L +
Sbjct: 321 KV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 303 VGSITSAT-LKKVNLSSNKLSGSLPARVGHC---TIVDLSNNRLSGDLSRMQNWGNYVED 358
+ + L +++S N +P ++LS+ + +E
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEV 435
Query: 359 IHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFL 418
+ +S+N L + L +S N L+ LP +P L V+ +S N L
Sbjct: 436 LDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVP 489
Query: 419 LPSFFTSTKLTDLNLSGNNF 438
F T L + L N +
Sbjct: 490 DGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-14
Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 31/187 (16%)
Query: 88 GLKMLCNVSVSNNQL----MGNITDIGSIQSLEFLDLSHNLFHGL--IPSGIVSLKNLML 141
LK L + +S N + + N G+ SL+ L LS N + +++LKNL
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRF-----------------GGDIMHLLSQL 184
L+IS N+F P K+++L+L + ++ L
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFL 450
Query: 185 GSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFD 244
+ + +S N+ L D+S + + IS N L + P +L+
Sbjct: 451 PRLQELYISRNKLKT-----LPDASLFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKIW 503
Query: 245 ASNNHLV 251
N
Sbjct: 504 LHTNPWD 510
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-36
Identities = 85/459 (18%), Positives = 167/459 (36%), Gaps = 60/459 (13%)
Query: 98 SNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG 156
S N L S L+ LDLS + SL +L L ++ N +
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 157 FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS-SFISSIQ 215
F GL L+ L + L ++ +++++N L + S +++++
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ---SFKLPEYFSNLTNLE 152
Query: 216 YLNISENSLVGELFPHDGMPYFDNLEVF----DASNNHLVGAIPSFNFV-FSLRILRLGS 270
+L++S N + + + + + D S N + I F L L L +
Sbjct: 153 HLDLSSNKI--QSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRN 209
Query: 271 NQLSGSLPVALLQESSMMLSELDLSLNQL----------EGPVGSITSATLKKVNLSSNK 320
N S ++ +Q + L L L + + + + + T+++ L+
Sbjct: 210 NFDSLNVMKTCIQGLAG-LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 321 LSGSLPARV----GHCTIVDLSNNRLSG--DLSRMQNWGNYVEDIHLSSNFLTGMVPNQT 374
+ + + L + + D S W + + L + +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW----QHLELVNCKFGQFPTLKL 324
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLN--GFLLPSFFTSTKLTDLN 432
RLT ++N G+ + + P L+ +DLS N L+ G S F +T L L+
Sbjct: 325 KSLKRLT---FTSNKG-GNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 433 LSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFH---NLVYLN 489
LS N + + +N L LD +++L + S F NL+YL+
Sbjct: 380 LSFNG------VITMSSNFLGLE----QLEHLDFQHSNLKQ--MSEFSVFLSLRNLIYLD 427
Query: 490 LSNNKFEG---SIPDGLPNGLKEFNVSFNNLSGVVPENL 525
+S+ I +GL + L+ ++ N+ ++
Sbjct: 428 ISHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-36
Identities = 91/436 (20%), Positives = 165/436 (37%), Gaps = 43/436 (9%)
Query: 88 GLKMLCNVSVSNNQL--MGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNL----ML 141
LK L ++V++N + ++ +LE LDLS N + + + L + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH-LLSQLGSVVHVDLSNNQFSGS 200
L++S N P F + +L L LR N ++M + L + L +F
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 201 LDLGLGDSSFISSIQYLNISENSLVG-ELFPHDGMPYFD---NLEVFDASNNHLVGAIPS 256
+L D S + + L I E L + + D + F+ N+ F + + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKD 299
Query: 257 FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNL 316
F++ F + L L + + P L+ L L + N+ + +L+ ++L
Sbjct: 300 FSYNFGWQHLELVNCKFG-QFPTLKLKS----LKRLTFTSNKGGNAFSEVDLPSLEFLDL 354
Query: 317 SSNKLS-----GSLPARVGHCTIVDLSNNRL---SGDLSRMQNWGNYVEDIHLSSNFLTG 368
S N LS +DLS N + S + ++ +E + + L
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ----LEHLDFQHSNLKQ 410
Query: 369 MVPNQTSQFLR-LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS-T 426
M LR L +S+ + L+V+ ++ N LP FT
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 427 KLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNL 485
LT L+LS L+++ + SL L++A N L + GI + +L
Sbjct: 471 NLTFLDLSQCQ------LEQLSPTAFNSLS---SLQVLNMASNQLK-SVPDGIFDRLTSL 520
Query: 486 VYLNLSNNKFEGSIPD 501
+ L N ++ S P
Sbjct: 521 QKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-20
Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 25/303 (8%)
Query: 62 CTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLS 121
N + L + + L + + S+ + + + D + L+L
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELV 312
Query: 122 HNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR--FGGDIMH 179
+ F + LK+L L +SN F L L++LDL N F G
Sbjct: 313 NCKFGQFPT---LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 180 LLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN 239
S+ ++DLS N ++ + + +++L+ ++L ++ N
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMS---SNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 422
Query: 240 LEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
L D S+ H A FN + SL +L++ N + + E L+ LDLS Q
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-LTFLDLSQCQ 481
Query: 299 LEG-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHC----TIVDLSNNRLSGDLSR---M 349
LE + S + L+ +N++SN+L S+P + + L N R +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540
Query: 350 QNW 352
W
Sbjct: 541 SRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-16
Identities = 52/241 (21%), Positives = 87/241 (36%), Gaps = 19/241 (7%)
Query: 308 SATLKKVNLSSNKLSGSLPARVGHC---TIVDLSNNRLS----GDLSRMQNWGNYVEDIH 360
+ K ++LS N L ++DLS + G + + + +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH----LSTLI 82
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
L+ N + + S L +L +G LK ++++ N + F LP
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 421 SFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
+F++ T L L+LS N + +++ L SLDL+ N ++ + PG
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQM----PLLNLSLDLSLNPMN-FIQPGA 196
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPEN-LRNFPDSAFHPGNS 538
K L L L NN ++ GL V L E L F SA +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 539 L 539
L
Sbjct: 257 L 257
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 39/207 (18%), Positives = 72/207 (34%), Gaps = 27/207 (13%)
Query: 333 TIVDLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+L +++ LS N L + F L +S
Sbjct: 10 ITYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
++ + L + L+ N + L +F + L L N L ++N
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN------LASLEN 117
Query: 450 NPSTGSTQNLSLTSLDLAYNSL-SGRLLPGISKFHNLVYLNLSNNKFEGSIPDG------ 502
P +L L++A+N + S +L S NL +L+LS+NK + SI
Sbjct: 118 FPIGHLK---TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173
Query: 503 -LPNGLKEFNVSFNNLSGVVPENLRNF 528
+P ++S N ++ + P +
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEI 200
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 63/409 (15%), Positives = 154/409 (37%), Gaps = 67/409 (16%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
G L + + I + L ++ L+++ L ++
Sbjct: 1 GAATL---ATLPAPI-NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207
G L L+YL+L N+ + LS L + ++ + N+ + +
Sbjct: 55 KV--ASIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT-----DISA 105
Query: 208 SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILR 267
+++++ L ++E+++ + P + + + NH + + + + L L
Sbjct: 106 LQNLTNLRELYLNEDNISD-ISPLANLT---KMYSLNLGANHNLSDLSPLSNMTGLNYLT 161
Query: 268 LGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSNKLSGSL 325
+ +++ P+A L + L L L+ NQ+E P+ S+TS L N+++
Sbjct: 162 VTESKVKDVTPIANLTD----LYSLSLNYNQIEDISPLASLTS--LHYFTAYVNQITDIT 215
Query: 326 PARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV 385
P ++ M + + + +N +T + P + +LT ++
Sbjct: 216 P-------------------VANMTR----LNSLKIGNNKITDLSP--LANLSQLTWLEI 250
Query: 386 SNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQ 445
N + D+ A + +LK++++ N ++ + ++L L L+ N ++
Sbjct: 251 GTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN-EDME 305
Query: 446 EIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNK 494
I +LT+L L+ N ++ + ++ + + +N
Sbjct: 306 VIGGLT--------NLTTLFLSQNHITD--IRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 52/322 (16%), Positives = 118/322 (36%), Gaps = 36/322 (11%)
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSN 271
+ + + S+ + + +++ + + I ++ +L L L N
Sbjct: 22 AEGIRAVLQKASVTDVVTQEE----LESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGN 76
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGH 331
Q++ P++ L + L+ L + N++ L+++ L+ + +S P + +
Sbjct: 77 QITDISPLSNLVK----LTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LAN 130
Query: 332 CT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNN 388
T ++L N DLS + N + + ++ + + + P + L S ++ N
Sbjct: 131 LTKMYSLNLGANHNLSDLSPLSNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 389 SLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQ 448
+E D+ L + L +N + + T+L L + N + PL +
Sbjct: 188 QIE-DISP-LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLS 243
Query: 449 NNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP-DGLPNGL 507
LT L++ N +S + + L LN+ +N+ + L L
Sbjct: 244 Q-----------LTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLNNLSQ-L 289
Query: 508 KEFNVSFNNLSGVVPENLRNFP 529
++ N L E +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLT 311
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-22
Identities = 40/243 (16%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ L + ++++ N + +++ + ++ L +L ++ + + P I +L +L
Sbjct: 124 DISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS 181
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
L+++ N E S L L Y N+ ++ + + + + NN+ +
Sbjct: 182 LSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS 237
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF 261
L +S + +L I N + + + L++ + +N + I N +
Sbjct: 238 PLA-----NLSQLTWLEIGTNQISD-INAVKDLT---KLKMLNVGSNQISD-ISVLNNLS 287
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSN 319
L L L +NQL + ++ L+ L LS N + P+ S++ + + ++
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTN--LTTLFLSQNHITDIRPLASLSK--MDSADFANQ 343
Query: 320 KLS 322
+
Sbjct: 344 VIK 346
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 90/469 (19%), Positives = 158/469 (33%), Gaps = 80/469 (17%)
Query: 84 PTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLN 143
P + L ++ L + +++S + + + P G + + +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 144 ISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203
+ + L+L + L + + S N + L
Sbjct: 65 LRDCLDR-----------QAHELELNNLG----LSSLPELPPHLESLVASCNSLT-ELPE 108
Query: 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSL 263
+ S+ N + +L +L P LE SNN L +P L
Sbjct: 109 LPQS---LKSLLVDNNNLKAL-SDLPP--------LLEYLGVSNNQLE-KLPELQNSSFL 155
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSNKL 321
+I+ + +N L LP L + NQLE + ++ L + +N L
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS-----LEFIAAGNNQLEELPELQNLPF--LTAIYADNNSL 207
Query: 322 SGSLPARVGHCTIVDLSNNRLSG--DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLR 379
LP + NN L +L + + I+ +N L +P+
Sbjct: 208 K-KLPDLPLSLESIVAGNNILEELPELQNLPF----LTTIYADNNLLK-TLPDLPPS--- 258
Query: 380 LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS 439
L + V +N L DLP + + L +D+S N +G L + L LN S N
Sbjct: 259 LEALNVRDNYLT-DLPELPQS---LTFLDVSENIFSG--LSELPPN--LYYLNASSNE-- 308
Query: 440 GPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSI 499
++ + + P SL L+++ N L LP + L L S N +
Sbjct: 309 ----IRSLCDLPP-------SLEELNVSNNKLIE--LP--ALPPRLERLIASFNHLA-EV 352
Query: 500 PDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSPSQ 548
P+ N LK+ +V +N L P+ + D + L P P
Sbjct: 353 PELPQN-LKQLHVEYNPLR-EFPDIPESVED--LRMNSHLAEVPELPQN 397
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 69/363 (19%), Positives = 126/363 (34%), Gaps = 57/363 (15%)
Query: 92 LCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEG 151
L + VSNNQL + ++ + L+ +D+ +N L +L + +N E
Sbjct: 133 LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLKKLPDL----PPSLEFIAAGNNQLE- 186
Query: 152 TFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFI 211
P L L + N + L S+ + NN +L +
Sbjct: 187 ELPE-LQNLPFLTAIYADNNS----LKKLPDLPLSLESIVAGNNILEELPELQN-----L 236
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSN 271
+ + N L + P +LE + +N+L SL L + N
Sbjct: 237 PFLTTIYADNNLL--KTLP----DLPPSLEALNVRDNYLTDLPELPQ---SLTFLDVSEN 287
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGH 331
SG L E L L+ S N++ S L+++N+S+NKL LPA
Sbjct: 288 IFSG------LSELPPNLYYLNASSNEIRSLCDLPPS--LEELNVSNNKLI-ELPALPPR 338
Query: 332 CTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM-----------VPNQTSQFLR- 379
+ S N L+ QN ++ +H+ N L + + ++
Sbjct: 339 LERLIASFNHLAEVPELPQN----LKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPEL 394
Query: 380 ---LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGN 436
L V N L + P + + ++ + ++ + + T+ KL D +
Sbjct: 395 PQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
Query: 437 NFS 439
+
Sbjct: 451 HHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-21
Identities = 61/307 (19%), Positives = 103/307 (33%), Gaps = 43/307 (14%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
P + L L + NN L SLE + +N+ + +L L
Sbjct: 187 ELPELQNLPFLTAIYADNNSL---KKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTT 241
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
+ +N + T P L+ L++R N + L S+ +D+S N FS L
Sbjct: 242 IYADNNLLK-TLPDL---PPSLEALNVRDNY----LTDLPELPQSLTFLDVSENIFS-GL 292
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF 261
S ++ YLN S N + L +LE + SNN L+ +P+
Sbjct: 293 ------SELPPNLYYLNASSNEIR-SLCDL-----PPSLEELNVSNNKLI-ELPAL--PP 337
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKL 321
L L N L+ +P L +L + N L S +L N
Sbjct: 338 RLERLIASFNHLA-EVPELPQN-----LKQLHVEYNPLREFPDIPESVE----DLRMNSH 387
Query: 322 SGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLT 381
+P + + + N L + VED+ ++S + +L
Sbjct: 388 LAEVPELPQNLKQLHVETNP----LREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLE 443
Query: 382 SFKVSNN 388
++
Sbjct: 444 DDVFEHH 450
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+ + G L+K G+ + VK L+ + ++F E +L HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN-E 854
P +I++++ SL L E + + ++ A+D+AR + +LH E
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ---SQAVKFALDMARGMAFLHTLE 131
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE-FASTS 913
IP L S +++++ M A ++ + S G A + PE
Sbjct: 132 PLIPRHALNSRSVMIDE-DMTARISMADVKFSFQSPG------RMYAPAWVAPEALQKKP 184
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
+ +D+++F ++L EL+T +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 738 EVIGRSCHGTLYKATLDS-GSILAVKRLREG-------IAKGKKEFAREVKKLGNIKHPN 789
+ IG+ G ++K L S++A+K L G + + +EF REV + N+ HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN 849
+V L G P ++ ++ L L K P+ +LR+ +D+A +
Sbjct: 85 IVKLYGLMHNPP----RMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIE 136
Query: 850 YLHNER-AIPHGNLKSTNILLEAPTMNAVLT----DYSLHRILTSAGTADQVLNAGALGY 904
Y+ N+ I H +L+S NI L++ NA + D+ L + + + G +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNFQW 192
Query: 905 RPPE-FASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE + + + K+D Y+F +IL +LTG+
Sbjct: 193 MAPETIGAEEESY-TEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
EV+GR G + KA +A+K++ +K F E+++L + HPN+V L G
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
P ++ Y SL L LP + + + ++ + YLH+ +
Sbjct: 71 LNPV----CLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 858 P--HGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
H +LK N+LL A + D+ + + T N G+ + PE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAAWMAPEVFE-GSN 179
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
S K DV+++GIIL E++T +
Sbjct: 180 Y-SEKCDVFSWGIILWEVITRR 200
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 65/347 (18%), Positives = 109/347 (31%), Gaps = 72/347 (20%)
Query: 725 LMFTAEELSHAPA-----EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREV 779
+ A E S E+IGR +G +YK +LD +AVK ++ F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEK 56
Query: 780 K--KLGNIKHPNLVSLQGY---YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSI 834
++ ++H N+ E L++ Y SL YL
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDW 110
Query: 835 DERLRVAVDVARCLNYLHNE--------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886
R+A V R L YLH E AI H +L S N+L++ V++D+ L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMR 169
Query: 887 LTSAGTADQVLN-------AGALGYRPPE-----FASTSKPCPSLKSDVYAFGIILLELL 934
LT G + Y PE + D+YA G+I E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 935 TGKSSG--------------EIVCVDPGVVDLTDWVRLLALENRSGECFDRL---IMDGH 977
+ V P D+ V ++ +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV-----------SREKQRPKFPE-- 276
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKDSQ 1023
++ + + + C A R E ++ +++ +
Sbjct: 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 40/299 (13%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
EV+G+ C G K T ++G ++ +K L + ++ F +EVK + ++HPN++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ K I+ YI +L ++ D +R+ A D+A + YLH
Sbjct: 76 LYKDKRL--NFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH-SMN 128
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPC 916
I H +L S N L+ N V+ D+ L R++ T + L + R + P
Sbjct: 129 IIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 917 ---P--------SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965
P K DV++FGI+L E++ DP + T L
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV------NADPDYLPRTMDFGLNVRGFL- 240
Query: 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
D PP + +RC L +RP + + L T+ +
Sbjct: 241 ------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 67/418 (16%), Positives = 132/418 (31%), Gaps = 44/418 (10%)
Query: 106 ITDI-GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLK 164
I +I + + ++ + + S S N+ L++S N + KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 YLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISEN 222
L+L +N + L L ++ +DL+NN L +G SI+ L+ + N
Sbjct: 62 LLNLSSNV----LYETLDLESLSTLRTLDLNNNYVQ-ELLVG-------PSIETLHAANN 109
Query: 223 SLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVAL 281
++ + +NN + ++ L L N++ ++ A
Sbjct: 110 NI--SRVS---CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAE 163
Query: 282 LQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLS 338
L SS L L+L N + G + A LK ++LSSNKL+ + + L
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 339 NNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQT-SQFLRLTSFKVSNNSLEGDL 394
NN+L L QN +E L N S+ R+ + V+ +++
Sbjct: 223 NNKLVLIEKALRFSQN----LEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLT 276
Query: 395 PAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTG 454
+ P L + + G + ++
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG-SETERLE----CE 331
Query: 455 STQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFN 511
+D ++ + + + L + E +
Sbjct: 332 RENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 48/405 (11%), Positives = 110/405 (27%), Gaps = 25/405 (6%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ L L + ++NN + ++ S+E L ++N + S +
Sbjct: 72 ETLDLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNISRVSCS---RGQGKKN 124
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG-DIMHLLSQLGSVVHVDLSNNQFSGS 200
+ +++N G +++YLDL+ N + L + ++ H++L N
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-- 182
Query: 201 LDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
+ + ++ L++S N L + NN LV + F
Sbjct: 183 ---DVKGQVVFAKLKTLDLSSNKL--AFMG-PEFQSAAGVTWISLRNNKLVLIEKALRFS 236
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNK 320
+L L N + + + + + +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 321 LSGSLPARVGHCTIVDLSNNRL-------SGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
+ + L + L + +I ++
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 374 TSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNL 433
T + + + +L+ + + EL L + + L L
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLLRA 414
Query: 434 SGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPG 478
+ Q+ N + LA + + L G
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNG 459
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 58/315 (18%), Positives = 120/315 (38%), Gaps = 31/315 (9%)
Query: 239 NLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLN 297
++ +++ L A+ S ++++ L L N LS L + L L+LS N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK--LELLNLSSN 68
Query: 298 QLEG--PVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSG-DLSRMQNWGN 354
L + S+++ L+ ++L++N + L + +NN +S SR Q
Sbjct: 69 VLYETLDLESLST--LRTLDLNNNYVQ-ELLV-GPSIETLHAANNNISRVSCSRGQG--- 121
Query: 355 YVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG-DLPAVLGTYPELKVIDLSLNH 413
++I+L++N +T + R+ + N ++ + + + L+ ++L N
Sbjct: 122 -KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 414 LNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG 473
+ + KL L+LS N + + E Q+ +T + L N L
Sbjct: 181 IYD--VKGQVVFAKLKTLDLSSNKLAF-MG-PEFQSAAG--------VTWISLRNNKLV- 227
Query: 474 RLLPGISKFHNLVYLNLSNNKFE-GSIPDGLPNGLKEFNVSFNNLSGVVPENLRN--FPD 530
+ + NL + +L N F G++ D + V+ + + +N P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 531 SAFHPGNSLLTFPNS 545
+ P
Sbjct: 288 LGHYGAYCCEDLPAP 302
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 63/319 (19%), Positives = 124/319 (38%), Gaps = 58/319 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFARE--VKKLGNIKHPNLVSLQG 795
E IG+ G +++ G +AVK + ++ + RE + + ++H N++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 796 YYWGPKEHEK--LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
++S+Y SL YL ++++ +++A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHM 157
Query: 854 ER-------AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG--- 903
E AI H +LKS NIL++ + D L SA + +G
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 904 YRPPEF---ASTSKPCPS-LKSDVYAFGIILLELLTGKSSG-----------EIVCVDPG 948
Y PE + K S ++D+YA G++ E+ S G ++V DP
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 949 VVDLTDWVRLLALENRSGECFDRL---IMDGHDMEQPPRILSDMLQVALRCILP-ASERP 1004
V ++ V C +L I + + R+++ +++ C + R
Sbjct: 277 VEEMRKVV-----------CEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARL 322
Query: 1005 DMMSVFEELSTIVLEKDSQ 1023
+ + + LS + ++ +
Sbjct: 323 TALRIKKTLSQLSQQEGIK 341
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E IG GT+++A GS +AVK L E A+ EF REV + ++HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
P +++ Y++ SL L ++ R+ L RL +A DVA+ +NYLHN
Sbjct: 102 AVTQPPNL--SIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 856 -AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
I H NLKS N+L++ + D+ L R+ S + + AG + PE +
Sbjct: 158 PPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLR-DE 214
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
P + KSDVY+FG+IL EL T +
Sbjct: 215 PS-NEKSDVYSFGVILWELATLQ 236
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 58/312 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVK--KLGNIKHPNLVSLQG 795
E +G+ +G +++ + G +AVK + +K + RE + ++H N++
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 796 Y-YWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+L +I++Y SL YLQ L LR+ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 854 ER-------AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG--- 903
E AI H +LKS NIL++ + D L + + + V N +G
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 904 YRPPEF----ASTSKPCPSLKSDVYAFGIILLELLTGKSSG-----------EIVCVDPG 948
Y PE + D++AFG++L E+ S ++V DP
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 949 VVDLTDWVRLLALENRSGECFDRL---IMDGHDMEQPPRILSDMLQVALRCILP-ASERP 1004
D+ V C D+ I + + L+ +++ C S R
Sbjct: 243 FEDMRKVV-----------CVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARL 288
Query: 1005 DMMSVFEELSTI 1016
+ + + L+ I
Sbjct: 289 TALRIKKTLTKI 300
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 84/418 (20%), Positives = 163/418 (38%), Gaps = 63/418 (15%)
Query: 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
++ + + DI ++ + + + ++ L + + S + + LLN++ E
Sbjct: 27 HIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 154 PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISS 213
F ++ L + N H+ + + + L N S
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--------------- 130
Query: 214 IQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSN 271
SL +F P L SNN+L I F SL+ L+L SN
Sbjct: 131 ---------SLPRGIF--HNTP---KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN 175
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSSNKLSGSLPARV- 329
+L+ + ++L+ L ++S N L ++ +++++ S N ++ + V
Sbjct: 176 RLT-HVDLSLIPS----LFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVN 225
Query: 330 GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
TI+ L +N L+ D + + N+ + ++ LS N L ++ + + RL +SNN
Sbjct: 226 VELTILKLQHNNLT-DTAWLLNYPG-LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
L L P LKV+DLS NHL + + +L +L L N+ + ++
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS------IVTLKL 335
Query: 450 NPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGL 507
+ +L +L L++N L + F N+ + + I L +GL
Sbjct: 336 STHH------TLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGL 385
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 84/400 (21%), Positives = 142/400 (35%), Gaps = 58/400 (14%)
Query: 123 NLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLS 182
+ I S + ++I + + F L K + + + LL
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 183 QLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEV 242
V ++L++ Q I + ++
Sbjct: 67 SFRQVELLNLNDLQIE-------------------EIDTYAFAY----------AHTIQK 97
Query: 243 FDASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
N + +P F V L +L L N LS SLP + + L+ L +S N LE
Sbjct: 98 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP-KLTTLSMSNNNLE 154
Query: 301 G-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVED 358
+ + T L+ + LSSN+L+ + + ++S N LS L+ VE+
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-TLAIPIA----VEE 209
Query: 359 IHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFL 418
+ S N + +V + LT K+ +N+L D L YP L +DLS N L +
Sbjct: 210 LDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIM 264
Query: 419 LPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPG 478
F +L L +S N + G +L LDL++N L +
Sbjct: 265 YHPFVKMQRLERLYISNNR---------LVALNLYGQ-PIPTLKVLDLSHNHLL-HVERN 313
Query: 479 ISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLS 518
+F L L L +N ++ + LK +S N+
Sbjct: 314 QPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 43/218 (19%), Positives = 86/218 (39%), Gaps = 25/218 (11%)
Query: 315 NLSSNKLSGSLPARVGHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFLTGMV 370
+ + G + + IV N+ + L + VE ++L+ + +
Sbjct: 30 MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ----VELLNLNDLQIEEID 85
Query: 371 PNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTD 430
+ + + N++ P V P L V+ L N L+ F + KLT
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 145
Query: 431 LNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISKFHNLVYLN 489
L++S NN L+ I++ + Q SL +L L+ N L+ + +S +L + N
Sbjct: 146 LSMSNNN------LERIED----DTFQATTSLQNLQLSSNRLTH--VD-LSLIPSLFHAN 192
Query: 490 LSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRN 527
+S N ++ + ++E + S N+++ V
Sbjct: 193 VSYNLLS-TLAIPI--AVEELDASHNSINVVRGPVNVE 227
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 19/155 (12%), Positives = 48/155 (30%), Gaps = 21/155 (13%)
Query: 394 LPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS-------GPLP-LQ 445
+ + L + + + + + T + + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 446 E--IQNNP----STGSTQNL-SLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEG 497
+ + T + ++ L + +N++ L P + L L L N
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 498 SIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFP 529
S+P G+ + L ++S NNL + + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 5/98 (5%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
++ L + +SNN+L+ I +L+ LDLSHN + L L + N
Sbjct: 270 KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGD-IMHLLSQL 184
S T LK L L N + + + L +
Sbjct: 329 SIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNV 363
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG----IAKGKKEFAREVKKLGNIKHPNLVSL 793
E+IG G +Y+A G +AVK R I++ + +E K +KHPN+++L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+G ++ + L L +++PP D + AV +AR +NYLH+
Sbjct: 72 RGVCLKEPNL--CLVMEFARGGPLNRVLSG---KRIPP---DILVNWAVQIARGMNYLHD 123
Query: 854 ERAIP--HGNLKSTNILLEAPTMNAV-------LTDYSLHRILTSAGTADQVLNAGALGY 904
E +P H +LKS+NIL+ N +TD+ L R AGA +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS---AAGAYAW 180
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE + S SDV+++G++L ELLTG+
Sbjct: 181 MAPEVIR-ASMF-SKGSDVWSYGVLLWELLTGE 211
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 83/460 (18%), Positives = 149/460 (32%), Gaps = 45/460 (9%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
L++S N L S I+SL L +L IS N + S F +L+YLDL N+
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDG 233
H L H+DLS N F + +S +++L +S L
Sbjct: 82 VKISCHPTVNL---KHLDLSFNAFDALPICKEFGN--MSQLKFLGLSTTHLEKSSVLPIA 136
Query: 234 MPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELD 293
+ + L + +L S ++ L+
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGL---QDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 294 LSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWG 353
LS + + L +N +L T S R+ + W
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT--WNSFIRILQLVWHTTVWY 251
Query: 354 NYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNH 413
+ ++ L + L+ +V ++ + + + + + +++
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 414 LNGFLLPSFFTSTKLTDLNLSGN--------NFSGPLPLQE--IQNN------PSTGSTQ 457
+ + L+ S N N L+ +Q N T
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 458 NL-SLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFN 515
+ SL LD++ NS+S G S +L+ LN+S+N +I LP +K ++ N
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
Query: 516 NLSGVVPEN----------------LRNFPDSAFHPGNSL 539
+ +P+ L++ PD F SL
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 58/392 (14%), Positives = 134/392 (34%), Gaps = 38/392 (9%)
Query: 72 LNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLI-P 130
+ + + F + L + +S L + + I L + L
Sbjct: 102 FDALPICKEFG-----NMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGETYGEK 154
Query: 131 SGIVSLKNLMLLN-----ISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLG 185
L++ + ++ F + L+ +++ + LS L
Sbjct: 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
Query: 186 SVV------HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN 239
+ ++ L+N + + + + + + +++ Y +IS L G+L D +
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274
Query: 240 LEVFDASNNHLVGAIPSFNFVF----SLRILRLGSNQLSGSLPVALLQESSMMLSELDLS 295
L+ ++++ ++ I + + + + S LD S
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISP-FLHLDFS 332
Query: 296 LNQL-EGPVGSITSAT-LKKVNLSSNKLSGSLPARVG------HCTIVDLSNNRLSGDLS 347
N L + + T L+ + L N+L L +D+S N +S D
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 348 RMQ-NWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKV 406
+ +W + +++SSN LT + R+ + +N ++ +P + L+
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQE 448
Query: 407 IDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF 438
++++ N L F T L + L N +
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 58/330 (17%), Positives = 121/330 (36%), Gaps = 28/330 (8%)
Query: 5 SLIVLLLVVNALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN 64
L + +F +L + + I + S + TN
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY--FLSILAKLQTN 219
Query: 65 GYVTSIMLNDMGLVGN--FSFPTIIGLKMLCNVSVSNNQLMGNITDIG------SIQSLE 116
++++ LN++ N ++ + S+SN +L G + S+++L
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 117 FLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGD 176
+ ++F N+ + N + + + +LD N
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 177 IMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPY 236
+ L + + L NQ L ++ + S+Q L+IS+NS+ +
Sbjct: 340 VFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK----GD 394
Query: 237 FD---NLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELD 293
+L + S+N L +++L L SN++ S+P +++ + L EL+
Sbjct: 395 CSWTKSLLSLNMSSNILT-DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEA--LQELN 450
Query: 294 LSLNQL----EGPVGSITSATLKKVNLSSN 319
++ NQL +G +TS L+K+ L +N
Sbjct: 451 VASNQLKSVPDGIFDRLTS--LQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 62/366 (16%), Positives = 116/366 (31%), Gaps = 46/366 (12%)
Query: 190 VDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNH 249
VD S N + L LNIS+N + EL+ D + L + S+N
Sbjct: 5 VDRSKNGLI-HVPKDLS-----QKTTILNISQNYIS-ELWTSD-ILSLSKLRILIISHNR 56
Query: 250 LVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE-----GP 302
+ + F F L L L N+L + L LDLS N +
Sbjct: 57 I-QYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVN----LKHLDLSFNAFDALPICKE 110
Query: 303 VGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDL-----SNNRLSGDLSRMQNWGNYVE 357
G+++ LK + LS+ L S + H I + D +Q++
Sbjct: 111 FGNMSQ--LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168
Query: 358 DIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYP----------ELKVI 407
I +N + + + + + LE + + + L +
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLA 467
++ + + T + ++S G L + T +L+ +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF----RDFDYSGTSLKALSIHQVV 284
Query: 468 YNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEF---NVSFNNLSGVVPEN 524
+ F N+ N + + + P+ + F + S N L+ V EN
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 525 LRNFPD 530
+ +
Sbjct: 344 CGHLTE 349
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 35/200 (17%), Positives = 68/200 (34%), Gaps = 22/200 (11%)
Query: 333 TIVDLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+VD S N L DLS+ +++S N+++ + + +L +S+N
Sbjct: 3 FLVDRSKNGLIHVPKDLSQ------KTTILNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
++ +V EL+ +DLS N L S + L L+LS N +
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFN------AFDAL-- 105
Query: 450 NPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
P N+ L L L+ L + I+ + L + +
Sbjct: 106 -PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164
Query: 509 EFNVSFNNLSGVVPENLRNF 528
++ + + +
Sbjct: 165 TESLHIVFPTNKEFHFILDV 184
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-29
Identities = 75/443 (16%), Positives = 141/443 (31%), Gaps = 62/443 (13%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGN-ITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLM 140
SF + + ++ + +L LD ++ + +GI L L
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLT 67
Query: 141 LLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGS 200
L +SN+ T L YL +N+ + L++L +++ N+ +
Sbjct: 68 KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKL---TYLNCDTNKLTKL 121
Query: 201 LDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
D S + YLN + N+L L D N + +
Sbjct: 122 ------DVSQNPLLTYLNCARNTL--TEIDVSHNT---QLTELDCHLNKKITKLDVTPQT 170
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSATLKKVNLSSN 319
L L N+++ L V+ + L+ L+ N + + L ++ SSN
Sbjct: 171 -QLTTLDCSFNKIT-ELDVSQNKL----LNRLNCDTNNITKLDLNQNIQ--LTFLDCSSN 222
Query: 320 KLSGSLPARVGHCT---IVDLSNNRLSG-DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTS 375
KL+ + V T D S N L+ D+S + + +H L + +
Sbjct: 223 KLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSK----LTTLHCIQTDLLEI---DLT 272
Query: 376 QFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435
+L F+ +L + +L ++D + + KL L L+
Sbjct: 273 HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNN 327
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKF 495
+ L + + N L SL + + K L + +
Sbjct: 328 TELTE-LDV-----------SHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQT 373
Query: 496 EGSIPDGLPNGLKEFNVSFNNLS 518
+ L N VS + L
Sbjct: 374 ITMPKETLTNNSLTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 42/244 (17%), Positives = 73/244 (29%), Gaps = 27/244 (11%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
L + S+N+L D+ + L + D S N L S L L L+
Sbjct: 210 QNIQLTFLDCSSNKL--TEIDVTPLTQLTYFDCSVNPLTELDVST---LSKLTTLHCIQT 264
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207
+L Y R ++ ++ + +D + LDL
Sbjct: 265 DLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDL---- 314
Query: 208 SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILR 267
S + YL ++ L L+ N H+ S + +L
Sbjct: 315 -SQNPKLVYLYLNNTELTE--LDVSHNT---KLKSLSCVNAHIQ-DFSSVGKIPALNNNF 367
Query: 268 LGSNQLSGSLPVALLQESSMMLS----ELDLSLNQLEGPVGSITSATLKKVNLSSNKLSG 323
Q ++P L +S+ ++ LD N + G ++ LS
Sbjct: 368 EAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
Query: 324 SLPA 327
PA
Sbjct: 427 DNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 35/189 (18%), Positives = 64/189 (33%), Gaps = 27/189 (14%)
Query: 339 NNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVL 398
+ ++ + + ++ +T M + LT ++N++ L L
Sbjct: 31 QATDTISEEQLAT----LTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT-TLD--L 81
Query: 399 GTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQN 458
L + N L TKLT LN N + L + +QN
Sbjct: 82 SQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLDV-----------SQN 126
Query: 459 LSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLS 518
LT L+ A N+L+ + +S L L+ NK + L + SFN ++
Sbjct: 127 PLLTYLNCARNTLT--EID-VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
Query: 519 GVVPENLRN 527
+ +
Sbjct: 184 ELDVSQNKL 192
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-29
Identities = 78/425 (18%), Positives = 165/425 (38%), Gaps = 38/425 (8%)
Query: 87 IGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISS 146
+G + NV + +++ + + ++L N ++ +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 147 NSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206
++ + +++ L+L + + + ++ + + N L +
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119
Query: 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLR 264
+ + + L + N L P L SNN+L I F SL+
Sbjct: 120 QN--VPLLTVLVLERNDL--SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 174
Query: 265 ILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSSNKLSG 323
L+L SN+L+ + ++L+ L ++S N L ++ +++++ S N ++
Sbjct: 175 NLQLSSNRLT-HVDLSLIPS----LFHANVSYNLLS----TLAIPIAVEELDASHNSIN- 224
Query: 324 SLPARV-GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTS 382
+ V TI+ L +N L+ D + + N+ + ++ LS N L ++ + + RL
Sbjct: 225 VVRGPVNVELTILKLQHNNLT-DTAWLLNYPG-LVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 383 FKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPL 442
+SNN L L P LKV+DLS NHL + + +L +L L N+
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS----- 335
Query: 443 PLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDG 502
+ ++ + + +L +L L++N L + F N+ + + I
Sbjct: 336 -IVTLKLS------THHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQ 386
Query: 503 LPNGL 507
L +GL
Sbjct: 387 LEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 85/465 (18%), Positives = 153/465 (32%), Gaps = 40/465 (8%)
Query: 81 FSFPTIIGLKMLCNVSVSNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNL 139
+ I L V+ N+ + + S + +E L+L+ + +
Sbjct: 42 YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTI 101
Query: 140 MLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSG 199
L + N+ P F + L L L N + + + +SNN
Sbjct: 102 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE- 160
Query: 200 SLDLGLGDSSF--ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSF 257
+ D +F +S+Q L +S N L +L + S N L +
Sbjct: 161 ----RIEDDTFQATTSLQNLQLSSNRL--THVDLSL---IPSLFHANVSYNLL----STL 207
Query: 258 NFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLS 317
++ L N ++ + + E L+ L L N L + L +V+LS
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPVNVE----LTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
Query: 318 SNKLSGSLPARVGHC----TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
N+L + + +SNNRL Q ++ + LS N L V
Sbjct: 263 YNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT-LKVLDLSHNHLL-HVERN 319
Query: 374 TSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNL 433
QF RL + + +NS+ L L T+ LK + LS N + L + F + ++
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDD 376
Query: 434 SGNNFSGPLPLQ------EIQNNPSTGSTQNLSLTSLDLAYNSLSGRL--LPGISKFHNL 485
+ + L+ E Q ++LTS+ GR I+ +L
Sbjct: 377 ADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 486 VYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPD 530
+ + L + E L+ + +
Sbjct: 437 SHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQG 481
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 64/319 (20%), Positives = 116/319 (36%), Gaps = 58/319 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVK--KLGNIKHPNLVSLQG 795
+ IG+ +G ++ G +AVK + + RE + + ++H N++
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 796 YYWGPKEHEK--LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+I++Y SL YL+ L L++A L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 854 ER-------AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG--- 903
E AI H +LKS NIL++ + D L S + +G
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 904 YRPPEF---ASTSKPCPS-LKSDVYAFGIILLELLTGKSSG-----------EIVCVDPG 948
Y PPE + S + +D+Y+FG+IL E+ SG ++V DP
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 949 VVDLTDWVRLLALENRSGECFDRL---IMDGHDMEQPPRILSDMLQVALRCILP-ASERP 1004
D+ + V C +L + ++ R + ++ C + R
Sbjct: 272 YEDMREIV-----------CIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRL 317
Query: 1005 DMMSVFEELSTIVLEKDSQ 1023
+ V + L+ + +D +
Sbjct: 318 TALRVKKTLAKMSESQDIK 336
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+ IG GT+YK G + AVK L + + F EV L +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKWH-GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y P+ +++ + SL +L ++ + + + + +A AR ++YLH +
Sbjct: 88 YSTAPQ---LAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHA-K 139
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVL-NAGALGYRPPEFASTSK 914
+I H +LKS NI L + D+ L + + Q +G++ + PE
Sbjct: 140 SIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 915 PCP-SLKSDVYAFGIILLELLTGK 937
P S +SDVYAFGI+L EL+TG+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 26/214 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E+IG+ G +Y G + A++ + K F REV +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 796 YYWGPKEHEKLVI-SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
P L I ++ ++L ++ L +++ ++A ++ + + YLH
Sbjct: 97 ACMSP---PHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ----VLNAGALGYRPPEFA 910
+ I H +LKS N+ + V+TD+ L I + + G L + PE
Sbjct: 149 KGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 911 STSKPCP-------SLKSDVYAFGIILLELLTGK 937
P S SDV+A G I EL +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 65/345 (18%), Positives = 117/345 (33%), Gaps = 41/345 (11%)
Query: 106 ITDI-GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLK 164
I +I + + ++ + + S S N+ L++S N + KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 YLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISEN 222
L+L +N + L L ++ +DL+NN +L +G SI+ L+ + N
Sbjct: 62 LLNLSSNV----LYETLDLESLSTLRTLDLNNNYVQ---ELLVG-----PSIETLHAANN 109
Query: 223 SLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVAL 281
++ + +NN + ++ L L N++ ++ A
Sbjct: 110 NI--SRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAE 163
Query: 282 LQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLS 338
L SS L L+L N + G + A LK ++LSSNKL+ + + L
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 339 NNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQT-SQFLRLTSFKVSNNSLEGDL 394
NN+L L QN +E L N S+ R+ +
Sbjct: 223 NNKLVLIEKALRFSQN----LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 395 PAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS 439
T P L H + + L ++
Sbjct: 279 NEEECTVPT-------LGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/325 (18%), Positives = 127/325 (39%), Gaps = 30/325 (9%)
Query: 238 DNLEVFDASNNHLVGAIPS-FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
+ ++ +++ L A+ S ++++ L L N LS + A L + L L+LS
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK-LELLNLSS 67
Query: 297 NQLEG--PVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSG-DLSRMQNWG 353
N L + S+++ L+ ++L++N + L + +NN +S SR Q
Sbjct: 68 NVLYETLDLESLST--LRTLDLNNNYVQ-ELLV-GPSIETLHAANNNISRVSCSRGQG-- 121
Query: 354 NYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG-DLPAVLGTYPELKVIDLSLN 412
++I+L++N +T + R+ + N ++ + + + L+ ++L N
Sbjct: 122 --KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 413 HLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLS 472
+ + KL L+LS N + + E Q+ +T + L N L
Sbjct: 180 FIYD--VKGQVVFAKLKTLDLSSNKLAF-MG-PEFQSAAG--------VTWISLRNNKLV 227
Query: 473 GRLLPGISKFHNLVYLNLSNNKFE-GSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFP-D 530
+ + NL + +L N F G++ D + V+ + + +N
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 531 SAFHPGNSLLTFPNSPSQQDVPDLT 555
+ H G +P + L
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 35/263 (13%), Positives = 78/263 (29%), Gaps = 19/263 (7%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ L L + ++NN + ++ S+E L ++N + S +
Sbjct: 72 ETLDLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNISRVSCS---RGQGKKN 124
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG-DIMHLLSQLGSVVHVDLSNNQFSGS 200
+ +++N G +++YLDL+ N + L + ++ H++L N
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-- 182
Query: 201 LDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
+ + ++ L++S N L + NN LV + F
Sbjct: 183 ---DVKGQVVFAKLKTLDLSSNKL--AFMG-PEFQSAAGVTWISLRNNKLVLIEKALRFS 236
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNK 320
+L L N S ++ ++ G
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFF---SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 321 LSGSLPARVGHCTIVDLSNNRLS 343
++ L ++
Sbjct: 294 YCCEDLPAPFADRLIALGHHHHH 316
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 77/386 (19%), Positives = 134/386 (34%), Gaps = 59/386 (15%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
L++ + L P + ++ L I N+ + P+ +L+ L++ N+
Sbjct: 41 GNAVLNVGESGLTTL-PDCL--PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQL 93
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDG 233
+ L L + + S + L I N L P
Sbjct: 94 -TSLPVLPPGLLELSIFSNPLTHL----------PALPSGLCKLWIFGNQL--TSLP--- 137
Query: 234 MPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELD 293
L+ S+N L ++P L L +NQL+ SLP+ L EL
Sbjct: 138 -VLPPGLQELSVSDNQL-ASLP--ALPSELCKLWAYNNQLT-SLPMLPSG-----LQELS 187
Query: 294 LSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSG---DLSRMQ 350
+S NQL + L K+ +N+L+ SLPA + +S NRL+ S ++
Sbjct: 188 VSDNQLASLPTLPSE--LYKLWAYNNRLT-SLPALPSGLKELIVSGNRLTSLPVLPSELK 244
Query: 351 NWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLS 410
+ +S N LT +P S L S V N L LP L ++L
Sbjct: 245 E-------LMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 411 LNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNS 470
N L+ + ++T P+ ++ + T+ L L + D +
Sbjct: 293 GNPLSE---RTLQALREITSAPGYSG----PIIRFDMAGASAPRETRALHLAAADWLVPA 345
Query: 471 LSGRLLPGISKFHNLVYLNLSNNKFE 496
G P ++H + ++
Sbjct: 346 REGEPAP-ADRWHMFGQEDNADAFSL 370
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 75/376 (19%), Positives = 132/376 (35%), Gaps = 57/376 (15%)
Query: 136 LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195
+LN+ + T P + L + N + L + + +++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNN----LTSLPALPPELRTLEVSGN 91
Query: 196 QFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP 255
Q + SL + + + + L L N L ++P
Sbjct: 92 QLT-SLPVLPPG---LLELSIFSNPLTHLPALP---------SGLCKLWIFGNQL-TSLP 137
Query: 256 SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVN 315
L+ L + NQL+ SLP + L +L NQL + L++++
Sbjct: 138 --VLPPGLQELSVSDNQLA-SLPALPSE-----LCKLWAYNNQLTSLPMLPSG--LQELS 187
Query: 316 LSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTS 375
+S N+L+ SLP + NNRL+ + ++++ +S N LT +P S
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG----LKELIVSGNRLTS-LPVLPS 241
Query: 376 QFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSG 435
+ L VS N L LP + L + + N L L S + T +NL G
Sbjct: 242 E---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKF 495
N S LQ ++ +TS + + G S L+L+ +
Sbjct: 294 NPLS-ERTLQALRE-----------ITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
Query: 496 EGSIPDGLPNGLKEFN 511
+G P ++
Sbjct: 342 LVPAREGEPAPADRWH 357
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 64/360 (17%), Positives = 120/360 (33%), Gaps = 55/360 (15%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDI-GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLM 140
+ P + + + + +N L T + L L++S N L P L L
Sbjct: 54 TLPDCLP-AHITTLVIPDNNL----TSLPALPPELRTLEVSGNQLTSL-PVLPPGLLELS 107
Query: 141 LLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGS 200
+ + L L + N+ + L + + +S+NQ + S
Sbjct: 108 IFSNPLTHLPAL-------PSGLCKLWIFGNQ----LTSLPVLPPGLQELSVSDNQLA-S 155
Query: 201 LDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
L + S + L N L P L+ S+N L ++P
Sbjct: 156 LP------ALPSELCKLWAYNNQL--TSLPML----PSGLQELSVSDNQLA-SLP--TLP 200
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNK 320
L L +N+L+ SLP L EL +S N+L + LK++ +S N+
Sbjct: 201 SELYKLWAYNNRLT-SLPALPSG-----LKELIVSGNRLTSLPVLPSE--LKELMVSGNR 252
Query: 321 LSGSLPARVGHCTIVDLSNNRLSG---DLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQF 377
L+ SLP + + N+L+ L + + ++L N L+ +
Sbjct: 253 LT-SLPMLPSGLLSLSVYRNQLTRLPESLIHLSS----ETTVNLEGNPLSERTLQALRE- 306
Query: 378 LRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNN 437
+TS + + A E + + L+ + + ++ G
Sbjct: 307 --ITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 81/368 (22%), Positives = 135/368 (36%), Gaps = 62/368 (16%)
Query: 162 KLKYLDLRANRFGGDIMHLLSQLG-SVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNIS 220
L++ + + L L + + + +N + SL + ++ L +S
Sbjct: 41 GNAVLNVGESG----LTTLPDCLPAHITTLVIPDNNLT-SLP------ALPPELRTLEVS 89
Query: 221 ENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVA 280
N L P P L +F HL A+PS L L + NQL+ SLPV
Sbjct: 90 GNQL--TSLP-VLPPGLLELSIFSNPLTHLP-ALPS-----GLCKLWIFGNQLT-SLPVL 139
Query: 281 LLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNN 340
L EL +S NQL + L K+ +N+L+ SLP + +S+N
Sbjct: 140 PPG-----LQELSVSDNQLASLPALPSE--LCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191
Query: 341 RLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAV 397
+L+ S + + +N LT +P S L VS N L LP +
Sbjct: 192 QLASLPTLPSELYK-------LWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVL 239
Query: 398 LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQ 457
ELK + +S N L LP + L L++ N + LP + + + S
Sbjct: 240 PS---ELKELMVSGNRLTS--LPMLPSG--LLSLSVYRNQLTR-LP-ESLIHLSS----- 285
Query: 458 NLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNL 517
T+++L N LS R L + + + + +F+ + + + L
Sbjct: 286 ---ETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
Query: 518 SGVVPENL 525
Sbjct: 343 VPAREGEP 350
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 91/450 (20%), Positives = 157/450 (34%), Gaps = 84/450 (18%)
Query: 105 NITDIGSI-QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGK 162
+ + + + ++DLS N L + L++L L + + + F GL
Sbjct: 21 GLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 163 LKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSF--ISSIQYLNIS 220
L L L N+F + L ++ + L+ L + F ++S++ L +
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD---GAVLSGNFFKPLTSLEMLVLR 137
Query: 221 ENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVA 280
+N++ ++ P +F N+ +L L N++
Sbjct: 138 DNNIK-KIQPA---SFFLNMR--------------------RFHVLDLTFNKVKSICEED 173
Query: 281 LLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNN 340
LL + L LS L+ + + L K P + T +DLS N
Sbjct: 174 LLNFQGKHFTLLRLSSITLQ---------DMNEYWLGWEKCG--NPFKNTSITTLDLSGN 222
Query: 341 RLSGDLSRM---QNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAV 397
+++ G ++ + LS+++ G T+FK +N L A
Sbjct: 223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMG-------SSFGHTNFKDPDNFTFKGLEA- 274
Query: 398 LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQ 457
+K DLS + + L F T L L L+ N + +I +
Sbjct: 275 ----SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE------INKI----DDNAFW 320
Query: 458 NL-SLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIP----DGLPNGLKEFN 511
L L L+L+ N L + + L L+LS N ++ GLPN LKE
Sbjct: 321 GLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPN-LKELA 377
Query: 512 VSFNNLSGVVPENLRNFPDSAFHPGNSLLT 541
+ N L V PD F SL
Sbjct: 378 LDTNQLKSV--------PDGIFDRLTSLQK 399
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 61/309 (19%), Positives = 115/309 (37%), Gaps = 47/309 (15%)
Query: 98 SNNQLMGNITDIGSIQ---SLEFLDLSHNLFHGLIPSGI-VSLKNLMLLNISSNSFEGTF 153
+ L G + + SLE L L N + P+ ++++ +L+++ N +
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 154 PSGFGGLGKL----------KYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203
D+ G + + S+ +DLS N F S+
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSL 263
D+ + IQ L +S + +G F H DN + +
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS-------------GV 277
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKL 321
+ L +++ +L ++ + L +L L+ N++ + T L K+NLS N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFT-DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
Query: 322 SGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQ 373
S+ +R+ ++DLS N + + N ++++ L +N L VP+
Sbjct: 336 G-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN----LKELALDTNQLK-SVPDG 389
Query: 374 TSQFLRLTS 382
F RLTS
Sbjct: 390 I--FDRLTS 396
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 3/111 (2%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
LE L L+ N + + + L +L+ LN+S N F L KL+ LDL N
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224
L ++ + L NQ S+ G+ D ++S+Q + + N
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR--LTSLQKIWLHTNPW 407
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 67/339 (19%), Positives = 125/339 (36%), Gaps = 51/339 (15%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
LDL N L S +L L ++ N P F L L+ L LR+NR
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSF--ISSIQYLNISENSLVGELFPH 231
+ + + L ++ +D+S N+ L D F + +++ L + +N LV +
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIV-----ILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146
Query: 232 --DGMPYFDNLEVFDASNNHLVGAIP--SFNFVFSLRILRLGSNQLSGSLPVALLQESSM 287
G+ +LE +L +IP + + + L +LRL ++ ++ +
Sbjct: 147 AFSGLN---SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLY- 200
Query: 288 MLSELDLSLNQL--EGPVGSITSATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNR 341
L L++S + L ++++ L+ ++P + ++LS N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 342 LSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTY 401
+S + + L ++ RL ++ L P
Sbjct: 260 IS----------------TIEGSMLHELL--------RLQEIQLVGGQLAVVEPYAFRGL 295
Query: 402 PELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFS 439
L+V+++S N L L S F S L L L N +
Sbjct: 296 NYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 64/331 (19%), Positives = 123/331 (37%), Gaps = 53/331 (16%)
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV--FSLRILRLG 269
+ + L++ +N + + D F +LE + + N + A+ F F+LR L L
Sbjct: 32 TETRLLDLGKNRI--KTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLR 88
Query: 270 SNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPA 327
SN+L +P+ + S L++LD+S N++ LK + + N L
Sbjct: 89 SNRLK-LIPLGVFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV----- 141
Query: 328 RVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSN 387
+S+ SG L+ ++ + L LT + S L ++ +
Sbjct: 142 --------YISHRAFSG-LNSLE-------QLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 388 NSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS-------G 440
++ LKV+++S + P+ LT L+++ N +
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
Query: 441 PLP-LQEIQ--NNP----STGSTQNL-SLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLS 491
L L+ + NP L L + L L+ + P + L LN+S
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVS 304
Query: 492 NNKFEGSIP----DGLPNGLKEFNVSFNNLS 518
N+ ++ + N L+ + N L+
Sbjct: 305 GNQLT-TLEESVFHSVGN-LETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 48/297 (16%), Positives = 100/297 (33%), Gaps = 36/297 (12%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGS-----IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
L + ++ N ++ + + +L L L N + L NL L
Sbjct: 54 SFPHLEELELNENI----VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKL 109
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLD 202
+IS N F L LK L++ N S L S+ + L +
Sbjct: 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT---- 165
Query: 203 LGLGDSSFI--SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
+ + + L + ++ L+V + S+ + +
Sbjct: 166 -SIPTEALSHLHGLIVLRLRHLNI--NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 261 -FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLS 317
+L L + L+ ++P ++ L L+LS N + + L+++ L
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLV-YLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 318 SNKLSGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFL 366
+L+ + + ++++S N+L+ + N +E + L SN L
Sbjct: 281 GGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN----LETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 52/299 (17%), Positives = 103/299 (34%), Gaps = 56/299 (18%)
Query: 244 DASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P 302
V A+P R+L LG N++ +L L EL+L+ N +
Sbjct: 17 LCHRKRFV-AVPE-GIPTETRLLDLGKNRIK-TLNQDEFASFPH-LEELELNENIVSAVE 72
Query: 303 VGSITS-ATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWG 353
G+ + L+ + L SN+L +P V + T +D+S N++ + N
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN-- 129
Query: 354 NYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNH 413
++ + + N L + ++ F L S L+ + L +
Sbjct: 130 --LKSLEVGDNDLV-YISHRA--FSGLNS---------------------LEQLTLEKCN 163
Query: 414 LNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG 473
L + L L L + I++ + L L++++
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHL------NINAIRDYSFKRLYR---LKVLEISHWPYLD 214
Query: 474 RLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFP 529
+ P NL L++++ ++P L+ N+S+N +S + L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 88/468 (18%), Positives = 159/468 (33%), Gaps = 63/468 (13%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANR 172
+ L LS N L I L L +L +S N + F L+YLD+ NR
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL----VGEL 228
++ L H+DLS N F L + + ++ + +L +S + +
Sbjct: 112 LQNISCCPMASL---RHLDLSFNDFD-VLPVC-KEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 229 FPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMM 288
+L + H+ G + + +L L + S L + S
Sbjct: 167 AHLHLSCILLDLV-----SYHIKGGETESLQIPNTTVLHLVFHPNS--LFSVQVNMSVNA 219
Query: 289 LSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSR 348
L L LS +L L ++ L+ +L ++ +
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL-------QHIETTWKCSVKLFQF 272
Query: 349 MQNWG---NYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405
+ ++ ++ + L V N A+ + E+
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGN--------NFSGPLPLQE--IQNN----- 450
+ LS++ + + + T LN + N S LQ +Q N
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 451 -PSTGSTQNL-SLTSLDLAYNSL-SGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGL 507
T+N+ SL +LD++ NSL S + +++ LNLS+N GS+ LP +
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
Query: 508 KEFNVSFNNLSGVVPEN----------------LRNFPDSAFHPGNSL 539
K ++ N + +P++ L++ PD F SL
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL 499
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-18
Identities = 92/454 (20%), Positives = 163/454 (35%), Gaps = 45/454 (9%)
Query: 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG--FGGLGKLKYLDLRA 170
Q LE+LD+SHN + + +L L++S N F+ P FG L KL +L L A
Sbjct: 100 QDLEYLDVSHNRLQNI-SCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSA 155
Query: 171 NRF-GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYL--NISENSLVGE 227
+F D++ + S + +DL + G L + N + V
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215
Query: 228 LFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQE-SS 286
G N+++ D + L+ + +L + L + + V L Q
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 287 MMLSELDLSLNQLEGPV----GSITSATLKKV---NLSSNKLSGSLPA---RVGHCTIVD 336
+ L++ + + + + LK + ++ + S A I
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 337 LSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPA 396
LS + + ++ + N T V S RL + + N L+ +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 397 V---LGTYPELKVIDLSLNHLNGFLLPSFFT-STKLTDLNLSGNNFSG------PLPLQE 446
V L+ +D+SLN LN + + LNLS N +G P ++
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKV 454
Query: 447 --IQNNP----STGSTQNLSLTSLDLAYNSLSGRLLPG--ISKFHNLVYLNLSNNKFEGS 498
+ NN T +L L++A N L + +P + +L Y+ L +N ++ +
Sbjct: 455 LDLHNNRIMSIPKDVTHLQALQELNVASNQL--KSVPDGVFDRLTSLQYIWLHDNPWDCT 512
Query: 499 IPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSA 532
P L E+ + V PDSA
Sbjct: 513 CPGIR--YLSEWIN--KHSGVVRNSAGSVAPDSA 542
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 61/374 (16%), Positives = 129/374 (34%), Gaps = 31/374 (8%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSG---IVSLKNLMLLNI 144
L L + +S + D+ + L + +L I G + + N +L++
Sbjct: 144 NLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 145 SSNSFEGTFPSGFGGLGKLKYLDLRANRFGG-------DIMHLLSQLGSVVHVDLSNNQF 197
+ + L +L L + + L++ ++++V L + +
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 198 SGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSF 257
+ + L + ++YLNI ++ + + L+ + + S
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 258 NFVFS----LRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL-EGPVGSITSAT-L 311
++S + I L + V SS + L+ + N + ++ L
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS--FTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 312 KKVNLSSNKLSGSLPARVGHCT------IVDLSNNRL-SGDLSRMQNWGNYVEDIHLSSN 364
+ + L N L + +D+S N L S R W + ++LSSN
Sbjct: 380 QTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 365 FLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
LTG V ++ + NN + +P + L+ ++++ N L F
Sbjct: 439 MLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495
Query: 425 STKLTDLNLSGNNF 438
T L + L N +
Sbjct: 496 LTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 42/275 (15%), Positives = 102/275 (37%), Gaps = 16/275 (5%)
Query: 55 RNWFGITCTNGYVTSIMLN--DMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDI--- 109
+ + ++ L + + + + +++ N + I
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298
Query: 110 ---GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYL 166
+++SL + + +F + + + +S + +L
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358
Query: 167 DLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVG 226
+ N F + S L + + L N + + +SS++ L++S NSL
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 227 ELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESS 286
+ + +++ V + S+N L G++ +++L L +N++ S+P + +
Sbjct: 418 HAYDRT-CAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIM-SIPKDVTHLQA 474
Query: 287 MMLSELDLSLNQLEG-PVGSITS-ATLKKVNLSSN 319
L EL+++ NQL+ P G +L+ + L N
Sbjct: 475 --LQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 47/281 (16%), Positives = 104/281 (37%), Gaps = 29/281 (10%)
Query: 256 SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVN 315
+ + L+ + ++ + + L + + + L G + + + L+++
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 316 LSSNKLSGSLPARVGHCT-----IVDLSNNRLSG---DLSRMQNWGN-YVEDIHLSSNFL 366
L + +++G+ P + T I++L N + L+ +Q W ++ + ++
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 367 TGMVPNQTSQFLRLTSFKVSNNSLEGDLP----AVLGTYPELKVIDLSLNHLN---GFLL 419
Q F L++ +S+N G+ +P L+V+ L + G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 420 PSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
+L L+LS N+ L SL+L++ L ++ G+
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ--------LNSLNLSFTGLK-QVPKGL 272
Query: 480 SKFHNLVYLNLSNNKFEG-SIPDGLPNGLKEFNVSFNNLSG 519
L L+LS N+ + PD LP + ++ N
Sbjct: 273 --PAKLSVLDLSYNRLDRNPSPDELPQ-VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 38/298 (12%)
Query: 157 FGGLGKLKYLDLRANRFGGDIMHL-LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQ 215
+GG L+YL R + + + S+ + + + + G IS +Q
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 216 YLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF-----SLRILRLGS 270
L + + G P +L + + N + L++L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 271 NQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSA------TLKKVNLSSNKLSGS 324
+ ++ LS LDLS N G G I++ TL+ + L + +
Sbjct: 159 AHSL-NFSCEQVRVFP-ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--- 213
Query: 325 LPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFL-RLTSF 383
SG S + ++ + LS N L + + +L S
Sbjct: 214 ---------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 384 KVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGP 441
+S L+ +P L +L V+DLS N L+ PS ++ +L+L GN F
Sbjct: 259 NLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 59/321 (18%), Positives = 100/321 (31%), Gaps = 64/321 (19%)
Query: 191 DLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHL 250
S +D F I+ L++ ++ P + L V S
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA--LRVLGISG--- 96
Query: 251 VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITS-- 308
L+ L L + +++G+ P LL+ + L+ L+L +
Sbjct: 97 ------------LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144
Query: 309 ----ATLKKVNLSSNKLSGSLPARVGHC---TIVDLSNNRLSGDLSRMQNWGNYVEDIHL 361
LK ++++ +V + +DLS+N G+ L
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE-------------RGL 191
Query: 362 SSNFLTGMVPNQTSQFLRLTSFKVSNN---SLEGDLPAVLGTYPELKVIDLSLNHLNGFL 418
S P L + N + G A+ +L+ +DLS N L
Sbjct: 192 ISALCPLKFPT-------LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 419 LPSFFT-STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLP 477
++L LNLS +P L+ LDL+YN L P
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAK-----------LSVLDLSYNRLDR--NP 290
Query: 478 GISKFHNLVYLNLSNNKFEGS 498
+ + L+L N F S
Sbjct: 291 SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 41/229 (17%), Positives = 77/229 (33%), Gaps = 14/229 (6%)
Query: 311 LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSR---MQNWGNYVEDIHLSSNFLT 367
LK+V+ ++ + + + + R+ + + ++++ L + +T
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 368 GMVPNQTSQF--LRLTSFKVSNNSLEGDLPAVLGTY----PELKVIDLSLNHLNGFLLPS 421
G P + L + N S + P LKV+ ++ H F
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 422 FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISK 481
L+ L+LS N G L + Q L+L + + + SG +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--ETPSGVCSALAAA 226
Query: 482 FHNLVYLNLSNNKFEGSIPDGL---PNGLKEFNVSFNNLSGVVPENLRN 527
L L+LS+N + P+ L N+SF L V
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 39/221 (17%), Positives = 70/221 (31%), Gaps = 43/221 (19%)
Query: 67 VTSIMLNDMGLVGNFSFPTIIGLKMLCNV---SVSNNQLMG-NITDIGSIQSLEFLDLSH 122
+ + L ++ ++ + + + S++ + + + +L LDLS
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 123 N-------LFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG 175
N L L P +L+ L L N + G + +L+ LDL
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL------- 235
Query: 176 DIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMP 235
S+N + + S + LN+S L ++
Sbjct: 236 -----------------SHNSLRDAAGAPS--CDWPSQLNSLNLSFTGLK-QVPK----G 271
Query: 236 YFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGS 276
L V D S N L PS + + + L L N S
Sbjct: 272 LPAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 28/180 (15%), Positives = 52/180 (28%), Gaps = 17/180 (9%)
Query: 358 DIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGF 417
D T ++ + + + L + + ++ + L G L + L+ + L + G
Sbjct: 53 DTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGAL--RVLGISGLQELTLENLEVTGT 110
Query: 418 LLPSFF--TSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRL 475
P T L LNL +++ L L +A
Sbjct: 111 APPPLLEATGPDLNILNLRNVSWATRDAWL-----AELQQWLKPGLKVLSIAQAHSLNFS 165
Query: 476 LPGISKFHNLVYLNLSNNKFEGSI-------PDGLPNGLKEFNVSFNNLSGVVPENLRNF 528
+ F L L+LS+N G P P L+ + +
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT-LQVLALRNAGMETPSGVCSALA 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 62/346 (17%), Positives = 120/346 (34%), Gaps = 71/346 (20%)
Query: 114 SLEFLDLSHNLFHGL--IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171
L + S GL +P + + LL++ +N F L L L L N
Sbjct: 32 HLRVVQCSDL---GLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 172 RFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLV---GEL 228
+ + L + + LS NQ L + ++Q L + EN + +
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM----P-KTLQELRVHENEITKVRKSV 140
Query: 229 FPHDGMPYFDNLEVFDASNNHL-VGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQES 285
F +G+ + V + N L I + F + L +R+ ++ ++P L
Sbjct: 141 F--NGLN---QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS- 193
Query: 286 SMMLSELDLSLNQLEGPVGSITSAT------LKKVNLSSNKLSGSLPARV----GHCTIV 335
L+EL L N++ + +A+ L K+ LS N +S ++ H +
Sbjct: 194 ---LTELHLDGNKIT----KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLREL 245
Query: 336 DLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
L+NN+L G L+ + ++ ++L +N ++ + +N
Sbjct: 246 HLNNNKLVKVPGGLADHKY----IQVVYLHNNNIS----------------AIGSNDFCP 285
Query: 393 DLPAVLGTYPELKVIDLSLNHLNGFLLPS--FFTSTKLTDLNLSGN 436
P + L N + + + F + L
Sbjct: 286 --PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 52/312 (16%), Positives = 98/312 (31%), Gaps = 59/312 (18%)
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP--SFNFVFSLRILRLG 269
L++ N + NL NN + I +F + L L L
Sbjct: 52 PDTALLDLQNNKI--TEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS 108
Query: 270 SNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT------LKKVNLSSNKLSG 323
NQL LP + + L EL + N++ + + + V L +N L
Sbjct: 109 KNQLK-ELPEKMPKT----LQELRVHENEIT----KVRKSVFNGLNQMIVVELGTNPL-- 157
Query: 324 SLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSF 383
+ N G + ++ I ++ +T +P LT
Sbjct: 158 ---------KSSGIENGAFQG-MKKLSY-------IRIADTNIT-TIPQGL--PPSLTEL 197
Query: 384 KVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP 443
+ N + A L L + LS N ++ S + L +L+L+ N
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK------ 251
Query: 444 LQEIQNNPSTGSTQNLSLTSLDLAYNSLSG------RLLPGISKFHNLVYLNLSNNKFE- 496
L ++ G + + + L N++S +K + ++L +N +
Sbjct: 252 LVKVPG----GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307
Query: 497 GSIPDGLPNGLK 508
I +
Sbjct: 308 WEIQPSTFRCVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 44/250 (17%), Positives = 90/250 (36%), Gaps = 34/250 (13%)
Query: 88 GLKMLCNVSVSNNQLMGNITDI--GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
L L + +S NQL ++ ++L+ L + N + S L ++++ +
Sbjct: 98 PLVKLERLYLSKNQL----KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 146 SNSF-EGTFPSG-FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203
+N +G F G+ KL Y+ + L L + L N+ +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL---TELHLDGNKIT----- 205
Query: 204 GLGDSSF--ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS-FNFV 260
+ +S ++++ L +S NS+ + + +L +NN LV +P
Sbjct: 206 KVDAASLKGLNNLAKLGLSFNSI--SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 261 FSLRILRLGSNQLS----GSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT------ 310
++++ L +N +S S + L N ++ I +T
Sbjct: 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ--YWEIQPSTFRCVYV 320
Query: 311 LKKVNLSSNK 320
V L + K
Sbjct: 321 RAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 37/203 (18%), Positives = 71/203 (34%), Gaps = 26/203 (12%)
Query: 333 TIVDLSNNRLS---GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+V S+ L DL + L +N +T + L + + NN
Sbjct: 34 RVVQCSDLGLEKVPKDLPP------DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
+ P +L+ + LS N L L + L +L + N + +++
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKT--LQELRVHENE------ITKVRK 138
Query: 450 NPSTGSTQNL-SLTSLDLAYNSLSGRLLPG--ISKFHNLVYLNLSNNKFEGSIPDGLPNG 506
L + ++L N L + L Y+ +++ +IP GLP
Sbjct: 139 ----SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS 193
Query: 507 LKEFNVSFNNLSGVVPENLRNFP 529
L E ++ N ++ V +L+
Sbjct: 194 LTELHLDGNKITKVDAASLKGLN 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 44/208 (21%), Positives = 85/208 (40%), Gaps = 21/208 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK--RLREGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
IGR T+YK ++ +A + R+ ++ F E + L ++HPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 795 GYYWGPKEHEKLV--ISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNY 850
+ + +K + ++ + + +L YL+ + ++ + + L +
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQF 144
Query: 851 LH-NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEF 909
LH I H +LK NI + PT + + D L + ++ + G + PE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEM 201
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
DVYAFG+ +LE+ T +
Sbjct: 202 YEEKY---DESVDVYAFGMCMLEMATSE 226
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 6e-20
Identities = 59/283 (20%), Positives = 98/283 (34%), Gaps = 33/283 (11%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGF 157
+ N+ + + + I L L+ L P + + +L I+ N+ + P
Sbjct: 45 NRNEAVSLLKEC-LINQFSELQLNRLNLSSL-PDNL--PPQITVLEITQNALI-SLPELP 99
Query: 158 GGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYL 217
L+YLD NR + L S+ H+D+ NNQ + L + ++Y+
Sbjct: 100 AS---LEYLDACDNR----LSTLPELPASLKHLDVDNNQLT-MLP------ELPALLEYI 145
Query: 218 NISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSL 277
N N L + P +LEV NN L +P SL L + +N L SL
Sbjct: 146 NADNNQL--TMLPEL----PTSLEVLSVRNNQL-TFLPE--LPESLEALDVSTNLLE-SL 195
Query: 278 P--VALLQESSMMLSELDLSLNQLEGPVGSITSAT-LKKVNLSSNKLSGSLPARVGHCTI 334
P S N++ +I S + L N LS + + T
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 335 V-DLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQ 376
D R+ +S Q + + + + SQ
Sbjct: 256 QPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 5e-18
Identities = 56/298 (18%), Positives = 101/298 (33%), Gaps = 38/298 (12%)
Query: 239 NLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
+ + N V + L+L LS SLP L + ++ L+++ N
Sbjct: 38 KQALPGENRNEAVSLLKECLIN-QFSELQLNRLNLS-SLPDNLPPQ----ITVLEITQNA 91
Query: 299 LEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVED 358
L S L+ ++ N+LS +LP +D+ NN+L+ + +E
Sbjct: 92 LISLPELPAS--LEYLDACDNRLS-TLPELPASLKHLDVDNNQLT----MLPELPALLEY 144
Query: 359 IHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFL 418
I+ +N LT M+P + L V NN L LP + + L+ +D+S N L
Sbjct: 145 INADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLES-- 194
Query: 419 LPSFFTS-----TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG 473
LP+ N + +P + I + ++ L N LS
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITH-IP-ENILSLDP--------TCTIILEDNPLSS 244
Query: 474 RLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDS 531
R+ +S+ + F S + ++ +
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHA 302
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 66/355 (18%), Positives = 117/355 (32%), Gaps = 44/355 (12%)
Query: 72 LNDMGLVGNFSFPTIIG--LKMLCNVSVSNNQLMGNITDI-GSIQSLEFLDLSHNLFHGL 128
LN + L S P + + +L ++ N L + SLE+LD N L
Sbjct: 66 LNRLNLS---SLPDNLPPQITVL---EITQNAL----ISLPELPASLEYLDACDNRLSTL 115
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
P SLK+ L++ +N P L+Y++ N+ + L S+
Sbjct: 116 -PELPASLKH---LDVDNNQLT-MLPE---LPALLEYINADNNQ----LTMLPELPTSLE 163
Query: 189 HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLE----VFD 244
+ + NNQ + L S++ L++S N L E P + E F
Sbjct: 164 VLSVRNNQLT-FL------PELPESLEALDVSTNLL--ESLP-AVPVRNHHSEETEIFFR 213
Query: 245 ASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVG 304
N + + + + L N LS + +L Q+++ + G
Sbjct: 214 CRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA--QPDYHGPRIYFSMSDG 271
Query: 305 SITSATLKKVNLSSNKLSGSLPARVG---HCTIVDLSNNRLSGDLSRMQNWGNYVEDIHL 361
+ + + + + V H + N S L R+ + +
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331
Query: 362 SSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
+ S LR SF V+ ++ E V T+ L+ L G
Sbjct: 332 REQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEG 386
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 16/121 (13%)
Query: 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF-SGPLPLQEIQNNPSTGSTQNLSLTSLDL 466
+ N ++G F K L G N L+E N + L L
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN---------QFSELQL 66
Query: 467 AYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLR 526
+LS L + + L ++ N S+P+ + L+ + N LS +PE
Sbjct: 67 NRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS-LEYLDACDNRLS-TLPELPA 120
Query: 527 N 527
+
Sbjct: 121 S 121
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-18
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 36/212 (16%)
Query: 738 EVIGRSCHGTLYKAT---LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSL 793
I G +Y A ++ G + +K L G A+ + E + L + HP++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 794 QGYYWGPKEHEKLVISN-------YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
+ + EH Y+ QSL + L + E + +++
Sbjct: 145 --FNFV--EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILP 193
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR 905
L+YLH + + +LK NI+L T + L D + S G + G G++
Sbjct: 194 ALSYLH-SIGLVYNDLKPENIML---TEEQLKLIDLGAVSRINSFGY---LY--GTPGFQ 244
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE T P++ +D+Y G L L
Sbjct: 245 APEIVRTG---PTVATDIYTVGRTLAALTLDL 273
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 65/394 (16%), Positives = 117/394 (29%), Gaps = 109/394 (27%)
Query: 114 SLEFLDLSHNLFHGL--IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171
L + S GL +P I + LL++ +N F GL L L L N
Sbjct: 34 HLRVVQCSDL---GLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 172 RFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLV---GEL 228
+ S L + + +S N + L SS+ L I +N + +
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL----P-SSLVELRIHDNRIRKVPKGV 142
Query: 229 FPHDGMPYFDNLEVFDASNNHL-VGAIPSFNFV-FSLRILRLGSNQLSGSLPVALLQESS 286
F G+ N+ + N L F L LR+ +L+ +P L +
Sbjct: 143 F--SGLR---NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPET-- 194
Query: 287 MMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDL 346
L+EL L N+++ +I L S + L +N++
Sbjct: 195 --LNELHLDHNKIQ----AIELEDLL--RYSK-------------LYRLGLGHNQIR--- 230
Query: 347 SRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKV 406
+ + L+ + P L+
Sbjct: 231 -------------MIENGSLSFL--------------------------------PTLRE 245
Query: 407 IDLSLNHLNGFLLPS-FFTSTKLTDLNLSGNNFSGPLPLQEIQNN---PSTGSTQNLSLT 462
+ L N L+ +P+ L + L NN + ++ N P +
Sbjct: 246 LHLDNNKLS--RVPAGLPDLKLLQVVYLHTNN------ITKVGVNDFCPVGFGVKRAYYN 297
Query: 463 SLDLAYNSLSGRLLPG--ISKFHNLVYLNLSNNK 494
+ L N + + + + + N K
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 42/229 (18%), Positives = 84/229 (36%), Gaps = 32/229 (13%)
Query: 311 LKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNF 365
L+ V S L ++P + T++DL NN +S D +Q+ + + L +N
Sbjct: 35 LRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQH----LYALVLVNNK 89
Query: 366 LTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS 425
++ + S +L +S N L ++P L + + N + F
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGL 146
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNP-STGSTQNLSLTSLDLAYNSLSGRLLPGISKFHN 484
+ + + GN ++N+ G+ L L L ++ L+ + +
Sbjct: 147 RNMNCIEMGGNP---------LENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PET 194
Query: 485 LVYLNLSNNKFEGSIPD----GLPNGLKEFNVSFNNLSGVVPENLRNFP 529
L L+L +NK + +I L + N + + +L P
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSK-LYRLGLGHNQIRMIENGSLSFLP 241
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 15/128 (11%)
Query: 403 ELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLT 462
L+V+ S L +P S T L+L N+ + E++ + G L
Sbjct: 34 HLRVVQCSDLGLKA--VPKEI-SPDTTLLDLQNND------ISELRKDDFKGLQH---LY 81
Query: 463 SLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVV 521
+L L N +S ++ S L L +S N IP LP+ L E + N + V
Sbjct: 82 ALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVP 139
Query: 522 PENLRNFP 529
Sbjct: 140 KGVFSGLR 147
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 24/229 (10%), Positives = 59/229 (25%), Gaps = 35/229 (15%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE---FAREVKKLGNIKHPNLVSL 793
E + ++ ++ A+K G + E + +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETD-------------------------PRK 828
+ + + + + L+ +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 829 LPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT 888
I + + R L + + HG+ N+ + P +L D S +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDNLFIM-PDGRLMLGDVSALWKVG 245
Query: 889 SAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ G A + + Y P EF + S + + + G+ + +
Sbjct: 246 TRGPAS----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 63/289 (21%), Positives = 125/289 (43%), Gaps = 25/289 (8%)
Query: 738 EVIGRSCHGTLYKATLD-----SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS 792
+ +G+ G++ D +G ++AVK+L+ + ++F RE++ L +++H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+G + +I Y+ SL YLQ+ R + + L+ + + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPEF 909
+R I H +L + NIL+E N V + D+ L ++L +V G PE
Sbjct: 163 TKRYI-HRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
+ SK S+ SDV++FG++L EL T + S ++ +++
Sbjct: 220 LTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------ 271
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
L+ + + +P ++ + C ++RP + + I
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 60/295 (20%), Positives = 119/295 (40%), Gaps = 24/295 (8%)
Query: 738 EVIGRSCHGTLYKATLD-----SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS 792
+G+ G++ D +G+++AVK+L+ +++F RE++ L + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+G +GP ++ Y+ + L +LQ R L L + + + + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPEF 909
+ R + H +L + NIL+E+ V + D+ L ++L V G PE
Sbjct: 145 SRRCV-HRDLAARNILVESE--AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969
S + S +SDV++FG++L EL T + C
Sbjct: 202 LSDNI--FSRQSDVWSFGVVLYELFTY---CDKSCSPSAEFLRMMGCERDVPALS--RLL 254
Query: 970 DRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ L+ +G + PP +++ ++ C +RP ++ +L +
Sbjct: 255 E-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 63/289 (21%), Positives = 125/289 (43%), Gaps = 25/289 (8%)
Query: 738 EVIGRSCHGTLYKATLD-----SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVS 792
+ +G+ G++ D +G ++AVK+L+ + ++F RE++ L +++H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+G + +I Y+ SL YLQ+ R + + L+ + + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPEF 909
+R I H +L + NIL+E N V + D+ L ++L +V G PE
Sbjct: 132 TKRYI-HRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
+ SK S+ SDV++FG++L EL T + S ++ +++
Sbjct: 189 LTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------ 240
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
L+ + + +P ++ + C ++RP + + I
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 33/243 (13%)
Query: 707 NACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLRE 766
++ S E+ GD + + + ++S P +V+G GT+ + +AVKR
Sbjct: 3 SSPSLEQDDGD----EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR--- 55
Query: 767 GIAKGKKEFA-REVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNYIN----AQSLAVY 820
I FA REV+ L +HPN++ + YI A +L Y
Sbjct: 56 -ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ-------YIAIELCAATLQEY 107
Query: 821 LQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNA---- 876
+++ D E + + L +LH I H +LK NIL+ P +
Sbjct: 108 VEQKDFA----HLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 877 VLTDYSLHRILTSAGTADQVLN--AGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLEL 933
+++D+ L + L + + G G+ PE + K P+ D+++ G + +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 934 LTG 936
++
Sbjct: 223 ISE 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E+IG G ++KA G +KR + ++ REVK L + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 797 YWGPKEHEKLVISNYINAQSLAVYL-----------QETDPRKLPPLSIDERLRVAVDVA 845
+ G + N +++ +++ Q + R+ L L + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR 905
+ ++Y+H+++ + + +LK +NI L T + D+ L L + G + G L Y
Sbjct: 133 KGVDYIHSKK-LINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYM 188
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938
PE S S+ + D+YA G+IL ELL
Sbjct: 189 SPEQIS-SQDY-GKEVDLYALGLILAELLHVCD 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 54/378 (14%), Positives = 108/378 (28%), Gaps = 70/378 (18%)
Query: 136 LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195
L ++ + + D + H + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-------NRWHSAWRQANSNNPQIETR 63
Query: 196 QFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP 255
G + ++ + + L P
Sbjct: 64 T-------GRALKATADLLEDAT------------------QPGRVALELRSVPLP-QFP 97
Query: 256 S--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P--VGSITSAT 310
F L+ + + + L LP + Q + L L L+ N L P + S+
Sbjct: 98 DQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAG--LETLTLARNPLRALPASIASLNR-- 151
Query: 311 LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMV 370
L+++++ + LP + + SG+ + N ++ + L + +
Sbjct: 152 LRELSIRACPELTELPEPLA--------STDASGEHQGLVN----LQSLRLEWTGIRS-L 198
Query: 371 PNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTD 430
P + L S K+ N+ L L + P+L+ +DL P F L
Sbjct: 199 PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257
Query: 431 LNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISKFHNLVYLN 489
L L + LP +I L L LDL RL I++ +
Sbjct: 258 LILKDCSNLLTLP-LDIHR---------LTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 490 LSNNKFEGSIPDGLPNGL 507
+ + + + P
Sbjct: 308 VPPH-LQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 47/335 (14%), Positives = 94/335 (28%), Gaps = 66/335 (19%)
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSN 271
S + L ++ + HD + + D + H + N + +I
Sbjct: 12 SGRENLYFQGSTALRPY--HDVLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGR 66
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLE---GPVGSITSATLKKVNLSSNKLSGSLPAR 328
L + L + L+L L ++ L+ + + + L LP
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSH--LQHMTIDAAGLM-ELPDT 122
Query: 329 VGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV 385
+ + L+ N L +P + RL +
Sbjct: 123 MQQFAGLETLTLARNPLRA-------------------------LPASIASLNRLRELSI 157
Query: 386 SNNSLEGDLPAVLGTYPE---------LKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSG 435
+LP L + L+ + L + LP+ + L L +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS--LPASIANLQNLKSLKIRN 215
Query: 436 NNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNK 494
+ S L P+ +L L LDL + P L L L +
Sbjct: 216 SPLSA-LG-------PAIH---HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 495 FEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRN 527
++P + L++ ++ +P +
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 41/291 (14%), Positives = 79/291 (27%), Gaps = 31/291 (10%)
Query: 71 MLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQS--LEFLDLSHNLFHGL 128
+ S + + L + L+L
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQF 96
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL---LSQLG 185
P L +L + I + P L+ L L N + L ++ L
Sbjct: 97 -PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNP----LRALPASIASLN 150
Query: 186 SVVHVDLSNNQFSGSLDLGLGDSSFISSI------QYLNISENSLVGELFPHDGMPYFDN 239
+ + + L L + Q L + + P + N
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI--RSLP-ASIANLQN 207
Query: 240 LEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLS-LNQ 298
L+ N+ L P+ + + L L L + P + L L L +
Sbjct: 208 LKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP--LKRLILKDCSN 265
Query: 299 LEG-P--VGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLS 343
L P + +T L+K++L LP+ + I+ + + +
Sbjct: 266 LLTLPLDIHRLTQ--LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 19/106 (17%), Positives = 30/106 (28%), Gaps = 3/106 (2%)
Query: 84 PTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSH-NLFHGLIPSGIVSLKNLML 141
P I L L + + + N G L+ L L + L P I L L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEK 281
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSV 187
L++ PS L + + + H +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 60/313 (19%), Positives = 101/313 (32%), Gaps = 48/313 (15%)
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
IPSG+ + L++S+N S L+ L L +N S LGS+
Sbjct: 46 IPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103
Query: 189 HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
H+DLS N S +L +SS+ +LN+ N L + L++ N
Sbjct: 104 HLDLSYNYLS-NLSSSWFKP--LSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159
Query: 249 HLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSI 306
I F + L L + ++ L S L+ +S L L + Q
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQN-VSHLILHMKQH------- 210
Query: 307 TSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFL 366
L ++L + L + L
Sbjct: 211 ------------ILLLEIFVDVTSSVECLELRDTDLD----------------TFHFSEL 242
Query: 367 TGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS- 425
+ N + + K+++ SL + +L L ++ S N L + F
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRL 300
Query: 426 TKLTDLNLSGNNF 438
T L + L N +
Sbjct: 301 TSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 48/296 (16%), Positives = 106/296 (35%), Gaps = 62/296 (20%)
Query: 244 DASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P 302
S+ L +IPS +++ L L +N+++ + + LQ L L L+ N +
Sbjct: 37 KGSSGSL-NSIPS-GLTEAVKSLDLSNNRIT-YISNSDLQRCVN-LQALVLTSNGINTIE 92
Query: 303 VGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS--GDLSRMQNWGNY 355
S +S L+ ++LS N LS +L + T ++L N G+ S +
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK- 150
Query: 356 VEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLN 415
++ + + + + + F LT L+ +++ + L
Sbjct: 151 LQILRVGNMDTFTKIQRKD--FAGLTF---------------------LEELEIDASDLQ 187
Query: 416 GFLLPSFFTSTKLTDLNLSGNNFS-----------------------GPLPLQEIQNNPS 452
+ S + ++ L L E+ +
Sbjct: 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 453 TGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
+ + ++ + SL +++ +++ L+ L S N+ + S+PDG+ + L
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT 301
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 50/247 (20%), Positives = 84/247 (34%), Gaps = 46/247 (18%)
Query: 88 GLKMLCNVSVSNNQLMGNITDI-----GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
L + +++N I I S+ SLE LDLS+N L S L +L L
Sbjct: 74 RCVNLQALVLTSNG----INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFL 129
Query: 143 NISSNSFEGTFPSG--------------------------FGGLGKLKYLDLRANRFGGD 176
N+ N ++ + F GL L+ L++ A+
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189
Query: 177 IMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPH----- 231
L + +V H+ L Q L D + SS++ L + + L F
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT--SSVECLELRDTDLDTFHFSELSTGE 246
Query: 232 -DGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLS 290
+ + ++ L + N + L L NQL S+P + + L
Sbjct: 247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT-SLQ 304
Query: 291 ELDLSLN 297
++ L N
Sbjct: 305 KIWLHTN 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 15/213 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+ +G + L G A+KR+ + ++E RE HPN++ L Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 797 YWGPKE--HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
+ HE ++ + +L ++ K L+ D+ L + + + R L +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERL-KDKGNFLTEDQILWLLLGICRGLEAIH-A 152
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--------GALGYRP 906
+ H +LK TNILL VL D + + YR
Sbjct: 153 KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 907 PE-FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
PE F+ S ++DV++ G +L ++ G+
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 738 EVIGRSCHGTLYKATLDS--GSILAVKRLREGIAKGK---KEFAREVKKLGNIKHPNLVS 792
+ +G T+Y A D+ +A+K + + + K F REV + H N+VS
Sbjct: 17 DKLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ ++ ++ YI +L+ Y++ PLS+D + + + + H
Sbjct: 76 M--IDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH 128
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG--TADQVLNAGALGYRPPEFA 910
+ I H ++K NIL+ + D+ + + L+ + VL G + Y PE A
Sbjct: 129 -DMRIVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQA 184
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
+D+Y+ GI+L E+L G+
Sbjct: 185 KGEATDE--CTDIYSIGIVLYEMLVGE 209
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 53/240 (22%), Positives = 94/240 (39%), Gaps = 21/240 (8%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR- 172
S + + +P+GI + L + SN + F L +L L L +N
Sbjct: 8 SGTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 173 -FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPH 231
F G S+ ++DLS N ++ + + +++L+ ++L ++
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS---SNFLGLEQLEHLDFQHSNLK-QMSEF 119
Query: 232 DGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMML 289
NL D S+ H + FN + SL +L++ N + + E L
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR-NL 177
Query: 290 SELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHC----TIVDLSNNRLS 343
+ LDLS QLE + S + L+ +N+S N SL C ++D S N +
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 44/216 (20%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGI-VSLKNLMLLNISS 146
G L + +S N ++ ++ ++ LE LD H+ + + +SL+NL+ L+IS
Sbjct: 76 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 147 NSFEGTFPSGFGGLGKLKYLDLRANRFGGDIM-HLLSQLGSVVHVDLSNNQFSGSLDLGL 205
F F GL L+ L + N F + + + ++L ++ +DLS Q
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE------- 188
Query: 206 GDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSL 263
+S + +L+V + S+N+ ++ + + + SL
Sbjct: 189 ------------QLSPTAFNS----------LSSLQVLNMSHNNFF-SLDTFPYKCLNSL 225
Query: 264 RILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
++L N + + LQ L+ L+L+ N
Sbjct: 226 QVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/312 (20%), Positives = 111/312 (35%), Gaps = 52/312 (16%)
Query: 244 DASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPV 303
++ L ++P+ S L L SN+L SLP + + + L++L LS N L
Sbjct: 13 RCNSKGLT-SVPT-GIPSSATRLELESNKLQ-SLPHGVFDKLTQ-LTKLSLSSNGLS--F 66
Query: 304 GSITSAT------LKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLS-----GDLSRM 349
S + LK ++LS N + ++ + +D ++ L +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 350 QNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV----SNNSLEGDLPAVLGTYPELK 405
+N + + +S + N F L+S +V N+ E LP + L
Sbjct: 126 RN----LIYLDISHTHTR-VAFNGI--FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLD 465
+DLS L +F + + L LN+S NN + P SL LD
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN------FFSLDTFPYKCLN---SLQVLD 229
Query: 466 LAYNSLSGRLLPGI--SKFHNLVYLNLSNNKFE---GSIPDGLPNGLKEFNVSFNNLSGV 520
+ N + +L +LNL+ N F +K+ + +
Sbjct: 230 YSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFACTCEHQS--FLQWIKDQRQLLVEVERM 286
Query: 521 V---PENLRNFP 529
P + + P
Sbjct: 287 ECATPSDKQGMP 298
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 43/238 (18%), Positives = 86/238 (36%), Gaps = 56/238 (23%)
Query: 312 KKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFL 366
++ +S L+ S+P + T ++L +N+L G ++ + + LSSN L
Sbjct: 10 TEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQ----LTKLSLSSNGL 64
Query: 367 TGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTST 426
+ + TS LK +DLS N + + +F
Sbjct: 65 S-FKGCCSQSDFGTTS---------------------LKYLDLSFNGVIT-MSSNFLGLE 101
Query: 427 KLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGI-SKFHN 484
+L L+ +N ++ +L +L LD+++ GI + +
Sbjct: 102 QLEHLDFQHSN---------LKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 151
Query: 485 LVYLNLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSL 539
L L ++ N F+ + + L ++S L + +AF+ +SL
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL--------SPTAFNSLSSL 201
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 9/117 (7%)
Query: 88 GLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
GL L + ++ N N +++L FLDLS L P+ SL +L +LN+S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 146 SNSFEGTFPSGFGGLGKLKYLDLRANRF----GGDIMHLLSQLGSVVHVDLSNNQFS 198
N+F + L L+ LD N ++ H S L ++L+ N F+
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL---AFLNLTQNDFA 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 738 EVIGRSCHGTLYKATLDS--GSILAVKRLREGIAKG---KKEFAREVKKLGNIKHPNLVS 792
++GR G +Y+A D+ I+A+K + E ++ + RE + G ++ P++V
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 793 LQGYYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
+ + +G + +L + IN LA L+ PL+ + + + L+
Sbjct: 99 I--HDFG-EIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAA 150
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG--TADQVLNAGALGYRPPEF 909
H H ++K NIL+ + A L D+ + T + G L Y PE
Sbjct: 151 H-AAGATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPER 206
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
S S ++D+YA +L E LTG
Sbjct: 207 FSESHATY--RADIYALTCVLYECLTGS 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 58/291 (19%), Positives = 122/291 (41%), Gaps = 27/291 (9%)
Query: 738 EVIGRSCHGTLYKATLD-----SGSILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+G G + D +G +AVK L+ + +E++ L N+ H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
+G + +I ++ + SL YL + + +++ ++L+ AV + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPE 908
+ + + H +L + N+L+E+ + V + D+ L + + + V + PE
Sbjct: 143 GSRQYV-HRDLAARNVLVESE--HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
SK + SDV++FG+ L ELLT S + + ++ T +
Sbjct: 200 CLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-------QMTVT 250
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
+ +G + PP ++ Q+ +C S R ++ E ++
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-16
Identities = 75/473 (15%), Positives = 145/473 (30%), Gaps = 102/473 (21%)
Query: 113 QSLEFLDLSHNLFHGLIPSGIVSL----KNLMLLNISSNSFEGT----FPSGFGGLGKLK 164
++ LD+ L + L + ++ + S L
Sbjct: 3 LDIQSLDIQCE---ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 165 YLDLRANRFGGDIMHLLSQL-----GSVVHVDLSNNQFS--GSLDLGLGDSSFISSIQYL 217
L+LR+N G +H + Q + + L N + G L + + ++Q L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT-LPTLQEL 118
Query: 218 NISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS--G 275
++S+N L DA L + L L+L LS
Sbjct: 119 HLSDNLLG------------------DAGLQLLCEGLLDPQC--RLEKLQLEYCSLSAAS 158
Query: 276 SLPVALLQESSMMLSELDLSLNQLEGPVG--------SITSATLKKVNLSSNKLS----G 323
P+A + + EL +S N + G + L+ + L S ++
Sbjct: 159 CEPLASVLRAKPDFKELTVSNNDI-NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217
Query: 324 SLPARVGHCTIV---DLSNNRLSGD----LSRMQNWGNY-VEDIHLSSNFLTG------- 368
L V + L +N+L L + + + + +T
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 369 -MVPNQTSQFLRLTSFKVSNNSLEGD-----LPAVLGTYPELKVIDLSLNHLNG----FL 418
++ + S L ++ N L + +L +L+ + +
Sbjct: 278 RVLRAKES----LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 333
Query: 419 LPSFFTSTKLTDLNLSGNNF--SGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLS---- 472
+ L +L +S N +G L + P + L L LA +S
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS------VLRVLWLADCDVSDSSC 387
Query: 473 GRLLPGISKFHNLVYLNLSNNKFEGS----IPDGLPN---GLKEFNVSFNNLS 518
L + H+L L+LSNN + + + + L++ + S
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 69/424 (16%), Positives = 123/424 (29%), Gaps = 113/424 (26%)
Query: 92 LCNVSVSNNQLMGNITDIG---------SIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
+ +S+ N +T G ++ +L+ L LS N L +G+ L +L
Sbjct: 87 IQKLSLQNC----CLTGAGCGVLSSTLRTLPTLQELHLSDN---LLGDAGLQLLCEGLL- 138
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFG----GDIMHLLSQLGSVVHVDLSNNQFS 198
+L+ L L + +L + +SNN +
Sbjct: 139 --DPQC-------------RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 199 --GSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFD-------NLEVFDASNNH 249
G L G ++ L + + D +L +N
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGV-----TSDNCRDLCGIVASKASLRELALGSNK 238
Query: 250 --------LVGAIPSFNFVFSLRILRLGSNQLS--GSLPVALLQESSMMLSELDLSLNQL 299
L + + LR L + ++ G + + + L EL L+ N+L
Sbjct: 239 LGDVGMAELCPGLLHPS--SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 300 EGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDI 359
+ TL + L + + +
Sbjct: 297 GDEGARLLCETLLEPGCQLESL--------------WVKSCSFTAACCS----------- 331
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGD-----LPAVLGTYPELKVIDLSLNHL 414
H SS + N+ L ++SNN LE + L+V+ L+ +
Sbjct: 332 HFSS----VLAQNRF-----LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 415 N----GFLLPSFFTSTKLTDLNLSGNNF--SGPLPLQEIQNNPSTGSTQNLSLTSLDLAY 468
+ L + + L +L+LS N +G L L E P L L L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP------GCLLEQLVLYD 436
Query: 469 NSLS 472
S
Sbjct: 437 IYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 45/249 (18%), Positives = 83/249 (33%), Gaps = 48/249 (19%)
Query: 308 SATLKKVNLSSNKLSGS----LPARVGHCTIVDLSNNRLS----GDLSRMQNWGNYVEDI 359
S ++ +++ +LS + L + C +V L + L+ D+S + ++
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 360 HLSSNFLTG----------MVPNQTSQFLRLTSFKVSNNSL--EG--DLPAVLGTYPELK 405
+L SN L P+ Q L L N L G L + L T P L+
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSL-----QNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 406 VIDLSLNHLNGFLLPSFFT-----STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
+ LS N L L +L L L + + + ++
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL-SAASCEPL----ASVLRAKPD 171
Query: 461 LTSLDLAYNSLSGR----LLPGISKFH-NLVYLNLSNNKF--EG--SIPDGLPN--GLKE 509
L ++ N ++ L G+ L L L + + + + + L+E
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 510 FNVSFNNLS 518
+ N L
Sbjct: 232 LALGSNKLG 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-16
Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 50/291 (17%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQG 795
E IGR G ++ L + + L AVK RE + K +F +E + L HPN+V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
++ ++ + +L+ R L + L++ D A + YL ++
Sbjct: 180 V--CTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTS 913
I H +L + N L+ ++D+ + R G + + PE +
Sbjct: 234 CI-HRDLAARNCLV-TEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYG 290
Query: 914 KPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966
+ S +SDV++FGI+L E + S+ +
Sbjct: 291 RY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTR----------------------- 325
Query: 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
+ G + P + ++ +C +RP ++++EL +I
Sbjct: 326 ----EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 51/207 (24%), Positives = 76/207 (36%), Gaps = 12/207 (5%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQ 794
IG +G K G IL K L G K+ EV L +KHPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
++ Y LA + + ++ L + LRV + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKG-TKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 855 RA----IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
+ H +LK N+ L+ N L D+ L RIL + + G Y PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQM 188
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
+ + KSD+++ G +L EL
Sbjct: 189 N-RMSY-NEKSDIWSLGCLLYELCALM 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 57/297 (19%), Positives = 112/297 (37%), Gaps = 52/297 (17%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+G+ C G ++ T + + +A+K L+ G + F +E + + ++H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
E +++ Y++ SL +L+ + L + + +A +A + Y+ +
Sbjct: 249 ---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQIASGMAYVERMNYV 302
Query: 858 PHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSK 914
H +L++ NIL+ + D+ L R++ + PE A +
Sbjct: 303 -HRDLRAANILVGEN--LVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 915 PCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
++KSDV++FGI+L EL T G + E++
Sbjct: 358 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------------------ 391
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ G+ M PP + + +C ERP + L + Q
Sbjct: 392 ---DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 45/243 (18%), Positives = 87/243 (35%), Gaps = 34/243 (13%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
+ +L+L N + L +L +L + NS F GL L L+L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW- 134
Query: 174 GGDIMHL----LSQLGSVVHVDLSNNQFSGSLDLGLGDSSF--ISSIQYLNISEN----S 223
+ + L + + L NN + +F + S+ L++ E
Sbjct: 135 ---LTVIPSGAFEYLSKLRELWLRNNPIE-----SIPSYAFNRVPSLMRLDLGELKKLEY 186
Query: 224 LVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQ 283
+ F +G+ NL+ + ++ +P+ + L L + N +
Sbjct: 187 ISEGAF--EGLF---NLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFP-EIRPGSFH 239
Query: 284 ESSMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDL 337
L +L + +Q+ + L ++NL+ N LS SLP + + + L
Sbjct: 240 -GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
Query: 338 SNN 340
+N
Sbjct: 298 HHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 47/260 (18%), Positives = 89/260 (34%), Gaps = 44/260 (16%)
Query: 308 SATLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLS 362
S KV + LS +P + + ++L N + + + +E + L
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHH----LEVLQLG 107
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSF 422
N + + + L + ++ +N L +L+ + L N + +
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 423 FTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGIS 480
F L L+L L+ I G+ + L +L L+L ++ +P ++
Sbjct: 167 FNRVPSLMRLDLGELK-----KLEYISE----GAFEGLFNLKYLNLGMCNIKD--MPNLT 215
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPE-------------- 523
L L +S N F I G +G LK+ V + +S +
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274
Query: 524 --NLRNFPDSAFHPGNSLLT 541
NL + P F P L+
Sbjct: 275 HNNLSSLPHDLFTPLRYLVE 294
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 59/273 (21%), Positives = 95/273 (34%), Gaps = 58/273 (21%)
Query: 212 SSIQYLNISEN---SLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP--SFNFVFSLRIL 266
S+ +YLN+ EN + + F H +LEV N + I +FN + SL L
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRH-----LHHLEVLQLGRNSI-RQIEVGAFNGLASLNTL 128
Query: 267 RLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKK-VNLSSNKLSGSL 325
L N L+ +P + S L EL L N +E SI S + +L L
Sbjct: 129 ELFDNWLT-VIPSGAFEYLSK-LRELWLRNNPIE----SIPSYAFNRVPSLMRLDLG--- 179
Query: 326 PARVGHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLT 381
+L G + N ++ ++L + +PN L
Sbjct: 180 ------------ELKKLEYISEGAFEGLFN----LKYLNLGMCNIK-DMPN----LTPLV 218
Query: 382 SFKV---SNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF 438
+ S N P LK + + + ++ +F L +LNL+ NN
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN- 277
Query: 439 SGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSL 471
L + ++ T L L L +N
Sbjct: 278 -----LSSLPHDLFTPLR---YLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 25/110 (22%), Positives = 48/110 (43%), Gaps = 1/110 (0%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
GL L +++ + ++ ++ + LE L++S N F + P L +L L + ++
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
+ F GL L L+L N L + L +V + L +N +
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 38/169 (22%), Positives = 61/169 (36%), Gaps = 21/169 (12%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGS-----IQSLEFLDLSH-NLFHGLIPSGIVSLKNLML 141
L L + + NN I I S + SL LDL + L NL
Sbjct: 145 YLSKLRELWLRNNP----IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
LN+ + L L+ L++ N F L S+ + + N+Q S
Sbjct: 201 LNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS--- 255
Query: 202 DLGLGDSSF--ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+ ++F ++S+ LN++ N+L PHD L +N
Sbjct: 256 --LIERNAFDGLASLVELNLAHNNL--SSLPHDLFTPLRYLVELHLHHN 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 34/223 (15%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA--KGKKEFAREVKKLGNI-KHPNLVSL 793
E IG G+++K G I A+KR ++ +A ++ REV + +H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 794 QGYY--WGPKEHEKLVISN-YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
Y+ W E + ++I N Y N SLA + E R + E + + V R L Y
Sbjct: 76 --YFSAW--AEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRY 130
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG------- 903
+H+ + H ++K +NI + + ++ S + + G LG
Sbjct: 131 IHSMSLV-HMDIKPSNIFI---SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 904 ---------YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ E + K+D++A + ++ +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 59/289 (20%), Positives = 119/289 (41%), Gaps = 36/289 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ +G G ++ AT + + +AVK ++ G + + F E + ++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+ +I+ ++ SL +L+ + K P + + + +A + ++ I
Sbjct: 253 ---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYI 306
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSKP 915
H +L++ NIL+ + ++ + D+ L R++ + PE +
Sbjct: 307 -HRDLRAANILV-SASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS- 361
Query: 916 CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975
++KSDV++FGI+L+E++T G I PG + N E +
Sbjct: 362 -FTIKSDVWSFGILLMEIVTY---GRIPY--PG------------MSNP--EVIRA-LER 400
Query: 976 GHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
G+ M +P ++ + +RC ERP + L +SQ
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 30/241 (12%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
+ L+L N + + L++L +L +S N F GL L L+L NR
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR- 123
Query: 174 GGDIMHL----LSQLGSVVHVDLSNNQFSGSLDLGLGDSSF--ISSIQYLNISENSLVGE 227
+ + L + + L NN + +F I S++ L++ E +
Sbjct: 124 ---LTTIPNGAFVYLSKLKELWLRNNPIE-----SIPSYAFNRIPSLRRLDLGELKRLSY 175
Query: 228 LFPH--DGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQES 285
+ +G+ NL + + +L IP+ + L L L N LS ++ Q
Sbjct: 176 ISEGAFEGLS---NLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQ-G 229
Query: 286 SMMLSELDLSLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSN 339
M L +L + +Q++ + + L ++NL+ N L+ LP + H + L +
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 340 N 340
N
Sbjct: 289 N 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 47/259 (18%), Positives = 89/259 (34%), Gaps = 42/259 (16%)
Query: 308 SATLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLS 362
S KV L +P + + +++L N++ +++ +E + LS
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRH----LEILQLS 96
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSF 422
N + + + L + ++ +N L +LK + L N + +F
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF 156
Query: 423 FTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLPGISK 481
L L+L L I G+ + L +L L+LA +L +P ++
Sbjct: 157 NRIPSLRRLDLGELK-----RLSYISE----GAFEGLSNLRYLNLAMCNLRE--IPNLTP 205
Query: 482 FHNLVYLNLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPE--------------- 523
L L+LS N +I G G L++ + + + +
Sbjct: 206 LIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH 264
Query: 524 -NLRNFPDSAFHPGNSLLT 541
NL P F P + L
Sbjct: 265 NNLTLLPHDLFTPLHHLER 283
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 42/220 (19%), Positives = 75/220 (34%), Gaps = 22/220 (10%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGS-----IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
L+ L + +S N I I + +L L+L N + V L L L
Sbjct: 86 HLRHLEILQLSRNH----IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKEL 141
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDL-RANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
+ +N E F + L+ LDL R L ++ +++L+
Sbjct: 142 WLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--- 198
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNF 259
+ + + + + L++S N L +L+ + + I F+
Sbjct: 199 --EIPNLTPLIKLDELDLSGNHL--SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
Query: 260 VFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
+ SL + L N L+ LP L L + L N
Sbjct: 254 LQSLVEINLAHNNLT-LLPHDLFTPLH-HLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 51/251 (20%), Positives = 91/251 (36%), Gaps = 38/251 (15%)
Query: 237 FDNLEVFDASNNHLVGAIPSFNFVF--SLRILRLGSNQLSGSLPVALLQESSMMLSELDL 294
N + + N + I +F L IL+L N + A ++ L+ L+L
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN--LNTLEL 119
Query: 295 SLNQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLS-NNRLS---- 343
N+L P G+ + LK++ L +N + S+P+ +DL RLS
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 344 GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKV---SNNSLEGDLPAVLGT 400
G + N + ++L+ L +PN L S N L P
Sbjct: 179 GAFEGLSN----LRYLNLAMCNLR-EIPN----LTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 401 YPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
L+ + + + + +F L ++NL+ NN L + ++ T
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN------LTLLPHDLFTPLH---H 280
Query: 461 LTSLDLAYNSL 471
L + L +N
Sbjct: 281 LERIHLHHNPW 291
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 64/308 (20%), Positives = 118/308 (38%), Gaps = 81/308 (26%)
Query: 738 EVIGRSCHGTLYKATL----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+V+G GT+YK + I A+K LRE K KE E + ++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G +I+ + L Y++E + L V +A+ +NYL
Sbjct: 81 RLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYL 133
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRIL--------TSAG------TADQV 896
+ R + H +L + N+L++ P V +TD+ L ++L G A +
Sbjct: 134 EDRRLV-HRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGV 949
+ +R + + +SDV+++G+ + EL+T G + EI
Sbjct: 191 IL-----HR--IY--------THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------ 229
Query: 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMS 1008
++ G + QPP D+ + +C ++ A RP
Sbjct: 230 ---------------------SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRE 268
Query: 1009 VFEELSTI 1016
+ E S +
Sbjct: 269 LIIEFSKM 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 4e-15
Identities = 47/294 (15%), Positives = 98/294 (33%), Gaps = 27/294 (9%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
++ + + + S++ + +++ + GI L N+ L ++ N
Sbjct: 19 AFAETIKDNLKKKSV-TDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 75
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGL 205
P L L +L L N+ I L L L + + L +N S ++ GL
Sbjct: 76 KLTDIKP--LTNLKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLEHNGIS-DIN-GL 127
Query: 206 GDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRI 265
+ ++ L + N + ++ + L+ +N + I + L+
Sbjct: 128 ---VHLPQLESLYLGNNKIT-DITVLSRLT---KLDTLSLEDNQIS-DIVPLAGLTKLQN 179
Query: 266 LRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSL 325
L L N +S +A L+ L L+L + I + V + GSL
Sbjct: 180 LYLSKNHISDLRALAGLKN----LDVLELFSQECLNK--PINHQSNLVVPNTVKNTDGSL 233
Query: 326 PARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLR 379
D + L N +++ ++ + +Q L+
Sbjct: 234 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLK 287
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 2e-13
Identities = 43/224 (19%), Positives = 77/224 (34%), Gaps = 32/224 (14%)
Query: 311 LKKVNLSSNKLSGSLP-ARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM 369
K NL ++ ++ + + +N+ + + +Q N V + L+ N LT +
Sbjct: 23 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQGIQYLPN-VTKLFLNGNKLTDI 80
Query: 370 VPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLT 429
P + L + N ++ DL + L +LK + L N ++ + +L
Sbjct: 81 KPL--TNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGLVHLPQLE 134
Query: 430 DLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLN 489
L L N + L + L +L L N +S + ++ L L
Sbjct: 135 SLYLGNNKITDITVLSRLTK-----------LDTLSLEDNQISD--IVPLAGLTKLQNLY 181
Query: 490 LSNNKFEGSIPD-----GLPNGLKEFNVSFNNLSGVVPENLRNF 528
LS N I D GL N L + + N
Sbjct: 182 LSKNH----ISDLRALAGLKN-LDVLELFSQECLNKPINHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 2e-11
Identities = 31/196 (15%), Positives = 60/196 (30%), Gaps = 29/196 (14%)
Query: 337 LSNNRLS--GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDL 394
+ + +L +T V ++ + +N+ ++ +
Sbjct: 6 TVSTPIKQIFPDDAFAE----TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SV 58
Query: 395 PAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTG 454
+ P + + L+ N L + L L L N L++++
Sbjct: 59 QG-IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSSLKDLKK----- 110
Query: 455 STQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP-DGLPNGLKEFNVS 513
L SL L +N +S + G+ L L L NNK L L ++
Sbjct: 111 ------LKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTK-LDTLSLE 161
Query: 514 FNNLSGVVPENLRNFP 529
N +S + L
Sbjct: 162 DNQISDI--VPLAGLT 175
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 51/326 (15%), Positives = 104/326 (31%), Gaps = 56/326 (17%)
Query: 131 SGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVV 188
+ + N+ S L + + + I + + L +V
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSD----IKSVQGIQYLPNVT 68
Query: 189 HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+ L+ N+ ++ I+ L NL N
Sbjct: 69 KLFLNGNK--------------LTDIKPLT-----------------NLKNLGWLFLDEN 97
Query: 249 HLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSI 306
+ + S + L+ L L N +S + L + L L L N++ + +
Sbjct: 98 KIK-DLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ----LESLYLGNNKITDITVLSRL 152
Query: 307 TSATLKKVNLSSNKLSGSLP--ARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSN 364
T L ++L N++S + A + + LS N +S DL + N ++ + L S
Sbjct: 153 TK--LDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKN-LDVLELFSQ 207
Query: 365 FLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
N S + + K ++ SL P ++ + + ++ + SF
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIF 265
Query: 425 STKLTDLNLSGN-NFSGPLPLQEIQN 449
+T + PL+E+
Sbjct: 266 YQPVTIGKAKARFHGRVTQPLKEVYT 291
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 23/112 (20%), Positives = 44/112 (39%), Gaps = 5/112 (4%)
Query: 86 IIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
++ L L ++ + NN++ +IT + + L+ L L N + + L L L +S
Sbjct: 127 LVHLPQLESLYLGNNKI-TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLS 183
Query: 146 SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
N + GL L L+L + ++ S L V ++
Sbjct: 184 KNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 738 EVIGRSCHGTLYKATLDS--GSILAVKRLREGIAKGK---KEFAREVKKLGNIKHPNLVS 792
E++G ++ A D +AVK LR +A+ F RE + + HP +V+
Sbjct: 18 EILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 793 L--QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
+ G P ++ Y++ +L + P ++ + V D + LN+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNF 131
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA----DQVLNAGALGYRP 906
H + I H ++K NI++ + T + D+ + R + +G + V+ G Y
Sbjct: 132 SH-QNGIIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLS 187
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE A +SDVY+ G +L E+LTG+
Sbjct: 188 PEQARGDSVDA--RSDVYSLGCVLYEVLTGE 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 29/297 (9%)
Query: 738 EVIGRSCHGTLYKATLD-----SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLV 791
+G G + D +G ++AVK L+ + + + +E+ L + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
+G ++ Y+ SL YL + + + L A + + YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYL 150
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPE 908
H + I H +L + N+LL+ V + D+ L + + +V G PE
Sbjct: 151 HAQHYI-HRDLAARNVLLDND--RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
K SDV++FG+ L ELLT SS ++ + +
Sbjct: 208 CLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG-------QMTVL 258
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
L+ G + +P + +++ + C AS RP ++ L T+ + Q
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-15
Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 56/300 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-AVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G +G +Y+ S+ AVK L+E +EF +E + IKHPNLV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+E +I+ ++ +L YL+E + +++ + + L +A ++ + YL +
Sbjct: 285 C--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLEKKNF 339
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP-----PEFAS 911
I H NL + N L+ + D+ L R++T A A P PE +
Sbjct: 340 I-HRNLAARNCLV-GENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPESLA 392
Query: 912 TSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENR 964
+K S+KSDV+AFG++L E+ T G ++
Sbjct: 393 YNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------------- 429
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
L+ + ME+P + ++ C S+RP + + T+ E
Sbjct: 430 ------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 9e-15
Identities = 57/296 (19%), Positives = 113/296 (38%), Gaps = 50/296 (16%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+G+ C G ++ T + + +A+K L+ G + F +E + + ++H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
E +++ Y++ SL +L+ + L + + +A +A + Y+ +
Sbjct: 332 ---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQIASGMAYVERMNYV 385
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSKP 915
H +L++ NIL+ + + D+ L R++ + PE A +
Sbjct: 386 -HRDLRAANILV-GENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 916 CPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
++KSDV++FGI+L EL T G + E++
Sbjct: 442 --TIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------------------- 474
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ G+ M PP + + +C ERP + L + Q
Sbjct: 475 --DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 46/262 (17%), Positives = 95/262 (36%), Gaps = 39/262 (14%)
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG--PVGSITSATLKKVNLSSN 319
+ + G + ++ ++ A L ++ L + V + + L + L N
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDG----ITTLSAFGTGVTTIEGVQYLNN--LIGLELKDN 73
Query: 320 KLS-----GSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQT 374
+++ +L T ++LS N L ++S + + ++ + L+S +T + P
Sbjct: 74 QITDLAPLKNLT----KITELELSGNPLK-NVSAIAGLQS-IKTLDLTSTQITDVTPL-- 125
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434
+ L + N + ++ L L+ + + ++ L +KLT L
Sbjct: 126 AGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKAD 181
Query: 435 GNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNK 494
N S PL + N L + L N +S + ++ NL + L+N
Sbjct: 182 DNKISDISPLASLPN-----------LIEVHLKNNQISD--VSPLANTSNLFIVTLTNQT 228
Query: 495 FEGSIPDGLPNGLKEFNVSFNN 516
+ P N L NV
Sbjct: 229 IT-NQPVFYNNNLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 21/218 (9%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
T L + +S + I + + +L L+L N L + + +L +
Sbjct: 33 DTVTQADLDGITTLSAFGTGV-TTIEGVQYLNNLIGLELKDNQITDL--APLKNLTKITE 89
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSL 201
L +S N S GL +K LDL + + D+ L+ L ++ + L NQ +
Sbjct: 90 LELSGNPL--KNVSAIAGLQSIKTLDLTSTQI-TDVTP-LAGLSNLQVLYLDLNQITNIS 145
Query: 202 DLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVF 261
L + ++++QYL+I + +L P + L A +N + I +
Sbjct: 146 PL-----AGLTNLQYLSIGNAQVS-DLTPLANLS---KLTTLKADDNKISD-ISPLASLP 195
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
+L + L +NQ+S P+A L + L+ +
Sbjct: 196 NLIEVHLKNNQISDVSPLANTSN----LFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 20/154 (12%), Positives = 48/154 (31%), Gaps = 18/154 (11%)
Query: 375 SQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434
+++ + + + + + L L L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 435 GNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNK 494
N + PL+ + +T L+L+ N L + I+ ++ L+L++ +
Sbjct: 72 DNQITDLAPLKNLTK-----------ITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQ 118
Query: 495 FEGSIPDGLPNGLKEFNVSFNNLSGVVP-ENLRN 527
P + L+ + N ++ + P L N
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTN 152
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 24/117 (20%), Positives = 49/117 (41%), Gaps = 7/117 (5%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ GL L + + NQ+ NI+ + + +L++L + + L + + +L L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTT 177
Query: 142 LNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFS 198
L N + S L L + L+ N+ D+ L+ ++ V L+N +
Sbjct: 178 LKADDNKI--SDISPLASLPNLIEVHLKNNQI-SDVSP-LANTSNLFIVTLTNQTIT 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 29/221 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+ +GR G +++A A+KR+R +++ REVK L ++HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 796 YYWGPKEHEKLVISN-----YI-----NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVA 845
+ EKL S+ YI ++L ++ + L + + +A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFLQIA 128
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG-- 903
+ +LH++ + H +LK +NI + D+ L + VL
Sbjct: 129 EAVEFLHSKGLM-HRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 904 ---------YRPPEFASTSKPCPSLKSDVYAFGIILLELLT 935
Y PE S K D+++ G+IL ELL
Sbjct: 187 HTGQVGTKLYMSPEQIH-GNSY-SHKVDIFSLGLILFELLY 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 45/211 (21%), Positives = 75/211 (35%), Gaps = 16/211 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL-REGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+++G+ +++ +G + A+K + RE + L + H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
K++I + SL L+E P L E L V DV +N+L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMNHLR-EN 131
Query: 856 AIPHGNLKSTNILLEA---PTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
I H N+K NI+ LTD+ R L + G Y P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYER 189
Query: 913 SKPCP------SLKSDVYAFGIILLELLTGK 937
+ D+++ G+ TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 26/205 (12%), Positives = 51/205 (24%), Gaps = 47/205 (22%)
Query: 738 EVIGRSCHGTLYKATLDS--GSILAVKRLREGIAKG---KKEFAREVKKLGNIKHPNLVS 792
G ++A D+ +A+ + +E +L I P +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ LV++ +I SL S +R +A + H
Sbjct: 96 V--LDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH 146
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
+ + + + + G VL P
Sbjct: 147 -RAGVALSIDHPSRVRV------------------SIDGDV--VL--AYPATMPDA---- 179
Query: 913 SKPCPSLKSDVYAFGIILLELLTGK 937
+ + D+ G L LL +
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 17/206 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
V+G+ +G +Y L + +A+K + E ++ + E+ ++KH N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 797 YWGPKEHE-KLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAV---DVARCLNYL 851
Y G + I + SL+ L+ K PL +E+ + + L YL
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLR----SKWGPLKDNEQT-IGFYTKQILEGLKYL 138
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
H+ + + H ++K N+L+ + ++D+ + L + G L Y PE
Sbjct: 139 HDNQIV-HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIID 196
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
+D+++ G ++E+ TGK
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGI--AKGKKEFAREVKKLGNIKHPNLVSL 793
+ IGR +Y+A L G +A+K+++ + AK + + +E+ L + HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 794 QGYYWGPKEHEKLVI-SNYINAQSLAVYLQETDPRKLPPLSIDER--LRVAVDVARCLNY 850
+ E +L I +A L+ ++ +K I ER + V + L +
Sbjct: 98 YASF---IEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQLCSALEH 151
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRPPEF 909
+H+ R + H ++K N+ + A V L D L R +S TA L G Y PE
Sbjct: 152 MHSRR-VMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPER 207
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ KSD+++ G +L E+ +
Sbjct: 208 IH-ENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFA-REVKKLGNIKHPNLVSLQ 794
+ IG G + G +K + ++ ++E + REV L N+KHPN+V +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 795 GYYWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ +E+ L I +Y L + +K D+ L V + L ++H+
Sbjct: 90 ESF---EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I H ++KS NI L L D+ + R+L S + G Y PE +
Sbjct: 144 RK-ILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICE-N 199
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
KP + KSD++A G +L EL T K
Sbjct: 200 KPY-NNKSDIWALGCVLYELCTLK 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 23/221 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQG 795
V+ +Y+A + SG A+KRL + + +EV + + HPN+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 796 YYWGPKE-----HEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
KE + ++ + L +L++ + R PLS D L++ R + +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQH 151
Query: 851 LHNER-AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILT----SAGTADQVLNA------ 899
+H ++ I H +LK N+LL L D+ ++ + +A +
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 900 -GALGYRPPEFASTSKPCP-SLKSDVYAFGIILLELLTGKS 938
YR PE P K D++A G IL L +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 49/308 (15%), Positives = 98/308 (31%), Gaps = 77/308 (25%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL--------AVKRLREGIAKGKKEFAREVKKLGNIKHPN 789
E +G+ ++K +K L + + F + + H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLN 849
LV G E +++ ++ SL YL++ ++I +L VA +A ++
Sbjct: 74 LVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMH 127
Query: 850 YLHNERAIPHGNLKSTNILLEAPTMNAV-------LTDYSLHRILTSAGTADQVLNAGAL 902
+L I HGN+ + NILL L+D + +
Sbjct: 128 FLEENTLI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------- 175
Query: 903 GYR------PPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGV 949
+ PPE K +L +D ++FG L E+ + S +
Sbjct: 176 ILQERIPWVPPECIENPKNL-NLATDKWSFGTTLWEICSGGDKPLSALDSQRKL------ 228
Query: 950 VDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMS 1008
+ D H + P +++ + C RP +
Sbjct: 229 ---------------------QFYEDRHQLPAPK--AAELANLINNCMDYEPDHRPSFRA 265
Query: 1009 VFEELSTI 1016
+ +L+++
Sbjct: 266 IIRDLNSL 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 18/205 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA--KGKKEFAREVKKLGNI-KHPNLVSL 793
+G +G ++K + G + AVKR K + EV + +HP V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ + +E L + + SL + + L + D L +LH+
Sbjct: 123 EQAW---EEGGILYLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ + H ++K NI L P L D+ L L +AG + G Y PE S
Sbjct: 176 QGLV-HLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELLQGS 231
Query: 914 KPCPSLKSDVYAFGIILLELLTGKS 938
+DV++ G+ +LE+
Sbjct: 232 ---YGTAADVFSLGLTILEVACNME 253
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 39/236 (16%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANR 172
S + LDLS N L S L +L++S + T G + L L L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHD 232
+ S L S+ + + SL+ + +++ LN++ N + + F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH--LKTLKELNVAHNLI--QSFKLP 142
Query: 233 GMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVAL---LQESSMML 289
YF NL +L L L SN++ S+ L + ++
Sbjct: 143 E--YFSNLT--------------------NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 290 SELDLSLNQLEG-PVGSITSATLKKVNLSSNKLSGSLP----ARVGHCTIVDLSNN 340
LDLSLN + G+ LK++ L +N+L S+P R+ + L N
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 46/208 (22%), Positives = 73/208 (35%), Gaps = 43/208 (20%)
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTY---PELKVIDLSLNHLNG 416
LS N L + F L +S ++ + G Y L + L+ N +
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED--GAYQSLSHLSTLILTGNPIQ- 89
Query: 417 FLLPS--FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGR 474
L F + L L N L ++N P L L++A+N +
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETN------LASLENFPIGHLKT---LKELNVAHNLIQSF 139
Query: 475 LLPGI-SKFHNLVYLNLSNNKFEGSIPDG-------LPNGLKEFNVSFNNLSGVVPE--- 523
LP S NL +L+LS+NK + SI +P ++S N ++ + P
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 524 ------------NLRNFPDSAFHPGNSL 539
L++ PD F SL
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSL 226
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 34/213 (15%)
Query: 309 ATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIH 360
+ K ++LS N L L + ++DLS + G + + + +
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH----LSTLI 82
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
L+ N + + S L +L +G LK ++++ N + F LP
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 421 SFFTS-TKLTDLNLSGNN--------FSGPLPLQ------EIQNNP----STGSTQNLSL 461
+F++ T L L+LS N + ++ NP G+ + + L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 462 TSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNN 493
L L N L + GI + +L + L N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 13/211 (6%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRF 173
+ + + L N + + + +NL +L + SN + F GL L+ LDL N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 174 GGDIM-HLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHD 232
+ LG + + L L GL ++++QYL + +N+L + P D
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG--LAALQYLYLQDNAL--QALPDD 147
Query: 233 GMPYFDNLEVFDASNNHLVGAIPSFNFV--FSLRILRLGSNQLSGSLPVALLQESSMMLS 290
NL N + ++P F SL L L N+++ + ++ L
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG-RLM 204
Query: 291 ELDLSLNQLEG-PVGSITSAT-LKKVNLSSN 319
L L N L P ++ L+ + L+ N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 41/268 (15%), Positives = 86/268 (32%), Gaps = 62/268 (23%)
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
+P GI + + N + F L L L +N
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-------------- 69
Query: 189 HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPH--DGMPYFDNLEVFDAS 246
+ F+G ++ ++ L++S+N+ + + P G+ L
Sbjct: 70 --RIDAAAFTG-----------LALLEQLDLSDNAQLRSVDPATFHGLG---RLHTLHLD 113
Query: 247 NNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PV 303
L + F + +L+ L L N L +LP + L+ L L N++ P
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR-DLGNLTHLFLHGNRISSVPE 170
Query: 304 GSITSAT-LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLS 362
+ L ++ L N+++ + DL + ++L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVA-HVHPHA----FRDLGR----------------LMTLYLF 209
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSL 390
+N L+ + + L ++++N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 32/214 (14%)
Query: 308 SATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDI 359
A +++ L N++S +PA + TI+ L +N L+ + + +E +
Sbjct: 31 PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL----LEQL 85
Query: 360 HLSSNFLTGMVPNQTSQFL-RLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHLNGF 417
LS N V T L RL + + L+ +L + L+ + L N L
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-A 143
Query: 418 LLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRL 475
L F LT L L GN + + + + L SL L L N ++ +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNR------ISSVPE----RAFRGLHSLDRLLLHQNRVA-HV 192
Query: 476 LPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
P L+ L L N ++P L+
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 13/166 (7%)
Query: 88 GLKMLCNVSVSNNQLMGNITD--IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
GL +L + +S+N + ++ + L L L L P L L L +
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 146 SNSFEGTFPSG-FGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLG 204
N+ + P F LG L +L L NR L S+ + L N+ +
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-----H 191
Query: 205 LGDSSF--ISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+ +F + + L + N+L P + + L+ ++N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNL--SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 41/213 (19%), Positives = 70/213 (32%), Gaps = 21/213 (9%)
Query: 239 NLEVFDASNNHLVGAIP--SFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
+ N + +P SF +L IL L SN L+ + A ++ L +LDLS
Sbjct: 33 ASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL-LEQLDLSD 89
Query: 297 N-QLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS----GD 345
N QL + L ++L L L + + L +N L
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 346 LSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405
+ N + + L N ++ + L + N + P L
Sbjct: 149 FRDLGN----LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNF 438
+ L N+L+ + L L L+ N +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 36/147 (24%), Positives = 53/147 (36%), Gaps = 24/147 (16%)
Query: 402 PELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNN--------FSGPLPLQE--IQNNP 451
+ I L N ++ SF LT L L N F+G L++ + +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 452 -----STGSTQNL-SLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDG-- 502
+ L L +L L L L PG+ L YL L +N + ++PD
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 503 --LPNGLKEFNVSFNNLSGVVPENLRN 527
L N L + N +S V R
Sbjct: 150 RDLGN-LTHLFLHGNRISSVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 9/115 (7%)
Query: 88 GLKMLCNVSVSNNQLMGNITDI-----GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
GL L + + +N + + + +L L L N + L +L L
Sbjct: 127 GLAALQYLYLQDNA----LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
+ N P F LG+L L L AN L+ L ++ ++ L++N +
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 66/309 (21%), Positives = 111/309 (35%), Gaps = 67/309 (21%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL----AVKRLREGI---AKGKKEFAREVKKLGNIKHPNL 790
E +G G + + D+ S AVK L+ + + +F REV + ++ H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 791 VSLQGYYWGPKEHEKLVISN---YINAQ-----SLAVYLQETDPRKLPPLSIDERLRVAV 842
+ L G V+ + + SL L++ + R AV
Sbjct: 84 IRLYG-----------VVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAV 128
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGA 901
VA + YL ++R I H +L + N+LL + V + D+ L R L D
Sbjct: 129 QVAEGMGYLESKRFI-HRDLAARNLLLATR--DLVKIGDFGLMRAL---PQNDDHYVMQE 182
Query: 902 LGYRP-----PEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWV 956
P PE T S SD + FG+ L E+ T G+ P W+
Sbjct: 183 HRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTY---GQE----P-------WI 226
Query: 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERP---DMMSVFEE 1012
L + ++ +G + +P D+ V ++C +RP + E
Sbjct: 227 ---GLNGS--QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281
Query: 1013 LSTIVLEKD 1021
+ +
Sbjct: 282 AQPTDMRAE 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 56/300 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-AVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G +G +Y+ S+ AVK L+E +EF +E + IKHPNLV L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+E +I+ ++ +L YL+E + +++ + + L +A ++ + YL +
Sbjct: 78 C--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLEKKNF 132
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP-----PEFAS 911
I H +L + N L+ + D+ L R++T A A P PE +
Sbjct: 133 I-HRDLAARNCLV-GENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPESLA 185
Query: 912 TSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENR 964
+K S+KSDV+AFG++L E+ T G ++
Sbjct: 186 YNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------------- 222
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
L+ + ME+P + ++ C S+RP + + T+ E
Sbjct: 223 ------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 38/239 (15%), Positives = 75/239 (31%), Gaps = 46/239 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK------RLREGIAKGKKEFAREVKKLGNIKHPNL 790
V+G+ +AT ++G V R K KE ++ L IK+
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 791 VSLQGYYWGPKEHEKL--------VISNYINAQSLAVYLQE---------------TDPR 827
+ + P + K V + + L+ + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 828 KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887
L RL++ + V R L LH+ + H L+ +I+L+ LT +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD 256
Query: 888 TSAGTADQVLNAGALGYRPPEFASTSKPCP---------SLKSDVYAFGIILLELLTGK 937
+ + + G+ PPE + + D +A G+++ +
Sbjct: 257 GARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 62/366 (16%), Positives = 116/366 (31%), Gaps = 68/366 (18%)
Query: 162 KLKYLDLRANRFGGDIMHLLSQL-----GSVVHVDLSNNQFS--GSLDLGLGDSSFISSI 214
+ LDL N L Q SV ++LS N S +L ++ +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 215 QYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS 274
LN+S N L S++ LV + + F++ +L LG N S
Sbjct: 83 TSLNLSGNFL------------------SYKSSDELVKTLAAIP--FTITVLDLGWNDFS 122
Query: 275 GSLPVAL---LQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGH 331
++ L+L N L L + + N L
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---------- 172
Query: 332 CTIVDLSNNRLS----GDLSRM-QNWGNYVEDIHLSSNFLTGMVPNQTSQFLR-----LT 381
+L N L+ +L++ + V + LS+N L + + +
Sbjct: 173 ----NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 382 SFKVSNNSLEGD----LPAVLGTYPELKVIDLSLNHLNGF-------LLPSFFTSTKLTD 430
S + N L G L + + L+ + L + + L +F K+
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 431 LNLSGNNF--SGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYL 488
++ +G S +P+ + S G SL + L + + ++ L
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELS-GKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRES 347
Query: 489 NLSNNK 494
+
Sbjct: 348 IQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 57/308 (18%), Positives = 97/308 (31%), Gaps = 62/308 (20%)
Query: 262 SLRILRLGSNQLSGSLPVAL---LQESSMMLSELDLSLNQLEGPVG--------SITSAT 310
+ L L N L V L + ++ L+LS N L G + A
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL-GFKNSDELVQILAAIPAN 81
Query: 311 LKKVNLSSNK--------LSGSLPARVGHCTIVDLSNNRLSGD----LSRM-QNWGNYVE 357
+ +NLS N L +L A T++DL N S + N +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 358 DIHLSSNFLT--GMV--------PNQTSQFLRLTSFKVSNNSL--EG--DLPAVLGTYPE 403
++L N L L L N+L + +L L + P
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNL-----RGNNLASKNCAELAKFLASIPA 196
Query: 404 -LKVIDLSLNHLN---GFLLPSFFTS--TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQ 457
+ +DLS N L L F+S + LNL N L+ +
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL-HGPSLENL----KLLKDS 251
Query: 458 NLSLTSLDLAYNSLSG-------RLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEF 510
L ++ L Y+ + L ++ ++ + + S + N ++E
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311
Query: 511 NVSFNNLS 518
+ + S
Sbjct: 312 SGKADVPS 319
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 58/307 (18%), Positives = 98/307 (31%), Gaps = 64/307 (20%)
Query: 266 LRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSI--------TSATLKKVNLS 317
+ GS PV ++ LDLSLN L + ++ T A++ +NLS
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNL-YSISTVELIQAFANTPASVTSLNLS 59
Query: 318 SNK--------LSGSLPARVGHCTIVDLSNNRLSGD----LSRM-QNWGNYVEDIHLSSN 364
N L L A + T ++LS N LS L + + + L N
Sbjct: 60 GNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 365 FLTGMVPNQTSQFLR-----LTSFKVSNNSLEGD----LPAVLGTYPE-LKVIDLSLNHL 414
+ ++ Q +TS + N L L +L P + ++L N+L
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
Query: 415 N-------GFLLPSFFTSTKLTDLNLSGNNF--SGPLPLQE-IQNNPSTGSTQNLSLTSL 464
L S +T L+LS N L + P+ + SL
Sbjct: 180 ASKNCAELAKFLAS--IPASVTSLDLSANLLGLKSYAELAYIFSSIPNH-------VVSL 230
Query: 465 DLAYNSLSG----RLLPGISKFHNLVYLNLSNNKFEGSIPDGL---------PNGLKEFN 511
+L N L G L +L + L + + + + +
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 512 VSFNNLS 518
+ +
Sbjct: 291 KNGKEIH 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 64/312 (20%), Positives = 122/312 (39%), Gaps = 77/312 (24%)
Query: 738 EVIGRSCHGTLYKATL----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+V+G GT+YK + I A+K LRE K KE E + ++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G +I+ + L Y++E + L V +A+ +NYL
Sbjct: 81 RLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYL 133
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAG---------- 900
+ R + H +L + N+L++ P V +TD+ L ++L G ++ +A
Sbjct: 134 EDRRLV-HRDLAARNVLVKTP--QHVKITDFGLAKLL---GAEEKEYHAEGGKVPIKWMA 187
Query: 901 --ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVD 951
++ +R + +SDV+++G+ + EL+T G + EI
Sbjct: 188 LESILHR--IYTH--------QSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------- 229
Query: 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVF 1010
++ G + QPP D+ + ++C ++ A RP +
Sbjct: 230 -------------------SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
Query: 1011 EELSTIVLEKDS 1022
E S + +
Sbjct: 271 IEFSKMARDPQR 282
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 64/399 (16%), Positives = 133/399 (33%), Gaps = 59/399 (14%)
Query: 639 HQDPLPSSPMESAYDAGETSSVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSR 698
++ P+S +A A + + + ++P + +
Sbjct: 250 LKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMP 309
Query: 699 FTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKATL--DSG 756
+ PE+L + A+ +G G++ +
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLLIADI-------ELGCGNFGSVRQGVYRMRKK 362
Query: 757 SIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814
I A+K L++G +E RE + + + +P +V L G + +++
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGG 419
Query: 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM 874
L +L + + + V+ + YL + + H NL + N+LL
Sbjct: 420 GPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKNFV-HRNLAARNVLLVNR-H 473
Query: 875 NAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSKPCPSLKSDVYAFGIILLE 932
A ++D+ L + L + + +AG + PE + K S +SDV+++G+ + E
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWE 531
Query: 933 LLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRI 985
L+ E++ I G ME PP
Sbjct: 532 ALSYGQKPYKKMKGPEVM---------------------------AFIEQGKRMECPPEC 564
Query: 986 LSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
++ + C I +RPD ++V + + S+
Sbjct: 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 32/273 (11%), Positives = 76/273 (27%), Gaps = 38/273 (13%)
Query: 684 SLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRS 743
LLS + S + L A P+ + L + ++G
Sbjct: 29 KLLSGLSKPVSSYPNTFEWQCKLPAIKPKT---EFQLGSKLVYVH---------HLLGEG 76
Query: 744 CHGTLYKAT------LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+Y+AT + +K + + +++L + +
Sbjct: 77 AFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+++ + +L + + + A+ + + +H + I
Sbjct: 137 LFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DCEI 193
Query: 858 PHGNLKSTNILLEAPTM----------NAVLTDYSLHRILTSAGTADQVLNA--GALGYR 905
HG++K N +L + L D + + A G++
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQ 252
Query: 906 PPEFASTSKPCP-SLKSDVYAFGIILLELLTGK 937
E P + + D + + +L G
Sbjct: 253 CVEML---SNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 37/239 (15%), Positives = 69/239 (28%), Gaps = 45/239 (18%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIKHP-- 788
V+G+ +AT ++G V K KE ++ L IK+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 789 -----------NLVSLQG----YYWGPKEHEKLVISNYINAQSLAVYLQE------TDPR 827
+LV E + V+S + + LQ +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 828 KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL---- 883
L RL++ + V R L LH+ + H L+ +I+L+ LT +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLV-HTYLRPVDIVLD-QRGGVFLTGFEHLVRD 261
Query: 884 -HRILTSAGTADQVLNAGALGYRPPEFASTSKPCP---SLKSDVYAFGIILLELLTGKS 938
++ G + P + D + G+ + +
Sbjct: 262 GASAVSPIGRG-----FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 61/307 (19%), Positives = 119/307 (38%), Gaps = 72/307 (23%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
E +G G ++ + + +AVK L++G + F E + ++H LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+ +I+ Y+ SL +L+ KL + L +A +A + ++ I
Sbjct: 78 ---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIEERNYI 131
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRIL------TSAG-------TADQVLNAGALGY 904
H +L++ NIL+ + T++ + D+ L R++ G TA + +N G
Sbjct: 132 -HRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG---- 185
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVR 957
F ++KSDV++FGI+L E++T G ++ E++
Sbjct: 186 ---TF--------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------------- 220
Query: 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
+ + G+ M +P ++ Q+ C +RP + L
Sbjct: 221 -------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 1017 VLEKDSQ 1023
+ Q
Sbjct: 268 FTATEGQ 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 45/211 (21%), Positives = 75/211 (35%), Gaps = 16/211 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL-REGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+++G+ +++ +G + A+K + RE + L + H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
K++I + SL L+E P L E L V DV +N+L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMNHLR-EN 131
Query: 856 AIPHGNLKSTNILLEA---PTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
I H N+K NI+ LTD+ R L + G Y P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYER 189
Query: 913 SKPCPSL------KSDVYAFGIILLELLTGK 937
+ D+++ G+ TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 34/187 (18%), Positives = 73/187 (39%), Gaps = 18/187 (9%)
Query: 309 ATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTG 368
L + + A++ T + L+N ++ DL+ ++ N ++D+ +++ T
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHN-IKDLTINNIHATN 80
Query: 369 MVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKL 428
P S L ++ + D L L ++D+S + + +L T K+
Sbjct: 81 YNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138
Query: 429 TDLNLSGNNF-SGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVY 487
++LS N + +PL+ + L SL++ ++ + GI F L
Sbjct: 139 NSIDLSYNGAITDIMPLKTLPE-----------LKSLNIQFDGVHD--YRGIEDFPKLNQ 185
Query: 488 LNLSNNK 494
L +
Sbjct: 186 LYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 23/135 (17%), Positives = 49/135 (36%), Gaps = 7/135 (5%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
+ +++++N N I + +LE L + + L +L LL+IS +
Sbjct: 64 YAHNIKDLTINNIHA-TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207
+ + + + L K+ +DL N DIM L L + +++ + +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGI---- 177
Query: 208 SSFISSIQYLNISEN 222
+ L
Sbjct: 178 -EDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 32/213 (15%), Positives = 73/213 (34%), Gaps = 43/213 (20%)
Query: 89 LKMLCNVSVSNNQLMGNITDI--GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISS 146
K N + + +I + SL ++ L++ L +GI N+ L I++
Sbjct: 22 FKAYLNGLLGQSS----TANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 147 NSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLG 206
+ GL L+ L + D + LS L S+ +D+S++ S+ +
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRIL 266
+ + +++S N + ++ P +P L+ L
Sbjct: 134 T---LPKVNSIDLSYNGAITDIMPLKTLP--------------------------ELKSL 164
Query: 267 RLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
+ + + + + L++L +
Sbjct: 165 NIQFDGVHDYRGIEDFPK----LNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 23/115 (20%), Positives = 47/115 (40%), Gaps = 4/115 (3%)
Query: 86 IIGLKMLCNVSVSNNQLMGN-ITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNI 144
I GL L + + + + I ++ + SL LD+SH+ I + I +L + +++
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 145 SSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSG 199
S N T L +LK L+++ + D + + + + G
Sbjct: 144 SYNG-AITDIMPLKTLPELKSLNIQFDGVH-DYRGI-EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 15/94 (15%), Positives = 38/94 (40%), Gaps = 13/94 (13%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
+ DL ++ + + P+ + N L L + ++ +P +S +L
Sbjct: 66 HNIKDLTINNIHATNYNPISGLSN-----------LERLRIMGKDVTSDKIPNLSGLTSL 114
Query: 486 VYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNL 517
L++S++ + SI + + ++S+N
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 15/106 (14%), Positives = 29/106 (27%), Gaps = 15/106 (14%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
LT + L+ N + ++ N + L + + IS NL
Sbjct: 44 NSLTYITLANINVTDLTGIEYAHN-----------IKDLTINNIHATN--YNPISGLSNL 90
Query: 486 VYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPENLRNFP 529
L + L L ++S + + + P
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 23/181 (12%), Positives = 62/181 (34%), Gaps = 32/181 (17%)
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE--GPVGSITSATLKKVNLSSN 319
SL + L + ++ + + +L ++ P+ +++ L+++ +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHN----IKDLTINNIHATNYNPISGLSN--LERLRIMGK 98
Query: 320 KLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLR 379
++ +LS + + + + +S + + + + +
Sbjct: 99 DVTSDKI-----------------PNLSGLTS----LTLLDISHSAHDDSILTKINTLPK 137
Query: 380 LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFS 439
+ S +S N D+ L T PELK +++ + ++ KL L
Sbjct: 138 VNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIG 194
Query: 440 G 440
G
Sbjct: 195 G 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 4/99 (4%)
Query: 78 VGNFSFPTIIGLKMLCNVSVSNNQLMG-NITDIGSIQSLEFLDLSHNLFHGLIPSGIVSL 136
V + P + GL L + +S++ +T I ++ + +DLS+N I + +L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG 175
L LNI + G KL L + GG
Sbjct: 159 PELKSLNIQFDGV--HDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 58/293 (19%), Positives = 114/293 (38%), Gaps = 56/293 (19%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG G ++ + +A+K +REG A +++F E + + + HP LV L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
++ +++ ++ L+ YL+ + + L + +DV + YL I
Sbjct: 73 --LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP-----PEFAST 912
H +L + N L+ ++D+ + R + D + P PE S
Sbjct: 127 -HRDLAARNCLV-GENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSF 179
Query: 913 SKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRS 965
S+ S KSDV++FG+++ E+ + +S+ E+V
Sbjct: 180 SR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------------------- 215
Query: 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
I G + +P + + Q+ C +RP + +L+ I
Sbjct: 216 -----EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 66/323 (20%), Positives = 117/323 (36%), Gaps = 85/323 (26%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREGIA--KGKKEFAREVKKLGNIKHPNLV 791
++G+ G++ +A L D + AVK L+ I +EF RE + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 792 SLQG--YYWGPKEHEK--LVISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVAR 846
L G K +VI ++ L +L + + P L + +R VD+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR- 905
+ YL + I H +L + N +L A M + D+ L R + S YR
Sbjct: 149 GMEYLSSRNFI-HRDLAARNCML-AEDMTVCVADFGLSRKIYSGDY-----------YRQ 195
Query: 906 -----------PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGE 941
E + ++ SDV+AFG+ + E++T G + E
Sbjct: 196 GCASKLPVKWLALESLADNLY--------TVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 942 IVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPA 1000
I ++ G+ ++QPP + ++ + +C
Sbjct: 248 IY---------------------------NYLIGGNRLKQPPECMEEVYDLMYQCWSADP 280
Query: 1001 SERPDMMSVFEELSTIVLEKDSQ 1023
+RP + EL I+
Sbjct: 281 KQRPSFTCLRMELENILGHLSVL 303
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 65/305 (21%), Positives = 110/305 (36%), Gaps = 74/305 (24%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG+ G + G+ +AVK ++ + F E + ++H NLV L G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG-- 253
Query: 798 WGPKEHEKLVISN----------YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC 847
VI Y+ SL YL+ L D L+ ++DV
Sbjct: 254 ---------VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDVCEA 301
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR-- 905
+ YL + H +L + N+L+ + A ++D+ L + +S G L +
Sbjct: 302 MEYLEGNNFV-HRDLAARNVLV-SEDNVAKVSDFGLTKEASSTQD------TGKLPVKWT 353
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRL 958
PE K S KSDV++FGI+L E+ + ++V
Sbjct: 354 APEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------------- 396
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
+ G+ M+ P + V C L A+ RP + + E+L I
Sbjct: 397 ------------PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
Query: 1018 LEKDS 1022
+
Sbjct: 445 THELH 449
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 58/313 (18%), Positives = 116/313 (37%), Gaps = 79/313 (25%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
IG G +++ ++ ++ A+K + +++F +E + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E+ +I L +LQ L + + A ++ L YL
Sbjct: 81 LIGVI---TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE 133
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRIL------TSAG-------TADQVLN 898
++R + H ++ + N+L+ + + V L D+ L R + ++ A + +N
Sbjct: 134 SKRFV-HRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVD 951
+R F S SDV+ FG+ + E+L G + +++
Sbjct: 191 -----FR--RFTS--------ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------- 227
Query: 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVF 1010
I +G + PP + + +C S RP +
Sbjct: 228 -------------------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268
Query: 1011 EELSTIVLEKDSQ 1023
+LSTI+ E+ +Q
Sbjct: 269 AQLSTILEEEKAQ 281
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 9e-13
Identities = 108/682 (15%), Positives = 210/682 (30%), Gaps = 189/682 (27%)
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLD 465
V + + + ++ + +S + SG L L + Q L
Sbjct: 30 VDNFDCKDVQDMPKS-ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLR 88
Query: 466 LAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENL 525
+ Y L + K E P + + + + L
Sbjct: 89 INYKFLMSPI------------------KTEQRQPSMM---TRMYIEQRDRLYNDNQV-- 125
Query: 526 RNFPDSAFHPGNSLLTFPNSPSQQDVPDLTLRGHGNHMKPATKIALIVGLV-CGVT-MVA 583
F N Q L LR ++PA + + G++ G T +
Sbjct: 126 -------FAKYNV-------SRLQPY--LKLRQALLELRPAKNVLI-DGVLGSGKTWVAL 168
Query: 584 LLC------MLIYFRALWQRHGRDSFKRDGEQKAFSEGSSSLSQRSGVNKKGDPSLSSFT 637
+C + F+ W + K + E L + DP+ +S +
Sbjct: 169 DVCLSYKVQCKMDFKIFWL-----NLKNCNSPETVLEMLQKLLYQI------DPNWTSRS 217
Query: 638 FHQDPLPSSPMESAYDAGETSSVVTKPKELYHP------DSVRKDE-----GLSSPVSLL 686
H + + S E ++ + +V+ + LS + LL
Sbjct: 218 DHSSNIKL-RIHSIQA--ELRRLLKSKP---YENCLLVLLNVQNAKAWNAFNLSCKI-LL 270
Query: 687 SSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHG 746
++ RF + +D L+A + ++ D S+ T +E+ + +
Sbjct: 271 TT---------RFKQVTDFLSAATTTHISLD----HHSMTLTPDEVKSLLLKYLDCRP-Q 316
Query: 747 TLYKATLDSGSILAV----KRLREGIAKGKKEFAREV--KKLGNIKHPNLVSLQGYYWGP 800
L + L + + + + +R+G+A + + V KL I +L L+ P
Sbjct: 317 DLPREVL-TTNPRRLSIIAESIRDGLAT--WDNWKHVNCDKLTTIIESSLNVLE-----P 368
Query: 801 KEHEKLVISNYINAQSLAVYLQETD-PRKLPPLSI-----DERLRVAVDVARCLNYLHNE 854
E+ K+ + L+V+ P L LS+ + DV +N LH
Sbjct: 369 AEYRKM----F---DRLSVFPPSAHIPTIL--LSLIWFDVIKS-----DVMVVVNKLHKY 414
Query: 855 RAIPHGNLKST----NILLE--APTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE 908
+ +ST +I LE N +Y+LHR + ++ Y P+
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLEN----EYALHRSI---------VDH----YNIPK 457
Query: 909 FASTSKPCPSLKSDVY-------------------AFGIILLEL--LTGK--SSGEIVCV 945
+ P D Y F ++ L+ L K
Sbjct: 458 TFDSDDLIP-PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 946 DPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC--ILPASER 1003
+++ L L+ + I D + R+++ +L + L S+
Sbjct: 517 SGSILNT-----LQQLKF-----YKPYICDNDP--KYERLVNAILDFLPKIEENLICSKY 564
Query: 1004 PDMM--SVFEELSTIVLEKDSQ 1023
D++ ++ E I E Q
Sbjct: 565 TDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 2e-04
Identities = 88/482 (18%), Positives = 155/482 (32%), Gaps = 128/482 (26%)
Query: 22 EALLQLK----------KGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTNG----YV 67
+ALL+L+ G K +W ++ D C + + + C ++
Sbjct: 142 QALLELRPAKNVLIDGVLGSGK--------TW----VALDVC-LS-YKVQCKMDFKIFWL 187
Query: 68 TSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHG 127
+ N + P + L+ML + + + +D S L + L
Sbjct: 188 N---------LKNCNSPETV-LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 128 LI-PSGIVSLKNLMLLNISS----NSFEG-------TFPSG---FGGLGKLKYLDLRANR 172
L L L+LLN+ + N+F T F ++ L +
Sbjct: 238 LKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 173 FGGDIMHLLSQLGSVVHV---DLSNNQFSGS-LDLGL-GDS--SFISSIQYL-------- 217
+ S L + DL + + L + +S +++
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 218 -NISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGS 276
I E+SL L P + FD L VF S + IP+ L ++ +
Sbjct: 356 TTIIESSL-NVLEPAEYRKMFDRLSVFPPSAH-----IPT----ILLSLIWFDVIK---- 401
Query: 277 LPVALLQESSMMLSEL-DLSL---NQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHC 332
+ +++++L SL E + SI S L+ N+ +L H
Sbjct: 402 ------SDVMVVVNKLHKYSLVEKQPKESTI-SIPSIYLELKVKLENEY--AL-----HR 447
Query: 333 TIVD---LSNNRLSGDLSRMQNWGNYV-EDI--HLSSNFLTGMVPNQTSQFLRLTSF--- 383
+IVD + S DL Y I HL + + FL F
Sbjct: 448 SIVDHYNIPKTFDSDDLIP-PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-RFLEQ 505
Query: 384 KVSNNSLEGDLPA-VLGTYPELK-----------VIDLSLNHLNGFLLP--SFFTSTKLT 429
K+ ++S + +L T +LK + +N + FL +K T
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 430 DL 431
DL
Sbjct: 566 DL 567
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNL--VSL 793
+ IG +++ + I A+K L E + + E+ L ++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 794 QGYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
Y + + ++ N L +L++ +K + ER ++ ++ +H
Sbjct: 94 YDYEI---TDQYIYMVMECGNI-DLNSWLKK---KK--SIDPWERKSYWKNMLEAVHTIH 144
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLN--AGALGYRPPE 908
I H +LK N L+ + + L D+ + + T V + G + Y PPE
Sbjct: 145 QHG-IVHSDLKPANFLIV----DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPE 198
Query: 909 ---------FASTSKPCPSLKSDVYAFGIILLELLTGK 937
SK S KSDV++ G IL + GK
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 53/296 (17%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ +G G + +A+K ++EG + + EF E K + N+ H LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
K+ +I+ Y+ L YL+E R + L + DV + YL +++ +
Sbjct: 89 --TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA-LGYR--PPEFASTSK 914
H +L + N L+ + V +D+ L R + + + G+ R PPE SK
Sbjct: 143 -HRDLAARNCLVNDQGVVKV-SDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 915 PCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
S KSD++AFG+++ E+ + ++ E
Sbjct: 198 --FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------------------------ 231
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDS 1022
I G + +P + + C A ERP + + + ++++S
Sbjct: 232 ---EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV-MDEES 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 55/299 (18%), Positives = 113/299 (37%), Gaps = 63/299 (21%)
Query: 738 EVIGRSCHGTLYKATL----DSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNLV 791
+V+G GT++K +S I +K + + + + + +G++ H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L G +++ Y+ SL ++++ L L V +A+ + YL
Sbjct: 79 RLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYL 131
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRP---- 906
+ H NL + N+LL++P + V + D+ + +L D + P
Sbjct: 132 EEHGMV-HRNLAARNVLLKSP--SQVQVADFGVADLLPP----DDKQLLYSEAKTPIKWM 184
Query: 907 -PEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRL 958
E K + +SDV+++G+ + EL+T G E+
Sbjct: 185 ALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--------------- 227
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTI 1016
L+ G + QP D+ V ++C ++ + RP + E + +
Sbjct: 228 ------------DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 44/222 (19%), Positives = 85/222 (38%), Gaps = 40/222 (18%)
Query: 738 EVIGR--SCHGTLYKAT-LDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNLVS 792
VIG+ T+ A +G + V+R L + E+ HPN+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 793 LQGYYWGP--KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
Y ++E V+++++ S + + L+I L+ V + L+Y
Sbjct: 91 ----YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ---GVLKALDY 143
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPE 908
+H+ + H ++K+++IL+ +++ L+ + + S G +V++ P
Sbjct: 144 IHHMGYV-HRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHD-----FPKY 194
Query: 909 FASTSKPC---P----------SLKSDVYAFGIILLELLTGK 937
P KSD+Y+ GI EL G
Sbjct: 195 SVKV--LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 27/215 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNL--VSL 793
+ IG +++ + I A+K L E + + E+ L ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
Y + + + L +L++ +K + ER ++ ++ +H
Sbjct: 75 YDYEI---TDQYIYMVMECGNIDLNSWLKK---KK--SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN--AGALGYRPPE--- 908
I H +LK N L+ L D+ + + T V + G + Y PPE
Sbjct: 127 HG-IVHSDLKPANFLIV--DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 909 ------FASTSKPCPSLKSDVYAFGIILLELLTGK 937
SK S KSDV++ G IL + GK
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 75/308 (24%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ +G G + +AVK ++EG + + EF +E + + + HP LV G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
KE+ +++ YI+ L YL+ L + L + DV + +L + + I
Sbjct: 73 --SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRIL------TSAG-------TADQVLNAGALGY 904
H +L + N L++ V +D+ + R + +S G +A +V + Y
Sbjct: 127 -HRDLAARNCLVDRDLCVKV-SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH-----Y 179
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVR 957
+++S KSDV+AFGI++ E+ + ++ E+V
Sbjct: 180 F--KYSS--------KSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-------------- 215
Query: 958 LLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC--ILPASERPDMMSVFEELST 1015
+ GH + +P + Q+ C LP +RP + +
Sbjct: 216 -------------LKVSQGHRLYRPHLASDTIYQIMYSCWHELP-EKRPTFQQLLSSIEP 261
Query: 1016 IVLEKDSQ 1023
+ EKD
Sbjct: 262 L-REKDKH 268
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 61/313 (19%), Positives = 113/313 (36%), Gaps = 66/313 (21%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNL 790
+G G +Y+ + D + AVK L E + + +F E + H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARCL 848
V G + + ++ + L +L+ET PR + L++ + L VA D+A
Sbjct: 96 VRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNAGALGYR- 905
YL I H ++ + N LL P V D+ + R + A + L +
Sbjct: 154 QYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-RKGGCAMLPVKW 211
Query: 906 -PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVD 951
PPE F + K+D ++FG++L E+ + KS+ E++
Sbjct: 212 MPPEAFMEGIF--------TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------- 255
Query: 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVF 1010
+ G M+ P + ++ +C +RP+ +
Sbjct: 256 -------------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296
Query: 1011 EELSTIVLEKDSQ 1023
E + + D
Sbjct: 297 ERIEYCTQDPDVI 309
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 22/236 (9%)
Query: 710 SPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLR-EG 767
S K G L + +L + +G G ++K +G ++AVK++R G
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 768 IAKGKKEFAREVKKLGN-IKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDP 826
+ K ++ + P +V G + + + + + + + P
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 827 RKLPPLSIDERL--RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLH 884
I ER+ ++ V + + L YL + + H ++K +NILL+ L D+ +
Sbjct: 121 -------IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGIS 172
Query: 885 RILTSAGTADQVLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L D+ +AG Y PE +KP +++DV++ GI L+EL TG+
Sbjct: 173 GRLVDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 54/302 (17%)
Query: 739 VIGRSCHGTLYKATLDSGSIL---AVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSL 793
+G GT+ K ++ AVK L+ K E E + + +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
G + +++ L YLQ+ K + + + V+ + YL
Sbjct: 84 IGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 135
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFAS 911
+ H +L + N+LL A ++D+ L + L + + G + PE +
Sbjct: 136 SNFV-HRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 912 TSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENR 964
K S KSDV++FG+++ E + G E+
Sbjct: 194 YYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--------------------- 230
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
++ G M P +M + C RP +V L + ++
Sbjct: 231 ------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
Query: 1024 GK 1025
G
Sbjct: 285 GH 286
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 27/215 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKR--LREGIAKGKKEFAREVKKLGNIKHPNL--VSL 793
+ IG +++ + I A+K L E + + E+ L ++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
Y + ++ N L +L++ +K + ER ++ ++ +H
Sbjct: 122 YDYEITDQYI--YMVMECGNI-DLNSWLKK---KK--SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN--AGALGYRPPE--- 908
I H +LK N L+ L D+ + + T V + GA+ Y PPE
Sbjct: 174 HG-IVHSDLKPANFLIV--DGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 909 ------FASTSKPCPSLKSDVYAFGIILLELLTGK 937
SK S KSDV++ G IL + GK
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 59/316 (18%), Positives = 115/316 (36%), Gaps = 84/316 (26%)
Query: 738 EVIGRSCHGTLYKATL----DSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLV 791
+++G G++ + L + +AVK ++ + + +EF E + + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 792 SLQG--YYWGPKEHEK-LVISNYINAQSLAVYLQETDPRKLP-PLSIDERLRVAVDVARC 847
L G + K +VI ++ L YL + P + + L+ VD+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR-- 905
+ YL N + H +L + N +L M + D+ L + + S YR
Sbjct: 160 MEYLSNRNFL-HRDLAARNCML-RDDMTVCVADFGLSKKIYSGDY-----------YRQG 206
Query: 906 ----------PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEI 942
E + + KSDV+AFG+ + E+ T G + E+
Sbjct: 207 RIAKMPVKWIAIESLADRVY--------TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 943 VCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPAS 1001
++ GH ++QP L ++ ++ C
Sbjct: 259 Y---------------------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPL 291
Query: 1002 ERPDMMSVFEELSTIV 1017
+RP + +L ++
Sbjct: 292 DRPTFSVLRLQLEKLL 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 54/298 (18%), Positives = 109/298 (36%), Gaps = 52/298 (17%)
Query: 740 IGRSCHGTLYKATL--DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+G G++ + I A+K L++G +E RE + + + +P +V L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
+ +++ L +L + + + V+ + YL +
Sbjct: 78 VC---QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN 130
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTS 913
+ H +L + N+LL A ++D+ L + L + + +AG + PE +
Sbjct: 131 FV-HRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 914 KPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966
K S +SDV+++G+ + E L+ E++
Sbjct: 189 K--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----------------------- 223
Query: 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
I G ME PP ++ + C I +RPD ++V + + S+
Sbjct: 224 ----AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+G G ++K + SG ++A K + E + + RE++ L P +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLHN 853
++ + E + +++ SL L++ I E++ +V++ V + L YL
Sbjct: 99 AFY--SDGEISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYLRE 149
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS--AGTADQVLNAGALGYRPPEFAS 911
+ I H ++K +NIL+ + L D+ + L A + G Y PE
Sbjct: 150 KHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQ 203
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
+ S++SD+++ G+ L+E+ G+
Sbjct: 204 GTH--YSVQSDIWSMGLSLVEMAVGR 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 58/305 (19%), Positives = 114/305 (37%), Gaps = 63/305 (20%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
IG G +++ ++ ++ A+K + +++F +E + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E+ +I L +LQ L + + A ++ L YL
Sbjct: 456 LIGVI---TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE 508
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRP----- 906
++R + H ++ + N+L+ + + V L D+ L R + D + G P
Sbjct: 509 SKRFV-HRDIAARNVLVSSN--DCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMA 560
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLL 959
PE + + + SDV+ FG+ + E+L G + +++
Sbjct: 561 PESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---------------- 602
Query: 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVL 1018
I +G + PP + + +C S RP + +LSTI+
Sbjct: 603 -----------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
Query: 1019 EKDSQ 1023
E+ Q
Sbjct: 652 EEKLQ 656
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 55/297 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL-----AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+VIG G +YK L + S A+K L+ G K + +F E +G H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L+G K ++I+ Y+ +L +L+E D S+ + + + +A + YL
Sbjct: 110 RLEGVI--SKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYL 163
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYR--PPE 908
N + H +L + NIL+ + ++D+ L R+L A + G + R PE
Sbjct: 164 ANMNYV-HRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLAL 961
S K + SDV++FGI++ E++T S+ E++
Sbjct: 221 AISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------------------ 260
Query: 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
+ I DG + P S + Q+ ++C + RP + L ++
Sbjct: 261 ---------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 63/296 (21%), Positives = 110/296 (37%), Gaps = 52/296 (17%)
Query: 738 EVIGRSCHGTLYKATLDSGS----ILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVS 792
EVIGR G +Y TL AVK L +F E + + HPN++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E LV+ Y+ L +++ ++ + + + VA+ + YL
Sbjct: 91 LLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLA 145
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR-ILTSAGTADQVLNAGALGYR--PPEF 909
+++ + H +L + N +L + D+ L R + + L + E
Sbjct: 146 SKKFV-HRDLAARNCML-DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALE 962
T K + KSDV++FG++L EL+T ++ +I
Sbjct: 204 LQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------------------- 242
Query: 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
++ G + QP + +V L+C A RP + +S I
Sbjct: 243 --------VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 42/228 (18%), Positives = 85/228 (37%), Gaps = 42/228 (18%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFA-REVKKLGNIK-HPNLVSLQG 795
+++G GT+ G +AVKR + + A E+K L HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKR----MLIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 796 YYWGPKEHEKLVISNYI-----NAQSLAVYLQETD--PRKLPPLSIDERLRVAVDVARCL 848
++ + YI N +L ++ + L + + +A +
Sbjct: 77 SE----TTDRFL---YIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 849 NYLHNERAIPHGNLKSTNILLEAPT------------MNAVLTDYSLHRILTSAGTADQV 896
+LH I H +LK NIL+ + + +++D+ L + L S ++ +
Sbjct: 129 AHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 897 LNAGALG---YRPPE-----FASTSKPCPSLKSDVYAFGIILLELLTG 936
G +R PE +K + D+++ G + +L+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 1e-11
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 15/208 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E +G G + + D+G +A+K+ R E K ++ + E++ + + HPN+VS +
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 796 YYWGPK----EHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
G + L+ Y L YL + L + D++ L YL
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISSALRYL 137
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPEF 909
H E I H +LK NI+L+ + + D + L + + G L Y PE
Sbjct: 138 H-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAPEL 194
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
K D ++FG + E +TG
Sbjct: 195 LEQKKYTV--TVDYWSFGTLAFECITGF 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 63/322 (19%), Positives = 113/322 (35%), Gaps = 86/322 (26%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNL 790
+G G +Y+ + D + AVK L E + + +F E + H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR--KLPPLSIDERLRVAVDVARCL 848
V G + + ++ + L +L+ET PR + L++ + L VA D+A
Sbjct: 137 VRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNAGALGYR- 905
YL I H ++ + N LL P V D+ + R + AG YR
Sbjct: 195 QYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----------YRK 242
Query: 906 -----------PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGE 941
PPE F + K+D ++FG++L E+ + KS+ E
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIF--------TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 942 IVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPA 1000
++ + G M+ P + ++ +C
Sbjct: 295 VL---------------------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQP 327
Query: 1001 SERPDMMSVFEELSTIVLEKDS 1022
+RP+ + E + + D
Sbjct: 328 EDRPNFAIILERIEYCTQDPDV 349
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 51/313 (16%), Positives = 108/313 (34%), Gaps = 79/313 (25%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL----AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
++G G +Y+ + AVK ++ K++F E + N+ HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G +E +I L YL+ L + + ++ + + + YL
Sbjct: 78 LIGII---EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLE 130
Query: 853 NERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRIL------TSAG-------TADQVLN 898
+ + H ++ NIL+ +P V L D+ L R + ++ + + +N
Sbjct: 131 SINCV-HRDIAVRNILVASP--ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 899 AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVD 951
+R F + SDV+ F + + E+L+ + +++
Sbjct: 188 -----FR--RF--------TTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------- 224
Query: 952 LTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVF 1010
++ G + +P + + RC S+RP +
Sbjct: 225 -------------------GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265
Query: 1011 EELSTIVLEKDSQ 1023
LS + +
Sbjct: 266 CSLSDVYQMEKDI 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/300 (18%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
++IG G + L + A+K L+ G + +++F E +G HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L+G + ++++ Y+ SL +L+ D + +I + + + V + YL
Sbjct: 115 LEGVV--TRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLS 168
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFA 910
+ + H +L + N+L+ + ++D+ L R+L A G + R PE
Sbjct: 169 DLGYV-HRDLAARNVLV-DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 911 STSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALEN 963
+ S SDV++FG+++ E+L ++ +++
Sbjct: 227 AFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-------------------- 264
Query: 964 RSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDS 1022
+ +G+ + P + Q+ L C ++RP + L ++ +S
Sbjct: 265 -------SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 41/206 (19%), Positives = 80/206 (38%), Gaps = 34/206 (16%)
Query: 748 LYKATLDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL 806
K+ L+ + K K + F E++ + +IK+ ++ +G ++
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD---EV 118
Query: 807 -VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC--------LNYLHNERAI 857
+I Y+ S+ + L + + + V +C +Y+HNE+ I
Sbjct: 119 YIIYEYMENDSILKFD-----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI 173
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSL------HRILTSAGTADQVLNAGALGYRPPEFAS 911
H ++K +NIL++ L+D+ +I S GT + + PPEF S
Sbjct: 174 CHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIKGSRGTYE---------FMPPEFFS 223
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
K D+++ GI L +
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 52/296 (17%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
VIG+ G +Y I A+K L + + F RE + + HPN+++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G P E V+ Y+ L +++ ++ + + + VAR + YL
Sbjct: 87 LIGIML-PPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYLA 141
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR-ILTSAGTADQVLNAGALGYR--PPEF 909
++ + H +L + N +L + + D+ L R IL + Q L + E
Sbjct: 142 EQKFV-HRDLAARNCML-DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALE 962
T + + KSDV++FG++L ELLT ++
Sbjct: 200 LQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT------------------- 238
Query: 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
+ G + QP + QV +C + RP + E+ IV
Sbjct: 239 --------HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 35/216 (16%), Positives = 75/216 (34%), Gaps = 21/216 (9%)
Query: 94 NVSVSNNQLMGNITDIGSI-QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGT 152
+ V+ + I S+ S + L L + +L N+ + +S +
Sbjct: 15 DFRVTCKDI----QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 153 FPSG-FGGLGKLKYLDLRANRFGGDIMHL----LSQLGSVVHVDLSNNQFSGSLDLGLGD 207
S F L K+ ++++R R ++ ++ L +L + + + N DL
Sbjct: 71 LESHSFYNLSKVTHIEIRNTR---NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 208 SSFISSIQYLNISENSLVGELFPH--DGMPYFDNLEVFDASNNHLVGAIPSFNFVF-SLR 264
S+ L I++N + + + G+ + NN ++ + F L
Sbjct: 128 ST--DIFFILEITDNPYMTSIPVNAFQGLC--NETLTLKLYNNGF-TSVQGYAFNGTKLD 182
Query: 265 ILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE 300
+ L N+ + S LD+S +
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 37/232 (15%), Positives = 78/232 (33%), Gaps = 32/232 (13%)
Query: 311 LKKVNLSSNKLSG--SLPARVGHCTIVDLSNNRL----SGDLSRMQNWGNYVEDIHLSSN 364
+ ++ + SLP + L L S S + N + I++S +
Sbjct: 13 EEDFRVTCKDIQRIPSLPPST---QTLKLIETHLRTIPSHAFSNLPN----ISRIYVSID 65
Query: 365 FLTGMVPNQT-SQFLRLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHLNGFLLPSF 422
+ + + ++T ++ N + L P LK + + L F +
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK 125
Query: 423 FTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS--LTSLDLAYNSLSGRLLPGI 479
S L ++ N + +P + Q L +L L N + +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIP---------VNAFQGLCNETLTLKLYNNGFT-SVQGYA 175
Query: 480 SKFHNLVYLNLSNNKFEGSIP----DGLPNGLKEFNVSFNNLSGVVPENLRN 527
L + L+ NK+ I G+ +G +VS +++ + + L +
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEH 227
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 32/204 (15%), Positives = 65/204 (31%), Gaps = 48/204 (23%)
Query: 380 LTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNN-- 437
F+V+ ++ +P++ P + + L HL +F ++ + +S +
Sbjct: 13 EEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68
Query: 438 -------FSGPLPLQE--IQNNP-----STGSTQNL-SLTSLDLAYNSLSGRLLPGISKF 482
F + I+N + + L L L + L ++ P ++K
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKV 126
Query: 483 HN---LVYLNLSNNKFEGSIPD----GLPNGLKEFNVSFNNLSGVVPEN----------- 524
++ L +++N + SIP GL N + N + V
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 525 ------LRNFPDSAFHPGNSLLTF 542
L AF S +
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSL 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 49/205 (23%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVS 792
+V+G G + L I A+K L+ G K +++F E +G HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L+G K ++++ Y+ SL +L++ D + ++ + + + +A + YL
Sbjct: 111 LEGVV--TKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS 164
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFA 910
+ + H +L + NIL+ + ++D+ L R+L A G + R PE
Sbjct: 165 DMGYV-HRDLAARNILI-NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 911 STSKPCPSLKSDVYAFGIILLELLT 935
+ K + SDV+++GI+L E+++
Sbjct: 223 AYRK--FTSASDVWSYGIVLWEVMS 245
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 52/311 (16%), Positives = 99/311 (31%), Gaps = 44/311 (14%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDL-RAN 171
+ L + +L + IS N + F L KL + + +AN
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 172 RFGGDIMHL----LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQ--YLNISEN--- 222
++++ L ++ ++ +SN L D I S+Q L+I +N
Sbjct: 91 N----LLYINPEAFQNLPNLQYLLISNTGIK-----HLPDVHKIHSLQKVLLDIQDNINI 141
Query: 223 -SLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPV 279
++ F G+ + + + N + I + FN + +N L LP
Sbjct: 142 HTIERNSF--VGLSF--ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPN 195
Query: 280 ALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVN----LSSNKLSGSLPARVG--HCT 333
+ +S LD+S ++ S+ S L+ + S+ L LP
Sbjct: 196 DVFHGAS-GPVILDISRTRIH----SLPSYGLENLKKLRARSTYNLK-KLPTLEKLVALM 249
Query: 334 IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGD 393
L+ NW + ++H N R ++ ++
Sbjct: 250 EASLTYPS---HCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSY 306
Query: 394 LPAVLGTYPEL 404
TY E
Sbjct: 307 SRGFDMTYTEF 317
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 34/230 (14%), Positives = 73/230 (31%), Gaps = 27/230 (11%)
Query: 310 TLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLSSN 364
+ + +K++ +P+ + + + +L G S + +E I +S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGD----LEKIEISQN 64
Query: 365 FLTGMVPNQTSQFL-RLTSFKVSN-NSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSF 422
+ ++ L +L ++ N+L P P L+ + +S +
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 124
Query: 423 FTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SK 481
S + L++ N + I+ N G + L L N + + +
Sbjct: 125 IHSLQKVLLDIQDNI-----NIHTIERNSFVGLSFE--SVILWLNKNGIQ-EIHNSAFNG 176
Query: 482 FHNLVYLNLSNNKFEGSIP----DGLPNGLKEFNVSFNNLSGVVPENLRN 527
NN E +P G ++S + + L N
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASG-PVILDISRTRIHSLPSYGLEN 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 41/224 (18%), Positives = 78/224 (34%), Gaps = 19/224 (8%)
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDI-MHLLSQLGSV 187
IPS + +N + L F G G L+ +++ N I + S L +
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 188 VHVDLSN-NQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDAS 246
+ + N ++ + + ++QYL IS + + P + + D
Sbjct: 82 HEIRIEKANNLL-YINPEAFQN--LPNLQYLLISNTGI--KHLPDVHKIHSLQKVLLDIQ 136
Query: 247 NNHLVGAIPSFNFV---FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P 302
+N + I +FV F IL L N + + + + + N LE P
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ-LDELNLSDNNNLEELP 194
Query: 303 VGSITSAT-LKKVNLSSNKLSGSLPARV--GHCTIVDLSNNRLS 343
A+ +++S ++ SLP+ + S L
Sbjct: 195 NDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 46/270 (17%), Positives = 92/270 (34%), Gaps = 61/270 (22%)
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT------LKKVN 315
S R+ ++++ +P L + EL L +L I L+K+
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRN----AIELRFVLTKLR----VIQKGAFSGFGDLEKIE 60
Query: 316 LSSNKLSGSLPARV----GHCTIVDLSN-NRLS----GDLSRMQNWGNYVEDIHLSSNFL 366
+S N + + A V + + N L + N ++ + +S+ +
Sbjct: 61 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPN----LQYLLISNTGI 116
Query: 367 TGMVPNQTSQFLRLTSFKVSNNSLEGDLP--AVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
+ L+ + +N + + +G E ++ L+ N + + S F
Sbjct: 117 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFN 175
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS-LTSLDLAYNSLSG---------- 473
T+L +LNLS NN L+E+ N S LD++ +
Sbjct: 176 GTQLDELNLSDNN-----NLEELPN----DVFHGASGPVILDISRTRIHSLPSYGLENLK 226
Query: 474 ----------RLLPGISKFHNLVYLNLSNN 493
+ LP + K L+ +L+
Sbjct: 227 KLRARSTYNLKKLPTLEKLVALMEASLTYP 256
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 52/296 (17%)
Query: 738 EVIGRSCHGTLYKATL---DSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVS 792
EVIGR G +Y TL D I AVK L +F E + + HPN++S
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E LV+ Y+ L +++ ++ + + + VA+ + +L
Sbjct: 155 LLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA 209
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR-ILTSAGTADQVLNAGALGYR--PPEF 909
+++ + H +L + N +L + D+ L R + + L + E
Sbjct: 210 SKKFV-HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALE 962
T K + KSDV++FG++L EL+T ++ +I
Sbjct: 268 LQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------------------- 306
Query: 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIV 1017
++ G + QP + +V L+C A RP + +S I
Sbjct: 307 --------VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 43/242 (17%), Positives = 92/242 (38%), Gaps = 26/242 (10%)
Query: 289 LSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGD 345
+ +L + V ++ ++ +++ + S+ + + + L+ N+L+ D
Sbjct: 26 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-D 82
Query: 346 LSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405
+ + N N + + L N + + +L S + +N + D+ L P+L+
Sbjct: 83 IKPLANLKN-LGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 137
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLD 465
+ L N + + TKL L+L N S + + L +L
Sbjct: 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD---IVPLAGLTK--------LQNLY 184
Query: 466 LAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENL 525
L+ N +S L ++ NL L L + + + N + V + S V PE +
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242
Query: 526 RN 527
+
Sbjct: 243 SD 244
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 45/244 (18%), Positives = 80/244 (32%), Gaps = 54/244 (22%)
Query: 86 IIGLKMLCNV---SVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
I ++ + + + S++ + +++ + GI L N+ L
Sbjct: 17 IFSDDAFAETIKDNLKKKSV-TDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 73
Query: 143 NISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGS 200
++ N P L L +L L N+ + L L L + + L +N
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNG---- 123
Query: 201 LDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFV 260
IS I L + LE NN + I + +
Sbjct: 124 ----------ISDINGLV-----------------HLPQLESLYLGNNKITD-ITVLSRL 155
Query: 261 FSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLE--GPVGSITSATLKKVNLSS 318
L L L NQ+S +P+A L + L L LS N + + + + L + L S
Sbjct: 156 TKLDTLSLEDNQISDIVPLAGLTK----LQNLYLSKNHISDLRALAGLKN--LDVLELFS 209
Query: 319 NKLS 322
+
Sbjct: 210 QECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 16/105 (15%), Positives = 35/105 (33%), Gaps = 18/105 (17%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
+ NL + + + E+ + + + + + + GI N+
Sbjct: 24 AETIKDNLKKKSVTDAVTQNELNS-----------IDQIIANNSDIKS--VQGIQYLPNV 70
Query: 486 VYLNLSNNKFEGSIP--DGLPNGLKEFNVSFNNLSGVVP-ENLRN 527
L L+ NK I L N L + N + + ++L+
Sbjct: 71 TKLFLNGNKLT-DIKPLANLKN-LGWLFLDENKVKDLSSLKDLKK 113
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 5/110 (4%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
L L ++ + NN++ +IT + + L+ L L N + + L L L +S N
Sbjct: 132 HLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKN 188
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
GL L L+L + ++ S L V ++
Sbjct: 189 HISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVK-KLGNIKHPNLVSLQ 794
IGR +G++ K SG I+AVKR+R K +K+ ++ + + P +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLH 852
G + +E + + ++ Y I E + ++ + + LN+L
Sbjct: 88 GALF--REGDCWICMELMSTSFDKFYKYVYSVLDDV---IPEEILGKITLATVKALNHLK 142
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE--FA 910
I H ++K +NILL+ + N L D+ + L + + +AG Y PE
Sbjct: 143 ENLKIIHRDIKPSNILLDR-SGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDP 199
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
S S+ ++SDV++ GI L EL TG+
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 65/294 (22%), Positives = 113/294 (38%), Gaps = 61/294 (20%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG+ G + G+ +AVK ++ + F E + ++H NLV L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 798 WGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+E L +++ Y+ SL YL+ L + L+ ++DV + YL
Sbjct: 84 --VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDVCEAMEYLEGNNF 138
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYR--PPEFASTSK 914
+ H +L + N+L+ + A ++D+ L + +S G L + PE K
Sbjct: 139 V-HRDLAARNVLV-SEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKK 190
Query: 915 PCPSLKSDVYAFGIILLELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967
S KSDV++FGI+L E+ + ++V
Sbjct: 191 --FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------------------ 224
Query: 968 CFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEK 1020
+ G+ M+ P + +V C L A+ RP F +L LE
Sbjct: 225 ---PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLRE-QLEH 270
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 26/208 (12%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+GR G +++ +G AVK++R + + E+ + P +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 797 YWGPKEHEKLVIS-NYINAQSLAVYLQETDPRKLPPLSIDERL--RVAVDVARCLNYLHN 853
+E + I + SL +++ + E L YLH
Sbjct: 119 V---REGPWVNIFMELLEGGSLGQLIKQMGC-------LPEDRALYYLGQALEGLEYLHT 168
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP----PEF 909
R + HG++K+ N+LL + A L D+ L G +L + PE
Sbjct: 169 RRIL-HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
KPC K D+++ ++L +L G
Sbjct: 228 V-MGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 38/221 (17%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
EVIG + A +A+KR+ E E +E++ + HPN+VS
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPR-KLPPLSIDERLRVAV--DVARCLNYLH 852
+ + E ++ ++ S+ ++ + + +DE + +V L YLH
Sbjct: 81 SFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 853 NERAIPHGNLKSTNILLE------------APTMNAVLTDYSLHRILTSAGT----ADQV 896
I H ++K+ NILL + + T GT A +V
Sbjct: 139 KNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ GY K+D+++FGI +EL TG
Sbjct: 198 MEQVR-GYDF-------------KADIWSFGITAIELATGA 224
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 64/248 (25%), Positives = 91/248 (36%), Gaps = 57/248 (22%)
Query: 302 PVGSIT-SATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
P+ ++ A+ +VN L+ +LP L D + + H
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPD-------------LPKDTTIL----------H 37
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
LS N L + RLT + L L V GT P L +DLS N L LP
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS--LP 93
Query: 421 SFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI 479
+ LT L++S N L + G + L L L N L L PG+
Sbjct: 94 LLGQTLPALTVLDVSFNR------LTSLPLGALRGLGE---LQELYLKGNELK-TLPPGL 143
Query: 480 -SKFHNLVYLNLSNNKFEGSIP----DGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFH 534
+ L L+L+NN +P +GL N L + N+L + P F
Sbjct: 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLEN-LDTLLLQENSLYTI--------PKGFF- 192
Query: 535 PGNSLLTF 542
G+ LL F
Sbjct: 193 -GSHLLPF 199
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 49/214 (22%), Positives = 75/214 (35%), Gaps = 27/214 (12%)
Query: 114 SLEFLDLSHNLFHGL--IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171
S ++ L +P + K+ +L++S N + +L L+L
Sbjct: 11 SHLEVNCDKR---NLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 172 RFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISEN---SLVGEL 228
+ + L + +DLS+NQ SL L + ++ L++S N SL
Sbjct: 66 ELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLG---QTLPALTVLDVSFNRLTSLPLGA 119
Query: 229 FPHDGMPYFDNLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESS 286
G+ L+ N L +P L L L +N L+ LP LL
Sbjct: 120 L--RGLG---ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE 172
Query: 287 MMLSELDLSLNQLEG-PVGSITSATLKKVNLSSN 319
L L L N L P G S L L N
Sbjct: 173 -NLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 50/213 (23%), Positives = 71/213 (33%), Gaps = 27/213 (12%)
Query: 289 LSELDLSLNQLEGPVGSITS---ATLKKVNLSSNKLSGSLPARV----GHCTIVDLSNNR 341
E++ L ++ ++LS N L + T ++L
Sbjct: 12 HLEVNCDKRNL----TALPPDLPKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAE 66
Query: 342 LSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTY 401
L+ L + + LS N L +P LT VS N L L
Sbjct: 67 LT-KLQVDGTLPV-LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 402 PELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
EL+ + L N L L P T KL L+L+ NN L E+ G
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN------LTELPAGLLNGLEN--- 173
Query: 461 LTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNN 493
L +L L NSL + G H L + L N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 15/142 (10%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
L +++ +L + G++ L LDLSHN L P +L L +L++S N
Sbjct: 53 PYTRLTQLNLDRAEL-TKLQVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFN 110
Query: 148 SFEGTFPSG-FGGLGKLKYLDLRANRFGGDIMHL----LSQLGSVVHVDLSNNQFSGSLD 202
+ P G GLG+L+ L L+ N + L L+ + + L+NN + L
Sbjct: 111 RLT-SLPLGALRGLGELQELYLKGNE----LKTLPPGLLTPTPKLEKLSLANNNLT-ELP 164
Query: 203 LGLGDSSFISSIQYLNISENSL 224
GL + + ++ L + ENSL
Sbjct: 165 AGLLNG--LENLDTLLLQENSL 184
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 43/231 (18%), Positives = 84/231 (36%), Gaps = 37/231 (16%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA-REVKKLGNIKHPNLVSLQG 795
V+G+ G + KA A+K++R + K EV L ++ H +V
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 796 YYWGPKEHEKLVISN-----------YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDV 844
+ + K + + Y +L + L DE R+ +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLN-QQRDEYWRLFRQI 125
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGY 904
L+Y+H++ I H +LK NI ++ + N + D+ L + + + D +
Sbjct: 126 LEALSYIHSQG-IIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHR--SLDILKLDSQNLP 181
Query: 905 RPPEFAST--------------SKPCPSLKSDVYAFGIILLELLTGKSSGE 941
+ ++ + K D+Y+ GII E++ S+G
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 52/324 (16%), Positives = 96/324 (29%), Gaps = 80/324 (24%)
Query: 92 LCNVSVSNNQLMGN-ITDIG---------SIQSLEFLDLSHN---------LFHGLIPSG 132
+ S+ L + IT S++ + LS N L + +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENI--AS 58
Query: 133 IVSLKNLMLLNISSNSFEGTFPSGFGGLGK-------LKYLDLRANRFGGD----IMHLL 181
L+ +I + + P L + L + L N FG ++ L
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 182 SQLGSVVHVDLSNNQFS--GSLDLG--------LGDSSFISSIQYLNISENSL------- 224
S+ + H+ L NN + + ++ + N L
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 225 VGELFPHDGMPYFDNLEVFDASNNHL--VGAIPSFNFVF----SLRILRLGSNQLS--GS 276
+ F L N + G L++L L N + GS
Sbjct: 179 WAKTFQS-----HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 277 LPVALLQESSMMLSELDLSLNQLEGPVGSI---------TSATLKKVNLSSNK------- 320
+A+ +S L EL L+ L G+ + L+ + L N+
Sbjct: 234 SALAIALKSWPNLRELGLNDCLL-SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292
Query: 321 -LSGSLPARVGHCTIVDLSNNRLS 343
L + ++ ++L+ NR S
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 67/378 (17%), Positives = 118/378 (31%), Gaps = 83/378 (21%)
Query: 163 LKYLDLRANRFGGD----IMHLLSQLGSVVHVDLSNNQFS--GSLDLGLGDSSFISSIQY 216
++ L+ + + + +L + SV + LS N + L +S ++
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS-KKDLEI 64
Query: 217 LNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS-- 274
S+ + + L+ A+ L +RL N
Sbjct: 65 AEFSDIFTG------------RVKDEIPEALRLLLQALLKCP---KLHTVRLSDNAFGPT 109
Query: 275 GSLPVALLQESSMMLSELDLSLNQLEGPVG--SITSATLKKVNLSSNKLSGSLPARVGHC 332
P+ L L L N L GP I A + K + L
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAKIARALQELAVNKKAKNAPPL------- 161
Query: 333 TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
+ NRL + S M+ W + ++ L + K+ N +
Sbjct: 162 RSIICGRNRL-ENGS-MKEWAKTFQS-------------HRL-----LHTVKMVQNGIRP 201
Query: 393 D-----LPAVLGTYPELKVIDLSLNHLN-------GFLLPSFFTSTKLTDLNLSGNNFS- 439
+ L L ELKV+DL N L S L +L L+ S
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS---WPNLRELGLNDCLLSA 258
Query: 440 -GPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-----SKFHNLVYLNLSNN 493
G + + + +N+ L +L L YN + + + K +L++L L+ N
Sbjct: 259 RGAAAVVD-----AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313
Query: 494 KF--EGSIPDGLPNGLKE 509
+F E + D +
Sbjct: 314 RFSEEDDVVDEIREVFST 331
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 746 GTLYKAT-LDSGSILAVKRL-REGIAKGKKE--FAREVKKLGNIKHPNLVSLQGYYWGPK 801
G +Y A S ILA+K L + + K E REV+ +++HPN++ L GY+
Sbjct: 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82
Query: 802 EHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHG 860
++ +I Y ++ L +KL ++A L+Y H + + H
Sbjct: 83 ---RVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH-SKRVIHR 133
Query: 861 NLKSTNILLEAPTMNAVLTDYSL------HRILTSAGTADQVLNAGALGYRPPEFASTSK 914
++K N+LL + + D+ R GT D Y PPE
Sbjct: 134 DIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLD---------YLPPEMIEGRM 183
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
K D+++ G++ E L GK
Sbjct: 184 --HDEKVDLWSLGVLCYEFLVGK 204
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 51/221 (23%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 724 SLMFTAEELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVK- 780
S+ A++L P +GR +G + K + SG I+AVKR+R ++ +K ++
Sbjct: 1 SMEVKADDL--EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 781 KLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERL-- 838
+ + P V+ G + +E + + ++ SL + ++ + I E +
Sbjct: 59 SMRTVDCPFTVTFYGALF--REGDVWICMELMDT-SLDKFYKQVIDKGQT---IPEDILG 112
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
++AV + + L +LH++ ++ H ++K +N+L+ A + D+ + L D +
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDI--D 169
Query: 899 AGALGYRPPE-FASTSKPCP-SLKSDVYAFGIILLELLTGK 937
AG Y PE S+KSD+++ GI ++EL +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 61/322 (18%), Positives = 111/322 (34%), Gaps = 92/322 (28%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREGIAKGKKEFAREVKKLGNIKHPNLV 791
+G G ++ A + +L AVK L+E +++F RE + L ++H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR----------KLPPLSIDERLRVA 841
G + L++ Y+ L +L+ P PL + + L VA
Sbjct: 107 RFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901
VA + YL + H +L + N L+ + + D+ + R + S
Sbjct: 165 SQVAAGMVYLAGLHFV-HRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDY--------- 213
Query: 902 LGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------G 936
YR PPE F + +SDV++FG++L E+ T
Sbjct: 214 --YRVGGRTMLPIRWMPPESILYRKF--------TTESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 937 KSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC 996
S+ E + I G ++E+P ++ + C
Sbjct: 264 LSNTEAI---------------------------DCITQGRELERPRACPPEVYAIMRGC 296
Query: 997 -ILPASERPDMMSVFEELSTIV 1017
+R + V L +
Sbjct: 297 WQREPQQRHSIKDVHARLQALA 318
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 40/243 (16%), Positives = 77/243 (31%), Gaps = 44/243 (18%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK-----RLREGIAKGKKEFAREVKKLGNIKHPNLV 791
IG+ +G + A + +I A+K ++R+ K + EV+ + + HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 792 SLQGYY---------------------------------WGPKEHEKLVISNYINAQSLA 818
L Y ++ N +++
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 819 VYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV- 877
+ + + L+YLH + I H ++K N L +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 878 LTDYSLHRILTSAGTADQVLNAGALG---YRPPEFASTSKPCPSLKSDVYAFGIILLELL 934
L D+ L + + G + PE +T+ K D ++ G++L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 935 TGK 937
G
Sbjct: 271 MGA 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E IG+ G ++K + ++A+K + E ++ +E+ L P + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y K+ + +I Y+ S L+ P L I LR ++ + L+YLH+E+
Sbjct: 88 SYL--KDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILR---EILKGLDYLHSEK 139
Query: 856 AIPHGNLKSTNILLEAPTMNAV--LTDY--------SLHRILTSAGT----ADQVLNAGA 901
I H ++K+ N+LL + + L D+ + + T GT A +V+
Sbjct: 140 KI-HRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS- 194
Query: 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
Y K+D+++ GI +EL G+
Sbjct: 195 -AYDS-------------KADIWSLGITAIELARGE 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 61/325 (18%), Positives = 116/325 (35%), Gaps = 97/325 (29%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREGIAKGKKEFAREVKKLGNIKHPNLV 791
+G G ++ A +L AVK L++ +K+F RE + L N++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 792 SLQG--YYWGPKEHEKLVISNYINAQSLAVYLQETDPR-----------KLPPLSIDERL 838
G P +++ Y+ L +L+ P L + + L
Sbjct: 81 KFYGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN 898
+A +A + YL ++ + H +L + N L+ + + D+ + R + S
Sbjct: 137 HIASQIASGMVYLASQHFV-HRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDY------ 188
Query: 899 AGALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT----- 935
YR PPE F + +SDV++FG+IL E+ T
Sbjct: 189 -----YRVGGHTMLPIRWMPPESIMYRKF--------TTESDVWSFGVILWEIFTYGKQP 235
Query: 936 --GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVA 993
S+ E++ I G +E+P ++ V
Sbjct: 236 WFQLSNTEVI---------------------------ECITQGRVLERPRVCPKEVYDVM 268
Query: 994 LRC-ILPASERPDMMSVFEELSTIV 1017
L C +R ++ +++ L +
Sbjct: 269 LGCWQREPQQRLNIKEIYKILHALG 293
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 9e-10
Identities = 46/236 (19%), Positives = 78/236 (33%), Gaps = 26/236 (11%)
Query: 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
+ ++ D + + L +LS ++ S + S K L L + T
Sbjct: 330 ECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI 388
Query: 154 PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSS--FI 211
L L Y + + S L +V + + S L
Sbjct: 389 ILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY 440
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSN 271
+ ++ L+++ L L + + D S+N L P+ + L +L+ N
Sbjct: 441 ADVRVLHLAHKDLT-VL---CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN 496
Query: 272 QLSGSLPVALLQESSMMLSELDLSLNQLE-----GPVGSITSATLKKVNLSSNKLS 322
L VA L L EL L N+L+ P+ S L +NL N L
Sbjct: 497 ALENVDGVANLPR----LQELLLCNNRLQQSAAIQPLVSCPR--LVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 40/254 (15%), Positives = 77/254 (30%), Gaps = 22/254 (8%)
Query: 270 SNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARV 329
++QL + S + L S T L + LS K +
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELE 369
Query: 330 GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNS 389
+ +L L+ + ++ + L + +R +
Sbjct: 370 SCKELQELEPENKWCLLTIILL-MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428
Query: 390 LEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN 449
+ + Y +++V+ L+ L +L +T L+LS N L+ +
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR------LRAL-- 478
Query: 450 NPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPD-----GLP 504
L L + N+L + G++ L L L NN+ + P
Sbjct: 479 --PPALAALRCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCP 533
Query: 505 NGLKEFNVSFNNLS 518
L N+ N+L
Sbjct: 534 R-LVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 6e-09
Identities = 24/143 (16%), Positives = 48/143 (33%), Gaps = 11/143 (7%)
Query: 85 TIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNI 144
+ ++ + + L+ N + L L+H L + L + L++
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDL 470
Query: 145 SSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLD 202
S N P L L+ L N + ++ ++ L + + L NN+
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNA----LENVDGVANLPRLQELLLCNNRLQ-QSA 524
Query: 203 LGLGDSSFISSIQYLNISENSLV 225
+ + LN+ NSL
Sbjct: 525 -AIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 19/111 (17%), Positives = 45/111 (40%), Gaps = 11/111 (9%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLML 141
+ L ++ ++ +S+N+L + +++ LE L S N + G+ +L L
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQE 512
Query: 142 LNISSNSFEGTFPS--GFGGLGKLKYLDLRANRFGGD------IMHLLSQL 184
L + +N + + +L L+L+ N + + +L +
Sbjct: 513 LLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 56/319 (17%), Positives = 109/319 (34%), Gaps = 92/319 (28%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREG-IAKGKKEFAREVKKLGNIKHPNL 790
+G+ G +Y+ D A+K + E + + EF E + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 791 VSLQG--YYWGPKEHEKLVISNYINAQSLAVYLQETDPR-----KLPPLSIDERLRVAVD 843
V L G P LVI + L YL+ P L P S+ + +++A +
Sbjct: 91 VRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG 903
+A + YL+ + + H +L + N ++ A + D+ + R +
Sbjct: 147 IADGMAYLNANKFV-HRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDY----------- 193
Query: 904 YR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT-------GKS 938
YR PE F + SDV++FG++L E+ T G S
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVF--------TTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 939 SGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-I 997
+ +++ R +M+G +++P + ++ C
Sbjct: 246 NEQVL---------------------------RFVMEGGLLDKPDNCPDMLFELMRMCWQ 278
Query: 998 LPASERPDMMSVFEELSTI 1016
RP + + +
Sbjct: 279 YNPKMRPSFLEIISSIKEE 297
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 30/198 (15%), Positives = 65/198 (32%), Gaps = 24/198 (12%)
Query: 331 HCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSL 390
+ +L ++ DL + V++ + ++ + + F L +S+N +
Sbjct: 20 NAVKQNLGKQSVT-DLVSQKELSG-VQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQI 75
Query: 391 EGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNN 450
DL L +L+ + ++ N L + S L+ L L N L ++N
Sbjct: 76 S-DLSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDSLIHLKN- 129
Query: 451 PSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP-DGLPNGLKE 509
L L + N L + + L L+L N+ + L +
Sbjct: 130 ----------LEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLTRLKK-VNW 176
Query: 510 FNVSFNNLSGVVPENLRN 527
+++ +
Sbjct: 177 IDLTGQKCVNEPVKYQPE 194
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 34/206 (16%), Positives = 73/206 (35%), Gaps = 25/206 (12%)
Query: 96 SVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPS 155
S+ + + + + +L L L + N +++ +
Sbjct: 2 SIQRPTPINQVFPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNI--QSLA 57
Query: 156 GFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISS 213
G LK L L N+ I L L L + + ++ N+ + +
Sbjct: 58 GMQFFTNLKELHLSHNQ----ISDLSPLKDLTKLEELSVNRNRLKNLNGIPS------AC 107
Query: 214 IQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQL 273
+ L + N L + + NLE+ NN L +I F+ L +L L N++
Sbjct: 108 LSRLFLDNNELR-DTDSLIHLK---NLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI 162
Query: 274 SGSLPVALLQESSMMLSELDLSLNQL 299
+ + + L++ ++ +DL+ +
Sbjct: 163 TNTGGLTRLKK----VNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 24/139 (17%), Positives = 56/139 (40%), Gaps = 17/139 (12%)
Query: 89 LKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNS 148
L + +S+NQ+ +++ + + LE L ++ N L + L L + +N
Sbjct: 62 FTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNE 117
Query: 149 FEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLGLG 206
L L+ L +R N+ + + L L + +DL N+ + + L
Sbjct: 118 L--RDTDSLIHLKNLEILSIRNNK----LKSIVMLGFLSKLEVLDLHGNEITNTGGL--- 168
Query: 207 DSSFISSIQYLNISENSLV 225
+ + + +++++ V
Sbjct: 169 --TRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 17/104 (16%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
NL + + + +E+ + + + +++ L G+ F NL
Sbjct: 19 ANAVKQNLGKQSVTDLVSQKELSG-----------VQNFNGDNSNIQS--LAGMQFFTNL 65
Query: 486 VYLNLSNNKFEGSIP--DGLPNGLKEFNVSFNNLSGVVPENLRN 527
L+LS+N+ + L L+E +V+ N L +
Sbjct: 66 KELHLSHNQIS-DLSPLKDLTK-LEELSVNRNRLKNLNGIPSAC 107
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 41/219 (18%), Positives = 77/219 (35%), Gaps = 45/219 (20%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G G +++ T +G+ A K + K+ +E++ + ++HP LV+L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 797 YWGPKEH-------------EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+ E EK+ + + E + + +R
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEY--------MRQVCK 266
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGAL 902
L ++H E H +LK NI+ N + L D+ L L + G
Sbjct: 267 G---LCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTA 320
Query: 903 GYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE D+++ G++ LL+G S
Sbjct: 321 EFAAPEVAEGKPVGYYT-----DMWSVGVLSYILLSGLS 354
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 31/195 (15%)
Query: 753 LDSGSILAVKRL-REGIAKGK--KEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKL-VI 808
+ I+A+K L + + K + RE++ +++HPN++ + Y+ K ++ ++
Sbjct: 36 KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK---RIYLM 92
Query: 809 SNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNIL 868
+ L LQ K ++A L+Y H ER + H ++K N+L
Sbjct: 93 LEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLL 146
Query: 869 LEAPTMNAVLTDYSL------HRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSD 922
+ + D+ R T GT D Y PPE K D
Sbjct: 147 MGY-KGELKIADFGWSVHAPSLRRRTMCGTLD---------YLPPEMIEGKTHDE--KVD 194
Query: 923 VYAFGIILLELLTGK 937
++ G++ E L G
Sbjct: 195 LWCAGVLCYEFLVGM 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 46/218 (21%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G G +YKA ++G++ A K + + +++ E++ L HP +V L G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
Y+ + + ++ + ++ + E D L+ + V + LN+LH++R
Sbjct: 85 YY--HDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 857 IPHGNLKSTNILLEAPTMNAV--LTDY--------SLHRILTSAGT----ADQVLNAGAL 902
I H +LK+ N+L+ T+ L D+ +L + + GT A +V+ +
Sbjct: 139 I-HRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 903 ---GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
Y K+D+++ GI L+E+ +
Sbjct: 195 KDTPYDY-------------KADIWSLGITLIEMAQIE 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 33/202 (16%)
Query: 749 YKAT-LDSGSILAVKRL-REGIAKGKKE--FAREVKKLGNIKHPNLVSLQGYYWGPKEHE 804
Y+A + +G +A+K + ++ + K EVK +KHP+++ L Y+
Sbjct: 28 YRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--- 84
Query: 805 KL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLK 863
+ ++ + + YL+ ++ P S +E + + YLH I H +L
Sbjct: 85 YVYLVLEMCHNGEMNRYLK----NRVKPFSENEARHFMHQIITGMLYLH-SHGILHRDLT 139
Query: 864 STNILLEAPTMN--------AVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
+N+LL MN A + T GT + Y PE A+ +
Sbjct: 140 LSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPN---------YISPEIAT--RS 187
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
L+SDV++ G + LL G+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 66/337 (19%), Positives = 116/337 (34%), Gaps = 105/337 (31%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNIKH 787
+ +GR G + +A + +AVK L+EG + E+ +G H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--HH 90
Query: 788 PNLVSLQG---YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-----------PLS 833
N+V+L G GP +VI + +L+ YL+ +P L+
Sbjct: 91 LNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 834 IDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893
++ + + VA+ + +L + + I H +L + NILL + + D+ L R +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILL-SEKNVVKICDFGLARDIYKDPD- 203
Query: 894 DQVLNAGALGYR------------PPEFASTSKPCPSL-------KSDVYAFGIILLELL 934
Y PE ++ +SDV++FG++L E+
Sbjct: 204 ----------YVRKGDARLPLKWMAPE---------TIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 935 T-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILS 987
+ G E C R + +G M P
Sbjct: 245 SLGASPYPGVKIDEEFC--------------------------RRLKEGTRMRAPDYTTP 278
Query: 988 DMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+M Q L C S+RP + E L ++ Q
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 40/226 (17%), Positives = 78/226 (34%), Gaps = 59/226 (26%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G G +++ +G + K + K E+ + + HP L++L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 797 YWGPKEH-------------EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+ E +++ +Y + E + +R A +
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINY--------MRQACE 160
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRIL-------TSAGTADQ 895
L ++H E +I H ++K NI+ E ++V + D+ L L + TA
Sbjct: 161 G---LKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA-- 214
Query: 896 VLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE D++A G++ LL+G S
Sbjct: 215 -------EFAAPEIVDREPVGFYT-----DMWAIGVLGYVLLSGLS 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 60/335 (17%), Positives = 121/335 (36%), Gaps = 101/335 (30%)
Query: 738 EVIGRSCHGTLYKATL--------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNI 785
+ +G C G + A +AVK L++ K + E+ K +G
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-- 144
Query: 786 KHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL-----------PPLSI 834
KH N+++L G ++ VI Y + +L YL+ P + ++
Sbjct: 145 KHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894
+ + +AR + YL +++ I H +L + N+L+ + D+ L R + +
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLV-TENNVMKIADFGLARDINNIDY-- 258
Query: 895 QVLNAGALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT- 935
Y+ PE + + +SDV++FG+++ E+ T
Sbjct: 259 ---------YKKTTNGRLPVKWMAPEALFDRVY--------THQSDVWSFGVLMWEIFTL 301
Query: 936 ------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDM 989
G E+ +L+ +GH M++P +++
Sbjct: 302 GGSPYPGIPVEELF---------------------------KLLKEGHRMDKPANCTNEL 334
Query: 990 LQVALRC-ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ C S+RP + E+L I+ ++
Sbjct: 335 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 46/217 (21%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G +G++YKA ++G I+A+K++ + +E +E+ + P++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV--DVARCLNYLHNE 854
Y+ K + ++ Y A S+ +D +L ++ E + + L YLH
Sbjct: 93 YF--KNTDLWIVMEYCGAGSV------SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 855 RAIPHGNLKSTNILLEAPTMNAV--LTDY--------SLHRILTSAGT----ADQVLNAG 900
R I H ++K+ NILL L D+ ++ + T GT A +V+
Sbjct: 145 RKI-HRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 901 ALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
GY +D+++ GI +E+ GK
Sbjct: 201 --GYNC-------------VADIWSLGITAIEMAEGK 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 70/337 (20%), Positives = 123/337 (36%), Gaps = 105/337 (31%)
Query: 738 EVIGRSCHGTLYKATL--------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNI 785
+ +G G + A + + +AVK L+ K + E+ K +G
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 132
Query: 786 KHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-----------PLSI 834
KH N+++L G ++ VI Y + +L YLQ P L LS
Sbjct: 133 KHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894
+ + A VAR + YL +++ I H +L + N+L+ + D+ L R +
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLV-TEDNVMKIADFGLARDIHHIDY-- 246
Query: 895 QVLNAGALGYR------------PPEFASTSKPCPSL-------KSDVYAFGIILLELLT 935
Y+ PE +L +SDV++FG++L E+ T
Sbjct: 247 ---------YKKTTNGRLPVKWMAPE---------ALFDRIYTHQSDVWSFGVLLWEIFT 288
Query: 936 -------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988
G E+ +L+ +GH M++P ++
Sbjct: 289 LGGSPYPGVPVEELF---------------------------KLLKEGHRMDKPSNCTNE 321
Query: 989 MLQVALRC--ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ + C +P S+RP + E+L IV +Q
Sbjct: 322 LYMMMRDCWHAVP-SQRPTFKQLVEDLDRIVALTSNQ 357
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 52/266 (19%), Positives = 103/266 (38%), Gaps = 49/266 (18%)
Query: 687 SSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAEVIGRSCHG 746
SS + + ++ V + L + D L+ + IG G
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYV-------KIGEGSTG 59
Query: 747 TLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEK 805
+ A SG +AVK + + ++ EV + + +H N+V + Y E
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL--VGEEL 117
Query: 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKST 865
V+ ++ +L TD L+ ++ V V + L YLH + I H ++KS
Sbjct: 118 WVLMEFLQGGAL------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI-HRDIKSD 170
Query: 866 NILLEAPTMNAV--LTDY--------SLHRILTSAGT----ADQVLNAGALGYRPPEFAS 911
+ILL T++ L+D+ + + + GT A +V++
Sbjct: 171 SILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT------- 220
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
+ D+++ GI+++E++ G+
Sbjct: 221 --------EVDIWSLGIMVIEMVDGE 238
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 308 SATLKKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLS----GDLSRMQNWGNYVEDIHLS 362
+ V+ SS KL+ ++P+ + +DL +N+LS R+ + ++L+
Sbjct: 15 NNNKNSVDCSSKKLT-AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTK----LRLLYLN 69
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYP-ELKVIDLSLNHLNGFLLPS 421
N L + + L + V++N L+ LP + L + L N L L P
Sbjct: 70 DNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
Query: 422 FFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI- 479
F S TKLT L+L N LQ + T L L L N L R+ G
Sbjct: 128 VFDSLTKLTYLSLGYNE------LQSLPKGVFDKLTS---LKELRLYNNQLK-RVPEGAF 177
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
K L L L NN+ + +P+G + L+
Sbjct: 178 DKLTELKTLKLDNNQLK-RVPEGAFDSLE 205
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 59/225 (26%), Positives = 85/225 (37%), Gaps = 53/225 (23%)
Query: 129 IPSGI-VSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFG---GDIMHLLSQL 184
IPS I K L L SN F L KL+ L L N+ I L L
Sbjct: 31 IPSNIPADTKKLDL---QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 185 GSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFD 244
+ +++N+ +L +G+ D + ++ L + N L + P VFD
Sbjct: 88 E---TLWVTDNKLQ-ALPIGVFDQ--LVNLAELRLDRNQL--KSLPPR---------VFD 130
Query: 245 ASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVAL---LQESSMMLSELDLSLNQLEG 301
L L L LG N+L SLP + L L EL L NQL+
Sbjct: 131 ----SLT----------KLTYLSLGYNELQ-SLPKGVFDKLTS----LKELRLYNNQLKR 171
Query: 302 -PVGSITSAT-LKKVNLSSNKLSGSLPA----RVGHCTIVDLSNN 340
P G+ T LK + L +N+L +P + ++ L N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 58/212 (27%), Positives = 82/212 (38%), Gaps = 40/212 (18%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANR 172
+ LDL N L L L LL ++ N + T P+G F L L+ L + N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 173 FG---GDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELF 229
+ L L + L NQ SL + DS ++ + YL++ N L +
Sbjct: 97 LQALPIGVFDQLVNLA---ELRLDRNQLK-SLPPRVFDS--LTKLTYLSLGYNEL--QSL 148
Query: 230 PHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMML 289
P VFD L SL+ LRL +NQL +P + L
Sbjct: 149 PKG---------VFD----KLT----------SLKELRLYNNQLK-RVPEGAF-DKLTEL 183
Query: 290 SELDLSLNQLEG-PVGSITSAT-LKKVNLSSN 319
L L NQL+ P G+ S LK + L N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 56/200 (28%), Positives = 78/200 (39%), Gaps = 30/200 (15%)
Query: 253 AIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-PVGSITSAT- 310
AIPS N + L L SN+LS SLP L L L+ N+L+ P G
Sbjct: 30 AIPS-NIPADTKKLDLQSNKLS-SLPSKAFH-RLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 311 LKKVNLSSNKLSGSLPARVGHC----TIVDLSNNRLSG-------DLSRMQNWGNYVEDI 359
L+ + ++ NKL +LP V + L N+L L+++ +
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLT-------YL 138
Query: 360 HLSSNFLTGMVPNQTSQFLRLTSFKV---SNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
L N L +P F +LTS K NN L+ ELK + L N L
Sbjct: 139 SLGYNELQ-SLPKGV--FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195
Query: 417 FLLPSFFTSTKLTDLNLSGN 436
+F + KL L L N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 66/322 (20%), Positives = 125/322 (38%), Gaps = 85/322 (26%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL---AVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVS 792
+VIG G + KA + + A+KR++E ++FA E++ L + HPN+++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPP-----------LSIDERLRVA 841
L G + Y +L +L+++ + P LS + L A
Sbjct: 91 LLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901
DVAR ++YL +++ H +L + NIL+ A + D+ L R +V
Sbjct: 149 ADVARGMDYL-SQKQFIHRDLAARNILV-GENYVAKIADFGLSR-------GQEVYVKKT 199
Query: 902 LGYRP-----PEFASTSKPCPSL-------KSDVYAFGIILLELLT-------GKSSGEI 942
+G P E SL SDV+++G++L E+++ G + E+
Sbjct: 200 MGRLPVRWMAIE---------SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 943 VCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC--ILPA 1000
+ G+ +E+P ++ + +C P
Sbjct: 251 Y---------------------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKP- 282
Query: 1001 SERPDMMSVFEELSTIVLEKDS 1022
ERP + L+ ++ E+ +
Sbjct: 283 YERPSFAQILVSLNRMLEERKT 304
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 61/330 (18%), Positives = 119/330 (36%), Gaps = 105/330 (31%)
Query: 738 EVIGRSCHGTLYKATL--------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNI 785
+ +G G + A +AVK L++ K + E+ K +G
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-- 98
Query: 786 KHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL-----------PPLSI 834
KH N+++L G ++ VI Y + +L YL+ P + ++
Sbjct: 99 KHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894
+ + +AR + YL +++ I H +L + N+L+ + D+ L R + +
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLV-TENNVMKIADFGLARDINNIDY-- 212
Query: 895 QVLNAGALGYR------------PPEFASTSKPCPSL-------KSDVYAFGIILLELLT 935
Y+ PE +L +SDV++FG+++ E+ T
Sbjct: 213 ---------YKKTTNGRLPVKWMAPE---------ALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 936 -------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988
G E+ +L+ +GH M++P ++
Sbjct: 255 LGGSPYPGIPVEELF---------------------------KLLKEGHRMDKPANCTNE 287
Query: 989 MLQVALRC--ILPASERPDMMSVFEELSTI 1016
+ + C +P S+RP + E+L I
Sbjct: 288 LYMMMRDCWHAVP-SQRPTFKQLVEDLDRI 316
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E IG+ GT+Y A + +G +A++++ K+ E+ + K+PN+V+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
Y E V+ Y+ SL TD + + V + + L +LH+ +
Sbjct: 86 YL--VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 857 IPHGNLKSTNILLEAPTMNAV--LTDY--------SLHRILTSAGT----ADQVLNAGAL 902
I H ++KS NILL M+ LTD+ + T GT A +V+ A
Sbjct: 138 I-HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 903 GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
G K D+++ GI+ +E++ G+
Sbjct: 194 GP---------------KVDIWSLGIMAIEMIEGE 213
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQG 795
E++G +G +YK + +G + A+K + + ++E +E+ L H N+ + G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 796 YY---WGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
+ P ++L ++ + A S+ ++ T L I R ++ R L++L
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---EILRGLSHL 145
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV--LTDY--------SLHRILTSAGTADQVLNAGA 901
H + I H ++K N+LL T NA L D+ ++ R T GT
Sbjct: 146 HQHKVI-HRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGT--------- 192
Query: 902 LGYRP----PEFASTSKPCPS---LKSDVYAFGIILLELLTGK 937
P PE + + + KSD+++ GI +E+ G
Sbjct: 193 ----PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 52/220 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
EV+G ++ +G + A+K +++ A E+ L IKH N+V+L+
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 797 YWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
Y + LV+ + I + E D + ++ + +
Sbjct: 75 YESTTHYY-LVMQLVSGGELFDRILERG---VYTEKDASLV--------IQQVLSA---V 119
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNA--VLTDYSLHRIL------TSAGT----ADQV 896
YLH E I H +LK N+L P N+ ++TD+ L ++ T+ GT A +V
Sbjct: 120 KYLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV 178
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
L Y SK D ++ G+I LL G
Sbjct: 179 LAQK--PY--------SKAV-----DCWSIGVITYILLCG 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 45/221 (20%), Positives = 83/221 (37%), Gaps = 49/221 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E++G G ++K +G LA K ++ K K+E E+ + + H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 797 YWGPKEH-------------EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+ + ++++ +Y L E D ++ +
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYN--------LTELDTILF--------MKQICE 198
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVL--NAG 900
+ ++H + I H +LK NIL + + D+ L R + L N G
Sbjct: 199 G---IRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP----REKLKVNFG 250
Query: 901 ALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE + S P D+++ G+I LL+G S
Sbjct: 251 TPEFLAPEVVNYDFVSFPT-----DMWSVGVIAYMLLSGLS 286
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 63/327 (19%), Positives = 114/327 (34%), Gaps = 112/327 (34%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNIKH 787
+ +G G + +AT D+ +AVK L+ A K+ E+ LG +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QH 109
Query: 788 PNLVSL-----QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL---------PPLS 833
N+V+L G GP LVI+ Y L +L+ S
Sbjct: 110 ENIVNLLGACTHG---GPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 834 IDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893
+ L + VA+ + +L ++ I H ++ + N+LL A + D+ L R + +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCI-HRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSN- 219
Query: 894 DQVLNAGALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT 935
Y PE + +++SDV+++GI+L E+ +
Sbjct: 220 ----------YIVKGNARLPVKWMAPESIFDCVY--------TVQSDVWSYGILLWEIFS 261
Query: 936 -------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSD 988
G +L+ DG+ M QP +
Sbjct: 262 LGLNPYPGILVNSKFY--------------------------KLVKDGYQMAQPAFAPKN 295
Query: 989 MLQVALRC--ILPASERPDMMSVFEEL 1013
+ + C + P + RP F+++
Sbjct: 296 IYSIMQACWALEP-THRPT----FQQI 317
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 40/219 (18%), Positives = 84/219 (38%), Gaps = 37/219 (16%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
+ G+ GT+ +G +A+K++ + F + ++ L + HPN+V
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD--------V 844
LQ Y++ E ++ I Y+N + + + ++ +
Sbjct: 84 LQSYFYTLGERDRRDI--YLN---VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 845 ARCLNYLHNERA-IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAG--- 900
R + LH + H ++K N+L+ L D+ + L+ + N
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-----NVAYIC 193
Query: 901 ALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ YR PE F + + D+++ G I E++ G+
Sbjct: 194 SRYYRAPELIFGNQH---YTTAVDIWSVGCIFAEMMLGE 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 44/218 (20%), Positives = 83/218 (38%), Gaps = 44/218 (20%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
+ +G +G + + A+K + + EV L + HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 795 GYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
++ E ++ LV+ + I + E D + ++ +
Sbjct: 103 DFF----EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVI--------IKQVLS 147
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN--A 899
+ YLH + I H +LK N+LLE+ +A++ D+ L + + + +
Sbjct: 148 G---VTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN----QKKMKERL 199
Query: 900 GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
G Y PE + K DV++ G+IL LL G
Sbjct: 200 GTAYYIAPE---VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 60/336 (17%), Positives = 110/336 (32%), Gaps = 102/336 (30%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREG-IAKGKKEFAREV---KKLGNIKH 787
+ +G G + +AT D+ +AVK L+ ++ E+ LG H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NH 86
Query: 788 PNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL-------------PPLSI 834
N+V+L G LVI+ Y L +L+ + L +
Sbjct: 87 MNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 835 DERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894
++ L + VA+ + +L ++ I H +L + NILL + D+ L R + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCI-HRDLAARNILL-THGRITKICDFGLARDIKNDSN-- 200
Query: 895 QVLNAGALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT- 935
Y PE + + +SDV+++GI L EL +
Sbjct: 201 ---------YVVKGNARLPVKWMAPESIFNCVY--------TFESDVWSYGIFLWELFSL 243
Query: 936 ------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDM 989
G ++I +G M P ++M
Sbjct: 244 GSSPYPGMPVDSKFY--------------------------KMIKEGFRMLSPEHAPAEM 277
Query: 990 LQVALRC--ILPASERPDMMSVFEELSTIVLEKDSQ 1023
+ C P +RP + + + + E +
Sbjct: 278 YDIMKTCWDADP-LKRPTFKQIVQLIEKQISESTNH 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 48/271 (17%), Positives = 86/271 (31%), Gaps = 74/271 (27%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLV---- 791
+ +GR G +++A A+KR+R +++ REVK L ++HP +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 792 -----------SLQGYYWGPKEHEKLVISN------------------------------ 810
W E +S+
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 811 -----YI-----NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHG 860
YI ++L ++ + L + + +A + +LH++ + H
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDRE--HGVCLHIFIQIAEAVEFLHSKGLM-HR 188
Query: 861 NLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALG-----------YRPPEF 909
+LK +NI + D+ L + VL Y PE
Sbjct: 189 DLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGKSSG 940
S K D+++ G+IL ELL S+
Sbjct: 248 IH-GNNY-SHKVDIFSLGLILFELLYSFSTQ 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 730 EELSHAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHP 788
+E+S+ +VIG G +Y+A L DSG ++A+K+ + + K+ RE++ + + H
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHC 107
Query: 789 NLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD----- 843
N+V L+ +++ E + V Y+N L + ++ + + V
Sbjct: 108 NIVRLRYFFYSSGEKKDEV---YLN---LVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 844 ---VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-ADQVLNA 899
+ R L Y+H+ I H ++K N+LL+ T L D+ + L +
Sbjct: 162 MYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 218
Query: 900 GALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ YR PE F +T + DV++ G +L ELL G+
Sbjct: 219 -SRYYRAPELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK-------KEFAREVKKLGNIKHPN 789
V+G+ G + +G AVK I+K + + REV+ L + HPN
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKV----ISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 790 LVSLQGYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERL 838
++ L ++ E + LV + I ++ E D ++ +
Sbjct: 88 IMKLYEFF----EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARI--------I 132
Query: 839 RVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQV 896
R + + Y+H + I H +LK N+LLE+ + +A + D+ L ++
Sbjct: 133 RQVLSG---ITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 897 LNAGALGYRPPEF--ASTSKPCPSLKSDVYAFGIILLELLTG 936
G Y PE + + C DV++ G+IL LL+G
Sbjct: 189 --IGTAYYIAPEVLHGTYDEKC-----DVWSTGVILYILLSG 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 50/232 (21%), Positives = 93/232 (40%), Gaps = 27/232 (11%)
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA- 776
H FD+ + + +G +G ++ A D +A+K+ I +
Sbjct: 5 HGFDLGSRYM-------DLKPLGCGGNGLVFSAVDNDCDKRVAIKK----IVLTDPQSVK 53
Query: 777 ---REVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVY--LQETDPRKL-- 829
RE+K + + H N+V + + + S+ + ETD +
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 830 -PPLSIDERLRVAV-DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887
PL +E R+ + + R L Y+H+ + H +LK N+ + + + D+ L RI+
Sbjct: 114 QGPLL-EEHARLFMYQLLRGLKYIHSANVL-HRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 888 TSAGTADQVLNAGALG--YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ L+ G + YR P + + D++A G I E+LTGK
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 9e-08
Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 48/209 (22%)
Query: 749 YKAT-LDSGSILAVKRL-REGIAKGKKE--FAREVKKLGNIKHPNLVSLQGYYWGPKEHE 804
++ + D+ + A K + + + K + + E+ ++ H ++V G++
Sbjct: 32 FEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV- 90
Query: 805 KLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC--------LNYLHNERA 856
V+ +SL + R + AR YLH
Sbjct: 91 -FVVLELCRRRSLLELHKR-------------RKALTEPEARYYLRQIVLGCQYLHR-NR 135
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSL--------HRILTSAGTADQVLNAGALGYRPPE 908
+ H +LK N+ L + + D+ L R GT + Y PE
Sbjct: 136 VIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPN---------YIAPE 185
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGK 937
S S + DV++ G I+ LL GK
Sbjct: 186 VLSKKGH--SFEVDVWSIGCIMYTLLVGK 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 59/296 (19%), Positives = 106/296 (35%), Gaps = 64/296 (21%)
Query: 659 SVVTKPKELYHPDSVRKDEGLSSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDL 718
S H + E L ++ P+ + K+ DV +
Sbjct: 2 SYYHHHHH--HDYDIPTTENLYFQGAM--DPMPAGGRAGSL-KDPDVAELFFKD------ 50
Query: 719 HLFDVSLMFTAEELSHAPAEVIGRSCHGTLYKAT-LDSGSILAVKRL---REGIAKGKKE 774
D +F+ IG G +Y A + + ++A+K++ + + ++
Sbjct: 51 ---DPEKLFSDLR-------EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 775 FAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSI 834
+EV+ L ++HPN + +G Y +EH ++ Y S +D ++ +
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYC-LGSA------SDLLEVHKKPL 151
Query: 835 DERLRVAV--DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV--LTDY----SLHRI 886
E AV + L YLH+ I H ++K+ NILL + + L D+ +
Sbjct: 152 QEVEIAAVTHGALQGLAYLHSHNMI-HRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 207
Query: 887 LTSAGTADQVLNAGALGYRP----PEFASTSKPCP-SLKSDVYAFGIILLELLTGK 937
+ GT P PE K DV++ GI +EL K
Sbjct: 208 NSFVGT-------------PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 48/230 (20%), Positives = 80/230 (34%), Gaps = 59/230 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-------------EGIAKGKKEFAREVKKLG 783
+G +G + + S A+K ++ + I K +E E+ L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 784 NIKHPNLVSLQGYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPL 832
++ HPN++ L + E +K LV I + E D
Sbjct: 102 SLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN---- 150
Query: 833 SIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSA 890
+ + + YLH + I H ++K NILLE + D+ L +
Sbjct: 151 -------IMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK- 201
Query: 891 GTADQVLN--AGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTG 936
D L G Y PE ++ C DV++ G+I+ LL G
Sbjct: 202 ---DYKLRDRLGTAYYIAPEVLKKKYNEKC-----DVWSCGVIMYILLCG 243
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 48/209 (22%)
Query: 749 YKAT-LDSGSILAVKRL-REGIAKGKKE--FAREVKKLGNIKHPNLVSLQGYYWGPKEHE 804
++ + D+ + A K + + + K + + E+ ++ H ++V G++
Sbjct: 58 FEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV- 116
Query: 805 KLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC--------LNYLHNERA 856
V+ +SL + R + AR YLH
Sbjct: 117 -FVVLELCRRRSLLELHKR-------------RKALTEPEARYYLRQIVLGCQYLHR-NR 161
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSL--------HRILTSAGTADQVLNAGALGYRPPE 908
+ H +LK N+ L + + D+ L R GT + Y PE
Sbjct: 162 VIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPN---------YIAPE 211
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGK 937
S S + DV++ G I+ LL GK
Sbjct: 212 VLSKKGH--SFEVDVWSIGCIMYTLLVGK 238
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 15/146 (10%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGS-----IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLL 142
L L ++ +S+N + I S + +L +LDLS N H L L+ L +L
Sbjct: 62 RLTNLHSLLLSHNH----LNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117
Query: 143 NISSNSFEGTFPSG-FGGLGKLKYLDLRANR---FGGDIMHLLSQLGSVVHVDLSNNQFS 198
+ +N F + +L+ L L N+ F +++ ++L ++ +DLS+N+
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 199 GSLDLGLGDSSFISSIQYLNISENSL 224
L L L + N L
Sbjct: 177 -KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 37/185 (20%), Positives = 67/185 (36%), Gaps = 30/185 (16%)
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANRFGGDIMHL----LSQ 183
+P + LL++S N+ L L L L N + +
Sbjct: 33 VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH----LNFISSEAFVP 86
Query: 184 LGSVVHVDLSNNQFSGSLDLGLGDSSF--ISSIQYLNISEN---SLVGELFPHDGMPYFD 238
+ ++ ++DLS+N L + F + +++ L + N + F + M
Sbjct: 87 VPNLRYLDLSSNHLHT-----LDEFLFSDLQALEVLLLYNNHIVVVDRNAF--EDMA--- 136
Query: 239 NLEVFDASNNHL----VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDL 294
L+ S N + V I N + L +L L SN+L L + + + + L L
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 295 SLNQL 299
N L
Sbjct: 197 HNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 34/137 (24%)
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS-LTSLDLAYNSLSGRLLPGI-SKF 482
+ L+LS NN + + + L+ L SL L++N L+ +
Sbjct: 38 PSYTALLDLSHNN---------LSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 483 HNLVYLNLSNNKFEGSIP----DGLPNGLKEFNVSFNNLSGVVPE--------------- 523
NL YL+LS+N ++ L L+ + N++ V
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQA-LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
Query: 524 -NLRNFPDSAFHPGNSL 539
+ FP GN L
Sbjct: 146 NQISRFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 33/169 (19%), Positives = 61/169 (36%), Gaps = 25/169 (14%)
Query: 239 NLEVFDASNNHL--VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
+ D S+N+L + A + + +L L L N L+ + L LDLS
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN-LRYLDLSS 97
Query: 297 NQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS------- 343
N L + L+ + L +N + + + LS N++S
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156
Query: 344 GDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
D +++ + + LSSN L +P +L ++ + L
Sbjct: 157 KDGNKLPK----LMLLDLSSNKLK-KLPLTD--LQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 42/176 (23%), Positives = 66/176 (37%), Gaps = 24/176 (13%)
Query: 308 SATLKKVNLSSNKLS----GSLPARVGHCTIVDLSNNRLS----GDLSRMQNWGNYVEDI 359
+ ++LS N LS P R+ + + LS+N L+ + N + +
Sbjct: 38 PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN----LRYL 93
Query: 360 HLSSNFLTGMVPNQTSQFL-RLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGF- 417
LSSN L + L L + NN + +L+ + LS N ++ F
Sbjct: 94 DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152
Query: 418 --LLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSL 471
L+ KL L+LS N LPL ++Q P+ L L N L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPA------WVKNGLYLHNNPL 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 62/342 (18%), Positives = 110/342 (32%), Gaps = 109/342 (31%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREV---KKLGNIKH 787
+V+G G + AT +AVK L+E + ++ E+ +LG H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SH 108
Query: 788 PNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQE------------------TDPRKL 829
N+V+L G +I Y L YL+ + L
Sbjct: 109 ENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 830 PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889
L+ ++ L A VA+ + +L + + H +L + N+L+ + D+ L R + S
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLV-THGKVVKICDFGLARDIMS 224
Query: 890 AGTADQVLNAGALGYR------------PPEFASTSKPCPSL-------KSDVYAFGIIL 930
Y PE SL KSDV+++GI+L
Sbjct: 225 DSN-----------YVVRGNARLPVKWMAPE---------SLFEGIYTIKSDVWSYGILL 264
Query: 931 LELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPP 983
E+ + G +LI +G M+QP
Sbjct: 265 WEIFSLGVNPYPGIPVDANFY--------------------------KLIQNGFKMDQPF 298
Query: 984 RILSDMLQVALRC--ILPASERPDMMSVFEELSTIVLEKDSQ 1023
++ + C +RP ++ L + + +
Sbjct: 299 YATEEIYIIMQSCWAFDS-RKRPSFPNLTSFLGCQLADAEEA 339
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 39/221 (17%), Positives = 82/221 (37%), Gaps = 43/221 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKE------FAREVKKLGNIKHP 788
+ +G G + A + +A++ + R+ +E E++ L + HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 789 NLVSLQGYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRV 840
++ ++ ++ + +V+ + + L+E +
Sbjct: 201 CIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNK---RLKEATCKLY--------FYQ 247
Query: 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN 898
+ + YLH E I H +LK N+LL + + ++ TD+ +IL ++
Sbjct: 248 MLLA---VQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE----TSLMR 299
Query: 899 --AGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLELLTG 936
G Y PE S + D ++ G+IL L+G
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 36/214 (16%), Positives = 79/214 (36%), Gaps = 40/214 (18%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
IGR G + A + A K++ + + F +E++ + ++ HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 797 YWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
+ + LV+ + + +E+D ++ ++ + +
Sbjct: 75 FEDNTDIY-LVMELCTGGELFERVVHKR---VFRESDAARI--------MKDVLSA---V 119
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN--AGALGY 904
Y H + + H +LK N L + ++ L D+ L +++ G Y
Sbjct: 120 AYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP----GKMMRTKVGTPYY 174
Query: 905 RPPEFASTS--KPCPSLKSDVYAFGIILLELLTG 936
P+ C D ++ G+++ LL G
Sbjct: 175 VSPQVLEGLYGPEC-----DEWSAGVMMYVLLCG 203
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 65/339 (19%), Positives = 115/339 (33%), Gaps = 106/339 (31%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNL 790
IG G +++A + AVK L+E A + +F RE + +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 791 VSLQG--YYWGPKEHEKLVISNYINAQSLAVYLQETDPR-------------------KL 829
V L G P ++ Y+ L +L+ P
Sbjct: 113 VKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 830 PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889
PPLS E+L +A VA + YL + + H +L + N L+ M + D+ L R + S
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLV-GENMVVKIADFGLSRNIYS 226
Query: 890 AGTADQVLNAGALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILL 931
A Y+ PPE + + +SDV+A+G++L
Sbjct: 227 ADY-----------YKADGNDAIPIRWMPPESIFYNRY--------TTESDVWAYGVVLW 267
Query: 932 ELLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPR 984
E+ + G + E++ + DG+ + P
Sbjct: 268 EIFSYGLQPYYGMAHEEVI---------------------------YYVRDGNILACPEN 300
Query: 985 ILSDMLQVALRC-ILPASERPDMMSVFEELSTIVLEKDS 1022
++ + C ++RP S+ L + +
Sbjct: 301 CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK-GKKEFA-REVKKLGNIKHPNLVSLQ 794
++G +G + K D+G I+A+K+ E K+ A RE+K L ++H NLV+L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL- 89
Query: 795 GYYWGPKE--HEK----LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
E +K LV +++ ++ L E P L + + L + +
Sbjct: 90 ------LEVCKKKKRWYLVF-EFVD-HTILDDL-ELFPNGLDYQVVQKYLF---QIINGI 137
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTA--DQVLNAGALGY 904
+ H+ I H ++K NIL+ + + V+ D+ R L + G D+V Y
Sbjct: 138 GFCHSHN-IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVA---TRWY 190
Query: 905 RPPE--FAST--SKPCPSLKSDVYAFGIILLELLTGK 937
R PE K DV+A G ++ E+ G+
Sbjct: 191 RAPELLVGDVKYGKAV-----DVWAIGCLVTEMFMGE 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 63/336 (18%), Positives = 120/336 (35%), Gaps = 106/336 (31%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNL 790
+ +G G + KAT +G AVK L+E ++ E L + HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-------------------P 831
+ L G ++ L+I Y SL +L+E+
Sbjct: 89 IKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 832 LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891
L++ + + A +++ + YL + + H +L + NIL+ A ++D+ L R +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLV-HRDLAARNILV-AEGRKMKISDFGLSRDVYEED 204
Query: 892 TADQVLNAGALGYR------------PPEFASTSKPCPSL-------KSDVYAFGIILLE 932
+ Y E SL +SDV++FG++L E
Sbjct: 205 S-----------YVKRSQGRIPVKWMAIE---------SLFDHIYTTQSDVWSFGVLLWE 244
Query: 933 LLT-------GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRI 985
++T G + L+ GH ME+P
Sbjct: 245 IVTLGGNPYPGIPPERLF---------------------------NLLKTGHRMERPDNC 277
Query: 986 LSDMLQVALRC--ILPASERPDMMSVFEELSTIVLE 1019
+M ++ L+C P +RP + ++L ++++
Sbjct: 278 SEEMYRLMLQCWKQEP-DKRPVFADISKDLEKMMVK 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK-GKKEFA-REVKKLGNIKHPNLVSLQ 794
IG +G ++K D+G I+A+K+ E K+ A RE++ L +KHPNLV+L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL- 67
Query: 795 GYYWGPKE--HEK----LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
E K LV Y + ++ L + R +P + + +
Sbjct: 68 ------LEVFRRKRRLHLVF-EYCD-HTVLHEL-DRYQRGVPEHLVKSITW---QTLQAV 115
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTA--DQVLNAGALGY 904
N+ H H ++K NIL+ T ++V L D+ R+LT D+V Y
Sbjct: 116 NFCHKHN-CIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWY 168
Query: 905 RPPE--FAST--SKPCPSLKSDVYAFGIILLELLTGK 937
R PE T P DV+A G + ELL+G
Sbjct: 169 RSPELLVGDTQYGPPV-----DVWAIGCVFAELLSGV 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 40/226 (17%), Positives = 78/226 (34%), Gaps = 53/226 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK-------RLREGIAKGKKE-FAREVKKLGNIKHP 788
+ +G G + A + +A+K + E++ L + HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 789 NLVSLQGYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRV 840
++ ++ ++ + +V+ + + L+E +
Sbjct: 76 CIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNK---RLKEATCKLY--------FYQ 122
Query: 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-------TSAG 891
+ + YLH E I H +LK N+LL + + ++ TD+ +IL T G
Sbjct: 123 MLLA---VQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 892 TADQVLNAGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLELLTG 936
T Y PE S + D ++ G+IL L+G
Sbjct: 179 TP---------TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 48/219 (21%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
++G+ G + K + AVK + K REV+ L + HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 795 GYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
E +V + I + E D ++ ++
Sbjct: 88 EIL----EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI--------IKQVFS 132
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN--A 899
+ Y+H + I H +LK NILLE+ + + D+ L + +
Sbjct: 133 G---ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ----NTKMKDRI 184
Query: 900 GALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTG 936
G Y PE + + C DV++ G+IL LL+G
Sbjct: 185 GTAYYIAPEVLRGTYDEKC-----DVWSAGVILYILLSG 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 46/219 (21%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 730 EELSHAPAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPN 789
E+++ +VIG G +++A L +A+K+ + + K+ RE++ + +KHPN
Sbjct: 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK----VLQDKRFKNRELQIMRIVKHPN 93
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD------ 843
+V L+ +++ + + ++N L + + + + +
Sbjct: 94 VVDLKAFFYSNGDKKD---EVFLN---LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 844 --VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-ADQVLNAG 900
+ R L Y+H+ I H ++K N+LL+ P+ L D+ +IL + +
Sbjct: 148 YQLLRSLAYIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--- 203
Query: 901 ALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ YR PE F +T+ + D+++ G ++ EL+ G+
Sbjct: 204 SRYYRAPELIFGATNY---TTNIDIWSTGCVMAELMQGQ 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 45/216 (20%), Positives = 78/216 (36%), Gaps = 42/216 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
++G+ G + K + AVK + K REV+ L + HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 795 GYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
+V + I + E D ++ ++
Sbjct: 88 EILEDSSSFY-IVGELYTGGELFDEIIKRK---RFSEHDAARI--------IKQVFSG-- 133
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN--AGAL 902
+ Y+H + I H +LK NILLE+ + + D+ L + + G
Sbjct: 134 -ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ----NTKMKDRIGTA 187
Query: 903 GYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTG 936
Y PE + + C DV++ G+IL LL+G
Sbjct: 188 YYIAPEVLRGTYDEKC-----DVWSAGVILYILLSG 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 44/222 (19%), Positives = 86/222 (38%), Gaps = 51/222 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQG 795
+G G ++ SG +K + + ++ E E++ L ++ HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 796 YYWGPKEHEKLVISNYI---------------NAQSLAVYLQETDPRKLPPLSIDERLRV 840
+ E + YI +AQ+ L E +L ++
Sbjct: 88 VF----EDYHNM---YIVMETCEGGELLERIVSAQARGKALSEGYVAEL--------MKQ 132
Query: 841 AVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN 898
++ L Y H + + H +LK NIL + + ++ + D+ L + S D+
Sbjct: 133 MMNA---LAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS----DEHST 184
Query: 899 --AGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTG 936
AG Y PE + C D+++ G+++ LLTG
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKC-----DIWSAGVVMYFLLTG 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 45/208 (21%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQG 795
+GR + +++A + + + VK L+ KK+ RE+K L N++ PN+++L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLAD 98
Query: 796 YYWGPKE-HEKLVISNYINAQSLAVYLQETDPRKL-PPLSIDERLRVAV-DVARCLNYLH 852
P LV ++ TD ++L L+ D +R + ++ + L+Y H
Sbjct: 99 IVKDPVSRTPALVFE----------HVNNTDFKQLYQTLT-DYDIRFYMYEILKALDYCH 147
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPE-F 909
+ I H ++K N++++ L D+ L Q N + ++ PE
Sbjct: 148 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF----YHPGQEYNVRVASRYFKGPELL 202
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
SL D+++ G +L ++ K
Sbjct: 203 VDYQMYDYSL--DMWSLGCMLASMIFRK 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 57/322 (17%), Positives = 110/322 (34%), Gaps = 94/322 (29%)
Query: 738 EVIGRSCHGTLYKATL-----DSGSIL-AVKRLREGI-AKGKKEFAREVKKLGNIKHPNL 790
E +G G +YK L + A+K L++ ++EF E ++HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR-----------KLPPLSIDERLR 839
V L G K+ +I +Y + L +L P L + +
Sbjct: 75 VCLLGVV--TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+ +A + YL + + H +L + N+L+ +N ++D L R + +A
Sbjct: 133 LVAQIAAGMEYLSSHHVV-HKDLATRNVLV-YDKLNVKISDLGLFREVYAADY------- 183
Query: 900 GALGYR------------PPE------FASTSKPCPSLKSDVYAFGIILLELLT------ 935
Y+ PE F S+ SD++++G++L E+ +
Sbjct: 184 ----YKLLGNSLLPIRWMAPEAIMYGKF--------SIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 936 -GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVAL 994
G S+ ++V +I + + P + + + +
Sbjct: 232 CGYSNQDVV---------------------------EMIRNRQVLPCPDDCPAWVYALMI 264
Query: 995 RC-ILPASERPDMMSVFEELST 1015
C S RP + L
Sbjct: 265 ECWNEFPSRRPRFKDIHSRLRA 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 47/217 (21%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE--FAREVKKLGNIKHPNLVSLQ 794
+GR +Y+ + A+K + K + E+ L + HPN++ L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKV----LKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 795 GYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
+ P E LV+ + I + Y E D ++ ++
Sbjct: 115 EIFETPTEIS-LVLELVTGGELFDRIVEKG---YYSERDAADA--------VKQILEA-- 160
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNA--VLTDYSLHRILTSAGTADQVLN--AGAL 902
+ YLH E I H +LK N+L P +A + D+ L +I+ ++ G
Sbjct: 161 -VAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH----QVLMKTVCGTP 214
Query: 903 GYRPPE-FASTS--KPCPSLKSDVYAFGIILLELLTG 936
GY PE + D+++ GII LL G
Sbjct: 215 GYCAPEILRGCAYGPEV-----DMWSVGIITYILLCG 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 35/221 (15%), Positives = 73/221 (33%), Gaps = 50/221 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +GR G +++ S K ++ + +E+ L +H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHES 69
Query: 797 YWGPKEH-------------EKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+ +E E++ S + L E + + +
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF--------ELNEREIVSY--------VHQVCE 113
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLN--AG 900
L +LH I H +++ NI+ + + + + ++ R L
Sbjct: 114 A---LQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP----GDNFRLLFT 165
Query: 901 ALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
A Y PE S D+++ G ++ LL+G +
Sbjct: 166 APEYYAPEVHQHDVVSTAT-----DMWSLGTLVYVLLSGIN 201
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGF 157
S + + LEFL + + + + L L L +S N G
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 158 GGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNN 195
L +L+L N+ D+ + L +L ++ +DL N
Sbjct: 85 EKCPNLTHLNLSGNKI-KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/98 (27%), Positives = 38/98 (38%), Gaps = 12/98 (12%)
Query: 400 TYPELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQN 458
T ++K + L + N L +L L+ L I N P
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG------LTSIANLPK-----L 63
Query: 459 LSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFE 496
L L+L+ N +SG L K NL +LNLS NK +
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 41/224 (18%), Positives = 81/224 (36%), Gaps = 58/224 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLG-NIKHPNLVSLQG 795
+V+G +G + + +G A+K + + +EV P++V +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKL----LYD-SPKARQEVDHHWQASGGPHIVCILD 89
Query: 796 YYWGPKEHEKLV-----------ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDV 844
Y ++ + + + I + + E + ++ +R D+
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-TEREAAEI--------MR---DI 137
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL------TSAGT---- 892
+ +LH I H ++K N+L + +AVL TD+ + T T
Sbjct: 138 GTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 196
Query: 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
A +VL Y K C D+++ G+I+ LL G
Sbjct: 197 APEVLGPE--KY--------DKSC-----DMWSLGVIMYILLCG 225
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 53/222 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
E +G+ + + +G A K + ++ A+ ++ RE + ++HPN+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 795 GYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
H LV I A+ + E D ++ ++
Sbjct: 72 DSIQEESFHY-LVFDLVTGGELFEDIVARE---FYSEADASHC--------IQQILES-- 117
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-------TSAGTADQVL 897
+ Y H I H NLK N+LL + A + D+ L + AGT
Sbjct: 118 -IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---- 171
Query: 898 NAGALGYRPPE-FAST--SKPCPSLKSDVYAFGIILLELLTG 936
GY PE SKP D++A G+IL LL G
Sbjct: 172 -----GYLSPEVLKKDPYSKPV-----DIWACGVILYILLVG 203
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 25/100 (25%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 98 SNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGF 157
+ +LEFL L + + S + L L L +S N G
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 158 GGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNN 195
L L +L+L N+ DI L L +L + +DL N
Sbjct: 92 EKLPNLTHLNLSGNKL-KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 24/98 (24%), Positives = 35/98 (35%), Gaps = 12/98 (12%)
Query: 400 TYPELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQN 458
T ++ + L N + L L+L L + N P
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG------LISVSNLPK-----L 70
Query: 459 LSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFE 496
L L+L+ N + G L K NL +LNLS NK +
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 10/103 (9%)
Query: 370 VPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLT 429
+ T++F+ L + N L + + L P+LK ++LS N + G L LT
Sbjct: 41 IEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98
Query: 430 DLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLS 472
LNLSGN L+ ++ L SLDL ++
Sbjct: 99 HLNLSGNKLKDISTLEPLKKLE--------CLKSLDLFNCEVT 133
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 49/233 (21%), Positives = 83/233 (35%), Gaps = 70/233 (30%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGI---AKGKKEFAREVKKLGNIKHP 788
+G +G +YKA + +A+KR+R EG+ A REV L ++H
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHR 93
Query: 789 NLVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLPPLSIDERLRVAV 842
N++ L + ++ ++ L Y+ K P +S+
Sbjct: 94 NIIEL---------KSVIHHNHRLHLIFEYAENDLKKYMD-----KNPDVSMRVIKSFLY 139
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV----LTDYSL------------HRI 886
+ +N+ H+ R H +LK N+LL + + D+ L H I
Sbjct: 140 QLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 887 LTSAGTADQVLNAGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+T L YRPPE S D+++ I E+L
Sbjct: 199 IT-------------LWYRPPEILLGSRHYSTS---VDIWSIACIWAEMLMKT 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 45/218 (20%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLR-----EGI---AKGKKEFAREVKKLGNIKHPN 789
E +G +G +YKA G I+A+KR+R EGI A RE+ L + HPN
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 790 LVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+VSL + + + + L L + + L I L
Sbjct: 81 IVSL---------IDVIHSERCLTLVFEFMEKDLKKVL-DENKTGLQDSQIKIYLY---Q 127
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA--DQVLNAGA 901
+ R + + H R I H +LK N+L+ L D+ L R + +V+
Sbjct: 128 LLRGVAHCHQHR-ILHRDLKPQNLLI-NSDGALKLADFGLARAFGIPVRSYTHEVV---T 182
Query: 902 LGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR P+ S D+++ G I E++TGK
Sbjct: 183 LWYRAPDVLMGSKKYSTS---VDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 45/221 (20%), Positives = 75/221 (33%), Gaps = 43/221 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK-----RLREGIAKGKKEFAREVKKLGNIKHPNLV 791
EVIG+ + + ++G AVK + ++ RE +KHP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 792 SLQGYYWGPKEHEKLVIS--------NYINAQ-SLAVYLQETDPRKLPPLSIDERLRVAV 842
L Y +V I + E +R +
Sbjct: 90 ELLETYSSDGMLY-MVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--------MRQIL 140
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN-- 898
+ L Y H + I H ++K +LL + +A + + + L +G V
Sbjct: 141 EA---LRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAGGR 193
Query: 899 AGALGYRPPEF---ASTSKPCPSLKSDVYAFGIILLELLTG 936
G + PE KP DV+ G+IL LL+G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPV-----DVWGCGVILFILLSG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 44/229 (19%), Positives = 80/229 (34%), Gaps = 58/229 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIKHPNL 790
E +G + K +G A K ++ ++E REV L + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 791 VSLQGYYWGPKEHEKLV--------ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842
++L Y + L+ + +++ + L E + ++ +
Sbjct: 78 ITLHDVYENRTDVV-LILELVSGGELFDFLAQKE---SLSEEEATSF--------IKQIL 125
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV---LTDYSLHRIL-------TSAGT 892
D +NYLH + I H +LK NI+L + L D+ L + GT
Sbjct: 126 DG---VNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 893 ADQVLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE + D+++ G+I LL+G S
Sbjct: 182 P---------EFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGAS 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 37/215 (17%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
+ IG G + A +A+K+L + A RE+ + + H N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL--PPLSIDERLRVAV-DVA 845
L + K E+ VY L + + ++ L ER+ + +
Sbjct: 89 LLNVFTPQKSLEEFQ----------DVYIVMELMDANLCQVIQMELD-HERMSYLLYQML 137
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-TSAGTADQVLNAGAL 902
+ +LH+ I H +LK +NI++++ + L D+ L R TS V
Sbjct: 138 CGIKHLHSAGII-HRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV---VTR 190
Query: 903 GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE ++ D+++ G I+ E++ G
Sbjct: 191 YYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 45/229 (19%), Positives = 81/229 (35%), Gaps = 58/229 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIKHPNL 790
E +G + K +G A K ++ ++E REV L + HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 791 VSLQGYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842
++L Y + L++ +++ + L E + ++ +
Sbjct: 78 ITLHDVYENRTDVV-LILELVSGGELFDFLAQKE---SLSEEEATSF--------IKQIL 125
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV---LTDYSLHRIL-------TSAGT 892
D +NYLH + I H +LK NI+L + L D+ L + GT
Sbjct: 126 DG---VNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 893 ADQVLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE + D+++ G+I LL+G S
Sbjct: 182 P---------EFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGAS 216
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 25/146 (17%), Positives = 50/146 (34%), Gaps = 26/146 (17%)
Query: 402 PELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
+ L+ N F +L +N S N + +I+ G++
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK------ITDIEEGAFEGASG--- 82
Query: 461 LTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIP----DGLPNGLKEFNVSFN 515
+ + L N L + + +L L L +N+ + GL + ++ ++ N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS-VRLLSLYDN 139
Query: 516 NLSGVVPENLRNFPDSAFHPGNSLLT 541
++ V AF +SL T
Sbjct: 140 QITTV--------APGAFDTLHSLST 157
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 31/143 (21%), Positives = 51/143 (35%), Gaps = 16/143 (11%)
Query: 355 YVEDIHLSSNFLTGMVPNQTSQFL-RLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNH 413
Y ++ L++N T + + L +L SNN + + I L+ N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 414 LNGFLLPS--FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSL 471
L + F L L L N + + N+ G + + L L N +
Sbjct: 93 LEN--VQHKMFKGLESLKTLMLRSNR------ITCVGNDSFIGLSS---VRLLSLYDNQI 141
Query: 472 SGRLLPGI-SKFHNLVYLNLSNN 493
+ + PG H+L LNL N
Sbjct: 142 T-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 4/113 (3%)
Query: 113 QSLEFLDLSHNLFHGLIPSGI-VSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171
Q L L++N F L +GI L L +N S+N F G + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 172 RFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224
R + L S+ + L +N+ + + +SS++ L++ +N +
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG--LSSVRLLSLYDNQI 141
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 47/226 (20%), Positives = 75/226 (33%), Gaps = 61/226 (26%)
Query: 262 SLRILRLGSNQLSGSLPVAL---LQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSS 318
SLR L L +++ + L L E++L+ QL P G TL V L +
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQL-DPAGL---RTLLPVFLRA 128
Query: 319 NKLSGSLPARVGHCTIVDLSNNRLSGD----LSRMQNWGNYVEDIHLSSNFLTGMVPNQT 374
KL L N L + L + L +
Sbjct: 129 RKL--------------GLQLNSLGPEACKDLRDL-----------LLHDQCQ------- 156
Query: 375 SQFLRLTSFKVSNNSL--EG--DLPAVLGTYPELKVIDLSLNHLN----GFLLPSFFTST 426
+T+ ++SNN L G L L + + L L L +
Sbjct: 157 -----ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211
Query: 427 KLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLS 472
+L +LN++ N G + + + ++ SL L L +N LS
Sbjct: 212 QLQELNVAYNGA-GDTAALAL----ARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 36/227 (15%), Positives = 62/227 (27%), Gaps = 54/227 (23%)
Query: 123 NLFHGLIPSGIVSL-----KNLMLLNISSNSFEGTFPSGFGGLGK--------LKYLDLR 169
+ +L LN++ P + L ++L
Sbjct: 53 DHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLA 109
Query: 170 ANRFGGD-IMHLLSQLGSVVHVDLSNNQFS--GSLDLGLGDSSFISSIQYLNISENSLVG 226
+ + + LL + L N DL I L +S N L
Sbjct: 110 SCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT- 168
Query: 227 ELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS----GSLPVALL 282
A L+ + S+ L L L L L
Sbjct: 169 -----------------AAGVAVLMEGLAGNT---SVTHLSLLHTGLGDEGLELLAAQLD 208
Query: 283 QESSMMLSELDLSLNQLEGPVG--SITSA-----TLKKVNLSSNKLS 322
+ L EL+++ N G ++ A +L+ ++L N+LS
Sbjct: 209 RNRQ--LQELNVAYNGA-GDTAALALARAAREHPSLELLHLYFNELS 252
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 47/219 (21%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLR-----EGI---AKGKKEFAREVKKLGNIKHPN 789
E IG +G +YKA + G A+K++R EGI RE+ L +KH N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT------IREISILKELKHSN 61
Query: 790 LVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+V L ++ + + Q L L + L ++ L
Sbjct: 62 IVKL---------YDVIHTKKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLL---Q 108
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG---TADQVLNAG 900
+ + Y H+ R + H +LK N+L+ + D+ L R T + V
Sbjct: 109 LLNGIAYCHDRR-VLHRDLKPQNLLI-NREGELKIADFGLARAFGIPVRKYTHEIV---- 162
Query: 901 ALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR P+ S D+++ G I E++ G
Sbjct: 163 TLWYRAPDVLMGSKKYSTT---IDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 48/229 (20%), Positives = 84/229 (36%), Gaps = 62/229 (27%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR----EGI---AKGKKEFAREVKKLGNIKHPN 789
E +G + T+YK +G +A+K ++ EG A RE+ + +KH N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHEN 64
Query: 790 LVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLP-PLSIDERLRVAV 842
+V L ++ + N + L Y+ P L ++
Sbjct: 65 IVRL---------YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL------------HRILTSA 890
+ + L + H + I H +LK N+L+ L D+ L ++T
Sbjct: 116 QLLQGLAFCHENK-ILHRDLKPQNLLI-NKRGQLKLGDFGLARAFGIPVNTFSSEVVT-- 171
Query: 891 GTADQVLNAGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR P+ S + D+++ G IL E++TGK
Sbjct: 172 -----------LWYRAPDVLMGSRTYSTS---IDIWSCGCILAEMITGK 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 65/228 (28%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR----EGI---AKGKKEFAREVKKLGNIKHPN 789
+ +G + T+YK + +++A+K +R EG A REV L ++KH N
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHAN 61
Query: 790 LVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLPPLSIDERLRVAVD 843
+V+L H+ + + + L YL + + ++ L
Sbjct: 62 IVTL---------HDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLF---Q 108
Query: 844 VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL------------HRILTSAG 891
+ R L Y H ++ + H +LK N+L+ L D+ L + ++T
Sbjct: 109 LLRGLAYCHRQK-VLHRDLKPQNLLI-NERGELKLADFGLARAKSIPTKTYDNEVVT--- 163
Query: 892 TADQVLNAGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YRPP+ ST D++ G I E+ TG+
Sbjct: 164 ----------LWYRPPDILLGSTDYSTQ---IDMWGVGCIFYEMATGR 198
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 31/115 (26%), Positives = 46/115 (40%), Gaps = 27/115 (23%)
Query: 386 SNNSLEGDLPAVLGTYPELKVIDLSLN------HLNGFLLPSFFTSTKLTDLNLSGNNFS 439
+E + A L T K + LS N L+G L L+L N
Sbjct: 33 MIPPIE-KMDATLSTLKACKHLALSTNNIEKISSLSGM--------ENLRILSLGRNL-- 81
Query: 440 GPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNK 494
+++I+N +L L ++YN ++ L GI K NL L +SNNK
Sbjct: 82 ----IKKIEN----LDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNK 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 23/138 (16%), Positives = 59/138 (42%), Gaps = 17/138 (12%)
Query: 105 NITDI----GSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGL 160
I + ++++ + L LS N + S + ++NL +L++ N + +
Sbjct: 36 PIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 161 GKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFSGSLDLG-LGDSSFISSIQYL 217
L+ L + N+ I L + +L ++ + +SNN+ + ++ L + ++ L
Sbjct: 93 DTLEELWISYNQ----IASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAA---LDKLEDL 145
Query: 218 NISENSLVGELFPHDGMP 235
++ N L + ++
Sbjct: 146 LLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 25/113 (22%), Positives = 48/113 (42%), Gaps = 9/113 (7%)
Query: 89 LKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSL-KNLMLLNISSN 147
LK ++++S N + I+ + +++L L L NL + + ++ L L IS N
Sbjct: 47 LKACKHLALSTNNI-EKISSLSGMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYN 103
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDLSNNQFS 198
SG L L+ L + N+ + + L+ L + + L+ N
Sbjct: 104 QIASL--SGIEKLVNLRVLYMSNNKI-TNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 44/220 (20%), Positives = 80/220 (36%), Gaps = 52/220 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLG-NIKHPNLVSLQG 795
E IG + + + AVK I K K++ E++ L +HPN+++L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 796 YYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDV 844
Y + K +V + I Q + E + + L
Sbjct: 84 VY----DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAV--------LFTITKT 128
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV---LTDYSLHRILTSAGTADQVLN--A 899
+ YLH + + H +LK +NIL + N + D+ + L + +L
Sbjct: 129 ---VEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPC 181
Query: 900 GALGYRPPE-FASTS--KPCPSLKSDVYAFGIILLELLTG 936
+ PE C D+++ G++L +LTG
Sbjct: 182 YTANFVAPEVLERQGYDAAC-----DIWSLGVLLYTMLTG 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 47/224 (20%), Positives = 87/224 (38%), Gaps = 56/224 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
+G +G++ A SG +A+K+L + FA RE+ L +++H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL--PPLSIDERLRVAV-DVA 845
L + Y +TD +K+ S +E+++ V +
Sbjct: 88 LLDVFTPASSLRNFY----------DFYLVMPFMQTDLQKIMGLKFS-EEKIQYLVYQML 136
Query: 846 RCLNYLHNERAIPHGNLKSTNILLE------------APTMNAVLTDYSLHRILTSAGTA 893
+ L Y+H+ + H +LK N+ + A +A +T Y + R
Sbjct: 137 KGLKYIHSAGVV-HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW------- 188
Query: 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE + + D+++ G I+ E+LTGK
Sbjct: 189 ----------YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 48/225 (21%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK-GKKEF----AREV---KKLGNIKHP 788
IG +GT+YKA SG +A+K +R G REV ++L +HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 789 NLVSLQGYYWGPKEHEKLVIS---NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVA 845
N+V L + ++ ++ +++ Q L YL D P L + +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYL---DKAPPPGLPAETIKDLMRQFL 130
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSL-----------HRILTSAGT 892
R L++LH I H +LK NIL+ T + D+ L ++T
Sbjct: 131 RGLDFLHANC-IVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVT---- 182
Query: 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR PE S + D+++ G I E+ K
Sbjct: 183 ---------LWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRK 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 739 VIGRSCHGTLYKATL----DSGSILAVKRLREGIAKGKKEFAR---EVKKLGNIKHPNLV 791
++G+ GT K L +G A+K L++ + K E A E + L N +HP L
Sbjct: 155 LLGK---GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNY 850
+L+ Y + + V+ Y N L +L R ++R R ++ L+Y
Sbjct: 212 ALK-YSFQTHDRLCFVME-YANGGELFFHLSRE--RVFS----EDRARFYGAEIVSALDY 263
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL--------HRILTSAGTADQVLNAGAL 902
LH+E+ + + +LK N++L+ + +TD+ L + T GT +
Sbjct: 264 LHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFCGTPE-------- 314
Query: 903 GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938
Y PE + ++ D + G+++ E++ G+
Sbjct: 315 -YLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRL 347
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 46/215 (21%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
+ IG G + A +A+K+L + A RE+ + + H N++S
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL--PPLSIDERLRVAV-DVA 845
L + K E+ VY L + + ++ L ER+ + +
Sbjct: 126 LLNVFTPQKTLEEFQ----------DVYLVMELMDANLCQVIQMELD-HERMSYLLYQML 174
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-TSAGTADQVLNAGAL 902
+ +LH+ I H +LK +NI++++ + L D+ L R TS V
Sbjct: 175 CGIKHLHSAGII-HRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV---VTR 227
Query: 903 GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE ++ D+++ G I+ E++ K
Sbjct: 228 YYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 260
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 38/215 (17%)
Query: 739 VIGRSCHGTLYKATL-DSGSILAVKRLR-EGIAKGKKE--FAREVKKLGNIKHPNLVSLQ 794
++G T+ A + A+K L I K K RE + + HP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 795 GYYWGPKEHEKL-VISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLH 852
+ ++ EKL +Y L Y+++ + R ++ L YLH
Sbjct: 97 FTF---QDDEKLYFGLSYAKNGELLKYIRKI--GSFD----ETCTRFYTAEIVSALEYLH 147
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA----------GTADQVLNAGAL 902
+ I H +LK NILL M+ +TD+ ++L+ GTA
Sbjct: 148 -GKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQ-------- 197
Query: 903 GYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
Y PE + C S SD++A G I+ +L+ G
Sbjct: 198 -YVSPELLTEKSACKS--SDLWALGCIIYQLVAGL 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 53/222 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
E +G+ + + +G A K + ++ A+ ++ RE + ++HPN+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 795 GYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
H LV I A+ + E D ++ ++
Sbjct: 95 DSIQEESFHY-LVFDLVTGGELFEDIVARE---FYSEADASHC--------IQQILES-- 140
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-------TSAGTADQVL 897
+ Y H I H NLK N+LL + A + D+ L + AGT
Sbjct: 141 -IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---- 194
Query: 898 NAGALGYRPPE-FAST--SKPCPSLKSDVYAFGIILLELLTG 936
GY PE SKP D++A G+IL LL G
Sbjct: 195 -----GYLSPEVLKKDPYSKPV-----DIWACGVILYILLVG 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 43/224 (19%), Positives = 78/224 (34%), Gaps = 52/224 (23%)
Query: 734 HAPAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIK-HPNL 790
+ +G K S AVK I+K + +E+ L + HPN+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKI----ISKRMEANTQKEITALKLCEGHPNI 68
Query: 791 VSLQGYYWGPKEHEK---LV--------ISNYINAQSLAVYLQETDPRKLPPLSIDERLR 839
V L + + LV + I + + ET+ + +R
Sbjct: 69 VKLHEVF----HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYI--------MR 113
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVL 897
+ ++++H + + H +LK N+L N + D+ R+ Q L
Sbjct: 114 ---KLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPL 166
Query: 898 N--AGALGYRPPE-FAST--SKPCPSLKSDVYAFGIILLELLTG 936
L Y PE + C D+++ G+IL +L+G
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESC-----DLWSLGVILYTMLSG 205
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/142 (21%), Positives = 54/142 (38%), Gaps = 17/142 (11%)
Query: 356 VEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHL 414
+ +I L N + + P S + +L +SNN + +L L + L N +
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 415 NGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLS 472
L S F L L L+ N + ++ + Q+L +L L L N L
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANK------INCLRV----DAFQDLHNLNLLSLYDNKLQ 141
Query: 473 GRLLPGI-SKFHNLVYLNLSNN 493
+ G S + ++L+ N
Sbjct: 142 -TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 11/111 (9%)
Query: 118 LDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSG-FGGLGKLKYLDLRANR---F 173
+ L N + P K L +++S+N F GL L L L N+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 174 GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224
+ L L + L+ N+ + L + + ++ L++ +N L
Sbjct: 96 PKSLFEGLFSL---QLLLLNANKIN-CLRVDAFQD--LHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 129 IPSGI-VSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL----LSQ 183
IP+ + ++ + L N+ + P F KL+ +DL N+ I L
Sbjct: 26 IPTNLPETITEIRL---EQNTIKVIPPGAFSPYKKLRRIDLSNNQ----ISELAPDAFQG 78
Query: 184 LGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDN---L 240
L S+ + L N+ + L L + + S+Q L ++ N + D F + L
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEG--LFSLQLLLLNANKI--NCLRVDA---FQDLHNL 130
Query: 241 EVFDASNNHLVGAIP--SFNFVFSLRILRLGSN 271
+ +N L I +F+ + +++ + L N
Sbjct: 131 NLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/131 (22%), Positives = 55/131 (41%), Gaps = 20/131 (15%)
Query: 246 SNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P 302
N + IP F+ LR + L +NQ+S L Q L+ L L N++ P
Sbjct: 40 EQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKITELP 96
Query: 303 VGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRLS----GDLSRMQNWG 353
L+ + L++NK++ L + ++ L +N+L G S ++
Sbjct: 97 KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA-- 153
Query: 354 NYVEDIHLSSN 364
++ +HL+ N
Sbjct: 154 --IQTMHLAQN 162
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 43/155 (27%), Positives = 61/155 (39%), Gaps = 16/155 (10%)
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPA-VLGTYPELKVIDLSLNHLN 415
E + L S L + +LT + N L+ L A V EL + L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 416 GFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGR 474
L F T+L L L GN L+ + + T+ L L L N L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQ------LKSLPSGVFDRLTK---LKELRLNTNQLQ-S 145
Query: 475 LLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
+ G K NL L+LS N+ + S+P G + L
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLG 179
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 12/112 (10%)
Query: 239 NLEVFDASNNHLVGAIPS--FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSL 296
L + N L + + F+ + L L L +NQL+ SLP+ + L +L L
Sbjct: 60 KLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFD-HLTQLDKLYLGG 116
Query: 297 NQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARV----GHCTIVDLSNNRL 342
NQL+ P G T LK++ L++N+L S+PA + + LS N+L
Sbjct: 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 45/160 (28%), Positives = 56/160 (35%), Gaps = 35/160 (21%)
Query: 405 KVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNN--------FSGPLPLQE--IQNN---- 450
+ +DL L +F TKLT LNL N F L + NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 451 -PSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLV---YLNLSNNKFEGSIPDG---- 502
P L L L N L L G+ F L L L+ N+ + SIP G
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGV--FDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 503 LPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTF 542
L N L+ ++S N L V P AF L T
Sbjct: 154 LTN-LQTLSLSTNQLQSV--------PHGAFDRLGKLQTI 184
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 312 KKVNLSSNKLSGSLPARV-GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMV 370
+ + +S+ P +L ++ ++ QN N ++ I +++ + +
Sbjct: 1 ETITVSTPIKQ-IFPDDAFAETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ 57
Query: 371 P-NQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPS--FFTSTK 427
+ + N L D+ L L + L+ N L LP+ F T
Sbjct: 58 GIQYLPN---VRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQS--LPNGVFDKLTN 110
Query: 428 LTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGI-SKFHNLV 486
L +L L N ++Q+ P + +LT L+LA+N L L G+ K NL
Sbjct: 111 LKELVLVEN---------QLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLT 160
Query: 487 YLNLSNNKFEGSIPDG----LPNGLKEFNVSFNNLSGVVPENLRNFPDSAF 533
L+LS N+ + S+P+G L LK+ + N L V PD F
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQ-LKDLRLYQNQLKSV--------PDGVF 201
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 16/112 (14%)
Query: 239 NLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPV--ALLQESSMMLSELDLSL 296
+++ A+N+ + ++ ++ ++R L LG N+L + L L+ L L+
Sbjct: 42 SIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLH-DISALKELTN-----LTYLILTG 94
Query: 297 NQLEG-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHC----TIVDLSNNRL 342
NQL+ P G T LK++ L N+L SLP V T ++L++N+L
Sbjct: 95 NQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 51/215 (23%), Positives = 79/215 (36%), Gaps = 53/215 (24%)
Query: 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF 153
++ + +T + S++ + +++ + GI L N+ L + N
Sbjct: 23 KANLKKKSVTDAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL--HD 77
Query: 154 PSGFGGLGKLKYLDLRANRFG---GDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSF 210
S L L YL L N+ + L+ L + L NQ SL G+ D
Sbjct: 78 ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK---ELVLVENQLQ-SLPDGVFDK-- 131
Query: 211 ISSIQYLNISENSLVGELFPHDGMPYFDNLE--VFDASNNHLVGAIPSFNFVFSLRILRL 268
++++ YLN++ N L +L VFD L +L L L
Sbjct: 132 LTNLTYLNLAHNQL-------------QSLPKGVFD----KLT----------NLTELDL 164
Query: 269 GSNQLSGSLPVA----LLQESSMMLSELDLSLNQL 299
NQL SLP L Q L +L L NQL
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQ-----LKDLRLYQNQL 193
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 43/223 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQG 795
+V+G H + L + AVK + + + REV+ L + H N++ L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 796 YYWGPKEHEK---LV--------ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDV 844
++ E E LV I ++I+ + + E + + ++ DV
Sbjct: 79 FF----EEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVV--------VQ---DV 120
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN---- 898
A L++LHN + I H +LK NIL E P + + D+ L + G +
Sbjct: 121 ASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 899 --AGALGYRPPEFASTSKPCPS---LKSDVYAFGIILLELLTG 936
G+ Y PE S + D+++ G+IL LL+G
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 62/232 (26%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK---------RLREGIAKGKKEFAREVKKLGNIK- 786
E++GR + + + AVK E + + ++ +EV L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 787 HPNLVSLQGYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSID 835
HPN++ L+ Y E LV +Y+ + V L E + RK+
Sbjct: 83 HPNIIQLKDTY----ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKI------ 129
Query: 836 ERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL-------T 888
+R ++V + LH + I H +LK NILL+ MN LTD+ L
Sbjct: 130 --MRALLEV---ICALH-KLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 889 SAGTADQVLNAGALGYRPPE----FASTSKPCPSLKSDVYAFGIILLELLTG 936
GT Y PE + + P + D+++ G+I+ LL G
Sbjct: 183 VCGTP---------SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 38/240 (15%), Positives = 86/240 (35%), Gaps = 53/240 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+ +G G + + ++SG A+K++ + + K RE+ + + H N++ L Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN---RELDIMKVLDHVNIIKLVDY 68
Query: 797 YW--GPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDER----------------L 838
++ G +E + + N + + + L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 839 RVAVD----------------VARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYS 882
+ + + R + ++H+ I H ++K N+L+ + L D+
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG-ICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 883 LHRILTSAGTADQVLNAG---ALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ L + + + YR PE +T + D+++ G + EL+ GK
Sbjct: 188 SAKKLIPSEP-----SVAYICSRFYRAPELMLGATE---YTPSIDLWSIGCVFGELILGK 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGI---AKGKKEFAREVKKLGNIKHP 788
E IG +GT++KA ++ I+A+KR+R EG+ A RE+ L +KH
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHK 61
Query: 789 NLVSLQGYYWGPKEHEKLVISNYIN------AQSLAVYLQETDPRKLPPLSIDERLRVAV 842
N+V L H+ L + Q L Y ++ L P + L
Sbjct: 62 NIVRL---------HDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLF--- 108
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG---TADQVLNA 899
+ + L + H+ + H +LK N+L+ L ++ L R +A+ V
Sbjct: 109 QLLKGLGFCHSRN-VLHRDLKPQNLLI-NRNGELKLANFGLARAFGIPVRCYSAEVV--- 163
Query: 900 GALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLT 935
L YRPP+ F + D+++ G I EL
Sbjct: 164 -TLWYRPPDVLFGAKLYSTS---IDMWSAGCIFAELAN 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 44/226 (19%), Positives = 79/226 (34%), Gaps = 54/226 (23%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVK--RLREGIAKGKKEFAREVKKLGNIKH-PNLVSL 793
+ +GR + + +G A K + R + E E+ L K P +++L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 794 QGYYWGPKEHEKLV--------ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVA 845
Y E L+ I + + + E D +L ++ ++
Sbjct: 95 HEVYENTSEI-ILILEYAAGGEIFSLCLPELAEMV-SENDVIRL--------IKQILEG- 143
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-------TSAGTAD-- 894
+ YLH + I H +LK NILL + + D+ + R + GT +
Sbjct: 144 --VYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 895 --QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS 938
++LN + +D++ GII LLT S
Sbjct: 201 APEILNYDPITT---------------ATDMWNIGIIAYMLLTHTS 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 72/238 (30%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-----EGI---AKGKKEFAREVKKLGNIKHP 788
IG+ G ++KA +G +A+K++ EG A RE+K L +KH
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHE 76
Query: 789 NLVSLQGYYWGPKEHEKLVISN--YINAQSLAVYL----QETDPRKL-----PPLSIDER 837
N+V+L + + N ++YL E D L ++ E
Sbjct: 77 NVVNLIE----------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 838 LRVAVDVARCLNYLHNERAIPHGNLKSTNILLE----------------APTMNAVLTDY 881
RV + L Y+H + I H ++K+ N+L+ + N+ Y
Sbjct: 127 KRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 882 SLHRILTSAGTADQVLNAGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
+ +R++T L YRPPE P D++ G I+ E+ T
Sbjct: 186 T-NRVVT-------------LWYRPPELLLGERDYGPP---IDLWGAGCIMAEMWTRS 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 42/217 (19%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
E +G+ + + + +G A + ++ A+ ++ RE + +KHPN+V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 795 GYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
H L+ I A+ Y E D ++ ++
Sbjct: 77 DSISEEGHHY-LIFDLVTGGELFEDIVARE---YYSEADASHC--------IQQILEA-- 122
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNA--VLTDYSLHRILTSAGTADQVLN--AGAL 902
+ + H + + H NLK N+LL + A L D+ L + Q AG
Sbjct: 123 -VLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---QAWFGFAGTP 177
Query: 903 GYRPPE-FAST--SKPCPSLKSDVYAFGIILLELLTG 936
GY PE KP D++A G+IL LL G
Sbjct: 178 GYLSPEVLRKDPYGKPV-----DLWACGVILYILLVG 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 62/313 (19%), Positives = 107/313 (34%), Gaps = 45/313 (14%)
Query: 652 YDAGETSSVVTKPKELYHPDSVRKD--------EGLSSPVSLLSSSNPSQSKNSRFTKNS 703
Y+ + L L + + P + T+ +
Sbjct: 90 YEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLT 149
Query: 704 DVLNACSPEKLAGDLHLFDVSLMFTAEELSHAPAE------VIGRSCHGTLYKATL-DSG 756
+ +P D F+ L + E V+G+ G + + +G
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209
Query: 757 SILAVKRLREGIAKGKKEFA---REVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813
+ A K+L + K +K A E + L + +VSL Y + K+ LV++ +N
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLT-LMN 267
Query: 814 AQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLHNERAIPHGNLKSTNILLEAP 872
L ++ P + R A ++ L LH ER I + +LK NILL+
Sbjct: 268 GGDLKFHIYHMGQAGFP----EARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDD- 321
Query: 873 TMNAVLTDYSL-------HRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYA 925
+ ++D L I GT Y PE + S D +A
Sbjct: 322 HGHIRISDLGLAVHVPEGQTIKGRVGTVG---------YMAPEVVKNERYTFSP--DWWA 370
Query: 926 FGIILLELLTGKS 938
G +L E++ G+S
Sbjct: 371 LGCLLYEMIAGQS 383
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 33/218 (15%)
Query: 740 IGRSCHGTLYKA---TLDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+GR +G +YKA A+K++ GI+ RE+ L +KHPN++SLQ
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQK 85
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYL----QETDPRKLPPLSIDERLRVAVDVARCLNYL 851
+ + + ++ +Y L + +K L + + ++YL
Sbjct: 86 VFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAV---LTDYSLHRILTS-----AGTADQVLNAGALG 903
H + H +LK NIL+ + D R+ S A V+
Sbjct: 145 HANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV---TFW 200
Query: 904 YRPPE--FAST--SKPCPSLKSDVYAFGIILLELLTGK 937
YR PE + +K D++A G I ELLT +
Sbjct: 201 YRAPELLLGARHYTKAI-----DIWAIGCIFAELLTSE 233
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 44/229 (19%), Positives = 81/229 (35%), Gaps = 58/229 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIKHPNL 790
E +G + K +G A K ++ +++ REV L I+HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 791 VSLQGYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842
++L Y + L++ +++ + L E + + L+ +
Sbjct: 77 ITLHEVYENKTDVI-LILELVAGGELFDFLAEKE---SLTEEEATEF--------LKQIL 124
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILL---EAPTMNAVLTDYSLHRIL-------TSAGT 892
+ + YLH I H +LK NI+L P + D+ L + GT
Sbjct: 125 NG---VYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 893 ADQVLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE + D+++ G+I LL+G S
Sbjct: 181 P---------EFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGAS 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 14/164 (8%)
Query: 777 REVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDE 836
+E+ L + HPN+V L P E ++ +N + PLS D+
Sbjct: 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQ 138
Query: 837 RLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896
D+ + + YLH + I H ++K +N+L+ + + D+ + + D +
Sbjct: 139 ARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGS---DAL 193
Query: 897 LN--AGALGYRPPE-FASTSKPCPSLKSDVYAFGIILLELLTGK 937
L+ G + PE + T K DV+A G+ L + G+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 55/226 (24%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
IG +G + A + +A+K++ + + RE+K L +H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIG 89
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLA----VY----LQETDPRKL---PPLSIDERLRVA 841
+ + I A ++ VY L ETD KL LS ++ +
Sbjct: 90 IN---------------DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICYF 133
Query: 842 V-DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN 898
+ + R L Y+H+ + H +LK +N+LL L D+ L R +
Sbjct: 134 LYQILRGLKYIHSANVL-HRDLKPSNLLLNT---TCDLKICDFGLAR-----VADPDHDH 184
Query: 899 AGALG-------YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
G L YR PE SK + D+++ G IL E+L+ +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 57/227 (25%)
Query: 736 PAEVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNL 790
+ +G +G + A +G+ +A+K+L + FA RE++ L +++H N+
Sbjct: 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRHENV 86
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL---PPLSIDERLRVAV- 842
+ L + + + Y TD KL L ++R++ V
Sbjct: 87 IGLLDVFTPDETLDDFT----------DFYLVMPFMGTDLGKLMKHEKLG-EDRIQFLVY 135
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLE------------APTMNAVLTDYSLHRILTSA 890
+ + L Y+H I H +LK N+ + A ++ +T Y + R
Sbjct: 136 QMLKGLRYIHAAGII-HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE + D+++ G I+ E++TGK
Sbjct: 191 -------------YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 39/217 (17%), Positives = 76/217 (35%), Gaps = 64/217 (29%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQG 795
+V+G +G + + + A+K L++ + REV+ + P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD 78
Query: 796 YYWGPKEHEKLVISNY--------------INAQSLAVYLQETDPRKLPPLSIDERLRVA 841
Y K + I + + E + ++ ++
Sbjct: 79 VYENLYAGRKCL---LIVMECLDGGELFSRIQDRGDQAF-TEREASEI--------MKSI 126
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLNA 899
+ + YLH I H ++K N+L + NA+L TD+ G A +
Sbjct: 127 GEA---IQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDF---------GFAKETTGE 173
Query: 900 GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
Y K C D+++ G+I+ LL G
Sbjct: 174 ---KY--------DKSC-----DMWSLGVIMYILLCG 194
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-05
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 54/227 (23%)
Query: 738 EVIGRSCHGTLYKA--TLDSGSILAVKRLR-----EGI---AKGKKEFAREV---KKLGN 784
IG +G ++KA + G +A+KR+R EG+ REV + L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLRHLET 70
Query: 785 IKHPNLVSLQGYYWGPKEHEKLVIS---NYINAQSLAVYLQETDPRKLPPLSIDERLRVA 841
+HPN+V L + + ++ +++ Q L YL D P + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYL---DKVPEPGVPTETIKDMM 126
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL-----------HRILTSA 890
+ R L++LH+ R + H +LK NIL+ + + L D+ L ++T
Sbjct: 127 FQLLRGLDFLHSHR-VVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVT-- 182
Query: 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
L YR PE S + D+++ G I E+ K
Sbjct: 183 -----------LWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 46/288 (15%), Positives = 92/288 (31%), Gaps = 67/288 (23%)
Query: 680 SSPVSLLSSSNPSQSKNSRFTKNSDVLNACSPEKLAGDLHLFDVSLMFTAEELSH--APA 737
SP + P + + P + H+ + + +
Sbjct: 8 QSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTS 67
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQG 795
+V+G +G + + + A+K L++ + REV+ + P++V +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD 122
Query: 796 YYWGPKEHEKLVISNY--------------INAQSLAVYLQETDPRKLPPLSIDERLRVA 841
Y K + I + + E + ++ ++
Sbjct: 123 VYENLYAGRKCL---LIVMECLDGGELFSRIQDRGDQAF-TEREASEI--------MK-- 168
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRIL-------TSAGT 892
+ + YLH I H ++K N+L + NA+L TD+ + T T
Sbjct: 169 -SIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 893 AD----QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTG 936
+VL Y K C D+++ G+I+ LL G
Sbjct: 227 PYYVAPEVLGPE--KY--------DKSC-----DMWSLGVIMYILLCG 259
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 17/105 (16%), Positives = 36/105 (34%), Gaps = 2/105 (1%)
Query: 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVS-LKNLMLLNISSNSFEGT 152
+ + + + ++ + ++L L + + + + L L L I +
Sbjct: 12 GLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 153 FPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQF 197
P F +L L+L N + L S+ + LS N
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 13/92 (14%)
Query: 419 LPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL-SLTSLDLAYNSLSGRLLP 477
L + LT+L + LQ ++ + L L +L + + L + P
Sbjct: 24 LHHLPGAENLTELYIENQQ-----HLQHLEL----RDLRGLGELRNLTIVKSGLR-FVAP 73
Query: 478 GI-SKFHNLVYLNLSNNKFEGSIPDGLPNGLK 508
L LNLS N E S+ GL
Sbjct: 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS 104
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 58/229 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIKHPNL 790
E +G + K +G A K ++ ++E REV L I+HPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 791 VSLQGYYWGPKEHEKLVIS--------NYINAQSLAVYLQETDPRKLPPLSIDERLRVAV 842
++L + + L++ +++ + L E + + L+ +
Sbjct: 71 ITLHDIFENKTDVV-LILELVSGGELFDFLAEKE---SLTEDEATQF--------LKQIL 118
Query: 843 DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV---LTDYSLHRIL-------TSAGT 892
D ++YLH + I H +LK NI+L + L D+ + + GT
Sbjct: 119 DG---VHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 893 ADQVLNAGALGYRPPE---FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ PE + D+++ G+I LL+G S
Sbjct: 175 P---------EFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGAS 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 52/228 (22%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
++G +G + AT +G I+A+K++ K FA RE+K L + KH N+++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLA----VY----LQETDPRKL---PPLSIDERLRVA 841
+ N S VY L +TD ++ LS D+ ++
Sbjct: 74 IF---------------NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS-DDHIQYF 117
Query: 842 V-DVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN 898
+ R + LH I H +LK +N+L+ + N L D+ L RI+ + +
Sbjct: 118 IYQTLRAVKVLHGSNVI-HRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPT 173
Query: 899 AGALG---------YRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
G YR PE TS S DV++ G IL EL +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 41/191 (21%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 754 DSGSILAVKRLREGIAKGKKEFA---REVKKLGNIKHPNLVSLQGYYWGPKEHEKL-VIS 809
D+ + A+K + + + E +E++ + ++HP LV+L + ++ E + ++
Sbjct: 38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF---QDEEDMFMVV 94
Query: 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLHNERAIPHGNLKSTNIL 868
+ + L +LQ+ +E +++ ++ L+YL + I H ++K NIL
Sbjct: 95 DLLLGGDLRYHLQQN--VHFK----EETVKLFICELVMALDYLQ-NQRIIHRDMKPDNIL 147
Query: 869 LEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKS-DVYAFG 927
L+ + +TD+++ +L + AG Y PE S+ K + D ++ G
Sbjct: 148 LDE-HGHVHITDFNIAAMLPRETQITTM--AGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 928 IILLELLTGKS 938
+ ELL G+
Sbjct: 205 VTAYELLRGRR 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 57/226 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA-----REVKKLGNIKHPNLV 791
+ +G T+YKA ++ I+A+K+++ G K+ RE+K L + HPN++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 792 SLQGYYWGPKEHEKLVIS---NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC- 847
L + K IS +++ L V + + + L P I +
Sbjct: 76 GLLDAF-----GHKSNISLVFDFME-TDLEVII-KDNSLVLTPSHI-----------KAY 117
Query: 848 -------LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSL-------HRILTSAGTA 893
L YLH I H +LK N+LL L D+ L +R T
Sbjct: 118 MLMTLQGLEYLHQHW-ILHRDLKPNNLLL-DENGVLKLADFGLAKSFGSPNRAYTH---- 171
Query: 894 DQVLNAGALGYRPPE--FASTSKPCPSLKSDVYAFGIILLELLTGK 937
QV+ YR PE F + D++A G IL ELL
Sbjct: 172 -QVV---TRWYRAPELLFGARMYGVG---VDMWAVGCILAELLLRV 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 61/231 (26%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL--------REGIAKGKKEFAREVKKLGNIK-H 787
+VIGR + + +G AVK + E + + ++ RE L + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 788 PNLVSLQGYYWGPKEHEK---LVIS--------NYINAQSLAVYLQETDPRKLPPLSIDE 836
P++++L Y E LV +Y+ + V L E + R +
Sbjct: 160 PHIITLIDSY----ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSI------- 205
Query: 837 RLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL-------TS 889
+R ++ +++LH I H +LK NILL+ M L+D+ L
Sbjct: 206 -MRSLLEA---VSFLH-ANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLREL 259
Query: 890 AGTADQVLNAGALGYRPPE----FASTSKPCPSLKSDVYAFGIILLELLTG 936
GT GY PE + P + D++A G+IL LL G
Sbjct: 260 CGTP---------GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 21/192 (10%)
Query: 754 DSGSILAVKRLREGIAKGKKEFA-----REV-KKLGNIKHPNLVSLQGYYWGPKEHEKLV 807
D+G + A+K L + K K+ R + + P +V + Y + + +
Sbjct: 212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFI 270
Query: 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRV-AVDVARCLNYLHNERAIPHGNLKSTN 866
+ +N L +L + + +R A ++ L ++HN + + +LK N
Sbjct: 271 LD-LMNGGDLHYHLSQH--GVFS----EADMRFYAAEIILGLEHMHNRF-VVYRDLKPAN 322
Query: 867 ILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAF 926
ILL+ + ++D L + V G GY PE +D ++
Sbjct: 323 ILLDE-HGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY-DSSADWFSL 377
Query: 927 GIILLELLTGKS 938
G +L +LL G S
Sbjct: 378 GCMLFKLLRGHS 389
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 57/225 (25%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFA----REVKKLGNIKHPNLVS 792
+G +G++ A +G +AVK+L A RE++ L ++KH N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL---PPLSIDERLRVAV-DV 844
L + + E+ VY L D + L+ D+ ++ + +
Sbjct: 93 LLDVFTPARSLEEFN----------DVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQI 141
Query: 845 ARCLNYLHNERAIPHGNLKSTNILLE------------APTMNAVLTDYSLHRILTSAGT 892
R L Y+H+ I H +LK +N+ + A +T Y R
Sbjct: 142 LRGLKYIHSADII-HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW------ 194
Query: 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
YR PE + D+++ G I+ ELLTG+
Sbjct: 195 -----------YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 830 PPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889
L+++ + + VA+ + +L R H +L + NILL + + D+ L R +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILL-SEKNVVKICDFGLARDIYK 245
Query: 890 AGTADQVLNAGALGYRP-----PEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIV 943
D P PE + +++SDV++FG++L E+ + G S
Sbjct: 246 ----DPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 296
Query: 944 CVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRC-ILPASE 1002
PGV + E F R + +G M P +M Q L C S+
Sbjct: 297 ---PGV--------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 339
Query: 1003 RPDMMSVFEELSTIVLEKDSQ 1023
RP + E L + L+ ++Q
Sbjct: 340 RPTFSELVEHLGNL-LQANAQ 359
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 43/237 (18%), Positives = 80/237 (33%), Gaps = 66/237 (27%)
Query: 736 PAEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFA-----------REVKKLGN 784
I +G + G +A+KR+ ++ G+ RE++ L +
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 785 IKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVY----LQETDPRKL-----PPLSID 835
HPN++ L + + ++ +Y L TD ++ +S
Sbjct: 86 FHHPNILGL-----------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS-P 133
Query: 836 ERLRVAV-DVARCLNYLHNERAIPHGNLKSTNILLEA--------------PTMNAVLTD 880
+ ++ + + L+ LH + H +L NILL T +A T
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVV-HRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 881 YSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
Y HR YR PE K + D+++ G ++ E+ K
Sbjct: 193 YVTHRW-----------------YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 43/140 (30%), Positives = 58/140 (41%), Gaps = 25/140 (17%)
Query: 405 KVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSL 464
+DL N L F T LT L L GN ++Q+ P+ + SLT L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGN---------KLQSLPNGVFNKLTSLTYL 81
Query: 465 DLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDG----LPNGLKEFNVSFNNLSG 519
+L+ N L L G+ K L L L+ N+ + S+PDG L LK+ + N L
Sbjct: 82 NLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ-LKDLRLYQNQLKS 138
Query: 520 VVPENLRNFPDSAFHPGNSL 539
V PD F SL
Sbjct: 139 V--------PDGVFDRLTSL 150
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 28/132 (21%), Positives = 45/132 (34%), Gaps = 22/132 (16%)
Query: 405 KVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSL 464
+++ L N + F + L +L L N ++ P LT L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSN---------QLGALPVGVFDSLTQLTVL 93
Query: 465 DLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVV 521
DL N L+ L + + +L L + NK +P G+ L + N L +
Sbjct: 94 DLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI- 150
Query: 522 PENLRNFPDSAF 533
P AF
Sbjct: 151 -------PHGAF 155
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 23/95 (24%), Positives = 33/95 (34%), Gaps = 12/95 (12%)
Query: 400 TYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNL 459
T + ID S N + L F +L L ++ N + I
Sbjct: 40 TLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNNR------ICRIGEGLDQALP--- 88
Query: 460 SLTSLDLAYNSLSG-RLLPGISKFHNLVYLNLSNN 493
LT L L NSL L ++ +L YL + N
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 53/220 (24%)
Query: 740 IGRSCHGTLYKAT-LDSGSILAVKRL-REGIAKGKKE-FAREVKKLGNIKHPNLVSLQGY 796
IG+ + A + +G +A+K + + + + REV+ + + HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 797 YWGPKEHEKLVISN---------YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC 847
E VI Y + + Y + R+ AR
Sbjct: 80 ------FE--VIETEKTLYLIMEYASGGEVFDY-------------LVAHGRMKEKEARS 118
Query: 848 --------LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+ Y H + I H +LK+ N+LL+A MN + D+ T L+A
Sbjct: 119 KFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTV----GGKLDA 172
Query: 900 --GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
GA Y PE K + DV++ G+IL L++G
Sbjct: 173 FCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 7e-04
Identities = 21/144 (14%), Positives = 45/144 (31%), Gaps = 24/144 (16%)
Query: 162 KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISE 221
LK L++ + + + ++ DL N + L L +G +
Sbjct: 194 NLKSLEIISGGLPDSV------VEDILGSDLPNLE---KLVLYVGVE---------DYGF 235
Query: 222 NSLVGELFPHDGMPYFDNLEVFDASNNHL----VGAIPSFNFVFSLRILRLGSNQLSGSL 277
+ + P F NL+ + V + + L + + + L+
Sbjct: 236 DGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295
Query: 278 PVALLQESSMM--LSELDLSLNQL 299
LL + L +++ N L
Sbjct: 296 ARLLLDHVDKIKHLKFINMKYNYL 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 42/203 (20%), Positives = 73/203 (35%), Gaps = 41/203 (20%)
Query: 754 DSGSILAVKRLREGIAKGKKEFAR---EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810
+G + A K+L + K +K + E K L + +VSL Y + K LV++
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMT- 265
Query: 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870
+N + ++ D P + + L +LH I + +LK N+LL+
Sbjct: 266 IMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLD 323
Query: 871 APTMNAVLTDYSL--------HRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSD 922
N ++D L + AGT + PE L +
Sbjct: 324 D-DGNVRISDLGLAVELKAGQTKTKGYAGTPG---------FMAPEL---------LLGE 364
Query: 923 VY-------AFGIILLELLTGKS 938
Y A G+ L E++ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARG 387
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1025 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-42 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 55/277 (19%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
E +G G ++ + + +AVK L++G + F E + ++H LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
+ +I+ Y+ SL +L+ KL ++ L +A +A + ++ ER
Sbjct: 78 ---TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIE-ERNY 130
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +L++ NIL+ T++ + D+ L R++ + + + PE +
Sbjct: 131 IHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--F 187
Query: 918 SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977
++KSDV++FGI+L E++T + + + + G+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGY 227
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEEL 1013
M +P ++ Q+ C +RP + L
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-41
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 28/282 (9%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG GT+YK + + + + + F EV L +H N++ GY
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
P+ +++ + SL +L + + + + + +A A+ ++YLH ++I
Sbjct: 74 TAPQ---LAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHA-KSI 125
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-AGALGYRPPEFASTSKPC 916
H +LKS NI L + + D+ L + + + Q +G++ + PE
Sbjct: 126 IHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 917 P-SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975
P S +SDVYAFGI+L EL+TG+ ++ + +++ + R +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQIIFMVGRG-------YLS 228
Query: 976 GHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTI 1016
+ M ++ C+ ERP + + +
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 32/281 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG G ++ + +A+K +REG A +++F E + + + HP LV L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
++ ++ ++ L+ YL+ + + + L + +DV + YL +
Sbjct: 70 L--EQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEAC-V 122
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +L + N L+ ++D+ + R + + + PE S S+
Sbjct: 123 IHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 918 SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977
KSDV++FG+++ E+ + + ENRS I G
Sbjct: 182 --KSDVWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGF 219
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIV 1017
+ +P + + Q+ C +RP + +L+ I
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 36/280 (12%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ IG+ G + G+ +AVK ++ + F E + ++H NLV L G
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
K +V Y+ SL YL+ R L D L+ ++DV + YL
Sbjct: 70 VEEKGGLYIVT-EYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN-F 124
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +L + N+L+ A ++D+ L + +S + + PE K
Sbjct: 125 VHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 918 SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977
KSDV++FGI+L E+ + + + + G+
Sbjct: 180 --KSDVWSFGILLWEIYSFGR--------------------VPYPRIPLKDVVPRVEKGY 217
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTI 1016
M+ P + +V C A+ RP + + E+L I
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 60/301 (19%), Positives = 107/301 (35%), Gaps = 26/301 (8%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
E IG+ G +++ G +AVK + E+ + ++H N++
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 798 W--GPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE- 854
+ ++S+Y SL YL ++++ +++A+ A L +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 855 ------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN---AGALGYR 905
AI H +LKS NIL+ + D L SA + G Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 906 PPEFASTSKPC----PSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961
PE S ++D+YA G++ E+ S G I
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEK 1020
E R C +L + + Q L M ++ C + R + + + LS + ++
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
Query: 1021 D 1021
Sbjct: 300 G 300
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 58/287 (20%), Positives = 115/287 (40%), Gaps = 32/287 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+G+ C G ++ T + + +A+K L+ G + F +E + + ++H LV L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
E +++ Y++ SL +L+ L + + + +A +A + Y+
Sbjct: 82 S---EEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMN-Y 134
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +L++ NIL+ + + D+ L R++ + + + PE A +
Sbjct: 135 VHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--F 191
Query: 918 SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977
++KSDV++FGI+L EL T R+ + E D+ + G+
Sbjct: 192 TIKSDVWSFGILLTELTTKG-------------------RVPYPGMVNREVLDQ-VERGY 231
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKDSQ 1023
M PP + + +C ERP + L + Q
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 39/294 (13%)
Query: 738 EVIGRSCHGTLYKATLDSGS-----ILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLV 791
+VIG G +YK L + S +A+K L+ G K + +F E +G H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L+G K ++I+ Y+ +L +L+E D S+ + + + +A + YL
Sbjct: 73 RLEGVIS--KYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYL 126
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPEF 909
N H +L + NIL+ + + ++D+ L R+L A + + + PE
Sbjct: 127 ANMN-YVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969
S K SDV++FGI++ E++T S
Sbjct: 185 ISYRKFTS--ASDVWSFGIVMWEVMTYGERPY--------------------WELSNHEV 222
Query: 970 DRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKDS 1022
+ I DG + P S + Q+ ++C + RP + L ++ DS
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 32/277 (11%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYY 797
+ +G G + +A+K ++EG + + EF E K + N+ H LV L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 798 WGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAI 857
K+ +I+ Y+ L YL+E R + L + DV + YL +++
Sbjct: 69 T--KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQ-F 121
Query: 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCP 917
H +L + N L+ ++D+ L R + V + + + PPE SK
Sbjct: 122 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 918 SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDGH 977
KSD++AFG+++ E+ + + E + I G
Sbjct: 181 --KSDIWAFGVLMWEIYSLGK--------------------MPYERFTNSETAEHIAQGL 218
Query: 978 DMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEEL 1013
+ +P + + C A ERP + +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 52/284 (18%), Positives = 106/284 (37%), Gaps = 38/284 (13%)
Query: 740 IGRSCHGTLYKATL---DSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQG 795
+G G++ + +A+K L++G K +E RE + + + +P +V L G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
+ +++ L +L K + + + V+ + YL +
Sbjct: 77 VC---QAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEE-K 128
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPEFASTS 913
H +L + N+LL A ++D+ L + L + + +A L + PE +
Sbjct: 129 NFVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 914 KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973
K +SDV+++G+ + E L+ + G I
Sbjct: 188 KFSS--RSDVWSYGVTMWEALSYGQ--------------------KPYKKMKGPEVMAFI 225
Query: 974 MDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTI 1016
G ME PP ++ + C + +RPD ++V + +
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 51/294 (17%), Positives = 95/294 (32%), Gaps = 40/294 (13%)
Query: 739 VIGRSCHGTLYKATL---DSGSILAVKRLREGIAKG--KKEFAREVKKLGNIKHPNLVSL 793
+G GT+ K +AVK L+ K E E + + +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
G +++ L YLQ+ + + + V+ + YL
Sbjct: 74 IGICEAES---WMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN--AGALGYRPPEFAS 911
H +L + N+LL A ++D+ L + L + + + + PE +
Sbjct: 126 SN-FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971
K KSDV++FG+++ E + G
Sbjct: 184 YYKFSS--KSDVWSFGVLMWEAFSYGQ--------------------KPYRGMKGSEVTA 221
Query: 972 LIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKDSQG 1024
++ G M P +M + C RP +V L + ++G
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 43/202 (21%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQG 795
+G G ++K + SG ++A K + I + + RE++ L P +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
++ + E + +++ SL L++ + +V++ V + L YL +
Sbjct: 72 AFY--SDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKH 124
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H ++K +NIL+ L D+ + L + V G Y PE +
Sbjct: 125 KIMHRDVKPSNILV-NSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHY 180
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
+SD+++ G+ L+E+ G+
Sbjct: 181 SV--QSDIWSMGLSLVEMAVGR 200
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 38/288 (13%)
Query: 738 EVIGRSCHGTLYKATLDSGS----ILAVKRLREGIAKGK-KEFAREVKKLGNIKHPNLVS 792
EVIGR G +Y TL AVK L G+ +F E + + HPN++S
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E LV+ Y+ L + + ++ + + + VA+ + +L
Sbjct: 93 LLGICLRS-EGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN---AGALGYRPPEF 909
+++ H +L + N +L+ + D+ L R + + + E
Sbjct: 148 SKK-FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969
T K KSDV++FG++L EL+T G D D+T +
Sbjct: 206 LQTQKFTT--KSDVWSFGVLLWELMTR---GAPPYPDVNTFDITVY-------------- 246
Query: 970 DRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTI 1016
++ G + QP + +V L+C P A RP + +S I
Sbjct: 247 ---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 7e-35
Identities = 56/315 (17%), Positives = 116/315 (36%), Gaps = 54/315 (17%)
Query: 727 FTAEELSHAPA--------------EVIGRSCHGTLYKATL----DSGSILAVKRLREG- 767
FT E+ + A +VIG G + L +A+K L+ G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 768 IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR 827
K +++F E +G HPN++ L K ++I+ ++ SL +L+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHL--EGVVTKSTPVMIITEFMENGSLDSFLR----Q 120
Query: 828 KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887
++ + + + +A + YL + H +L + NIL+ + + ++D+ L R L
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLADMN-YVHRDLAARNILVNS-NLVCKVSDFGLSRFL 178
Query: 888 TSAGTAD----QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIV 943
+ + + + PE K SDV+++GI++ E+++
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS--ASDVWSYGIVMWEVMSYGE----- 231
Query: 944 CVDPGVVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASE 1002
+ + + I + + P S + Q+ L C +
Sbjct: 232 ---------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 1003 RPDMMSVFEELSTIV 1017
RP + L ++
Sbjct: 277 RPKFGQIVNTLDKMI 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 9e-35
Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 32/286 (11%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G +G +Y+ +AVK L+E +EF +E + IKHPNLV L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL--L 79
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+E +I+ ++ +L YL+E + +++ L +A ++ + YL ++
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQISSAMEYLE-KKN 135
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPC 916
H +L + N L+ + D+ L R++T + + PE + +K
Sbjct: 136 FIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-- 192
Query: 917 PSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976
S+KSDV+AFG++L E+ T + L+
Sbjct: 193 FSIKSDVWAFGVLLWEIATY--------------------GMSPYPGIDLSQVYELLEKD 232
Query: 977 HDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKD 1021
+ ME+P + ++ C S+RP + + T+ E
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-34
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 54/307 (17%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNL 790
IG G +++A + +++AVK L+ E A + +F RE + +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKL-------------------PP 831
V + ++ Y+ L +L+ P + PP
Sbjct: 79 V--KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 832 LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891
LS E+L +A VA + YL + H +L + N L+ M + D+ L R + SA
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSAD 194
Query: 892 TADQVLN-AGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVV 950
N A + + PPE ++ +SDV+A+G++L E+ +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYGVVLWEIFSY-------------- 238
Query: 951 DLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSV 1009
L + E + DG+ + P ++ + C ++RP S+
Sbjct: 239 ------GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 1010 FEELSTI 1016
L +
Sbjct: 293 HRILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 52/282 (18%), Positives = 104/282 (36%), Gaps = 39/282 (13%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRL--REGIAKGKKEFAREVKKLGNIKHPNLVSLQ 794
IGR T+YK ++ +A L R+ ++ F E + L ++HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 795 GYYWGPKEHEKLV--ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ + +K + ++ + + +L YL ++ + I + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 853 -NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
I H +LK NI + PT + + D L + ++ + G + PE
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMYE 186
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971
DVYAFG+ +LE+ T + + + ++ R
Sbjct: 187 EK---YDESVDVYAFGMCMLEMATSE---------YPYSECQNAAQIY-----------R 223
Query: 972 LIMDGHDMEQPPRILS-DMLQVALRCILP-ASERPDMMSVFE 1011
+ G ++ ++ ++ CI ER + +
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 5e-34
Identities = 54/292 (18%), Positives = 105/292 (35%), Gaps = 37/292 (12%)
Query: 738 EVIGRSCHGTLYKATL----DSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVS 792
IG G +++ + +A+K + + +E F +E + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
L G E+ +I L + + L + + A ++ L YL
Sbjct: 73 LIGVIT---ENPVWIIMELCTLGELRSF----LQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
++R H ++ + N+L+ + L D+ L R + + + + PE +
Sbjct: 126 SKR-FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 913 SKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972
+ SDV+ FG+ + E+L G D+
Sbjct: 184 RRFTS--ASDVWMFGVCMWEILMH---GVKPFQGVKNNDVIGR----------------- 221
Query: 973 IMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEKDSQ 1023
I +G + PP + + +C S RP + +LSTI+ E+ +Q
Sbjct: 222 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-33
Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 45/302 (14%)
Query: 738 EVIGRSCHGTLYKATLDSGSIL---AVKRLREGIAK-GKKEFAREVKKLGNI-KHPNLVS 792
+VIG G + KA + + A+KR++E +K ++FA E++ L + HPN+++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPP-----------LSIDERLRVA 841
L G + Y +L +L+++ + P LS + L A
Sbjct: 76 LLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 842 VDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGA 901
DVAR ++YL ++ H +L + NIL+ A + D+ L R
Sbjct: 134 ADVARGMDYLS-QKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMG--RLP 189
Query: 902 LGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961
+ + E + S SDV+++G++L E+++
Sbjct: 190 VRWMAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGG--------------------TPY 227
Query: 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIVLEK 1020
+ + G+ +E+P ++ + +C ERP + L+ ++ E+
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 1021 DS 1022
+
Sbjct: 288 KT 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 60/282 (21%), Positives = 93/282 (32%), Gaps = 34/282 (12%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQ 794
IG +G K G IL K L G K+ EV L +KHPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH-- 852
++ Y LA + + ++ L + LRV + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 853 --NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
+ H +LK N+ L+ N L D+ L RIL + + G Y PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQM 186
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970
+ KSD+++ G +L EL S +
Sbjct: 187 NRMSYNE--KSDIWSLGCLLYELCALM---------------------PPFTAFSQKELA 223
Query: 971 RLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFE 1011
I +G P R ++ ++ R + RP + + E
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 13/204 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
+G G +YKA ++ + A K + + +++ E+ L + HPN+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
++ E+ ++ + ++ + E + PL+ + V LNYLH +
Sbjct: 78 FY--YENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH-DNK 130
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPC 916
I H +LK+ NIL + L D+ + T G + PE
Sbjct: 131 IIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSK 188
Query: 917 P---SLKSDVYAFGIILLELLTGK 937
K+DV++ GI L+E+ +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-32
Identities = 55/286 (19%), Positives = 102/286 (35%), Gaps = 40/286 (13%)
Query: 738 EVIGRSCHGTLYKATLDS----GSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNL 790
E +G G + + D+ +AVK L+ + + +F REV + ++ H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
+ L G P +++ S L + + + R AV VA + Y
Sbjct: 74 IRLYGVVLTPPMK---MVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN--AGALGYRPPE 908
L + H +L + N+LL A + D+ L R L + + PE
Sbjct: 127 LE-SKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
T SD + FG+ L E+ T + + +
Sbjct: 185 SLKTRTFSH--ASDTWMFGVTLWEMFTYG-------------------QEPWIGLNGSQI 223
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEEL 1013
++ +G + +P D+ V ++C +RP +++ + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (311), Expect = 1e-31
Identities = 51/280 (18%), Positives = 93/280 (33%), Gaps = 40/280 (14%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK---KEFAREVKKLGNIKHPNLVSL 793
IG G +Y A + + ++A+K++ + ++ +EV+ L ++HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+G Y +EH ++ Y + + PL E V + L YLH
Sbjct: 81 RGCYL--REHTAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ H ++K+ NILL P L D+ I+ A + G + PE
Sbjct: 133 SHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAM 186
Query: 914 KPCP-SLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972
K DV++ GI +EL + + +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAER--------------------KPPLFNMNAMSALYHI 226
Query: 973 IMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFE 1011
+ Q C+ +RP + +
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 57/305 (18%), Positives = 107/305 (35%), Gaps = 48/305 (15%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIK-HPN 789
+ +G G + +AT D+ +AVK L+ ++ E+K L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-------------PLSIDE 836
+V+L G LVI+ Y L +L+ + L +++
Sbjct: 89 IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 837 RLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896
L + VA+ + +L + H +L + NILL + D+ L R + +
Sbjct: 147 LLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVK 204
Query: 897 -LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDW 955
+ + PE + +SDV+++GI L EL +
Sbjct: 205 GNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLG------------------ 244
Query: 956 VRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELS 1014
F ++I +G M P ++M + C +RP + + +
Sbjct: 245 -SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 1015 TIVLE 1019
+ E
Sbjct: 304 KQISE 308
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-30
Identities = 56/287 (19%), Positives = 109/287 (37%), Gaps = 39/287 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSIL----AVKRLREGI-AKGKKEFAREVKKLGNIKHPNLV 791
+V+G GT+YK + G + A+K LRE K KE E + ++ +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L +L+ L + + L V +A+ +NYL
Sbjct: 75 RL--LGICLTSTVQLITQLMPFGC-----LLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-GALGYRPPEFA 910
+ R + H +L + N+L++ P + +TD+ L ++L + + + E
Sbjct: 128 EDRR-LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970
+ +SDV+++G+ + EL+T S +
Sbjct: 186 LHRI--YTHQSDVWSYGVTVWELMTFGS--------------------KPYDGIPASEIS 223
Query: 971 RLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTI 1016
++ G + QPP D+ + ++C + A RP + E S +
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 49/294 (16%), Positives = 107/294 (36%), Gaps = 40/294 (13%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGIA-KGKKEFAREVKKLGNIKHPNL 790
+G+ G +Y+ + + +A+K + E + + + EF E + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR-----KLPPLSIDERLRVAVDVA 845
V + + LVI + L YL+ P L P S+ + +++A ++A
Sbjct: 86 V--RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 846 RCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-GALGY 904
+ YL+ + H +L + N ++ A + D+ + R + + + +
Sbjct: 144 DGMAYLNANK-FVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 905 RPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964
PE SDV++FG++L E+ T +
Sbjct: 202 MSPESLKDGVFTT--YSDVWSFGVVLWEIATLAE--------------------QPYQGL 239
Query: 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIV 1017
S E R +M+G +++P + ++ C RP + + + +
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (303), Expect = 3e-30
Identities = 43/202 (21%), Positives = 86/202 (42%), Gaps = 13/202 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G G +++ T +G+ A K + K+ +E++ + ++HP LV+L +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL--H 89
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
++E ++I +++ L + + +S DE + V + L ++H E
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMH-ENN 144
Query: 857 IPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
H +LK NI+ N + L D+ L L + G + PE A
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPV 202
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
+D+++ G++ LL+G
Sbjct: 203 GY--YTDMWSVGVLSYILLSGL 222
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 5e-30
Identities = 44/278 (15%), Positives = 97/278 (34%), Gaps = 33/278 (11%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR-EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
+ +G +G + A + +AVK + + + +E+ + H N+V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
+ + + + + Y + L + + + R + + YLH
Sbjct: 71 HRR--EGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH-GI 122
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-AGALGYRPPEFASTSK 914
I H ++K N+LL+ N ++D+ L + + G L Y PE +
Sbjct: 123 GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-R 180
Query: 915 PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974
+ DV++ GI+L +L G+ + + S + +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWD-------------------QPSDSCQEYSDWKE 221
Query: 975 DGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFE 1011
+ +I S L + + ++ S R + + +
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 60/304 (19%), Positives = 108/304 (35%), Gaps = 53/304 (17%)
Query: 738 EVIGRSCHGTLYKATL------DSGSILAVKRLREGIAKG-KKEFAREVKKLGNI-KHPN 789
+V+G G + AT +AVK L+E ++ E+K + + H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 790 LVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPR------------------KLPP 831
+V+L G +I Y L YL+ + L
Sbjct: 103 IVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 832 LSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891
L+ ++ L A VA+ + +L ++ H +L + N+L+ + D+ L R + S
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDS 218
Query: 892 TADQVLNA-GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVV 950
NA + + PE KSDV+++GI+L E+ +
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTI--KSDVWSYGILLWEIFSLG------------- 263
Query: 951 DLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSV 1009
F +LI +G M+QP ++ + C + +RP ++
Sbjct: 264 ------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 1010 FEEL 1013
L
Sbjct: 318 TSFL 321
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 6e-30
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 43/300 (14%)
Query: 738 EVIGRSCHGTLYKAT------LDSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNL 790
+ +GR G + +A + +AVK L+EG + E+K L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-----------PLSIDERLR 839
V +VI + +L+ YL+ +P L+++ +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 840 VAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA 899
+ VA+ + +L + + H +L + NILL + + D+ L R + + +A
Sbjct: 139 YSFQVAKGMEFLASRK-CIHRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 900 -GALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958
L + PE +SDV++FG++L E+ +
Sbjct: 197 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEIFSLG-------------------AS 235
Query: 959 LALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELSTIV 1017
+ E F R + +G M P +M Q L C S+RP + E L ++
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E IG+ GT+Y A + +G +A++++ K+ E+ + K+PN+V+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
Y E V+ Y+ SL + ET + + V + + L +LH
Sbjct: 86 YLVGDEL--WVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH-SNQ 136
Query: 857 IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPC 916
+ H ++KS NILL + LTD+ +T + G + PE +
Sbjct: 137 VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 194
Query: 917 PSLKSDVYAFGIILLELLTGK 937
P K D+++ GI+ +E++ G+
Sbjct: 195 P--KVDIWSLGIMAIEMIEGE 213
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 59/302 (19%), Positives = 108/302 (35%), Gaps = 47/302 (15%)
Query: 738 EVIGRSCHGTLYKATL--------DSGSILAVKRLR-EGIAKGKKEFAREVKKLGNI-KH 787
+ +G G + A + + +AVK L+ + K + E++ + I KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 788 PNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP-----------PLSIDE 836
N++ ++ VI Y + +L YLQ P L LS +
Sbjct: 79 KNII--NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 837 RLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896
+ A VAR + YL + H +L + N+L+ + + I
Sbjct: 137 LVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWV 956
+ + PE + +SDV++FG++L E+ T
Sbjct: 196 NGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGG------------------ 235
Query: 957 RLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILP-ASERPDMMSVFEELST 1015
E +L+ +GH M++P +++ + C S+RP + E+L
Sbjct: 236 --SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 1016 IV 1017
IV
Sbjct: 294 IV 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 8e-28
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 18/204 (8%)
Query: 738 EVIGRSCHGTLYKATL-DSGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSL 793
+G+ G +Y A S ILA+K L + A + + REV+ +++HPN++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
GY+ +I Y ++ L +KL ++A L+Y H
Sbjct: 72 YGYFH--DATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH- 123
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ + H ++K N+LL + D+ S+ G L Y PPE
Sbjct: 124 SKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPPEMIEGR 179
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
K D+++ G++ E L GK
Sbjct: 180 MHDE--KVDLWSLGVLCYEFLVGK 201
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 112 bits (280), Expect = 3e-27
Identities = 36/202 (17%), Positives = 76/202 (37%), Gaps = 13/202 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +G G +++ +G + K + K E+ + + HP L++L +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL--H 92
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
++E ++I +++ L + + +S E + L ++H E +
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMH-EHS 147
Query: 857 IPHGNLKSTNILLEAP-TMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H ++K NI+ E + + D+ L L + PE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 205
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
+D++A G++ LL+G
Sbjct: 206 GF--YTDMWAIGVLGYVLLSGL 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 109 bits (273), Expect = 6e-27
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK---KEFAREVKKLGNIKHPNLVSL 793
E++G ++ A L +AVK LR +A+ F RE + + HP +V++
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 794 QGYYWGPKEHEKLV--ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L + Y++ +L + P++ + V D + LN+
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFS 127
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA--GALGYRPPEF 909
H + I H ++K NI++ T + D+ + R + +G + A G Y PE
Sbjct: 128 H-QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 910 ASTSKPCPSLKSDVYAFGIILLELLTGK 937
A +SDVY+ G +L E+LTG+
Sbjct: 186 ARGDSVDA--RSDVYSLGCVLYEVLTGE 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 730 EELSHAPAEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHP 788
+E+S+ +VIG G +Y+A L DSG ++A+K++ + K+ RE++ + + H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHC 73
Query: 789 NLVSLQGYYWGPKEHEKLVISNYIN--AQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
N+V L+ +++ E + V N + + R L + + R
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP 906
L Y+H I H ++K N+LL+ T L D+ + L + + YR
Sbjct: 134 SLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRA 190
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE + + DV++ G +L ELL G+
Sbjct: 191 PELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (260), Expect = 4e-25
Identities = 39/293 (13%), Positives = 85/293 (29%), Gaps = 35/293 (11%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
IG G +Y T + +G +A+K + + E K ++ + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
++ N + + L L++ S+ L +A + + Y+H +
Sbjct: 71 CGAEGDY------NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKN 123
Query: 857 IPHGNLKSTNILLEAPTMNAVL--TDYSLHRILTSAGTADQVLN------AGALGYRPPE 908
H ++K N L+ ++ D+ L + A T + G Y
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968
+ + D+ + G +L+ G + + E
Sbjct: 184 THLGIEQSR--RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--------------ER 227
Query: 969 FDRLIMDGHDMEQPPRILSDMLQVALRCI-LPASERPDMMSVFEELSTIVLEK 1020
M S+ C L ++PD + + + +
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 5e-25
Identities = 35/202 (17%), Positives = 75/202 (37%), Gaps = 14/202 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGY 796
E +GR G +++ S K ++ + +E+ L +H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHES 69
Query: 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA 856
+ E ++I +I+ + + L+ E + V L +LH
Sbjct: 70 FE--SMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLH-SHN 122
Query: 857 IPHGNLKSTNILLEAPTMNAV-LTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H +++ NI+ + + + + ++ R L + A Y PE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVV 180
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
+D+++ G ++ LL+G
Sbjct: 181 ST--ATDMWSLGTLVYVLLSGI 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-24
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKG-KKEFAREVKKLGNIKHPNLVSLQG 795
IG +G + A + +A+K++ + + RE+K L +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 796 YYWGP--KEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
P ++ + + + ++ L L+ LS D + R L Y+H+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS 127
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN--AGALGYRPPEFAS 911
+ H +LK +N+LL T + + D+ L R+ L YR PE
Sbjct: 128 AN-VLHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
SK D+++ G IL E+L+ +
Sbjct: 186 NSKGYTK-SIDIWSVGCILAEMLSNR 210
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-24
Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 19/206 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQG 795
+V+G +G + + + A+K L++ + REV+ + P++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD 72
Query: 796 YYWGPKEHEK--LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
Y K L++ ++ L +Q+ R + E + + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 854 ERAIPHGNLKSTNILLEAPTMNAV--LTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
I H ++K N+L + NA+ LTD+ + TS + Y PE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
K D+++ G+I+ LL G
Sbjct: 187 PEKYDK--SCDMWSLGVIMYILLCGY 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSL 793
+++G T+ A L + A+K L + RE + + HP V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
Y+ + + +Y L Y++ K+ ++ L YLH
Sbjct: 74 --YFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLH- 125
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN-AGALGYRPPEFAST 912
+ I H +LK NILL M+ +TD+ ++L+ + + G Y PE +
Sbjct: 126 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 913 SKPCPSLKSDVYAFGIILLELLTGK 937
C SD++A G I+ +L+ G
Sbjct: 185 KSACK--SSDLWALGCIIYQLVAGL 207
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 5e-24
Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 16/204 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE-FAREVKKLGNIKHPNLVSLQG 795
+V+G + A + ++A+K + + +GK+ E+ L IKHPN+V+L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
Y +I ++ L + E + + R+ V + YLH +
Sbjct: 75 IYESGGHL--YLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH-DL 126
Query: 856 AIPHGNLKSTNILL--EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
I H +LK N+L +++D+ L ++ G GY PE +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 184
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
D ++ G+I LL G
Sbjct: 185 PYSK--AVDCWSIGVIAYILLCGY 206
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 6e-24
Identities = 47/203 (23%), Positives = 77/203 (37%), Gaps = 13/203 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQ 794
E IG +G +YKA +G ++A+K++R RE+ L + HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
KL + Q L ++ + +P + + L + H
Sbjct: 68 DVI---HTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH-S 120
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
+ H +LK N+L+ L D+ L R L YR PE K
Sbjct: 121 HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCK 178
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
S D+++ G I E++T +
Sbjct: 179 YY-STAVDIWSLGCIFAEMVTRR 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (250), Expect = 6e-24
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 26/215 (12%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR---------EGIAKGKKEFAREVKKLGNIK- 786
E++GR + + + AVK + E + + ++ +EV L +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 787 HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVAR 846
HPN++ L ++ + + L YL + LS E ++ +
Sbjct: 69 HPNIIQL--KDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLE 121
Query: 847 CLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRP 906
+ LH + I H +LK NILL+ MN LTD+ L +V G Y
Sbjct: 122 VICALH-KLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREV--CGTPSYLA 177
Query: 907 PEFASTS----KPCPSLKSDVYAFGIILLELLTGK 937
PE S P + D+++ G+I+ LL G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 100 bits (250), Expect = 7e-24
Identities = 40/292 (13%), Positives = 87/292 (29%), Gaps = 39/292 (13%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRL-REGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
IG G +++ T L + +A+K R A ++ R K L V
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV---- 66
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
YY+G + +++ + + + S+ A + + +H E+
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIH-EK 120
Query: 856 AIPHGNLKSTNILLEAPTMN----AVLTDYSLHRILTSAGTADQVLN------AGALGYR 905
++ + ++K N L+ P + D+ + + T + +G Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 906 PPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965
+ + D+ A G + + L G G+ T+ + + +
Sbjct: 181 SINTHLGREQSR--RDDLEALGHVFMYFLRGS------LPWQGLKAATNKQKYERIGEK- 231
Query: 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCI-LPASERPDMMSVFEELSTI 1016
E + + L PD + S +
Sbjct: 232 -------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 20/210 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLR------EGIAKGKKEFAREVKKLGNIK--HP 788
++G G++Y + +A+K + G EV L +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 789 NLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
++ L ++ P L++ Q L ++ E L + V +
Sbjct: 70 GVIRLLDWFERPDSF-VLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAV 123
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE 908
+ H + H ++K NIL++ L D+ +L D G Y PPE
Sbjct: 124 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE 179
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGKS 938
+ + + V++ GI+L +++ G
Sbjct: 180 WIRYHRYH-GRSAAVWSLGILLYDMVCGDI 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 17/206 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE-----FAREVKKLGNIKHPNLV 791
+ +G T+YKA ++ I+A+K+++ G K+ RE+K L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 792 SLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYL 851
L + ++ +++ + L+ + + L YL
Sbjct: 64 GL--LDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
H + I H +LK N+LL+ L D+ L + S A YR PE
Sbjct: 117 H-QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTH-QVVTRWYRAPELLF 173
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
++ + D++A G IL ELL
Sbjct: 174 GARMY-GVGVDMWAVGCILAELLLRV 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (246), Expect = 4e-23
Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 19/205 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSL 793
+G G ++ +G A+K L++ I K + E L + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ + +I +YI L L+++ A +V L YLH
Sbjct: 70 --WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLH- 121
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ I + +LK NILL+ + +TD+ + + G Y PE ST
Sbjct: 122 SKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTK 176
Query: 914 KPCPSLKSDVYAFGIILLELLTGKS 938
D ++FGI++ E+L G +
Sbjct: 177 PYNK--SIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 7e-23
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 14/207 (6%)
Query: 738 EVIGRSCHGTLYKAT--LDSGSILAVKRLR-----EGIAKGKKEFAREVKKLGNIKHPNL 790
IG +G ++KA + G +A+KR+R EG+ ++ L +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
V L + + + + D P + + + + R L++
Sbjct: 73 VRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
LH+ R + H +LK NIL+ + L D+ L RI + V L YR PE
Sbjct: 132 LHSHR-VVHRDLKPQNILV-TSSGQIKLADFGLARIYSFQMALTSV--VVTLWYRAPEVL 187
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
S D+++ G I E+ K
Sbjct: 188 LQSSYAT--PVDLWSVGCIFAEMFRRK 212
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 47/289 (16%), Positives = 107/289 (37%), Gaps = 28/289 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQG 795
+GR + +++A + + + VK L+ KK+ RE+K L N++ PN+++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLAD 97
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
P ++ ++N Q L+ + ++ + L+Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH-SM 148
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
I H ++K N++++ L D+ L + + ++ PE +
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELLVDYQM 206
Query: 916 CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975
D+++ G +L ++ K P ++ +L+ + G +D
Sbjct: 207 YDY-SLDMWSLGCMLASMIFRKE--------PFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 976 GHDMEQPPR---ILSDMLQVALRCILPASERPDMMSVFEELSTIVLEKD 1021
+++E PR IL + + + + + + +L D
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 13/202 (6%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLR--EGIAKGKKEFAREVKKLGNIKHPNLVSLQG 795
E IG +G +YKA + G A+K++R + RE+ L +KH N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 796 YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNER 855
+ +++ +++ + L + + + Y H +R
Sbjct: 68 VIH--TKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH-DR 119
Query: 856 AIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKP 915
+ H +LK N+L+ + D+ L R L YR P+ SK
Sbjct: 120 RVLHRDLKPQNLLI-NREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 916 CPSLKSDVYAFGIILLELLTGK 937
S D+++ G I E++ G
Sbjct: 178 Y-STTIDIWSVGCIFAEMVNGT 198
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.1 bits (241), Expect = 5e-22
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 20/207 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK------KEFAREVKKLGNIKHPNL 790
+IGR G +Y D+G + A+K L + K K + + P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
V + Y + I + +N L +L + + A ++ L +
Sbjct: 70 VCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEH 122
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
+H R + + +LK NILL+ + ++D L + + G GY PE
Sbjct: 123 MH-NRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVL 177
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
+D ++ G +L +LL G
Sbjct: 178 QKGVAY-DSSADWFSLGCMLFKLLRGH 203
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.0 bits (237), Expect = 5e-22
Identities = 70/323 (21%), Positives = 121/323 (37%), Gaps = 23/323 (7%)
Query: 19 SDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN----GYVTSIMLND 74
D +ALLQ+KK + +P+ + SW ++D C R W G+ C V ++ L+
Sbjct: 6 QDKQALLQIKKDL-GNPT--TLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 75 MGLVGNFSFPTIIG-LKMLCNVSVSN--NQLMGNITDIGSIQSLEFLDLSHNLFHGLIPS 131
+ L + P+ + L L + + N + I + L +L ++H G IP
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 132 GIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVD 191
+ +K L+ L+ S N+ GT P L L + NR G I
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS-----FSK 174
Query: 192 LSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLV 251
L + L +++ + + + E N + + N L
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 252 GAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITS-AT 310
+ +L L L +N++ G+LP L Q L L++S N L G + +
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF--LHSLNVSFNNLCGEIPQGGNLQR 292
Query: 311 LKKVNLSSNKLSGSLPARVGHCT 333
++NK P + CT
Sbjct: 293 FDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 1e-12
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 25/255 (9%)
Query: 311 LKKVNLSSNKLSG--SLPARVGHCT---IVDLSNN-RLSGDLSRMQNWGNYVEDIHLSSN 364
+ ++LS L +P+ + + + + L G + + ++++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 365 FLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
++G +P+ SQ L + S N+L G LP + + P L I N ++G + S+ +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 425 STKLTDLNLSGNN--------------FSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNS 470
+KL N + + + ++ + T +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 471 LSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNVSFNNLSGVVPE--NLR 526
L + NL L+L NN+ G++P GL L NVSFNNL G +P+ NL+
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 527 NFPDSAFHPGNSLLT 541
F SA+ N L
Sbjct: 292 RFDVSAYA-NNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 49/278 (17%), Positives = 87/278 (31%), Gaps = 19/278 (6%)
Query: 207 DSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASN--NHLVGAIPSFNFVFSLR 264
+ + L++S +L + L N + P+ + L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 265 ILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGS 324
L + +SG++P L Q +++ + + P + L + N++SG+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 325 LPARVGHCT----IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRL 380
+P G + + +S NRL+G + N S + + +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGK--IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 381 TSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSG 440
T + +G L +DL N + G L L LN+S NN G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 441 PLPLQEIQNNPSTGSTQNLSLTSLDLAYNS-LSGRLLP 477
+P A N L G LP
Sbjct: 283 EIP----------QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 59/264 (22%), Positives = 94/264 (35%), Gaps = 18/264 (6%)
Query: 244 DASNNHLVGAIPSFNFVFSLRILRL----GSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
D S +L P + + +L L G N L G +P A+ + + + + +
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 300 EGPVGSITSATLKKVNLSSNKLSGSLPARVGHCT---IVDLSNNRLSGDLSRMQNWGNYV 356
P TL ++ S N LSG+LP + + NR+SG + + +
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 357 EDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNG 416
S T L L +S N LEGD + G+ + I L+ N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 417 FLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLL 476
L + +L N G LP Q + L SL++++N+L G +
Sbjct: 236 DLGKVGLSKNLNGL-DLRNNRIYGTLP-QGLTQLKF--------LHSLNVSFNNLCGEI- 284
Query: 477 PGISKFHNLVYLNLSNNKFEGSIP 500
P +NNK P
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 7e-22
Identities = 38/206 (18%), Positives = 78/206 (37%), Gaps = 17/206 (8%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE---FAREVKKLG-NIKHPNLVS 792
+++G+ G ++ A + A+K L++ + + E + L +HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 793 LQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLH 852
+ + + + Y+N L ++ + + A ++ L +LH
Sbjct: 68 MFCTFQ--TKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 853 NERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAST 912
+ I + +LK NIL + + D+ + + G Y PE
Sbjct: 121 -SKGIVYRDLKLDNIL-LDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILLG 177
Query: 913 SKPCPSLKSDVYAFGIILLELLTGKS 938
K D ++FG++L E+L G+S
Sbjct: 178 QKYNH--SVDWWSFGVLLYEMLIGQS 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-21
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 13/203 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK--KEFAREVKKLGNIKHPNLVSLQ 794
+ +G +G + A +G+ +A+K+L K RE++ L +++H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
+ P E Y+ + L + K L D + + + L Y+H
Sbjct: 84 DVFT-PDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-A 139
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
I H +LK N+ + + D+ L R S T YR PE
Sbjct: 140 AGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNWM 194
Query: 915 PCPSLKSDVYAFGIILLELLTGK 937
D+++ G I+ E++TGK
Sbjct: 195 RYTQ-TVDIWSVGCIMAEMITGK 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 8e-21
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 10/207 (4%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK--KEFAREVKKLGNIKHPNLVSLQ 794
IG+ G ++KA +G +A+K++ K RE+K L +KH N+V+L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 795 GYYW-GPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ + S Y+ L L ++ E RV + L Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLN---AGALGYRPPEFA 910
+ I H ++K+ N+L+ L D+ L R + A + L YRPPE
Sbjct: 136 NK-ILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
+ D++ G I+ E+ T
Sbjct: 194 LGERDY-GPPIDLWGAGCIMAEMWTRS 219
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.0 bits (227), Expect = 2e-20
Identities = 31/211 (14%), Positives = 72/211 (34%), Gaps = 14/211 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQG- 795
+G T++ A + + + +A+K +R + E+K L + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 796 --------YYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC 847
+ V + L + + + +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNA-GALGYRP 906
L+Y+H I H ++K N+L+E L + + + + N+ YR
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 907 PEFASTSKPCPSLKSDVYAFGIILLELLTGK 937
PE + +D+++ ++ EL+TG
Sbjct: 198 PEVLLGAPWGC--GADIWSTACLIFELITGD 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 4e-20
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 738 EVIGRSCHGTLYKATL----DSGSILAVKRLREGI----AKGKKEFAREVKKLGNIKH-P 788
+V+G +G ++ D+G + A+K L++ AK + E + L +I+ P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 789 NLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCL 848
LV+L +Y E + +I +YIN L +L + + E ++ L
Sbjct: 90 FLVTL--HYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLAL 142
Query: 849 NYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPE 908
+LH + I + ++K NILL+ + VLTD+ L + + T G + Y P+
Sbjct: 143 EHLH-KLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 909 FASTSKPCPSLKSDVYAFGIILLELLTGK 937
D ++ G+++ ELLTG
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 6e-20
Identities = 41/204 (20%), Positives = 77/204 (37%), Gaps = 14/204 (6%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAK--GKKEFAREVKKLGNIKHPNLVSLQ 794
E IG +GT++KA ++ I+A+KR+R RE+ L +KH N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV--R 65
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE 854
+ + + ++ + + + + + + L + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-----EIVKSFLFQLLKGLGFCHSR 120
Query: 855 RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSK 914
+ H +LK N+L+ L ++ L R L YRPP+ +K
Sbjct: 121 N-VLHRDLKPQNLLI-NRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAK 177
Query: 915 PCPSLKSDVYAFGIILLELLTGKS 938
S D+++ G I EL
Sbjct: 178 LY-STSIDMWSAGCIFAELANAGR 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 2e-19
Identities = 42/210 (20%), Positives = 81/210 (38%), Gaps = 22/210 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKG------KKEFAREVKKLGNIKHPNL 790
E +G + K +G A K +++ K +++ REV L I+HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 791 VSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
++L + + + ++I + L + L+ +E + + Y
Sbjct: 76 ITL--HEVYENKTDVILILELVAGGEL-----FDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 851 LHNERAIPHGNLKSTNILL---EAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPP 907
LH I H +LK NI+L P + D+ L + + G + P
Sbjct: 129 LH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPEFVAP 185
Query: 908 EFASTSKPCPSLKSDVYAFGIILLELLTGK 937
E + ++D+++ G+I LL+G
Sbjct: 186 EIVNYEPLGL--EADMWSIGVITYILLSGA 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 2e-19
Identities = 42/204 (20%), Positives = 80/204 (39%), Gaps = 16/204 (7%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE---FAREVKKLGNIKHPNLVSL 793
+++G+ G + +G A+K LR+ + K E E + L N +HP L +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
Y + Y N L +L + + + ++ L YLH
Sbjct: 71 --KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
R + + ++K N++L + +TD+ L + S G + G Y PE +
Sbjct: 123 SRDVVYRDIKLENLML-DKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLEDN 180
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
D + G+++ E++ G+
Sbjct: 181 DYGR--AVDWWGLGVVMYEMMCGR 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.2 bits (215), Expect = 7e-19
Identities = 35/204 (17%), Positives = 71/204 (34%), Gaps = 19/204 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGKKE---FAREVKKLGNIKHPNLVSL 793
+ +G G + +SG+ A+K L + K+ E + L + P LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 794 QGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHN 853
+ ++ Y+ + +L+ ++ S A + YLH
Sbjct: 107 --EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 854 ERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTS 913
+ + +LK N+L++ +TD+ + + G PE +
Sbjct: 159 SLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSK 213
Query: 914 KPCPSLKSDVYAFGIILLELLTGK 937
D +A G+++ E+ G
Sbjct: 214 GYNK--AVDWWALGVLIYEMAAGY 235
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.8 bits (211), Expect = 3e-18
Identities = 64/378 (16%), Positives = 119/378 (31%), Gaps = 40/378 (10%)
Query: 105 NITDIGS---IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLG 161
N+TD S + + L + G+ L NL +N S+N P L
Sbjct: 33 NVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLT 88
Query: 162 KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISE 221
KL + + N+ + + + + L + S ++
Sbjct: 89 KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 222 NSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRI---------LRLGSNQ 272
A+ L S N V + + L +NQ
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 208
Query: 273 LSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLP-ARVGH 331
+S P L EL L+ NQL+ + L ++L++N++S P + +
Sbjct: 209 ISDITP----LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTK 264
Query: 332 CTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLE 391
T + L N++S + +L N + S LT + N++
Sbjct: 265 LTELKLGANQISN----ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNIS 320
Query: 392 GDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNP 451
P + + +L+ + + N ++ + S T + L+ N S PL +
Sbjct: 321 DISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTR-- 374
Query: 452 STGSTQNLSLTSLDLAYN 469
+T L L
Sbjct: 375 ---------ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 1e-15
Identities = 61/391 (15%), Positives = 131/391 (33%), Gaps = 37/391 (9%)
Query: 135 SLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHL--LSQLGSVVHVDL 192
+L M + + T L ++ L I + + L ++ ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG----IKSIDGVEYLNNLTQINF 73
Query: 193 SNNQFSGSLDLG-------LGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDA 245
SNNQ + L + ++ + + +L G ++ + D L+
Sbjct: 74 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 246 SNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGS 305
N + + + + L + + L LD+S N++
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 306 ITSATLKKVNLSSNKLSGSLPARVGHC-TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSN 364
L+ + ++N++S P + + L+ N+L + + + N + D+ L++N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-IGTLASLTN-LTDLDLANN 251
Query: 365 FLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFT 424
++ + P S +LT K+ N + P T LN +
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDISPISN 305
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHN 484
LT L L NN S P+ + L L A N +S + ++ N
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTK-----------LQRLFFANNKVSD--VSSLANLTN 352
Query: 485 LVYLNLSNNKFEGSIPDGLPNGLKEFNVSFN 515
+ +L+ +N+ P + + ++
Sbjct: 353 INWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.7 bits (182), Expect = 1e-14
Identities = 68/376 (18%), Positives = 125/376 (33%), Gaps = 50/376 (13%)
Query: 182 SQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLE 241
+ L + L + ++ + + + L + + DG+ Y +NL
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-----TDLDQVTTLQADRLGIK-SI---DGVEYLNNLT 69
Query: 242 VFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG 301
+ SNN L P N L + + +NQ++ P+A L + + + +
Sbjct: 70 QINFSNNQLTDITPLKNLT-KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 302 PVGSITSATLKKVNL-------SSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGN 354
+ + N S L + L+N L N +
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 355 YVED---------IHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405
+ + ++N ++ + P L ++ N L+ L + L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS----- 460
+DL+ N ++ L TKLT+L L N S PL + + +N
Sbjct: 245 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 461 ------LTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKEFNV 512
LT L L +N++S + +S L L +NNK L N + +
Sbjct: 303 ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 513 SFNNLSGVVP-ENLRN 527
N +S + P NL
Sbjct: 359 GHNQISDLTPLANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 5e-10
Identities = 31/175 (17%), Positives = 56/175 (32%), Gaps = 11/175 (6%)
Query: 1 MQTVSLIVLLLVVNALGQSDFEALLQLKKGIAKDPSG----QIIDSWDTKSLSSDGCPRN 56
+L L L N L D L L D + + L+ N
Sbjct: 216 GILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGAN 273
Query: 57 WFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLE 116
+T++ ++ I LK L +++ N + I+ + S+ L+
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQ 332
Query: 117 FLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRAN 171
L ++N S + +L N+ L+ N P L ++ L L
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 1e-09
Identities = 29/150 (19%), Positives = 59/150 (39%), Gaps = 7/150 (4%)
Query: 46 KSLSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGN 105
+L+ N +T + +G + + GL L N+ ++ NQ + +
Sbjct: 241 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ-LED 299
Query: 106 ITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKY 165
I+ I ++++L +L L N + P + SL L L ++N S L + +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 166 LDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195
L N+ L+ L + + L++
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.3 bits (137), Expect = 4e-09
Identities = 55/347 (15%), Positives = 102/347 (29%), Gaps = 56/347 (16%)
Query: 217 LNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGS 276
+ + ++ + D D + A + +I ++ +L + +NQL+
Sbjct: 27 TVLGKTNVTDTVSQTD----LDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDI 81
Query: 277 LPVALLQE--------------SSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLS 322
P+ L + + + L + I S
Sbjct: 82 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141
Query: 323 GSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTS 382
++ + L ++ ++ N L + + ++ L S
Sbjct: 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 201
Query: 383 FKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPL 442
+NN + P + L + L+ N L + + + T LTDL+L+ N S
Sbjct: 202 LIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 443 PLQEIQNNPSTGSTQNLSLTSLDLAYNSLSG--------------------RLLPGISKF 482
PL + LT L L N +S + IS
Sbjct: 258 PLSGLTK-----------LTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 483 HNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFP 529
NL YL L N P L+ + N +S +L N
Sbjct: 307 KNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLT 351
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 4e-06
Identities = 53/308 (17%), Positives = 97/308 (31%), Gaps = 37/308 (12%)
Query: 268 LGSNQLSGSLPVALLQESSMMLSELDLS---LNQLEGPVGSITSATLKKVNLSSNKLSGS 324
LG ++ ++ L + ++ L + ++G V + + L ++N S+N+L+
Sbjct: 29 LGKTNVTDTVSQTDLDQ----VTTLQADRLGIKSIDG-VEYLNN--LTQINFSNNQLTDI 81
Query: 325 LP-------------ARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVP 371
P + L+G + +L++ +
Sbjct: 82 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141
Query: 372 NQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS-TKLTD 430
N S L+ G+ L L ++ N S T L
Sbjct: 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 201
Query: 431 LNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNL 490
L + N S PL + N L L L N L + ++ NL L+L
Sbjct: 202 LIATNNQISDITPLGILTN-----------LDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 491 SNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSAFHPGNSLLTFPNSPSQQD 550
+NN+ P L E + N +S + P + N L + ++
Sbjct: 249 ANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 551 VPDLTLRG 558
+ LTL
Sbjct: 309 LTYLTLYF 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 5e-17
Identities = 44/206 (21%), Positives = 76/206 (36%), Gaps = 19/206 (9%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIAKGK--KEFAREVKKLGNIKHPNLVSLQ 794
+G +G++ A +G +AVK+L K RE++ L ++KH N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 795 GYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLP---PLSIDERLRVAVDVARCLNYL 851
+ + N L +L D + L+ D + + R L Y+
Sbjct: 84 DVFTPARSL------EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 852 HNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFAS 911
H I H +LK +N+ + +L YR PE
Sbjct: 138 H-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 191
Query: 912 TSKPCPSLKSDVYAFGIILLELLTGK 937
+ D+++ G I+ ELLTG+
Sbjct: 192 NWMHY-NQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 3e-16
Identities = 40/207 (19%), Positives = 77/207 (37%), Gaps = 21/207 (10%)
Query: 738 EVIGRSCHGTLYKAT-LDSGSILAVKRLREGIA--KGKKEFAREVKKLGNIKHPNLVSLQ 794
+ IG G + A +A+K+L K RE+ + + H N++SL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 795 GYYWGPKEHEK----LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNY 850
+ K E+ ++ ++A V E D + + + + +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH--------ERMSYLLYQMLCGIKH 134
Query: 851 LHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQVLNAGALGYRPPEFA 910
LH+ I H +LK +NI+++ + D+ L R ++ YR PE
Sbjct: 135 LHSAGII-HRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVI 190
Query: 911 STSKPCPSLKSDVYAFGIILLELLTGK 937
D+++ G I+ E++ K
Sbjct: 191 LGMGYKE--NVDIWSVGCIMGEMVRHK 215
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.8 bits (172), Expect = 1e-13
Identities = 52/261 (19%), Positives = 92/261 (35%), Gaps = 15/261 (5%)
Query: 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172
LDL +N + +LKNL L + +N P F L KL+ L L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHD 232
+ + + + N+ + + + ++ S E
Sbjct: 91 LKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 233 GMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSEL 292
GM L ++ ++ IP SL L L N+++ +L + L++L
Sbjct: 148 GMK---KLSYIRIADTNI-TTIPQGLPP-SLTELHLDGNKITKVDAASL--KGLNNLAKL 200
Query: 293 DLSLNQLEGPVGSITSAT--LKKVNLSSNKLSGSLPARVGHC--TIVDLSNNRLSG-DLS 347
LS N + + T L++++L++NKL H +V L NN +S +
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 348 RMQNWGNYVEDIHLSSNFLTG 368
G + S L
Sbjct: 261 DFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 1e-13
Identities = 45/313 (14%), Positives = 98/313 (31%), Gaps = 40/313 (12%)
Query: 129 IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188
+P + + LL++ +N F L L L L N+ + L +
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 189 HVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248
+ LS NQ +L + ++ + +F + +E+
Sbjct: 83 RLYLSKNQLK---ELPEKMPKTLQELRVHENEITKVRKSVFNG--LNQMIVVELGTNPLK 137
Query: 249 HLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITS 308
+F + L +R+ ++ ++P L L+EL L N++
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS----LTELHLDGNKITKV------ 186
Query: 309 ATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTG 368
+ + + + LS N +S + ++ ++HL++N L
Sbjct: 187 -------------DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232
Query: 369 MVPNQTSQFLRLTSFKVSNNSLEG------DLPAVLGTYPELKVIDLSLNHLNGFLLP-- 420
VP + + + NN++ P + L N + + +
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 421 SFFTSTKLTDLNL 433
+F + L
Sbjct: 293 TFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.1 bits (157), Expect = 8e-12
Identities = 43/274 (15%), Positives = 85/274 (31%), Gaps = 14/274 (5%)
Query: 208 SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRIL 266
L++ N + NL NN + P +F + L L
Sbjct: 27 KDLPPDTALLDLQNNKITE--IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84
Query: 267 RLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLP 326
L NQL LP + + + + + + + ++ + K SG
Sbjct: 85 YLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 327 ARVGHCT---IVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSF 383
+ +++ ++ + Q + ++HL N +T + L
Sbjct: 144 GAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 384 KVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP 443
+S NS+ L P L+ + L+ N L + + L NN S
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISA--- 256
Query: 444 LQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLP 477
+ P +T+ S + + L N + +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.0 bits (149), Expect = 9e-11
Identities = 46/282 (16%), Positives = 96/282 (34%), Gaps = 31/282 (10%)
Query: 239 NLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
+L V S+ L +P + +L L +N+++ + L L L N+
Sbjct: 11 HLRVVQCSDLGLE-KVPK-DLPPDTALLDLQNNKITEIKDGDFKNLKN--LHTLILINNK 66
Query: 299 LEG-PVGSITSAT-LKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYV 356
+ G+ L+++ LS N+L + + N ++ + N N +
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 357 EDIHLSSNFL--TGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHL 414
+ L +N L +G+ +L+ ++++ ++ +P G P L + L N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 415 NGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQN--------------NPSTGSTQNLS 460
S L L LS N+ S G +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 461 LTSLDLAYNSLSG------RLLPGISKFHNLVYLNLSNNKFE 496
+ + L N++S +K + ++L +N +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 32/197 (16%), Positives = 60/197 (30%), Gaps = 14/197 (7%)
Query: 333 TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
+V S+ L ++ + L +N +T + L + + NN +
Sbjct: 13 RVVQCSDLGLE---KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 393 DLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPS 452
P +L+ + LS N L T +L
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV----------RKSV 119
Query: 453 TGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNV 512
+ + L SG L Y+ +++ +IP GLP L E ++
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL 178
Query: 513 SFNNLSGVVPENLRNFP 529
N ++ V +L+
Sbjct: 179 DGNKITKVDAASLKGLN 195
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.8 bits (133), Expect = 1e-08
Identities = 31/269 (11%), Positives = 73/269 (27%), Gaps = 57/269 (21%)
Query: 82 SFPTIIGLKMLCNVSVSNNQLMGNI-TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLM 140
P + + + NN++ D ++++L L L +N + P L L
Sbjct: 24 KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 141 LLNISSNSFEGTFPSGFGGLGKLKYLDLRAN-----------------------RFGGDI 177
L +S N + L +L+ + + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 178 MHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGEL--------- 228
+ + ++ +++ + S+ L++ N +
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTI------PQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 229 -------------FPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS- 274
+ + +L +NN LV ++++ L +N +S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 275 ---GSLPVALLQESSMMLSELDLSLNQLE 300
S + L N ++
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 3e-06
Identities = 49/264 (18%), Positives = 90/264 (34%), Gaps = 32/264 (12%)
Query: 311 LKKVNLSSNKLSGSLPARVG-HCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM 369
L+ V S L +P + ++DL NN+++ + + L +N ++ +
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 370 VPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLT 429
P + ++L +S N L+ + T EL+V + + + + + +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF-NGLNQMIVV 129
Query: 430 DLNLSGNNFSGPLP----------LQEIQNNPSTGSTQNL--SLTSLDLAYNSLSGRLLP 477
+L + SG I + T Q L SLT L L N ++
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAA 189
Query: 478 GISKFHNLVYLNLSNNKFEGSIPDGLPNG--LKEFNVSFNNLSGVVPE------------ 523
+ +NL L LS N L N L+E +++ N L V
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYL 249
Query: 524 ---NLRNFPDSAFHPGNSLLTFPN 544
N+ + F P +
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKAS 273
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 5e-13
Identities = 37/193 (19%), Positives = 63/193 (32%), Gaps = 10/193 (5%)
Query: 109 IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDL 168
+ L L L L P L L L + N+ + F LG L +L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 169 RANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGEL 228
NR L S+ + L N+ + +F + + + +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRV-----AHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 229 FPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMM 288
P + + L+ ++N V + L+ R S+++ SLP L
Sbjct: 216 LPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG----- 270
Query: 289 LSELDLSLNQLEG 301
L+ N L+G
Sbjct: 271 RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (152), Expect = 3e-11
Identities = 48/276 (17%), Positives = 85/276 (30%), Gaps = 34/276 (12%)
Query: 95 VSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF- 153
S L I + + + + L N + + + +NL +L + SN
Sbjct: 16 TSCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 154 ------------------------PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVH 189
P+ F GLG+L L L L L ++ +
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 190 VDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNH 249
+ L +N D + ++ +L + N + P +L+ N
Sbjct: 134 LYLQDNALQALPD---DTFRDLGNLTHLFLHGNRISS--VPERAFRGLHSLDRLLLHQNR 188
Query: 250 LVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSIT-S 308
+ P + +LP L L L+ N +
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEA-LAPLRALQYLRLNDNPWVCDCRARPLW 247
Query: 309 ATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSG 344
A L+K SS+++ SLP R+ + L+ N L G
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 8e-11
Identities = 36/246 (14%), Positives = 71/246 (28%), Gaps = 16/246 (6%)
Query: 289 LSELDLSLNQLEG-PVGSITSATLKKVNL-----SSNKLSGSLPARVGHCTIVDLSNNRL 342
+ L N++ P S + + + + + + N +L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 343 SGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYP 402
+ + +HL L + P L + +N+L+
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 403 ELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLT 462
L + L N ++ +F L L L N + P
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF---- 209
Query: 463 SLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIP-DGLPNGLKEFNVSFNNLSGVV 521
N+LS ++ L YL L++N + L L++F S + + +
Sbjct: 210 -----ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264
Query: 522 PENLRN 527
P+ L
Sbjct: 265 PQRLAG 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 31/163 (19%), Positives = 55/163 (33%), Gaps = 10/163 (6%)
Query: 91 MLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSF 149
L + + +N L D + +L L L N + L +L L + N
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 150 EGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSS 209
P F LG+L L L AN L+ L ++ ++ L++N +
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA----RP 245
Query: 210 FISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVG 252
+ +Q S + + L ++ + N L G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQR-----LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 41/235 (17%), Positives = 64/235 (27%), Gaps = 17/235 (7%)
Query: 333 TIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
L + + I L N ++ + LT + +N L
Sbjct: 14 VTTSCPQQGLQ---AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 393 DLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTS-TKLTDLNLSGNNFSGPLPLQEIQNNP 451
A L+ +DLS N + P+ F +L L+L Q
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL---------QELG 121
Query: 452 STGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPN--GLKE 509
+L L L N+L NL +L L N+ L
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 510 FNVSFNNLSGVVPENLRNFPDSAF--HPGNSLLTFPNSPSQQDVPDLTLRGHGNH 562
+ N ++ V P R+ N+L P LR + N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.4 bits (143), Expect = 1e-10
Identities = 23/160 (14%), Positives = 51/160 (31%), Gaps = 23/160 (14%)
Query: 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIA----------KGKKEFAREVKKLGNIKH 787
+++G ++ + VK + G G F+ + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 788 PNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARC 847
L LQG + + AV ++ D ++L + ++ V +
Sbjct: 66 RALQKLQGLA----------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 848 LNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887
+ + R I HG+L N+L+ + D+ +
Sbjct: 116 VAKFY-HRGIVHGDLSQYNVLVS--EEGIWIIDFPQSVEV 152
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 8/201 (3%)
Query: 240 LEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQL 299
LEV + +L A+P + IL L N L L+ + L++L+L +L
Sbjct: 13 LEV-NCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTR--LTQLNLDRAEL 67
Query: 300 EGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVD--LSNNRLSGDLSRMQNWGNYVE 357
T L ++LS N+L + +S NRL+ ++
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 358 DIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGF 417
+++L N L + P + +L ++NN+L +L L + L N L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 418 LLPSFFTSTKLTDLNLSGNNF 438
+ FF S L L GN +
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 32/209 (15%), Positives = 53/209 (25%), Gaps = 14/209 (6%)
Query: 92 LCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEG 151
V+ L D+ L LS NL + + ++ L LN+
Sbjct: 12 HLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69
Query: 152 TFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFI 211
L + L L+ S + L +
Sbjct: 70 LQVD--------GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 212 SSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGS 270
+ + + P + LE +NN+L N + +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 271 NQLSGSLPVALLQESSMMLSELDLSLNQL 299
N L ++P L L N
Sbjct: 182 NSLY-TIPKGFFGSHL--LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 10/51 (19%), Positives = 19/51 (37%), Gaps = 1/51 (1%)
Query: 479 ISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFP 529
+SK + + +N ++P LP ++S N L L +
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYT 55
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 47/210 (22%), Positives = 67/210 (31%), Gaps = 33/210 (15%)
Query: 308 SATLKKVNLSSNKLSGSLPARVG-HCTIVDLSNNRLSG---------------DLSRMQN 351
A+ +VN L+ +LP + TI+ LS N L +L R +
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 352 WGNYVED------IHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELK 405
V+ S+ +P LT VS N L L EL+
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 406 VIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLD 465
+ L N L P T T + NN LP + + L +L
Sbjct: 128 ELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN--------LDTLL 178
Query: 466 LAYNSLSGRLLPGISKFHNLVYLNLSNNKF 495
L NSL + G H L + L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 1/82 (1%)
Query: 122 HNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLL 181
N L P + L L++++N+ GL L L L+ N I
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 182 SQLGSVVHVDLSNNQFSGSLDL 203
+ L N + + ++
Sbjct: 192 FGSHLLPFAFLHGNPWLCNCEI 213
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 14/98 (14%), Positives = 28/98 (28%), Gaps = 12/98 (12%)
Query: 425 STKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGR----LLPGIS 480
S + L++ S + + + L L+ + +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQ--------CQVVRLDDCGLTEARCKDISSALR 52
Query: 481 KFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLS 518
L LNL +N+ + GL+ + LS
Sbjct: 53 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 13/91 (14%), Positives = 25/91 (27%), Gaps = 10/91 (10%)
Query: 458 NLSLTSLDLAYNSLSGRLLPGI-SKFHNLVYLNLSNNKFEGSIPDGLPNG------LKEF 510
+L + SLD+ LS + + L + + + + L E
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 511 NVSFNNLSGVVPENLRNFPDSAFHPGNSLLT 541
N+ N L + P +
Sbjct: 61 NLRSNELGD---VGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 11/90 (12%), Positives = 29/90 (32%), Gaps = 7/90 (7%)
Query: 138 NLMLLNISSNSF-EGTFPSGFGGLGKLKYLDLRANRFGGD----IMHLLSQLGSVVHVDL 192
++ L+I + + L + + + L I L ++ ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 193 SNNQFSGSLDLGLGDS--SFISSIQYLNIS 220
+N+ + + IQ L++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 9/94 (9%)
Query: 378 LRLTSFKVSNNSL-EGDLPAVLGTYPELKVIDLSLNHLNG----FLLPSFFTSTKLTDLN 432
L + S + L + +L + +V+ L L + + + L +LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 433 LSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDL 466
L N + T + + L L
Sbjct: 62 LRSNELGD----VGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 17/78 (21%), Positives = 28/78 (35%), Gaps = 11/78 (14%)
Query: 460 SLTSLDLAYNSLSGR----LLPGISKFHNLVYLNLSNNKFEGSIPDGLPNG-------LK 508
L L LA +S L + H+L L+LSNN + L L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 509 EFNVSFNNLSGVVPENLR 526
+ + S + + L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 12/91 (13%), Positives = 27/91 (29%), Gaps = 5/91 (5%)
Query: 114 SLEFLDLSHNLFHGLIPSGIVS-LKNLMLLNISSNSFEG----TFPSGFGGLGKLKYLDL 168
++ LD+ + ++ L+ ++ + S L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 169 RANRFGGDIMHLLSQLGSVVHVDLSNNQFSG 199
R+N G +H + Q +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 111 SIQSLEFLDLSHNLFHGL----IPSGIVSLKNLMLLNISSNSFEGTFPSGFGG-----LG 161
L L L+ + + +++ +L L++S+N
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 162 KLKYLDLRANRFGGDIMHLLSQL 184
L+ L L + ++ L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 11/102 (10%)
Query: 422 FFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISK 481
+ L L L+ + S ++ + N SL LDL+ N L + + +
Sbjct: 365 GQPGSVLRVLWLADCDVSD-----SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 482 F-----HNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLS 518
L L L + + + D L L++ S +S
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRL-QALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 28/112 (25%), Positives = 42/112 (37%), Gaps = 9/112 (8%)
Query: 349 MQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVID 408
+Q N +ED + P + L L VS++S L A L L+ +D
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELD 403
Query: 409 LSLNHLNGFLLPSFFTS-----TKLTDLNLSGNNFSGPLP--LQEI-QNNPS 452
LS N L + S L L L +S + LQ + ++ PS
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPS 455
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 11/67 (16%), Positives = 23/67 (34%), Gaps = 2/67 (2%)
Query: 163 LKYLDLRANRFG-GDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS-SFISSIQYLNIS 220
++ LD++ LL L V L + + + + + ++ LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 221 ENSLVGE 227
N L
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 15/88 (17%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 239 NLEVFDASNNHL--VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQ--ESSMMLSELDL 294
+++ D L + +++RL L+ + + + L+EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 295 SLNQLEGPVGSITSATLKKVNLSSNKLS 322
N+L L+ + KLS
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 18/85 (21%), Positives = 28/85 (32%), Gaps = 12/85 (14%)
Query: 395 PAVLGTYPELKVIDLSLNHLNG----FLLPSFFTSTKLTDLNLSGNNFS--GPLPLQEIQ 448
+ L+V+ L+ ++ L + + L +L+LS N G L L E
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 449 NNPSTGSTQNLSLTSLDLAYNSLSG 473
P L L L S
Sbjct: 422 RQPGC------LLEQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 13/93 (13%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 356 VEDIHLSSNFLTGMVPNQTSQFLR-LTSFKVSNNSLEGD----LPAVLGTYPELKVIDLS 410
++ + + L+ + L+ ++ + L + + L P L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 411 LNHLNGFLLPSFF-----TSTKLTDLNLSGNNF 438
N L + S K+ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 14/95 (14%)
Query: 162 KLKYLDLRANRFGGD----IMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS--SFISSIQ 215
L+ L L + L S+ +DLSNN + L L +S ++
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 216 YLNISENSLVGELFPHDGMPYFDNLEVFDASNNHL 250
L + + E+ D L+ + L
Sbjct: 430 QLVLYDIYWSEEM--------EDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 11/72 (15%), Positives = 23/72 (31%), Gaps = 9/72 (12%)
Query: 137 KNLMLLNISSNSFEGT----FPSGFGGLGKLKYLDLRANRFGGDIMHLLSQ-----LGSV 187
L +L ++ + + L+ LDL N G + L + +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 188 VHVDLSNNQFSG 199
+ L + +S
Sbjct: 429 EQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 18/90 (20%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 311 LKKVNLSSNKLSG----SLPARVGHCTIVDLSNNRLSGD----LSRMQNWGNYVEDIHLS 362
++ +++ +LS L + C +V L + L+ +S + +++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSLEG 392
SN L + + Q L+ S K+ SL+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 39/293 (13%), Positives = 84/293 (28%), Gaps = 29/293 (9%)
Query: 244 DASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEG-P 302
D + +L + + R + + L S + +DLS + +E
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF---SPFRVQHMDLSNSVIEVST 62
Query: 303 VGSITSA--TLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIH 360
+ I S L+ ++L +LS + + + + RL+ + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS----NLVRLNLSGCSGFSEFALQTLLS 118
Query: 361 LSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLP 420
S + + V++ S + G N L
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------NLQKSDLST 169
Query: 421 SFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAY-NSLSGRLLPGI 479
L L+LS + QE L L L+ + L +
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN--------YLQHLSLSRCYDIIPETLLEL 221
Query: 480 SKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGVVPENLRNFPDSA 532
+ L L + +G++ L L ++ ++ + + + N +
Sbjct: 222 GEIPTLKTLQVFGIVPDGTLQL-LKEALPHLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 21/110 (19%), Positives = 37/110 (33%), Gaps = 12/110 (10%)
Query: 381 TSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLN-GFLLPSFFTSTKLTDLNLSGNNFS 439
+ ++ +L P V G VI L F+ ++ ++LS +
Sbjct: 3 QTLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 440 GPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLN 489
+ L +L L LS ++ ++K NLV LN
Sbjct: 60 VSTLHGILSQCS--------KLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 40/266 (15%), Positives = 91/266 (34%), Gaps = 13/266 (4%)
Query: 77 LVGNFSFPTIIG---LKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGI 133
L G P + G + + + + + + S ++ +DLS+++ GI
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66
Query: 134 VS-LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLR--ANRFGGDIMHLLSQLGSVVHV 190
+S L L++ + L L+L + + LLS + +
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 191 DLSNNQFSGSLDLGLGDSSFISSIQYLNISE-NSLVGELFPHDGMPYFDNLEVFDASNNH 249
+LS + + + +I LN+S + + + NL D S++
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 250 LVGAIPSFNFVFS--LRILRL-GSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSI 306
++ F L+ L L + + L + + L L + +G + +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT--LKTLQVFGIVPDGTLQLL 244
Query: 307 TSATLKKVNLSSNKLSGSLPARVGHC 332
A L + ++ + + +G+
Sbjct: 245 KEA-LPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 21/102 (20%), Positives = 42/102 (41%), Gaps = 5/102 (4%)
Query: 333 TIVDLSNNRLSGD-LSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLE 391
+DL+ L D R+ + G V +F+ + S R+ +SN+ +E
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIE 59
Query: 392 GD-LPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLN 432
L +L +L+ + L L+ ++ + ++ L LN
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 15/104 (14%), Positives = 35/104 (33%), Gaps = 14/104 (13%)
Query: 429 TDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYL 488
L+L+G N + + + + + + + L + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG----------VIAFRCPRSFMDQ-PLAEHFSPFRVQHM 51
Query: 489 NLSNNKFEGSIPDGLPNG---LKEFNVSFNNLSGVVPENLRNFP 529
+LSN+ E S G+ + L+ ++ LS + L
Sbjct: 52 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 21/108 (19%)
Query: 409 LSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAY 468
LN + + L +LN+S N L E+ P L L ++
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNK------LIELPALPP-------RLERLIASF 313
Query: 469 NSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNN 516
N L+ +P + NL L++ N PD +P ++ ++ N+
Sbjct: 314 NHLAE--VPEL--PQNLKQLHVEYNPLR-EFPD-IPESVE--DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 25/83 (30%), Positives = 37/83 (44%), Gaps = 8/83 (9%)
Query: 468 YNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLPNGLKEFNVSFNNLSGV--VPENL 525
N+ S + +L LN+SNNK +P P L+ SFN+L+ V +P+NL
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR-LERLIASFNHLAEVPELPQNL 326
Query: 526 RNFPDSAFHPGNSLLTFPNSPSQ 548
+ N L FP+ P
Sbjct: 327 KQLHVE----YNPLREFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 54/356 (15%), Positives = 107/356 (30%), Gaps = 40/356 (11%)
Query: 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQ 196
+ L +++ + P L+ L N + L S+ + + NN
Sbjct: 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNS----LTELPELPQSLKSLLVDNNN 89
Query: 197 FSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
DL ++YL +S N +L + L++ D NN L
Sbjct: 90 LKALSDL-------PPLLEYLGVSNN----QLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138
Query: 257 FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNL 316
+ + +L + L + L + + + +
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198
Query: 317 SSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQ 376
L + + L + S + +++ S + N S
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258
Query: 377 FLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGN 436
L N+ ++ ++ P L+ +++S N L LP+ L L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE--LPALPPR--LERLIASFN 314
Query: 437 NFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSN 492
+ L E+ P +L L + YN L P I ++ L +++
Sbjct: 315 H------LAEVPELPQ-------NLKQLHVEYNPLRE--FPDI--PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 16/101 (15%), Positives = 33/101 (32%), Gaps = 15/101 (14%)
Query: 120 LSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH 179
N I S +L LN+S+N P+ +L+ L N +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNH----LAE 318
Query: 180 LLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNIS 220
+ ++ + + N D+ S++ L ++
Sbjct: 319 VPELPQNLKQLHVEYNPLREFPDI-------PESVEDLRMN 352
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 5/123 (4%)
Query: 96 SVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPS 155
+++ L + + + + LDLSHN L P+ + +L+ L +L S N+
Sbjct: 4 HLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNAL--ENVD 59
Query: 156 GFGGLGKLKYLDLRANRF-GGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSI 214
G L +L+ L L NR + L +V ++L N + + + S+
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 215 QYL 217
+
Sbjct: 120 SSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 22/106 (20%), Positives = 30/106 (28%), Gaps = 15/106 (14%)
Query: 405 KVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLP------------LQEIQNNPS 452
+V+ L+ L L +T L+LS N P +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 453 TGSTQNLSLTSLDLAYNSL-SGRLLPGISKFHNLVYLNLSNNKFEG 497
G L L L N L + + LV LNL N
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 23/120 (19%), Positives = 40/120 (33%), Gaps = 4/120 (3%)
Query: 292 LDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQN 351
L L+ L + ++LS N+L PA + L + + +
Sbjct: 3 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 352 WGNYVEDIHLSSNFLTGMVPNQT-SQFLRLTSFKVSNNSL---EGDLPAVLGTYPELKVI 407
++++ L +N L Q RL + NSL EG + P + I
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 27/128 (21%), Positives = 47/128 (36%), Gaps = 10/128 (7%)
Query: 191 DLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHL 250
L++ + L + + +L++S N L + LEV AS+N
Sbjct: 4 HLAHKDLTVLCHLE-----QLLLVTHLDLSHNRLRA---LPPALAALRCLEVLQASDNA- 54
Query: 251 VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSAT 310
+ + + L+ L L +N+L S + L L L+L N L G
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-LVLLNLQGNSLCQEEGIQERLA 113
Query: 311 LKKVNLSS 318
++SS
Sbjct: 114 EMLPSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 26/114 (22%), Positives = 42/114 (36%), Gaps = 12/114 (10%)
Query: 164 KYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENS 223
+ L L ++ L QL V H+DLS+N+ +++++ L + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-------LPPALAALRCLEV-LQA 50
Query: 224 LVGELFPHDGMPYFDNLEVFDASNNHL--VGAIPSFNFVFSLRILRLGSNQLSG 275
L DG+ L+ NN L AI L +L L N L
Sbjct: 51 SDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 6e-06
Identities = 38/340 (11%), Positives = 90/340 (26%), Gaps = 26/340 (7%)
Query: 137 KNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGD----IMHLLSQLGSVVHVDL 192
K+L L I++ + + + +K + L N G + + ++ + +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 193 SNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVG 252
S+ D + +++ ++
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 253 AIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLK 312
+ + + Q A + L + T + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 313 KVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPN 372
++ +G P + H + L+ Q + ++ + +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAY---------CQELKVLDLQDNTFTHLGSSALAI 237
Query: 373 QTSQFLRLTSFKVSNNSLEGDLPAVLGTY------PELKVIDLSLNHLNGFLLPSFFTS- 425
+ L +++ L A + L+ + L N + + + T
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 426 ----TKLTDLNLSGNNFSG-PLPLQEIQNNPSTGSTQNLS 460
L L L+GN FS + EI+ ST L
Sbjct: 298 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 5e-05
Identities = 42/356 (11%), Positives = 85/356 (23%), Gaps = 42/356 (11%)
Query: 162 KLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDS-SFISSIQYLNIS 220
LK + + +L + SV + LS N L ++ + ++ S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 221 ENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVA 280
+ + L L S N
Sbjct: 68 DIFT--GRVKDEIPEALRLLLQALLKCPKLHTVRLSDN---------------------- 103
Query: 281 LLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNN 340
L + L L + A N
Sbjct: 104 ------AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA 157
Query: 341 RLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGT 400
+ +N + F + + + + + L L
Sbjct: 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 217
Query: 401 YPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLS 460
+ + + L + + L +L L+ S + +N+
Sbjct: 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL---ENIG 274
Query: 461 LTSLDLAYNSLSGRLLPGI-----SKFHNLVYLNLSNNKF--EGSIPDGLPNGLKE 509
L +L L YN + + + K +L++L L+ N+F E + D +
Sbjct: 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 31/231 (13%), Positives = 64/231 (27%), Gaps = 24/231 (10%)
Query: 262 SLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKL 321
+ + G + ++ ++ A L ++ L + G L + L N++
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDG----ITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75
Query: 322 SGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLT 381
+ +L+ + + + L
Sbjct: 76 -------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 382 SFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGP 441
S + + + LS+ + L +KLT L N S
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 442 LPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSN 492
PL + N L + L N +S + ++ NL + L+N
Sbjct: 189 SPLASLPN-----------LIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 32/222 (14%), Positives = 65/222 (29%), Gaps = 22/222 (9%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
L ++ + + +T + + L + G+ L NL+ L + N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207
T + L K+ L+L N Q + + + L
Sbjct: 74 QI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 208 SSFISSIQYLNI-----------SENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPS 256
+ + + ++ + L A +N + I
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP 190
Query: 257 FNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
+ +L + L +NQ+S P+A L + L+ NQ
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSN----LFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 14/93 (15%), Positives = 36/93 (38%), Gaps = 3/93 (3%)
Query: 53 CPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSI 112
N +T++ +G + L L + +N++ I+ + S+
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASL 194
Query: 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145
+L + L +N + P + + NL ++ ++
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 32/249 (12%), Positives = 71/249 (28%), Gaps = 26/249 (10%)
Query: 218 NISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSL 277
+I++ + + +FP P N A +++ + + + L ++
Sbjct: 2 SITQPTAINVIFPD---PALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVTTIE 57
Query: 278 PVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVGHCTIVDL 337
V L L L+L NQ+ L K+ +
Sbjct: 58 GVQYLNN----LIGLELKDNQITDL---APLKNLTKITELELSGNPLKNVSAIAGLQSIK 110
Query: 338 SNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAV 397
+ + S ++ + L + + N + +S + +
Sbjct: 111 TLDLTSTQITDVTPLAGLSNLQVLYLDL--NQITNISPLAGLTNLQYLSIGNAQVSDLTP 168
Query: 398 LGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQ 457
L +L + N ++ + + L +++L N S PL N
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSN-------- 218
Query: 458 NLSLTSLDL 466
L + L
Sbjct: 219 ---LFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 9/70 (12%), Positives = 25/70 (35%), Gaps = 13/70 (18%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
+ +N + + ++ +T+L ++ + G+ +NL
Sbjct: 19 ANAIKIAAGKSNVTDTVTQADLDG-----------ITTLSAFGTGVTT--IEGVQYLNNL 65
Query: 486 VYLNLSNNKF 495
+ L L +N+
Sbjct: 66 IGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 25/211 (11%), Positives = 62/211 (29%), Gaps = 10/211 (4%)
Query: 309 ATLKKVNLSSNKLSGSLP-ARVGHCTIVDLSNNRLS-----GDLSRMQNWGNYVEDIHLS 362
A K+ + ++ ++ A + T + ++ L+ + I
Sbjct: 19 ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDL 78
Query: 363 SNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSF 422
+ + + L+ L + V L+ L
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 423 FTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKF 482
T ++ L N + ++ + + L+ D N +S + ++
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD--DNKISD--ISPLASL 194
Query: 483 HNLVYLNLSNNKFEGSIPDGLPNGLKEFNVS 513
NL+ ++L NN+ P + L ++
Sbjct: 195 PNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 27/215 (12%), Positives = 64/215 (29%), Gaps = 28/215 (13%)
Query: 258 NFVFSLRILR------LGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATL 311
+FS L ++ ++ L + ++ + + ++ G +
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDIKSVQGIQYLPNV 70
Query: 312 KKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVP 371
K+ L+ NKL+ + + + + + +
Sbjct: 71 TKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 372 NQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDL 431
+ + +N + + + L L + D ++ + TKL +L
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNL 183
Query: 432 NLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDL 466
LS N+ S L ++N L L+L
Sbjct: 184 YLSKNHISDLRALAGLKN-----------LDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 28/211 (13%), Positives = 62/211 (29%), Gaps = 22/211 (10%)
Query: 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSN 147
++ + +T + S++ + +++ + GI L N+ L ++ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGN 78
Query: 148 SFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGD 207
+ L LK L + + + ++ +
Sbjct: 79 KL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 208 SSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILR 267
S N + V ++ ++ D I + L+ L
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD---------IVPLAGLTKLQNLY 184
Query: 268 LGSNQLSGSLPVALLQESSMMLSELDLSLNQ 298
L N +S +A L+ L L+L +Q
Sbjct: 185 LSKNHISDLRALAGLKN----LDVLELF-SQ 210
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 10/47 (21%), Positives = 16/47 (34%), Gaps = 3/47 (6%)
Query: 109 IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPS 155
LD+S H L G+ +LK L + + P+
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 9/49 (18%), Positives = 16/49 (32%), Gaps = 1/49 (2%)
Query: 122 HNLFHGLIPSGIVS-LKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLR 169
N +P+ + ++L+IS G L KL+
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 12/82 (14%)
Query: 419 LPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPG 478
+ + + +L+L G + I+N +T ++D + N + R L G
Sbjct: 11 AAQYTNAVRDRELDLRGYK------IPVIENLGATLD----QFDAIDFSDNEI--RKLDG 58
Query: 479 ISKFHNLVYLNLSNNKFEGSIP 500
L L ++NN+
Sbjct: 59 FPLLRRLKTLLVNNNRICRIGE 80
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 11/72 (15%), Positives = 24/72 (33%), Gaps = 13/72 (18%)
Query: 426 TKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNL 485
+ L N + + ++ +T+L + + G+ +NL
Sbjct: 18 AEKMKTVLGKTNVTDTVSQTDLDQ-----------VTTLQADRLGIKS--IDGVEYLNNL 64
Query: 486 VYLNLSNNKFEG 497
+N SNN+
Sbjct: 65 TQINFSNNQLTD 76
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.004
Identities = 31/139 (22%), Positives = 49/139 (35%), Gaps = 13/139 (9%)
Query: 315 NLSSNKLSGSLPARV-----GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM 369
L ++ L + G +DL R DL ++ S+ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVV----LNRRSSMAATL 57
Query: 370 VPNQTSQFLRLTSFKVSNNSLEG--DLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTK 427
L S +SNN L D+ +++ P LK+++LS N L K
Sbjct: 58 -RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 428 LTDLNLSGNNFSGPLPLQE 446
L +L L GN+ S Q
Sbjct: 117 LEELWLDGNSLSDTFRDQS 135
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1025 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.96 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.92 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.9 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.81 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.78 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.78 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.75 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.72 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.71 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.71 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.68 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.13 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.98 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.34 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.91 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.9 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.95 Aligned_cols=252 Identities=23% Similarity=0.428 Sum_probs=205.1
Q ss_pred CCEEEEECCEEEEEEEEC-CCC---EEEEEECCCC-CHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 763531033699999956-998---9999992544-01119999999999955999861232463535789804999961
Q 001700 737 AEVIGRSCHGTLYKATLD-SGS---ILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
.++||+|+||+||+|+++ +++ .||||++... .....++|.+|++++++++|||||+++|+|. .....++||||
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~iv~Ey 108 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVMIITEF 108 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCEEEEEC
T ss_pred EEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEEE
T ss_conf 5698027882999999957997889999999784459899999999999998579988861899996--28877999972
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|+|.+++..... .++|.+++.++.|||+||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 109 ~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 109 MENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC----------
T ss_pred CCCCCCEEEECCCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCEEEECC-CCCEEECCCCCCEECCCCC
T ss_conf 279853002104567----99999999999999998898852-79835761504489889-9919988844315756777
Q ss_pred CCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 755----10357445447533346888999970158999999999991-9989984335999752579999997521666
Q 001700 892 TAD----QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 892 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
... .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.... ..++..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~------------ 244 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVIN------------ 244 (299)
T ss_dssp -------------CGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHH------------
T ss_pred CCCEEEECCCCCCCCCCCCHHHHHCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCC----HHHHHH------------
T ss_conf 765365025666883003878883699--78612144535789999867999999999----999999------------
Q ss_pred CCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 3102342289999996589999999998813999-9999989999999630035
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.+..+.+++.+..++.++.+++.+||+.+ ++||||+||++.|+++...
T Consensus 245 -----~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 -----AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -----9973788999742269999999997587976892999999999998418
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.78 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=206.5
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCCC
Q ss_conf 76353103369999995699899999925440111999999999995599986123246353578980499996146542
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|. .....++|+||+++|+
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEEECCTTCB
T ss_pred EEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEC--CCCCEEEEEEECCCCC
T ss_conf 8898208882999999889999999998788-676899999999999668997565352431--5993379998369991
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 99998212999999999999999999999999998639997125889999776069997899622352102568875510
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~ 896 (1025)
|.+++..... .+++..++.++.|+|.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...........
T Consensus 87 L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC--------------
T ss_pred HHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHC-CCEEECCCCHHHEEECC-CCCEEECCCCHHEECCCCCCEEEC
T ss_conf 8997520134----78899999999999998776531-64310443153266668-877686553210023688733504
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCCC
Q ss_conf 35744544753334688899997015899999999999199899843359997525799999975216663102342289
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...||+.|+|||++.+.. ++.++|||||||++|||+|+..|+... ....+...... .+
T Consensus 161 ~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~------~~~~~~~~~i~--------------~~ 218 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYEN------RSNSEVVEDIS--------------TG 218 (263)
T ss_dssp ----CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCS------CCHHHHHHHHH--------------HT
T ss_pred CEECCCCCCCHHHHCCCC--CCCHHHHCCHHHHHHHHHHCCCCCCCC------CCHHHHHHHHH--------------HC
T ss_conf 300176667857860799--984033210599999998789888778------99999999998--------------06
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 999996589999999998813999-9999989999999630035
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 977 ~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.+...+..++.++.+++.+||+.+ ++||||+||++.|++|.++
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88899543679999999997657976891999999999999857
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.17 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=205.8
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCCC
Q ss_conf 76353103369999995699899999925440111999999999995599986123246353578980499996146542
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++|||||+++|++. ....++||||+++|+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEEEECCTTCB
T ss_pred EEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEC---CCCEEEEEEECCCCC
T ss_conf 67981079828999999999999999986476-88899999999998679998857873104---597699999578982
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 99998212999999999999999999999999998639997125889999776069997899622352102568875510
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~ 896 (1025)
|.+++...... .+++..++.|+.|||+||+|||+ .+|+||||||+|||++. ++.+||+|||+|+...........
T Consensus 94 L~~~~~~~~~~---~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 94 LVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp HHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHEEEEC-CCCEEECCCCCEEECCCCCCCCCC
T ss_conf 88887514789---88788999999999999999974-89546756422515620-244042341014773588644203
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCCC
Q ss_conf 35744544753334688899997015899999999999199899843359997525799999975216663102342289
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...|++.|+|||++.+.. ++.++|||||||++|||+||..|+.... ...+... .+..+
T Consensus 169 ~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~~~~~~--------------~i~~~ 226 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQ--------------NLERG 226 (272)
T ss_dssp TCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHH--------------HHHTT
T ss_pred CCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCC------CHHHHHH--------------HHHHC
T ss_conf 567744445828983799--9824564525799999996898888888------9999999--------------99706
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 999996589999999998813999-9999989999999630035
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 977 ~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.++..+...+.++.+++.+||+.+ ++||||+||++.|+.+...
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88889655719999999997588976893999999986113213
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.38 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=202.4
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCC--CHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 7635310336999999569989999992544--01119999999999955999861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREG--IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||+++|++. ....++|+||+++
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIVTQWCEG 87 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEEECCCE
T ss_pred EEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCEEEEEEECCCC
T ss_conf 889830788589999999--98999999734699899999999999998479987864567971---5589999965899
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC-C
Q ss_conf 429999821299999999999999999999999999863999712588999977606999789962235210256887-5
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-A 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~-~ 893 (1025)
|+|.+++..... .+++..++.|+.|||+||+|||+ .+|+||||||+|||++. ++.+||+|||+|+....... .
T Consensus 88 g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 88 SSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSCC--------
T ss_pred CCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHC-CCEECCCCCHHHEEECC-CCCEEECCCCCEEECCCCCCCC
T ss_conf 888999852357----89999999999999999888750-99951614789979818-9978875002213335567763
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 5103574454475333468889-999701589999999999919989984335999752579999997521666310234
Q 001700 894 DQVLNAGALGYRPPEFASTSKP-CPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~-~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
......||+.|+|||++.+... .++.++|||||||++|||+||+.||.... . ...+......+... +.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~------~-~~~~~~~~~~~~~~----p~ 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------N-RDQIIFMVGRGYLS----PD 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------C-HHHHHHHHHHTSCC----CC
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC------H-HHHHHHHHHCCCCC----CC
T ss_conf 1256655743179999950568999953151635999999997889989989------6-99999999658889----86
Q ss_pred HCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 2289999996589999999998813999-9999989999999630035
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
. ...+..++.++.+++.+||+.+ ++||||+||++.|+.+...
T Consensus 231 ~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 L-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-----HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 0-----003655549999999997588976892999999999999970
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=370.28 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=208.8
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|. .....++||||+++|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYG 98 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEEECCTTC
T ss_pred EEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEE--ECCEEEEEEECCCCC
T ss_conf 659820888089999999999699999977761-03999999999998679998826775274--578547876314676
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606999789962235210256887551
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~ 895 (1025)
+|.+++...... .+++..++.++.|+|.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..........
T Consensus 99 ~l~~~l~~~~~~---~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 99 NLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp BHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCCSSSSEEE
T ss_pred CHHHHHHHCCCC---CHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCEEEECC-CCCEEECCCCCEEECCCCCCEEE
T ss_conf 067775303554---15799999999999997888987-89305760457689989-99289832445465378872210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCC
Q ss_conf 03574454475333468889999701589999999999919989984335999752579999997521666310234228
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
....|++.|+|||++.+.. ++.++|||||||++|||++|..|+... .+..+.. ..+..
T Consensus 174 ~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~------~~~~~~~--------------~~i~~ 231 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVY--------------ELLEK 231 (287)
T ss_dssp TTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTT------CCHHHHH--------------HHHHT
T ss_pred CCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHH--------------HHHHC
T ss_conf 3556654666927872799--981043021789999998679988774------2599999--------------99855
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 9999996589999999998813999-9999989999999630035
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 976 ~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
+.+++.+...+.++.+++.+||+.+ ++||||+||++.|+.+...
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 888888743309999999997577976893999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.33 Aligned_cols=250 Identities=20% Similarity=0.366 Sum_probs=203.1
Q ss_pred C-EEEEECCEEEEEEEEC---CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECC
Q ss_conf 6-3531033699999956---99899999925440-11199999999999559998612324635357898049999614
Q 001700 738 E-VIGRSCHGTLYKATLD---SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~-~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~ 812 (1025)
+ .||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|+|.. ...++||||+
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~lvmE~~ 90 (285)
T d1u59a_ 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMA 90 (285)
T ss_dssp EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CEEEEEEEEC
T ss_conf 8487306080999999960897689999998820397899999999999986799888068656036---8079999807
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
++|+|.+++..... .+++..++.++.|+|.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 91 ~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 91 GGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp TTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTTCEECTTCSC
T ss_pred CCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEECC-CCCEEECCCHHHHCCCCCCC
T ss_conf 89968997521256----99999999999999998789986-88105767646604546-88542033134211554343
Q ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 5--510357445447533346888999970158999999999991-9989984335999752579999997521666310
Q 001700 893 A--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
. ......||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.... ..++..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~----~~~~~~--------------- 223 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMA--------------- 223 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THHHHH---------------
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCC--CCCCCHHHCCHHHHHHHHHCCCCCCCCCC----HHHHHH---------------
T ss_conf 211356211374335868872799--99541232201789999938999999979----999999---------------
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 2342289999996589999999998813999-9999989999999630035
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.+..+.+++.+..++.++.+++.+||+.+ ++||||.+|++.|+.+..+
T Consensus 224 --~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 224 --FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --9981899999976789999999997577976890999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.86 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=207.5
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCCC
Q ss_conf 76353103369999995699899999925440111999999999995599986123246353578980499996146542
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||+||+|+++++..||||+++... ..+++|.+|+.++++++|||||+++|+|. +....++|+||+++|+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEECCTTEE
T ss_pred EEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCCEEEEEECCCCCC
T ss_conf 68982078839999998899899999987475-77899999999999668986015889985--0781699997048993
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 99998212999999999999999999999999998639997125889999776069997899622352102568875510
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~ 896 (1025)
+.+++..... .+++..+++++.|+|+||+|||+ .+|+||||||+|||++. ++.+||+|||+++...........
T Consensus 86 l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCEEEEECC-CCCEEECCCHHHEECCCCCCEEEC
T ss_conf 8886410246----77689999999999999998754-68434665413588769-984798861442023578722524
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCC
Q ss_conf 357445447533346888999970158999999999991-9989984335999752579999997521666310234228
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...||+.|+|||++.+.. ++.++||||||+++|||+| |+.||.... ..+... .+..
T Consensus 160 ~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-------~~~~~~--------------~i~~ 216 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAE--------------HIAQ 216 (258)
T ss_dssp CSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHHHH--------------HHHT
T ss_pred CCCCCCCCCCCHHHCCCC--CCCCEEECCCCHHHHHHHHCCCCCCCCCC-------HHHHHH--------------HHHH
T ss_conf 657887757807863799--88521033643246739755999988999-------999999--------------9980
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHC
Q ss_conf 9999996589999999998813999-9999989999999630
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 976 ~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i 1016 (1025)
+.+.+.+...+.++.+++.+||..+ ++|||++|+++.|..|
T Consensus 217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 797899654659999999997668976893999999874188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.98 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=204.3
Q ss_pred CCEEEEECCEEEEEEEECC-C----CEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEE
Q ss_conf 7635310336999999569-9----899999925440-111999999999995599986123246353578980499996
Q 001700 737 AEVIGRSCHGTLYKATLDS-G----SILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISN 810 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~-g----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e 810 (1025)
.++||+|+||.||+|.++. + ..||||+++... .....+|.+|++++++++|||||+++|+|. .....++|+|
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~~~v~e 89 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPMMIITE 89 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred EEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCCCEEEEEE
T ss_conf 15981177909999999689987879999999884459689999999999998568987832367783--3880389997
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 14654299998212999999999999999999999999998639997125889999776069997899622352102568
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~ 890 (1025)
|+.+|++.+++..... .++|.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 90 ~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 90 YMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC-------
T ss_pred ECCCCCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCEEEECC-CCEEEECCCCHHHCCCCC
T ss_conf 2135740222102345----42089999999999985412121-23425765644278889-984998455103003578
Q ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 875--510357445447533346888999970158999999999991998998433599975257999999752166631
Q 001700 891 GTA--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+.... ...+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~~~~~----------- 224 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMK----------- 224 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHH-----------
T ss_pred CCCCEEECCCCCCCCCCCHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCC------CHHHHHH-----------
T ss_conf 76526742677773434888870499--9973556344898999996798865568------9999999-----------
Q ss_pred CHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCC
Q ss_conf 02342289999996589999999998813999-99999899999996300352
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~ 1020 (1025)
.+..+.+++.+..++.++.+++.+||+.+ ++||||.||++.|+.+.+.-
T Consensus 225 ---~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 225 ---AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---HHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ---98635789985045799999999977679768939999999999986695
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.43 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=201.4
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++. .....++||||+++|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGG 102 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEECCTTC
T ss_pred EEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEEECCCC
T ss_conf 789812858299999998999899999984301727999999999998679998805857798--899989999703798
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606999789962235210256887551
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~ 895 (1025)
+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 103 ~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 103 SLTDVVTET------CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp BHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSTTC-CB
T ss_pred CHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHEEECC-CCCEEECCCHHHEEECCCCC-CC
T ss_conf 089886415------99999999999999999999998-79722677688868878-99686425156413213666-44
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCC
Q ss_conf 03574454475333468889999701589999999999919989984335999752579999997521666310234228
Q 001700 896 VLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...+||+.|+|||++.+.. ++.++||||+||++|||+||+.||.... ..+........ .
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~~~~~------------~ 232 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATN------------G 232 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHH------------C
T ss_pred CCCCCCCCCCCHHHHCCCC--CCCHHCEEHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHHC------------C
T ss_conf 4444477736826644799--8801203137299999804889989979-------99999999857------------9
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 9999996589999999998813999-99999899999
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 976 ~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
.+..+.+...+.++.+++.+||..+ ++|||+.|+++
T Consensus 233 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9988885537999999999986699668909999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.90 Aligned_cols=254 Identities=21% Similarity=0.358 Sum_probs=208.0
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCCC
Q ss_conf 76353103369999995699899999925440111999999999995599986123246353578980499996146542
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|+++++..||||+++.. ....+.|.+|+.++++++|||||+++|+|. ....++||||+++|+
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~---~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEEECCCTTCB
T ss_pred EEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCCEEEEEEECCCCC
T ss_conf 4699307980999999999999999998804-488899999999998666678868999982---397599999447994
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 99998212999999999999999999999999998639997125889999776069997899622352102568875510
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~ 896 (1025)
|..++...... .++|.+++.|+.|||.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...........
T Consensus 98 l~~~~~~~~~~---~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 98 LLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp HHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC-----------
T ss_pred HHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHH-HHEECCCCCCEEEEECC-CCCEEECCCCHHHHCCCCCCEEEC
T ss_conf 35420000355---30599999999999999998754-11433531230799989-992998442555425688733524
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCCC
Q ss_conf 35744544753334688899997015899999999999199899843359997525799999975216663102342289
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMDG 976 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 976 (1025)
...|++.|+|||++..+. ++.++||||||+++|||+||..|+.... ...+.... +...
T Consensus 173 ~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~------~~~~~~~~--------------i~~~ 230 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQ--------------VERG 230 (285)
T ss_dssp ---CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHH--------------HHTT
T ss_pred CCCCCCCCCCHHHHHCCC--CCCHHHHHCCHHHHHHHHHCCCCCCCCC------CHHHHHHH--------------HHHC
T ss_conf 545566545808983799--8917741323589999986899999888------89999999--------------9826
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCCC
Q ss_conf 999996589999999998813999-999998999999963003525
Q 001700 977 HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 977 ~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~~ 1021 (1025)
.+.+.+..++.++.+++.+||+.+ ++||+|++|++.|+......+
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 8999983237999999999756697589199999998766623899
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.92 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=201.3
Q ss_pred CEEEEECCEEEEEEEEC---CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECC
Q ss_conf 63531033699999956---99899999925440--11199999999999559998612324635357898049999614
Q 001700 738 EVIGRSCHGTLYKATLD---SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 738 ~~iG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~ 812 (1025)
+.||+|+||+||+|.++ .++.||||+++... ....++|.+|++++++++|||||+++|+|.. ...++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---CCEEEEEECC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505---9779999747
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..++.++.|||.||+|||+ .+|+||||||+|||++. ++.+|++|||+++.......
T Consensus 90 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTTCS
T ss_pred CCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCHHHCCCC-CCCCCCCCHHHHHHCCCCCC
T ss_conf 8896899975225-----78999999999999999766874-79556777611310235-67512341345331343234
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 55--10357445447533346888999970158999999999991-9989984335999752579999997521666310
Q 001700 893 AD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 893 ~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.. .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.... ..++..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~~~~--------------- 221 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVTA--------------- 221 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHH---------------
T ss_pred CCCCCCCCCCCCEECCCHHHCCCC--CCCHHHHCCCHHHHHHHHHCCCCCCCCCC----HHHHHH---------------
T ss_conf 432244567784203916653799--98434430340313289658999999989----999999---------------
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCC
Q ss_conf 2342289999996589999999998813999-99999899999996300
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIV 1017 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~ 1017 (1025)
.+..+.+++.+..++.++.+++.+||+.+ ++||||+||++.|+...
T Consensus 222 --~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 222 --MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf --99828999998656799999999975889768909899999852887
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.41 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=202.3
Q ss_pred CCEEEEECCEEEEEEEEC-CC-----CEEEEEECCCCC-HHCHHHHHHHHHHHHCC-CCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 763531033699999956-99-----899999925440-11199999999999559-99861232463535789804999
Q 001700 737 AEVIGRSCHGTLYKATLD-SG-----SILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~lv 808 (1025)
.+.||+|+||+||+|++. .+ ..||+|.+.... ......+.+|+.++.++ +|||||+++|+|. .....++|
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv 119 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--LSGPIYLI 119 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred EEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEE
T ss_conf 0198307881999999857885542049999996633587899999999999997158996868778886--29958999
Q ss_pred EECCCCCCHHHHHHHCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEE
Q ss_conf 9614654299998212999------------------9999999999999999999999986399971258899997760
Q 001700 809 SNYINAQSLAVYLQETDPR------------------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~ 870 (1025)
|||+++|+|.+++...... ....+++..++.|+.||+.||+|||+ .+|+||||||+|||++
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVT 198 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGEEEE
T ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCHHCCCCC
T ss_conf 972799959999986257775102210000122200125778999999999999999999973-9905052703214434
Q ss_pred CCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCC
Q ss_conf 69997899622352102568875-510357445447533346888999970158999999999991-9989984335999
Q 001700 871 APTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPG 948 (1025)
Q Consensus 871 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~ 948 (1025)
. ++.+||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||+| |+.||......
T Consensus 199 ~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~-- 273 (325)
T d1rjba_ 199 H-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-- 273 (325)
T ss_dssp T-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred C-CCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC--CCCCEECCCHHHHHHHHHHCCCCCCCCCCHH--
T ss_conf 5-9828985142222045778615623435787657838872799--9963303000399999983899999998989--
Q ss_pred CCCHHHHHHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHH
Q ss_conf 7525799999975216663102342289999996589999999998813999-999998999999963
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELST 1015 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~ 1015 (1025)
.. +...+....+++.+..++.++.+++.+||+.+ ++||||+||++.|..
T Consensus 274 -~~-----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 -AN-----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -HH-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HH-----------------HHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf -99-----------------999985699899887678999999999758896689399999999748
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.23 Aligned_cols=266 Identities=19% Similarity=0.313 Sum_probs=201.4
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 763531033699999956-99899999925440-1119999999999955999861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|. +....++||||+++
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iVmEy~~g 88 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG 88 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEEEECCTT
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCC
T ss_conf 7897127780999999989996999999875409789999999999998679999994999999--89999999976799
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 42999982129999999999999999999999999986399971258899997760699978996223521025688755
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~ 894 (1025)
|+|.+++.... .+++..+..++.|++.||.|||+.++|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 89 g~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~~~~~~~-- 160 (322)
T d1s9ja_ 89 GSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMA-- 160 (322)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHHHHHHTC--
T ss_pred CCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECC-CCCEEEEECCCCCCCCCCCC--
T ss_conf 86899874249-----99999999999999999999998599971445779946878-99899954877625678862--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHH----------------HH---
Q ss_conf 10357445447533346888999970158999999999991998998433599975257----------------99---
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLT----------------DW--- 955 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~----------------~~--- 955 (1025)
...+||+.|+|||++.+.. ++.++||||+||++|||++|+.||....... .... .+
T Consensus 161 -~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 161 -NSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ----CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH--HHHHC--------------------
T ss_pred -CCCCCCCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf -1113771411946875899--8948889989999999998889989988789--9999988751775457742123332
Q ss_pred -HHHHHHHCCC----CCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf -9999752166----63102342289999996589999999998813999-999998999999--96300
Q 001700 956 -VRLLALENRS----GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 956 -~~~~~~~~~~----~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
.......... .+..+......+........+.++.+++.+|+..+ .+|||++|+++. +++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 2111122235413477887665026876676444899999999998689946790899996098647698
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.11 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=205.6
Q ss_pred CCEEEEECCEEEEEEEECC----CCEEEEEECCCC-CHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 7635310336999999569----989999992544-01119999999999955999861232463535789804999961
Q 001700 737 AEVIGRSCHGTLYKATLDS----GSILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
.++||+|+||+||+|++.. ...||||+++.. .....++|.+|++++++++|||||+++|+|.. .....++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE-TTTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCCEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980-69943899987
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|+|.+++..... .+++..++.++.|+|+||.|+|+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHCC-CCCCCCCCCHHHEEECC-CCCEEEECCCCHHHCCCCC
T ss_conf 406741442101345----40489999999998876520033-67625776687576779-9988991065232255665
Q ss_pred CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 75---510357445447533346888999970158999999999991998998433599975257999999752166631
Q 001700 892 TA---DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 892 ~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. ......||+.|+|||++.... ++.++||||||+++|||+||..||...... .++..+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~------------- 246 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVY------------- 246 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH-------------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH-------------
T ss_conf 55310025655564556768874379--997457466199999999789999888999---999999-------------
Q ss_pred CHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCCC
Q ss_conf 02342289999996589999999998813999-999998999999963003525
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~~ 1021 (1025)
+..+.++..+..++.++.+++.+||+.+ ++||+|.||++.|+++..+..
T Consensus 247 ----i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 247 ----LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf ----98089889964475999999999768897689399999999999997520
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.86 Aligned_cols=247 Identities=17% Similarity=0.223 Sum_probs=198.7
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 763531033699999956-99899999925440-1119999999999955999861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. +....++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~--~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEEEECCTT
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCEEEEEEECCCC
T ss_conf 9897217480999999999997999999845664127999999999998579988846965404--67436798864589
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC-C
Q ss_conf 429999821299999999999999999999999999863999712588999977606999789962235210256887-5
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT-A 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~-~ 893 (1025)
|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+....... .
T Consensus 88 g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 88 GELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEECEETTEEC
T ss_pred CCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHEEECC-CCCEEECCCHHHEEECCCCCCC
T ss_conf 80899975379-----99999999999999999999997-59835754689978878-9987983231422404688653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 51035744544753334688899997015899999999999199899843359997525799999975216663102342
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....+||+.|+|||++.+..+ ++.++||||+||++|||+||+.||...... ...+. ...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~-~~~------------- 220 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYS-DWK------------- 220 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-----SHHHH-HHH-------------
T ss_pred CCCCEEECCCCCCHHHHCCCCC-CCCCEEEEHHHHHHHHHHHCCCCCCCCCHH-----HHHHH-HHH-------------
T ss_conf 1113255747428728618999-997101617379999998299788889859-----99999-986-------------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 289999996589999999998813999-999998999999
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
............+.++.+++.+|+..+ ++|||++|+++.
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3888788644699999999999767996689099999619
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.78 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=198.9
Q ss_pred CCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 7763531033699999956-99899999925440---1119999999999955999861232463535789804999961
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++. +....++||||
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ivmEy 87 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYLILEY 87 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEEEC
T ss_pred EEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEEE
T ss_conf 9889851778589999998999499999981688567689999999999998568888885999999--89998999850
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 88 ~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 88 APLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSCSCCCCCC
T ss_pred CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEEEEECCCCCEECC-CCCEEECCCCEEEECCCCC
T ss_conf 47985898875048-----99999999999999999999998-89465220234414668-9987115556335448885
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHH
Q ss_conf 75510357445447533346888999970158999999999991998998433599975257999999752166631023
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ...+... .
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~-------------~ 215 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYK-------------R 215 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHH-------------H
T ss_pred ---CCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHH-------------H
T ss_conf ---23557887634999975899--893144046759999983299998889-------9999999-------------9
Q ss_pred HHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 42289999996589999999998813999-99999899999
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
...... ..+...+.++.+++.+|+..+ ++|||++|+++
T Consensus 216 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 ISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 971899--998668999999999976479768909999971
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.62 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=198.7
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCC
Q ss_conf 763531033699999956-99899999925440--111999999999995599986123246353578980499996146
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++|||||++++++.+......++||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEECCC
T ss_conf 67983088919999999999979999998746579799999999999999778999824899999178998999995689
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC----CCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 54299998212999999999999999999999999998639----99712588999977606999789962235210256
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE----RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
+|+|.+++......+ ..+++..++.++.|++.||+|||+. .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 89 ~g~L~~~i~~~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 89 GGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNH 166 (269)
T ss_dssp TEEHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT-TSCEEECCHHHHHHC--
T ss_pred CCCHHHHHHHCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCC-CCCEEEEECCCEEECCC
T ss_conf 993899998515457-8999999999999999999999971677887885867654257478-88579800100032245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997521666310
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||... ...+..... ..+
T Consensus 167 ~~~-~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~-------~~~~~~~~i-~~~------ 229 (269)
T d2java1 167 DTS-FAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAGKI-REG------ 229 (269)
T ss_dssp ----------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHH-HHT------
T ss_pred CCC-CCCCCCCCCCCCCHHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCC-------CHHHHHHHH-HCC------
T ss_conf 777-556677882327999983999--993898875278999980188998998-------999999999-718------
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 2342289999996589999999998813999-99999899999
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
...+.+...+.++.+++.+||..+ .+|||+.|+++
T Consensus 230 -------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 -------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -------998897435999999999976799557918999972
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=353.65 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=200.8
Q ss_pred CCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 7763531033699999956-998999999254401119999999999955999861232463535789804999961465
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++. +....++||||+++
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~~~g 107 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--ETTEEEEEECCCCS
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCC
T ss_conf 9889840768199999988999899999984524316999999999998679979992999999--89999999985799
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEEECCCCCCCCCCCCCC
Q ss_conf 429999821299999999999999999999999999863999712588999977606-9997899622352102568875
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA-PTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~ 893 (1025)
|+|.+++..... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++. .++.+||+|||+++.......
T Consensus 108 g~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 108 GELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHH-CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC-
T ss_conf 889999976237----89999999999999999999975-697600015467364168898699954521044256543-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 51035744544753334688899997015899999999999199899843359997525799999975216663102342
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
.....||+.|+|||++.+.. ++.++||||+||++|||++|+.||... ...+...........
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~-------- 243 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGE-------NDDETLRNVKSCDWN-------- 243 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCC--------
T ss_pred -CCEECCCCCCCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCC--------
T ss_conf -20006862421889975899--872676554659999998598998997-------999999999847889--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 289999996589999999998813999-999998999999
Q 001700 974 MDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 974 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.........+.++.+++.+|+..+ ++|||+.|+++.
T Consensus 244 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ---MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---8942235899999999999756896679089998629
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.37 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=203.2
Q ss_pred CCCEEEEECCEEEEEEEEC-CCC----EEEEEECCCC-CHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 7763531033699999956-998----9999992544-011199999999999559998612324635357898049999
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGS----ILAVKRLREG-IAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~ 809 (1025)
..++||+|+||+||+|++. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.. . ..++++
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~-~~~~v~ 89 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S-TVQLIT 89 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S-SEEEEE
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--C-CEEEEE
T ss_conf 8319820899299999995899889899999996513497999999999999986799888158999961--9-836999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||+.+|+|.+++..... .+++..++.++.|||.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 90 e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSHHHHTTT
T ss_pred EECCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCHHHCCEECC-CCCEEEECCCCCEECCC
T ss_conf 84268740101113345----79999999999999999999987-69504762120311679-98758602552223354
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 88755-10357445447533346888999970158999999999991-99899843359997525799999975216663
Q 001700 890 AGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 890 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
..... .....||+.|+|||++.++. ++.++|||||||++|||+| |+.||+.... ..+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~~~~------------- 224 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISS------------- 224 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GGHHH-------------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHH-------------
T ss_conf 44532236510586446708874699--983565440799999999779999999998----99999-------------
Q ss_pred CCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 102342289999996589999999998813999-999998999999963003
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~ 1018 (1025)
.+..+.+++.+..++.++.+++.+||..+ .+|||+.||++.|+.+..
T Consensus 225 ----~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 225 ----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----997599899985568999999998478993469199999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.00 Aligned_cols=247 Identities=20% Similarity=0.318 Sum_probs=199.1
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|+.. ++..||+|+++.......+.+.+|++++++++|||||++++++. .....++||||+++|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEECCTTE
T ss_pred EEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEECCCCC
T ss_conf 479930778199999999999399999987289999999999999998679999884988980--099589999627998
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606999789962235210256887551
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQ 895 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~ 895 (1025)
+|.+++..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+|+....... ..
T Consensus 95 ~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 95 AVDAVMLELER----PLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp EHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECHHHHH-HH
T ss_pred CHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEEEEECCHHHEEECC-CCCEEEEECHHHHCCCCCCC-CC
T ss_conf 18899986289----99999999999999999999998-89887140700314878-99989971612303577864-10
Q ss_pred CCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 035744544753334688---89999701589999999999919989984335999752579999997521666310234
Q 001700 896 VLNAGALGYRPPEFASTS---KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 896 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....||+.|+|||++... ...++.++|||||||++|||+||+.||..... .+. +...
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~~----------------~~~i 227 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRV----------------LLKI 227 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGH----------------HHHH
T ss_pred CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH----HHH----------------HHHH
T ss_conf 01025626479999832025788888066578789999998208899999899----999----------------9999
Q ss_pred HCCC-CCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 2289-999996589999999998813999-999998999999
Q 001700 973 IMDG-HDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.... .....+...+.++.+++.+||..+ ++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 707998777656699999999999766996689199999629
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.39 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=193.1
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECC--CCCEEEEEEEC
Q ss_conf 763531033699999956-99899999925440--11199999999999559998612324635357--89804999961
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP--KEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~--~~~~~~lv~e~ 811 (1025)
.+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|++++++++|||||+++|++... .....++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred EEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEEEC
T ss_conf 16970082849999999999959999998512279899999999999998579998506999984033458889999957
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 465429999821299999999999999999999999999863999--712588999977606999789962235210256
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERA--IPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~--ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
+++|+|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+|||++..++.+||+|||+++....
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 89894899975135-----54699999999999999999997-8997996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997521666310
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
.. ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.... .......... .+
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~~---~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~-~~------ 228 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVT-SG------ 228 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHT-TT------
T ss_pred CC---CCCCCCCCCCCCHHHHCCC---CCCCCCHHHHHHHHHHHHHCCCCCCCCC------CHHHHHHHHH-CC------
T ss_conf 76---6775538130089884789---9986711007999999987889998765------5999999997-38------
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 2342289999996589999999998813999-99999899999
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
......+...+.++.+++.+||..+ ++|||+.|+++
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 ------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------9986567557899999999976379758929999967
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.03 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=194.0
Q ss_pred CCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 7763531033699999956-99899999925440---1119999999999955999861232463535789804999961
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||+++|++. .....++||||
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~iv~E~ 96 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEY 96 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEEEEC
T ss_pred EEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEEE
T ss_conf 6279701888099999998999399999984444358899999999999999778999823899999--89988999980
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|++..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 97 ~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 97 CLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp CSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBSSSSBC
T ss_pred CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCCCEEEECC-CCCEEEEECCCCCCCCCCC
T ss_conf 69994578997379-----99999999999999999999986-89766678842179879-9978984436533467787
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCH
Q ss_conf 75510357445447533346888-99997015899999999999199899843359997525799999975216663102
Q 001700 892 TADQVLNAGALGYRPPEFASTSK-PCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
...||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.... . .+....
T Consensus 170 -----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~-~~~~~~------------ 225 (309)
T d1u5ra_ 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------A-MSALYH------------ 225 (309)
T ss_dssp -----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------H-HHHHHH------------
T ss_pred -----CCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC------H-HHHHHH------------
T ss_conf -----3134766368899834678886721454558999999987889999979------9-999999------------
Q ss_pred HHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 342289999996589999999998813999-99999899999
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
..........+...+.++.+++.+||..+ .+|||+.|+++
T Consensus 226 -i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 -IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -98289998887888999999999977379657918999971
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.15 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=206.0
Q ss_pred CCEEEEECCEEEEEEEECC----CCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 7635310336999999569----9899999925440-1119999999999955999861232463535789804999961
Q 001700 737 AEVIGRSCHGTLYKATLDS----GSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|++++++++|||||+++|++. ....++|+||
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~~iv~E~ 88 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMEL 88 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSCEEEEEC
T ss_pred EEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCEEEEEEEE
T ss_conf 7799307882999999936996449999999365668799999999999998689999856988995---3747999984
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|++.+++..... .+++..++.++.||++||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 89 ~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 89 CTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp CTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-----------
T ss_pred CCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHCC-CCEECCCCCHHHEEECC-CCCEEECCCHHHEECCCCC
T ss_conf 069807765422478----99999999999999877523022-67441410265532067-8967876503421336776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCH
Q ss_conf 75510357445447533346888999970158999999999991-99899843359997525799999975216663102
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
........||+.|+|||++.+.. ++.++|||||||++|||+| |+.||..... .++...
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~~~--------------- 221 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGR--------------- 221 (273)
T ss_dssp --------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHH---------------
T ss_pred CEECCCEECCCCCCHHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCH----HHHHHH---------------
T ss_conf 23305400583103266751699--887452444247899998269999888999----999999---------------
Q ss_pred HHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCCC
Q ss_conf 342289999996589999999998813999-999998999999963003525
Q 001700 971 RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEKD 1021 (1025)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~~ 1021 (1025)
+..+.+++.+..++.++.+++.+||..+ ++|||+.||++.|++|..+..
T Consensus 222 --i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 222 --IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf --98189998987779999999999768797689299999999999977861
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=350.48 Aligned_cols=245 Identities=16% Similarity=0.250 Sum_probs=200.2
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++. .....++||||+++|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEEECCCCC
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCCC
T ss_conf 899931778299999998999799999988726467999999999998679979891999999--899999999828998
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606-99978996223521025688755
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA-PTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~ 894 (1025)
+|.+++..... .+++.++..|+.||+.||+|||+ .+|+||||||+|||++. .++.+||+|||+|+........
T Consensus 112 ~L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~- 185 (352)
T d1koba_ 112 ELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV- 185 (352)
T ss_dssp BHHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE-
T ss_pred HHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCCE-
T ss_conf 08888986389----98999999999999999999997-7926513144553113467884899525630343788720-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHC
Q ss_conf 10357445447533346888999970158999999999991998998433599975257999999752166631023422
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
....||+.|+|||++.+.. ++.++||||+||++|||+||+.||.... ..+... ....
T Consensus 186 -~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~-------------~i~~ 242 (352)
T d1koba_ 186 -KVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQ-------------NVKR 242 (352)
T ss_dssp -EEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHH-------------HHHH
T ss_pred -EECCCCCCCCCHHHHCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCC-------HHHHHH-------------HHHH
T ss_conf -1004764534899974799--8976333898999999996889989979-------999999-------------9984
Q ss_pred CCCC--CCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 8999--9996589999999998813999-999998999999
Q 001700 975 DGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~--~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.... .......+.++.+++.+|+..+ .+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 78898930024799999999999756996689189999609
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=351.51 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=204.2
Q ss_pred CCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 763531033699999956------99899999925440-11199999999999559998612324635357898049999
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++||||++++|+|. .....++++
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~~v~ 95 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--VGKPMCLLF 95 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSCEEEE
T ss_pred EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC--CCCCEEEEE
T ss_conf 679820788399999988876577882999999882108579999999999999668997655246660--598038999
Q ss_pred ECCCCCCHHHHHHHCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEE
Q ss_conf 61465429999821299-------------------99999999999999999999999986399971258899997760
Q 001700 810 NYINAQSLAVYLQETDP-------------------RKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLE 870 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~ 870 (1025)
||+++|+|.+++..... .....+++..++.|+.|+|.||+|||+ .+|+||||||+|||+|
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDlKp~NILld 174 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVG 174 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred EECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC-CCEEEEEECCCCEEEC
T ss_conf 815899299999852755421000011100121034678898999999999999998554135-7868548840116898
Q ss_pred CCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC-CCCCCCCCCC
Q ss_conf 69997899622352102568875-510357445447533346888999970158999999999991998-9984335999
Q 001700 871 APTMNAVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS-SGEIVCVDPG 948 (1025)
Q Consensus 871 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~-P~~~~~~~~~ 948 (1025)
. ++.+||+|||+++........ ......|++.|+|||++.+.. ++.++|||||||++|||++|.. ||...
T Consensus 175 ~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~~~~p~~~~----- 246 (301)
T d1lufa_ 175 E-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGM----- 246 (301)
T ss_dssp G-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTS-----
T ss_pred C-CCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHCCCHHHHHHHHCCCCCCCCCC-----
T ss_conf 9-9928983314421136776411157777676767989972688--9805630252362999980689999998-----
Q ss_pred CCCHHHHHHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 7525799999975216663102342289999996589999999998813999-999998999999963003
Q 001700 949 VVDLTDWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 949 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~ 1018 (1025)
...+.... +..+..++.+...+.++.+++.+||+.+ ++||||.||+++|++|.+
T Consensus 247 --~~~e~~~~--------------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 --AHEEVIYY--------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --CHHHHHHH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --CHHHHHHH--------------HHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf --99999999--------------97399788873252999999999748896579399999999998429
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=350.12 Aligned_cols=244 Identities=18% Similarity=0.254 Sum_probs=198.1
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 763531033699999956-99899999925440-1119999999999955999861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. +....++||||+++
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lvmE~~~g 91 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLIMQLVSG 91 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEECCCCS
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCC
T ss_conf 8899406583999999999998999999815773128999999999998679989991989999--89988898852689
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEEECCCCCCCCCCCCC
Q ss_conf 429999821299999999999999999999999999863999712588999977606--999789962235210256887
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~--~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+.. .++.+||+|||+++.......
T Consensus 92 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 92 GELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCCE
T ss_conf 84888653036-----78878999999999999875241-3055687046300110468882499831543587258970
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 55103574454475333468889999701589999999999919989984335999752579999997521666310234
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
. ...+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... ..+... ..
T Consensus 166 ~--~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~-------------~i 221 (307)
T d1a06a_ 166 L--STACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFE-------------QI 221 (307)
T ss_dssp ---------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHH-------------HH
T ss_pred E--EEEEECCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHH-------------HH
T ss_conf 4--4003284225918873799--9807873451599999985979999989-------999999-------------98
Q ss_pred HCCCCC--CCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 228999--9996589999999998813999-999998999999
Q 001700 973 IMDGHD--MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 973 ~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
...... .+.....+.++.+++.+|+..+ ++|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6168777876666789999999999760897579189998629
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.64 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=203.1
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCCC
Q ss_conf 76353103369999995699899999925440111999999999995599986123246353578980499996146542
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQS 816 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs 816 (1025)
.+.||+|+||.||+|+++ |..||||+++.. ...+++.+|++++++++|||||+++|+|.+ .....++|+||+++|+
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEECCCTTEE
T ss_pred EEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCCEEEEEECCCCCC
T ss_conf 579820798089999999-909999998857--779999999999986789898549878872-3892899996369998
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 99998212999999999999999999999999998639997125889999776069997899622352102568875510
Q 001700 817 LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTADQV 896 (1025)
Q Consensus 817 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~ 896 (1025)
|.+++...... .++|..++.|+.||+.||+|||+ .+|+||||||+||+++. ++.+|++|||+++.......
T Consensus 88 L~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~~~~---- 158 (262)
T d1byga_ 88 LVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQD---- 158 (262)
T ss_dssp HHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC-------------
T ss_pred HHHHHHHCCCC---CCCHHHHHHHHHHHHHHCCCCCC-CCEECCCCCHHHHEECC-CCCEEECCCCCCEECCCCCC----
T ss_conf 99998745788---88999999999999852321133-76553666567601468-99776324560034478776----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHCC
Q ss_conf 357445447533346888999970158999999999991-9989984335999752579999997521666310234228
Q 001700 897 LNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIMD 975 (1025)
Q Consensus 897 ~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 975 (1025)
...++..|+|||++.+.. ++.++||||||+++|||+| |+.||... ...++..++ ..
T Consensus 159 ~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~i-----------------~~ 215 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRV-----------------EK 215 (262)
T ss_dssp ---CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHH-----------------TT
T ss_pred CCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHH-----------------HC
T ss_conf 556664677817872798--8858877757999999997899999999----999999999-----------------80
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 9999996589999999998813999-999998999999963003
Q 001700 976 GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 976 ~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~ 1018 (1025)
+.+++.+...+.++.+++.+||..+ .+||||.||+++|+.++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89999976579999999999756697689399999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.16 Aligned_cols=242 Identities=19% Similarity=0.281 Sum_probs=198.6
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECC
Q ss_conf 763531033699999956-99899999925440---11199999999999559998612324635357898049999614
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++. +....++||||+
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYFGLSYA 90 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEEEECCC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEECC
T ss_conf 889850879099999998999799999986577557778999999999998768888617999999--899889999704
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 91 ~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 91 KNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECC----
T ss_pred CCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHCC-CCEECCCCCCCCCCCCC-CCEEEECCCCCCEECCCCCC
T ss_conf 8987777653159-----99999999999999999976216-50884767741236688-85388603210242256776
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHH
Q ss_conf -5510357445447533346888999970158999999999991998998433599975257999999752166631023
Q 001700 893 -ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 893 -~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||... +..+-. ..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~-------------~~ 221 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAG-------NEYLIF-------------QK 221 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHH-------------HH
T ss_pred CCCCCCCCCCCCCCCCEEECCCC--CCCCCCEEHHHHHHHHHHHCCCCCCCC-------CHHHHH-------------HH
T ss_conf 43335556775525844002689--896662304569999980388998995-------999999-------------99
Q ss_pred HHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 42289999996589999999998813999-99999899999
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
...... ..+...+.++.+++.+|+..+ .+|||++|++.
T Consensus 222 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 222 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 971899--998547999999999985579768919789737
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.15 Aligned_cols=241 Identities=18% Similarity=0.278 Sum_probs=198.4
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECC
Q ss_conf 763531033699999956-99899999925440---11199999999999559998612324635357898049999614
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +|+.||+|++++.. ....+.+.+|+.++++++|||||++++++. +....++||||+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~iv~ey~ 87 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYA 87 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEEEEECC
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCCCCCEECC
T ss_conf 889831768499999998999899999981565449799999999999998679998877876403--564211100035
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 88 ~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 88 NGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCTTC
T ss_pred CCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHEEECC-CCCEEEEECCCCCCCCCCCC
T ss_conf 7986055553256-----77599999999999652113431-59622464777847658-99888820565200356786
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 55103574454475333468889999701589999999999919989984335999752579999997521666310234
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
.....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... ..+... ..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~-------------~i 217 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFE-------------LI 217 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH-------------HH
T ss_pred -CCCCCEECHHHHHHHHCCCCC--CCHHHCCCCHHHHHHHHHHCCCCCCCCC-------HHHHHH-------------HH
T ss_conf -205510088996666504898--8833310223067889987899999969-------999999-------------98
Q ss_pred HCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCC-----HHHHHH
Q ss_conf 2289999996589999999998813999-99999-----899999
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs-----~~ev~~ 1011 (1025)
..... ..+...+.++.+++.+|+..+ .+||+ +.|+++
T Consensus 218 ~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HCCCC--CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 52899--89866899999999866638934422565234999972
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.61 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=202.7
Q ss_pred CCEEEEECCEEEEEEEEC-CCC--EEEEEECCCC-CHHCHHHHHHHHHHHHCC-CCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 763531033699999956-998--9999992544-011199999999999559-99861232463535789804999961
Q 001700 737 AEVIGRSCHGTLYKATLD-SGS--ILAVKRLREG-IAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||+||+|++. +|. .||||+++.. .....++|.+|++++.++ +|||||+++|+|. .....++|+||
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~iV~ey 92 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEY 92 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETTEEEEEECC
T ss_pred EEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--CCCEEEEEEEE
T ss_conf 7798207882899999989996999999997823385799999999999986228998836788884--18736999980
Q ss_pred CCCCCHHHHHHHCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEEC
Q ss_conf 46542999982129-----------9999999999999999999999999863999712588999977606999789962
Q 001700 812 INAQSLAVYLQETD-----------PRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTD 880 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~D 880 (1025)
+++|+|.++++... ......+++..++.++.|||+||.|+|+ .+|+||||||+|||++. ++.+||+|
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~-~~~~kl~D 170 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIAD 170 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECC
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCEEEECC-CCCEEECC
T ss_conf 28986999986403555551231012345789999999999999999876630-89545550520489868-87638743
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCHHHHHHHH
Q ss_conf 2352102568875510357445447533346888999970158999999999991998-998433599975257999999
Q 001700 881 YSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS-SGEIVCVDPGVVDLTDWVRLL 959 (1025)
Q Consensus 881 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~-P~~~~~~~~~~~~l~~~~~~~ 959 (1025)
||+++........ ....||..|+|||.+.+.. ++.++|||||||++|||++|.. ||... ...+..
T Consensus 171 fG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~~~--- 236 (309)
T d1fvra_ 171 FGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELY--- 236 (309)
T ss_dssp TTCEESSCEECCC------CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHH---
T ss_pred CCCCCCCCCCCCC--CCEECCCCCCCHHHHCCCC--CCCCCEEEHHHHHHHHHHHCCCCCCCCC-------CHHHHH---
T ss_conf 4432244422345--5301377555538752699--9962215313889999983689999999-------999999---
Q ss_pred HHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 75216663102342289999996589999999998813999-9999989999999630035
Q 001700 960 ALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 960 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
+ .+..+.+++.+...+.++.+++.+||+.+ ++||||.||++.|+++..+
T Consensus 237 ----------~-~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 ----------E-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----------H-HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----------H-HHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----------9-9982688888766789999999997678966894999999999999861
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.21 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=202.2
Q ss_pred CCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCC-CCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 763531033699999956------99899999925440-11199999999999559-99861232463535789804999
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~lv 808 (1025)
.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|...+.++ +|+|||.+++++.. .....++|
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~~iv 96 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVI 96 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTSCCEEE
T ss_pred EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC-CCCEEEEE
T ss_conf 44984167839999998677755578399999986001717899999999998861499849974115404-79757999
Q ss_pred EECCCCCCHHHHHHHCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEE
Q ss_conf 9614654299998212999-----------99999999999999999999999863999712588999977606999789
Q 001700 809 SNYINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAV 877 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~k 877 (1025)
|||+++|+|.+++...... ....+++.+++.++.||++||+|||+ .+|+||||||+|||++. ++.+|
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl~~-~~~~K 174 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVK 174 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEE
T ss_pred EEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECC-CCCEE
T ss_conf 98458992999998536666653222023321468999999999999999998873-79717867731065779-98289
Q ss_pred EECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCHHHH
Q ss_conf 9622352102568875-510357445447533346888999970158999999999991998-99843359997525799
Q 001700 878 LTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKS-SGEIVCVDPGVVDLTDW 955 (1025)
Q Consensus 878 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~-P~~~~~~~~~~~~l~~~ 955 (1025)
|+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||+||.. ||..... .+.
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-------~~~ 245 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEE 245 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-------SHH
T ss_pred ECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC--CCCCCCEEEHHHHHHHHHHCCCCCCCCCCH-------HHH
T ss_conf 84575200113566522247516672102036864688--996632213678999998688999989998-------999
Q ss_pred HHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCC
Q ss_conf 999975216663102342289999996589999999998813999-99999899999996300352
Q 001700 956 VRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 956 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~ 1020 (1025)
+... +..+.+++.+...+.++.+++.+||+.+ ++||||.||++.|+++.+.+
T Consensus 246 ~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 246 FCRR-------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH-------------HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9999-------------9638988888657899999999976779667919999999997998677
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.59 Aligned_cols=268 Identities=22% Similarity=0.259 Sum_probs=198.3
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC--CEEEEEEECCCC
Q ss_conf 763531033699999956998999999254401119999999999955999861232463535789--804999961465
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE--HEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e~~~~ 814 (1025)
.+.||+|+||.||+|++. |+.||||+++.... .......|+..+.+++|||||+++|+|..... ...++||||+++
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEECCCEEEEEEEEC-CEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEECCCC
T ss_conf 889820788199999999-98999999872004-6799999999996279986832688998379860489999964669
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-------CCCCCCCCCCCCEEEECCCCCEEEECCCCCCCC
Q ss_conf 4299998212999999999999999999999999998639-------997125889999776069997899622352102
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNE-------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~ 887 (1025)
|+|.++++.. .++|..++.++.|+|.||+|+|+. ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRH 158 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCTTCEEE
T ss_pred CCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECC-CCCEEEEECCCCCCC
T ss_conf 8989998658------999899999999999999998876652046898661531731357868-877688763866234
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC-C------CCHH
Q ss_conf 568875---51035744544753334688899----99701589999999999919989984335999-7------5257
Q 001700 888 TSAGTA---DQVLNAGALGYRPPEFASTSKPC----PSLKSDVYAFGIILLELLTGKSSGEIVCVDPG-V------VDLT 953 (1025)
Q Consensus 888 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----~s~~~DV~SlGvil~elltG~~P~~~~~~~~~-~------~~l~ 953 (1025)
...... ......||+.|+|||++.+.... ++.++|||||||++|||+||..||........ . ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf 67776200135525035476782210565454677767501220159999999628998876631124101225564309
Q ss_pred HHHHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCCC
Q ss_conf 99999975216663102342289999996589999999998813999-99999899999996300352
Q 001700 954 DWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLEK 1020 (1025)
Q Consensus 954 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~~ 1020 (1025)
............ ++.+.. .....+.+..+.+++.+||..+ .+||||.||++.|+++....
T Consensus 239 ~~~~~~~~~~~~----~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 239 EEMRKVVCEQKL----RPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCC----CCCCCC---CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 999998750246----888776---5577689999999999976069858959999999999888865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.50 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=203.5
Q ss_pred CCEEEEECCEEEEEEEE------CCCCEEEEEECCCCC-HHCHHHHHHHHHHHHCC-CCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 76353103369999995------699899999925440-11199999999999559-99861232463535789804999
Q 001700 737 AEVIGRSCHGTLYKATL------DSGSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~lv 808 (1025)
++.||+|+||.||+|++ .+++.||||+++... .....++.+|+.+++++ +|||||+++|+|. .....++|
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~~~~~~lv 105 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--IGGPTLVI 105 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred EEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--ECCEEEEE
T ss_conf 5498206882999999806644778869999998742487799999999999876269998878998983--19978999
Q ss_pred EECCCCCCHHHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 9614654299998212999-------------999999999999999999999998639997125889999776069997
Q 001700 809 SNYINAQSLAVYLQETDPR-------------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMN 875 (1025)
Q Consensus 809 ~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~ 875 (1025)
|||+++|+|.++++..... ....+++..++.++.||++||+|||+ .+++||||||+||+++. ++.
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~NIl~~~-~~~ 183 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRI 183 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEET-TTE
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCCCCCC-CCC
T ss_conf 9737998799999853566544444533222334588999999999999999998875-79266624102100002-575
Q ss_pred EEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHH
Q ss_conf 89962235210256887-55103574454475333468889999701589999999999919989984335999752579
Q 001700 876 AVLTDYSLHRILTSAGT-ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTD 954 (1025)
Q Consensus 876 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~ 954 (1025)
+|++|||.++....... .......||+.|+|||++.+.. ++.++|||||||++|||+|+..|+....... ..+..
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~~~~ 259 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKFYK 259 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHHHH
T ss_pred CCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HHHHH
T ss_conf 2102340102336788615862013596876778861799--9974001025899999985899887789989--99999
Q ss_pred HHHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 9999975216663102342289999996589999999998813999-9999989999999630035
Q 001700 955 WVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 955 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.+..+.++..+...+..+.+++.+||..+ .+||||.||+++|+++..+
T Consensus 260 -----------------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 260 -----------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -----------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -----------------9866898898543659999999997577965792999999999876534
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.48 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=196.9
Q ss_pred CCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC------HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 77763531033699999956-99899999925440------111999999999995599986123246353578980499
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI------AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLV 807 (1025)
Q Consensus 735 ~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~l 807 (1025)
...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++. +....++
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i 90 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKTDVIL 90 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEE
T ss_conf 98279811789599999999999899999987566321340689999999999998679989993889999--7998999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCC---CCEEEECCCCC
Q ss_conf 996146542999982129999999999999999999999999986399971258899997760699---97899622352
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPT---MNAVLTDYSLH 884 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~---~~~kl~Dfgla 884 (1025)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++..+ ..+|++|||++
T Consensus 91 v~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEECCCCCCCCCHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCEEEEECCCCCCCCEEECCHHHH
T ss_conf 998677864310010356-----42155789999999999876662-542211333012798258986664696433442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 10256887551035744544753334688899997015899999999999199899843359997525799999975216
Q 001700 885 RILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 885 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
+........ ....||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... ..+.....
T Consensus 165 ~~~~~~~~~--~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i----- 228 (293)
T d1jksa_ 165 HKIDFGNEF--KNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANV----- 228 (293)
T ss_dssp EECTTSCBC--SCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH-----
T ss_pred HHCCCCCCC--CCCCCCCCCCCHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHH-----
T ss_conf 105777631--2247777430999981899--9976652214099999970889988999-------99999999-----
Q ss_pred CCCCCHHHHCCCCCC--CCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 663102342289999--996589999999998813999-999998999999
Q 001700 965 SGECFDRLIMDGHDM--EQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
....... +.+...+.++.+++.+||..+ ++|||++|+++.
T Consensus 229 --------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 229 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --------HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------HHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------8168888701047889999999999863896689199999619
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=339.15 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 7763531033699999956-99899999925440---1119999999999955999861232463535789804999961
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++. .....++||||
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~ 85 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEEEECC
T ss_pred EEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEE--ECCEEEEEEEE
T ss_conf 8889720768089999998999799999984577548899999999999998636967533035685--28800567650
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|++..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSCEECSSCB
T ss_pred CCCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHCC-CCEECCCCCCHHEEECC-CCCEEEECCCCCEEECCCC
T ss_conf 37863223432222-----11100799999999876554124-76770556810503868-9988983175216712456
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHH
Q ss_conf 75510357445447533346888999970158999999999991998998433599975257999999752166631023
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
...+||+.|+|||++.+.. ++.++||||+||++|||+||+.||... ...+... .
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~-------------~ 212 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYE-------------K 212 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHH-------------H
T ss_pred ----CCCCCCCCCCCHHHHCCCC--CCCHHHCCCCCHHHHHHHHCCCCCCCC-------CHHHHHH-------------H
T ss_conf ----4345763435999983899--980430465333689997598999996-------9999999-------------9
Q ss_pred HHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCC-----CHHHHHHH
Q ss_conf 42289999996589999999998813999-9999-----98999999
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-----DMMSVFEE 1012 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RP-----s~~ev~~~ 1012 (1025)
...... ..+...+.++.+++.+|+..+ .+|| |++|+++.
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHCCCC--CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 970898--899778999999999995449976664310219999819
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=337.82 Aligned_cols=243 Identities=20% Similarity=0.255 Sum_probs=192.3
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHH---HHHHHHCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 763531033699999956-99899999925440---111999999---99999559998612324635357898049999
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAR---EVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ ++++++.++|||||++++++. .....++||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~~~ivm 86 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFIL 86 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--ECCEEEEEE
T ss_conf 018842889099999999999799999984587542667999999999999985089985889999999--899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCCTTCEECSS
T ss_pred EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCEEEECC-CCCEEEEEECEEEECCC
T ss_conf 9148983899987325-----53278999999999999999997-79622044422167858-89679822010233378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997521666310
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
... ....||+.|+|||++..... ++.++|||||||++|||+||+.||...... +.....
T Consensus 160 ~~~---~~~~GT~~y~APE~~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~------------- 218 (364)
T d1omwa3 160 KKP---HASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEID------------- 218 (364)
T ss_dssp SCC---CSCCSCGGGCCHHHHSTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHH-------------
T ss_pred CCC---CCCCCCCCCCHHHHHHCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH-------------
T ss_conf 864---33113455421687603899-984410467789999998599988889989----999999-------------
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCC-----HHHHHH
Q ss_conf 2342289999996589999999998813999-99999-----899999
Q 001700 970 DRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 970 d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs-----~~ev~~ 1011 (1025)
... .......+...+.++.+++.+|+..+ .+||| ++|+++
T Consensus 219 -~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 -RMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -HHS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -HHC-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf -860-4688878877899999999998566988808874357999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.00 Aligned_cols=256 Identities=18% Similarity=0.319 Sum_probs=203.8
Q ss_pred CCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 763531033699999956------99899999925440-11199999999999559998612324635357898049999
Q 001700 737 AEVIGRSCHGTLYKATLD------SGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||+||+|++. +++.||||+++... ......|.+|++++++++|||||+++|+|. .....++|+
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~~~~lv~ 102 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIM 102 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SSSSCEEEE
T ss_pred EEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCCCEEEEE
T ss_conf 359820788189999987864477896899999870128689999999999999769998841254784--288106777
Q ss_pred ECCCCCCHHHHHHHCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 6146542999982129-----99999999999999999999999998639997125889999776069997899622352
Q 001700 810 NYINAQSLAVYLQETD-----PRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLH 884 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla 884 (1025)
||+++|+|.+++.... ......+++..+..++.|+|+||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~~Kl~DFGla 180 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMT 180 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCCEEECCTTCC
T ss_pred EECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECEECCCCEEECC-CCEEEEEECCCC
T ss_conf 6048998899987503321134446887999999999999999998764-79654328677540359-964999424542
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 1025688755-1035744544753334688899997015899999999999199-8998433599975257999999752
Q 001700 885 RILTSAGTAD-QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGK-SSGEIVCVDPGVVDLTDWVRLLALE 962 (1025)
Q Consensus 885 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~-~P~~~~~~~~~~~~l~~~~~~~~~~ 962 (1025)
+......... .....|++.|+|||.+.+.. ++.++||||||+++|||+||. .||... ...++....
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~~i--- 248 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLRFV--- 248 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHHHH---
T ss_pred EECCCCCCEEECCCEECCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCC-------CHHHHHHHH---
T ss_conf 0235776303134023163237888873699--8833344437899999996899999998-------999999999---
Q ss_pred CCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 16663102342289999996589999999998813999-9999989999999630035
Q 001700 963 NRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 963 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
..+..++.+..++..+.+++.+||+.+ ++||||.||++.|++..++
T Consensus 249 -----------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 -----------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -----------HHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf -----------80888888633539999999997577965893999999997876177
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=336.87 Aligned_cols=238 Identities=16% Similarity=0.209 Sum_probs=196.3
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECC
Q ss_conf 763531033699999956-99899999925440---11199999999999559998612324635357898049999614
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~ 812 (1025)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. .....++|+||+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECC
T ss_pred EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCC--CCCCCCCCCCCC
T ss_conf 889611768089999998999899999982677458899999999999999748772740344443--222223222233
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
.+|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 124 ~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 124 AGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp TTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSCB-
T ss_pred CCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHCCCCC-CCCEEEEECEEEEECCCCC-
T ss_conf 4662266675158-----98999999999999998999985-99861767999936077-8978861010333225666-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 55103574454475333468889999701589999999999919989984335999752579999997521666310234
Q 001700 893 ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRL 972 (1025)
Q Consensus 893 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 972 (1025)
....||+.|+|||++.+.. ++.++|||||||++|||+||+.||... .........
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i------------- 250 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKI------------- 250 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHH-------------
T ss_pred ---CCCCCCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCC-------CHHHHHHHH-------------
T ss_conf ---4336763567889971799--885331145007899997588998995-------999999998-------------
Q ss_pred HCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCC-----CCHHHHHH
Q ss_conf 2289999996589999999998813999-999-----99899999
Q 001700 973 IMDGHDMEQPPRILSDMLQVALRCILPA-SER-----PDMMSVFE 1011 (1025)
Q Consensus 973 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~R-----Ps~~ev~~ 1011 (1025)
..... ..+...+.++.+++.+|+..+ .+| ||++|+++
T Consensus 251 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 VSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HCCCC--CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 61798--89766899999999998340998606553454999971
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.35 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=203.9
Q ss_pred CCEEEEECCEEEEEEEEC-C-------CCEEEEEECCCCC-HHCHHHHHHHHHHHHCC-CCCCCCCCCCEEECCCCCEEE
Q ss_conf 763531033699999956-9-------9899999925440-11199999999999559-998612324635357898049
Q 001700 737 AEVIGRSCHGTLYKATLD-S-------GSILAVKRLREGI-AKGKKEFAREVKKLGNI-KHPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 806 (1025)
++.||+|+||.||+|+.. . +..||||+++... .....++.+|+..+.++ +|||||+++|+|. +....+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--~~~~~~ 95 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLY 95 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCE
T ss_pred EEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC--CCCEEE
T ss_conf 009851678289999985787555667549999998811286889999999999998139996973465220--188689
Q ss_pred EEEECCCCCCHHHHHHHCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 999614654299998212999-----------999999999999999999999998639997125889999776069997
Q 001700 807 VISNYINAQSLAVYLQETDPR-----------KLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMN 875 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~ 875 (1025)
+||||+++|+|.+++...... ....+++.+++.++.|+|.||+|||+ .+|+||||||+|||++. ++.
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~NiLl~~-~~~ 173 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNV 173 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCC
T ss_pred EEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEEEECCCCEEECC-CCC
T ss_conf 9997369990999998606776432223345743467999999999999999987663-79786302210224547-897
Q ss_pred EEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHH
Q ss_conf 899622352102568875-510357445447533346888999970158999999999991-998998433599975257
Q 001700 876 AVLTDYSLHRILTSAGTA-DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLT 953 (1025)
Q Consensus 876 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~ 953 (1025)
+||+|||+++........ ......|++.|+|||++.+.. ++.++||||||+++|||++ |+.||.... ...+.
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----~~~~~ 247 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELF 247 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHH
T ss_pred EEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC--CCCHHHHHHHHHHHHHHCCCCCCCCCCCC----HHHHH
T ss_conf 6762211101135555543146678884663266751798--88255547758888874017989899999----99999
Q ss_pred HHHHHHHHHCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 99999975216663102342289999996589999999998813999-999998999999963003
Q 001700 954 DWVRLLALENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 954 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~ 1018 (1025)
+ .+..+.+++.+...+.++.+++.+||+.+ .+|||+.||++.|++|..
T Consensus 248 ~-----------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 K-----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H-----------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-----------------HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9-----------------997288889874352999999999766797679399999999988860
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.63 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred CCEEEEECCEEEEEEEEC--CC--CEEEEEECCCCC---HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEE
Q ss_conf 763531033699999956--99--899999925440---11199999999999559998612324635357898049999
Q 001700 737 AEVIGRSCHGTLYKATLD--SG--SILAVKRLREGI---AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~ 809 (1025)
.+.||+|+||.||+|++. ++ ..||||+++... ....++|.+|+.++++++|||||+++|+|.. . ..++|+
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~-~~~lv~ 89 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--P-PMKMVT 89 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S-SCEEEE
T ss_pred EEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--C-CHHEEE
T ss_conf 7898038883999999988999079999999983555798999999999999986899998789877740--1-001146
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||+++|++.+++..... .+++..++.++.|+|+||.|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 90 e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp ECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCTTCEECCC
T ss_pred EEECCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEEEEEECHHHHCCCC-CCCEEECCCHHHHHCCC
T ss_conf 54238612544421268----99999999999999999987521-78752056688815655-65433256115553035
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 88755--10357445447533346888999970158999999999991-9989984335999752579999997521666
Q 001700 890 AGTAD--QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLT-GKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 890 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ellt-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
..... .....|+..|+|||++.+.. ++.++||||||+++|||+| |+.||.... ..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----~~~~~------------- 224 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQIL------------- 224 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHH-------------
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHH-------------
T ss_conf 887526547632573107999983799--99421566148999999968999999969----99999-------------
Q ss_pred CCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHC
Q ss_conf 3102342289999996589999999998813999-9999989999999630
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTI 1016 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i 1016 (1025)
......+.+++.+...+.++.+++.+||..+ ++||||.||++.|++.
T Consensus 225 ---~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 ---HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---999847999998544539999999997688966792999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.89 Aligned_cols=247 Identities=17% Similarity=0.252 Sum_probs=192.9
Q ss_pred CCEEEEECCEEEEEEEE-CCCCEEEEEECCCCCHHCHHHHHHHHHHHHCC-CCCCCCCCCCEEEC--CCCCEEEEEEECC
Q ss_conf 76353103369999995-69989999992544011199999999999559-99861232463535--7898049999614
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGIAKGKKEFAREVKKLGNI-KHPNLVSLQGYYWG--PKEHEKLVISNYI 812 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~--~~~~~~~lv~e~~ 812 (1025)
+++||+|+||+||+|+. .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.. ......++||||+
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECC
T ss_conf 07965454869999998899989999998974-----7799999999986699997829899950346897899999778
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEEECCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606--9997899622352102568
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~--~~~~~kl~Dfgla~~~~~~ 890 (1025)
++|+|.+++...... .+++.++..|+.|++.||+|||+ .+|+||||||+|||++. ..+.+||+|||+|+.....
T Consensus 92 ~gg~L~~~i~~~~~~---~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp CSEEHHHHHHSCSCC---CEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CCCCHHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 998499999862787---75799999999999999999997-69864441002201135555663113545512333688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCH
Q ss_conf 87551035744544753334688899997015899999999999199899843359997525799999975216663102
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFD 970 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 970 (1025)
... ....||+.|+|||++.+.. ++.++||||+||++|||+||+.||....... .... +..
T Consensus 168 ~~~--~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~------------~~~ 227 (335)
T d2ozaa1 168 NSL--TTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPG------------MKT 227 (335)
T ss_dssp CCC--CCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------------
T ss_pred CCC--CCCCCCCCCCCCHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH----HHHH------------HHH
T ss_conf 864--3226775637927774898--8888888764516778865889988988778----8999------------999
Q ss_pred HHHCCCCCCC--CCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 3422899999--96589999999998813999-999998999999
Q 001700 971 RLIMDGHDME--QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 971 ~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.........+ .....+.++.+++.+|+..+ ++|||+.|+++.
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 985388888985434699999999999756996579099999709
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=331.29 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=202.2
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCH---HCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC--CEEEEEEE
Q ss_conf 763531033699999956-998999999254401---119999999999955999861232463535789--80499996
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA---KGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE--HEKLVISN 810 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e 810 (1025)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++..... ...++|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEEEEE
T ss_conf 68996089929999999999989999998556646989999999999999856999887311435432688766999997
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 14654299998212999999999999999999999999998639997125889999776069997899622352102568
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~ 890 (1025)
|+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +...+++|||.+......
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADS 164 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTTCEECC--
T ss_pred CCCCCEEHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCC-CCCCEEEHHHHHHHHCCC
T ss_conf 788987101120358-----99999999999999999999985-79527634675566575-432010034443221235
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 87--5510357445447533346888999970158999999999991998998433599975257999999752166631
Q 001700 891 GT--ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGEC 968 (1025)
Q Consensus 891 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 968 (1025)
.. ......+||+.|+|||++.+.. ++.++||||+||++|||+||+.||... ...+...........
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~~~~~~~~--- 232 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPI--- 232 (277)
T ss_dssp --------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHCCCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCEECCCCHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCC---
T ss_conf 44333346425762436999983999--996632026528999997697998996-------999999999846999---
Q ss_pred CHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCC-CHHHHHHHHHHCC
Q ss_conf 02342289999996589999999998813999-9999-9899999996300
Q 001700 969 FDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERP-DMMSVFEELSTIV 1017 (1025)
Q Consensus 969 ~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RP-s~~ev~~~L~~i~ 1017 (1025)
.+. ......+.++.+++.+|+..+ ++|| |++++.+.|.++.
T Consensus 233 -~~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 -PPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -CGG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -CCC-------HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -971-------0034789999999999866797677739999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.68 Aligned_cols=244 Identities=17% Similarity=0.227 Sum_probs=196.3
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||+||+|+.. +++.||+|.++... .....+.+|++++++++|||||++++++. +....++||||+++|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE--SMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE--ETTEEEEEECCCCCC
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEECCCCC
T ss_conf 789831778399999998999699999975786-65999999999998579979890989998--899889999538998
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606-99978996223521025688755
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA-PTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~ 894 (1025)
+|.+++..... .+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ....+||+|||+++.......
T Consensus 87 ~L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 87 DIFERINTSAF----ELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp BHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC--
T ss_conf 08899875389----99999999999999999999987-699751355444344378851899764411100346775--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHHC
Q ss_conf 10357445447533346888999970158999999999991998998433599975257999999752166631023422
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLIM 974 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 974 (1025)
.....|++.|+|||...+.. ++.++||||+||++|||++|+.||.... ..+..... ..
T Consensus 160 ~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~-------~~~~~~~i-------------~~ 217 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENI-------------MN 217 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH-------------HH
T ss_pred CCCCCCCCCCCCCHHCCCCC--CCCHHHCCCHHHHHHHHHHCCCCCCCCC-------HHHHHHHH-------------HH
T ss_conf 32122332223402104877--7840113027999999982899999989-------99999999-------------83
Q ss_pred CCCCCC--CCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 899999--96589999999998813999-999998999999
Q 001700 975 DGHDME--QPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 975 ~~~~~~--~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.....+ .....+.++.+++.+|+..+ .+|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89998802236789999999999866996689099999639
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.24 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=194.7
Q ss_pred CEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHC-----HHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 63531033699999956-99899999925440111-----9999999999955999861232463535789804999961
Q 001700 738 EVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKG-----KKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 738 ~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++|||||++++++. .....++||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEEEC
T ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCEEEHHHH
T ss_conf 3851272829999999999969999998420212456799999999999998679999868985422--58740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+.++++..+..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCCEEEECC-CCCCCCCCCCCCCCCCCCC
T ss_conf 34507765541266-----77899999999999999988631-63550357762588537-7841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHH
Q ss_conf 75510357445447533346888999970158999999999991998998433599975257999999752166631023
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
.. ....+||+.|+|||++.+... ++.++||||+||++|||+||+.||.... ..+....+....... ..+....
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~~~-~~~~~~~ 227 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTP-TEEQWPD 227 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCC-CTTTSSS
T ss_pred CC-CCCEECCHHHCCHHHHCCCCC-CCHHHHHHHCCHHHHHHHHCCCCCCCCC----HHHHHHHHHHHCCCC-CHHHCCC
T ss_conf 54-330204733363999726778-8805643630428999985969999999----999999999851899-7254521
Q ss_pred -------HHCCCCCCCCC-----HHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHC
Q ss_conf -------42289999996-----589999999998813999-999998999999--9630
Q 001700 972 -------LIMDGHDMEQP-----PRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTI 1016 (1025)
Q Consensus 972 -------~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i 1016 (1025)
...... +..+ .....++.+++.+|+..+ ++|||++|+++. ++..
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 228 MCSLPDYVTFKSF-PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSTTCCCCCCC-CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHCCCHHHHHCCC-CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 0002134430347-8988678565689999999999763894569089999679965789
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.46 Aligned_cols=241 Identities=18% Similarity=0.302 Sum_probs=194.8
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHCHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 763531033699999956-99899999925440---111999999999995-5999861232463535789804999961
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---AKGKKEFAREVKKLG-NIKHPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|..++. .++|||||++++++. +....++||||
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~yivmEy 84 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLFFVMEY 84 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEEEEEEC
T ss_pred EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCEEEEEEE
T ss_conf 6589408782899999999998999999805553384899999999999998479996878988970--49831677750
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 85 ~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 85 LNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTT
T ss_pred CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECC-CCCEECCCCCHHHHCCCCC
T ss_conf 37980899864047-----89999999999999999999986-89340347654044448-9963015553023235665
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHH
Q ss_conf 75510357445447533346888999970158999999999991998998433599975257999999752166631023
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDR 971 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 971 (1025)
. ......||+.|+|||++.+.. ++.++||||+||++|||+||+.||.... ..+-. ..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~-------------~~ 214 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELF-------------HS 214 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH-------------HH
T ss_pred C-CCCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHH-------------HH
T ss_conf 3-345457877768999982799--8832320112278989873889999989-------99999-------------99
Q ss_pred HHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHH-HHHH
Q ss_conf 42289999996589999999998813999-9999989-9999
Q 001700 972 LIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMM-SVFE 1011 (1025)
Q Consensus 972 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~-ev~~ 1011 (1025)
.....+ ..+...+.++.+++.+|+..+ ++||++. |+++
T Consensus 215 i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 215 IRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHCCCC--CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 971899--8975679999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=330.61 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=196.8
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---------HHCHHHHHHHHHHHHCCC-CCCCCCCCCEEECCCCCEE
Q ss_conf 763531033699999956-99899999925440---------111999999999995599-9861232463535789804
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI---------AKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~ 805 (1025)
.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++ |||||++++++. +....
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~~~ 85 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFF 85 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred CEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC--CCCCE
T ss_conf 5288417684999999999998999999962446411478889999999999999998507997479976214--67605
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 99996146542999982129999999999999999999999999986399971258899997760699978996223521
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~ 885 (1025)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~ 158 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCEEEECC-CCCEEECCCHHEE
T ss_conf 99997689866899998659-----99999999999999999999987-59943234625489868-9983871240316
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 0256887551035744544753334688----899997015899999999999199899843359997525799999975
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTS----KPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLAL 961 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~ 961 (1025)
....... .....||+.|+|||++.+. ...++.++||||+||++|||++|+.||.... ..+-... ..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-------~~~~~~~-i~ 228 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRM-IM 228 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH-HH
T ss_pred ECCCCCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC-------HHHHHHH-HH
T ss_conf 7268872--134524678889888605344567889923318565602310322888988999-------9999999-98
Q ss_pred HCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 216663102342289999996589999999998813999-999998999999
Q 001700 962 ENRSGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 962 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.+.. ....+.....+.++.+++.+|+..+ .+|||+.||++.
T Consensus 229 ~~~~----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCC----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HCCC----------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1898----------88985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.50 Aligned_cols=266 Identities=18% Similarity=0.266 Sum_probs=197.4
Q ss_pred CCEEEEECCEEEEEEEE-CCCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCC
Q ss_conf 76353103369999995-699899999925440--111999999999995599986123246353578980499996146
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++. .....++|+||+.
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~--~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEEEECCS
T ss_pred CCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCC--CCCCEEEEEEECC
T ss_conf 51772376809999999999979999998022257589999999999998679983887445332--2432037886237
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 54299998212999999999999999999999999998639997125889999776069997899622352102568875
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~ 893 (1025)
+ .+.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. +..+||+|||.|+.......
T Consensus 85 ~-~~~~~~~~~~~~---~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 85 Q-DLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp E-EHHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHHCCCSB-
T ss_pred C-CHHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCHHEEECC-CCCCEECCCCCCEECCCCCC-
T ss_conf 7-445554420256---88889999999999999998652-88992135711401134-67621035786134368864-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 51035744544753334688899997015899999999999199899843359997525799999975216663102342
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECFDRLI 973 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 973 (1025)
......||+.|+|||+.....+ .+.++||||+||++|||++|+.||... .....+.......+...+...+..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~-~~~~~DiwSlGvily~m~~G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGD------SEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CCEEECCCCEEEEHHHHCCCCC-CCCCCCCCCCCHHHHHHHHCCCCCCCC------CHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 1001036521541122136657-774221033331342796687998988------999999999983289833314442
Q ss_pred C------CCCC---CC----CCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCCC
Q ss_conf 2------8999---99----96589999999998813999-999998999999--963003
Q 001700 974 M------DGHD---ME----QPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIVL 1018 (1025)
Q Consensus 974 ~------~~~~---~~----~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~~ 1018 (1025)
. .... .. .......++.+++.+|+..+ .+|||++|+++. ++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 2242124345432222044416678999999999976399557918999967870146999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.86 Aligned_cols=268 Identities=20% Similarity=0.267 Sum_probs=191.7
Q ss_pred CCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECC----CCCEEEEEE
Q ss_conf 77763531033699999956-9989999992544011199999999999559998612324635357----898049999
Q 001700 735 APAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP----KEHEKLVIS 809 (1025)
Q Consensus 735 ~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~----~~~~~~lv~ 809 (1025)
...++||+|+||+||+|+.. +|+.||||+++.... ...+|++++++++||||+++++++... .....++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEE
T ss_conf 751698217683999999999997999999881606----8999999998668989873878997447657731899998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||++++.+....+..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++..+..+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred ECCCCCCHHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCCC
T ss_conf 416886078888631036--899999999999999999999986-68764578860378735897116733660544047
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997521666310
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGECF 969 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 969 (1025)
..... ...|+..|+|||.+.+... ++.++||||+||++|||++|+.||...... ..+....... .....+.+
T Consensus 176 ~~~~~--~~~gt~~y~aPE~~~~~~~-~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~--g~~~~~~~ 247 (350)
T d1q5ka_ 176 GEPNV--SYICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVL--GTPTREQI 247 (350)
T ss_dssp TSCCC--SCCSCTTSCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHH--CCCCHHHH
T ss_pred CCCCC--CCCCCCCCCCHHHHHCCCC-CCCCEEECCCCEEEEEHHHCCCCCCCCCHH---HHHHHHHHHH--CCCHHHHH
T ss_conf 76532--0025555568277640468-882100024652778550287998987999---9999999974--89817765
Q ss_pred --------HHHHCCCC----CCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf --------23422899----99996589999999998813999-999998999999--96300
Q 001700 970 --------DRLIMDGH----DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 970 --------d~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
+....... ..........++.+++.+|+..+ ++|||+.|+++. ++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 430621011035544567444431568999999999997658955792999996698452466
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.48 Aligned_cols=242 Identities=17% Similarity=0.264 Sum_probs=193.5
Q ss_pred CCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCH------HCHHHHHHHHHHHHCCC--CCCCCCCCCEEECCCCCEEE
Q ss_conf 7763531033699999956-998999999254401------11999999999995599--98612324635357898049
Q 001700 736 PAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIA------KGKKEFAREVKKLGNIK--HPNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--Hpniv~l~g~~~~~~~~~~~ 806 (1025)
..+.||+|+||+||+|+.. +|+.||||+++.... ....++.+|+.++++++ |||||++++++. .....+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~~~~~ 85 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RPDSFV 85 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CSSEEE
T ss_pred EEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--ECCEEE
T ss_conf 967984087839999999999979999998568844334556799999999999974358988127999983--099689
Q ss_pred EEEECCCC-CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 99961465-42999982129999999999999999999999999986399971258899997760699978996223521
Q 001700 807 VISNYINA-QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 807 lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~ 885 (1025)
+|+||+.+ +++.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++..++.+||+|||+|+
T Consensus 86 lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEECCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 99983368622899986158-----99999999999999999999987-7975566761114774478848977546535
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 02568875510357445447533346888999970158999999999991998998433599975257999999752166
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRS 965 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 965 (1025)
...... .....||+.|+|||++.+..+ ++.++||||+||++|||+||+.||.... . ...
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~------~-------i~~---- 218 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDE------E-------IIR---- 218 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSCSCCSHH------H-------HHH----
T ss_pred ECCCCC---CCCCCCCCCCCCHHHHCCCCC-CCCCCCCCCCEEEEHHHHHCCCCCCCCH------H-------HHH----
T ss_conf 324445---566565877479999848997-8865332554034536756889988736------7-------761----
Q ss_pred CCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf 63102342289999996589999999998813999-999998999999--96300
Q 001700 966 GECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 966 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
... ..+...+.++.+++.+|+..+ ++|||++|+++. ++.+.
T Consensus 219 ---------~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 ---------GQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------CCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------CCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ---------544--77877999999999997608975893999985398667887
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=317.67 Aligned_cols=260 Identities=19% Similarity=0.201 Sum_probs=195.8
Q ss_pred CCEEEEECCEEEEEEEECCCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 76353103369999995699899999925440--1119999999999955999861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLDSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.++++++|||||++++++. .....++++||+.+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEEECCSE
T ss_pred CCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECC--CCCCEEEEEEEEHH
T ss_conf 3187227781899999689999999998123268589999999999998679986876601204--67731589974004
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 42999982129999999999999999999999999986399971258899997760699978996223521025688755
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTAD 894 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~ 894 (1025)
+.+..+..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+|++|||.+........ .
T Consensus 85 ~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 85 DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHCC-CCEEECCCCCCEEEECC-CCCEEECCCCCCEECCCCCC-C
T ss_conf 56789986047-----75144568999999999998605-74882678775056868-99787323664301146765-4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC---CC--
Q ss_conf 1035744544753334688899997015899999999999199899843359997525799999975216663---10--
Q 001700 895 QVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE---CF-- 969 (1025)
Q Consensus 895 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~-- 969 (1025)
.....|++.|+|||.+.+..+ ++.++||||+||++|||++|+.||.... ..+....+........... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -----CCCTTCCHHHHTTCCS-CCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCEECCCCHHHHHHHHHCCCC-CCCCEEEHHCCCHHHHHHHCCCCCCCCC----HHHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 101024311013788717888-8841002111758999977979989889----89999999986389971104212333
Q ss_pred ---HHHHCCCCC---CCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf ---234228999---9996589999999998813999-99999899999
Q 001700 970 ---DRLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 970 ---d~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
+........ ..........+.+++.+|+..+ ++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2214333335676466651258999999999986689668909999856
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.67 Aligned_cols=261 Identities=16% Similarity=0.221 Sum_probs=195.8
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCC----CCEEEEEE
Q ss_conf 763531033699999956-99899999925440--111999999999995599986123246353578----98049999
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPK----EHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~----~~~~~lv~ 809 (1025)
.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||+++++|.... ..+.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEEEEE
T ss_conf 88980177819999999999989999998522259699999999999998668987547999863576555541599998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||+ +.+|..+.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+|++|||+++....
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQADS 173 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECCS
T ss_pred ECC-CCCHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHCCC-CCCCCCCCCCCEECCCC
T ss_conf 405-52189998740------22699999999999999999873-78764566851111210-01221134310220687
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC-C-
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997521666-3-
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG-E- 967 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~-~- 967 (1025)
.. ....||+.|+|||++.+... .+.++||||+||++|||++|+.||.... ............+... +
T Consensus 174 ~~----~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlGvil~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 174 EM----TGYVVTRWYRAPEVILNWMR-YTQTVDIWSVGCIMAEMITGKTLFKGSD------HLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp SC----CSSCSCGGGCCTHHHHTTTC-CCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHH
T ss_pred CC----CCCCCCCCCCCHHHHCCCCC-CCCCCHHHCCHHHHHHHHHCCCCCCCCC------HHHHHHHHHHCCCCCCHHH
T ss_conf 63----10245533358899817878-9965010300389999997869988897------6899999985037884888
Q ss_pred -------CCH---HHHCCCCC---CCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf -------102---34228999---9996589999999998813999-999998999999--96300
Q 001700 968 -------CFD---RLIMDGHD---MEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 968 -------~~d---~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
... ........ ..........+.+++.+|+..+ .+|||+.|+++. ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 865300034433115786665566775568999999999997729955792999996396237587
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.81 Aligned_cols=266 Identities=20% Similarity=0.239 Sum_probs=194.3
Q ss_pred CCEEEEECCEEEEEEEE-CCCCEEEEEECCCCC-HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC--CEEEEEEECC
Q ss_conf 76353103369999995-699899999925440-1119999999999955999861232463535789--8049999614
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI-AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKE--HEKLVISNYI 812 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e~~ 812 (1025)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++..+.. ...+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEE
T ss_conf 78994064809999999999949999998031095899999999999997689898858889950564554149999962
Q ss_pred CCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 65429999821299999999999999999999999999863999712588999977606999789962235210256887
Q 001700 813 NAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGT 892 (1025)
Q Consensus 813 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~ 892 (1025)
.+|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECCGGGC
T ss_pred CCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCEEEECC-CCCEEECCCCCEEECCCCCC
T ss_conf 598656644058------99999999999999999999997-89867778764378879-99778754570565047776
Q ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC-C--
Q ss_conf 5--5103574454475333468889999701589999999999919989984335999752579999997521666-3--
Q 001700 893 A--DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG-E-- 967 (1025)
Q Consensus 893 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~-~-- 967 (1025)
. .....+|++.|+|||++..... ++.++||||+||++|||++|+.||..... ...+........... +
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~eml~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHY------LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCS-CSTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCHHHH
T ss_pred CCEEECCCCCCCEECHHHHHHCCCC-CCCHHHHHCCCCEEHHHHHCCCCCCCCCH------HHHHHHHHHHCCCCCHHHH
T ss_conf 4101011026520003878604788-87410100467013377669799788888------9999987652069975664
Q ss_pred -------CCHHHHCCCCCCCC-----CHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf -------10234228999999-----6589999999998813999-999998999999--96300
Q 001700 968 -------CFDRLIMDGHDMEQ-----PPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 968 -------~~d~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
.............. ......++.+++.+|+..+ .+|||+.|+++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 23433222202446775577877783789999999999997648956790899986198655588
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.08 Aligned_cols=268 Identities=21% Similarity=0.237 Sum_probs=190.9
Q ss_pred CCCEEEEECCEEEEEEEE-CC-CCEEEEEECCCCCH--HCHHHHHHHHHHHHCC---CCCCCCCCCCEEEC---CCCCEE
Q ss_conf 776353103369999995-69-98999999254401--1199999999999559---99861232463535---789804
Q 001700 736 PAEVIGRSCHGTLYKATL-DS-GSILAVKRLREGIA--KGKKEFAREVKKLGNI---KHPNLVSLQGYYWG---PKEHEK 805 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~Hpniv~l~g~~~~---~~~~~~ 805 (1025)
..+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+++.+ +||||++++++|.. ......
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCEE
T ss_conf 88899215586999999988899899999980232451679999999999998742589880236632214666667469
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 99996146542999982129999999999999999999999999986399971258899997760699978996223521
Q 001700 806 LVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 806 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~ 885 (1025)
++++||++++.+........ ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||.++
T Consensus 91 ~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLAR 164 (305)
T ss_dssp EEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSCCSCC
T ss_pred EEEEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCEEEECC-CCCEEECCHHHHH
T ss_conf 99997405871444443037----899989999999999999999975-88983579862789858-9975421000101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHH---
Q ss_conf 02568875510357445447533346888999970158999999999991998998433599975257999999752---
Q 001700 886 ILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE--- 962 (1025)
Q Consensus 886 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~--- 962 (1025)
....... .....||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... ..+...-+......
T Consensus 165 ~~~~~~~--~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 165 IYSFQMA--LTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCCGGGG--GCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCG
T ss_pred HHCCCCC--CCCCCCCHHHCCCCHHCCCC--CCHHEHHHCHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHHCCCCH
T ss_conf 1002345--77765485114831001798--8811100032899999987879989989----89999999984079961
Q ss_pred -CCCCCCC-HHHHC-CCC---CCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH--HHHCC
Q ss_conf -1666310-23422-899---99996589999999998813999-999998999999--96300
Q 001700 963 -NRSGECF-DRLIM-DGH---DMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE--LSTIV 1017 (1025)
Q Consensus 963 -~~~~~~~-d~~~~-~~~---~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~--L~~i~ 1017 (1025)
....... ..... ... ...........+.+++.+|+..+ ++|||+.|+++. ++.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 1053211110333022345645440445899999999998748966791899996696340752
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=310.35 Aligned_cols=258 Identities=17% Similarity=0.215 Sum_probs=194.7
Q ss_pred CCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCC-CCCCCCCCCEEECCCCCEEEEEEEC
Q ss_conf 177763531033699999956-99899999925440111999999999995599-9861232463535789804999961
Q 001700 734 HAPAEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 734 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv~e~ 811 (1025)
|...+.||+|+||+||+|+.. +|+.||||+++.. ..+++.+|++++++++ ||||+++++++..+.....++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEE
T ss_conf 18978983174819999998899979999998889---999999999999851579987679999981687712688863
Q ss_pred CCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 46542999982129999999999999999999999999986399971258899997760699978996223521025688
Q 001700 812 INAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAG 891 (1025)
Q Consensus 812 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~ 891 (1025)
+++++|..+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++..+|++|||+|+......
T Consensus 114 ~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 114 VNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCCCHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 17985899746--------89999999999999999988764-3344345644123774899836641565426646887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHH-----------H
Q ss_conf 75510357445447533346888999970158999999999991998998433599975257999999-----------7
Q 001700 892 TADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLL-----------A 960 (1025)
Q Consensus 892 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~-----------~ 960 (1025)
.. ....||+.|+|||.+.+... ++.++||||+||++||+++|+.||..... ....+.... .
T Consensus 185 ~~--~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~~l~e~~~g~~pf~~~~~-----~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 185 EY--NVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHD-----NYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CC--CSCCSCGGGCCHHHHTTCCC-CCTHHHHHHHHHHHHHHHHTCSSSSCCSS-----HHHHHHHHHHHHCHHHHHHHH
T ss_pred CC--CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCH-----HHHHHHHHHHHHCCCHHHHHH
T ss_conf 44--43224864247610268888-88452323354555876048899988760-----189999999987884155555
Q ss_pred HHC--CCCCCCHHHHCC--------CCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH
Q ss_conf 521--666310234228--------9999996589999999998813999-99999899999
Q 001700 961 LEN--RSGECFDRLIMD--------GHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFE 1011 (1025)
Q Consensus 961 ~~~--~~~~~~d~~~~~--------~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~ 1011 (1025)
... .....+...... ............++.+++.+|+..+ .+|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 42254447430000033343311211552112448999999999986699568908999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=310.80 Aligned_cols=257 Identities=14% Similarity=0.134 Sum_probs=194.9
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 763531033699999956-9989999992544011199999999999559998612324635357898049999614654
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+.||+|+||+||+|+.. +|+.||||++.... ..+++.+|++++++++|++++..++.+.. .....++|+||+ ++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEEECC-CC
T ss_pred EEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCCEEEEEEEEC-CC
T ss_conf 689850788099999998899899999972100--58889999999997038996017999995-198778999873-87
Q ss_pred CHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEEECCCCCCCCCCCCCC
Q ss_conf 29999821299999999999999999999999999863999712588999977606--9997899622352102568875
Q 001700 816 SLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA--PTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 816 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~--~~~~~kl~Dfgla~~~~~~~~~ 893 (1025)
++.+.+..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. .+..+|++|||+|+........
T Consensus 88 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 88 SLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp BHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCC
T ss_conf 13332443068----87689999999999999999997-99442667876606433577761565046751342554455
Q ss_pred ------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf ------51035744544753334688899997015899999999999199899843359997525799999975216663
Q 001700 894 ------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSGE 967 (1025)
Q Consensus 894 ------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 967 (1025)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.||..............+.......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 235 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----- 235 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-----
T ss_pred CCEECCCCCCCCCCCCCCCHHHHHCCC--CCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC-----
T ss_conf 410001357767873532999991899--8983218861778999984987665530577999999852356789-----
Q ss_pred CCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCC
Q ss_conf 102342289999996589999999998813999-999998999999963003
Q 001700 968 CFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVL 1018 (1025)
Q Consensus 968 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~ 1018 (1025)
..+.. ....+.++.+++.+||..+ ++||++.++.+.|+.+..
T Consensus 236 -~~~~~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 -PIEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -CHHHH--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -CHHHH--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -83575--------34788999999999843995579199999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.56 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=199.1
Q ss_pred CCCEEEEECCEEEEEEEE---C-CCCEEEEEECCCCC----HHCHHHHHHHHHHHHCCCC-CCCCCCCCEEECCCCCEEE
Q ss_conf 776353103369999995---6-99899999925440----1119999999999955999-8612324635357898049
Q 001700 736 PAEVIGRSCHGTLYKATL---D-SGSILAVKRLREGI----AKGKKEFAREVKKLGNIKH-PNLVSLQGYYWGPKEHEKL 806 (1025)
Q Consensus 736 ~~~~iG~G~~g~Vy~~~~---~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-pniv~l~g~~~~~~~~~~~ 806 (1025)
..+.||+|+||+||+|+. + +|+.||||.++... ....+.+.+|++++++++| |||+++++++. .....+
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--~~~~~~ 105 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TETKLH 105 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--ETTEEE
T ss_pred EEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCCCEE
T ss_conf 998983287839999998765887948999998367721016899999999999986467983999620002--487300
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 99961465429999821299999999999999999999999999863999712588999977606999789962235210
Q 001700 807 VISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 807 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~ 886 (1025)
+++||+.+|+|.+++.... .++...+..++.|++.||+|+|+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEESCSSEEEE
T ss_pred EEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHC-CCEEECCCCCCCEEECC-CCCEEEEECCCHHH
T ss_conf 1231234117999987304-----54378888889999999988514-99896547732012469-99888741320222
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 25688755103574454475333468889999701589999999999919989984335999752579999997521666
Q 001700 887 LTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG 966 (1025)
Q Consensus 887 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 966 (1025)
.............|++.|+|||.+.+....++.++||||+||++|||++|+.||....... ....+....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~------ 248 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRI------ 248 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHH------
T ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHC------
T ss_conf 0344443221222333331068760577688713251777799999976899988887777----999999833------
Q ss_pred CCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCC-----HHHHHH
Q ss_conf 3102342289999996589999999998813999-99999-----899999
Q 001700 967 ECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPD-----MMSVFE 1011 (1025)
Q Consensus 967 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs-----~~ev~~ 1011 (1025)
... .++.+...+.++.+++.+|+..+ ++||| ++|+++
T Consensus 249 ------~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 ------LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf ------568--9988654799999999997445898819997450999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.77 Aligned_cols=262 Identities=19% Similarity=0.198 Sum_probs=191.6
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECC------CCCEEEE
Q ss_conf 763531033699999956-99899999925440--11199999999999559998612324635357------8980499
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP------KEHEKLV 807 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~------~~~~~~l 807 (1025)
.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||++++++++... .....++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCEEEE
T ss_conf 99972274829999999899979999998422246378999999999999835999660676540246544445763899
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCC
Q ss_conf 99614654299998212999999999999999999999999998639997125889999776069997899622352102
Q 001700 808 ISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRIL 887 (1025)
Q Consensus 808 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~ 887 (1025)
|+||+.++.+........ .++...+..++.|++.||.|||+ .+|+||||||+|||++. ++.+|++|||+++..
T Consensus 95 v~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAF 167 (318)
T ss_dssp EEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEECCCCCCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHCC-CCEEECCCCCHHEEECC-CCCEEEEECCEEEEC
T ss_conf 985357874101222034-----43308999999999999988522-99885676722203668-996876313500223
Q ss_pred CCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 56887---551035744544753334688899997015899999999999199899843359997525799999975216
Q 001700 888 TSAGT---ADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 888 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
..... ......+||+.|+|||++.+... ++.++||||+||++|||++|+.||.... ............ +.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-~~~k~DiwSlGvil~el~~g~~pf~~~~----~~~~~~~i~~~~--~~ 240 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLC--GS 240 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHH--CC
T ss_pred CCCCCCCCCCCCCEECCHHHHHHHHHCCCCC-CCCHHHCCCCCCEEEEHHHCCCCCCCCC----HHHHHHHHHHHC--CC
T ss_conf 5544432113566024978742899707999-8917870067864661744879989989----999999999841--89
Q ss_pred CC-CCC--------HHHHCCCCCCC-CCHH------HHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf 66-310--------23422899999-9658------9999999998813999-999998999999
Q 001700 965 SG-ECF--------DRLIMDGHDME-QPPR------ILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 965 ~~-~~~--------d~~~~~~~~~~-~~~~------~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.. +.. ........... ...+ ....+.+++.+|+..+ ++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98255344320344433201334455503340444599899999999873896589099999749
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=310.83 Aligned_cols=160 Identities=28% Similarity=0.513 Sum_probs=104.7
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCC----CCEEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 18945699999998615889999734687888999999999852248079----98899993899960135910003998
Q 001700 15 ALGQSDFEALLQLKKGIAKDPSGQIIDSWDTKSLSSDGCPRNWFGITCTN----GYVTSIMLNDMGLVGNFSFPTIIGLK 90 (1025)
Q Consensus 15 ~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~~d~C~~~w~gv~C~~----~~v~~l~l~~~~l~g~~~~~~~~~L~ 90 (1025)
.|.++|++||++||+++ .||. .+ ++|..+ .|||.+.|+||+|++ +||+.|+|.+.++.|..+
T Consensus 2 ~c~~~e~~aLl~~k~~~-~~~~-~l-~sW~~~---~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~-------- 67 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDL-GNPT-TL-SSWLPT---TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP-------- 67 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GG-TTCCTT---SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEE--------
T ss_pred CCCHHHHHHHHHHHHHC-CCCC-CC-CCCCCC---CCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCC--------
T ss_conf 98989999999999977-9998-67-788999---9998894889697489994798899898998888887--------
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 99988755885865788889999999996668-84852382013389999979734774556799643344356476444
Q 001700 91 MLCNVSVSNNQLMGNITDIGSIQSLEFLDLSH-NLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLR 169 (1025)
Q Consensus 91 ~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (1025)
.++.++.|++|++|||+. |.++|.+|..|+++++|++|+|++|+|.+..+..+..+..|+.++++
T Consensus 68 --------------lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~ 133 (313)
T d1ogqa_ 68 --------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp --------------CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred --------------CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf --------------984784675335202026543330024311454200110203564344332222201110011112
Q ss_pred CCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCC
Q ss_conf 678899832676420447678284475632247
Q 001700 170 ANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLD 202 (1025)
Q Consensus 170 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 202 (1025)
.|.+.+.+|..+.++++++.+++++|.+++.+|
T Consensus 134 ~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip 166 (313)
T d1ogqa_ 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166 (313)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC
T ss_conf 245555685122067400000023553356203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=304.89 Aligned_cols=257 Identities=12% Similarity=0.131 Sum_probs=196.9
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCC-CCCCCCCCEEECCCCCEEEEEEECCCC
Q ss_conf 763531033699999956-998999999254401119999999999955999-861232463535789804999961465
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIKH-PNLVSLQGYYWGPKEHEKLVISNYINA 814 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~g~~~~~~~~~~~lv~e~~~~ 814 (1025)
.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+++++.+.| +|++.+++++. .....++|+||+ +
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~vme~~-~ 84 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEEEECC-C
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEE--CCCCCEEEEEEC-C
T ss_conf 799841788299999998899799999975025--82999999999999648999877999960--188117999964-8
Q ss_pred CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC----CCCCEEEECCCCCCCCCCC
Q ss_conf 429999821299999999999999999999999999863999712588999977606----9997899622352102568
Q 001700 815 QSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEA----PTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 815 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~----~~~~~kl~Dfgla~~~~~~ 890 (1025)
++|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. .+..+||+|||+|+.....
T Consensus 85 ~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 85 PSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHHHCC----CHHHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCC
T ss_conf 887999975203----11068999999999999999997-7966266771315234754344795687236605771467
Q ss_pred CCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 875------51035744544753334688899997015899999999999199899843359997525799999975216
Q 001700 891 GTA------DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENR 964 (1025)
Q Consensus 891 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 964 (1025)
... ......||+.|+|||++.+.. ++.++||||||+++|||+||+.||....... .............
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~----~~~~~~~i~~~~~ 233 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----NKQKYERIGEKKQ 233 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC----HHHHHHHHHHHHH
T ss_pred CCCCCEEECCCCCEEECHHHCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHHHHCCC
T ss_conf 665411102467627751026798964888--8869998983199999986987678853021----9999999970567
Q ss_pred CCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHCCCC
Q ss_conf 663102342289999996589999999998813999-9999989999999630035
Q 001700 965 SGECFDRLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEELSTIVLE 1019 (1025)
Q Consensus 965 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~L~~i~~~ 1019 (1025)
.. ..+.+ ....+.++.+++..|+..+ ++||+++.+.+.|+++..+
T Consensus 234 ~~--~~~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 ST--PLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HS--CHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CC--CHHHH--------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 99--95896--------579989999999998439930085999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.49 Aligned_cols=259 Identities=19% Similarity=0.228 Sum_probs=198.0
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEEECCC
Q ss_conf 763531033699999956-99899999925440--111999999999995599986123246353578980499996146
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGPKEHEKLVISNYIN 813 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~ 813 (1025)
.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++. .....++|++++.
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~iv~~~~~ 84 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECCS
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCC--CCCCEEEEEEECC
T ss_conf 26971286819999999999969999998032178689999999999998567578882135444--4431158863023
Q ss_pred CCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 54299998212999999999999999999999999998639997125889999776069997899622352102568875
Q 001700 814 AQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSAGTA 893 (1025)
Q Consensus 814 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~ 893 (1025)
++++..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. +..+|++|||.++........
T Consensus 85 ~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 85 QDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSCCSC
T ss_pred CCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHC-CCEEEECCCCCCCCCCC-CCCEEEEECCHHHCCCCCCCC
T ss_conf 322211212356-----54036789999999999877433-99860014676121133-782665204601104688751
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHH-CCC-CCCCH-
Q ss_conf 510357445447533346888999970158999999999991998998433599975257999999752-166-63102-
Q 001700 894 DQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALE-NRS-GECFD- 970 (1025)
Q Consensus 894 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~-~~~~d- 970 (1025)
.....+++.|+|||++..... .+.++||||+||++|||++|+.||... .+..+........ +.. .....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~-~~~~~DiwSlG~il~ell~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPG------NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSC-CCTHHHHHHHHHHHHHHTTTSCCSCCC------SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred -CEEECCCCCHHHHHHHCCCCC-CCCHHHCCCCCHHHHHHHHCCCCCCCC------CCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf -001034431014667506988-880444026541889985189999889------999999999986118997355134
Q ss_pred --HH---------HCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf --34---------2289999996589999999998813999-999998999999
Q 001700 971 --RL---------IMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 971 --~~---------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.. ................+.+++.+|+..+ .+|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 432221133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=300.52 Aligned_cols=255 Identities=16% Similarity=0.147 Sum_probs=191.4
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECC----CCCEEEEEE
Q ss_conf 763531033699999956-99899999925440--11199999999999559998612324635357----898049999
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP----KEHEKLVIS 809 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~----~~~~~~lv~ 809 (1025)
.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++... .....++|+
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEEEEE
T ss_conf 88962175859999999999989999998823369799999999999998648987648998970256434576269998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 61465429999821299999999999999999999999999863999712588999977606999789962235210256
Q 001700 810 NYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTS 889 (1025)
Q Consensus 810 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~ 889 (1025)
||+.++.+. .+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++. +..+|++|||+++....
T Consensus 102 Ey~~~~l~~-~~~~-------~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 102 ELMDANLCQ-VIQM-------ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGT 171 (355)
T ss_dssp ECCSEEHHH-HHTS-------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC------
T ss_pred ECCCHHHHH-HHHC-------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCC-CCCEEEECHHHHHCCCC
T ss_conf 414467787-6503-------89999999999999999988652-21124567763211365-44313201023211466
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHH---------
Q ss_conf 88755103574454475333468889999701589999999999919989984335999752579999997---------
Q 001700 890 AGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLA--------- 960 (1025)
Q Consensus 890 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~--------- 960 (1025)
.... ....||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... . ........
T Consensus 172 ~~~~--~~~~~t~~y~aPE~l~~~~--~~~~~DiwSlG~~l~ell~g~~pF~~~~------~-~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 172 SFMM--TPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRD------Y-IDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp -----------CCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSSCCSS------H-HHHHHHHHHHHCCCCHH
T ss_pred CCCC--CCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCCHHHHHHHCCCCCCCCC------H-HHHHHHHHHHCCCCCHH
T ss_conf 6553--3221465555813314777--7877433356625789865989988897------7-88999999720589879
Q ss_pred -------------HHCC-CCCCCHHHHC----CCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHH
Q ss_conf -------------5216-6631023422----89999996589999999998813999-999998999999
Q 001700 961 -------------LENR-SGECFDRLIM----DGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSVFEE 1012 (1025)
Q Consensus 961 -------------~~~~-~~~~~d~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~~ 1012 (1025)
.... ....-.+... .............++.+++.+|+..+ ++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.66 Aligned_cols=262 Identities=19% Similarity=0.222 Sum_probs=193.2
Q ss_pred CCEEEEECCEEEEEEEE-CCCCEEEEEECCCCC--HHCHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEEEEE
Q ss_conf 76353103369999995-699899999925440--11199999999999559998612324635357---8980499996
Q 001700 737 AEVIGRSCHGTLYKATL-DSGSILAVKRLREGI--AKGKKEFAREVKKLGNIKHPNLVSLQGYYWGP---KEHEKLVISN 810 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~---~~~~~~lv~e 810 (1025)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||+|++++++... .....+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEEEEE
T ss_conf 88983178839999999999979999998820028689999999999998668987425999996346456686499999
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 14654299998212999999999999999999999999998639997125889999776069997899622352102568
Q 001700 811 YINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNAVLTDYSLHRILTSA 890 (1025)
Q Consensus 811 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~~~~~ 890 (1025)
|+.+|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+|++|||.+......
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLARHTDDE 174 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----CCTGG
T ss_pred EECCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCC-CCCCCCCCCCHHCCCCCC
T ss_conf 62588623200224------53099999999999999999973-88765166776334554-322001321000125754
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC----
Q ss_conf 8755103574454475333468889999701589999999999919989984335999752579999997521666----
Q 001700 891 GTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRLLALENRSG---- 966 (1025)
Q Consensus 891 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~---- 966 (1025)
.....|++.|+|||+..+... .+.++||||+||++|||++|+.||.... .......+... .+...
T Consensus 175 ----~~~~~g~~~y~apE~~~~~~~-~~~~~DiwSlGv~l~~ll~g~~pF~~~~----~~~~~~~i~~~--~~~~~~~~~ 243 (348)
T d2gfsa1 175 ----MTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLILRL--VGTPGAELL 243 (348)
T ss_dssp ----GSSSCHHHHTSCHHHHTTCSC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH--HCCCCHHHH
T ss_pred ----CCCCCCCCCCCCCHHHCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHH--CCCCCHHHH
T ss_conf ----444345435558355337756-7855124320589999976889978898----89999999973--079975773
Q ss_pred -----CCCHHHHCCCCC-CCC-----CHHHHHHHHHHHHHCCCCC-CCCCCHHHHHH--HHHHCC
Q ss_conf -----310234228999-999-----6589999999998813999-99999899999--996300
Q 001700 967 -----ECFDRLIMDGHD-MEQ-----PPRILSDMLQVALRCILPA-SERPDMMSVFE--ELSTIV 1017 (1025)
Q Consensus 967 -----~~~d~~~~~~~~-~~~-----~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev~~--~L~~i~ 1017 (1025)
............ ... ......++.+++.+|+..+ .+|||+.|+++ .++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 20010244544430355787555662678999999999997758834593899985599548799
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=280.08 Aligned_cols=268 Identities=14% Similarity=0.154 Sum_probs=187.8
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHCHHHHHHHHHHHHCCC-----------CCCCCCCCCEEECCCCCE
Q ss_conf 763531033699999956-99899999925440111999999999995599-----------986123246353578980
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGIAKGKKEFAREVKKLGNIK-----------HPNLVSLQGYYWGPKEHE 804 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~g~~~~~~~~~ 804 (1025)
.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++.......
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 899750778189999999999799999983431-3368999999999984014555554227676478998763125652
Q ss_pred EEEEEECCCCCC-HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCC-----CEEE
Q ss_conf 499996146542-9999821299999999999999999999999999863999712588999977606999-----7899
Q 001700 805 KLVISNYINAQS-LAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTM-----NAVL 878 (1025)
Q Consensus 805 ~~lv~e~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~-----~~kl 878 (1025)
.+++++++..+. .......... ..+++..+..++.|++.||+|||+..+|+||||||+|||++..+. .+++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred EEEEEEECCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEEE
T ss_conf 02343200035420000012234---678689999999999999888764058646567705705630576564430567
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 62235210256887551035744544753334688899997015899999999999199899843359997525799999
Q 001700 879 TDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILLELLTGKSSGEIVCVDPGVVDLTDWVRL 958 (1025)
Q Consensus 879 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~elltG~~P~~~~~~~~~~~~l~~~~~~ 958 (1025)
+|||.+....... ....|++.|+|||++.+.. ++.++||||+||+++||++|+.||..................
T Consensus 174 ~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 174 ADLGNACWYDEHY----TNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp CCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 5314421234454----2236652105713214667--776432012378999998788998987554321026899999
Q ss_pred HHHHCCC-----------CCCCH-----------------HHHCCCCCCCCCHHHHHHHHHHHHHCCCCC-CCCCCHHHH
Q ss_conf 9752166-----------63102-----------------342289999996589999999998813999-999998999
Q 001700 959 LALENRS-----------GECFD-----------------RLIMDGHDMEQPPRILSDMLQVALRCILPA-SERPDMMSV 1009 (1025)
Q Consensus 959 ~~~~~~~-----------~~~~d-----------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~-~~RPs~~ev 1009 (1025)
...-+.. ...++ ..... ..........++.+++.+|+..+ .+|||++|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 998379987886245322000132012202432357764442100--015674358999999999877994579089999
Q ss_pred HHH--HHHC
Q ss_conf 999--9630
Q 001700 1010 FEE--LSTI 1016 (1025)
Q Consensus 1010 ~~~--L~~i 1016 (1025)
++. +++.
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred HCCCCCCCC
T ss_conf 669340789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.6e-39 Score=218.55 Aligned_cols=342 Identities=20% Similarity=0.234 Sum_probs=165.0
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99899988755885865788889999999996668848523820133899999797347745567996433443564764
Q 001700 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLD 167 (1025)
Q Consensus 88 ~L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (1025)
.|..|++|+++++.|... ..++.+++|++|||++|+|+++. .|+++++|++|++++|+|.+.. .++++++|+.|+
T Consensus 42 ~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~ 116 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 116 (384)
T ss_dssp HHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred HHCCCCEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCC
T ss_conf 957878998999898776-24245899998968188179886--3347711010301343332222--111233433344
Q ss_pred CCCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 44678899832676420447678284475632247999887545555578654666657447899998899878886558
Q 001700 168 LRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASN 247 (1025)
Q Consensus 168 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 247 (1025)
+++|.+++.... .....+..+....|.+........... ............+. .+.............
T Consensus 117 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 184 (384)
T d2omza2 117 LFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTS---LQQLSFGNQVTDLK-------PLANLTTLERLDISS 184 (384)
T ss_dssp CCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTT---CSEEEEEESCCCCG-------GGTTCTTCCEEECCS
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCHHH-------HHCCCCCCCCCCCCC
T ss_conf 332222222222--222222112134663131002322221---12222212322011-------112454211011222
Q ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 83556678531113345121145215235894577314456586876566676854655788745898459855698899
Q 001700 248 NHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPA 327 (1025)
Q Consensus 248 N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 327 (1025)
|.... ...+..+.+++ .++++.|.+++..+......|+.|++++|.+.. ++
T Consensus 185 ~~~~~-~~~~~~l~~~~--------------------------~l~l~~n~i~~~~~~~~~~~L~~L~l~~n~l~~-~~- 235 (384)
T d2omza2 185 NKVSD-ISVLAKLTNLE--------------------------SLIATNNQISDITPLGILTNLDELSLNGNQLKD-IG- 235 (384)
T ss_dssp SCCCC-CGGGGGCTTCS--------------------------EEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred CCCCC-CCCCCCCCCCC--------------------------EEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CC-
T ss_conf 43332-11002235323--------------------------330357744787864445778788887777789-61-
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 88776655123754778632124578864667713787789893000378888999824863678856013899999876
Q 001700 328 RVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVI 407 (1025)
Q Consensus 328 ~l~~l~~L~Ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L 407 (1025)
.+.....++.+++++|.+++..+ +..+++|+.|++++|.+.+..+ +..++.++.+
T Consensus 236 ---------------------~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l 290 (384)
T d2omza2 236 ---------------------TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290 (384)
T ss_dssp ---------------------GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred ---------------------HHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf ---------------------34325653410044674478775--3554668775456744578773--2356522223
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCE
Q ss_conf 24797245558612228999878966799474668933324899855444456348985378485568732216899997
Q 001700 408 DLSLNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVY 487 (1025)
Q Consensus 408 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 487 (1025)
.++.|.+.+. ..+..+++++.|++++|++++..+. ..+. +|+.|++++|.+++ ++.+..+++|+.
T Consensus 291 ~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~l---------~~l~--~L~~L~L~~n~l~~--l~~l~~l~~L~~ 355 (384)
T d2omza2 291 ELNENQLEDI--SPISNLKNLTYLTLYFNNISDISPV---------SSLT--KLQRLFFANNKVSD--VSSLANLTNINW 355 (384)
T ss_dssp ECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGGG---------GGCT--TCCEEECCSSCCCC--CGGGGGCTTCCE
T ss_pred CCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCCCC---------CCCC--CCCEEECCCCCCCC--CHHHCCCCCCCE
T ss_conf 3232333332--2100002467677778877898453---------6689--88989898998999--746708999998
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 6285784722259885799957978788
Q 001700 488 LNLSNNKFEGSIPDGLPNGLKEFNVSFN 515 (1025)
Q Consensus 488 L~Ls~N~l~g~~p~~~~~~L~~L~ls~N 515 (1025)
|+|++|++++.+|-.-.+.|+.|++++|
T Consensus 356 L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 356 LSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp EECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred EECCCCCCCCCHHHCCCCCCCEEECCCC
T ss_conf 9897995899800003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.3e-38 Score=213.83 Aligned_cols=147 Identities=24% Similarity=0.391 Sum_probs=73.9
Q ss_pred CCCEEEECCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 64667713787789893000378888999824863678856013899999876247972455586122289998789667
Q 001700 355 YVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLSLNHLNGFLLPSFFTSTKLTDLNLS 434 (1025)
Q Consensus 355 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 434 (1025)
.++.|++++|.++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|+++.|++++.. .+..+..++.++++
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 787888877777896--134325653410044674478775--355466877545674457877--32356522223323
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEEC
Q ss_conf 9947466893332489985544445634898537848556873221689999762857847222598857--99957978
Q 001700 435 GNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNLSNNKFEGSIPDGLP--NGLKEFNV 512 (1025)
Q Consensus 435 ~N~l~~~~p~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~l 512 (1025)
.|.+.+.... ... ..++.|++++|++++.. .+..+++|+.|++++|++++ ++ .+. ++|+.|++
T Consensus 294 ~n~l~~~~~~---------~~~--~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 294 ENQLEDISPI---------SNL--KNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSA 358 (384)
T ss_dssp SSCCSCCGGG---------GGC--TTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEEC
T ss_pred CCCCCCCCCC---------CHH--CCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEEC
T ss_conf 2333332210---------000--24676777788778984--53668988989898998999-74-6708999998989
Q ss_pred CCCCCCCCCC
Q ss_conf 7882645689
Q 001700 513 SFNNLSGVVP 522 (1025)
Q Consensus 513 s~N~l~g~~p 522 (1025)
++|++++.+|
T Consensus 359 ~~N~l~~l~~ 368 (384)
T d2omza2 359 GHNQISDLTP 368 (384)
T ss_dssp CSSCCCBCGG
T ss_pred CCCCCCCCHH
T ss_conf 7995899800
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.4e-41 Score=227.95 Aligned_cols=109 Identities=28% Similarity=0.432 Sum_probs=79.5
Q ss_pred CCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCE
Q ss_conf 999999666884852--3820133899999797347-7455679964334435647644467889983267642044767
Q 001700 113 QSLEFLDLSHNLFHG--LIPSGIVSLKNLMLLNISS-NSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVH 189 (1025)
Q Consensus 113 ~~L~~LdLs~N~i~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 189 (1025)
.+++.|||+.|.++| .+|..+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 79889989899888888798478467533520202654333002431145420011020356434433222220111001
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 82844756322479998875455555786546666
Q 001700 190 VDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224 (1025)
Q Consensus 190 L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l 224 (1025)
+++++|.+.+.+|..++.+ +.++.+++++|.+
T Consensus 130 l~l~~N~~~~~~p~~l~~l---~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSL---PNLVGITFDGNRI 161 (313)
T ss_dssp EECCSSEEESCCCGGGGGC---TTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCHHHCCC---CCCCEEECCCCCC
T ss_conf 1112245555685122067---4000000235533
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-36 Score=203.23 Aligned_cols=119 Identities=16% Similarity=0.223 Sum_probs=57.8
Q ss_pred CCCCCCCCCCCCEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCC
Q ss_conf 999999998522480799889999389996013591000399899988755885865788-8899999999966688485
Q 001700 48 LSSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNIT-DIGSIQSLEFLDLSHNLFH 126 (1025)
Q Consensus 48 ~~~d~C~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~~~-~~~~l~~L~~LdLs~N~i~ 126 (1025)
.|+..|.|.|.+|.|++...+.+ | +.+ .+.++.|++++|+|+..++ .|.++++|++|++++|.+.
T Consensus 3 ~~p~~c~c~~~~~~C~~~~L~~l-----------P-~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~ 68 (305)
T d1xkua_ 3 VCPFRCQCHLRVVQCSDLGLEKV-----------P-KDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68 (305)
T ss_dssp CCCTTCEEETTEEECTTSCCCSC-----------C-CSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCEECCCEEEECCCCCCCC-----------C-CCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 89998895599998559998851-----------9-888--999798978499189869657604656523112344344
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHH
Q ss_conf 238201338999997973477455679964334435647644467889983267642
Q 001700 127 GLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQ 183 (1025)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 183 (1025)
.+.|..|.++++|++|++++|+|+. +|..+ ...|..|+++.|.+....+..+..
T Consensus 69 ~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~ 122 (305)
T d1xkua_ 69 KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNG 122 (305)
T ss_dssp CBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTT
T ss_pred CCCHHHHHCCCCCCEECCCCCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHC
T ss_conf 5235665279855783156875676-76400--111323210246102344445401
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-36 Score=199.12 Aligned_cols=85 Identities=20% Similarity=0.221 Sum_probs=38.7
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC-CCCCCCCCCHHHHHHCCCCCEEE
Q ss_conf 99999966688485238201338999997973477455679964334435647644-46788998326764204476782
Q 001700 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDL-RANRFGGDIMHLLSQLGSVVHVD 191 (1025)
Q Consensus 113 ~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~~~~~~~l~~L~~L~ 191 (1025)
+.+++|+|++|.|+.+.+..|.++++|++|++++|+|..+.+..+.+++.++.++. ..|.++...+..|.++++|+.|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 99888977488179879778641421300001344543321112122222222222210223544620101010277875
Q ss_pred CCCCCC
Q ss_conf 844756
Q 001700 192 LSNNQF 197 (1025)
Q Consensus 192 Ls~N~l 197 (1025)
+++|.+
T Consensus 112 l~~n~~ 117 (284)
T d1ozna_ 112 LDRCGL 117 (284)
T ss_dssp CTTSCC
T ss_pred CCCCCC
T ss_conf 688544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-34 Score=188.51 Aligned_cols=241 Identities=20% Similarity=0.224 Sum_probs=116.6
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 98875588586578888999999999666884852382013389999979734774556799643344356476444678
Q 001700 93 CNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172 (1025)
Q Consensus 93 ~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 172 (1025)
+.++-+++.++..|+.+. +++++|+|++|.|+.+.+..|.++++|++|++++|.+..+.|..|.++++|+.|++++|+
T Consensus 13 ~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp TEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEECCCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCC
T ss_conf 999855999885198889--997989784991898696576046565231123443445235665279855783156875
Q ss_pred CCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 89983267642044767828447563224799988754555557865466665744789999889987888655883556
Q 001700 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVG 252 (1025)
Q Consensus 173 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 252 (1025)
++..... + ...+..|+++.|.+.+..+.. +.....+..++...|....
T Consensus 91 l~~l~~~-~--~~~l~~L~~~~n~l~~l~~~~-----------------------------~~~~~~~~~l~~~~n~~~~ 138 (305)
T d1xkua_ 91 LKELPEK-M--PKTLQELRVHENEITKVRKSV-----------------------------FNGLNQMIVVELGTNPLKS 138 (305)
T ss_dssp CSBCCSS-C--CTTCCEEECCSSCCCBBCHHH-----------------------------HTTCTTCCEEECCSSCCCG
T ss_pred CCCCCCC-H--HHHHHHHHCCCCCHHHHHHHH-----------------------------HHCCCCCCCCCCCCCCCCC
T ss_conf 6767640-0--111323210246102344445-----------------------------4013311000012333334
Q ss_pred CC---CCCCCCCCCCCEECCCCCCCCCCCHHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 67---853111334512114521523589457731445658687656667685465578874589845985569889988
Q 001700 253 AI---PSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARV 329 (1025)
Q Consensus 253 ~~---~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~l 329 (1025)
.. ..+..+ ..|+.+++++|.+.. +|..
T Consensus 139 ~~~~~~~~~~l------------------------------------------------~~L~~l~l~~n~l~~-l~~~- 168 (305)
T d1xkua_ 139 SGIENGAFQGM------------------------------------------------KKLSYIRIADTNITT-IPQG- 168 (305)
T ss_dssp GGBCTTGGGGC------------------------------------------------TTCCEEECCSSCCCS-CCSS-
T ss_pred CCCCCCCCCCC------------------------------------------------CCCCCCCCCCCCCCC-CCCC-
T ss_conf 67776422345------------------------------------------------656712034677451-6710-
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 77665512375477863212457886466771378778989300037888899982486367885601389999987624
Q 001700 330 GHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDL 409 (1025)
Q Consensus 330 ~~l~~L~Ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~L 409 (1025)
. ...++.|++++|......+..+..++.++.|++++|.+++..+..+..+++|+.|+|
T Consensus 169 -------------------~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 169 -------------------L---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp -------------------C---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred -------------------C---CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf -------------------1---776678989788677888267641341330154455332223454334433224302
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 7972455586122289998789667994746
Q 001700 410 SLNHLNGFLLPSFFTSTKLTDLNLSGNNFSG 440 (1025)
Q Consensus 410 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 440 (1025)
++|+++.. |..+..+++|+.|++++|+++.
T Consensus 227 ~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 227 NNNKLVKV-PGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CSSCCSSC-CTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCCCCC-CCCCCCCCCCCEEECCCCCCCC
T ss_conf 55400246-3110334678989898986576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-33 Score=183.32 Aligned_cols=230 Identities=20% Similarity=0.215 Sum_probs=148.3
Q ss_pred CCCCCCC---CCCCEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCC
Q ss_conf 9999999---85224807998899993899960135910003998999887558858657888-8999999999666884
Q 001700 49 SSDGCPR---NWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNL 124 (1025)
Q Consensus 49 ~~d~C~~---~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~~~~-~~~l~~L~~LdLs~N~ 124 (1025)
|+-.|.| .|.-|.|++..++.+ |.-. .+.+++|+|++|.|+..++. |..+++|++||+++|.
T Consensus 2 cp~~C~C~~~~~~~v~c~~~~L~~i-------------P~~i-p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~ 67 (284)
T d1ozna_ 2 CPGACVCYNEPKVTTSCPQQGLQAV-------------PVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67 (284)
T ss_dssp CCTTCEEECSSSCEEECCSSCCSSC-------------CTTC-CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCEECCCCCEEEECCCCCCCCC-------------CCCC-CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCC
T ss_conf 5998898699996998479998944-------------9788-9998889774881798797786414213000013445
Q ss_pred CCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCC
Q ss_conf 852382013389999979734-7745567996433443564764446788998326764204476782844756322479
Q 001700 125 FHGLIPSGIVSLKNLMLLNIS-SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDL 203 (1025)
Q Consensus 125 i~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 203 (1025)
|..+.+..+..++.+..++.. .|.+..+.+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..+.
T Consensus 68 l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~ 147 (284)
T d1ozna_ 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHH
T ss_conf 43321112122222222222210223544620101010277875688544320135332000121102001431445805
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCHHHH
Q ss_conf 9988754555557865466665744789999889987888655883556678-531113345121145215235894577
Q 001700 204 GLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIP-SFNFVFSLRILRLGSNQLSGSLPVALL 282 (1025)
Q Consensus 204 ~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~g~~p~~~~ 282 (1025)
.+... ++|+.|++++|++.. .+...+..+++|+.+++++|++.+..| .|..+.+|+.|++++|++.+..+..+.
T Consensus 148 ~f~~~---~~L~~L~l~~N~l~~--l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~ 222 (284)
T d1ozna_ 148 TFRDL---GNLTHLFLHGNRISS--VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222 (284)
T ss_dssp TTTTC---TTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHT
T ss_pred HHCCC---CCHHHCCCCCCCCCC--CCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 74043---405022314176566--2566654656341314211434662816766532000233333522100000235
Q ss_pred HHCCCCCCEEECCCCCC
Q ss_conf 31445658687656667
Q 001700 283 QESSMMLSELDLSLNQL 299 (1025)
Q Consensus 283 ~~~~~~L~~L~ls~N~l 299 (1025)
... .|+.|++++|.+
T Consensus 223 ~~~--~L~~L~l~~N~l 237 (284)
T d1ozna_ 223 PLR--ALQYLRLNDNPW 237 (284)
T ss_dssp TCT--TCCEEECCSSCE
T ss_pred CCC--CCCEEEECCCCC
T ss_conf 546--568898119988
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.6e-31 Score=174.23 Aligned_cols=175 Identities=23% Similarity=0.252 Sum_probs=65.2
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 87558858657888899999999966688485238201338999997973477455679964334435647644467889
Q 001700 95 VSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFG 174 (1025)
Q Consensus 95 L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 174 (1025)
.+.+++.++..++++. +++++|||++|.|+++.+..|.++++|++|+|++|+|+.+ +.++.+++|++|+|++|+++
T Consensus 15 v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l--~~~~~l~~L~~L~Ls~N~l~ 90 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ 90 (266)
T ss_dssp EECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE--ECCSCCTTCCEEECCSSCCS
T ss_pred EECCCCCCCEECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf 9806999886196757--6889898849928985977863456552213566544443--11111223211111222221
Q ss_pred CCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 98326764204476782844756322479998875455555786546666574478999988998788865588355667
Q 001700 175 GDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAI 254 (1025)
Q Consensus 175 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 254 (1025)
. .+..+..+++|+.|++++|.+....+..+.. +.+++.|++++|.+.. ++...+..+++++.+++++|++++.+
T Consensus 91 ~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~---l~~l~~L~l~~n~l~~--l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 91 S-LPLLGQTLPALTVLDVSFNRLTSLPLGALRG---LGELQELYLKGNELKT--LPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp S-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTT---CTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred C-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCC---CCCCCCCCCCCCCCCE--ECCCCCCCCCCCHHCCCCCCCCCCCC
T ss_conf 1-1112122222222222223110110011222---2111122124342102--21233322111000000015652237
Q ss_pred CC-CCCCCCCCCEECCCCCCCCCCCHH
Q ss_conf 85-311133451211452152358945
Q 001700 255 PS-FNFVFSLRILRLGSNQLSGSLPVA 280 (1025)
Q Consensus 255 ~~-~~~l~~L~~L~L~~N~l~g~~p~~ 280 (1025)
+. |..+.+|+.|+|++|+|+ .+|..
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~ 190 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKG 190 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTT
T ss_pred CCCCCCCCCCCEEECCCCCCC-CCCHH
T ss_conf 200134212423430139785-56866
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-30 Score=172.59 Aligned_cols=176 Identities=21% Similarity=0.157 Sum_probs=80.7
Q ss_pred CCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 999887558858657888-8999999999666884852382013389999979734774556799643344356476444
Q 001700 91 MLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLR 169 (1025)
Q Consensus 91 ~L~~L~l~~N~~~~~~~~-~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (1025)
.++.|+|++|.|.+.++. |..+++|++|+|++|.|+.+ + .++.+++|++|+|++|+++. .+..|.++++|++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf 889898849928985977863456552213566544443-1-11112232111112222211-11121222222222222
Q ss_pred CCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 67889983267642044767828447563224799988754555557865466665744789999889987888655883
Q 001700 170 ANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNH 249 (1025)
Q Consensus 170 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 249 (1025)
+|.+....+..+..+.++..|++++|.++...+..+.. +++++.+++++|++++ .+...+..+++|+.|+|++|+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~---l~~l~~l~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP---TPKLEKLSLANNNLTE--LPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT---CTTCCEEECTTSCCSC--CCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC---CCCCHHCCCCCCCCCC--CCCCCCCCCCCCCEEECCCCC
T ss_conf 23110110011222211112212434210221233322---1110000000156522--372001342124234301397
Q ss_pred CCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 5566785311133451211452152
Q 001700 250 LVGAIPSFNFVFSLRILRLGSNQLS 274 (1025)
Q Consensus 250 l~~~~~~~~~l~~L~~L~L~~N~l~ 274 (1025)
|+.+++.+..+.+|+.|+|++|.+.
T Consensus 184 L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 184 LYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCHHHCCCCCCCEEEECCCCCC
T ss_conf 8556866777888999983699987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.97 E-value=3.5e-28 Score=159.73 Aligned_cols=313 Identities=22% Similarity=0.237 Sum_probs=146.2
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99988755885865788889999999996668848523820133899999797347745567996433443564764446
Q 001700 91 MLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRA 170 (1025)
Q Consensus 91 ~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (1025)
.+++|++++|.++..++ .+++|++|+|++|+|+ .+|.. +.+|+.|++++|+++. ++. + .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCS
T ss_pred CCCEEEECCCCCCCCCC---CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCCH-HHH-H--CCCCCCCCCCC
T ss_conf 99899937999887889---8789888989999796-33620---3320332665514320-321-0--22111113345
Q ss_pred CCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 78899832676420447678284475632247999887545555578654666657447899998899878886558835
Q 001700 171 NRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHL 250 (1025)
Q Consensus 171 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 250 (1025)
|.+... |. +..+++|+.|++++|.+...... ...+..+.+..+.... . ..+..++.++.++++.|..
T Consensus 108 n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~~~~-------~~~l~~l~~~~~~~~~--~--~~l~~l~~l~~L~l~~n~~ 174 (353)
T d1jl5a_ 108 NQLEKL-PE-LQNSSFLKIIDVDNNSLKKLPDL-------PPSLEFIAAGNNQLEE--L--PELQNLPFLTAIYADNNSL 174 (353)
T ss_dssp SCCSSC-CC-CTTCTTCCEEECCSSCCSCCCCC-------CTTCCEEECCSSCCSS--C--CCCTTCTTCCEEECCSSCC
T ss_pred CCCCCC-CC-HHHHCCCEEECCCCCCCCCCCCC-------CCCCCCHHHCCCCCCC--C--CCCCCCCCCEECCCCCCCC
T ss_conf 543222-10-01101312311356510013223-------3332100001222223--3--3200012220011123344
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 56678531113345121145215235894577314456586876566676854655788745898459855698899887
Q 001700 251 VGAIPSFNFVFSLRILRLGSNQLSGSLPVALLQESSMMLSELDLSLNQLEGPVGSITSATLKKVNLSSNKLSGSLPARVG 330 (1025)
Q Consensus 251 ~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~l~ 330 (1025)
....... .. ...+..+.+.+........++.++.+++++|... .++....
T Consensus 175 ~~~~~~~---~~--------------------------~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~~~~ 224 (353)
T d1jl5a_ 175 KKLPDLP---LS--------------------------LESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPP 224 (353)
T ss_dssp SSCCCCC---TT--------------------------CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCSCCT
T ss_pred CCCCCCC---CC--------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 3222212---22--------------------------2223344432222122345553331222542223-4553233
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 76655123754778632124578864667713787789893000378888999824863678856013899999876247
Q 001700 331 HCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGMVPNQTSQFLRLTSFKVSNNSLEGDLPAVLGTYPELKVIDLS 410 (1025)
Q Consensus 331 ~l~~L~Ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls 410 (1025)
++..+.+..+.+..... ....+...++..+.+.+. +. ........++.
T Consensus 225 ~l~~~~~~~~~~~~~~~----------------------------~~~~l~~~~~~~~~~~~l-~~---l~~~~~~~~~~ 272 (353)
T d1jl5a_ 225 SLEALNVRDNYLTDLPE----------------------------LPQSLTFLDVSENIFSGL-SE---LPPNLYYLNAS 272 (353)
T ss_dssp TCCEEECCSSCCSCCCC----------------------------CCTTCCEEECCSSCCSEE-SC---CCTTCCEEECC
T ss_pred CCCCCCCCCCCCCCCCC----------------------------CCCCCCCCCCCCCCCCCC-CC---CCCHHCCCCCC
T ss_conf 43332223333344433----------------------------344322222222333222-34---53000123333
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEC
Q ss_conf 97245558612228999878966799474668933324899855444456348985378485568732216899997628
Q 001700 411 LNHLNGFLLPSFFTSTKLTDLNLSGNNFSGPLPLQEIQNNPSTGSTQNLSLTSLDLAYNSLSGRLLPGISKFHNLVYLNL 490 (1025)
Q Consensus 411 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 490 (1025)
.+.+.+.. ..+++|+.|++++|+++. +|.. . .+|+.|+|++|+++ .+|.. +.+|+.|+|
T Consensus 273 ~~~~~~~~----~~~~~L~~L~Ls~N~l~~-lp~~----------~--~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L 331 (353)
T d1jl5a_ 273 SNEIRSLC----DLPPSLEELNVSNNKLIE-LPAL----------P--PRLERLIASFNHLA-EVPEL---PQNLKQLHV 331 (353)
T ss_dssp SSCCSEEC----CCCTTCCEEECCSSCCSC-CCCC----------C--TTCCEEECCSSCCS-CCCCC---CTTCCEEEC
T ss_pred CCCCCCCC----CCCCCCCEEECCCCCCCC-CCCC----------C--CCCCEEECCCCCCC-CCCCC---CCCCCEEEC
T ss_conf 57532345----668988989797991683-5665----------4--87998989999687-54532---288898987
Q ss_pred CCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 5784722259885799957978
Q 001700 491 SNNKFEGSIPDGLPNGLKEFNV 512 (1025)
Q Consensus 491 s~N~l~g~~p~~~~~~L~~L~l 512 (1025)
++|+++ .+|. ++..|+.|.+
T Consensus 332 ~~N~L~-~lp~-~~~~L~~L~~ 351 (353)
T d1jl5a_ 332 EYNPLR-EFPD-IPESVEDLRM 351 (353)
T ss_dssp CSSCCS-SCCC-CCTTCCEEEC
T ss_pred CCCCCC-CCCC-CCCCCCEEEC
T ss_conf 699189-7776-5265671289
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.97 E-value=1.1e-26 Score=151.94 Aligned_cols=179 Identities=23% Similarity=0.207 Sum_probs=71.0
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 88999938999601359100039989998875588586578888999999999666884852382013389999979734
Q 001700 66 YVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNIS 145 (1025)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls 145 (1025)
.++.|+|++.++.. +| . .+++|+.|++++|+|+..+.. +.+|+.|++++|.++.+ +. +. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp--~--~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l-~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LP--E--LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKAL-SD-LP--PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CC--S--CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCC-CS-CC--TTCCEEECC
T ss_pred CCCEEEECCCCCCC-CC--C--CCCCCCEEECCCCCCCCCCCC---HHHHHHHHHHHCCCCHH-HH-HC--CCCCCCCCC
T ss_conf 99899937999887-88--9--878988898999979633620---33203326655143203-21-02--211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 77455679964334435647644467889983267642044767828447563224799988754555557865466665
Q 001700 146 SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLV 225 (1025)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~ 225 (1025)
+|.|.. +|. ++.+++|+.|++++|.+..... ....+..+.+..+..... .. +..++.++.+.+..|.+.
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~--~~---l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEEL--PE---LQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC--CC---CTTCTTCCEEECCSSCCS
T ss_pred CCCCCC-CCC-HHHHCCCEEECCCCCCCCCCCC----CCCCCCCHHHCCCCCCCC--CC---CCCCCCCEECCCCCCCCC
T ss_conf 554322-210-0110131231135651001322----333321000012222233--32---000122200111233443
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 7447899998899878886558835566785311133451211452152
Q 001700 226 GELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLS 274 (1025)
Q Consensus 226 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 274 (1025)
. .+. .......+....+.+. ..+.+..+..|+.++++.|...
T Consensus 176 ~--~~~----~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 176 K--LPD----LPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp S--CCC----CCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred C--CCC----CCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 2--222----1222222334443222-2122345553331222542223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.96 E-value=1.1e-29 Score=167.50 Aligned_cols=170 Identities=14% Similarity=0.166 Sum_probs=118.9
Q ss_pred CCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCH------------------HCHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 77763531033699999956998999999254401------------------119999999999955999861232463
Q 001700 735 APAEVIGRSCHGTLYKATLDSGSILAVKRLREGIA------------------KGKKEFAREVKKLGNIKHPNLVSLQGY 796 (1025)
Q Consensus 735 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~g~ 796 (1025)
+.++.||+|+||+||+|+..+|+.||||+++.... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCE
Q ss_conf 53578980499996146542999982129999999999999999999999999986399971258899997760699978
Q 001700 797 YWGPKEHEKLVISNYINAQSLAVYLQETDPRKLPPLSIDERLRVAVDVARCLNYLHNERAIPHGNLKSTNILLEAPTMNA 876 (1025)
Q Consensus 797 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ivHrdlkp~NILl~~~~~~~ 876 (1025)
. ..+++|||++++.+. .++......++.|+++|++|||+ .+|+|||+||+|||++. + .+
T Consensus 83 ~------~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-~-~~ 141 (191)
T d1zara2 83 E------GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-E-GI 141 (191)
T ss_dssp E------TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET-T-EE
T ss_pred C------CCEEEEEEECCCCCC------------CHHHHHHHHHHHHHHHHHHHHHH-CCEEECCCCHHHEEEEC-C-CE
T ss_conf 2------888999950456542------------00157899999999999999826-88898368903611428-9-89
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9962235210256887551035744544753334688899997015899999999
Q 001700 877 VLTDYSLHRILTSAGTADQVLNAGALGYRPPEFASTSKPCPSLKSDVYAFGIILL 931 (1025)
Q Consensus 877 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DV~SlGvil~ 931 (1025)
+++|||.|.....+.......+ ... .-.+.+. .. ++.++||||..--+.
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~r--d~~-~~~~~f~-r~--y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILER--DVR-NIITYFS-RT--YRTEKDINSAIDRIL 190 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHH--HHH-HHHHHHH-HH--HCCCCCHHHHHHHHH
T ss_pred EEEECCCCCCCCCCCCHHHHHH--HHH-HHHHHHC-CC--CCCCCCHHHHHHHHH
T ss_conf 9987788430899870999987--799-9999975-78--998446899999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.94 E-value=3e-28 Score=160.08 Aligned_cols=137 Identities=21% Similarity=0.285 Sum_probs=93.7
Q ss_pred CCCCCCCCCCCEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCEEECCCCCCC
Q ss_conf 99999998522480799889999389996013591000399899988755885865788--8899999999966688485
Q 001700 49 SSDGCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNIT--DIGSIQSLEFLDLSHNLFH 126 (1025)
Q Consensus 49 ~~d~C~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~~~--~~~~l~~L~~LdLs~N~i~ 126 (1025)
|+..|.|.|..|.|++.+.+.+ | +.+. +.++.|+|++|.|+..++ .|..+++|++|+|++|.+.
T Consensus 2 CP~~C~C~~~~v~Cs~~~L~~i-----------P-~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~ 67 (192)
T d1w8aa_ 2 CPAMCHCEGTTVDCTGRGLKEI-----------P-RDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67 (192)
T ss_dssp CCTTSEEETTEEECTTSCCSSC-----------C-SCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC
T ss_pred CCCCCEECCCEEEEECCCCCCC-----------C-CCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCC
T ss_conf 3999897699999708996702-----------9-8989--787889848987755302002578762721301363221
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEEECCCCCCCC
Q ss_conf 2382013389999979734774556799643344356476444678899832676420447678284475632
Q 001700 127 GLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNNQFSG 199 (1025)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 199 (1025)
...+..|..+++|++|+|++|+|+.+.+.+|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+..
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 2121222112222101003553443497998079746552457745353597785687533420003644343
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.6e-29 Score=166.65 Aligned_cols=389 Identities=17% Similarity=0.112 Sum_probs=176.6
Q ss_pred CCCEEECCCCCCCCCC-CC-CCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf 9998875588586578-88-8999999999666884852----3820133899999797347745567----996433-4
Q 001700 91 MLCNVSVSNNQLMGNI-TD-IGSIQSLEFLDLSHNLFHG----LIPSGIVSLKNLMLLNISSNSFEGT----FPSGFG-G 159 (1025)
Q Consensus 91 ~L~~L~l~~N~~~~~~-~~-~~~l~~L~~LdLs~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 159 (1025)
.|+.||+++|++++.. .. +..+++++.|+|++|.|+. .+...+...++|+.|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCCC----HHHHHHCCCCCEEECCCCCCCCCCCCCCCC-C-CCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 435647644467889983----267642044767828447563224799988-7-5455555786546666574478999
Q 001700 160 LGKLKYLDLRANRFGGDI----MHLLSQLGSVVHVDLSNNQFSGSLDLGLGD-S-SFISSIQYLNISENSLVGELFPHDG 233 (1025)
Q Consensus 160 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-~-~~l~~L~~L~L~~N~l~~~~~~~~~ 233 (1025)
..+|+.|+|++|.++... +..+..+++|+.|+|++|.++......+.. . ...............+.....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~---- 158 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC---- 158 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH----
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHH----
T ss_conf 8877887788877543221012110000343200244433202345555443013554333222222322200110----
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHH---HHHCCCCCCEEECCCCCCCCCC------C
Q ss_conf 988998788865588355667853111334512114521523589457---7314456586876566676854------6
Q 001700 234 MPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGSNQLSGSLPVAL---LQESSMMLSELDLSLNQLEGPV------G 304 (1025)
Q Consensus 234 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~---~~~~~~~L~~L~ls~N~l~~~~------~ 304 (1025)
......+.....++.++++.+.+....-... ..........+++..+.+.... .
T Consensus 159 -----------------~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 159 -----------------EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp -----------------HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred -----------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
T ss_conf -----------------011222333322222332222124555543234332112210012411245421011012233
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC----CCHHCCCCCCC
Q ss_conf 55788745898459855698899887766551237547786321245788646677137877898----93000378888
Q 001700 305 SITSATLKKVNLSSNKLSGSLPARVGHCTIVDLSNNRLSGDLSRMQNWGNYVEDIHLSSNFLTGM----VPNQTSQFLRL 380 (1025)
Q Consensus 305 ~~~~~~L~~L~ls~N~l~~~~p~~l~~l~~L~Ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 380 (1025)
......++.+++.+|.+.... +.............++.+++++|.+... ....+.....+
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~----------------~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l 285 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVG----------------MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 285 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHH----------------HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC
T ss_pred CCCCCCCCCCCHHHCCCCCCC----------------CCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 222222100100211223344----------------2011000111111100001345433212334332211123433
Q ss_pred CEEEECCCCCCCCCCCC----C-CCCCCCCEEECCCCCCCCCCCCC----CCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 99982486367885601----3-89999987624797245558612----228999878966799474668933324899
Q 001700 381 TSFKVSNNSLEGDLPAV----L-GTYPELKVIDLSLNHLNGFLLPS----FFTSTKLTDLNLSGNNFSGPLPLQEIQNNP 451 (1025)
Q Consensus 381 ~~L~Ls~N~l~g~~p~~----l-~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 451 (1025)
..+++++|.+....... + .....|+.+++++|.++...... +....+|+.|+|++|+++..-. ..+...
T Consensus 286 ~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~-~~l~~~- 363 (460)
T d1z7xw1 286 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV-RELCQG- 363 (460)
T ss_dssp CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH-HHHHHH-
T ss_pred CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCC-CHHHHH-
T ss_conf 344444333224564211101233344433332333410233443213322110111132012101357664-001112-
Q ss_pred CCCCCCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCEEECCCCCCCCCCCCC----C---CCCCCEEECCCCCCCCC
Q ss_conf 85544445634898537848556----8732216899997628578472225988----5---79995797878826456
Q 001700 452 STGSTQNLSLTSLDLAYNSLSGR----LLPGISKFHNLVYLNLSNNKFEGSIPDG----L---PNGLKEFNVSFNNLSGV 520 (1025)
Q Consensus 452 ~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~----~---~~~L~~L~ls~N~l~g~ 520 (1025)
.. .....|+.|+|++|.++.. +...+...++|+.|+|++|+++...... + ...|+.+++++|.+...
T Consensus 364 -l~-~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 364 -LG-QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp -HT-STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred -HH-CCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHH
T ss_conf -20-4567778898979979759999999999629988989899996987999999999974788667898989878989
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9.2e-29 Score=162.75 Aligned_cols=111 Identities=18% Similarity=0.178 Sum_probs=66.3
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC----CC-CCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf 8899993899960135910003998999887558858657----88-889999999996668848523----820133-8
Q 001700 66 YVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGN----IT-DIGSIQSLEFLDLSHNLFHGL----IPSGIV-S 135 (1025)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~----~~-~~~~l~~L~~LdLs~N~i~~~----~p~~~~-~ 135 (1025)
.+..||++...+.+..-..-+..+++++.|+|++|.++.. +. .+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 99999797347745567----996433443564764446788998
Q 001700 136 LKNLMLLNISSNSFEGT----FPSGFGGLGKLKYLDLRANRFGGD 176 (1025)
Q Consensus 136 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 176 (1025)
..+|+.|+|++|+|+.. ++..+..+++|++|+|++|.++..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHH
T ss_conf 887788778887754322101211000034320024443320234
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9.3e-25 Score=141.99 Aligned_cols=86 Identities=16% Similarity=0.107 Sum_probs=38.8
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECC-CCCCCCCCHHHHHHCCCCCEE
Q ss_conf 9999996668848523820133899999797347745567-99643344356476444-678899832676420447678
Q 001700 113 QSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGT-FPSGFGGLGKLKYLDLR-ANRFGGDIMHLLSQLGSVVHV 190 (1025)
Q Consensus 113 ~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L 190 (1025)
+++++|||++|.|+.+.+..|.++++|++|++++|.+... .+..|.+++.+++|.+. .|.+....+..|.++++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred ECCCCCCC
Q ss_conf 28447563
Q 001700 191 DLSNNQFS 198 (1025)
Q Consensus 191 ~Ls~N~l~ 198 (1025)
++++|.+.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred CCCHHHHC
T ss_conf 34211112
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=2.2e-24 Score=140.05 Aligned_cols=127 Identities=21% Similarity=0.242 Sum_probs=91.9
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 88755885865788889999999996668848523-82013389999979734774556799643344356476444678
Q 001700 94 NVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGL-IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172 (1025)
Q Consensus 94 ~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 172 (1025)
.++.+++.++..++++. +++++|+|++|.|++. .+..|..+++|+.|+|++|.+..+.+..|.++++|++|+|++|+
T Consensus 12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEEECCCCCCCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 99970899670298989--7878898489877553020025787627213013632212121222112222101003553
Q ss_pred CCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 89983267642044767828447563224799988754555557865466665
Q 001700 173 FGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLV 225 (1025)
Q Consensus 173 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~ 225 (1025)
|+...+..|.++++|+.|+|++|+|++..+..+..+ ++|++|+|++|.+.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l---~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL---NSLTSLNLASNPFN 139 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTC---TTCCEEECTTCCBC
T ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCC---CCCCCCCCCCCCCC
T ss_conf 443497998079746552457745353597785687---53342000364434
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.9e-23 Score=135.21 Aligned_cols=12 Identities=33% Similarity=0.504 Sum_probs=3.7
Q ss_pred CCCCEEECCCCC
Q ss_conf 999876247972
Q 001700 402 PELKVIDLSLNH 413 (1025)
Q Consensus 402 ~~L~~L~Ls~N~ 413 (1025)
++|+.|++++|+
T Consensus 195 ~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 195 PNLIEVHLKNNQ 206 (227)
T ss_dssp TTCCEEECTTSC
T ss_pred CCCCEEECCCCC
T ss_conf 999989795996
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=3.5e-23 Score=133.80 Aligned_cols=163 Identities=21% Similarity=0.253 Sum_probs=65.7
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 98999887558858657888899999999966688485238201338999997973477455679964334435647644
Q 001700 89 LKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDL 168 (1025)
Q Consensus 89 L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 168 (1025)
|..|++|++++|.+... +.+..+++|++|+|++|.|++.. .++.+++|+.|++++|+|+.+ | .+.++++|+.|++
T Consensus 45 L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSL 119 (210)
T ss_dssp HHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEEC
T ss_pred HCCCCEEECCCCCCCCC-HHHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCC
T ss_conf 54845897827988874-44764899898769896025860--113586212014333332122-2-1212221112234
Q ss_pred CCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 46788998326764204476782844756322479998875455555786546666574478999988998788865588
Q 001700 169 RANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNN 248 (1025)
Q Consensus 169 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 248 (1025)
++|.+... ..+..+++++.++++.|.++... ....+++|+.+++++|.+.+ ++. +..+++|+.|++++|
T Consensus 120 ~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~-----~~~~l~~L~~l~l~~n~l~~--i~~--l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDIT-----VLSRLTKLDTLSLEDNQISD--IVP--LAGLTKLQNLYLSKN 188 (210)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-----GGGGCTTCSEEECCSSCCCC--CGG--GTTCTTCCEEECCSS
T ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCC--CCC--CCCCCCCCEEECCCC
T ss_conf 56532211--22011111222112223334543-----10001332100134643025--645--367898999989799
Q ss_pred CCCCCCCCCCCCCCCCCEEC
Q ss_conf 35566785311133451211
Q 001700 249 HLVGAIPSFNFVFSLRILRL 268 (1025)
Q Consensus 249 ~l~~~~~~~~~l~~L~~L~L 268 (1025)
+++.. +.+..+++|+.|+|
T Consensus 189 ~i~~l-~~l~~l~~L~~L~L 207 (210)
T d1h6ta2 189 HISDL-RALAGLKNLDVLEL 207 (210)
T ss_dssp CCCBC-GGGTTCTTCSEEEE
T ss_pred CCCCC-HHHCCCCCCCEEEC
T ss_conf 89987-21169999899971
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.9e-23 Score=133.56 Aligned_cols=158 Identities=16% Similarity=0.107 Sum_probs=102.0
Q ss_pred CCCCCCCCEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCC-
Q ss_conf 999985224807998899993899960135910003998999887558858657888-899999999966688485238-
Q 001700 52 GCPRNWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNNQLMGNITD-IGSIQSLEFLDLSHNLFHGLI- 129 (1025)
Q Consensus 52 ~C~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N~~~~~~~~-~~~l~~L~~LdLs~N~i~~~~- 129 (1025)
.|.|.+..|.|....++.+ | +.+. +.++.|++++|.|...++. |.++++|++|+|++|.+...+
T Consensus 5 ~C~C~~~~i~c~~~~l~~i-----------P-~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~ 70 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEI-----------P-SDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70 (242)
T ss_dssp SEEECSSEEEEESCSCSSC-----------C-SCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEEC
T ss_pred CCCCCCCEEEEECCCCCCC-----------C-CCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEE
T ss_conf 2887399999818998876-----------8-8889--988999876991896496686146432321102211242010
Q ss_pred CCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHH-HHHHCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 2013389999979734-7745567996433443564764446788998326-7642044767828447563224799988
Q 001700 130 PSGIVSLKNLMLLNIS-SNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMH-LLSQLGSVVHVDLSNNQFSGSLDLGLGD 207 (1025)
Q Consensus 130 p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 207 (1025)
+..|..+++++.|.+. .|.+....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+....+..+..
T Consensus 71 ~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~ 150 (242)
T d1xwdc1 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150 (242)
T ss_dssp SSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 01122222222211111234322222212222222222342111125543332221111222222212111222222222
Q ss_pred CCCCCCCCEEECCCCCCC
Q ss_conf 754555557865466665
Q 001700 208 SSFISSIQYLNISENSLV 225 (1025)
Q Consensus 208 ~~~l~~L~~L~L~~N~l~ 225 (1025)
. ...++.|++++|.+.
T Consensus 151 ~--~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 151 L--SFESVILWLNKNGIQ 166 (242)
T ss_dssp S--BSSCEEEECCSSCCC
T ss_pred C--CCCCEEEECCCCCCC
T ss_conf 2--331001220012333
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=8.8e-23 Score=131.75 Aligned_cols=160 Identities=20% Similarity=0.278 Sum_probs=79.4
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99899988755885865788889999999996668848523820133899999797347745567996433443564764
Q 001700 88 GLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLD 167 (1025)
Q Consensus 88 ~L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (1025)
.+..++.|++++|.+... +.+..+++|++|++++|+|++..| +.++++|++|++++|.+... ..+.+++.|+.|+
T Consensus 38 ~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 112 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLT 112 (199)
T ss_dssp HHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred HHCCCCEEECCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 946878998999999775-202137886757545655667640--16775223111122222222--1111122322211
Q ss_pred CCCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 44678899832676420447678284475632247999887545555578654666657447899998899878886558
Q 001700 168 LRANRFGGDIMHLLSQLGSVVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASN 247 (1025)
Q Consensus 168 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 247 (1025)
+++|.+... ..+..+++|+.|++++|++.... .+..+++|+.|++.+|.+++ ++ .+..+++|+.|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-----~l~~~~~L~~L~l~~n~l~~--l~--~l~~l~~L~~L~ls~ 181 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDIS-----ALSGLTSLQQLNFSSNQVTD--LK--PLANLTTLERLDISS 181 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-----GGTTCTTCSEEECCSSCCCC--CG--GGTTCTTCCEEECCS
T ss_pred CCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCC-----CCCCCCCCCCCCCCCCCCCC--CC--CCCCCCCCCEEECCC
T ss_conf 122222232--10001223677643111100234-----33321111112234555567--70--116799899997879
Q ss_pred CCCCCCCCCCCCCCCCC
Q ss_conf 83556678531113345
Q 001700 248 NHLVGAIPSFNFVFSLR 264 (1025)
Q Consensus 248 N~l~~~~~~~~~l~~L~ 264 (1025)
|+++.. +.+..+++|+
T Consensus 182 N~i~~i-~~l~~L~~L~ 197 (199)
T d2omxa2 182 NKVSDI-SVLAKLTNLE 197 (199)
T ss_dssp SCCCCC-GGGGGCTTCS
T ss_pred CCCCCC-CCCCCCCCCC
T ss_conf 979988-1012789989
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=1e-22 Score=131.46 Aligned_cols=81 Identities=21% Similarity=0.288 Sum_probs=33.4
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEEE
Q ss_conf 99999996668848523820133899999797347745567996433443564764446788998326764204476782
Q 001700 112 IQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVD 191 (1025)
Q Consensus 112 l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 191 (1025)
+.+|+.|++++|.|+... .+..+++|++|+|++|+|+++. .++.+++|++|++++|+++. ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 548458978279888744--4764899898769896025860--11358621201433333212-22-121222111223
Q ss_pred CCCCCCC
Q ss_conf 8447563
Q 001700 192 LSNNQFS 198 (1025)
Q Consensus 192 Ls~N~l~ 198 (1025)
+++|.+.
T Consensus 119 l~~~~~~ 125 (210)
T d1h6ta2 119 LEHNGIS 125 (210)
T ss_dssp CTTSCCC
T ss_pred CCCCCCC
T ss_conf 4565322
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=1.1e-21 Score=126.06 Aligned_cols=148 Identities=20% Similarity=0.271 Sum_probs=66.1
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEE
Q ss_conf 99999999666884852382013389999979734774556799643344356476444678899832676420447678
Q 001700 111 SIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHV 190 (1025)
Q Consensus 111 ~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 190 (1025)
.+.++++|++++|.|+.+ ..+..+++|++|++++|+|++.. .|+++++|++|++++|.+.... .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred HHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 946878998999999775--20213788675754565566764--0167752231111222222221--11112232221
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC
Q ss_conf 28447563224799988754555557865466665744789999889987888655883556678531113345121145
Q 001700 191 DLSNNQFSGSLDLGLGDSSFISSIQYLNISENSLVGELFPHDGMPYFDNLEVFDASNNHLVGAIPSFNFVFSLRILRLGS 270 (1025)
Q Consensus 191 ~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~ 270 (1025)
++++|.+....+ +..+++|+.|++++|.+.. ++ .+..+++++.|++.+|++++.. .+..+++|+.|++++
T Consensus 112 ~l~~~~~~~~~~-----~~~l~~L~~L~l~~n~l~~--~~--~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~ 181 (199)
T d2omxa2 112 TLFNNQITDIDP-----LKNLTNLNRLELSSNTISD--IS--ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISS 181 (199)
T ss_dssp ECCSSCCCCCGG-----GTTCTTCSEEECCSSCCCC--CG--GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCS
T ss_pred CCCCCCCCCCCC-----CCHHHHHHHHHHHHHHHCC--CC--CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCEEECCC
T ss_conf 112222223210-----0012236776431111002--34--3332111111223455556770-116799899997879
Q ss_pred CCCC
Q ss_conf 2152
Q 001700 271 NQLS 274 (1025)
Q Consensus 271 N~l~ 274 (1025)
|+++
T Consensus 182 N~i~ 185 (199)
T d2omxa2 182 NKVS 185 (199)
T ss_dssp SCCC
T ss_pred CCCC
T ss_conf 9799
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.3e-20 Score=120.45 Aligned_cols=112 Identities=16% Similarity=0.055 Sum_probs=46.5
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 00399899988755885865788889999999996668848523820133899999797347745567996433443564
Q 001700 85 TIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLK 164 (1025)
Q Consensus 85 ~~~~L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 164 (1025)
.+.+...+++|+|++|+|+.....+..+++|+.||||+|.|+.+ +.|..+++|+.|++++|+|+.+.+..+..+++|+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred HCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 51685748489788997886576200414599898979978764--7744576130643102134577763223345344
Q ss_pred EEECCCCCCCCCCH-HHHHHCCCCCEEECCCCCCC
Q ss_conf 76444678899832-67642044767828447563
Q 001700 165 YLDLRANRFGGDIM-HLLSQLGSVVHVDLSNNQFS 198 (1025)
Q Consensus 165 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 198 (1025)
.|+|++|+++.... ..+..+++|+.|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 34203000166542110013653206640799634
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.78 E-value=8.8e-21 Score=121.39 Aligned_cols=37 Identities=32% Similarity=0.558 Sum_probs=18.0
Q ss_pred CCCEEECCCCCCCCCC----CHHH-HCCCCCCEEECCCCCCC
Q ss_conf 6348985378485568----7322-16899997628578472
Q 001700 460 SLTSLDLAYNSLSGRL----LPGI-SKFHNLVYLNLSNNKFE 496 (1025)
Q Consensus 460 ~L~~L~Ls~N~l~~~~----p~~~-~~l~~L~~L~Ls~N~l~ 496 (1025)
.|+.|++++|.++... ...+ .+.+.|+.|+|++|.|.
T Consensus 274 ~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 274 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 889898989869808999999999703899998978798089
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.78 E-value=7.3e-19 Score=111.42 Aligned_cols=103 Identities=24% Similarity=0.370 Sum_probs=64.7
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 98875588586578888999999999666884852382013389999979734774556799643344356476444678
Q 001700 93 CNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANR 172 (1025)
Q Consensus 93 ~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 172 (1025)
+.|++++|+++.. +.++.+++|++||+++|.|+. +|..|+.+++|+.|++++|+|+.. +.|..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSSC
T ss_pred CEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCC-CHHHHHHHHCCCCCCCCCCCCCCC--CCCCCCCCCCEEECCCCC
T ss_conf 9898689989887-101058988989797871686-521565543135453243211235--741233555768888986
Q ss_pred CCCCC-HHHHHHCCCCCEEECCCCCCCC
Q ss_conf 89983-2676420447678284475632
Q 001700 173 FGGDI-MHLLSQLGSVVHVDLSNNQFSG 199 (1025)
Q Consensus 173 l~~~~-~~~~~~l~~L~~L~Ls~N~l~~ 199 (1025)
++... ...+..+++|+.|++++|.++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf 5888882565379999999897996886
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=3.7e-19 Score=112.99 Aligned_cols=113 Identities=23% Similarity=0.184 Sum_probs=81.9
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCC
Q ss_conf 88899999999966688485238201338999997973477455679964334435647644467889983267642044
Q 001700 107 TDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGS 186 (1025)
Q Consensus 107 ~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 186 (1025)
+.+.++.++++|||++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HHCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 7516857484897889978865-76200414599898979978764--77445761306431021345777632233453
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 76782844756322479998875455555786546666
Q 001700 187 VVHVDLSNNQFSGSLDLGLGDSSFISSIQYLNISENSL 224 (1025)
Q Consensus 187 L~~L~Ls~N~l~~~~~~~l~~~~~l~~L~~L~L~~N~l 224 (1025)
|+.|++++|+++.... +..+..+++|+.|++++|.+
T Consensus 89 L~~L~L~~N~i~~~~~--l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 89 LTELILTNNSLVELGD--LDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEEECCSCCCCCGGG--GGGGGGCTTCCEEECCSSGG
T ss_pred CCCCEECCCCCCCCCC--CCCCCCCCCCCHHHCCCCCC
T ss_conf 4434203000166542--11001365320664079963
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.3e-20 Score=116.96 Aligned_cols=58 Identities=19% Similarity=0.120 Sum_probs=20.0
Q ss_pred CCCCEEEECCC-CCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 88899982486-36788560138999998762479-724555861222899987896679
Q 001700 378 LRLTSFKVSNN-SLEGDLPAVLGTYPELKVIDLSL-NHLNGFLLPSFFTSTKLTDLNLSG 435 (1025)
Q Consensus 378 ~~L~~L~Ls~N-~l~g~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~ 435 (1025)
++|+.|++++| .+++.....+..+++|+.|++++ +.++......+..+++|+.|++++
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEEC
T ss_conf 221235532234778303333213576877989999978737899972699989896448
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.72 E-value=3.4e-19 Score=113.16 Aligned_cols=90 Identities=23% Similarity=0.187 Sum_probs=37.4
Q ss_pred CCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCC----------CCCCCCCCCCCEEECCCCCCC
Q ss_conf 89999999996668848523----8201338999997973477455679----------964334435647644467889
Q 001700 109 IGSIQSLEFLDLSHNLFHGL----IPSGIVSLKNLMLLNISSNSFEGTF----------PSGFGGLGKLKYLDLRANRFG 174 (1025)
Q Consensus 109 ~~~l~~L~~LdLs~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~N~l~ 174 (1025)
+.....|+.|+|++|.|... +...+...++|+.|+++++.+.... ...+...++|+.|+|++|.++
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 96389978897849837789999999999858998888887775433454210678799988754777563300001345
Q ss_pred CCCH----HHHHHCCCCCEEECCCCCCC
Q ss_conf 9832----67642044767828447563
Q 001700 175 GDIM----HLLSQLGSVVHVDLSNNQFS 198 (1025)
Q Consensus 175 ~~~~----~~~~~l~~L~~L~Ls~N~l~ 198 (1025)
.... ..+...++|+.|++++|.+.
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred CCCCCCHHHHHCCCCCCHHEECCCCCCC
T ss_conf 5433310111002343210000024666
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.5e-18 Score=108.68 Aligned_cols=58 Identities=14% Similarity=0.176 Sum_probs=19.9
Q ss_pred CCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 9999996668848523-820133899999797347745567996433443564764446
Q 001700 113 QSLEFLDLSHNLFHGL-IPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRA 170 (1025)
Q Consensus 113 ~~L~~LdLs~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (1025)
.+|++|||+++.++.. +...+.++++|++|+|+++.++...+..++.+++|++|+|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf 87887889898457779999997487765145234679867899985189975715100
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=5e-17 Score=101.91 Aligned_cols=91 Identities=20% Similarity=0.190 Sum_probs=56.1
Q ss_pred CCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCC
Q ss_conf 88899999999966688-48523820133899999797347745567996433443564764446788998326764204
Q 001700 107 TDIGSIQSLEFLDLSHN-LFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLG 185 (1025)
Q Consensus 107 ~~~~~l~~L~~LdLs~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 185 (1025)
..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++|+|+...+..|..+
T Consensus 25 ~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~- 103 (156)
T d2ifga3 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL- 103 (156)
T ss_dssp TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-
T ss_pred CCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-
T ss_conf 0025765657431689866443692122566666721620212477420111245543333226787851574563353-
Q ss_pred CCCEEECCCCCCC
Q ss_conf 4767828447563
Q 001700 186 SVVHVDLSNNQFS 198 (1025)
Q Consensus 186 ~L~~L~Ls~N~l~ 198 (1025)
+|+.|+|++|.|.
T Consensus 104 ~l~~L~L~~Np~~ 116 (156)
T d2ifga3 104 SLQELVLSGNPLH 116 (156)
T ss_dssp CCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCC
T ss_conf 2124335798633
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.8e-17 Score=102.01 Aligned_cols=113 Identities=21% Similarity=0.217 Sum_probs=86.2
Q ss_pred CCCCCC-CCCCEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCC-CCCCCCCCEEECCCCCCC
Q ss_conf 999999-852248079988999938999601359100039989998875588-58657888-899999999966688485
Q 001700 50 SDGCPR-NWFGITCTNGYVTSIMLNDMGLVGNFSFPTIIGLKMLCNVSVSNN-QLMGNITD-IGSIQSLEFLDLSHNLFH 126 (1025)
Q Consensus 50 ~d~C~~-~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~~L~~L~~L~l~~N-~~~~~~~~-~~~l~~L~~LdLs~N~i~ 126 (1025)
++.|.| .+.+|.|.....+. .+ ..+.+++.|++|++++| .+....+. |.++++|+.|+|++|+|+
T Consensus 2 P~~C~c~~~~~l~c~~~~~~~-----------~p-~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 69 (156)
T d2ifga3 2 PDACCPHGSSGLRCTRDGALD-----------SL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69 (156)
T ss_dssp CSSSCCSSSSCEECCSSCCCT-----------TT-TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC
T ss_pred CCCCCCCCCCEEEECCCCCCC-----------CC-CCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCC
T ss_conf 697886999969852899765-----------86-002576565743168986644369212256666672162021247
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 2382013389999979734774556799643344356476444678899
Q 001700 127 GLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGG 175 (1025)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 175 (1025)
.+.+..|..+++|++|+|++|+|+.+.+..|..+ .|+.|+|++|.+.-
T Consensus 70 ~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C 117 (156)
T d2ifga3 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHC 117 (156)
T ss_dssp EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-CCCCCCCCCCCCCC
T ss_conf 7420111245543333226787851574563353-21243357986338
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.68 E-value=1.8e-19 Score=114.59 Aligned_cols=85 Identities=18% Similarity=0.235 Sum_probs=42.0
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCC
Q ss_conf 89999999996668848523820133899999797347745567996433443564764446788998326764204476
Q 001700 109 IGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188 (1025)
Q Consensus 109 ~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 188 (1025)
+..+++|++|+|++|.|+.+ + .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++.. ..+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HHCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 76260461519944689986-4-4247825357341353432-1000033221233333333222222--2222222341
Q ss_pred EEECCCCCCC
Q ss_conf 7828447563
Q 001700 189 HVDLSNNQFS 198 (1025)
Q Consensus 189 ~L~Ls~N~l~ 198 (1025)
.|+|++|+++
T Consensus 119 ~L~L~~N~i~ 128 (198)
T d1m9la_ 119 VLYMSNNKIT 128 (198)
T ss_dssp EEEESEEECC
T ss_pred CCCCCCCHHC
T ss_conf 1123410212
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.68 E-value=2.9e-19 Score=113.52 Aligned_cols=110 Identities=24% Similarity=0.244 Sum_probs=43.6
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 00399899988755885865788889999999996668848523820133899999797347745567996433443564
Q 001700 85 TIIGLKMLCNVSVSNNQLMGNITDIGSIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLK 164 (1025)
Q Consensus 85 ~~~~L~~L~~L~l~~N~~~~~~~~~~~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 164 (1025)
++..|++|+.|++++|.|+.. +.+..+++|+.|+|++|.|+. +|..+..+++|+.|++++|+|+.+ ..+..+++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HHHCCCCCCEEECCCCCCCCC-CCCCCCCCCCCHHHCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 776260461519944689986-442478253573413534321-000033221233333333222222--2222222341
Q ss_pred EEECCCCCCCCCCH-HHHHHCCCCCEEECCCCCCC
Q ss_conf 76444678899832-67642044767828447563
Q 001700 165 YLDLRANRFGGDIM-HLLSQLGSVVHVDLSNNQFS 198 (1025)
Q Consensus 165 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 198 (1025)
.|+|++|+++.... ..+..+++|+.|+|++|.+.
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 11234102125542212367776302342798434
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=4.7e-16 Score=96.87 Aligned_cols=103 Identities=22% Similarity=0.254 Sum_probs=71.5
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCCEEECCCC
Q ss_conf 99966688485238201338999997973477455679964334435647644467889983267642044767828447
Q 001700 116 EFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTFPSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVVHVDLSNN 195 (1025)
Q Consensus 116 ~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 195 (1025)
+.|||++|.|+.. + .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|+.. + .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCC
T ss_conf 9898689989887-1-0105898898979787168-6521565543135453243211235-7-4123355576888898
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 563224799988754555557865466665
Q 001700 196 QFSGSLDLGLGDSSFISSIQYLNISENSLV 225 (1025)
Q Consensus 196 ~l~~~~~~~l~~~~~l~~L~~L~L~~N~l~ 225 (1025)
+++.... +..+..+++|+.|++++|.+.
T Consensus 76 ~i~~~~~--~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAA--IQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSST--TGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCC--CHHHCCCCCCCEEECCCCCCC
T ss_conf 6588888--256537999999989799688
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=1.8e-12 Score=78.28 Aligned_cols=87 Identities=17% Similarity=0.051 Sum_probs=42.8
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCHHHHHHCCCCC
Q ss_conf 9999999966688485238201338999997973477455679--96433443564764446788998326764204476
Q 001700 111 SIQSLEFLDLSHNLFHGLIPSGIVSLKNLMLLNISSNSFEGTF--PSGFGGLGKLKYLDLRANRFGGDIMHLLSQLGSVV 188 (1025)
Q Consensus 111 ~l~~L~~LdLs~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 188 (1025)
.+..+..++.+.+.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+++......+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred HCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCC
T ss_conf 4664011225556766-607889748787886377766667731588986588561000435721342344222033104
Q ss_pred EEECCCCCCC
Q ss_conf 7828447563
Q 001700 189 HVDLSNNQFS 198 (1025)
Q Consensus 189 ~L~Ls~N~l~ 198 (1025)
.|++++|.++
T Consensus 119 ~L~L~~Npl~ 128 (162)
T d1koha1 119 ELWLDGNSLS 128 (162)
T ss_dssp SCCCTTSTTS
T ss_pred EEECCCCCCC
T ss_conf 2664899767
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=3.6e-12 Score=76.76 Aligned_cols=16 Identities=31% Similarity=0.397 Sum_probs=5.7
Q ss_pred CCCCCCEEECCCCCCC
Q ss_conf 4435647644467889
Q 001700 159 GLGKLKYLDLRANRFG 174 (1025)
Q Consensus 159 ~l~~L~~L~Ls~N~l~ 174 (1025)
.+++|++|+|++|+|+
T Consensus 63 ~~~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 63 NIPELLSLNLSNNRLY 78 (162)
T ss_dssp HCTTCCCCCCCSSCCC
T ss_pred HCCCCCEEECCCCCCC
T ss_conf 4878788637776666
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.86 E-value=1.3e-08 Score=58.37 Aligned_cols=130 Identities=12% Similarity=0.113 Sum_probs=82.0
Q ss_pred ECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCC-CCCCCCCCCEEECCCCCEEEEEEECCCCCCHHHHH
Q ss_conf 03369999995699899999925440111999999999995599-98612324635357898049999614654299998
Q 001700 743 SCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVISNYINAQSLAVYL 821 (1025)
Q Consensus 743 G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv~e~~~~gsL~~~l 821 (1025)
++...||+.... +..+.+|+...........+.+|...+..+. +-.+.+++.++. .+...++||+++++.++.+..
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEE--CCCCEEEEEEECCCCCCCCCC
T ss_conf 987718999908-98699998488765325569999999998760699872899975--089649999860433435433
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------------------------------------------
Q ss_conf 212999999999999999999999999998639-----------------------------------------------
Q 001700 822 QETDPRKLPPLSIDERLRVAVDVARCLNYLHNE----------------------------------------------- 854 (1025)
Q Consensus 822 ~~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------------------------------------------- 854 (1025)
... - ....++.++++.++.||+.
T Consensus 102 ~~~-------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 102 EDE-------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TTC-------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred CCC-------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
T ss_conf 440-------2---699999989999999855684214357644656555778998776555543033232005799999
Q ss_pred -----------CCCCCCCCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf -----------99712588999977606999789962235210
Q 001700 855 -----------RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 855 -----------~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~ 886 (1025)
..++|+|+.|.|||++. +....++||+.+..
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEEEECCCCCEEECC-CCEEEEEECHHCCC
T ss_conf 9998449867817898600476423649-96599960231441
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.52 E-value=4.2e-08 Score=55.65 Aligned_cols=14 Identities=7% Similarity=0.271 Sum_probs=5.0
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 99999797347745
Q 001700 136 LKNLMLLNISSNSF 149 (1025)
Q Consensus 136 l~~L~~L~Ls~N~l 149 (1025)
.+.|+.|+|++|.+
T Consensus 43 n~~L~~L~Ls~n~l 56 (167)
T d1pgva_ 43 SKHIEKFSLANTAI 56 (167)
T ss_dssp CSCCCEEECTTSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 77645401201562
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.50 E-value=7.5e-07 Score=49.16 Aligned_cols=142 Identities=17% Similarity=0.206 Sum_probs=77.6
Q ss_pred EEEEECC-EEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCC--CCCCCCCCCEEECCCCCEEEEEEECCCCC
Q ss_conf 3531033-69999995699899999925440111999999999995599--98612324635357898049999614654
Q 001700 739 VIGRSCH-GTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK--HPNLVSLQGYYWGPKEHEKLVISNYINAQ 815 (1025)
Q Consensus 739 ~iG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~g~~~~~~~~~~~lv~e~~~~g 815 (1025)
.+..|.. ..||+....++..+.+|....... ..+.+|...++.+. .-.+.++++++. .....++|++++++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECC--CCCCEEEEEEEEECC
T ss_conf 76786547758999938987899995896677---6899999999999865999886132224--566159998744135
Q ss_pred CHHH--------------H---HHHCCCCCCC-CCCHHHHHHHHH--------------------HHHHHHHHHHCC---
Q ss_conf 2999--------------9---8212999999-999999999999--------------------999999998639---
Q 001700 816 SLAV--------------Y---LQETDPRKLP-PLSIDERLRVAV--------------------DVARCLNYLHNE--- 854 (1025)
Q Consensus 816 sL~~--------------~---l~~~~~~~~~-~l~~~~~~~i~~--------------------~ia~aL~~LH~~--- 854 (1025)
++.+ . +|.......+ ...+.....-.. .....+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 54322126899999999999987368854488755412468899999987541101134011213799999999871876
Q ss_pred ---CCCCCCCCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf ---99712588999977606999789962235210
Q 001700 855 ---RAIPHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 855 ---~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~~ 886 (1025)
..++|+|+.|.|||++. +..+.|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~-~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred CCCCEEEECCCCCCCEEEEC-CCEEEEEECHHCCC
T ss_conf 57956786788876357737-96589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.34 E-value=2.5e-06 Score=46.47 Aligned_cols=76 Identities=9% Similarity=-0.024 Sum_probs=47.4
Q ss_pred CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-------HHCHHHHHHHHHHHHCC-CC--CCCCCCCCEEECCCCCEE
Q ss_conf 763531033699999956-99899999925440-------11199999999999559-99--861232463535789804
Q 001700 737 AEVIGRSCHGTLYKATLD-SGSILAVKRLREGI-------AKGKKEFAREVKKLGNI-KH--PNLVSLQGYYWGPKEHEK 805 (1025)
Q Consensus 737 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~H--pniv~l~g~~~~~~~~~~ 805 (1025)
.+.||.|....||++... +++.+++|.-.... .....+..+|.+.+..+ .+ ..+++++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC----CCCC
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985----9887
Q ss_pred EEEEECCCCCC
Q ss_conf 99996146542
Q 001700 806 LVISNYINAQS 816 (1025)
Q Consensus 806 ~lv~e~~~~gs 816 (1025)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEECCCCCC
T ss_conf 79871357765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.29 E-value=1.2e-07 Score=53.22 Aligned_cols=14 Identities=14% Similarity=0.280 Sum_probs=5.1
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 99999996668848
Q 001700 112 IQSLEFLDLSHNLF 125 (1025)
Q Consensus 112 l~~L~~LdLs~N~i 125 (1025)
.++|+.|+|++|.+
T Consensus 43 n~~L~~L~Ls~n~l 56 (167)
T d1pgva_ 43 SKHIEKFSLANTAI 56 (167)
T ss_dssp CSCCCEEECTTSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 77645401201562
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.25 E-value=1.1e-05 Score=43.13 Aligned_cols=137 Identities=12% Similarity=0.112 Sum_probs=74.6
Q ss_pred EEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCCC---C--CCCCCCCEEECCCCCEEEEEEECCCCCCH---
Q ss_conf 699999956998999999254401119999999999955999---8--61232463535789804999961465429---
Q 001700 746 GTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIKH---P--NLVSLQGYYWGPKEHEKLVISNYINAQSL--- 817 (1025)
Q Consensus 746 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---p--niv~l~g~~~~~~~~~~~lv~e~~~~gsL--- 817 (1025)
-.||+++.++|..+++|..+.+ ....+++..|...+..+.. | ..+..-|-.........+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 0269998389997999984787-788999999999999998559987875206898056653479999865277688999
Q ss_pred ---------------HHHHHHCCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHHH-CC--CCC
Q ss_conf ---------------999821299999999999----------------------99999999999999986-39--997
Q 001700 818 ---------------AVYLQETDPRKLPPLSID----------------------ERLRVAVDVARCLNYLH-NE--RAI 857 (1025)
Q Consensus 818 ---------------~~~l~~~~~~~~~~l~~~----------------------~~~~i~~~ia~aL~~LH-~~--~~i 857 (1025)
+...........+.+++. .....+..+...+.-.- +. .++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred CCCCCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 12588999977606999789962235210
Q 001700 858 PHGNLKSTNILLEAPTMNAVLTDYSLHRI 886 (1025)
Q Consensus 858 vHrdlkp~NILl~~~~~~~kl~Dfgla~~ 886 (1025)
+|+|+.+.|||+++ + ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~-~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRD-G--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESS-S--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEEC-C--CEEEECHHCCC
T ss_conf 24788804287838-9--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.91 E-value=3.8e-05 Score=40.31 Aligned_cols=72 Identities=13% Similarity=0.120 Sum_probs=44.0
Q ss_pred CEEEEECCEEEEEEEECC--------CCEEEEEECCCCCHHCHHHHHHHHHHHHCCC-CCCCCCCCCEEECCCCCEEEEE
Q ss_conf 635310336999999569--------9899999925440111999999999995599-9861232463535789804999
Q 001700 738 EVIGRSCHGTLYKATLDS--------GSILAVKRLREGIAKGKKEFAREVKKLGNIK-HPNLVSLQGYYWGPKEHEKLVI 808 (1025)
Q Consensus 738 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv 808 (1025)
+.|+.|-.-.+|++...+ ...|.+++.... ...-...+|..+++.+. +.-.+++++++. + ..|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---~---g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS---G---GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---T---EEE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEECC---C---CEE
T ss_conf 99178533434899968877544578981799965996--116589999999999975799980899818---9---569
Q ss_pred EECCCCCCH
Q ss_conf 961465429
Q 001700 809 SNYINAQSL 817 (1025)
Q Consensus 809 ~e~~~~gsL 817 (1025)
++|+++..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEECCCCC
T ss_conf 997345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.71 E-value=3.4e-06 Score=45.78 Aligned_cols=111 Identities=12% Similarity=0.109 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCH--
Q ss_conf 9999999996668-848523----820133899999797347745567----99643344356476444678899832--
Q 001700 110 GSIQSLEFLDLSH-NLFHGL----IPSGIVSLKNLMLLNISSNSFEGT----FPSGFGGLGKLKYLDLRANRFGGDIM-- 178 (1025)
Q Consensus 110 ~~l~~L~~LdLs~-N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~-- 178 (1025)
.+.++|++|+|++ +.|+.. +-..+...++|+.|+|++|.++.. +...+...+.|+.|+++.|.++....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHHHCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf --67642044767--8284475632----247999887545555578654666
Q 001700 179 --HLLSQLGSVVH--VDLSNNQFSG----SLDLGLGDSSFISSIQYLNISENS 223 (1025)
Q Consensus 179 --~~~~~l~~L~~--L~Ls~N~l~~----~~~~~l~~~~~l~~L~~L~L~~N~ 223 (1025)
..+...++|+. |++++|.+.. .+...+... ++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n---~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKN---TTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHC---SSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHC---CCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849---984788581898
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.90 E-value=0.00078 Score=33.51 Aligned_cols=144 Identities=10% Similarity=0.084 Sum_probs=68.1
Q ss_pred CEEEEECCEEEEEEEECCCCEEEEEECCCCCHHCHHHHHHHHHHHHCCC-----CCCCCCC-CCEEECCCCCEEEEEEEC
Q ss_conf 6353103369999995699899999925440111999999999995599-----9861232-463535789804999961
Q 001700 738 EVIGRSCHGTLYKATLDSGSILAVKRLREGIAKGKKEFAREVKKLGNIK-----HPNLVSL-QGYYWGPKEHEKLVISNY 811 (1025)
Q Consensus 738 ~~iG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----Hpniv~l-~g~~~~~~~~~~~lv~e~ 811 (1025)
+.|..|.--+.|+.+..+|+ +++|+..... ..++...|++.+..+. -|..+.. -|............++.+
T Consensus 24 ~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~ 100 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 100 (316)
T ss_dssp EEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred ECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEE
T ss_conf 23788852673899978972-8999807899--98899999999875430255545564104897621341255024531
Q ss_pred CCCCC--------------HHHHHHHCCCCC----CCCCCH------------------HHHHHHHHHHHHHHHHHHCC-
Q ss_conf 46542--------------999982129999----999999------------------99999999999999998639-
Q 001700 812 INAQS--------------LAVYLQETDPRK----LPPLSI------------------DERLRVAVDVARCLNYLHNE- 854 (1025)
Q Consensus 812 ~~~gs--------------L~~~l~~~~~~~----~~~l~~------------------~~~~~i~~~ia~aL~~LH~~- 854 (1025)
..+.. ....++...... ...... ......+......++-.+..
T Consensus 101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (316)
T d2ppqa1 101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 180 (316)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCC
T ss_conf 14655333204678888899876454443202453101110120024567777653114127999999987642048554
Q ss_pred --CCCCCCCCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf --9971258899997760699978996223521
Q 001700 855 --RAIPHGNLKSTNILLEAPTMNAVLTDYSLHR 885 (1025)
Q Consensus 855 --~~ivHrdlkp~NILl~~~~~~~kl~Dfgla~ 885 (1025)
.+++|+|+.+.||+++. +...-+.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CCCCCCCCCCCHHHHHCCC-CCCEEEECCCCCC
T ss_conf 5450333786365640204-5412674222123
|